data_2bds_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bds _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.95 39.01 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 109.08 -1.161 . . . . 0.0 109.08 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.41 121.23 22.75 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.838 -175.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 8.4 m-85 -78.23 163.5 25.72 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 117.956 -1.498 . . . . 0.0 109.776 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.93 175.27 8.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.092 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -81.81 116.51 21.53 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.859 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -15.18 63.89 Favored Glycine 0 C--N 1.296 -1.643 0 C-N-CA 119.452 -1.356 . . . . 0.0 109.934 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -130.1 111.67 17.0 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.208 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -74.46 -175.31 2.18 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 N-CA-C 109.079 -1.162 . . . . 0.0 109.079 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.19 -104.67 3.21 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 6.2 ptm180 -160.21 165.4 31.59 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.173 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.13 149.94 20.72 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 173.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.601 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -77.22 124.51 27.94 Favored 'General case' 0 C--O 1.166 -3.314 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.29 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 tp -84.69 111.07 19.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.037 -1.865 . . . . 0.0 112.543 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.438 ' N ' ' O ' ' A' ' 38' ' ' ILE . 65.6 m95 -100.64 171.72 7.53 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.675 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -104.32 -161.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.722 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.539 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.99 70.89 0.15 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.298 1.523 . . . . 0.0 108.087 -177.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.581 ' C ' ' H ' ' A' ' 21' ' ' THR . 47.7 mtp180 -115.96 -13.02 11.29 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 112.11 -2.314 . . . . 0.0 110.9 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 48.3 4.67 0.02 OUTLIER Glycine 0 C--N 1.263 -3.511 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.38 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.581 ' H ' ' C ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -151.92 154.88 36.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.17 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -116.13 151.19 46.37 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.028 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.69 106.12 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 120.721 0.947 . . . . 0.0 110.908 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.31 89.96 1.01 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.42 -11.06 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.212 -1.47 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.61 -18.76 40.08 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.25 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.59 -16.88 2.24 Favored Glycine 0 N--CA 1.482 1.736 0 C-N-CA 119.51 -1.328 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 29.2 m-85 -77.3 167.73 21.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.992 1.377 . . . . 0.0 112.624 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.3 p -162.59 -46.05 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.749 -2.478 . . . . 0.0 105.65 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' TYR . 70.0 p -98.73 124.41 43.57 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.548 -2.114 . . . . 0.0 110.19 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -148.41 156.09 42.05 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.337 178.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.39 147.22 39.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.88 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.477 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 7.3 m-85 -127.92 131.26 49.38 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.485 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 77.66 1.62 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.449 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.81 158.94 0.27 Allowed Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.151 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.1 Cg_endo -78.89 35.25 0.8 Allowed 'Cis proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.351 -1.104 . . . . 0.0 112.54 -5.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.469 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 4.0 m-80 -147.73 -166.47 2.53 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.228 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.477 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -156.63 147.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.511 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.8 m -117.35 136.31 53.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 166.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -107.09 140.04 40.55 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -170.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.3 m-85 -107.83 176.71 1.51 Allowed Pre-proline 0 N--CA 1.509 2.507 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 7.8 Cg_exo -58.99 -53.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.164 0 N-CA-C 117.196 1.96 . . . . 0.0 117.196 5.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.622 0 CA-C-O 116.468 -1.729 . . . . 0.0 109.179 -170.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -77.96 35.28 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.6 124.0 29.15 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -176.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 164.57 25.15 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.724 -1.591 . . . . 0.0 110.276 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.2 m -109.17 -178.7 3.64 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.306 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.403 ' H ' ' HG ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -81.14 111.45 17.59 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.991 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.18 -12.31 48.47 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.471 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.51 115.1 14.68 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.127 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -161.58 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.89 -93.52 1.6 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.154 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.567 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.98 160.06 30.24 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.744 -178.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -145.63 141.96 10.24 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 42.3 m-20 -75.33 125.5 29.1 Favored 'General case' 0 C--O 1.175 -2.846 0 C-N-CA 118.217 -1.393 . . . . 0.0 108.135 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -84.15 132.79 34.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 116.931 -1.908 . . . . 0.0 111.448 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.88 175.65 7.15 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.481 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -99.33 -162.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.441 -176.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.51 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.22 67.36 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.343 1.544 . . . . 0.0 108.343 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.8 mtp85 -103.81 128.88 51.22 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.1 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.3 -49.44 60.09 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.204 -1.474 . . . . 0.0 109.468 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.33 161.37 38.06 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.954 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.36 150.33 76.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.217 179.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.95 129.18 31.99 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 120.937 1.091 . . . . 0.0 110.667 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 26' ' ' TYR . . . -74.18 -48.16 15.87 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.833 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.32 -9.03 0.57 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.397 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.5 m-85 -79.52 -75.97 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.197 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.2 -13.24 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.002 -1.571 . . . . 0.0 112.08 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.632 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 53.4 m-85 -66.25 172.31 4.01 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 122.618 1.199 . . . . 0.0 112.688 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -161.93 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.312 -2.222 . . . . 0.0 106.354 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -97.56 118.87 35.02 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.429 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.472 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.94 158.47 44.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.044 -1.463 . . . . 0.0 112.884 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.418 ' O ' HG13 ' A' ' 38' ' ' ILE . 26.2 p -113.06 147.64 36.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.49 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 40.4 m-85 -122.19 117.51 26.38 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.5 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 31.8 mttp -130.87 75.24 1.64 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.877 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.42 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -41.45 156.02 0.22 Allowed Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.437 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 6.6 Cg_endo -78.56 28.71 1.88 Allowed 'Cis proline' 0 C--O 1.206 -1.117 0 C-N-CA 124.167 -1.18 . . . . 0.0 112.123 -3.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.2 m-80 -144.98 -160.15 1.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.232 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -160.93 154.32 3.9 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.046 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.843 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 80.4 m -124.56 116.61 22.73 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 117.903 -1.519 . . . . 0.0 107.104 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.632 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.15 148.64 25.59 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.531 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -120.19 167.81 11.8 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -73.95 159.26 97.87 Favored 'Cis proline' 0 C--O 1.214 -0.71 0 CA-C-O 122.788 1.078 . . . . 0.0 113.838 3.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.567 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.191 -2.277 . . . . 0.0 109.928 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -91.22 40.63 0.35 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 109.929 -0.835 . . . . 0.0 109.929 168.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -77.09 126.97 31.84 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.128 -176.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.37 167.2 21.7 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.832 -179.002 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -175.68 2.78 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.9 177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.0 123.22 26.02 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.236 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.0 -11.69 47.03 Favored Glycine 0 C--N 1.299 -1.476 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.735 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -116.47 109.5 43.85 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.433 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.41 -167.7 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 107.684 -1.698 . . . . 0.0 107.684 172.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.71 -111.67 3.75 Favored Glycine 0 C--N 1.283 -2.381 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.378 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -156.11 154.98 31.77 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 118.245 -1.382 . . . . 0.0 114.189 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.07 153.64 23.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -78.97 125.74 29.78 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.971 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.98 108.15 18.08 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.966 -1.494 . . . . 0.0 111.893 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' ILE . 60.3 m95 -95.16 176.79 6.09 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.616 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -100.14 -162.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.221 -176.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.427 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.87 70.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.288 1.518 . . . . 0.0 108.27 -176.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' ILE . 40.6 mtp180 -112.47 115.64 29.0 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.05 -23.87 18.21 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 110.795 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.73 158.07 42.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.384 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' N ' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -86.34 151.41 53.64 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.837 178.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.6 Cg_exo -50.11 120.94 6.77 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.174 1.249 . . . . 0.0 111.428 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.04 -4.74 4.83 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.512 -1.327 . . . . 0.0 110.29 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -119.72 1.05 13.77 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 130.684 7.034 . . . . 0.0 130.684 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -79.54 -36.43 38.38 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.274 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.84 -17.15 2.19 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.353 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.1 m-85 -60.78 168.95 2.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.303 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -162.02 -43.0 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 112.283 -2.235 . . . . 0.0 106.418 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.4 p -97.31 121.56 39.34 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.357 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.83 154.8 34.62 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.81 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -110.17 137.84 47.36 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.643 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 38' ' ' ILE . 38.9 m-85 -113.71 129.93 56.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.553 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -147.77 81.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.149 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.413 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.47 159.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.349 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 4.6 Cg_endo -78.51 28.23 2.01 Favored 'Cis proline' 0 C--O 1.21 -0.879 0 C-N-CA 124.273 -1.136 . . . . 0.0 111.813 -5.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.2 m-80 -147.06 -172.35 3.98 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.709 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -154.98 147.92 12.93 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.833 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -116.64 142.53 46.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.714 165.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.5 t -112.63 148.53 34.41 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.693 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.7 OUTLIER -119.86 170.44 6.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.15 158.08 83.44 Favored 'Cis proline' 0 CA--C 1.503 -1.039 0 CA-C-O 122.857 1.107 . . . . 0.0 113.661 4.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.693 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.966 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.468 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -74.75 57.76 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.06 -1.939 . . . . 0.0 107.06 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.59 138.97 45.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.46 -179.13 6.17 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.869 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -162.66 1.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.111 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.566 ' C ' ' H ' ' A' ' 9' ' ' LYS . 8.7 m -59.9 110.94 1.29 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.473 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.8 3.67 0.12 Allowed Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.224 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 7' ' ' SER . 61.5 mttt -94.14 116.81 66.88 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.474 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 9.8 Cg_endo -73.69 -166.19 0.3 Allowed 'Trans proline' 0 C--O 1.206 -1.093 0 N-CA-C 109.264 -1.091 . . . . 0.0 109.264 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 -120.33 5.29 Favored Glycine 0 C--N 1.29 -2.001 0 C-N-CA 118.674 -1.726 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.573 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -161.1 162.19 31.47 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 118.185 -1.406 . . . . 0.0 113.42 -178.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.13 148.31 19.93 Favored Glycine 0 C--O 1.199 -2.092 0 N-CA-C 106.917 -2.473 . . . . 0.0 106.917 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.532 ' CG ' HH22 ' A' ' 12' ' ' ARG . 10.1 m-20 -76.62 128.41 34.65 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.632 -1.227 . . . . 0.0 109.142 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.57 98.43 11.65 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 116.962 -1.895 . . . . 0.0 112.087 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' ILE . 62.0 m95 -77.34 163.86 26.05 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 111.779 -2.464 . . . . 0.0 109.442 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -85.55 -158.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 118.846 -1.141 . . . . 0.0 111.268 -177.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.67 72.54 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.916 1.341 . . . . 0.0 109.053 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' ILE . 4.1 mtp180 -121.55 110.17 15.69 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.086 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.88 -20.31 40.36 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.657 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.14 153.64 50.44 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.838 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.82 151.26 43.4 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -47.81 112.6 0.59 Allowed 'Trans proline' 0 C--O 1.214 -0.724 0 C-N-CA 120.971 1.114 . . . . 0.0 111.444 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.46 -25.93 55.89 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -22.42 71.91 Favored Glycine 0 N--CA 1.485 1.951 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.456 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.51 175.74 10.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.141 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.27 70.68 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 41.6 m-85 -59.94 167.92 2.04 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.051 -1.459 . . . . 0.0 110.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 2.0 p -163.13 -43.0 0.03 OUTLIER 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.7 -2.045 . . . . 0.0 106.225 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 8.5 p -97.36 118.46 33.88 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.794 -2.003 . . . . 0.0 109.156 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.556 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.08 152.01 36.63 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.876 -1.53 . . . . 0.0 113.52 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -101.66 156.05 17.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.981 174.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.453 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 22.4 m-85 -134.98 125.76 27.24 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.545 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 35' ' ' TRP . 6.4 mttt -137.72 71.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.958 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.456 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 17.0 t-105 -38.82 146.19 0.33 Allowed Pre-proline 0 N--CA 1.508 2.46 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.864 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.507 ' C ' HD22 ' A' ' 37' ' ' ASN . 7.3 Cg_endo -78.06 38.44 0.46 Allowed 'Cis proline' 0 N--CA 1.495 1.603 0 CA-C-N 118.52 0.507 . . . . 0.0 111.69 -5.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.532 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -148.09 -168.03 2.97 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.509 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.03 144.9 3.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.298 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.65 140.37 50.02 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 117.488 -1.685 . . . . 0.0 107.586 169.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -114.62 135.8 53.75 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -169.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -107.96 -179.51 0.71 Allowed Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.555 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 3.0 Cg_exo -64.3 -49.21 0.18 OUTLIER 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 122.036 1.763 . . . . 0.0 116.587 5.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.588 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.781 0 CA-C-O 116.28 -1.819 . . . . 0.0 109.565 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.505 2.317 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.26 35.46 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 167.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -75.38 142.87 43.03 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -87.36 166.01 15.17 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 117.79 -1.564 . . . . 0.0 109.335 177.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.469 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -108.84 -173.3 2.24 Favored 'General case' 0 N--CA 1.51 2.538 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.727 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -71.07 117.23 12.31 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.921 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.0 -1.59 3.39 Favored Glycine 0 C--N 1.297 -1.589 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.141 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 7' ' ' SER . 5.6 mttt -108.82 118.05 52.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.367 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -74.87 -168.91 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.14 -113.47 4.13 Favored Glycine 0 C--N 1.291 -1.918 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.178 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.619 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 6.5 ptm180 -157.66 163.09 38.58 Favored 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 118.184 -1.407 . . . . 0.0 114.086 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -148.81 151.21 23.41 Favored Glycine 0 N--CA 1.494 2.503 1 N-CA-C 126.364 5.305 . . . . 0.0 126.364 173.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.9 m-20 -77.38 118.57 19.97 Favored 'General case' 0 C--O 1.171 -3.055 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.924 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 48.9 tp -85.7 102.55 13.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.002 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.488 ' N ' ' O ' ' A' ' 38' ' ' ILE . 58.7 m95 -91.79 165.07 13.46 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 112.3 -2.227 . . . . 0.0 109.968 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -90.61 -159.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.632 -177.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 73.87 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.718 1.247 . . . . 0.0 108.793 -174.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -115.26 123.13 48.03 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.317 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.7 -35.27 73.3 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 160.54 42.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.751 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.09 163.54 59.42 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.669 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.51 -164.98 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 121.676 1.584 . . . . 0.0 112.035 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.62 33.56 2.47 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.17 -2.52 1.58 Allowed Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.789 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.45 -70.71 0.62 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.223 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.33 17.19 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.509 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 43.4 m-85 -76.41 171.13 15.09 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.577 1.179 . . . . 0.0 112.068 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -161.42 -43.95 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.142 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.24 134.2 40.85 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.123 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -160.04 159.61 32.21 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.887 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.0 p -120.9 133.7 55.29 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.567 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 76.1 m-85 -109.1 114.02 27.39 Favored 'General case' 0 C--N 1.259 -3.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.757 -174.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -129.23 71.86 1.45 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.595 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.467 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.46 155.35 0.19 Allowed Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.259 -178.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.6 Cg_endo -78.45 33.12 0.97 Allowed 'Cis proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.409 -1.08 . . . . 0.0 111.417 -3.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.467 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 3.5 m-80 -147.85 -160.48 1.17 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.805 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -167.87 144.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.383 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 8.1 m -113.57 109.29 18.39 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.577 168.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -80.73 139.85 35.88 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.527 -172.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.9 m-85 -110.97 -177.84 0.49 Allowed Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.445 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 19.1 Cg_exo -56.72 -55.43 0.11 OUTLIER 'Cis proline' 0 N--CA 1.505 2.169 0 CA-C-N 122.31 1.861 . . . . 0.0 116.698 5.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.619 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.388 0 CA-C-O 116.379 -1.772 . . . . 0.0 109.228 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.38 57.05 4.67 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 N-CA-C 108.737 -1.293 . . . . 0.0 108.737 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.01 145.95 39.86 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.473 -176.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.71 -175.77 5.45 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.135 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.95 179.82 5.85 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.64 0.733 . . . . 0.0 109.685 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.15 114.43 21.77 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.23 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.65 -10.53 72.53 Favored Glycine 0 C--N 1.295 -1.714 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.955 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -117.24 106.85 46.35 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.872 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.8 146.44 66.14 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.676 -1.317 . . . . 0.0 108.676 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.71 -104.58 0.84 Allowed Glycine 0 C--N 1.285 -2.277 1 N-CA-C 129.814 6.686 . . . . 0.0 129.814 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -161.14 151.35 17.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.761 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.14 166.74 25.65 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.498 ' CG ' ' HH ' ' A' ' 28' ' ' TYR . 10.7 m-20 -79.68 114.58 18.71 Favored 'General case' 0 C--O 1.172 -2.982 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.158 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 tp -84.13 96.24 8.87 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.091 -1.843 . . . . 0.0 113.205 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' ILE . 70.5 m95 -69.94 145.81 51.63 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 111.818 -2.446 . . . . 0.0 104.837 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -110.25 -8.41 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -168.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 2.2 mt -153.1 59.63 0.78 Allowed 'General case' 0 C--N 1.248 -3.805 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.872 -173.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -154.89 156.32 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.581 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -109.01 -7.88 28.38 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 174.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 157.0 47.26 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.483 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -107.41 149.4 38.74 Favored Pre-proline 0 N--CA 1.494 1.748 0 C-N-CA 119.62 -0.832 . . . . 0.0 108.867 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -66.35 142.06 64.63 Favored 'Trans proline' 0 C--O 1.217 -0.568 0 C-N-CA 120.6 0.866 . . . . 0.0 111.177 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.62 63.5 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.77 -19.28 27.43 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.684 -1.245 . . . . 0.0 110.458 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.49 -34.59 41.19 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.958 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.95 -3.03 19.41 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.303 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.666 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.5 m-85 -60.5 169.17 1.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.691 1.234 . . . . 0.0 112.561 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -162.32 -43.76 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.263 -2.244 . . . . 0.0 106.027 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.84 114.15 26.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.62 178.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.684 HD21 ' H ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -146.35 154.14 41.32 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.884 -177.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -97.33 149.39 22.14 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.852 175.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.557 ' HH ' HD22 ' A' ' 31' ' ' ASN . 71.1 m-85 -132.01 119.99 21.81 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.009 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -132.41 72.07 1.49 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -45.57 153.57 0.59 Allowed Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.084 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -70.52 -5.5 10.08 Favored 'Cis proline' 0 N--CA 1.485 1.012 0 C-N-CA 124.299 -1.125 . . . . 0.0 112.038 -5.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -94.87 178.75 5.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.775 0.797 . . . . 0.0 110.851 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -158.93 140.43 4.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.034 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.486 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -120.19 116.44 25.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.307 172.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.666 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -95.42 144.47 25.91 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.866 -1.97 . . . . 0.0 114.955 -167.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -116.85 167.92 9.81 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.63 160.12 88.01 Favored 'Cis proline' 0 C--O 1.217 -0.556 0 CA-C-O 123.262 1.276 . . . . 0.0 114.822 3.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.603 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.251 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.531 ' HB1' ' H ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.38 36.09 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 109.187 -1.12 . . . . 0.0 109.187 166.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -82.07 122.71 28.18 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.388 -176.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.48 164.14 24.17 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.833 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.36 -178.39 4.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.072 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t -76.8 127.02 31.96 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.31 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.58 -18.08 31.49 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.562 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.08 105.95 20.04 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.21 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.04 -166.34 0.31 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.26 -98.52 2.38 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.729 -1.7 . . . . 0.0 110.862 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 3.1 ptm180 -162.32 160.82 27.14 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.784 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -139.17 150.96 21.56 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 175.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.68 111.59 14.93 Favored 'General case' 0 C--O 1.171 -3.069 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.445 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 6.3 tt -85.2 93.6 8.7 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.623 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' ILE . 61.5 m95 -70.13 122.75 20.04 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 112.293 -2.231 . . . . 0.0 107.287 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.26 -8.08 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 C-N-CA 118.983 -1.087 . . . . 0.0 113.499 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 mt -151.89 74.51 1.11 Allowed 'General case' 0 C--N 1.254 -3.553 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.464 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.534 ' NH1' ' CG ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -162.95 142.85 9.11 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.222 -1.791 . . . . 0.0 113.085 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.17 -22.04 23.57 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.533 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 1.4 p -143.48 152.32 41.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.514 -0.843 . . . . 0.0 109.24 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -88.53 148.11 41.3 Favored Pre-proline 0 C--N 1.286 -2.178 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.366 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.08 178.44 0.4 Allowed 'Trans proline' 0 C--O 1.219 -0.442 0 C-N-CA 120.379 0.719 . . . . 0.0 111.211 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.15 8.36 25.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.22 -16.36 15.12 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -84.67 -6.89 59.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.04 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.73 11.49 85.18 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.758 -1.21 . . . . 0.0 112.326 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 40.5 m-85 -67.19 170.57 6.86 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.885 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.91 -44.07 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 112.763 -2.017 . . . . 0.0 106.691 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 41' ' ' TYR . 3.2 p -96.86 125.88 41.62 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -160.07 147.5 16.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 117.19 -1.804 . . . . 0.0 113.132 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 146.42 32.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.002 -1.453 . . . . 0.0 108.049 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 51.0 m-85 -118.01 140.72 49.34 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.688 -170.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 35' ' ' TRP . 7.9 mttt -142.27 59.27 1.46 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.965 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -40.41 147.36 0.38 Allowed Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.31 -176.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.79 2.1 6.24 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.635 -4.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -101.23 -160.59 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.725 0.774 . . . . 0.0 111.359 -177.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 171.34 141.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.471 -178.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 79.4 m -110.13 110.86 21.89 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 117.741 -1.584 . . . . 0.0 107.176 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.0 t -88.98 151.16 22.46 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.924 -171.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' SER . 3.0 m-85 -125.33 163.14 40.11 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -79.16 162.61 86.47 Favored 'Cis proline' 0 C--N 1.326 -0.64 0 CA-C-O 123.324 1.302 . . . . 0.0 115.374 5.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.393 0 CA-C-N 111.11 -2.768 . . . . 0.0 109.447 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.505 2.295 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -83.34 38.55 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 167.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.87 127.09 33.59 Favored 'General case' 0 N--CA 1.513 2.685 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.082 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.61 159.92 27.83 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 117.924 -1.51 . . . . 0.0 110.299 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.2 m -108.19 -172.89 2.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.38 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -57.68 140.02 52.3 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.327 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 29.01 11.1 0.0 OUTLIER Glycine 0 N--CA 1.481 1.633 1 N-CA-C 125.134 4.814 . . . . 0.0 125.134 -174.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.0 mttt -111.25 102.06 52.01 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 114.385 -0.908 . . . . 0.0 110.041 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.04 -164.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 120.946 1.097 . . . . 0.0 109.303 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.89 -103.17 1.97 Allowed Glycine 0 C--N 1.29 -1.994 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.543 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -161.19 166.12 28.32 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 118.063 -1.455 . . . . 0.0 114.054 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.01 154.21 25.24 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.52 126.62 31.11 Favored 'General case' 0 C--O 1.178 -2.665 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.243 178.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.0 tp -87.89 108.41 19.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.334 -1.346 . . . . 0.0 112.443 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ILE . 70.1 m95 -99.65 161.74 13.43 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.313 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -87.35 -158.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.136 -175.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.96 66.02 0.1 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.464 1.602 . . . . 0.0 107.793 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.32 105.81 15.94 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 112.272 -2.24 . . . . 0.0 110.631 -179.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -44.58 -35.17 3.98 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.03 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -141.42 163.2 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.153 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 157.34 56.21 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.937 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.8 119.42 5.62 Favored 'Trans proline' 0 C--O 1.208 -0.991 0 C-N-CA 120.812 1.008 . . . . 0.0 110.541 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.17 176.83 25.82 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.094 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.76 8.1 38.9 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.97 -168.54 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.18 0.04 74.75 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.428 -1.368 . . . . 0.0 111.443 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 26.1 m-85 -76.55 170.35 16.57 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.371 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -162.11 -44.74 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 112.338 -2.21 . . . . 0.0 106.376 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.6 p -99.0 128.09 45.06 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.867 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.5 142.73 25.09 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 117.939 -1.504 . . . . 0.0 112.385 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 22.2 p -99.62 137.12 38.55 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.778 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 51.1 m-85 -114.93 121.08 42.08 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.2 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -140.41 77.23 1.59 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.711 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -39.4 158.58 0.12 Allowed Pre-proline 0 C--N 1.307 -1.27 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.515 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 1.6 Cg_endo -78.58 30.07 1.53 Allowed 'Cis proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.402 -1.083 . . . . 0.0 111.501 -6.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 3.1 m-80 -145.89 -171.28 3.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -153.23 141.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 17.4 m -112.68 117.27 31.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.492 -1.683 . . . . 0.0 106.997 168.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.11 149.19 25.31 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.465 -172.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -122.15 174.52 3.21 Favored Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -86.15 155.31 53.52 Favored 'Cis proline' 0 CA--C 1.505 -0.959 0 CA-C-O 122.854 1.106 . . . . 0.0 113.362 -1.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.266 -3.035 0 CA-C-N 111.876 -2.42 . . . . 0.0 109.795 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.504 2.245 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.25 37.93 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 108.564 -1.36 . . . . 0.0 108.564 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.545 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.56 124.86 28.6 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -174.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.61 163.18 26.47 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.806 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -100.82 -179.54 4.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.73 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 9' ' ' LYS . 88.7 p -70.96 122.02 19.21 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.47 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.93 -15.59 1.24 Allowed Glycine 0 C--N 1.296 -1.659 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.585 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 7' ' ' SER . 47.6 mttt -106.8 117.01 57.81 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.758 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -77.13 -161.75 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.929 1.086 . . . . 0.0 109.287 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.91 -111.16 3.77 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.232 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.579 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -157.98 157.46 33.07 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.434 -1.306 . . . . 0.0 112.523 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.75 147.5 18.96 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.37 128.24 33.36 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.527 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.7 tp -87.51 109.49 19.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.021 -1.472 . . . . 0.0 111.984 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.689 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 65.4 m95 -98.16 179.2 4.83 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.844 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -103.59 -160.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.162 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.389 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.86 71.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.337 1.541 . . . . 0.0 108.329 -176.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ILE . 12.1 mtp85 -114.12 131.75 56.3 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.197 -2.274 . . . . 0.0 111.236 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.22 86.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.302 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 163.25 37.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.966 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.29 160.26 73.43 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.1 Cg_exo -51.57 92.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 120.792 0.995 . . . . 0.0 111.008 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' CYS . . . -7.91 -32.07 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 1 N-CA-C 132.796 7.878 . . . . 0.0 132.796 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -134.9 43.09 1.28 Allowed Glycine 0 N--CA 1.499 2.843 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.311 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.85 -164.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.417 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.05 -1.61 56.64 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.654 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.689 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 28.7 m-85 -86.1 169.25 13.31 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 123.129 1.442 . . . . 0.0 113.338 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.79 -43.66 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.732 175.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 41' ' ' TYR . 5.1 p -97.94 138.08 35.81 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.594 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.23 151.02 20.6 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.918 176.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.2 p -113.09 142.38 45.81 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.834 176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 18.5 m-85 -114.28 128.96 56.61 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.869 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.545 ' NZ ' ' SG ' ' A' ' 4' ' ' CYS . 12.9 mttt -126.09 67.68 1.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.241 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.441 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 40.2 t-105 -36.55 144.87 0.26 Allowed Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.328 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 2.2 Cg_endo -77.6 35.48 0.59 Allowed 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 125.801 -0.5 . . . . 0.0 112.399 -5.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.541 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -145.73 -160.13 1.1 Allowed 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.339 178.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -166.37 144.94 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.037 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.416 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.5 m -112.8 147.03 37.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 3.0 t -115.15 143.88 44.54 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.613 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -113.73 -177.22 0.42 Allowed Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.541 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 5.5 Cg_exo -62.84 -51.0 0.16 OUTLIER 'Cis proline' 0 N--CA 1.506 2.22 0 CA-C-N 121.866 1.702 . . . . 0.0 115.907 6.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.598 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.754 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.358 -171.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB1' ' H ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.504 2.262 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -87.67 38.62 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 N-CA-C 109.321 -1.069 . . . . 0.0 109.321 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.66 124.14 27.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.78 -176.48 4.96 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.109 -1.436 . . . . 0.0 110.132 -176.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.17 -173.91 4.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.037 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -68.85 118.18 11.47 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.616 -176.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.47 -12.62 1.84 Allowed Glycine 0 C--N 1.297 -1.599 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.532 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.9 mttm -96.4 135.47 22.45 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.159 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 9' ' ' LYS . 11.3 Cg_exo -47.14 -169.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.212 1.941 . . . . 0.0 113.875 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.09 32.36 0.25 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 114.297 -1.32 . . . . 0.0 113.959 -174.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.454 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 7.8 ptm180 -161.84 137.87 7.83 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 116.294 -2.162 . . . . 0.0 115.352 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -151.08 160.92 28.88 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.75 122.07 26.13 Favored 'General case' 0 C--O 1.18 -2.587 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.186 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 4.0 tt -89.18 118.3 28.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 117.624 -1.631 . . . . 0.0 111.711 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.688 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 57.0 m95 -103.41 170.99 7.62 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.351 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -96.16 -157.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.744 -175.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.547 HD11 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.94 67.57 0.15 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.363 1.554 . . . . 0.0 108.4 -177.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.7 mtt-85 -116.07 100.3 7.85 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.151 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -41.68 -26.48 0.26 Allowed Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.701 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -147.21 160.47 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.147 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -87.13 150.17 49.03 Favored Pre-proline 0 C--N 1.292 -1.9 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.086 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.44 163.54 17.55 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 110.888 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.26 -10.75 47.41 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.84 -26.73 67.43 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.726 -1.226 . . . . 0.0 111.155 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -87.35 -32.95 19.35 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.874 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.56 16.32 29.5 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.813 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.688 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 58.8 m-85 -53.97 173.47 0.06 Allowed 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.954 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 p -161.33 -46.48 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 112.909 -1.95 . . . . 0.0 106.083 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.84 120.06 38.64 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.646 -2.07 . . . . 0.0 109.312 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.36 148.39 30.32 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.023 -1.471 . . . . 0.0 112.618 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 143.94 40.3 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.553 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 24.7 m-85 -113.3 137.23 51.8 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.307 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 11.0 mmtt -121.46 70.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.424 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -40.03 140.84 0.86 Allowed Pre-proline 0 C--N 1.294 -1.822 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.091 -176.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -72.67 -22.77 11.79 Favored 'Cis proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.743 -4.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.629 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -78.63 -161.38 0.28 Allowed 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 -176.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.513 ' HA ' ' H ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -164.7 154.19 2.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.873 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.8 m -124.66 127.15 46.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.539 164.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -96.53 153.9 17.58 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -172.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.562 ' O ' ' O ' ' A' ' 30' ' ' SER . 4.6 m-85 -127.66 165.72 28.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.75 159.21 91.74 Favored 'Cis proline' 0 C--N 1.323 -0.805 0 CA-C-O 122.783 1.076 . . . . 0.0 114.47 1.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.596 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.387 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.259 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.49 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -87.12 34.75 0.44 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.35 -1.442 . . . . 0.0 108.35 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -74.77 116.33 15.36 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.219 -174.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.6 164.12 24.92 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 117.588 -1.645 . . . . 0.0 108.87 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.58 -178.94 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.36 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 99.9 p -76.99 124.12 27.31 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.143 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.25 -13.16 28.38 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.478 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -115.5 108.9 46.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.981 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.32 -154.21 0.04 OUTLIER 'Trans proline' 0 C--O 1.208 -0.976 0 N-CA-C 109.033 -1.179 . . . . 0.0 109.033 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 -108.92 2.63 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 119.254 -1.45 . . . . 0.0 111.507 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.675 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -160.16 168.63 25.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 118.923 -1.111 . . . . 0.0 113.023 -176.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.7 146.49 18.05 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.444 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -79.48 118.07 21.01 Favored 'General case' 0 C--O 1.171 -3.058 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.115 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 tp -85.76 92.6 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.526 -1.67 . . . . 0.0 113.723 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.478 ' N ' ' O ' ' A' ' 38' ' ' ILE . 70.3 m95 -75.53 126.27 30.67 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.801 -1.999 . . . . 0.0 107.744 172.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -94.88 -7.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.135 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -170.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mt -153.13 73.39 0.99 Allowed 'General case' 0 C--N 1.253 -3.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.469 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -166.16 148.59 7.06 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 116.637 -2.025 . . . . 0.0 113.204 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.08 -13.22 27.62 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -142.87 153.96 43.66 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.235 -0.982 . . . . 0.0 109.22 177.276 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -95.51 152.52 39.29 Favored Pre-proline 0 C--N 1.288 -2.085 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.832 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.83 -170.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.221 1.281 . . . . 0.0 111.651 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.77 -19.27 3.4 Favored Glycine 0 N--CA 1.489 2.212 1 N-CA-C 129.221 6.448 . . . . 0.0 129.221 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.75 4.57 68.91 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -79.35 -56.61 4.21 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.467 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.8 7.05 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.82 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.608 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 34.1 m-85 -76.54 165.77 24.32 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 123.016 1.388 . . . . 0.0 112.769 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 p -163.32 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 111.757 -2.474 . . . . 0.0 106.005 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' TYR . 13.9 p -98.7 124.26 43.42 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.378 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.662 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -153.63 157.1 39.13 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.816 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 147.81 39.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.62 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 13.1 m-85 -124.31 139.3 54.04 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.539 -172.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 73.72 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -43.93 155.42 0.33 Allowed Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.175 -174.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.87 10.25 8.54 Favored 'Cis proline' 0 N--CA 1.485 1.016 0 C-N-CA 124.293 -1.128 . . . . 0.0 111.142 -2.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.661 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -111.49 -162.07 0.78 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.871 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -177.33 138.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.536 -178.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 29.0 m -108.21 113.35 26.4 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 117.698 -1.601 . . . . 0.0 106.939 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -93.22 130.72 38.82 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.921 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' CE2' ' O ' ' A' ' 12' ' ' ARG . 24.1 m-85 -106.89 -174.55 0.32 Allowed Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 43' ' ' HIS . 35.9 Cg_exo -54.81 -49.01 0.14 OUTLIER 'Cis proline' 0 N--CA 1.501 1.913 0 CA-C-N 122.745 2.016 . . . . 0.0 116.727 5.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.675 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.742 0 CA-C-O 116.349 -1.786 . . . . 0.0 109.1 -172.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.508 2.471 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -84.33 20.36 1.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 N-CA-C 107.993 -1.579 . . . . 0.0 107.993 164.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -81.12 115.41 20.54 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.4 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.85 178.22 8.11 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.43 -174.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -176.91 3.24 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.839 0.828 . . . . 0.0 110.152 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 p -77.66 128.02 33.42 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.34 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.67 -9.19 11.35 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -119.81 108.62 38.76 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -73.95 -163.44 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 -110.45 3.74 Favored Glycine 0 C--N 1.282 -2.472 0 C-N-CA 118.535 -1.793 . . . . 0.0 110.65 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -163.11 164.7 25.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 117.812 -1.555 . . . . 0.0 114.012 -177.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . -146.26 -170.3 14.76 Favored Glycine 0 N--CA 1.502 3.053 1 N-CA-C 127.074 5.59 . . . . 0.0 127.074 173.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.589 ' CB ' ' HH ' ' A' ' 28' ' ' TYR . 1.4 m-20 -99.32 127.22 45.31 Favored 'General case' 0 C--O 1.182 -2.463 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.99 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 4.2 tp -102.0 97.1 7.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.922 1.344 . . . . 0.0 110.256 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.483 ' N ' ' O ' ' A' ' 38' ' ' ILE . 80.0 m95 -89.02 151.99 21.95 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.963 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.63 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.38 -157.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.653 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.4 -178.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -70.07 76.82 0.5 Allowed 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 123.627 1.68 . . . . 0.0 109.236 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 21' ' ' THR . 9.9 mtt180 -126.45 75.93 1.58 Allowed 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 110.987 -2.824 . . . . 0.0 110.715 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -17.54 -32.02 0.0 OUTLIER Glycine 0 N--CA 1.499 2.858 1 N-CA-C 126.665 5.426 . . . . 0.0 126.665 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -140.41 154.14 46.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.297 176.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -86.12 153.73 57.13 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.14 -178.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.81 172.22 4.99 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.157 1.238 . . . . 0.0 110.81 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.42 18.17 35.92 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.79 -13.63 25.19 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.662 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -90.28 1.93 56.0 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.824 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 -0.14 39.22 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.732 -1.223 . . . . 0.0 111.367 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.678 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.9 m-85 -54.83 169.97 0.19 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.787 1.279 . . . . 0.0 111.736 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 p -160.18 -44.82 0.05 OUTLIER 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 112.174 -2.285 . . . . 0.0 105.175 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 12.4 p -98.25 137.39 37.06 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 112.968 -1.924 . . . . 0.0 108.621 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -155.16 148.98 25.51 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 117.707 -1.597 . . . . 0.0 113.116 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -93.43 158.34 15.77 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 26.5 m-85 -136.95 131.47 33.06 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.793 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -136.56 77.96 1.68 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.402 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.43 150.98 1.48 Allowed Pre-proline 0 C--N 1.293 -1.886 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.111 -177.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' LEU . 1.9 Cg_endo -69.17 -19.18 10.62 Favored 'Cis proline' 0 C--O 1.198 -1.499 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.285 -3.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.628 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -85.9 -169.44 2.64 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -177.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -149.22 144.74 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.652 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.3 m -117.21 116.52 27.44 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.731 -1.187 . . . . 0.0 107.902 171.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.678 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -97.46 155.0 17.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -131.35 173.13 6.23 Favored Pre-proline 0 N--CA 1.503 2.18 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -88.65 156.05 37.77 Favored 'Cis proline' 0 C--O 1.214 -0.685 0 N-CA-C 115.764 1.409 . . . . 0.0 115.764 0.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 110.985 -2.825 . . . . 0.0 110.109 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 110.827 -0.064 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -76.6 52.67 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 N-CA-C 106.075 -2.317 . . . . 0.0 106.075 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -68.1 131.18 44.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.13 175.02 11.02 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.167 -1.413 . . . . 0.0 110.769 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.22 177.43 11.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.779 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.7 m -86.77 106.35 17.62 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.894 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.68 -17.78 8.21 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.5 mptt -134.42 136.83 26.52 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.126 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 9' ' ' LYS . 6.0 Cg_exo -50.52 -156.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.378 2.052 . . . . 0.0 114.033 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 31.8 0.1 OUTLIER Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -161.34 137.26 8.01 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 115.775 -2.37 . . . . 0.0 116.071 175.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.63 -166.82 10.83 Favored Glycine 0 N--CA 1.509 3.546 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.733 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.8 m-20 -108.18 127.31 53.71 Favored 'General case' 0 C--O 1.181 -2.52 0 CA-C-O 118.27 -0.872 . . . . 0.0 109.203 176.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 tp -91.04 135.61 33.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.964 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.4 ' CD1' ' HB2' ' A' ' 40' ' ' CYS . 59.7 m95 -127.73 -176.17 3.69 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 111.434 -2.621 . . . . 0.0 108.949 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 19' ' ' ARG . 1.8 mt -105.02 -167.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -173.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.498 ' N ' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.03 68.98 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.978 1.371 . . . . 0.0 107.606 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.1 mtt-85 -116.75 125.45 51.67 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 112.223 -2.262 . . . . 0.0 110.4 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.27 69.61 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -142.98 160.72 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.768 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 158.01 42.77 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.268 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.07 125.56 15.49 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.3 1.333 . . . . 0.0 110.899 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 3.86 69.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.593 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.94 -12.73 58.73 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.56 -46.5 15.64 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.459 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.43 -7.89 5.31 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.469 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.9 m-85 -50.22 171.27 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.66 1.219 . . . . 0.0 111.187 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.6 p -161.87 -45.6 0.04 OUTLIER 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 112.34 -2.209 . . . . 0.0 105.874 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.95 130.19 44.82 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.729 -2.032 . . . . 0.0 110.298 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.593 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -157.51 157.29 33.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 117.861 -1.536 . . . . 0.0 112.148 177.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 140.02 53.18 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.592 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 22.4 m-85 -112.88 136.47 52.49 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.731 -173.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -142.76 75.5 1.49 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.257 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.485 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -45.51 156.79 0.4 Allowed Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.106 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.473 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 8.7 Cg_endo -78.91 30.72 1.47 Allowed 'Cis proline' 0 C--O 1.194 -1.68 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.196 -1.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.485 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 m-80 -146.62 -168.68 3.09 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.173 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.476 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -152.62 149.03 13.85 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.024 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.115 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -119.84 120.06 35.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.555 167.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -91.11 157.57 17.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.254 -171.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' O ' ' O ' ' A' ' 30' ' ' SER . 15.4 m-85 -133.24 167.62 22.04 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.71 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.46 160.93 95.49 Favored 'Cis proline' 0 C--O 1.213 -0.736 0 CA-C-O 122.591 0.996 . . . . 0.0 113.585 0.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.579 -2.101 . . . . 0.0 109.859 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -85.76 28.46 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 N-CA-C 106.996 -1.963 . . . . 0.0 106.996 164.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.8 p -88.51 116.58 26.85 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.407 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -177.1 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.803 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -119.79 -176.46 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.567 178.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.56 116.86 20.01 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.425 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.7 79.32 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.435 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mppp? -119.74 117.96 32.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.503 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.44 178.58 7.24 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 121.236 1.291 . . . . 0.0 109.821 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.52 -100.19 2.12 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.409 -1.377 . . . . 0.0 111.294 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.1 ptm180 -162.03 178.23 9.02 Favored 'General case' 0 C--O 1.209 -1.078 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.364 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -162.57 165.34 36.15 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 175.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.567 ' CB ' ' HH ' ' A' ' 28' ' ' TYR . 1.5 m-20 -87.19 132.25 33.93 Favored 'General case' 0 C--O 1.18 -2.553 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.34 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.499 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 10.7 tp -97.18 100.07 11.54 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.647 1.213 . . . . 0.0 111.802 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.509 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 67.0 m95 -93.01 160.88 14.67 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 112.515 -2.13 . . . . 0.0 110.831 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -84.45 -163.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.919 -176.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.401 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -68.39 71.77 0.19 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.74 1.257 . . . . 0.0 107.984 -176.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' THR . 38.8 mtt180 -122.08 86.8 2.64 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.765 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -22.23 -28.02 0.0 OUTLIER Glycine 0 N--CA 1.495 2.593 1 N-CA-C 125.837 5.095 . . . . 0.0 125.837 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' ARG . 1.4 p -150.01 151.35 33.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.04 -1.08 . . . . 0.0 109.866 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -85.72 151.57 55.58 Favored Pre-proline 0 C--N 1.289 -2.053 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.385 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.23 146.88 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.073 1.182 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.54 3.44 17.49 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.066 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.68 9.25 5.81 Favored Glycine 0 N--CA 1.491 2.32 1 N-CA-C 130.575 6.99 . . . . 0.0 130.575 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.67 14.94 8.96 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.45 79.82 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.382 -1.389 . . . . 0.0 111.619 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.623 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.7 m-85 -69.91 168.6 14.93 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.188 1.47 . . . . 0.0 113.492 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 p -161.57 -46.69 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 111.549 -2.569 . . . . 0.0 105.911 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.461 ' H ' ' HG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -99.12 119.7 38.28 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.808 -1.996 . . . . 0.0 110.319 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -144.03 152.98 41.73 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.526 178.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -108.76 149.18 29.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.429 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.521 ' OH ' ' ND2' ' A' ' 31' ' ' ASN . 18.5 m-85 -125.98 134.35 51.52 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.962 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -151.53 76.57 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.603 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -40.65 156.65 0.19 Allowed Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.593 -178.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.487 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.8 Cg_endo -79.09 35.05 0.87 Allowed 'Cis proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.768 -0.93 . . . . 0.0 111.464 -5.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.2 m-80 -149.03 -171.43 3.87 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.489 -1.284 . . . . 0.0 110.318 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.473 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -154.75 144.91 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.534 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -113.65 107.73 16.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.148 171.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.623 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -83.75 130.92 34.95 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.876 -173.245 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.608 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -103.97 -177.73 0.56 Allowed Pre-proline 0 N--CA 1.505 2.312 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 13.6 Cg_exo -63.11 -50.18 0.16 OUTLIER 'Cis proline' 0 N--CA 1.505 2.196 0 N-CA-C 117.449 2.057 . . . . 0.0 117.449 5.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.792 0 CA-C-O 116.239 -1.838 . . . . 0.0 109.167 -169.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.513 ' O ' ' NH2' ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -82.73 40.47 0.97 Allowed 'Trans proline' 0 CA--C 1.551 1.325 0 N-CA-C 108.634 -1.333 . . . . 0.0 108.634 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.612 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.79 128.99 34.1 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.17 169.51 18.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.422 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.68 178.3 7.33 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.504 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.31 128.02 33.08 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.277 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.71 -16.85 33.86 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.336 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 110.93 23.37 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.386 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -75.49 -179.73 5.38 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 N-CA-C 108.6 -1.346 . . . . 0.0 108.6 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.24 -99.38 2.5 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.814 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 2' ' ' ALA . 2.6 ptm180 -156.12 159.11 38.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.051 -175.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.26 148.42 20.04 Favored Glycine 0 N--CA 1.499 2.837 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.229 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 15.6 m-20 -78.57 124.07 27.76 Favored 'General case' 0 C--O 1.181 -2.552 0 C-N-CA 119.304 -0.959 . . . . 0.0 109.751 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.5 tp -83.8 132.74 34.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 117.683 -1.607 . . . . 0.0 110.355 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.657 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 53.5 m95 -124.94 167.55 14.53 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.493 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -90.92 -161.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 C-N-CA 118.109 -1.436 . . . . 0.0 112.639 -175.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.15 69.98 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.532 -176.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 6.0 mtp180 -110.4 119.83 40.48 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 112.109 -2.314 . . . . 0.0 111.803 -177.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.27 -46.93 51.39 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.305 -1.426 . . . . 0.0 109.595 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.93 156.93 48.02 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.212 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.16 160.94 67.11 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -51.09 110.9 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 120.971 1.114 . . . . 0.0 111.662 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -15.73 -113.18 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 1 N-CA-C 130.349 6.899 . . . . 0.0 130.349 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.41 46.62 3.52 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.384 -1.389 . . . . 0.0 109.787 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -83.67 -60.73 2.03 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.32 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -160.38 -27.24 0.02 OUTLIER Glycine 0 C--N 1.288 -2.099 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 48.5 m-85 -84.22 173.04 11.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 122.897 1.332 . . . . 0.0 112.666 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.47 -48.9 0.05 Allowed 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.014 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -100.23 111.3 23.57 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 113.138 -1.846 . . . . 0.0 109.607 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.83 143.67 41.1 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.471 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 140.58 38.33 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 28.6 m-85 -115.94 149.27 39.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.203 -173.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.03 81.99 0.71 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.68 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.415 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.51 158.56 0.27 Allowed Pre-proline 0 C--N 1.307 -1.26 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.37 -177.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.528 ' C ' HD21 ' A' ' 37' ' ' ASN . 8.2 Cg_endo -79.52 33.58 1.24 Allowed 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.44 -1.067 . . . . 0.0 111.456 -5.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.528 HD21 ' C ' ' A' ' 36' ' ' PRO . 7.5 m-80 -147.92 -160.2 1.13 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.916 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.476 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -164.5 137.62 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.113 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.496 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.7 m -108.87 115.47 30.14 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 116.763 -1.975 . . . . 0.0 107.029 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -86.59 148.29 25.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 113.564 -1.653 . . . . 0.0 113.28 -171.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -125.79 168.41 14.0 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -84.32 156.87 68.17 Favored 'Cis proline' 0 N--CA 1.454 -0.849 0 CA-C-O 122.939 1.141 . . . . 0.0 114.062 4.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.625 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.428 175.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -92.43 51.49 0.55 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 O-C-N 122.621 0.8 . . . . 0.0 110.664 167.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -88.97 136.25 33.11 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.775 -1.57 . . . . 0.0 107.731 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.4 174.2 11.81 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.837 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -126.4 179.8 5.12 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.708 0.766 . . . . 0.0 109.845 177.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 m -76.86 128.41 34.52 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.455 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.39 27.34 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.846 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -125.28 99.3 34.03 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.51 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.98 155.91 47.83 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 N-CA-C 108.586 -1.351 . . . . 0.0 108.586 173.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.93 -97.62 0.51 Allowed Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.171 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' C ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.33 157.46 28.0 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 118.186 -1.405 . . . . 0.0 113.294 -178.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -150.82 162.28 29.32 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 77.6 m-20 -78.03 125.2 29.0 Favored 'General case' 0 C--O 1.184 -2.364 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.6 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.415 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 8.4 tt -91.06 109.89 21.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.557 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.558 ' N ' ' O ' ' A' ' 38' ' ' ILE . 63.2 m95 -91.56 161.69 14.84 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.931 -2.395 . . . . 0.0 109.052 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -81.15 -157.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 119.416 -0.913 . . . . 0.0 112.022 -176.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 67.01 0.11 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.359 1.552 . . . . 0.0 107.244 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -113.86 111.44 21.73 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 112.065 -2.334 . . . . 0.0 110.284 -178.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.12 -20.83 65.34 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.341 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.42 152.58 44.4 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.195 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -94.7 155.08 39.78 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.599 179.144 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -66.91 143.06 64.92 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.037 1.158 . . . . 0.0 110.985 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.22 2.83 87.35 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.81 -22.13 53.94 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.34 -16.98 55.44 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.675 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.39 0.4 73.34 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.093 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.651 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 49.0 m-85 -54.34 161.74 1.28 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.29 -1.364 . . . . 0.0 111.542 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.5 p -146.2 -48.44 0.21 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 112.076 -2.329 . . . . 0.0 105.891 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -100.06 116.43 32.07 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.254 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' ND2' ' HH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -139.14 149.18 44.19 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.787 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.6 p -106.05 141.53 37.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HH ' ' ND2' ' A' ' 31' ' ' ASN . 17.7 m-85 -119.97 138.95 53.17 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.147 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 80.5 0.95 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.41 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -44.39 158.4 0.27 Allowed Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.731 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.41 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 2.8 Cg_endo -78.04 28.75 1.61 Allowed 'Cis proline' 0 C--O 1.211 -0.857 0 C-N-CA 124.492 -1.045 . . . . 0.0 111.945 -5.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.46 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -144.44 179.44 7.26 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.232 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -145.96 148.44 17.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -122.22 123.37 41.32 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 117.343 -1.743 . . . . 0.0 107.856 167.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.651 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.74 147.09 23.15 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.839 -171.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -121.85 169.32 9.55 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.84 157.62 80.48 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 CA-C-O 123.133 1.222 . . . . 0.0 114.553 3.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.72 0 CA-C-N 111.455 -2.612 . . . . 0.0 110.161 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.03 58.75 5.64 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 N-CA-C 107.234 -1.872 . . . . 0.0 107.234 168.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.33 136.92 39.56 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.3 m-85 -77.96 163.04 26.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.221 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.507 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -104.65 -173.87 2.41 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.659 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.55 122.86 21.24 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.166 -177.39 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.82 -3.34 0.99 Allowed Glycine 0 N--CA 1.48 1.595 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.819 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 7' ' ' SER . 11.2 mttm -107.69 108.59 61.72 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.474 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.22 -173.81 1.21 Allowed 'Trans proline' 0 C--N 1.324 -0.716 0 C-N-CA 120.807 1.004 . . . . 0.0 109.615 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 93.81 -115.26 4.93 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.418 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.534 ' NH1' ' OD1' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -160.41 160.93 32.83 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.216 -1.393 . . . . 0.0 113.471 -178.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.82 148.57 20.28 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.534 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 9.6 m-20 -76.53 126.7 31.44 Favored 'General case' 0 C--O 1.171 -3.068 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.599 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 10.7 tp -83.11 104.8 13.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.282 -1.767 . . . . 0.0 111.703 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.539 ' N ' ' O ' ' A' ' 38' ' ' ILE . 62.6 m95 -87.56 167.14 14.2 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.466 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -88.58 -161.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.026 -177.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.46 73.57 0.15 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.1 1.428 . . . . 0.0 108.599 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 17' ' ' ILE . 23.8 mtp85 -112.83 143.76 43.54 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 112.235 -2.257 . . . . 0.0 111.203 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.16 -20.64 66.86 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.47 157.19 35.05 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.857 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.87 148.12 71.72 Favored Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.44 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 22' ' ' CYS . 5.8 Cg_exo -53.67 -173.94 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 120.685 0.923 . . . . 0.0 111.054 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.52 -11.39 6.65 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 129.314 6.486 . . . . 0.0 129.314 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.89 19.32 55.23 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.61 -73.76 0.61 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.264 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.73 3.43 0.16 Allowed Glycine 0 N--CA 1.488 2.167 0 C-N-CA 118.974 -1.584 . . . . 0.0 112.418 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.3 m-85 -63.93 171.58 2.76 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.808 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.436 ' HG1' ' H ' ' A' ' 30' ' ' SER . 1.2 p -161.99 -44.86 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 112.592 -2.095 . . . . 0.0 106.433 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 41' ' ' TYR . 4.0 p -99.06 121.66 41.28 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.961 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.632 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.66 150.81 36.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.109 -1.436 . . . . 0.0 113.197 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.36 147.18 31.91 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.523 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.446 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 13.1 m-85 -121.32 136.01 55.02 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.654 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 4.6 mttp -138.35 63.64 1.52 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.572 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.467 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 27.5 t-105 -32.76 145.77 0.1 Allowed Pre-proline 0 N--CA 1.507 2.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.211 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.3 Cg_endo -78.62 40.41 0.4 Allowed 'Cis proline' 0 N--CA 1.499 1.81 0 C-N-CA 125.768 -0.513 . . . . 0.0 111.269 -5.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.467 ' H ' ' CA ' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -148.91 -163.53 1.81 Allowed 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.974 177.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -166.25 147.2 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.801 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -121.21 131.69 54.38 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 118.076 -1.45 . . . . 0.0 107.888 167.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -101.64 146.94 27.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.527 -1.215 . . . . 0.0 114.27 -168.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -116.51 -179.17 0.59 Allowed Pre-proline 0 N--CA 1.513 2.711 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.0 Cg_exo -63.8 -50.96 0.16 OUTLIER 'Cis proline' 0 N--CA 1.503 2.031 0 CA-C-N 122.117 1.792 . . . . 0.0 116.7 6.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.956 0 CA-C-O 116.356 -1.783 . . . . 0.0 109.24 -171.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.513 2.697 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.43 32.55 0.27 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 N-CA-C 108.804 -1.268 . . . . 0.0 108.804 165.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.78 141.86 33.13 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.227 -174.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -89.98 171.32 9.65 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.6 -179.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -115.45 -175.66 2.76 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.11 178.182 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.13 115.09 17.6 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.811 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.47 64.3 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.625 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.92 114.27 46.59 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.067 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -77.03 166.65 26.38 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 N-CA-C 108.277 -1.47 . . . . 0.0 108.277 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.41 -106.18 2.4 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.233 -1.46 . . . . 0.0 111.069 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.66 165.04 31.27 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.105 -1.438 . . . . 0.0 113.903 -177.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.5 -174.7 15.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -104.51 111.86 24.7 Favored 'General case' 0 C--O 1.173 -2.952 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.448 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.432 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 23.2 tp -82.9 94.22 7.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 116.89 -1.924 . . . . 0.0 112.954 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.475 ' N ' ' O ' ' A' ' 38' ' ' ILE . 73.0 m95 -70.19 111.9 6.15 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 112.458 -2.156 . . . . 0.0 105.859 169.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.31 -10.0 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.979 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -169.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mt -151.05 78.39 1.29 Allowed 'General case' 0 C--N 1.249 -3.796 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.786 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -175.99 166.61 3.0 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 117.641 -1.624 . . . . 0.0 112.209 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.87 -24.26 4.34 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -130.24 152.23 49.89 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.0 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.609 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -88.19 147.91 41.53 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.682 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -59.45 103.57 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.57 0.846 . . . . 0.0 110.597 -176.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 7.79 -93.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.931 1 N-CA-C 130.684 7.033 . . . . 0.0 130.684 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.32 46.04 1.71 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.299 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -79.31 0.66 27.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.577 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.0 27.94 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.1 m-85 -76.41 164.08 26.34 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 122.909 1.338 . . . . 0.0 112.588 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -162.72 -42.84 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.643 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.28 115.03 26.89 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.374 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.33 151.68 37.91 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.309 -1.357 . . . . 0.0 112.994 -177.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.91 144.91 32.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 15.9 m-85 -120.03 129.2 54.13 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.683 -173.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -135.93 73.17 1.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.431 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -48.41 154.7 1.07 Allowed Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.28 -175.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -70.96 7.7 3.85 Favored 'Cis proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.105 -1.206 . . . . 0.0 110.901 -5.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 35' ' ' TRP . 4.6 m-80 -104.37 -164.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.948 0.88 . . . . 0.0 111.357 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -177.34 135.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 7.5 m -105.69 113.26 26.72 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 117.807 -1.557 . . . . 0.0 107.625 171.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -91.52 133.25 35.67 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.001 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.684 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -110.51 168.38 7.7 Favored Pre-proline 0 N--CA 1.512 2.671 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.324 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.81 158.79 71.53 Favored 'Cis proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.05 1.187 . . . . 0.0 114.678 2.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.684 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.449 0 CA-C-N 111.741 -2.481 . . . . 0.0 109.763 175.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -82.27 36.35 0.62 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 107.701 -1.692 . . . . 0.0 107.701 165.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.24 125.38 29.05 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.385 -174.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -81.6 -175.86 5.75 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 117.896 -1.522 . . . . 0.0 109.388 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -172.14 3.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.669 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -69.82 134.05 48.09 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.507 -176.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.94 -1.76 0.2 Allowed Glycine 0 N--CA 1.482 1.7 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.779 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 7' ' ' SER . 19.0 mttm -121.8 102.54 41.31 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.313 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -170.99 0.59 Allowed 'Trans proline' 0 C--O 1.21 -0.885 0 C-N-CA 121.263 1.309 . . . . 0.0 109.252 175.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 -106.13 3.27 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.726 -1.702 . . . . 0.0 111.323 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.423 ' NH2' ' OD1' ' A' ' 14' ' ' ASP . 1.2 ptm180 -161.55 165.93 27.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.881 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -146.4 146.13 15.82 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -78.19 118.49 20.47 Favored 'General case' 0 C--O 1.173 -2.933 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.178 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -81.3 129.5 34.64 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 116.938 -1.905 . . . . 0.0 110.683 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -117.96 122.01 42.15 Favored 'General case' 0 C--N 1.263 -3.172 0 CA-C-N 111.902 -2.408 . . . . 0.0 105.444 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.64 -12.68 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 mt -152.36 66.86 0.83 Allowed 'General case' 0 C--N 1.246 -3.901 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.226 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.32 123.26 13.52 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.215 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.04 -36.41 31.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.86 155.4 49.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.75 153.38 67.51 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.579 -177.191 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -67.53 -164.73 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.481 1.454 . . . . 0.0 111.684 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -132.98 -18.17 1.1 Allowed Glycine 0 N--CA 1.489 2.206 1 N-CA-C 130.631 7.012 . . . . 0.0 130.631 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.85 47.0 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.326 -1.416 . . . . 0.0 109.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -83.2 -91.06 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.45 25.03 0.02 OUTLIER Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.275 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.4 m-85 -69.27 171.86 7.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.598 1.189 . . . . 0.0 111.099 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 p -162.65 -45.83 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.373 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 125.76 44.72 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.302 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.635 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -156.47 149.88 24.48 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 117.534 -1.666 . . . . 0.0 113.369 177.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.54 143.96 40.12 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.529 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 57.7 m-85 -111.36 138.01 48.4 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.235 -0.986 . . . . 0.0 113.026 -172.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 35' ' ' TRP . 11.5 mmtm -135.02 60.21 1.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.406 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -41.63 148.58 0.44 Allowed Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.619 -175.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -71.75 -3.81 11.35 Favored 'Cis proline' 0 C--O 1.211 -0.863 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.032 -1.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.619 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -99.22 -160.32 0.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.803 -178.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.469 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 178.56 136.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.19 -2.07 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.177 -178.186 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 33.9 m -105.3 117.36 33.81 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.231 -1.787 . . . . 0.0 107.021 171.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -98.48 126.32 43.98 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.535 -170.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 30' ' ' SER . 15.7 m-85 -98.5 -172.66 0.28 Allowed Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -56.31 -52.11 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 123.206 2.181 . . . . 0.0 115.948 5.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.612 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 116.332 -1.794 . . . . 0.0 109.221 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -85.71 33.74 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 108.516 -1.378 . . . . 0.0 108.516 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.8 136.18 36.66 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -176.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.686 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.1 -175.83 4.79 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.125 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -128.62 -171.89 2.58 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.291 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -70.71 114.29 8.65 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.78 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.44 1.12 4.11 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.092 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.2 mptm? -103.55 151.15 38.66 Favored Pre-proline 0 N--CA 1.498 1.934 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.192 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 9' ' ' LYS . 17.1 Cg_exo -38.88 177.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.779 2.986 . . . . 0.0 115.051 -173.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.06 31.37 0.65 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.909 -1.496 . . . . 0.0 114.911 -172.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -161.21 142.78 11.77 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 115.884 -2.327 . . . . 0.0 114.754 175.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -161.88 152.41 22.82 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.947 174.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 118.37 19.27 Favored 'General case' 0 C--O 1.174 -2.91 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.572 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' H ' ' CB ' ' A' ' 2' ' ' ALA . 7.2 tt -87.63 94.98 9.89 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.141 -1.824 . . . . 0.0 112.341 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.565 ' N ' ' O ' ' A' ' 38' ' ' ILE . 66.5 m95 -70.56 127.65 33.41 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.307 -2.224 . . . . 0.0 107.464 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.81 -10.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -153.74 76.43 1.07 Allowed 'General case' 0 C--N 1.247 -3.872 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.477 -174.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -161.69 129.32 4.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 117.239 -1.784 . . . . 0.0 112.737 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.49 -18.74 65.62 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 175.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -142.61 154.66 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.582 -0.809 . . . . 0.0 109.242 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 156.66 39.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.628 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -61.94 -172.99 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 121.163 1.242 . . . . 0.0 111.509 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.91 -5.24 4.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.28 -18.16 47.21 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.438 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.74 -31.21 41.04 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.48 7.01 30.67 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.556 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.9 m-85 -66.03 167.86 9.19 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.591 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 p -161.12 -44.14 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.386 -2.188 . . . . 0.0 105.953 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.22 124.86 41.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.819 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -157.09 158.6 36.7 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.112 -1.435 . . . . 0.0 112.699 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.1 p -115.82 140.64 49.02 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.29 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.488 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 35.9 m-85 -108.77 131.76 54.64 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.643 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -131.57 67.65 1.51 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.09 149.24 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.573 -175.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -71.68 -5.12 12.16 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.017 -5.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.664 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -92.68 -161.91 0.88 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.867 -177.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 176.21 143.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.46 -177.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 71.2 m -112.38 125.41 54.17 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.016 169.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -105.02 138.08 41.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' CE2' ' ND1' ' A' ' 43' ' ' HIS . 2.2 m-85 -108.16 -178.96 0.62 Allowed Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.6 Cg_exo -58.37 -55.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.507 2.322 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 5.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.672 0 CA-C-O 116.377 -1.773 . . . . 0.0 109.133 -171.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.414 ' HB1' ' H ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.501 2.121 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -84.93 34.31 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.644 0.896 . . . . 0.0 109.94 168.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.18 123.31 26.75 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.392 -176.044 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -79.31 164.68 23.9 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.551 -1.26 . . . . 0.0 110.083 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 179.22 6.5 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.107 0.956 . . . . 0.0 111.281 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.25 133.23 38.9 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.522 -177.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.86 -17.03 28.79 Favored Glycine 0 C--N 1.296 -1.644 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.711 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.94 114.27 10.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -73.72 -160.89 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 N-CA-C 108.627 -1.336 . . . . 0.0 108.627 172.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 79.52 -106.87 2.47 Favored Glycine 0 C--N 1.288 -2.12 0 C-N-CA 118.809 -1.662 . . . . 0.0 111.229 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -157.14 158.85 37.08 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.273 -176.686 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.22 161.75 24.97 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 174.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -79.25 128.67 33.6 Favored 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.35 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 16.6 tp -92.4 108.0 19.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.691 1.234 . . . . 0.0 111.958 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' ILE . 64.8 m95 -99.82 150.38 22.41 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 112.546 -2.115 . . . . 0.0 109.709 177.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.544 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -81.22 -155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.341 -177.581 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.75 72.94 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.212 1.482 . . . . 0.0 108.272 -174.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 17' ' ' ILE . 10.5 mtp85 -114.53 103.94 11.52 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.449 179.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.99 -27.77 14.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.219 -1.467 . . . . 0.0 109.884 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 157.39 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.75 159.89 70.49 Favored Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.647 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -50.46 168.87 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.071 1.181 . . . . 0.0 110.948 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.02 140.62 15.13 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.845 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.36 85.8 Favored Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.513 -1.327 . . . . 0.0 111.074 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -171.58 2.8 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.696 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.46 6.67 71.38 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.055 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.3 m-85 -86.96 168.02 13.74 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 118.373 -1.331 . . . . 0.0 112.334 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.81 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 111.961 -2.382 . . . . 0.0 105.697 177.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.524 ' H ' ' HG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -99.33 117.02 32.85 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.534 179.338 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.638 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -143.07 153.3 42.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.742 -179.864 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 140.77 47.66 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.222 177.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.505 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 34.8 m-85 -117.38 142.64 46.86 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.371 -172.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.22 81.25 0.69 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.662 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.488 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -51.06 158.79 1.13 Allowed Pre-proline 0 C--N 1.308 -1.208 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.727 -176.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.83 33.18 1.43 Allowed 'Cis proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.12 -1.2 . . . . 0.0 111.826 -2.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.488 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 m-80 -145.29 -166.12 2.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.403 176.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -165.98 144.92 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.14 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 3.4 m -115.55 122.16 44.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.048 -1.861 . . . . 0.0 107.289 167.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.49 135.81 33.74 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.865 -172.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.703 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -105.92 167.19 10.02 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.444 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -86.98 158.66 50.13 Favored 'Cis proline' 0 C--O 1.214 -0.696 0 N-CA-C 115.068 1.142 . . . . 0.0 115.068 2.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.703 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 111.926 -2.397 . . . . 0.0 109.508 174.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.02 35.55 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 167.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.06 122.38 20.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -175.081 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.43 178.71 6.97 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 117.558 -1.657 . . . . 0.0 108.863 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.491 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -130.96 -177.48 4.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.381 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -77.73 113.67 15.82 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.961 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.03 64.16 Favored Glycine 0 C--N 1.297 -1.612 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.379 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -119.51 107.07 41.42 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.696 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -72.42 174.15 12.04 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.161 1.24 . . . . 0.0 109.55 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.47 -99.72 1.97 Allowed Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.635 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.599 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -159.38 159.9 34.31 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.666 -176.268 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.44 143.86 12.93 Favored Glycine 0 C--N 1.288 -2.105 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 171.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -76.17 127.72 33.5 Favored 'General case' 0 C--O 1.17 -3.079 0 C-N-CA 118.994 -1.082 . . . . 0.0 108.359 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 117.49 23.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 117.542 -1.663 . . . . 0.0 112.139 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -111.1 159.69 17.58 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 112.225 -2.261 . . . . 0.0 109.458 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.471 ' C ' ' HA ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -81.93 -163.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.701 -176.443 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -68.34 70.78 0.17 Allowed 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 123.181 1.467 . . . . 0.0 108.579 -175.748 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.9 mtp180 -105.74 141.54 37.0 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.997 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.85 -34.31 53.36 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.9 157.72 44.31 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.86 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.0 149.97 64.12 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.035 -179.629 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 144.47 97.47 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 121.006 1.137 . . . . 0.0 111.163 176.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.26 -15.34 72.05 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.089 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.77 -29.76 74.95 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -81.81 4.62 21.5 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.08 16.22 68.39 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.491 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 39.4 m-85 -66.07 169.56 6.75 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.126 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 p -162.15 -46.98 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.474 -2.148 . . . . 0.0 106.117 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 41' ' ' TYR . 33.3 p -98.02 118.21 34.12 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.219 -2.264 . . . . 0.0 110.378 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.77 158.4 40.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.931 -1.508 . . . . 0.0 112.998 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.43 148.43 45.12 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.312 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.463 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 12.2 m-85 -114.93 137.8 51.56 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.511 -171.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 mttp -138.49 73.69 1.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.145 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.491 ' CD1' ' C ' ' A' ' 35' ' ' TRP . 6.9 t-105 -37.78 147.99 0.23 Allowed Pre-proline 0 N--CA 1.504 2.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 2.4 Cg_endo -78.13 37.68 0.5 Allowed 'Cis proline' 0 N--CA 1.495 1.572 0 C-N-CA 124.976 -0.843 . . . . 0.0 110.87 -6.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -146.29 -155.91 0.66 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.259 -179.101 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.463 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -170.86 141.72 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.299 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.179 179.185 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.2 m -110.63 144.74 39.07 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 167.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.9 t -117.74 135.42 54.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.6 m-85 -102.61 174.11 3.07 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 176.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.5 Cg_exo -55.19 -61.5 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.917 0 N-CA-C 117.209 1.965 . . . . 0.0 117.209 5.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.599 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.123 0 CA-C-O 116.438 -1.744 . . . . 0.0 109.879 -170.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.6 ' HB2' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.457 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.6 Cg_endo -86.1 23.97 0.79 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 N-CA-C 107.089 -1.927 . . . . 0.0 107.089 164.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.6 ' H ' ' HB2' ' A' ' 2' ' ' ALA . 12.7 p -75.07 116.62 16.01 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-N 113.447 -1.706 . . . . 0.0 108.939 -177.081 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.13 179.44 6.85 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.92 -175.359 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -113.09 -173.71 2.31 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.345 177.63 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -75.14 120.37 20.55 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.041 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -8.52 51.1 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.763 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -115.82 100.99 54.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.701 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.56 152.22 37.96 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.188 1.259 . . . . 0.0 109.804 174.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.85 -93.33 0.3 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.929 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -162.05 159.21 25.99 Favored 'General case' 0 C--O 1.199 -1.588 0 C-N-CA 118.624 -1.231 . . . . 0.0 112.217 -178.532 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -153.51 151.18 22.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 174.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -78.42 128.08 33.1 Favored 'General case' 0 C--O 1.182 -2.46 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.166 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 12.6 tp -94.08 101.92 13.96 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.865 1.317 . . . . 0.0 111.717 -177.109 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.42 ' O ' ' N ' ' A' ' 38' ' ' ILE . 78.4 m95 -88.87 123.4 33.21 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 111.889 -2.414 . . . . 0.0 107.402 176.041 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.77 -16.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -170.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.8 mt -151.73 71.57 0.99 Allowed 'General case' 0 C--N 1.247 -3.86 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.907 -171.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -156.29 141.19 17.17 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 117.841 -1.544 . . . . 0.0 112.297 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.556 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -91.28 -19.48 41.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.16 43.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.18 162.07 63.01 Favored Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.948 -179.111 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.29 114.51 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 121.489 1.459 . . . . 0.0 112.33 -171.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -0.94 65.6 0.0 OUTLIER Glycine 0 N--CA 1.488 2.123 1 N-CA-C 131.162 7.225 . . . . 0.0 131.162 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.11 48.8 71.53 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.033 -1.556 . . . . 0.0 110.365 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.61 -77.78 0.17 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.042 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.11 -23.19 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.504 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.0 m-85 -77.66 170.48 16.5 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.568 1.175 . . . . 0.0 112.337 -179.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 p -160.88 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 112.353 -2.203 . . . . 0.0 105.957 176.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -96.36 118.06 32.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.333 -179.909 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.56 149.62 29.4 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.031 -1.468 . . . . 0.0 113.185 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.6 p -103.4 142.74 33.72 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.017 175.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.5 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 29.4 m-85 -117.12 134.79 54.34 Favored 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 119.267 -0.973 . . . . 0.0 112.479 -173.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -147.56 80.0 1.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.556 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -53.36 152.99 7.67 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.343 -175.437 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 5.2 Cg_endo -72.66 -6.9 15.96 Favored 'Cis proline' 0 C--O 1.208 -0.996 0 C-N-CA 124.197 -1.168 . . . . 0.0 110.451 -5.298 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 37' ' ' ASN . 1.6 m-80 -91.61 -165.15 1.29 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.284 1.04 . . . . 0.0 111.873 -178.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.5 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 179.42 142.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.005 -178.116 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 18.4 m -113.56 103.87 11.69 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.421 -1.312 . . . . 0.0 107.795 172.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -82.27 138.05 34.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.32 -1.309 . . . . 0.0 113.342 -172.673 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.567 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -109.73 -178.8 0.58 Allowed Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.1 Cg_exo -63.81 -50.48 0.17 OUTLIER 'Cis proline' 0 N--CA 1.507 2.287 0 N-CA-C 116.813 1.813 . . . . 0.0 116.813 5.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.589 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.752 0 CA-C-O 116.382 -1.771 . . . . 0.0 110.074 -171.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -84.26 29.64 0.54 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 106.586 -2.121 . . . . 0.0 106.586 165.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.598 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.2 p -92.0 117.3 29.69 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.237 -174.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 2.2 m-85 -78.06 172.46 13.49 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.398 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -108.78 -171.89 1.94 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.589 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -74.86 114.95 13.9 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.304 -1.358 . . . . 0.0 111.009 -177.693 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.88 3.52 60.0 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.414 178.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -113.05 113.64 49.24 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.093 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.28 -163.22 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.573 1.516 . . . . 0.0 111.664 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 69.22 -118.25 8.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.582 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.9 ptp180 -152.46 -171.52 3.96 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 118.398 -1.321 . . . . 0.0 112.133 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -152.02 155.95 26.42 Favored Glycine 0 C--N 1.273 -2.925 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 173.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -76.28 131.93 39.54 Favored 'General case' 0 C--O 1.176 -2.78 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.936 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.454 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 14.5 tp -92.3 110.16 21.55 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.908 1.337 . . . . 0.0 110.774 -177.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -106.84 160.0 15.83 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 112.068 -2.333 . . . . 0.0 109.875 -177.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -86.15 -161.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.788 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -67.96 72.95 0.18 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.413 1.577 . . . . 0.0 108.728 -175.706 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.8 mtp85 -110.86 125.75 53.95 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 111.952 -2.385 . . . . 0.0 109.877 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.25 -26.2 70.34 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 p -149.38 153.43 37.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.789 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -81.31 152.37 70.54 Favored Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.164 179.37 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 25' ' ' GLY . 2.7 Cg_exo -51.25 124.53 14.28 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 C-N-CA 121.015 1.143 . . . . 0.0 111.641 -178.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.74 25.23 2.54 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -133.7 -4.27 3.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.572 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -56.36 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.996 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.24 0.72 1.0 Allowed Glycine 0 C--N 1.288 -2.128 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.824 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.597 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 47.7 m-85 -68.62 170.68 8.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 122.569 1.176 . . . . 0.0 111.896 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.5 ' HG1' ' H ' ' A' ' 30' ' ' SER . 1.1 p -161.03 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.544 -2.117 . . . . 0.0 106.055 177.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.5 ' H ' ' HG1' ' A' ' 29' ' ' THR . 0.9 OUTLIER -97.66 123.54 41.62 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.79 178.785 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.578 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -155.2 149.49 26.01 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.882 -1.527 . . . . 0.0 112.485 178.911 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 7.8 p -108.81 146.08 34.2 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.441 177.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.471 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 46.8 m-85 -123.01 133.89 54.34 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.22 -175.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.45 83.17 1.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.278 -0.873 . . . . 0.0 108.754 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.78 160.19 0.2 Allowed Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.949 -176.221 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 18' ' ' LEU . 8.2 Cg_endo -80.12 34.06 1.36 Allowed 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.21 -1.162 . . . . 0.0 110.435 -5.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.459 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 7.0 m-80 -147.15 -163.32 1.73 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.871 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.471 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -162.22 146.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.031 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.9 m -117.76 105.32 11.86 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.695 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -81.73 141.71 33.32 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.194 -172.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.3 m-85 -110.04 175.8 1.78 Allowed Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.4 Cg_exo -57.49 -58.45 0.04 OUTLIER 'Cis proline' 0 N--CA 1.506 2.215 0 N-CA-C 117.773 2.182 . . . . 0.0 117.773 6.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.179 0 CA-C-O 116.273 -1.823 . . . . 0.0 109.594 -169.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.506 2.328 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.55 37.03 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 N-CA-C 108.308 -1.458 . . . . 0.0 108.308 165.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.76 122.14 21.92 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.585 -174.5 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.44 174.03 12.01 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.241 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.41 179.99 6.47 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.012 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -71.75 134.55 46.28 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.534 -174.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.68 -12.23 0.53 Allowed Glycine 0 N--CA 1.478 1.464 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.767 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 mttt -113.05 105.86 55.36 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.102 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -72.09 154.58 57.4 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 173.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -105.06 1.25 Allowed Glycine 0 C--N 1.287 -2.152 1 N-CA-C 129.604 6.602 . . . . 0.0 129.604 -176.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.671 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 5.5 ptm180 -162.65 152.84 16.4 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.815 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.69 152.12 23.62 Favored Glycine 0 N--CA 1.493 2.472 1 N-CA-C 125.716 5.046 . . . . 0.0 125.716 171.961 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 4.8 m-20 -77.11 122.34 24.84 Favored 'General case' 0 C--O 1.171 -3.037 0 C-N-CA 118.015 -1.474 . . . . 0.0 109.709 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -86.56 100.24 12.27 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.335 -178.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.698 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 61.5 m95 -87.59 165.11 15.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.406 177.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -90.86 -159.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.939 -176.824 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.05 70.27 0.15 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.202 1.477 . . . . 0.0 108.411 -176.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' ILE . 3.6 mtp180 -113.62 120.87 42.38 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 112.202 -2.272 . . . . 0.0 110.49 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -23.38 64.94 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.157 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 154.07 38.33 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.934 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.97 149.96 54.42 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.975 179.2 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.83 143.69 95.15 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.83 1.02 . . . . 0.0 110.815 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.23 -1.22 75.82 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.239 -1.457 . . . . 0.0 110.095 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.58 -14.68 70.1 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.15 -91.78 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.036 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.68 24.61 0.03 OUTLIER Glycine 0 C--N 1.29 -2.0 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.54 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.698 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 44.2 m-85 -86.37 170.11 12.31 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.921 1.343 . . . . 0.0 112.347 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 p -162.55 -44.44 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 112.041 -2.345 . . . . 0.0 105.849 176.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' TYR . 29.8 p -96.98 114.24 25.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.513 -2.131 . . . . 0.0 109.806 -179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.561 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.55 151.36 37.2 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.956 177.984 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.09 145.65 35.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.752 177.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 15.9 m-85 -118.23 125.91 51.1 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.86 -171.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 35' ' ' TRP . 25.8 mttt -127.04 70.55 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.612 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' LYS . 31.7 t-105 -39.22 144.09 0.47 Allowed Pre-proline 0 C--N 1.296 -1.738 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.483 178.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 9.5 Cg_endo -79.39 39.35 0.57 Allowed 'Cis proline' 0 N--CA 1.494 1.514 0 C-N-CA 125.66 -0.558 . . . . 0.0 111.372 -5.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.46 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -149.31 -159.73 1.08 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.474 -1.291 . . . . 0.0 110.935 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -170.94 142.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.991 179.582 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 16.0 m -111.18 133.15 53.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -105.82 130.84 53.72 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -170.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -103.83 179.19 1.0 Allowed Pre-proline 0 N--CA 1.513 2.698 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 177.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.574 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.0 Cg_exo -59.11 -54.91 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.177 0 N-CA-C 117.217 1.968 . . . . 0.0 117.217 6.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.671 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.659 0 CA-C-O 116.373 -1.775 . . . . 0.0 109.247 -171.389 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.537 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 119.502 -0.285 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -80.32 59.49 7.46 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -74.8 142.42 44.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.569 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -78.44 169.14 18.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.369 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -114.0 -166.22 1.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 9' ' ' LYS . 3.0 t -62.27 110.39 1.62 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.671 -177.74 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.91 1.12 0.79 Allowed Glycine 0 N--CA 1.479 1.528 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.208 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 7' ' ' SER . 30.3 mttt -99.33 116.44 65.04 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.573 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 1.2 Cg_endo -70.76 -167.89 0.29 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 173.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.97 -119.53 5.46 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.57 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -162.0 159.56 26.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.585 -179.771 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.84 149.77 20.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 172.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 12.8 m-20 -77.03 125.84 29.98 Favored 'General case' 0 C--O 1.175 -2.854 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.186 -179.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.0 tp -83.23 106.42 15.0 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 117.056 -1.858 . . . . 0.0 111.793 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.557 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 53.4 m95 -90.48 171.53 9.36 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 111.723 -2.489 . . . . 0.0 110.374 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -88.94 -163.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.079 -178.867 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -68.06 72.31 0.18 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.945 1.355 . . . . 0.0 108.454 -176.197 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.8 mtp85 -113.1 111.1 21.54 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.356 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.49 -24.95 40.46 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.204 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 p -141.77 151.54 42.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.39 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.62 147.26 55.2 Favored Pre-proline 0 C--N 1.289 -2.051 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.387 -179.68 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.55 148.21 54.6 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 121.004 1.136 . . . . 0.0 111.737 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLY . . . -84.48 -33.05 20.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.997 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.97 -28.25 16.53 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.13 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.28 -25.93 42.39 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.733 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . 87.68 12.61 66.42 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.674 -1.25 . . . . 0.0 111.566 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 45.6 m-85 -57.9 172.56 0.39 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.636 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.405 ' HG1' ' H ' ' A' ' 30' ' ' SER . 17.1 p -162.36 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.804 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.904 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.67 110.21 22.82 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.318 -177.592 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.08 156.11 40.38 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.339 -1.344 . . . . 0.0 112.778 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 p -112.17 146.81 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.738 176.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 26.1 m-85 -117.07 133.24 56.24 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.3 -0.96 . . . . 0.0 112.38 -174.044 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -134.82 70.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.588 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.477 ' CD1' ' C ' ' A' ' 35' ' ' TRP . 11.8 t-105 -37.92 148.39 0.22 Allowed Pre-proline 0 N--CA 1.506 2.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.725 178.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 6.2 Cg_endo -77.64 33.79 0.73 Allowed 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 125.613 -0.578 . . . . 0.0 111.095 -6.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.558 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -147.15 -167.16 2.7 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.22 178.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.01 153.32 4.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.904 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -125.2 130.8 52.84 Favored 'General case' 0 C--O 1.216 -0.707 0 C-N-CA 117.948 -1.501 . . . . 0.0 107.586 168.189 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -167.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -111.42 -178.07 0.51 Allowed Pre-proline 0 N--CA 1.51 2.566 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.175 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.539 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.9 Cg_exo -57.79 -54.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.506 2.258 0 CA-C-N 122.485 1.923 . . . . 0.0 117.027 4.302 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.483 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.71 -171.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.551 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.505 2.287 0 CA-C-O 119.774 -0.155 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -81.55 49.73 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 168.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.31 138.33 45.37 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.039 -1.064 . . . . 0.0 108.16 -172.762 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.499 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -78.65 175.66 10.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.07 -1.452 . . . . 0.0 109.831 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -169.02 1.39 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.813 179.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.21 108.52 10.37 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.062 -178.342 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.97 89.14 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.683 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -115.52 113.41 42.92 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.054 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.58 -161.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.793 0 C-N-CA 120.904 1.069 . . . . 0.0 109.335 174.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.47 -109.11 2.77 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.911 178.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.59 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.14 177.01 10.07 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.658 -1.217 . . . . 0.0 113.423 -177.353 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.59 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -157.46 158.37 28.91 Favored Glycine 0 N--CA 1.503 3.151 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.3 m-20 -78.06 122.97 26.28 Favored 'General case' 0 C--O 1.177 -2.731 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.287 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 4.5 tt -91.53 99.64 12.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 117.397 -1.721 . . . . 0.0 113.14 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.556 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 70.3 m95 -75.72 122.68 24.37 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.0 174.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.1 mt -89.96 -10.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.2 mt -150.14 71.23 1.06 Allowed 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.536 -171.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.93 158.38 10.58 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.093 178.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.96 -29.25 4.4 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -129.01 152.16 48.92 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.801 177.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.61 153.51 47.97 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.99 -179.09 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.2 -178.75 0.09 OUTLIER 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.513 1.475 . . . . 0.0 112.071 -175.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.76 12.6 10.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -108.44 -5.48 32.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.99 -28.43 14.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.137 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.74 54.46 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.717 -1.23 . . . . 0.0 111.51 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.629 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 47.0 m-85 -53.7 167.17 0.26 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.986 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 3.9 p -163.38 -43.27 0.03 OUTLIER 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.544 177.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -96.56 111.58 23.65 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.706 -2.043 . . . . 0.0 109.119 -179.575 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -150.96 146.9 26.56 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.751 -177.784 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.55 138.2 36.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.222 177.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.491 ' CE1' ' CD1' ' A' ' 38' ' ' ILE . 95.8 m-85 -118.35 134.38 55.1 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.861 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.2 82.38 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.21 158.85 0.43 Allowed Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.825 -176.417 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.3 Cg_endo -74.2 5.16 10.82 Favored 'Cis proline' 0 C--O 1.204 -1.206 0 C-N-CA 124.215 -1.161 . . . . 0.0 111.435 -3.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.664 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -114.36 -162.93 0.84 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 122.195 0.997 . . . . 0.0 111.268 -176.46 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -178.61 144.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.377 -179.538 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.22 111.86 19.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 117.469 -1.692 . . . . 0.0 108.049 170.029 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.629 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -82.87 148.17 27.87 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.211 -170.478 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.74 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.8 OUTLIER -124.06 168.71 12.09 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 178.114 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -77.39 157.6 96.12 Favored 'Cis proline' 0 C--N 1.325 -0.698 0 CA-C-O 122.88 1.117 . . . . 0.0 114.147 4.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.74 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.602 0 CA-C-N 111.981 -2.372 . . . . 0.0 109.711 175.571 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 4' ' ' CYS 0.255 . . . . . . . 0 N--CA 1.506 2.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.86 31.88 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.4 p -85.62 114.56 22.71 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.791 -176.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -77.76 175.41 9.99 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.493 -1.283 . . . . 0.0 110.274 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.7 m -113.24 -177.21 3.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.83 121.47 24.14 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.541 -178.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.93 60.88 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.49 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -123.65 113.6 28.79 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.801 -178.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -74.71 -164.39 0.22 Allowed 'Trans proline' 0 C--O 1.212 -0.795 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 173.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -99.75 2.59 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.31 177.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.594 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.93 161.61 31.73 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.267 -177.232 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -147.42 147.36 18.06 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 174.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 14.9 m-20 -79.62 121.7 25.61 Favored 'General case' 0 C--O 1.17 -3.125 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.008 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 15.5 tp -92.19 92.79 8.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.842 1.306 . . . . 0.0 112.86 -175.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.538 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 68.6 m95 -74.14 120.12 19.28 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 112.165 -2.289 . . . . 0.0 108.196 174.209 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 mp -84.82 -11.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -171.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 mt -152.41 75.9 1.13 Allowed 'General case' 0 C--N 1.253 -3.59 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.672 -175.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.21 155.53 41.48 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.748 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.4 -26.71 4.16 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.67 151.49 45.97 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.303 175.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -91.36 138.1 25.73 Favored Pre-proline 0 C--N 1.288 -2.082 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.083 -178.781 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.76 152.22 75.68 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 121.035 1.157 . . . . 0.0 111.615 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.66 -16.24 46.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.24 -19.7 59.85 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.617 -1.277 . . . . 0.0 109.93 179.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.88 -60.51 2.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.958 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.75 13.07 0.64 Allowed Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 38.9 m-85 -72.78 170.22 15.07 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.874 1.321 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 p -161.97 -45.75 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 112.066 -2.333 . . . . 0.0 106.065 177.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 123.22 43.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.928 179.786 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -152.12 157.94 42.27 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 117.972 -1.491 . . . . 0.0 114.08 179.143 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.457 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 p -113.97 147.9 37.81 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.253 172.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 40.1 m-85 -116.69 136.83 52.64 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.295 -172.245 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' SG ' ' A' ' 32' ' ' CYS . 4.5 mttt -138.96 70.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.948 178.575 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.4 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -47.83 144.98 4.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.326 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 3.6 Cg_endo -70.57 -7.83 11.64 Favored 'Cis proline' 0 C--O 1.206 -1.105 0 C-N-CA 124.952 -0.853 . . . . 0.0 111.208 -4.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.628 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -93.29 -164.93 1.24 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.297 -177.323 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -179.03 137.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.801 -179.097 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 50.5 m -107.08 105.56 15.63 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.278 174.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -91.27 130.26 37.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.969 -1.469 . . . . 0.0 114.17 -172.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.543 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -97.78 176.27 2.14 Favored Pre-proline 0 N--CA 1.511 2.611 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.095 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 11.7 Cg_exo -58.07 -57.16 0.08 OUTLIER 'Cis proline' 0 N--CA 1.503 2.056 0 N-CA-C 117.339 2.015 . . . . 0.0 117.339 7.172 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.357 0 CA-C-O 116.331 -1.795 . . . . 0.0 109.864 -170.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.09 31.84 0.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 166.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.67 120.98 19.05 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -175.59 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -174.4 3.53 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.64 -1.624 . . . . 0.0 109.418 -178.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.48 -175.32 4.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.439 178.004 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.58 130.03 38.16 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.271 -176.345 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.24 41.94 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.722 179.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 109.65 21.9 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.819 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.75 150.8 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 N-CA-C 108.959 -1.208 . . . . 0.0 108.959 172.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -89.63 0.47 Allowed Glycine 0 N--CA 1.491 2.304 1 N-CA-C 130.521 6.968 . . . . 0.0 130.521 -177.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.535 ' C ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.08 149.11 17.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.542 -1.263 . . . . 0.0 112.567 179.181 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.78 148.5 20.14 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 175.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.9 m-20 -77.74 121.11 23.59 Favored 'General case' 0 C--O 1.18 -2.605 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.071 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 tp -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.333 -1.747 . . . . 0.0 110.891 179.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -119.75 152.65 36.88 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 111.303 -2.681 . . . . 0.0 106.975 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.561 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.54 -158.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.845 -176.265 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.54 68.84 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 123.128 1.442 . . . . 0.0 108.18 -177.049 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.65 136.73 46.9 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 112.5 -2.136 . . . . 0.0 110.427 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.06 -21.28 78.55 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.17 157.44 35.93 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.708 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.28 157.86 72.54 Favored Pre-proline 0 C--N 1.299 -1.6 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.219 177.894 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.59 -172.76 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 121.268 1.312 . . . . 0.0 111.794 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.69 10.98 10.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.23 -2.11 54.26 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.467 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -102.97 -52.45 3.05 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.16 30.65 2.05 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.598 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 79.0 m-85 -79.55 172.36 13.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.415 1.103 . . . . 0.0 110.999 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.634 ' HG1' ' H ' ' A' ' 30' ' ' SER . 6.1 p -162.41 -45.72 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 112.896 -1.957 . . . . 0.0 106.681 176.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.634 ' H ' ' HG1' ' A' ' 29' ' ' THR . 1.5 p -98.39 97.66 8.98 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 112.861 -1.972 . . . . 0.0 110.36 -178.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.678 HD22 ' H ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -129.64 151.16 50.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.661 -1.215 . . . . 0.0 113.013 -177.804 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 146.07 36.13 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.132 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 8.8 m-85 -120.53 127.99 52.68 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.346 -172.714 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.1 mttt -128.81 73.01 1.48 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.754 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.44 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -35.72 148.45 0.15 Allowed Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.941 179.734 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 4.9 Cg_endo -78.44 36.92 0.57 Allowed 'Cis proline' 0 N--CA 1.487 1.118 0 C-N-CA 125.221 -0.741 . . . . 0.0 111.44 -5.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.1 m-80 -147.48 -162.21 1.5 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.335 -179.403 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.47 140.33 2.1 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.223 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.437 179.652 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 32.0 m -112.83 119.67 38.82 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.171 168.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.0 t -88.86 142.32 27.75 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.848 -171.622 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.496 ' CB ' ' O ' ' A' ' 30' ' ' SER . 1.1 m-85 -122.28 167.76 13.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.444 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -78.82 158.52 91.93 Favored 'Cis proline' 0 C--N 1.32 -0.944 0 CA-C-O 122.914 1.131 . . . . 0.0 114.525 6.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.543 0 CA-C-N 111.975 -2.375 . . . . 0.0 109.245 175.412 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.505 2.301 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.41 30.6 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 108.318 -1.455 . . . . 0.0 108.318 166.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -66.52 125.25 25.15 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -174.938 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -78.24 165.33 24.04 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 117.269 -1.772 . . . . 0.0 109.402 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -134.31 176.96 8.13 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.896 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -74.47 139.48 43.92 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.732 -176.552 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.04 -17.81 0.92 Allowed Glycine 0 C--N 1.295 -1.719 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.898 179.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 7' ' ' SER . 7.5 mptt -128.63 107.03 18.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.21 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.41 162.99 27.62 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.908 -1.228 . . . . 0.0 108.908 173.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.85 -90.53 0.52 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.553 178.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.564 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.4 153.33 21.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.808 -176.794 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.72 146.54 18.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 173.287 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 22.0 m-20 -77.59 119.05 20.6 Favored 'General case' 0 C--O 1.173 -2.958 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.2 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -81.22 132.21 35.33 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.008 -1.877 . . . . 0.0 111.711 -178.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.881 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 59.7 m95 -123.34 120.02 31.8 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 111.562 -2.563 . . . . 0.0 105.379 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.454 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -83.84 -16.91 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -168.201 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 mt -151.88 70.9 0.95 Allowed 'General case' 1 C--N 1.239 -4.214 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.087 -171.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -153.73 140.69 19.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 117.064 -1.854 . . . . 0.0 112.928 178.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.49 -25.0 29.31 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 177.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.28 153.68 45.33 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.507 ' N ' ' HH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -90.83 151.53 43.68 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.636 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.31 109.39 0.97 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.922 1.081 . . . . 0.0 111.122 -178.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -21.33 70.44 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.186 -1.483 . . . . 0.0 109.903 178.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.18 -1.88 76.34 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.058 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -92.05 -101.88 0.12 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.18 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.65 -2.48 0.38 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.397 -1.382 . . . . 0.0 111.167 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.881 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 53.0 m-85 -82.77 168.2 17.41 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 122.692 1.234 . . . . 0.0 112.062 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -158.63 -45.55 0.06 Allowed 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 112.153 -2.294 . . . . 0.0 105.78 177.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -98.69 118.15 34.77 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.03 178.751 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.642 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -144.45 149.42 35.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 117.917 -1.513 . . . . 0.0 113.577 179.621 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 148.07 29.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.068 176.282 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.507 ' HH ' ' N ' ' A' ' 22' ' ' CYS . 36.4 m-85 -118.71 137.33 53.41 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.748 -172.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 35' ' ' TRP . 39.7 mmtt -130.21 56.77 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.291 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 34' ' ' LYS . 31.3 t-105 -29.05 139.89 0.11 Allowed Pre-proline 0 N--CA 1.504 2.236 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.596 -177.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -71.89 -7.52 14.41 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.869 -6.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.649 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.58 -158.2 0.44 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.606 -177.003 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER 176.49 139.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.193 -1.916 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.461 -178.55 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 11.5 m -109.37 108.75 19.41 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 117.337 -1.745 . . . . 0.0 107.028 170.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.658 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.4 t -83.78 142.81 30.4 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.627 -171.45 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.6 m-85 -117.7 166.01 14.5 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.273 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -76.31 159.88 96.08 Favored 'Cis proline' 0 CA--C 1.509 -0.735 0 CA-C-O 122.885 1.119 . . . . 0.0 113.651 4.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.564 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.897 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.514 178.282 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -84.24 30.15 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 N-CA-C 108.001 -1.577 . . . . 0.0 108.001 167.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -71.46 119.24 15.33 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -174.728 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.0 160.6 29.01 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.25 -1.78 . . . . 0.0 109.966 -178.331 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.65 179.41 4.35 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.684 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.3 p -80.87 118.98 22.85 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.99 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 -11.16 71.21 Favored Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.203 -179.247 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -127.41 110.95 21.13 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.445 -179.706 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -165.94 0.27 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.062 1.174 . . . . 0.0 109.398 173.466 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.14 -96.78 2.25 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 118.961 -1.59 . . . . 0.0 111.105 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.579 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.88 160.32 30.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.963 -178.591 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -144.54 140.42 9.26 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 172.732 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -76.02 129.18 36.47 Favored 'General case' 0 C--O 1.173 -2.953 0 C-N-CA 118.628 -1.229 . . . . 0.0 108.136 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -83.45 125.65 31.94 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.58 -1.648 . . . . 0.0 111.455 -178.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.732 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 54.3 m95 -122.03 161.39 23.08 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.023 -178.554 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -83.79 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.736 -176.998 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -68.45 68.94 0.14 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.224 1.487 . . . . 0.0 107.807 -177.824 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' ILE . 16.5 mtp85 -101.77 113.34 26.42 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.593 -2.094 . . . . 0.0 110.845 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.32 -35.94 36.25 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.33 -1.414 . . . . 0.0 109.685 179.088 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.22 156.72 45.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.99 178.712 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.12 147.07 49.84 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.768 178.656 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.04 -175.83 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.093 1.195 . . . . 0.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.25 -41.22 1.41 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.64 12.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.488 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 28' ' ' TYR . 7.0 m-85 -81.79 15.48 2.19 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.335 -179.69 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.51 11.49 0.29 Allowed Glycine 0 N--CA 1.487 2.046 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.78 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.732 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 35.7 m-85 -63.93 167.57 6.06 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 117.84 -1.544 . . . . 0.0 111.189 179.455 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -162.59 -43.83 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.372 -2.195 . . . . 0.0 106.616 177.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.62 125.77 42.55 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.929 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.73 HD21 ' H ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -160.52 162.98 33.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.923 -1.511 . . . . 0.0 112.841 -179.718 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.8 p -116.79 137.25 52.33 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.826 176.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.514 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 60.3 m-85 -112.52 120.43 41.58 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.468 -174.42 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -139.69 73.64 1.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.548 179.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.455 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.64 157.83 0.43 Allowed Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.727 -176.793 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' O ' ' CA ' ' A' ' 18' ' ' LEU . 14.0 Cg_endo -80.99 26.48 4.98 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.442 0.4 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.455 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.2 m-80 -144.74 178.3 8.09 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.463 175.636 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.514 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -148.07 148.58 16.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.951 -179.534 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 31.6 m -114.14 151.32 32.83 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 166.342 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.2 t -123.05 137.36 54.96 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.839 -1.144 . . . . 0.0 114.012 -169.354 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.553 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.7 m-85 -104.48 176.14 1.89 Allowed Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.631 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.9 Cg_exo -52.74 -62.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.928 0 N-CA-C 117.328 2.011 . . . . 0.0 117.328 4.388 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.579 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 116.265 -1.826 . . . . 0.0 109.6 -170.167 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.23 40.79 0.7 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 165.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -82.24 122.61 28.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -175.796 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.05 177.9 8.45 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.871 -1.532 . . . . 0.0 109.526 179.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.63 175.16 9.24 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.642 177.072 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.53 129.27 36.23 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.816 -177.693 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.91 -22.27 6.0 Favored Glycine 0 C--N 1.296 -1.662 0 C-N-CA 119.064 -1.541 . . . . 0.0 110.165 -178.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -110.4 115.41 54.23 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.838 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -76.33 -163.59 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 173.433 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.69 -106.04 2.05 Favored Glycine 0 C--N 1.287 -2.189 0 C-N-CA 118.832 -1.651 . . . . 0.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.548 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 8.2 ptm180 -159.25 177.42 11.05 Favored 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 118.176 -1.41 . . . . 0.0 114.224 -176.325 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -156.61 144.23 10.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 173.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 32.5 m-20 -76.25 124.57 27.69 Favored 'General case' 0 C--O 1.177 -2.719 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.199 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tt -86.09 111.37 20.27 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.019 -1.872 . . . . 0.0 112.296 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' ILE . 46.1 m95 -92.65 -178.13 4.78 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 112.25 -2.25 . . . . 0.0 108.864 176.045 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -102.03 -162.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.691 -176.288 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.72 66.81 0.13 Allowed 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 122.964 1.364 . . . . 0.0 107.726 -177.672 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 17' ' ' ILE . 1.1 mtt85 -111.54 113.26 25.55 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 112.573 -2.103 . . . . 0.0 110.665 -179.398 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.08 -34.52 16.78 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.42 157.4 45.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.305 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -86.03 152.33 55.9 Favored Pre-proline 0 C--N 1.298 -1.633 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.173 179.277 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.98 115.5 2.47 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 120.698 0.932 . . . . 0.0 110.181 174.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.58 -4.87 47.97 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.375 -1.393 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 -0.56 55.87 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.179 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.23 -16.08 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.396 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.75 -3.36 23.02 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.761 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 43.1 m-85 -77.3 169.76 17.75 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.834 1.302 . . . . 0.0 112.471 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -162.97 -45.37 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 112.055 -2.339 . . . . 0.0 106.345 176.056 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 41' ' ' TYR . 80.2 p -99.38 115.29 28.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.066 -179.37 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -143.54 148.8 36.5 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.935 -179.932 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.5 144.47 33.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.788 176.105 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 26.8 m-85 -117.98 133.21 56.14 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.894 -173.005 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -138.72 75.59 1.53 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.957 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.448 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.9 155.73 0.39 Allowed Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.46 -177.994 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 7.3 Cg_endo -78.08 32.92 0.9 Allowed 'Cis proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.5 -1.042 . . . . 0.0 111.571 -4.51 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.546 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -145.07 -160.7 1.17 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.811 177.754 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.28 147.76 4.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.918 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 39.1 m -116.88 119.05 34.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.015 168.216 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.3 t -90.57 139.15 30.98 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.968 -171.501 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.6 m-85 -112.12 178.41 0.98 Allowed Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 15.7 Cg_exo -59.49 -56.64 0.12 OUTLIER 'Cis proline' 0 N--CA 1.502 2.02 0 N-CA-C 116.695 1.767 . . . . 0.0 116.695 4.818 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.567 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.7 0 CA-C-O 116.439 -1.743 . . . . 0.0 109.325 -171.043 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.23 33.7 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 164.249 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.552 ' H ' ' C ' ' A' ' 2' ' ' ALA . 12.7 p -84.98 115.37 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.455 -176.25 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.46 172.7 13.26 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.989 -178.508 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.89 -173.62 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.727 178.877 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -75.41 118.59 18.45 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.631 -175.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.38 44.87 Favored Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.844 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -113.51 109.43 51.01 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.319 -179.503 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.87 -172.6 1.0 Allowed 'Trans proline' 0 C--N 1.32 -0.927 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 173.222 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.3 -110.57 3.58 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.58 -1.772 . . . . 0.0 110.807 179.079 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.577 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -160.35 168.71 24.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.125 -177.967 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.577 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -147.9 157.38 27.32 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 174.268 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.577 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 1.2 m-20 -78.48 130.0 35.53 Favored 'General case' 0 C--O 1.172 -3.005 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.628 178.511 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 13.7 tp -96.08 97.33 9.49 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.923 1.344 . . . . 0.0 111.784 -177.294 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.454 ' O ' ' N ' ' A' ' 38' ' ' ILE . 78.5 m95 -83.08 115.52 21.92 Favored 'General case' 0 C--N 1.263 -3.157 0 CA-C-N 112.063 -2.335 . . . . 0.0 107.494 175.56 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 mt -88.31 -8.85 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 mt -154.83 71.58 0.81 Allowed 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.674 -173.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.591 ' NH2' ' N ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -153.25 162.36 41.39 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 117.592 -1.643 . . . . 0.0 111.95 177.129 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -109.06 -32.48 3.03 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.454 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -136.21 153.94 51.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.412 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.74 149.08 39.84 Favored Pre-proline 0 C--N 1.293 -1.855 0 C-N-CA 118.779 -1.168 . . . . 0.0 110.068 -179.195 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.591 ' N ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 Cg_endo -66.83 146.47 78.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.878 1.052 . . . . 0.0 111.665 -178.69 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.68 -16.48 54.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 177.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.39 -9.13 87.25 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.05 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.73 -30.23 18.18 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.623 178.908 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.66 -9.48 12.82 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.227 177.576 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 45.4 m-85 -63.25 167.17 5.4 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.145 -178.821 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -162.23 -43.43 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 112.224 -2.262 . . . . 0.0 106.107 177.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.469 ' H ' ' HG ' ' A' ' 30' ' ' SER . 2.8 p -97.38 119.01 35.13 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.4 179.627 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.541 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -156.45 155.19 31.63 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.404 -1.718 . . . . 0.0 113.599 179.91 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 150.27 38.58 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.331 176.474 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.497 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 36.4 m-85 -118.23 140.83 49.22 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.693 -171.212 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' ASN . 19.3 mttt -134.9 70.75 1.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.835 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -40.68 140.21 1.06 Allowed Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.222 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.89 2.47 14.57 Favored 'Cis proline' 0 N--CA 1.498 1.793 0 C-N-CA 125.319 -0.7 . . . . 0.0 110.425 -6.428 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -93.41 -163.24 1.02 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.898 0.856 . . . . 0.0 112.301 -175.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 177.5 139.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.081 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.328 178.728 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 36.4 m -110.52 115.42 29.59 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.698 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -97.49 136.57 37.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.842 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.5 m-85 -107.03 179.49 0.88 Allowed Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.254 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 4.1 Cg_exo -65.45 -52.37 0.15 OUTLIER 'Cis proline' 0 N--CA 1.508 2.347 0 N-CA-C 116.632 1.743 . . . . 0.0 116.632 7.856 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.97 0 CA-C-O 116.411 -1.757 . . . . 0.0 109.588 -170.155 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.495 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.506 2.365 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.72 30.44 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 107.941 -1.6 . . . . 0.0 107.941 164.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.86 123.93 30.43 Favored 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.553 -174.464 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.0 m-85 -84.52 158.69 20.89 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.378 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -124.83 178.89 5.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.573 178.645 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 127.34 32.38 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.355 -175.431 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.28 54.46 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.887 178.747 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 113.25 18.97 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.637 -179.107 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -70.19 -158.73 0.05 OUTLIER 'Trans proline' 0 C--O 1.217 -0.54 0 C-N-CA 121.204 1.269 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 70.43 -108.68 2.56 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.849 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 1.7 ptp180 -160.09 -176.22 5.53 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.059 177.188 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -139.39 160.36 25.94 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 3.4 m-20 -78.95 128.85 33.82 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 118.145 -1.422 . . . . 0.0 108.048 177.695 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.495 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 22.8 tp -92.77 103.55 15.9 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.951 1.358 . . . . 0.0 112.503 -175.409 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.443 ' O ' ' N ' ' A' ' 38' ' ' ILE . 73.9 m95 -93.05 110.05 21.52 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.701 175.17 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.1 mt -81.38 -10.53 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -170.261 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mt -154.32 78.42 1.09 Allowed 'General case' 0 C--N 1.255 -3.519 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.274 -173.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 148.1 11.19 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.454 -1.699 . . . . 0.0 112.219 178.494 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.19 -17.86 28.3 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 177.225 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.75 161.61 39.52 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.608 178.596 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -105.42 150.94 39.55 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.87 179.403 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.22 165.43 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.837 1.024 . . . . 0.0 110.736 175.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.69 -22.13 8.69 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.137 179.62 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.76 83.15 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.193 179.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.5 -13.4 59.13 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.963 179.764 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.47 55.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.091 177.006 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.634 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.9 m-85 -75.75 168.0 20.84 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.241 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -162.85 -45.08 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 111.966 -2.379 . . . . 0.0 105.654 175.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 14.9 p -98.97 113.51 25.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.893 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -138.0 150.7 47.21 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.522 -1.271 . . . . 0.0 113.215 179.318 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -106.01 151.24 24.88 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.065 176.358 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 34.1 m-85 -129.03 145.31 51.29 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.207 -172.701 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 78.02 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.224 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.423 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.76 152.95 0.42 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.426 -175.284 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -73.58 -1.81 14.14 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.444 -1.065 . . . . 0.0 110.64 -5.516 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.644 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -94.16 -166.14 1.44 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.654 1.216 . . . . 0.0 111.524 -178.132 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -172.4 139.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.36 178.772 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 57.7 m -109.7 102.89 11.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 171.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.634 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.9 t -79.01 142.97 36.13 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.558 -171.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -116.86 165.45 15.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.553 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -77.31 160.08 94.4 Favored 'Cis proline' 0 C--O 1.214 -0.691 0 CA-C-O 122.771 1.071 . . . . 0.0 114.27 4.249 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.432 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.34 177.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.584 ' HB2' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.515 2.806 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.96 20.67 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 107.924 -1.606 . . . . 0.0 107.924 163.604 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' H ' ' HB2' ' A' ' 2' ' ' ALA . 1.9 p -79.95 116.76 20.27 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.917 -178.551 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -80.89 -167.65 1.49 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.766 -173.383 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -175.98 3.7 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.78 176.674 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m -80.74 115.73 20.39 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.205 -178.626 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.7 -13.74 64.91 Favored Glycine 0 C--N 1.296 -1.668 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.237 -179.415 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -111.72 108.62 55.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -73.14 156.89 51.23 Favored 'Trans proline' 0 CA--C 1.507 -0.866 0 C-N-CA 120.999 1.132 . . . . 0.0 109.372 176.371 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.91 -90.56 0.57 Allowed Glycine 0 N--CA 1.484 1.862 1 N-CA-C 130.544 6.977 . . . . 0.0 130.544 -178.517 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' C ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.44 156.59 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.597 178.485 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -149.74 167.98 29.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 175.647 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -82.54 129.42 34.92 Favored 'General case' 0 C--O 1.178 -2.684 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.809 178.695 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.532 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 16.6 tp -96.62 106.6 18.89 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.909 1.338 . . . . 0.0 111.575 -178.535 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.455 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 69.4 m95 -93.47 108.95 20.55 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-N 111.79 -2.459 . . . . 0.0 107.021 176.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.2 mt -83.15 -4.81 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.52 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 mt -151.67 80.24 1.28 Allowed 'General case' 0 C--N 1.253 -3.612 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.604 -174.598 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.19 159.37 4.81 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.659 177.678 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.67 -26.06 3.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 175.224 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 p -128.99 149.09 50.97 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.191 176.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 153.26 39.65 Favored Pre-proline 0 C--N 1.287 -2.112 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.298 -179.346 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.9 Cg_exo -55.3 99.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.857 1.038 . . . . 0.0 111.099 -178.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.06 6.23 4.13 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.291 -1.433 . . . . 0.0 109.756 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -100.24 -17.06 25.77 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.42 -86.27 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.976 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.57 -16.51 0.02 OUTLIER Glycine 0 C--N 1.287 -2.153 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.894 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.647 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 36.7 m-85 -56.18 167.16 0.68 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.702 -178.693 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 p -162.89 -43.93 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 112.337 -2.211 . . . . 0.0 106.094 177.453 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 78.0 p -96.85 116.99 30.12 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.236 -179.952 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.59 155.28 40.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 117.953 -1.499 . . . . 0.0 113.917 -177.835 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -99.4 158.52 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.851 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.468 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 44.0 m-85 -138.58 133.64 32.77 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.909 -176.493 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.79 84.3 0.68 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.766 178.413 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.455 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -49.05 157.34 0.81 Allowed Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.656 -177.469 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.1 Cg_endo -71.16 0.99 7.29 Favored 'Cis proline' 0 C--O 1.206 -1.076 0 C-N-CA 124.277 -1.134 . . . . 0.0 111.042 -3.912 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.66 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -105.74 -165.6 1.12 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.691 1.234 . . . . 0.0 111.774 -177.042 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -172.25 143.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.131 -1.85 . . . . 0.0 107.314 178.735 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.2 m -113.61 109.58 18.84 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.208 174.228 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.647 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -89.62 140.81 29.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.963 -171.997 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.754 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -116.45 169.94 6.51 Favored Pre-proline 0 N--CA 1.503 2.214 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.196 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -81.24 156.49 82.89 Favored 'Cis proline' 0 CA--C 1.507 -0.864 0 CA-C-O 123.03 1.179 . . . . 0.0 114.384 3.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.754 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.979 0 CA-C-N 111.599 -2.546 . . . . 0.0 109.607 174.779 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -84.28 40.51 0.88 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 107.806 -1.652 . . . . 0.0 107.806 166.126 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.93 125.39 29.31 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.847 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.97 168.6 19.64 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.413 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.485 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -127.95 -175.24 3.42 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.951 -179.19 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -74.91 125.52 29.02 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.34 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.53 -2.06 24.69 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.615 -1.278 . . . . 0.0 111.043 178.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -126.4 115.24 23.29 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.94 -179.58 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.4 -175.98 3.01 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 108.16 -1.515 . . . . 0.0 108.16 171.05 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.96 -109.08 3.74 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.735 179.171 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.652 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 4.0 ptm180 -159.51 157.29 29.71 Favored 'General case' 0 C--O 1.207 -1.177 0 C-N-CA 118.58 -1.248 . . . . 0.0 112.791 -178.682 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.36 143.12 13.14 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.348 176.309 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.503 ' OD1' ' NH2' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -77.6 127.87 33.19 Favored 'General case' 0 C--O 1.172 -3.011 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.593 179.69 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.2 tp -86.1 129.5 34.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.825 -1.55 . . . . 0.0 111.186 -179.505 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.59 159.38 30.82 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.102 -178.136 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -84.03 -163.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.452 -177.44 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 70.59 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.131 1.443 . . . . 0.0 108.605 -176.459 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.8 mtp180 -102.12 133.7 46.54 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.474 178.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -60.23 -53.0 49.25 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.73 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.95 158.74 39.43 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.607 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.2 147.94 73.69 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.636 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.35 130.46 39.96 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.775 0.983 . . . . 0.0 111.391 -177.122 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.93 -17.86 58.89 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 178.566 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.98 -14.74 68.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -86.68 -70.54 0.6 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.347 179.632 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.95 -14.12 0.07 OUTLIER Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.128 -1.511 . . . . 0.0 111.751 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 51.4 m-85 -56.25 169.33 0.43 Allowed 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 122.656 1.217 . . . . 0.0 111.778 -179.385 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.602 ' HG1' ' H ' ' A' ' 30' ' ' SER . 7.3 p -162.57 -45.43 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 112.298 -2.228 . . . . 0.0 106.604 177.131 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.602 ' H ' ' HG1' ' A' ' 29' ' ' THR . 82.9 p -98.37 112.13 24.24 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 112.89 -1.959 . . . . 0.0 110.082 -178.693 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.734 HD21 ' H ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.16 156.28 42.41 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.584 -1.246 . . . . 0.0 112.712 -179.092 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 145.76 40.39 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.575 177.771 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.483 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 20.6 m-85 -118.82 126.55 52.08 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.874 -172.525 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 16.7 mttt -122.77 67.19 0.96 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.301 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.449 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 33.3 t-105 -34.8 142.69 0.23 Allowed Pre-proline 0 N--CA 1.496 1.85 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.405 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.3 Cg_endo -79.42 44.33 0.32 Allowed 'Cis proline' 0 N--CA 1.494 1.537 0 C-N-CA 125.62 -0.575 . . . . 0.0 111.487 -5.564 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.47 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -150.79 -157.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.329 178.15 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.483 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -173.95 138.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.99 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.681 -179.892 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 49.1 m -110.76 123.86 50.87 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 117.463 -1.695 . . . . 0.0 106.518 168.535 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.9 t -94.03 141.62 28.33 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.711 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -114.23 179.71 0.74 Allowed Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 176.722 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.535 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.0 Cg_exo -57.34 -56.15 0.09 OUTLIER 'Cis proline' 0 N--CA 1.503 2.054 0 CA-C-N 122.434 1.905 . . . . 0.0 116.95 6.065 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.652 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.475 0 CA-C-O 116.282 -1.818 . . . . 0.0 109.182 -170.669 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.514 2.764 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -84.17 21.87 1.01 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 N-CA-C 107.793 -1.657 . . . . 0.0 107.793 164.245 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.7 p -83.51 118.33 23.71 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.083 -176.788 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -175.42 4.69 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.213 -176.043 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -123.38 -174.44 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 177.308 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.89 110.52 15.33 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.609 -178.313 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.68 73.14 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.517 179.715 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.2 112.79 34.36 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.435 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -71.75 -159.26 0.07 OUTLIER 'Trans proline' 0 C--O 1.213 -0.77 0 N-CA-C 109.144 -1.137 . . . . 0.0 109.144 173.376 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.0 -106.21 2.43 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.901 177.966 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.691 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.54 177.23 9.64 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.096 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.691 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -154.07 175.83 32.17 Favored Glycine 0 N--CA 1.504 3.17 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.469 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.5 m-20 -91.12 126.13 36.12 Favored 'General case' 0 C--O 1.182 -2.465 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.817 177.683 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 13.7 tp -97.12 102.61 14.42 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.038 1.399 . . . . 0.0 111.958 -177.398 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 38' ' ' ILE . 79.3 m95 -88.98 123.97 33.82 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-N 111.758 -2.473 . . . . 0.0 107.112 175.854 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 17' ' ' ILE . 51.3 mt -90.4 -7.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.247 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -168.888 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -150.36 74.83 1.2 Allowed 'General case' 0 C--N 1.254 -3.558 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.264 -173.354 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.63 151.21 1.85 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.559 178.366 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.57 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -101.98 -24.41 8.58 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 173.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 157.13 38.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.565 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -82.28 172.55 9.31 Favored Pre-proline 0 CA--C 1.58 2.109 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.065 -178.38 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.8 Cg_exo -52.22 -139.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.085 2.524 . . . . 0.0 114.557 -170.692 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.87 114.23 2.57 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 176.189 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.94 80.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.25 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.34 -51.53 3.62 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 122.15 0.976 . . . . 0.0 111.606 -175.892 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.96 -19.23 3.11 Favored Glycine 0 C--N 1.281 -2.515 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -174.126 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.583 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 33.8 m-85 -72.74 173.95 8.34 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 122.558 1.171 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p -162.05 -42.66 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.133 177.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.4 p -96.69 126.28 41.75 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.031 178.178 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.416 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -154.74 153.2 30.87 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 117.644 -1.622 . . . . 0.0 113.832 -179.422 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.4 p -114.24 153.87 28.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.781 174.961 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 14.7 m-85 -130.95 130.86 43.97 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.955 -175.701 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -134.67 74.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.577 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.57 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -46.1 153.49 0.68 Allowed Pre-proline 0 C--N 1.298 -1.671 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.48 -174.419 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.5 -0.18 12.67 Favored 'Cis proline' 0 C--O 1.204 -1.223 0 C-N-CA 124.11 -1.204 . . . . 0.0 110.842 -4.195 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.654 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -96.43 -168.12 1.68 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.952 0.882 . . . . 0.0 110.758 -179.008 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.442 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -169.38 141.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 114.372 -1.285 . . . . 0.0 108.679 -179.882 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 56.5 m -110.05 97.21 6.76 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.209 -1.396 . . . . 0.0 107.553 172.958 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.583 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -81.36 127.95 33.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.587 -173.348 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -100.04 171.62 5.39 Favored Pre-proline 0 N--CA 1.514 2.757 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.222 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -84.36 158.1 68.52 Favored 'Cis proline' 0 CA--C 1.507 -0.83 0 CA-C-O 123.246 1.269 . . . . 0.0 114.643 1.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.914 0 CA-C-N 111.271 -2.695 . . . . 0.0 109.744 174.435 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.417 ' HB1' ' H ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.511 2.603 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -90.43 31.32 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 109.039 -1.177 . . . . 0.0 109.039 166.763 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.34 130.57 36.33 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -175.218 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.52 165.48 23.68 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.313 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -110.93 180.0 3.89 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.326 177.275 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.1 103.14 13.84 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.118 -178.659 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.04 18.16 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -178.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.06 117.42 9.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.958 -179.05 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -78.11 170.24 19.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 N-CA-C 108.534 -1.372 . . . . 0.0 108.534 172.09 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.57 -96.35 1.06 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.795 178.803 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.78 152.25 19.34 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.556 -1.657 . . . . 0.0 114.455 -178.143 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.28 155.31 23.37 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 174.312 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -79.52 119.13 22.07 Favored 'General case' 0 C--O 1.169 -3.161 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.365 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 17.0 tp -85.77 93.3 8.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.889 -177.654 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ILE . 72.6 m95 -74.24 126.33 30.38 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 112.706 -2.043 . . . . 0.0 107.106 172.211 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 11.6 mt -94.41 -8.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -169.723 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -152.71 55.64 0.79 Allowed 'General case' 0 C--N 1.261 -3.25 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 -173.602 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.96 157.08 46.96 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.563 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.55 -32.32 2.15 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 174.262 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.27 150.43 52.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.58 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -85.92 145.18 40.51 Favored Pre-proline 0 C--N 1.284 -2.264 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.737 -178.861 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.96 -174.76 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 120.865 1.043 . . . . 0.0 111.323 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.06 13.3 9.09 Favored Glycine 0 N--CA 1.484 1.889 1 N-CA-C 128.912 6.325 . . . . 0.0 128.912 177.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.35 -14.73 27.33 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -79.42 -21.17 45.93 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.126 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.46 61.23 Favored Glycine 0 C--N 1.292 -1.862 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.086 179.326 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 43.5 m-85 -56.43 164.34 1.42 Allowed 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 117.967 -1.493 . . . . 0.0 110.934 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -163.16 -45.06 0.03 OUTLIER 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.41 -2.177 . . . . 0.0 106.112 177.61 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.7 p -99.73 110.7 23.08 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.651 -2.068 . . . . 0.0 109.385 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.741 HD21 ' H ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -142.84 147.15 34.93 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.338 -1.345 . . . . 0.0 113.349 -179.007 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 14.5 p -99.57 143.7 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.2 175.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.478 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 61.8 m-85 -119.58 139.12 52.66 Favored 'General case' 0 C--N 1.275 -2.64 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.86 -173.273 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.6 mttt -137.07 60.91 1.64 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.145 176.742 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' LYS . 1.2 t90 -35.06 143.67 0.23 Allowed Pre-proline 0 N--CA 1.497 1.886 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.079 -177.901 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.17 -1.3 10.47 Favored 'Cis proline' 0 N--CA 1.486 1.07 0 C-N-CA 125.106 -0.789 . . . . 0.0 111.469 -4.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.766 HD21 ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -95.55 -162.44 0.95 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.546 0.689 . . . . 0.0 110.881 -178.416 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 175.66 137.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.852 -179.414 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 20.6 m -107.65 121.6 45.01 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 117.718 -1.593 . . . . 0.0 106.976 170.174 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -100.27 139.17 36.32 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -169.305 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -115.31 166.01 12.96 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.268 177.756 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.69 160.32 87.65 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 CA-C-O 122.842 1.101 . . . . 0.0 113.918 5.327 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.577 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.573 0 CA-C-N 112.155 -2.293 . . . . 0.0 109.679 176.124 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -91.15 27.84 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.3 1.333 . . . . 0.0 108.825 167.443 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.596 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -70.39 126.21 28.99 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.802 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -77.47 166.95 22.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 117.712 -1.595 . . . . 0.0 110.653 -177.188 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.52 -179.39 4.75 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.639 0.733 . . . . 0.0 110.203 179.12 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 9' ' ' LYS . 86.2 p -72.1 142.48 49.19 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.427 -179.081 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.86 -10.76 1.07 Allowed Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.634 178.642 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 7' ' ' SER . 4.5 mttt -136.48 113.26 10.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.484 -179.409 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -77.1 -165.72 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 172.795 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -88.1 1.55 Allowed Glycine 0 C--N 1.289 -2.078 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.05 176.447 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.532 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -160.65 154.64 22.81 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 117.827 -1.549 . . . . 0.0 114.069 -175.476 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.1 149.98 21.88 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 172.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 125.64 29.61 Favored 'General case' 0 C--O 1.17 -3.121 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.85 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.63 110.83 20.68 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 116.925 -1.91 . . . . 0.0 112.274 -177.983 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.711 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 58.0 m95 -96.23 175.51 6.42 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 112.471 -2.15 . . . . 0.0 109.201 176.64 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -102.38 -158.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.769 -176.854 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.69 73.49 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.741 1.734 . . . . 0.0 108.201 -176.374 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.2 mtt-85 -133.82 97.01 3.79 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.845 178.994 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.45 -5.05 0.68 Allowed Glycine 0 N--CA 1.486 1.984 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.608 -179.646 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 19' ' ' ARG . 1.6 p -137.53 151.9 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.221 179.823 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -103.8 142.86 25.46 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.3 179.108 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.408 ' CG ' ' CH2' ' A' ' 16' ' ' TRP . 5.8 Cg_exo -55.88 144.64 76.87 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.004 1.136 . . . . 0.0 111.305 179.595 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.79 -2.75 78.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.706 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.49 -19.76 70.6 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.587 -179.757 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -87.09 -12.04 48.38 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.027 -179.168 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.89 76.66 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.612 176.639 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.711 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 46.9 m-85 -56.48 174.14 0.15 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.213 179.36 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.494 ' HG1' ' H ' ' A' ' 30' ' ' SER . 1.1 p -161.61 -43.67 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.666 -2.061 . . . . 0.0 106.335 175.783 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.3 p -97.21 133.9 41.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.558 179.335 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.632 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -160.04 157.28 28.39 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.849 178.78 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.7 p -113.34 142.74 45.5 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.995 176.139 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 11.9 m-85 -120.44 125.31 47.61 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.272 -174.023 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -146.12 81.67 1.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.707 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.419 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -40.06 157.78 0.15 Allowed Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.461 179.672 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.4 Cg_endo -78.34 28.68 1.78 Allowed 'Cis proline' 0 C--O 1.21 -0.903 0 C-N-CA 124.227 -1.156 . . . . 0.0 110.751 -5.209 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.453 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 4.0 m-80 -145.01 -170.26 3.38 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -154.41 150.12 12.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.773 178.822 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -116.66 158.66 23.42 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 166.282 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -130.52 147.18 52.18 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.518 -1.273 . . . . 0.0 114.103 -170.189 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -118.53 166.91 12.68 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.404 179.734 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.44 158.53 97.26 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 CA-C-O 122.679 1.033 . . . . 0.0 113.94 4.599 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.503 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.502 0 CA-C-N 112.359 -2.201 . . . . 0.0 110.121 177.898 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -81.61 35.27 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 166.179 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.39 123.23 25.65 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.779 -1.168 . . . . 0.0 108.357 -175.25 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.08 179.62 7.24 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.151 -1.42 . . . . 0.0 108.778 179.424 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -179.29 6.11 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.794 -1.162 . . . . 0.0 111.021 178.561 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 9' ' ' LYS . 22.9 p -74.07 128.27 35.08 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.293 -176.146 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -8.48 3.99 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.005 178.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -119.51 107.08 41.4 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.18 -179.803 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -72.07 -173.51 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.078 1.185 . . . . 0.0 109.854 174.717 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.69 -112.36 3.84 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.288 178.291 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.58 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 4.3 ptm180 -152.56 166.25 32.61 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.503 -177.18 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.68 146.78 18.11 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 174.356 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -77.12 117.82 19.06 Favored 'General case' 0 C--O 1.179 -2.615 0 C-N-CA 118.989 -1.085 . . . . 0.0 108.272 178.896 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.21 112.59 19.99 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 116.387 -2.125 . . . . 0.0 112.441 -178.684 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' ILE . 57.2 m95 -94.71 174.26 7.19 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 112.144 -2.298 . . . . 0.0 106.659 173.15 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -96.56 -158.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 C-N-CA 118.651 -1.219 . . . . 0.0 113.02 -174.376 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.94 72.91 0.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 123.619 1.676 . . . . 0.0 108.221 -177.063 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ILE . 5.2 mtp85 -131.84 97.53 4.21 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 111.637 -2.529 . . . . 0.0 109.729 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.53 -22.98 1.18 Allowed Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.019 -179.516 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.427 ' N ' ' C ' ' A' ' 19' ' ' ARG . 1.1 p -130.4 152.31 49.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.983 179.524 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 173.07 8.09 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.35 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 14.9 Cg_endo -67.0 98.9 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.576 1.517 . . . . 0.0 113.364 -174.614 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' PRO . . . -30.85 101.11 0.01 OUTLIER Glycine 0 N--CA 1.512 3.758 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.573 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.78 68.58 0.66 Allowed Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.703 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -117.52 -172.56 2.25 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.189 0.519 . . . . 0.0 110.683 -177.471 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.86 -18.3 54.64 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 172.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 23.1 m-85 -69.94 177.72 3.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.956 1.36 . . . . 0.0 112.476 178.766 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -161.55 -44.36 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.759 -2.473 . . . . 0.0 105.475 176.4 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.21 114.69 27.02 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.751 178.517 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' ND2' ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -136.52 151.85 49.87 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 118.55 -1.26 . . . . 0.0 112.819 178.558 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.35 146.18 43.56 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.766 176.721 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' OH ' ' ND2' ' A' ' 31' ' ' ASN . 7.2 m-85 -126.27 136.21 52.5 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.222 -174.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -147.12 79.79 1.51 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.588 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.404 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -42.75 159.05 0.21 Allowed Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.135 -178.154 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.498 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 10.1 Cg_endo -81.15 32.29 2.28 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.542 -1.024 . . . . 0.0 111.635 -3.725 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.0 m-80 -148.98 171.17 16.79 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.411 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -131.62 152.31 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.832 178.35 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 28.9 m -123.46 110.23 14.84 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.014 -1.475 . . . . 0.0 107.523 167.58 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -83.79 133.41 34.77 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.02 -174.31 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -102.89 -173.85 0.31 Allowed Pre-proline 0 N--CA 1.517 2.919 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.647 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.8 Cg_exo -62.56 -48.58 0.18 OUTLIER 'Cis proline' 0 N--CA 1.508 2.348 0 CA-C-N 122.653 1.983 . . . . 0.0 116.497 3.958 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.608 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.987 0 CA-C-O 116.481 -1.724 . . . . 0.0 109.244 -171.382 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.501 2.1 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -81.22 27.77 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 N-CA-C 108.022 -1.569 . . . . 0.0 108.022 164.001 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.3 p -87.95 120.3 29.15 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.097 -177.608 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -82.52 -175.13 5.58 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.111 -173.379 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.44 -176.39 5.57 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.703 176.073 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.7 t -78.92 113.34 16.94 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.584 -177.728 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.23 67.58 Favored Glycine 0 C--N 1.296 -1.65 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -112.25 136.01 21.37 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.802 -178.904 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 9' ' ' LYS . 2.9 Cg_exo -48.74 -166.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.602 2.201 . . . . 0.0 114.244 -173.063 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.94 24.73 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.062 -174.543 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.456 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 8.2 ptm180 -161.36 146.91 13.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 116.695 -2.002 . . . . 0.0 114.612 176.862 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -160.65 173.59 37.2 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 176.088 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 40' ' ' CYS . 2.7 m-20 -84.31 135.0 34.49 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.974 179.89 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.5 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 36.3 tp -96.59 133.62 40.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.358 1.075 . . . . 0.0 110.114 -179.62 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.422 ' N ' ' O ' ' A' ' 38' ' ' ILE . 64.9 m95 -135.08 151.37 50.69 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 112.899 -1.955 . . . . 0.0 108.047 -177.483 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.621 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -78.56 -157.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.835 -175.562 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.74 67.44 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.017 1.389 . . . . 0.0 108.235 -176.8 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -103.82 112.16 25.0 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.102 -178.972 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -23.52 57.18 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.382 -1.39 . . . . 0.0 109.789 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.85 156.47 40.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.982 178.631 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -91.65 149.82 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.918 179.263 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.91 128.52 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.972 1.115 . . . . 0.0 111.452 -177.614 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.36 6.95 55.87 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.01 179.489 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.51 -7.23 16.44 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.386 -179.975 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.55 -35.77 39.37 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.798 179.604 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.93 -13.07 6.44 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.642 178.367 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 42.9 m-85 -60.7 170.55 1.42 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.744 -179.136 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 p -161.46 -44.96 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 112.319 -2.219 . . . . 0.0 106.038 178.438 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.4 129.8 44.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.714 179.379 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.82 157.3 28.99 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.922 -1.511 . . . . 0.0 112.438 178.266 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 142.19 47.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.141 177.173 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.46 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 21.3 m-85 -117.77 124.62 48.89 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.813 -172.735 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.9 81.06 1.67 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.195 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.422 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.98 159.62 0.13 Allowed Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.883 -178.775 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -77.76 23.06 3.76 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.127 -1.197 . . . . 0.0 110.721 -5.208 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.434 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.8 m-80 -140.76 175.76 9.35 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.968 179.663 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.46 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -136.2 145.83 30.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.523 177.355 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.9 m -115.07 115.69 27.21 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 117.688 -1.605 . . . . 0.0 107.087 169.844 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -87.91 160.37 17.97 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.598 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 30' ' ' SER . 5.7 m-85 -132.62 161.9 60.56 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.139 179.185 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -85.95 160.32 58.35 Favored 'Cis proline' 0 C--N 1.325 -0.708 0 N-CA-C 115.209 1.196 . . . . 0.0 115.209 5.412 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.038 0 CA-C-N 112.02 -2.354 . . . . 0.0 109.588 175.57 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.567 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.88 51.9 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 170.962 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -69.26 141.36 54.41 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -174.396 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -78.38 173.29 12.49 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 117.984 -1.486 . . . . 0.0 108.909 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.33 -168.18 1.28 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.191 -178.656 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 9' ' ' LYS . 4.5 m -65.35 113.63 4.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.107 -177.991 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.8 -3.12 0.73 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.807 179.131 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 7' ' ' SER . 22.3 mttt -93.81 120.95 65.46 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 118.296 -1.362 . . . . 0.0 111.156 -178.99 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -71.11 155.93 60.51 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 N-CA-C 109.386 -1.044 . . . . 0.0 109.386 174.321 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -116.54 3.55 Favored Glycine 0 N--CA 1.482 1.724 1 N-CA-C 129.591 6.596 . . . . 0.0 129.591 -178.008 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.583 ' C ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.9 149.33 16.21 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.627 -1.229 . . . . 0.0 112.343 178.683 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . -135.3 158.26 23.55 Favored Glycine 0 C--O 1.195 -2.297 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 172.909 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -77.61 113.63 15.64 Favored 'General case' 0 C--O 1.176 -2.776 0 C-N-CA 118.364 -1.334 . . . . 0.0 108.245 178.871 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.35 85.74 7.18 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 116.715 -1.994 . . . . 0.0 112.826 -176.461 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' ILE . 68.6 m95 -59.43 131.06 49.82 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.199 171.861 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.37 -5.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.017 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -171.021 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 mt -148.92 57.24 1.03 Allowed 'General case' 1 C--N 1.241 -4.115 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.335 -173.399 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -159.95 164.16 33.61 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.406 -1.718 . . . . 0.0 112.315 179.798 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.02 -16.24 5.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 176.144 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 155.5 40.54 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.668 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -103.13 144.44 28.64 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.062 178.518 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.94 130.68 41.13 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.777 0.984 . . . . 0.0 111.516 -178.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.2 -18.5 78.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 177.941 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -13.43 83.64 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.54 -62.04 1.81 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.053 179.933 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.77 -15.19 0.81 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 118.892 -1.623 . . . . 0.0 111.994 178.316 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.626 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.8 m-85 -61.44 170.52 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.708 1.242 . . . . 0.0 112.423 -178.704 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -160.89 -44.87 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 112.123 -2.308 . . . . 0.0 105.917 177.612 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 41' ' ' TYR . 67.9 p -96.04 113.0 24.57 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.859 179.222 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.27 151.24 33.88 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.217 -1.393 . . . . 0.0 113.582 -177.422 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -101.16 140.88 34.84 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.3 175.025 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.47 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 72.9 m-85 -120.76 134.8 55.27 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.405 -174.125 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -149.43 66.89 1.01 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.938 178.779 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.455 ' CD1' ' C ' ' A' ' 35' ' ' TRP . 12.1 t-105 -30.55 147.22 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.01 178.564 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.6 Cg_endo -71.37 2.74 6.77 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 C-N-CA 125.368 -0.68 . . . . 0.0 112.31 -5.321 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -110.19 -165.37 1.0 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.945 0.879 . . . . 0.0 111.693 -176.941 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.47 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -178.26 130.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.349 179.541 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -108.42 109.44 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.526 -1.67 . . . . 0.0 107.349 174.202 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.8 t -87.93 134.72 33.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.484 -2.143 . . . . 0.0 114.214 -168.602 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.54 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.7 m-85 -106.56 -178.53 0.6 Allowed Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 178.086 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.3 Cg_exo -55.85 -59.26 0.03 OUTLIER 'Cis proline' 0 N--CA 1.506 2.255 0 N-CA-C 117.618 2.122 . . . . 0.0 117.618 5.981 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.499 0 CA-C-O 116.337 -1.792 . . . . 0.0 108.924 -169.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.706 ' H1 ' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -44.95 139.15 3.96 Favored Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -176.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.95 39.01 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 109.08 -1.161 . . . . 0.0 109.08 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.41 121.23 22.75 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.838 -175.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 8.4 m-85 -78.23 163.5 25.72 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 117.956 -1.498 . . . . 0.0 109.776 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.93 175.27 8.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.092 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -81.81 116.51 21.53 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.859 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -15.18 63.89 Favored Glycine 0 C--N 1.296 -1.643 0 C-N-CA 119.452 -1.356 . . . . 0.0 109.934 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -130.1 111.67 17.0 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.208 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -74.46 -175.31 2.18 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 N-CA-C 109.079 -1.162 . . . . 0.0 109.079 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.19 -104.67 3.21 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.706 HH22 ' H1 ' ' A' ' 1' ' ' ALA . 6.2 ptm180 -160.21 165.4 31.59 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.173 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.13 149.94 20.72 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 173.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.601 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -77.22 124.51 27.94 Favored 'General case' 0 C--O 1.166 -3.314 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.29 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 tp -84.69 111.07 19.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.037 -1.865 . . . . 0.0 112.543 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.438 ' N ' ' O ' ' A' ' 38' ' ' ILE . 65.6 m95 -100.64 171.72 7.53 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.675 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -104.32 -161.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.722 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.539 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.99 70.89 0.15 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.298 1.523 . . . . 0.0 108.087 -177.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' C ' ' H ' ' A' ' 21' ' ' THR . 47.7 mtp180 -115.96 -13.02 11.29 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 112.11 -2.314 . . . . 0.0 110.9 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 48.3 4.67 0.02 OUTLIER Glycine 0 C--N 1.263 -3.511 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.38 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.581 ' H ' ' C ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -151.92 154.88 36.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.17 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -116.13 151.19 46.37 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.028 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.69 106.12 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 120.721 0.947 . . . . 0.0 110.908 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.31 89.96 1.01 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.42 -11.06 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.212 -1.47 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.61 -18.76 40.08 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.25 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.59 -16.88 2.24 Favored Glycine 0 N--CA 1.482 1.736 0 C-N-CA 119.51 -1.328 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 29.2 m-85 -77.3 167.73 21.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.992 1.377 . . . . 0.0 112.624 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.3 p -162.59 -46.05 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.749 -2.478 . . . . 0.0 105.65 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' TYR . 70.0 p -98.73 124.41 43.57 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.548 -2.114 . . . . 0.0 110.19 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -148.41 156.09 42.05 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.337 178.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.39 147.22 39.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.88 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.477 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 7.3 m-85 -127.92 131.26 49.38 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.485 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 77.66 1.62 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.449 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.81 158.94 0.27 Allowed Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.151 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.1 Cg_endo -78.89 35.25 0.8 Allowed 'Cis proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.351 -1.104 . . . . 0.0 112.54 -5.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.469 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 4.0 m-80 -147.73 -166.47 2.53 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.228 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.477 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -156.63 147.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.511 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.8 m -117.35 136.31 53.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 166.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -107.09 140.04 40.55 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -170.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.3 m-85 -107.83 176.71 1.51 Allowed Pre-proline 0 N--CA 1.509 2.507 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 7.8 Cg_exo -58.99 -53.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.164 0 N-CA-C 117.196 1.96 . . . . 0.0 117.196 5.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.622 0 CA-C-O 116.468 -1.729 . . . . 0.0 109.179 -170.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -57.9 138.09 83.25 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -77.96 35.28 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.6 124.0 29.15 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -176.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 164.57 25.15 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.724 -1.591 . . . . 0.0 110.276 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.2 m -109.17 -178.7 3.64 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.306 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.403 ' H ' ' HG ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -81.14 111.45 17.59 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.991 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.18 -12.31 48.47 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.471 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.51 115.1 14.68 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.127 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -161.58 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.89 -93.52 1.6 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.154 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.567 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.98 160.06 30.24 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.744 -178.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -145.63 141.96 10.24 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 42.3 m-20 -75.33 125.5 29.1 Favored 'General case' 0 C--O 1.175 -2.846 0 C-N-CA 118.217 -1.393 . . . . 0.0 108.135 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -84.15 132.79 34.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 116.931 -1.908 . . . . 0.0 111.448 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.88 175.65 7.15 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.481 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -99.33 -162.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.441 -176.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.51 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.22 67.36 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.343 1.544 . . . . 0.0 108.343 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.8 mtp85 -103.81 128.88 51.22 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.1 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.3 -49.44 60.09 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.204 -1.474 . . . . 0.0 109.468 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.33 161.37 38.06 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.954 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.36 150.33 76.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.217 179.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.95 129.18 31.99 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 120.937 1.091 . . . . 0.0 110.667 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 26' ' ' TYR . . . -74.18 -48.16 15.87 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.833 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.32 -9.03 0.57 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.397 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.5 m-85 -79.52 -75.97 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.197 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.2 -13.24 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.002 -1.571 . . . . 0.0 112.08 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.632 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 53.4 m-85 -66.25 172.31 4.01 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 122.618 1.199 . . . . 0.0 112.688 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -161.93 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.312 -2.222 . . . . 0.0 106.354 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -97.56 118.87 35.02 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.429 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.472 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.94 158.47 44.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.044 -1.463 . . . . 0.0 112.884 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.418 ' O ' HG13 ' A' ' 38' ' ' ILE . 26.2 p -113.06 147.64 36.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.49 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 40.4 m-85 -122.19 117.51 26.38 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.5 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 31.8 mttp -130.87 75.24 1.64 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.877 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.42 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -41.45 156.02 0.22 Allowed Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.437 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 6.6 Cg_endo -78.56 28.71 1.88 Allowed 'Cis proline' 0 C--O 1.206 -1.117 0 C-N-CA 124.167 -1.18 . . . . 0.0 112.123 -3.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.2 m-80 -144.98 -160.15 1.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.232 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -160.93 154.32 3.9 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.046 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.843 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 80.4 m -124.56 116.61 22.73 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 117.903 -1.519 . . . . 0.0 107.104 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.632 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.15 148.64 25.59 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.531 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -120.19 167.81 11.8 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -73.95 159.26 97.87 Favored 'Cis proline' 0 C--O 1.214 -0.71 0 CA-C-O 122.788 1.078 . . . . 0.0 113.838 3.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.567 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.191 -2.277 . . . . 0.0 109.928 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -60.74 154.81 55.49 Favored Pre-proline 0 N--CA 1.498 1.939 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.085 -178.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -91.22 40.63 0.35 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 109.929 -0.835 . . . . 0.0 109.929 168.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -77.09 126.97 31.84 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.128 -176.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.37 167.2 21.7 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.832 -179.002 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -175.68 2.78 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.9 177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.0 123.22 26.02 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.236 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.0 -11.69 47.03 Favored Glycine 0 C--N 1.299 -1.476 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.735 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -116.47 109.5 43.85 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.433 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.41 -167.7 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 107.684 -1.698 . . . . 0.0 107.684 172.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.71 -111.67 3.75 Favored Glycine 0 C--N 1.283 -2.381 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.378 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -156.11 154.98 31.77 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 118.245 -1.382 . . . . 0.0 114.189 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.07 153.64 23.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -78.97 125.74 29.78 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.971 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.98 108.15 18.08 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.966 -1.494 . . . . 0.0 111.893 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' ILE . 60.3 m95 -95.16 176.79 6.09 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.616 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -100.14 -162.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.221 -176.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.427 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.87 70.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.288 1.518 . . . . 0.0 108.27 -176.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' ILE . 40.6 mtp180 -112.47 115.64 29.0 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.05 -23.87 18.21 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 110.795 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.73 158.07 42.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.384 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' N ' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -86.34 151.41 53.64 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.837 178.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.6 Cg_exo -50.11 120.94 6.77 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.174 1.249 . . . . 0.0 111.428 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.04 -4.74 4.83 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.512 -1.327 . . . . 0.0 110.29 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -119.72 1.05 13.77 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 130.684 7.034 . . . . 0.0 130.684 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -79.54 -36.43 38.38 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.274 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.84 -17.15 2.19 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.353 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.1 m-85 -60.78 168.95 2.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.303 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -162.02 -43.0 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 112.283 -2.235 . . . . 0.0 106.418 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.4 p -97.31 121.56 39.34 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.357 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.83 154.8 34.62 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.81 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -110.17 137.84 47.36 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.643 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 38' ' ' ILE . 38.9 m-85 -113.71 129.93 56.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.553 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -147.77 81.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.149 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.413 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.47 159.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.349 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 4.6 Cg_endo -78.51 28.23 2.01 Favored 'Cis proline' 0 C--O 1.21 -0.879 0 C-N-CA 124.273 -1.136 . . . . 0.0 111.813 -5.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.2 m-80 -147.06 -172.35 3.98 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.709 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -154.98 147.92 12.93 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.833 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -116.64 142.53 46.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.714 165.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.5 t -112.63 148.53 34.41 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.693 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.7 OUTLIER -119.86 170.44 6.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.15 158.08 83.44 Favored 'Cis proline' 0 CA--C 1.503 -1.039 0 CA-C-O 122.857 1.107 . . . . 0.0 113.661 4.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.693 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.966 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.468 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -40.79 138.72 1.26 Allowed Pre-proline 0 N--CA 1.503 2.181 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.509 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -74.75 57.76 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.06 -1.939 . . . . 0.0 107.06 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.59 138.97 45.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.46 -179.13 6.17 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.869 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -162.66 1.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.111 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.566 ' C ' ' H ' ' A' ' 9' ' ' LYS . 8.7 m -59.9 110.94 1.29 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.473 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.8 3.67 0.12 Allowed Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.224 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 7' ' ' SER . 61.5 mttt -94.14 116.81 66.88 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.474 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 9.8 Cg_endo -73.69 -166.19 0.3 Allowed 'Trans proline' 0 C--O 1.206 -1.093 0 N-CA-C 109.264 -1.091 . . . . 0.0 109.264 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 -120.33 5.29 Favored Glycine 0 C--N 1.29 -2.001 0 C-N-CA 118.674 -1.726 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.573 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -161.1 162.19 31.47 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 118.185 -1.406 . . . . 0.0 113.42 -178.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.13 148.31 19.93 Favored Glycine 0 C--O 1.199 -2.092 0 N-CA-C 106.917 -2.473 . . . . 0.0 106.917 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.532 ' CG ' HH22 ' A' ' 12' ' ' ARG . 10.1 m-20 -76.62 128.41 34.65 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.632 -1.227 . . . . 0.0 109.142 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.57 98.43 11.65 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 116.962 -1.895 . . . . 0.0 112.087 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' ILE . 62.0 m95 -77.34 163.86 26.05 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 111.779 -2.464 . . . . 0.0 109.442 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -85.55 -158.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 118.846 -1.141 . . . . 0.0 111.268 -177.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.67 72.54 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.916 1.341 . . . . 0.0 109.053 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' ILE . 4.1 mtp180 -121.55 110.17 15.69 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.086 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.88 -20.31 40.36 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.657 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.14 153.64 50.44 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.838 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.82 151.26 43.4 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -47.81 112.6 0.59 Allowed 'Trans proline' 0 C--O 1.214 -0.724 0 C-N-CA 120.971 1.114 . . . . 0.0 111.444 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.46 -25.93 55.89 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -22.42 71.91 Favored Glycine 0 N--CA 1.485 1.951 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.456 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.51 175.74 10.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.141 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.27 70.68 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 41.6 m-85 -59.94 167.92 2.04 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.051 -1.459 . . . . 0.0 110.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 2.0 p -163.13 -43.0 0.03 OUTLIER 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.7 -2.045 . . . . 0.0 106.225 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 8.5 p -97.36 118.46 33.88 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.794 -2.003 . . . . 0.0 109.156 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.556 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.08 152.01 36.63 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.876 -1.53 . . . . 0.0 113.52 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -101.66 156.05 17.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.981 174.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.453 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 22.4 m-85 -134.98 125.76 27.24 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.545 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 35' ' ' TRP . 6.4 mttt -137.72 71.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.958 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.456 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 17.0 t-105 -38.82 146.19 0.33 Allowed Pre-proline 0 N--CA 1.508 2.46 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.864 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.507 ' C ' HD22 ' A' ' 37' ' ' ASN . 7.3 Cg_endo -78.06 38.44 0.46 Allowed 'Cis proline' 0 N--CA 1.495 1.603 0 CA-C-N 118.52 0.507 . . . . 0.0 111.69 -5.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.532 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -148.09 -168.03 2.97 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.509 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.03 144.9 3.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.298 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.65 140.37 50.02 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 117.488 -1.685 . . . . 0.0 107.586 169.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -114.62 135.8 53.75 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -169.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -107.96 -179.51 0.71 Allowed Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.555 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 3.0 Cg_exo -64.3 -49.21 0.18 OUTLIER 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 122.036 1.763 . . . . 0.0 116.587 5.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.588 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.781 0 CA-C-O 116.28 -1.819 . . . . 0.0 109.565 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.403 ' C ' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -48.86 144.59 7.12 Favored Pre-proline 0 N--CA 1.505 2.317 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.735 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.26 35.46 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 167.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -75.38 142.87 43.03 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -87.36 166.01 15.17 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 117.79 -1.564 . . . . 0.0 109.335 177.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.469 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -108.84 -173.3 2.24 Favored 'General case' 0 N--CA 1.51 2.538 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.727 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -71.07 117.23 12.31 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.921 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.0 -1.59 3.39 Favored Glycine 0 C--N 1.297 -1.589 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.141 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 7' ' ' SER . 5.6 mttt -108.82 118.05 52.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.367 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -74.87 -168.91 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.14 -113.47 4.13 Favored Glycine 0 C--N 1.291 -1.918 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.178 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.619 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 6.5 ptm180 -157.66 163.09 38.58 Favored 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 118.184 -1.407 . . . . 0.0 114.086 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -148.81 151.21 23.41 Favored Glycine 0 N--CA 1.494 2.503 1 N-CA-C 126.364 5.305 . . . . 0.0 126.364 173.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.9 m-20 -77.38 118.57 19.97 Favored 'General case' 0 C--O 1.171 -3.055 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.924 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 48.9 tp -85.7 102.55 13.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.002 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.488 ' N ' ' O ' ' A' ' 38' ' ' ILE . 58.7 m95 -91.79 165.07 13.46 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 112.3 -2.227 . . . . 0.0 109.968 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -90.61 -159.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.632 -177.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 73.87 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.718 1.247 . . . . 0.0 108.793 -174.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -115.26 123.13 48.03 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.317 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.7 -35.27 73.3 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 160.54 42.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.751 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.09 163.54 59.42 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.669 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.51 -164.98 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 121.676 1.584 . . . . 0.0 112.035 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.62 33.56 2.47 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.17 -2.52 1.58 Allowed Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.789 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.45 -70.71 0.62 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.223 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.33 17.19 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.509 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 43.4 m-85 -76.41 171.13 15.09 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.577 1.179 . . . . 0.0 112.068 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -161.42 -43.95 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.142 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.24 134.2 40.85 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.123 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -160.04 159.61 32.21 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.887 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.0 p -120.9 133.7 55.29 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.567 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 76.1 m-85 -109.1 114.02 27.39 Favored 'General case' 0 C--N 1.259 -3.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.757 -174.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -129.23 71.86 1.45 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.595 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.467 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.46 155.35 0.19 Allowed Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.259 -178.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.6 Cg_endo -78.45 33.12 0.97 Allowed 'Cis proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.409 -1.08 . . . . 0.0 111.417 -3.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.467 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 3.5 m-80 -147.85 -160.48 1.17 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.805 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -167.87 144.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.383 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 8.1 m -113.57 109.29 18.39 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.577 168.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -80.73 139.85 35.88 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.527 -172.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.9 m-85 -110.97 -177.84 0.49 Allowed Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.445 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 19.1 Cg_exo -56.72 -55.43 0.11 OUTLIER 'Cis proline' 0 N--CA 1.505 2.169 0 CA-C-N 122.31 1.861 . . . . 0.0 116.698 5.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.619 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.388 0 CA-C-O 116.379 -1.772 . . . . 0.0 109.228 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -41.94 143.74 0.94 Allowed Pre-proline 0 N--CA 1.503 2.184 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.96 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.38 57.05 4.67 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 N-CA-C 108.737 -1.293 . . . . 0.0 108.737 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.01 145.95 39.86 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.473 -176.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.71 -175.77 5.45 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.135 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.95 179.82 5.85 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.64 0.733 . . . . 0.0 109.685 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.15 114.43 21.77 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.23 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.65 -10.53 72.53 Favored Glycine 0 C--N 1.295 -1.714 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.955 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -117.24 106.85 46.35 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.872 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.8 146.44 66.14 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.676 -1.317 . . . . 0.0 108.676 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.71 -104.58 0.84 Allowed Glycine 0 C--N 1.285 -2.277 1 N-CA-C 129.814 6.686 . . . . 0.0 129.814 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -161.14 151.35 17.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.761 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.14 166.74 25.65 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.498 ' CG ' ' HH ' ' A' ' 28' ' ' TYR . 10.7 m-20 -79.68 114.58 18.71 Favored 'General case' 0 C--O 1.172 -2.982 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.158 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 tp -84.13 96.24 8.87 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.091 -1.843 . . . . 0.0 113.205 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' ILE . 70.5 m95 -69.94 145.81 51.63 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 111.818 -2.446 . . . . 0.0 104.837 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -110.25 -8.41 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -168.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 2.2 mt -153.1 59.63 0.78 Allowed 'General case' 0 C--N 1.248 -3.805 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.872 -173.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -154.89 156.32 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.581 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -109.01 -7.88 28.38 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 174.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 157.0 47.26 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.483 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -107.41 149.4 38.74 Favored Pre-proline 0 N--CA 1.494 1.748 0 C-N-CA 119.62 -0.832 . . . . 0.0 108.867 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -66.35 142.06 64.63 Favored 'Trans proline' 0 C--O 1.217 -0.568 0 C-N-CA 120.6 0.866 . . . . 0.0 111.177 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.62 63.5 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.77 -19.28 27.43 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.684 -1.245 . . . . 0.0 110.458 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.49 -34.59 41.19 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.958 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.95 -3.03 19.41 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.303 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.666 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.5 m-85 -60.5 169.17 1.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.691 1.234 . . . . 0.0 112.561 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -162.32 -43.76 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.263 -2.244 . . . . 0.0 106.027 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.84 114.15 26.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.62 178.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.684 HD21 ' H ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -146.35 154.14 41.32 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.884 -177.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -97.33 149.39 22.14 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.852 175.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.557 ' HH ' HD22 ' A' ' 31' ' ' ASN . 71.1 m-85 -132.01 119.99 21.81 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.009 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -132.41 72.07 1.49 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -45.57 153.57 0.59 Allowed Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.084 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -70.52 -5.5 10.08 Favored 'Cis proline' 0 N--CA 1.485 1.012 0 C-N-CA 124.299 -1.125 . . . . 0.0 112.038 -5.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -94.87 178.75 5.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.775 0.797 . . . . 0.0 110.851 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -158.93 140.43 4.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.034 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.486 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -120.19 116.44 25.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.307 172.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.666 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -95.42 144.47 25.91 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.866 -1.97 . . . . 0.0 114.955 -167.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -116.85 167.92 9.81 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.63 160.12 88.01 Favored 'Cis proline' 0 C--O 1.217 -0.556 0 CA-C-O 123.262 1.276 . . . . 0.0 114.822 3.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.603 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.251 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.531 ' HB1' ' H ' ' A' ' 15' ' ' LEU . . . -39.12 137.79 0.91 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.38 36.09 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 109.187 -1.12 . . . . 0.0 109.187 166.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -82.07 122.71 28.18 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.388 -176.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.48 164.14 24.17 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.833 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.36 -178.39 4.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.072 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t -76.8 127.02 31.96 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.31 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.58 -18.08 31.49 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.562 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.08 105.95 20.04 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.21 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.04 -166.34 0.31 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.26 -98.52 2.38 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.729 -1.7 . . . . 0.0 110.862 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 3.1 ptm180 -162.32 160.82 27.14 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.784 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -139.17 150.96 21.56 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 175.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.68 111.59 14.93 Favored 'General case' 0 C--O 1.171 -3.069 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.445 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 6.3 tt -85.2 93.6 8.7 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.623 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' ILE . 61.5 m95 -70.13 122.75 20.04 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 112.293 -2.231 . . . . 0.0 107.287 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.26 -8.08 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 C-N-CA 118.983 -1.087 . . . . 0.0 113.499 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 mt -151.89 74.51 1.11 Allowed 'General case' 0 C--N 1.254 -3.553 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.464 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.534 ' NH1' ' CG ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -162.95 142.85 9.11 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.222 -1.791 . . . . 0.0 113.085 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.17 -22.04 23.57 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.533 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 1.4 p -143.48 152.32 41.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.514 -0.843 . . . . 0.0 109.24 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -88.53 148.11 41.3 Favored Pre-proline 0 C--N 1.286 -2.178 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.366 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.08 178.44 0.4 Allowed 'Trans proline' 0 C--O 1.219 -0.442 0 C-N-CA 120.379 0.719 . . . . 0.0 111.211 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.15 8.36 25.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.22 -16.36 15.12 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -84.67 -6.89 59.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.04 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.73 11.49 85.18 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.758 -1.21 . . . . 0.0 112.326 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 40.5 m-85 -67.19 170.57 6.86 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.885 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.91 -44.07 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 112.763 -2.017 . . . . 0.0 106.691 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 41' ' ' TYR . 3.2 p -96.86 125.88 41.62 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -160.07 147.5 16.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 117.19 -1.804 . . . . 0.0 113.132 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 146.42 32.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.002 -1.453 . . . . 0.0 108.049 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 51.0 m-85 -118.01 140.72 49.34 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.688 -170.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 35' ' ' TRP . 7.9 mttt -142.27 59.27 1.46 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.965 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -40.41 147.36 0.38 Allowed Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.31 -176.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.79 2.1 6.24 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.635 -4.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -101.23 -160.59 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.725 0.774 . . . . 0.0 111.359 -177.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 171.34 141.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.471 -178.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 79.4 m -110.13 110.86 21.89 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 117.741 -1.584 . . . . 0.0 107.176 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.0 t -88.98 151.16 22.46 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.924 -171.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' SER . 3.0 m-85 -125.33 163.14 40.11 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -79.16 162.61 86.47 Favored 'Cis proline' 0 C--N 1.326 -0.64 0 CA-C-O 123.324 1.302 . . . . 0.0 115.374 5.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.393 0 CA-C-N 111.11 -2.768 . . . . 0.0 109.447 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -42.63 143.75 1.1 Allowed Pre-proline 0 N--CA 1.505 2.295 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -83.34 38.55 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 167.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.87 127.09 33.59 Favored 'General case' 0 N--CA 1.513 2.685 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.082 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.61 159.92 27.83 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 117.924 -1.51 . . . . 0.0 110.299 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.2 m -108.19 -172.89 2.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.38 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -57.68 140.02 52.3 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.327 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 29.01 11.1 0.0 OUTLIER Glycine 0 N--CA 1.481 1.633 1 N-CA-C 125.134 4.814 . . . . 0.0 125.134 -174.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.0 mttt -111.25 102.06 52.01 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 114.385 -0.908 . . . . 0.0 110.041 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.04 -164.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 120.946 1.097 . . . . 0.0 109.303 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.89 -103.17 1.97 Allowed Glycine 0 C--N 1.29 -1.994 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.543 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -161.19 166.12 28.32 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 118.063 -1.455 . . . . 0.0 114.054 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.01 154.21 25.24 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.52 126.62 31.11 Favored 'General case' 0 C--O 1.178 -2.665 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.243 178.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.0 tp -87.89 108.41 19.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.334 -1.346 . . . . 0.0 112.443 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ILE . 70.1 m95 -99.65 161.74 13.43 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.313 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -87.35 -158.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.136 -175.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.96 66.02 0.1 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.464 1.602 . . . . 0.0 107.793 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.32 105.81 15.94 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 112.272 -2.24 . . . . 0.0 110.631 -179.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -44.58 -35.17 3.98 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.03 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -141.42 163.2 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.153 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 157.34 56.21 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.937 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.8 119.42 5.62 Favored 'Trans proline' 0 C--O 1.208 -0.991 0 C-N-CA 120.812 1.008 . . . . 0.0 110.541 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.17 176.83 25.82 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.094 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.76 8.1 38.9 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.97 -168.54 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.18 0.04 74.75 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.428 -1.368 . . . . 0.0 111.443 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 26.1 m-85 -76.55 170.35 16.57 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.371 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -162.11 -44.74 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 112.338 -2.21 . . . . 0.0 106.376 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.6 p -99.0 128.09 45.06 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.867 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.5 142.73 25.09 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 117.939 -1.504 . . . . 0.0 112.385 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 22.2 p -99.62 137.12 38.55 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.778 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 51.1 m-85 -114.93 121.08 42.08 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.2 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -140.41 77.23 1.59 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.711 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -39.4 158.58 0.12 Allowed Pre-proline 0 C--N 1.307 -1.27 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.515 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 1.6 Cg_endo -78.58 30.07 1.53 Allowed 'Cis proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.402 -1.083 . . . . 0.0 111.501 -6.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 3.1 m-80 -145.89 -171.28 3.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -153.23 141.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 17.4 m -112.68 117.27 31.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.492 -1.683 . . . . 0.0 106.997 168.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.11 149.19 25.31 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.465 -172.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -122.15 174.52 3.21 Favored Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -86.15 155.31 53.52 Favored 'Cis proline' 0 CA--C 1.505 -0.959 0 CA-C-O 122.854 1.106 . . . . 0.0 113.362 -1.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.266 -3.035 0 CA-C-N 111.876 -2.42 . . . . 0.0 109.795 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -47.96 146.01 4.44 Favored Pre-proline 0 N--CA 1.504 2.245 0 C-N-CA 119.784 -0.767 . . . . 0.0 112.11 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.25 37.93 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 108.564 -1.36 . . . . 0.0 108.564 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.545 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.56 124.86 28.6 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -174.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.61 163.18 26.47 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.806 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -100.82 -179.54 4.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.73 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 9' ' ' LYS . 88.7 p -70.96 122.02 19.21 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.47 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.93 -15.59 1.24 Allowed Glycine 0 C--N 1.296 -1.659 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.585 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 7' ' ' SER . 47.6 mttt -106.8 117.01 57.81 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.758 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -77.13 -161.75 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.929 1.086 . . . . 0.0 109.287 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.91 -111.16 3.77 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.232 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.579 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -157.98 157.46 33.07 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.434 -1.306 . . . . 0.0 112.523 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.75 147.5 18.96 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.37 128.24 33.36 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.527 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.7 tp -87.51 109.49 19.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.021 -1.472 . . . . 0.0 111.984 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.689 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 65.4 m95 -98.16 179.2 4.83 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.844 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -103.59 -160.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.162 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.389 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.86 71.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.337 1.541 . . . . 0.0 108.329 -176.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ILE . 12.1 mtp85 -114.12 131.75 56.3 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.197 -2.274 . . . . 0.0 111.236 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.22 86.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.302 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 163.25 37.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.966 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.29 160.26 73.43 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.1 Cg_exo -51.57 92.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 120.792 0.995 . . . . 0.0 111.008 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' CYS . . . -7.91 -32.07 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 1 N-CA-C 132.796 7.878 . . . . 0.0 132.796 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -134.9 43.09 1.28 Allowed Glycine 0 N--CA 1.499 2.843 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.311 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.85 -164.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.417 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.05 -1.61 56.64 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.654 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.689 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 28.7 m-85 -86.1 169.25 13.31 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 123.129 1.442 . . . . 0.0 113.338 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.79 -43.66 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.732 175.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 41' ' ' TYR . 5.1 p -97.94 138.08 35.81 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.594 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.23 151.02 20.6 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.918 176.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.2 p -113.09 142.38 45.81 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.834 176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 18.5 m-85 -114.28 128.96 56.61 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.869 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' NZ ' ' SG ' ' A' ' 4' ' ' CYS . 12.9 mttt -126.09 67.68 1.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.241 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.441 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 40.2 t-105 -36.55 144.87 0.26 Allowed Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.328 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 2.2 Cg_endo -77.6 35.48 0.59 Allowed 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 125.801 -0.5 . . . . 0.0 112.399 -5.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.541 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -145.73 -160.13 1.1 Allowed 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.339 178.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -166.37 144.94 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.037 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.416 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.5 m -112.8 147.03 37.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 3.0 t -115.15 143.88 44.54 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.613 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -113.73 -177.22 0.42 Allowed Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.541 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 5.5 Cg_exo -62.84 -51.0 0.16 OUTLIER 'Cis proline' 0 N--CA 1.506 2.22 0 CA-C-N 121.866 1.702 . . . . 0.0 115.907 6.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.598 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.754 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.358 -171.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB1' ' H ' ' A' ' 15' ' ' LEU . . . -40.69 149.22 0.33 Allowed Pre-proline 0 N--CA 1.504 2.262 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -87.67 38.62 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 N-CA-C 109.321 -1.069 . . . . 0.0 109.321 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.66 124.14 27.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.78 -176.48 4.96 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.109 -1.436 . . . . 0.0 110.132 -176.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.17 -173.91 4.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.037 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -68.85 118.18 11.47 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.616 -176.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.47 -12.62 1.84 Allowed Glycine 0 C--N 1.297 -1.599 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.532 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.9 mttm -96.4 135.47 22.45 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.159 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 9' ' ' LYS . 11.3 Cg_exo -47.14 -169.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.212 1.941 . . . . 0.0 113.875 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.09 32.36 0.25 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 114.297 -1.32 . . . . 0.0 113.959 -174.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.454 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 7.8 ptm180 -161.84 137.87 7.83 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 116.294 -2.162 . . . . 0.0 115.352 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -151.08 160.92 28.88 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.75 122.07 26.13 Favored 'General case' 0 C--O 1.18 -2.587 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.186 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 4.0 tt -89.18 118.3 28.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 117.624 -1.631 . . . . 0.0 111.711 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.688 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 57.0 m95 -103.41 170.99 7.62 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.351 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -96.16 -157.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.744 -175.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.547 HD11 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.94 67.57 0.15 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.363 1.554 . . . . 0.0 108.4 -177.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.7 mtt-85 -116.07 100.3 7.85 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.151 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -41.68 -26.48 0.26 Allowed Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.701 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -147.21 160.47 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.147 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -87.13 150.17 49.03 Favored Pre-proline 0 C--N 1.292 -1.9 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.086 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.44 163.54 17.55 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 110.888 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.26 -10.75 47.41 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.84 -26.73 67.43 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.726 -1.226 . . . . 0.0 111.155 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -87.35 -32.95 19.35 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.874 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.56 16.32 29.5 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.813 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.688 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 58.8 m-85 -53.97 173.47 0.06 Allowed 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.954 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 p -161.33 -46.48 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 112.909 -1.95 . . . . 0.0 106.083 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.84 120.06 38.64 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.646 -2.07 . . . . 0.0 109.312 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.36 148.39 30.32 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.023 -1.471 . . . . 0.0 112.618 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 143.94 40.3 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.553 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 24.7 m-85 -113.3 137.23 51.8 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.307 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 11.0 mmtt -121.46 70.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.424 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -40.03 140.84 0.86 Allowed Pre-proline 0 C--N 1.294 -1.822 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.091 -176.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -72.67 -22.77 11.79 Favored 'Cis proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.743 -4.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.629 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -78.63 -161.38 0.28 Allowed 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 -176.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.513 ' HA ' ' H ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -164.7 154.19 2.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.873 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.8 m -124.66 127.15 46.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.539 164.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -96.53 153.9 17.58 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -172.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.562 ' O ' ' O ' ' A' ' 30' ' ' SER . 4.6 m-85 -127.66 165.72 28.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.75 159.21 91.74 Favored 'Cis proline' 0 C--N 1.323 -0.805 0 CA-C-O 122.783 1.076 . . . . 0.0 114.47 1.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.596 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.387 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.259 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.82 147.36 6.57 Favored Pre-proline 0 N--CA 1.509 2.49 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -87.12 34.75 0.44 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.35 -1.442 . . . . 0.0 108.35 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -74.77 116.33 15.36 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.219 -174.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.6 164.12 24.92 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 117.588 -1.645 . . . . 0.0 108.87 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.58 -178.94 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.36 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 99.9 p -76.99 124.12 27.31 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.143 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.25 -13.16 28.38 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.478 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -115.5 108.9 46.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.981 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.32 -154.21 0.04 OUTLIER 'Trans proline' 0 C--O 1.208 -0.976 0 N-CA-C 109.033 -1.179 . . . . 0.0 109.033 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 -108.92 2.63 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 119.254 -1.45 . . . . 0.0 111.507 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.675 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -160.16 168.63 25.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 118.923 -1.111 . . . . 0.0 113.023 -176.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.7 146.49 18.05 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.444 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -79.48 118.07 21.01 Favored 'General case' 0 C--O 1.171 -3.058 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.115 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 tp -85.76 92.6 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.526 -1.67 . . . . 0.0 113.723 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.478 ' N ' ' O ' ' A' ' 38' ' ' ILE . 70.3 m95 -75.53 126.27 30.67 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.801 -1.999 . . . . 0.0 107.744 172.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -94.88 -7.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.135 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -170.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mt -153.13 73.39 0.99 Allowed 'General case' 0 C--N 1.253 -3.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.469 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -166.16 148.59 7.06 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 116.637 -2.025 . . . . 0.0 113.204 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.08 -13.22 27.62 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -142.87 153.96 43.66 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.235 -0.982 . . . . 0.0 109.22 177.276 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -95.51 152.52 39.29 Favored Pre-proline 0 C--N 1.288 -2.085 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.832 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.83 -170.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.221 1.281 . . . . 0.0 111.651 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.77 -19.27 3.4 Favored Glycine 0 N--CA 1.489 2.212 1 N-CA-C 129.221 6.448 . . . . 0.0 129.221 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.75 4.57 68.91 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -79.35 -56.61 4.21 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.467 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.8 7.05 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.82 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.608 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 34.1 m-85 -76.54 165.77 24.32 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 123.016 1.388 . . . . 0.0 112.769 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 p -163.32 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 111.757 -2.474 . . . . 0.0 106.005 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' TYR . 13.9 p -98.7 124.26 43.42 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.378 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.662 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -153.63 157.1 39.13 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.816 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 147.81 39.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.62 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 13.1 m-85 -124.31 139.3 54.04 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.539 -172.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 73.72 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -43.93 155.42 0.33 Allowed Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.175 -174.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.87 10.25 8.54 Favored 'Cis proline' 0 N--CA 1.485 1.016 0 C-N-CA 124.293 -1.128 . . . . 0.0 111.142 -2.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.661 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -111.49 -162.07 0.78 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.871 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -177.33 138.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.536 -178.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 29.0 m -108.21 113.35 26.4 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 117.698 -1.601 . . . . 0.0 106.939 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -93.22 130.72 38.82 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.921 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' CE2' ' O ' ' A' ' 12' ' ' ARG . 24.1 m-85 -106.89 -174.55 0.32 Allowed Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 43' ' ' HIS . 35.9 Cg_exo -54.81 -49.01 0.14 OUTLIER 'Cis proline' 0 N--CA 1.501 1.913 0 CA-C-N 122.745 2.016 . . . . 0.0 116.727 5.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.675 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.742 0 CA-C-O 116.349 -1.786 . . . . 0.0 109.1 -172.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.661 ' N ' HH12 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -39.13 146.41 0.34 Allowed Pre-proline 0 N--CA 1.508 2.471 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -84.33 20.36 1.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 N-CA-C 107.993 -1.579 . . . . 0.0 107.993 164.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.52 ' H ' ' C ' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -81.12 115.41 20.54 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.4 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.85 178.22 8.11 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.43 -174.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -176.91 3.24 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.839 0.828 . . . . 0.0 110.152 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 p -77.66 128.02 33.42 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.34 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.67 -9.19 11.35 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -119.81 108.62 38.76 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -73.95 -163.44 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 -110.45 3.74 Favored Glycine 0 C--N 1.282 -2.472 0 C-N-CA 118.535 -1.793 . . . . 0.0 110.65 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.661 HH12 ' N ' ' A' ' 1' ' ' ALA . 0.3 OUTLIER -163.11 164.7 25.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 117.812 -1.555 . . . . 0.0 114.012 -177.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . -146.26 -170.3 14.76 Favored Glycine 0 N--CA 1.502 3.053 1 N-CA-C 127.074 5.59 . . . . 0.0 127.074 173.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.589 ' CB ' ' HH ' ' A' ' 28' ' ' TYR . 1.4 m-20 -99.32 127.22 45.31 Favored 'General case' 0 C--O 1.182 -2.463 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.99 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 4.2 tp -102.0 97.1 7.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.922 1.344 . . . . 0.0 110.256 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.483 ' N ' ' O ' ' A' ' 38' ' ' ILE . 80.0 m95 -89.02 151.99 21.95 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.963 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.63 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.38 -157.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.653 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.4 -178.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -70.07 76.82 0.5 Allowed 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 123.627 1.68 . . . . 0.0 109.236 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 21' ' ' THR . 9.9 mtt180 -126.45 75.93 1.58 Allowed 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 110.987 -2.824 . . . . 0.0 110.715 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -17.54 -32.02 0.0 OUTLIER Glycine 0 N--CA 1.499 2.858 1 N-CA-C 126.665 5.426 . . . . 0.0 126.665 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -140.41 154.14 46.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.297 176.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -86.12 153.73 57.13 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.14 -178.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.81 172.22 4.99 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.157 1.238 . . . . 0.0 110.81 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.42 18.17 35.92 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.79 -13.63 25.19 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.662 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -90.28 1.93 56.0 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.824 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 -0.14 39.22 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.732 -1.223 . . . . 0.0 111.367 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.678 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.9 m-85 -54.83 169.97 0.19 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.787 1.279 . . . . 0.0 111.736 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 p -160.18 -44.82 0.05 OUTLIER 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 112.174 -2.285 . . . . 0.0 105.175 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 12.4 p -98.25 137.39 37.06 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 112.968 -1.924 . . . . 0.0 108.621 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -155.16 148.98 25.51 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 117.707 -1.597 . . . . 0.0 113.116 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -93.43 158.34 15.77 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 26.5 m-85 -136.95 131.47 33.06 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.793 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -136.56 77.96 1.68 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.402 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.43 150.98 1.48 Allowed Pre-proline 0 C--N 1.293 -1.886 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.111 -177.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' LEU . 1.9 Cg_endo -69.17 -19.18 10.62 Favored 'Cis proline' 0 C--O 1.198 -1.499 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.285 -3.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.628 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -85.9 -169.44 2.64 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -177.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -149.22 144.74 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.652 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.3 m -117.21 116.52 27.44 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.731 -1.187 . . . . 0.0 107.902 171.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.678 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -97.46 155.0 17.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -131.35 173.13 6.23 Favored Pre-proline 0 N--CA 1.503 2.18 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -88.65 156.05 37.77 Favored 'Cis proline' 0 C--O 1.214 -0.685 0 N-CA-C 115.764 1.409 . . . . 0.0 115.764 0.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 110.985 -2.825 . . . . 0.0 110.109 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -41.86 146.88 0.56 Allowed Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.827 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -76.6 52.67 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 N-CA-C 106.075 -2.317 . . . . 0.0 106.075 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -68.1 131.18 44.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.13 175.02 11.02 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.167 -1.413 . . . . 0.0 110.769 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.22 177.43 11.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.779 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.7 m -86.77 106.35 17.62 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.894 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.68 -17.78 8.21 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.5 mptt -134.42 136.83 26.52 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.126 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 9' ' ' LYS . 6.0 Cg_exo -50.52 -156.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.378 2.052 . . . . 0.0 114.033 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 31.8 0.1 OUTLIER Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -161.34 137.26 8.01 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 115.775 -2.37 . . . . 0.0 116.071 175.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.63 -166.82 10.83 Favored Glycine 0 N--CA 1.509 3.546 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.733 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.8 m-20 -108.18 127.31 53.71 Favored 'General case' 0 C--O 1.181 -2.52 0 CA-C-O 118.27 -0.872 . . . . 0.0 109.203 176.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 tp -91.04 135.61 33.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.964 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.4 ' CD1' ' HB2' ' A' ' 40' ' ' CYS . 59.7 m95 -127.73 -176.17 3.69 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 111.434 -2.621 . . . . 0.0 108.949 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 19' ' ' ARG . 1.8 mt -105.02 -167.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -173.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.498 ' N ' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.03 68.98 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.978 1.371 . . . . 0.0 107.606 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.1 mtt-85 -116.75 125.45 51.67 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 112.223 -2.262 . . . . 0.0 110.4 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.27 69.61 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -142.98 160.72 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.768 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 158.01 42.77 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.268 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.07 125.56 15.49 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.3 1.333 . . . . 0.0 110.899 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 3.86 69.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.593 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.94 -12.73 58.73 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.56 -46.5 15.64 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.459 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.43 -7.89 5.31 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.469 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.9 m-85 -50.22 171.27 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.66 1.219 . . . . 0.0 111.187 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.6 p -161.87 -45.6 0.04 OUTLIER 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 112.34 -2.209 . . . . 0.0 105.874 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.95 130.19 44.82 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.729 -2.032 . . . . 0.0 110.298 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.593 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -157.51 157.29 33.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 117.861 -1.536 . . . . 0.0 112.148 177.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 140.02 53.18 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.592 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 22.4 m-85 -112.88 136.47 52.49 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.731 -173.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -142.76 75.5 1.49 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.257 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.485 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -45.51 156.79 0.4 Allowed Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.106 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.473 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 8.7 Cg_endo -78.91 30.72 1.47 Allowed 'Cis proline' 0 C--O 1.194 -1.68 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.196 -1.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.485 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 m-80 -146.62 -168.68 3.09 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.173 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.476 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -152.62 149.03 13.85 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.024 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.115 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -119.84 120.06 35.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.555 167.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -91.11 157.57 17.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.254 -171.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' O ' ' O ' ' A' ' 30' ' ' SER . 15.4 m-85 -133.24 167.62 22.04 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.71 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.46 160.93 95.49 Favored 'Cis proline' 0 C--O 1.213 -0.736 0 CA-C-O 122.591 0.996 . . . . 0.0 113.585 0.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.579 -2.101 . . . . 0.0 109.859 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.485 ' H1 ' HH12 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -41.9 147.52 0.53 Allowed Pre-proline 0 N--CA 1.502 2.138 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -85.76 28.46 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 N-CA-C 106.996 -1.963 . . . . 0.0 106.996 164.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.8 p -88.51 116.58 26.85 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.407 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -177.1 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.803 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -119.79 -176.46 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.567 178.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.56 116.86 20.01 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.425 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.7 79.32 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.435 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mppp? -119.74 117.96 32.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.503 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.44 178.58 7.24 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 121.236 1.291 . . . . 0.0 109.821 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.52 -100.19 2.12 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.409 -1.377 . . . . 0.0 111.294 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.1 ptm180 -162.03 178.23 9.02 Favored 'General case' 0 C--O 1.209 -1.078 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.364 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -162.57 165.34 36.15 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 175.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.567 ' CB ' ' HH ' ' A' ' 28' ' ' TYR . 1.5 m-20 -87.19 132.25 33.93 Favored 'General case' 0 C--O 1.18 -2.553 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.34 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.499 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 10.7 tp -97.18 100.07 11.54 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.647 1.213 . . . . 0.0 111.802 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.509 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 67.0 m95 -93.01 160.88 14.67 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 112.515 -2.13 . . . . 0.0 110.831 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -84.45 -163.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.919 -176.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.401 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -68.39 71.77 0.19 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.74 1.257 . . . . 0.0 107.984 -176.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' THR . 38.8 mtt180 -122.08 86.8 2.64 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.765 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -22.23 -28.02 0.0 OUTLIER Glycine 0 N--CA 1.495 2.593 1 N-CA-C 125.837 5.095 . . . . 0.0 125.837 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' ARG . 1.4 p -150.01 151.35 33.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.04 -1.08 . . . . 0.0 109.866 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -85.72 151.57 55.58 Favored Pre-proline 0 C--N 1.289 -2.053 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.385 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.23 146.88 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.073 1.182 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.54 3.44 17.49 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.066 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.68 9.25 5.81 Favored Glycine 0 N--CA 1.491 2.32 1 N-CA-C 130.575 6.99 . . . . 0.0 130.575 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.67 14.94 8.96 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.45 79.82 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.382 -1.389 . . . . 0.0 111.619 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.623 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.7 m-85 -69.91 168.6 14.93 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.188 1.47 . . . . 0.0 113.492 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 p -161.57 -46.69 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 111.549 -2.569 . . . . 0.0 105.911 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.461 ' H ' ' HG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -99.12 119.7 38.28 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.808 -1.996 . . . . 0.0 110.319 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -144.03 152.98 41.73 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.526 178.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -108.76 149.18 29.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.429 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.521 ' OH ' ' ND2' ' A' ' 31' ' ' ASN . 18.5 m-85 -125.98 134.35 51.52 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.962 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -151.53 76.57 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.603 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -40.65 156.65 0.19 Allowed Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.593 -178.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.487 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.8 Cg_endo -79.09 35.05 0.87 Allowed 'Cis proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.768 -0.93 . . . . 0.0 111.464 -5.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.2 m-80 -149.03 -171.43 3.87 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.489 -1.284 . . . . 0.0 110.318 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.473 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -154.75 144.91 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.534 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -113.65 107.73 16.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.148 171.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.623 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -83.75 130.92 34.95 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.876 -173.245 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.608 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -103.97 -177.73 0.56 Allowed Pre-proline 0 N--CA 1.505 2.312 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 13.6 Cg_exo -63.11 -50.18 0.16 OUTLIER 'Cis proline' 0 N--CA 1.505 2.196 0 N-CA-C 117.449 2.057 . . . . 0.0 117.449 5.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.792 0 CA-C-O 116.239 -1.838 . . . . 0.0 109.167 -169.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' O ' ' NH2' ' A' ' 12' ' ' ARG . . . -62.76 142.98 97.05 Favored Pre-proline 0 N--CA 1.502 2.171 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -82.73 40.47 0.97 Allowed 'Trans proline' 0 CA--C 1.551 1.325 0 N-CA-C 108.634 -1.333 . . . . 0.0 108.634 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.612 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.79 128.99 34.1 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.17 169.51 18.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.422 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.68 178.3 7.33 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.504 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.31 128.02 33.08 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.277 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.71 -16.85 33.86 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.336 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 110.93 23.37 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.386 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -75.49 -179.73 5.38 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 N-CA-C 108.6 -1.346 . . . . 0.0 108.6 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.24 -99.38 2.5 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.814 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 2' ' ' ALA . 2.6 ptm180 -156.12 159.11 38.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.051 -175.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.26 148.42 20.04 Favored Glycine 0 N--CA 1.499 2.837 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.229 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 15.6 m-20 -78.57 124.07 27.76 Favored 'General case' 0 C--O 1.181 -2.552 0 C-N-CA 119.304 -0.959 . . . . 0.0 109.751 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.5 tp -83.8 132.74 34.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 117.683 -1.607 . . . . 0.0 110.355 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.657 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 53.5 m95 -124.94 167.55 14.53 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.493 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -90.92 -161.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 C-N-CA 118.109 -1.436 . . . . 0.0 112.639 -175.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.15 69.98 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.532 -176.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 6.0 mtp180 -110.4 119.83 40.48 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 112.109 -2.314 . . . . 0.0 111.803 -177.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.27 -46.93 51.39 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.305 -1.426 . . . . 0.0 109.595 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.93 156.93 48.02 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.212 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.16 160.94 67.11 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -51.09 110.9 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 120.971 1.114 . . . . 0.0 111.662 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -15.73 -113.18 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 1 N-CA-C 130.349 6.899 . . . . 0.0 130.349 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.41 46.62 3.52 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.384 -1.389 . . . . 0.0 109.787 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -83.67 -60.73 2.03 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.32 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -160.38 -27.24 0.02 OUTLIER Glycine 0 C--N 1.288 -2.099 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 48.5 m-85 -84.22 173.04 11.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 122.897 1.332 . . . . 0.0 112.666 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.47 -48.9 0.05 Allowed 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.014 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -100.23 111.3 23.57 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 113.138 -1.846 . . . . 0.0 109.607 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.83 143.67 41.1 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.471 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 140.58 38.33 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 28.6 m-85 -115.94 149.27 39.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.203 -173.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.03 81.99 0.71 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.68 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.415 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.51 158.56 0.27 Allowed Pre-proline 0 C--N 1.307 -1.26 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.37 -177.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' C ' HD21 ' A' ' 37' ' ' ASN . 8.2 Cg_endo -79.52 33.58 1.24 Allowed 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.44 -1.067 . . . . 0.0 111.456 -5.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.528 HD21 ' C ' ' A' ' 36' ' ' PRO . 7.5 m-80 -147.92 -160.2 1.13 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.916 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.476 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -164.5 137.62 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.113 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.496 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.7 m -108.87 115.47 30.14 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 116.763 -1.975 . . . . 0.0 107.029 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -86.59 148.29 25.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 113.564 -1.653 . . . . 0.0 113.28 -171.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -125.79 168.41 14.0 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -84.32 156.87 68.17 Favored 'Cis proline' 0 N--CA 1.454 -0.849 0 CA-C-O 122.939 1.141 . . . . 0.0 114.062 4.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.625 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.428 175.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -39.86 155.45 0.17 Allowed Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -92.43 51.49 0.55 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 O-C-N 122.621 0.8 . . . . 0.0 110.664 167.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -88.97 136.25 33.11 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.775 -1.57 . . . . 0.0 107.731 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.4 174.2 11.81 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.837 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -126.4 179.8 5.12 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.708 0.766 . . . . 0.0 109.845 177.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 m -76.86 128.41 34.52 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.455 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.39 27.34 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.846 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -125.28 99.3 34.03 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.51 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.98 155.91 47.83 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 N-CA-C 108.586 -1.351 . . . . 0.0 108.586 173.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.93 -97.62 0.51 Allowed Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.171 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.589 ' C ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.33 157.46 28.0 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 118.186 -1.405 . . . . 0.0 113.294 -178.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -150.82 162.28 29.32 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 77.6 m-20 -78.03 125.2 29.0 Favored 'General case' 0 C--O 1.184 -2.364 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.6 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.415 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 8.4 tt -91.06 109.89 21.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.557 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.558 ' N ' ' O ' ' A' ' 38' ' ' ILE . 63.2 m95 -91.56 161.69 14.84 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.931 -2.395 . . . . 0.0 109.052 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -81.15 -157.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 119.416 -0.913 . . . . 0.0 112.022 -176.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 67.01 0.11 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.359 1.552 . . . . 0.0 107.244 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -113.86 111.44 21.73 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 112.065 -2.334 . . . . 0.0 110.284 -178.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.12 -20.83 65.34 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.341 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.42 152.58 44.4 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.195 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -94.7 155.08 39.78 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.599 179.144 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -66.91 143.06 64.92 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.037 1.158 . . . . 0.0 110.985 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.22 2.83 87.35 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.81 -22.13 53.94 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.34 -16.98 55.44 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.675 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.39 0.4 73.34 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.093 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.651 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 49.0 m-85 -54.34 161.74 1.28 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.29 -1.364 . . . . 0.0 111.542 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.5 p -146.2 -48.44 0.21 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 112.076 -2.329 . . . . 0.0 105.891 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -100.06 116.43 32.07 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.254 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' ND2' ' HH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -139.14 149.18 44.19 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.787 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.6 p -106.05 141.53 37.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HH ' ' ND2' ' A' ' 31' ' ' ASN . 17.7 m-85 -119.97 138.95 53.17 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.147 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 80.5 0.95 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.41 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -44.39 158.4 0.27 Allowed Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.731 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.41 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 2.8 Cg_endo -78.04 28.75 1.61 Allowed 'Cis proline' 0 C--O 1.211 -0.857 0 C-N-CA 124.492 -1.045 . . . . 0.0 111.945 -5.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.46 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -144.44 179.44 7.26 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.232 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -145.96 148.44 17.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -122.22 123.37 41.32 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 117.343 -1.743 . . . . 0.0 107.856 167.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.651 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.74 147.09 23.15 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.839 -171.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -121.85 169.32 9.55 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.84 157.62 80.48 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 CA-C-O 123.133 1.222 . . . . 0.0 114.553 3.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.72 0 CA-C-N 111.455 -2.612 . . . . 0.0 110.161 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -46.53 140.0 5.9 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.417 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.03 58.75 5.64 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 N-CA-C 107.234 -1.872 . . . . 0.0 107.234 168.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.33 136.92 39.56 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.3 m-85 -77.96 163.04 26.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.221 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.507 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -104.65 -173.87 2.41 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.659 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.55 122.86 21.24 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.166 -177.39 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.82 -3.34 0.99 Allowed Glycine 0 N--CA 1.48 1.595 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.819 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 7' ' ' SER . 11.2 mttm -107.69 108.59 61.72 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.474 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.22 -173.81 1.21 Allowed 'Trans proline' 0 C--N 1.324 -0.716 0 C-N-CA 120.807 1.004 . . . . 0.0 109.615 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 93.81 -115.26 4.93 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.418 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.534 ' NH1' ' OD1' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -160.41 160.93 32.83 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.216 -1.393 . . . . 0.0 113.471 -178.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.82 148.57 20.28 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.534 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 9.6 m-20 -76.53 126.7 31.44 Favored 'General case' 0 C--O 1.171 -3.068 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.599 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 10.7 tp -83.11 104.8 13.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.282 -1.767 . . . . 0.0 111.703 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.539 ' N ' ' O ' ' A' ' 38' ' ' ILE . 62.6 m95 -87.56 167.14 14.2 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.466 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -88.58 -161.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.026 -177.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.46 73.57 0.15 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.1 1.428 . . . . 0.0 108.599 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 17' ' ' ILE . 23.8 mtp85 -112.83 143.76 43.54 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 112.235 -2.257 . . . . 0.0 111.203 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.16 -20.64 66.86 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.47 157.19 35.05 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.857 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.87 148.12 71.72 Favored Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.44 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 22' ' ' CYS . 5.8 Cg_exo -53.67 -173.94 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 120.685 0.923 . . . . 0.0 111.054 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.52 -11.39 6.65 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 129.314 6.486 . . . . 0.0 129.314 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.89 19.32 55.23 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.61 -73.76 0.61 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.264 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.73 3.43 0.16 Allowed Glycine 0 N--CA 1.488 2.167 0 C-N-CA 118.974 -1.584 . . . . 0.0 112.418 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.3 m-85 -63.93 171.58 2.76 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.808 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.436 ' HG1' ' H ' ' A' ' 30' ' ' SER . 1.2 p -161.99 -44.86 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 112.592 -2.095 . . . . 0.0 106.433 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 41' ' ' TYR . 4.0 p -99.06 121.66 41.28 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.961 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.632 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.66 150.81 36.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.109 -1.436 . . . . 0.0 113.197 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.36 147.18 31.91 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.523 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.446 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 13.1 m-85 -121.32 136.01 55.02 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.654 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 4.6 mttp -138.35 63.64 1.52 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.572 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.467 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 27.5 t-105 -32.76 145.77 0.1 Allowed Pre-proline 0 N--CA 1.507 2.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.211 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.3 Cg_endo -78.62 40.41 0.4 Allowed 'Cis proline' 0 N--CA 1.499 1.81 0 C-N-CA 125.768 -0.513 . . . . 0.0 111.269 -5.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.467 ' H ' ' CA ' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -148.91 -163.53 1.81 Allowed 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.974 177.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -166.25 147.2 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.801 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -121.21 131.69 54.38 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 118.076 -1.45 . . . . 0.0 107.888 167.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -101.64 146.94 27.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.527 -1.215 . . . . 0.0 114.27 -168.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -116.51 -179.17 0.59 Allowed Pre-proline 0 N--CA 1.513 2.711 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.0 Cg_exo -63.8 -50.96 0.16 OUTLIER 'Cis proline' 0 N--CA 1.503 2.031 0 CA-C-N 122.117 1.792 . . . . 0.0 116.7 6.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.956 0 CA-C-O 116.356 -1.783 . . . . 0.0 109.24 -171.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -82.28 160.98 61.27 Favored Pre-proline 0 N--CA 1.513 2.697 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.43 32.55 0.27 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 N-CA-C 108.804 -1.268 . . . . 0.0 108.804 165.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.78 141.86 33.13 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.227 -174.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -89.98 171.32 9.65 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.6 -179.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -115.45 -175.66 2.76 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.11 178.182 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.13 115.09 17.6 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.811 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.47 64.3 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.625 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.92 114.27 46.59 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.067 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -77.03 166.65 26.38 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 N-CA-C 108.277 -1.47 . . . . 0.0 108.277 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.41 -106.18 2.4 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.233 -1.46 . . . . 0.0 111.069 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.66 165.04 31.27 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.105 -1.438 . . . . 0.0 113.903 -177.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.5 -174.7 15.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -104.51 111.86 24.7 Favored 'General case' 0 C--O 1.173 -2.952 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.448 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 23.2 tp -82.9 94.22 7.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 116.89 -1.924 . . . . 0.0 112.954 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.475 ' N ' ' O ' ' A' ' 38' ' ' ILE . 73.0 m95 -70.19 111.9 6.15 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 112.458 -2.156 . . . . 0.0 105.859 169.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.31 -10.0 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.979 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -169.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mt -151.05 78.39 1.29 Allowed 'General case' 0 C--N 1.249 -3.796 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.786 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -175.99 166.61 3.0 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 117.641 -1.624 . . . . 0.0 112.209 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.87 -24.26 4.34 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -130.24 152.23 49.89 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.0 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.609 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -88.19 147.91 41.53 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.682 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -59.45 103.57 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.57 0.846 . . . . 0.0 110.597 -176.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 7.79 -93.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.931 1 N-CA-C 130.684 7.033 . . . . 0.0 130.684 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.32 46.04 1.71 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.299 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -79.31 0.66 27.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.577 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.0 27.94 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.1 m-85 -76.41 164.08 26.34 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 122.909 1.338 . . . . 0.0 112.588 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -162.72 -42.84 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.643 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.28 115.03 26.89 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.374 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.33 151.68 37.91 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.309 -1.357 . . . . 0.0 112.994 -177.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.91 144.91 32.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 15.9 m-85 -120.03 129.2 54.13 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.683 -173.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -135.93 73.17 1.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.431 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -48.41 154.7 1.07 Allowed Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.28 -175.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -70.96 7.7 3.85 Favored 'Cis proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.105 -1.206 . . . . 0.0 110.901 -5.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 35' ' ' TRP . 4.6 m-80 -104.37 -164.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.948 0.88 . . . . 0.0 111.357 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -177.34 135.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 7.5 m -105.69 113.26 26.72 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 117.807 -1.557 . . . . 0.0 107.625 171.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -91.52 133.25 35.67 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.001 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.684 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -110.51 168.38 7.7 Favored Pre-proline 0 N--CA 1.512 2.671 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.324 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -83.81 158.79 71.53 Favored 'Cis proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.05 1.187 . . . . 0.0 114.678 2.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.684 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.449 0 CA-C-N 111.741 -2.481 . . . . 0.0 109.763 175.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -67.67 142.49 96.02 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 119.543 -0.863 . . . . 0.0 113.053 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -82.27 36.35 0.62 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 107.701 -1.692 . . . . 0.0 107.701 165.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.24 125.38 29.05 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.385 -174.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -81.6 -175.86 5.75 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 117.896 -1.522 . . . . 0.0 109.388 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -172.14 3.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.669 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -69.82 134.05 48.09 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.507 -176.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.94 -1.76 0.2 Allowed Glycine 0 N--CA 1.482 1.7 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.779 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 7' ' ' SER . 19.0 mttm -121.8 102.54 41.31 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.313 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -170.99 0.59 Allowed 'Trans proline' 0 C--O 1.21 -0.885 0 C-N-CA 121.263 1.309 . . . . 0.0 109.252 175.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 -106.13 3.27 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.726 -1.702 . . . . 0.0 111.323 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.423 ' NH2' ' OD1' ' A' ' 14' ' ' ASP . 1.2 ptm180 -161.55 165.93 27.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.881 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -146.4 146.13 15.82 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -78.19 118.49 20.47 Favored 'General case' 0 C--O 1.173 -2.933 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.178 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -81.3 129.5 34.64 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 116.938 -1.905 . . . . 0.0 110.683 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -117.96 122.01 42.15 Favored 'General case' 0 C--N 1.263 -3.172 0 CA-C-N 111.902 -2.408 . . . . 0.0 105.444 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.64 -12.68 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 mt -152.36 66.86 0.83 Allowed 'General case' 0 C--N 1.246 -3.901 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.226 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.32 123.26 13.52 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.215 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.04 -36.41 31.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.86 155.4 49.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.75 153.38 67.51 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.579 -177.191 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -67.53 -164.73 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.481 1.454 . . . . 0.0 111.684 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -132.98 -18.17 1.1 Allowed Glycine 0 N--CA 1.489 2.206 1 N-CA-C 130.631 7.012 . . . . 0.0 130.631 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.85 47.0 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.326 -1.416 . . . . 0.0 109.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -83.2 -91.06 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.45 25.03 0.02 OUTLIER Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.275 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.4 m-85 -69.27 171.86 7.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.598 1.189 . . . . 0.0 111.099 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 p -162.65 -45.83 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.373 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 125.76 44.72 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.302 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.635 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -156.47 149.88 24.48 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 117.534 -1.666 . . . . 0.0 113.369 177.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.54 143.96 40.12 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.529 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 57.7 m-85 -111.36 138.01 48.4 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.235 -0.986 . . . . 0.0 113.026 -172.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 35' ' ' TRP . 11.5 mmtm -135.02 60.21 1.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.406 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -41.63 148.58 0.44 Allowed Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.619 -175.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -71.75 -3.81 11.35 Favored 'Cis proline' 0 C--O 1.211 -0.863 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.032 -1.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.619 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -99.22 -160.32 0.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.803 -178.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.469 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 178.56 136.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.19 -2.07 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.177 -178.186 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 33.9 m -105.3 117.36 33.81 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.231 -1.787 . . . . 0.0 107.021 171.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -98.48 126.32 43.98 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.535 -170.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 30' ' ' SER . 15.7 m-85 -98.5 -172.66 0.28 Allowed Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -56.31 -52.11 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 123.206 2.181 . . . . 0.0 115.948 5.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.612 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 116.332 -1.794 . . . . 0.0 109.221 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -71.38 145.64 90.82 Favored Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -85.71 33.74 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 108.516 -1.378 . . . . 0.0 108.516 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.8 136.18 36.66 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -176.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.686 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.1 -175.83 4.79 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.125 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -128.62 -171.89 2.58 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.291 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -70.71 114.29 8.65 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.78 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.44 1.12 4.11 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.092 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.2 mptm? -103.55 151.15 38.66 Favored Pre-proline 0 N--CA 1.498 1.934 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.192 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 9' ' ' LYS . 17.1 Cg_exo -38.88 177.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.779 2.986 . . . . 0.0 115.051 -173.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.06 31.37 0.65 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.909 -1.496 . . . . 0.0 114.911 -172.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -161.21 142.78 11.77 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 115.884 -2.327 . . . . 0.0 114.754 175.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -161.88 152.41 22.82 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.947 174.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 118.37 19.27 Favored 'General case' 0 C--O 1.174 -2.91 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.572 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' H ' ' CB ' ' A' ' 2' ' ' ALA . 7.2 tt -87.63 94.98 9.89 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.141 -1.824 . . . . 0.0 112.341 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.565 ' N ' ' O ' ' A' ' 38' ' ' ILE . 66.5 m95 -70.56 127.65 33.41 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.307 -2.224 . . . . 0.0 107.464 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.81 -10.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -153.74 76.43 1.07 Allowed 'General case' 0 C--N 1.247 -3.872 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.477 -174.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -161.69 129.32 4.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 117.239 -1.784 . . . . 0.0 112.737 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.49 -18.74 65.62 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 175.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -142.61 154.66 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.582 -0.809 . . . . 0.0 109.242 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 156.66 39.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.628 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -61.94 -172.99 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 121.163 1.242 . . . . 0.0 111.509 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.91 -5.24 4.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.28 -18.16 47.21 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.438 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.74 -31.21 41.04 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.48 7.01 30.67 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.556 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.9 m-85 -66.03 167.86 9.19 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.591 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 p -161.12 -44.14 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.386 -2.188 . . . . 0.0 105.953 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.22 124.86 41.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.819 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -157.09 158.6 36.7 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.112 -1.435 . . . . 0.0 112.699 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.1 p -115.82 140.64 49.02 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.29 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.488 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 35.9 m-85 -108.77 131.76 54.64 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.643 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -131.57 67.65 1.51 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.09 149.24 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.573 -175.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -71.68 -5.12 12.16 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.017 -5.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.664 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -92.68 -161.91 0.88 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.867 -177.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 176.21 143.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.46 -177.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 71.2 m -112.38 125.41 54.17 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.016 169.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -105.02 138.08 41.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' CE2' ' ND1' ' A' ' 43' ' ' HIS . 2.2 m-85 -108.16 -178.96 0.62 Allowed Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.6 Cg_exo -58.37 -55.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.507 2.322 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 5.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.672 0 CA-C-O 116.377 -1.773 . . . . 0.0 109.133 -171.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' HB1' ' H ' ' A' ' 15' ' ' LEU . . . -52.0 148.53 10.69 Favored Pre-proline 0 N--CA 1.501 2.121 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.996 -177.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -84.93 34.31 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.644 0.896 . . . . 0.0 109.94 168.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.18 123.31 26.75 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.392 -176.044 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -79.31 164.68 23.9 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.551 -1.26 . . . . 0.0 110.083 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 179.22 6.5 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.107 0.956 . . . . 0.0 111.281 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.25 133.23 38.9 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.522 -177.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.86 -17.03 28.79 Favored Glycine 0 C--N 1.296 -1.644 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.711 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.94 114.27 10.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -73.72 -160.89 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 N-CA-C 108.627 -1.336 . . . . 0.0 108.627 172.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 79.52 -106.87 2.47 Favored Glycine 0 C--N 1.288 -2.12 0 C-N-CA 118.809 -1.662 . . . . 0.0 111.229 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -157.14 158.85 37.08 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.273 -176.686 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.22 161.75 24.97 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 174.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -79.25 128.67 33.6 Favored 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.35 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 16.6 tp -92.4 108.0 19.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.691 1.234 . . . . 0.0 111.958 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' ILE . 64.8 m95 -99.82 150.38 22.41 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 112.546 -2.115 . . . . 0.0 109.709 177.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.544 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -81.22 -155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.341 -177.581 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.75 72.94 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.212 1.482 . . . . 0.0 108.272 -174.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 17' ' ' ILE . 10.5 mtp85 -114.53 103.94 11.52 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.449 179.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.99 -27.77 14.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.219 -1.467 . . . . 0.0 109.884 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 157.39 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.75 159.89 70.49 Favored Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.647 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -50.46 168.87 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.071 1.181 . . . . 0.0 110.948 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.02 140.62 15.13 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.845 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.36 85.8 Favored Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.513 -1.327 . . . . 0.0 111.074 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -171.58 2.8 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.696 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.46 6.67 71.38 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.055 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.3 m-85 -86.96 168.02 13.74 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 118.373 -1.331 . . . . 0.0 112.334 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.81 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 111.961 -2.382 . . . . 0.0 105.697 177.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.524 ' H ' ' HG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -99.33 117.02 32.85 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.534 179.338 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.638 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -143.07 153.3 42.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.742 -179.864 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 140.77 47.66 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.222 177.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.505 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 34.8 m-85 -117.38 142.64 46.86 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.371 -172.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.22 81.25 0.69 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.662 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.488 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -51.06 158.79 1.13 Allowed Pre-proline 0 C--N 1.308 -1.208 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.727 -176.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.83 33.18 1.43 Allowed 'Cis proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.12 -1.2 . . . . 0.0 111.826 -2.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.488 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 m-80 -145.29 -166.12 2.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.403 176.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -165.98 144.92 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.14 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 3.4 m -115.55 122.16 44.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.048 -1.861 . . . . 0.0 107.289 167.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.49 135.81 33.74 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.865 -172.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.703 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -105.92 167.19 10.02 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.444 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -86.98 158.66 50.13 Favored 'Cis proline' 0 C--O 1.214 -0.696 0 N-CA-C 115.068 1.142 . . . . 0.0 115.068 2.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.703 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 111.926 -2.397 . . . . 0.0 109.508 174.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -46.8 135.94 7.95 Favored Pre-proline 0 N--CA 1.495 1.812 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.61 -177.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.02 35.55 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 167.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.06 122.38 20.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -175.081 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.43 178.71 6.97 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 117.558 -1.657 . . . . 0.0 108.863 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.491 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -130.96 -177.48 4.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.381 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -77.73 113.67 15.82 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.961 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.03 64.16 Favored Glycine 0 C--N 1.297 -1.612 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.379 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -119.51 107.07 41.42 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.696 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -72.42 174.15 12.04 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.161 1.24 . . . . 0.0 109.55 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.47 -99.72 1.97 Allowed Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.635 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.599 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -159.38 159.9 34.31 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.666 -176.268 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.44 143.86 12.93 Favored Glycine 0 C--N 1.288 -2.105 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 171.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -76.17 127.72 33.5 Favored 'General case' 0 C--O 1.17 -3.079 0 C-N-CA 118.994 -1.082 . . . . 0.0 108.359 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 117.49 23.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 117.542 -1.663 . . . . 0.0 112.139 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -111.1 159.69 17.58 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 112.225 -2.261 . . . . 0.0 109.458 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.471 ' C ' ' HA ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -81.93 -163.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.701 -176.443 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -68.34 70.78 0.17 Allowed 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 123.181 1.467 . . . . 0.0 108.579 -175.748 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.9 mtp180 -105.74 141.54 37.0 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.997 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.85 -34.31 53.36 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.9 157.72 44.31 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.86 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.0 149.97 64.12 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.035 -179.629 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 144.47 97.47 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 121.006 1.137 . . . . 0.0 111.163 176.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.26 -15.34 72.05 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.089 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.77 -29.76 74.95 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -81.81 4.62 21.5 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.08 16.22 68.39 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.491 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 39.4 m-85 -66.07 169.56 6.75 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.126 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 p -162.15 -46.98 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.474 -2.148 . . . . 0.0 106.117 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 41' ' ' TYR . 33.3 p -98.02 118.21 34.12 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.219 -2.264 . . . . 0.0 110.378 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.77 158.4 40.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.931 -1.508 . . . . 0.0 112.998 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.43 148.43 45.12 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.312 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.463 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 12.2 m-85 -114.93 137.8 51.56 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.511 -171.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 mttp -138.49 73.69 1.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.145 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.491 ' CD1' ' C ' ' A' ' 35' ' ' TRP . 6.9 t-105 -37.78 147.99 0.23 Allowed Pre-proline 0 N--CA 1.504 2.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 2.4 Cg_endo -78.13 37.68 0.5 Allowed 'Cis proline' 0 N--CA 1.495 1.572 0 C-N-CA 124.976 -0.843 . . . . 0.0 110.87 -6.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -146.29 -155.91 0.66 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.259 -179.101 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.463 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -170.86 141.72 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.299 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.179 179.185 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.2 m -110.63 144.74 39.07 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 167.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.9 t -117.74 135.42 54.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.6 m-85 -102.61 174.11 3.07 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 176.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.5 Cg_exo -55.19 -61.5 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.917 0 N-CA-C 117.209 1.965 . . . . 0.0 117.209 5.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.599 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.123 0 CA-C-O 116.438 -1.744 . . . . 0.0 109.879 -170.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.6 ' HB2' ' H ' ' A' ' 4' ' ' CYS . . . -48.79 144.99 6.59 Favored Pre-proline 0 N--CA 1.504 2.259 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.6 Cg_endo -86.1 23.97 0.79 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 N-CA-C 107.089 -1.927 . . . . 0.0 107.089 164.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.6 ' H ' ' HB2' ' A' ' 2' ' ' ALA . 12.7 p -75.07 116.62 16.01 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-N 113.447 -1.706 . . . . 0.0 108.939 -177.081 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.13 179.44 6.85 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.92 -175.359 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -113.09 -173.71 2.31 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.345 177.63 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -75.14 120.37 20.55 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.041 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -8.52 51.1 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.763 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -115.82 100.99 54.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.701 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.56 152.22 37.96 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.188 1.259 . . . . 0.0 109.804 174.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.85 -93.33 0.3 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.929 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -162.05 159.21 25.99 Favored 'General case' 0 C--O 1.199 -1.588 0 C-N-CA 118.624 -1.231 . . . . 0.0 112.217 -178.532 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -153.51 151.18 22.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 174.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -78.42 128.08 33.1 Favored 'General case' 0 C--O 1.182 -2.46 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.166 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 12.6 tp -94.08 101.92 13.96 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.865 1.317 . . . . 0.0 111.717 -177.109 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.42 ' O ' ' N ' ' A' ' 38' ' ' ILE . 78.4 m95 -88.87 123.4 33.21 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 111.889 -2.414 . . . . 0.0 107.402 176.041 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.77 -16.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -170.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.8 mt -151.73 71.57 0.99 Allowed 'General case' 0 C--N 1.247 -3.86 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.907 -171.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -156.29 141.19 17.17 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 117.841 -1.544 . . . . 0.0 112.297 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.556 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -91.28 -19.48 41.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.16 43.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.18 162.07 63.01 Favored Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.948 -179.111 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.29 114.51 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 121.489 1.459 . . . . 0.0 112.33 -171.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -0.94 65.6 0.0 OUTLIER Glycine 0 N--CA 1.488 2.123 1 N-CA-C 131.162 7.225 . . . . 0.0 131.162 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.11 48.8 71.53 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.033 -1.556 . . . . 0.0 110.365 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.61 -77.78 0.17 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.042 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.11 -23.19 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.504 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.0 m-85 -77.66 170.48 16.5 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.568 1.175 . . . . 0.0 112.337 -179.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 p -160.88 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 112.353 -2.203 . . . . 0.0 105.957 176.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -96.36 118.06 32.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.333 -179.909 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.56 149.62 29.4 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.031 -1.468 . . . . 0.0 113.185 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.6 p -103.4 142.74 33.72 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.017 175.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.5 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 29.4 m-85 -117.12 134.79 54.34 Favored 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 119.267 -0.973 . . . . 0.0 112.479 -173.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -147.56 80.0 1.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.556 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -53.36 152.99 7.67 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.343 -175.437 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 5.2 Cg_endo -72.66 -6.9 15.96 Favored 'Cis proline' 0 C--O 1.208 -0.996 0 C-N-CA 124.197 -1.168 . . . . 0.0 110.451 -5.298 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 37' ' ' ASN . 1.6 m-80 -91.61 -165.15 1.29 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.284 1.04 . . . . 0.0 111.873 -178.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.5 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 179.42 142.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.005 -178.116 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 18.4 m -113.56 103.87 11.69 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.421 -1.312 . . . . 0.0 107.795 172.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -82.27 138.05 34.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.32 -1.309 . . . . 0.0 113.342 -172.673 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.567 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -109.73 -178.8 0.58 Allowed Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.1 Cg_exo -63.81 -50.48 0.17 OUTLIER 'Cis proline' 0 N--CA 1.507 2.287 0 N-CA-C 116.813 1.813 . . . . 0.0 116.813 5.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.589 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.752 0 CA-C-O 116.382 -1.771 . . . . 0.0 110.074 -171.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -39.21 145.17 0.41 Allowed Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -177.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -84.26 29.64 0.54 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 106.586 -2.121 . . . . 0.0 106.586 165.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.598 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.2 p -92.0 117.3 29.69 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.237 -174.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 2.2 m-85 -78.06 172.46 13.49 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.398 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -108.78 -171.89 1.94 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.589 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -74.86 114.95 13.9 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.304 -1.358 . . . . 0.0 111.009 -177.693 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.88 3.52 60.0 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.414 178.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -113.05 113.64 49.24 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.093 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.28 -163.22 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.573 1.516 . . . . 0.0 111.664 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 69.22 -118.25 8.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.582 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.9 ptp180 -152.46 -171.52 3.96 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 118.398 -1.321 . . . . 0.0 112.133 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -152.02 155.95 26.42 Favored Glycine 0 C--N 1.273 -2.925 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 173.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -76.28 131.93 39.54 Favored 'General case' 0 C--O 1.176 -2.78 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.936 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 14.5 tp -92.3 110.16 21.55 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.908 1.337 . . . . 0.0 110.774 -177.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -106.84 160.0 15.83 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 112.068 -2.333 . . . . 0.0 109.875 -177.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -86.15 -161.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.788 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -67.96 72.95 0.18 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.413 1.577 . . . . 0.0 108.728 -175.706 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.8 mtp85 -110.86 125.75 53.95 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 111.952 -2.385 . . . . 0.0 109.877 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.25 -26.2 70.34 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 p -149.38 153.43 37.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.789 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -81.31 152.37 70.54 Favored Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.164 179.37 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 25' ' ' GLY . 2.7 Cg_exo -51.25 124.53 14.28 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 C-N-CA 121.015 1.143 . . . . 0.0 111.641 -178.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.74 25.23 2.54 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -133.7 -4.27 3.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.572 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -56.36 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.996 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.24 0.72 1.0 Allowed Glycine 0 C--N 1.288 -2.128 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.824 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.597 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 47.7 m-85 -68.62 170.68 8.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 122.569 1.176 . . . . 0.0 111.896 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.5 ' HG1' ' H ' ' A' ' 30' ' ' SER . 1.1 p -161.03 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.544 -2.117 . . . . 0.0 106.055 177.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.5 ' H ' ' HG1' ' A' ' 29' ' ' THR . 0.9 OUTLIER -97.66 123.54 41.62 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.79 178.785 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.578 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -155.2 149.49 26.01 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.882 -1.527 . . . . 0.0 112.485 178.911 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 7.8 p -108.81 146.08 34.2 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.441 177.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.471 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 46.8 m-85 -123.01 133.89 54.34 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.22 -175.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.45 83.17 1.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.278 -0.873 . . . . 0.0 108.754 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.78 160.19 0.2 Allowed Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.949 -176.221 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 18' ' ' LEU . 8.2 Cg_endo -80.12 34.06 1.36 Allowed 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.21 -1.162 . . . . 0.0 110.435 -5.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.459 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 7.0 m-80 -147.15 -163.32 1.73 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.871 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.471 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -162.22 146.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.031 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.9 m -117.76 105.32 11.86 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.695 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -81.73 141.71 33.32 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.194 -172.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.3 m-85 -110.04 175.8 1.78 Allowed Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.4 Cg_exo -57.49 -58.45 0.04 OUTLIER 'Cis proline' 0 N--CA 1.506 2.215 0 N-CA-C 117.773 2.182 . . . . 0.0 117.773 6.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.179 0 CA-C-O 116.273 -1.823 . . . . 0.0 109.594 -169.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -50.28 144.74 11.1 Favored Pre-proline 0 N--CA 1.506 2.328 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.313 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.55 37.03 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 N-CA-C 108.308 -1.458 . . . . 0.0 108.308 165.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.76 122.14 21.92 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.585 -174.5 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.44 174.03 12.01 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.241 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.41 179.99 6.47 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.012 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -71.75 134.55 46.28 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.534 -174.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.68 -12.23 0.53 Allowed Glycine 0 N--CA 1.478 1.464 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.767 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 mttt -113.05 105.86 55.36 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.102 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -72.09 154.58 57.4 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 173.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -105.06 1.25 Allowed Glycine 0 C--N 1.287 -2.152 1 N-CA-C 129.604 6.602 . . . . 0.0 129.604 -176.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.671 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 5.5 ptm180 -162.65 152.84 16.4 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.815 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.69 152.12 23.62 Favored Glycine 0 N--CA 1.493 2.472 1 N-CA-C 125.716 5.046 . . . . 0.0 125.716 171.961 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 4.8 m-20 -77.11 122.34 24.84 Favored 'General case' 0 C--O 1.171 -3.037 0 C-N-CA 118.015 -1.474 . . . . 0.0 109.709 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -86.56 100.24 12.27 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.335 -178.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.698 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 61.5 m95 -87.59 165.11 15.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.406 177.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -90.86 -159.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.939 -176.824 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.05 70.27 0.15 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.202 1.477 . . . . 0.0 108.411 -176.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' ILE . 3.6 mtp180 -113.62 120.87 42.38 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 112.202 -2.272 . . . . 0.0 110.49 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -23.38 64.94 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.157 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 154.07 38.33 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.934 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.97 149.96 54.42 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.975 179.2 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.83 143.69 95.15 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.83 1.02 . . . . 0.0 110.815 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.23 -1.22 75.82 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.239 -1.457 . . . . 0.0 110.095 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.58 -14.68 70.1 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.15 -91.78 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.036 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.68 24.61 0.03 OUTLIER Glycine 0 C--N 1.29 -2.0 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.54 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.698 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 44.2 m-85 -86.37 170.11 12.31 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.921 1.343 . . . . 0.0 112.347 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 p -162.55 -44.44 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 112.041 -2.345 . . . . 0.0 105.849 176.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' TYR . 29.8 p -96.98 114.24 25.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.513 -2.131 . . . . 0.0 109.806 -179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.561 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.55 151.36 37.2 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.956 177.984 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.09 145.65 35.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.752 177.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 15.9 m-85 -118.23 125.91 51.1 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.86 -171.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 35' ' ' TRP . 25.8 mttt -127.04 70.55 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.612 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' LYS . 31.7 t-105 -39.22 144.09 0.47 Allowed Pre-proline 0 C--N 1.296 -1.738 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.483 178.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 9.5 Cg_endo -79.39 39.35 0.57 Allowed 'Cis proline' 0 N--CA 1.494 1.514 0 C-N-CA 125.66 -0.558 . . . . 0.0 111.372 -5.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.46 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -149.31 -159.73 1.08 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.474 -1.291 . . . . 0.0 110.935 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -170.94 142.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.991 179.582 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 16.0 m -111.18 133.15 53.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -105.82 130.84 53.72 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -170.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -103.83 179.19 1.0 Allowed Pre-proline 0 N--CA 1.513 2.698 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 177.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.574 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.0 Cg_exo -59.11 -54.91 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.177 0 N-CA-C 117.217 1.968 . . . . 0.0 117.217 6.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.671 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.659 0 CA-C-O 116.373 -1.775 . . . . 0.0 109.247 -171.389 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.537 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -39.66 146.84 0.35 Allowed Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.956 179.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -80.32 59.49 7.46 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -74.8 142.42 44.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.569 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -78.44 169.14 18.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.369 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -114.0 -166.22 1.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 9' ' ' LYS . 3.0 t -62.27 110.39 1.62 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.671 -177.74 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.91 1.12 0.79 Allowed Glycine 0 N--CA 1.479 1.528 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.208 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 7' ' ' SER . 30.3 mttt -99.33 116.44 65.04 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.573 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 1.2 Cg_endo -70.76 -167.89 0.29 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 173.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.97 -119.53 5.46 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.57 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -162.0 159.56 26.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.585 -179.771 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.84 149.77 20.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 172.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 12.8 m-20 -77.03 125.84 29.98 Favored 'General case' 0 C--O 1.175 -2.854 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.186 -179.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.0 tp -83.23 106.42 15.0 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 117.056 -1.858 . . . . 0.0 111.793 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.557 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 53.4 m95 -90.48 171.53 9.36 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 111.723 -2.489 . . . . 0.0 110.374 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -88.94 -163.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.079 -178.867 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -68.06 72.31 0.18 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.945 1.355 . . . . 0.0 108.454 -176.197 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.8 mtp85 -113.1 111.1 21.54 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.356 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.49 -24.95 40.46 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.204 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 p -141.77 151.54 42.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.39 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.62 147.26 55.2 Favored Pre-proline 0 C--N 1.289 -2.051 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.387 -179.68 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.55 148.21 54.6 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 121.004 1.136 . . . . 0.0 111.737 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLY . . . -84.48 -33.05 20.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.997 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.97 -28.25 16.53 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.13 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.28 -25.93 42.39 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.733 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . 87.68 12.61 66.42 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.674 -1.25 . . . . 0.0 111.566 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 45.6 m-85 -57.9 172.56 0.39 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.636 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.405 ' HG1' ' H ' ' A' ' 30' ' ' SER . 17.1 p -162.36 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.804 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.904 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.67 110.21 22.82 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.318 -177.592 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.08 156.11 40.38 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.339 -1.344 . . . . 0.0 112.778 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 p -112.17 146.81 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.738 176.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 26.1 m-85 -117.07 133.24 56.24 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.3 -0.96 . . . . 0.0 112.38 -174.044 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -134.82 70.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.588 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.477 ' CD1' ' C ' ' A' ' 35' ' ' TRP . 11.8 t-105 -37.92 148.39 0.22 Allowed Pre-proline 0 N--CA 1.506 2.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.725 178.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 6.2 Cg_endo -77.64 33.79 0.73 Allowed 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 125.613 -0.578 . . . . 0.0 111.095 -6.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.558 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -147.15 -167.16 2.7 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.22 178.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.01 153.32 4.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.904 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -125.2 130.8 52.84 Favored 'General case' 0 C--O 1.216 -0.707 0 C-N-CA 117.948 -1.501 . . . . 0.0 107.586 168.189 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -167.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -111.42 -178.07 0.51 Allowed Pre-proline 0 N--CA 1.51 2.566 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.175 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.9 Cg_exo -57.79 -54.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.506 2.258 0 CA-C-N 122.485 1.923 . . . . 0.0 117.027 4.302 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.483 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.71 -171.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.551 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -39.52 151.57 0.22 Allowed Pre-proline 0 N--CA 1.505 2.287 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.916 -179.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -81.55 49.73 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 168.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.31 138.33 45.37 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.039 -1.064 . . . . 0.0 108.16 -172.762 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.499 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -78.65 175.66 10.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.07 -1.452 . . . . 0.0 109.831 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -169.02 1.39 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.813 179.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.21 108.52 10.37 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.062 -178.342 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.97 89.14 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.683 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -115.52 113.41 42.92 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.054 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.58 -161.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.793 0 C-N-CA 120.904 1.069 . . . . 0.0 109.335 174.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.47 -109.11 2.77 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.911 178.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.59 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.14 177.01 10.07 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.658 -1.217 . . . . 0.0 113.423 -177.353 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.59 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -157.46 158.37 28.91 Favored Glycine 0 N--CA 1.503 3.151 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.3 m-20 -78.06 122.97 26.28 Favored 'General case' 0 C--O 1.177 -2.731 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.287 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 4.5 tt -91.53 99.64 12.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 117.397 -1.721 . . . . 0.0 113.14 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.556 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 70.3 m95 -75.72 122.68 24.37 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.0 174.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.1 mt -89.96 -10.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.2 mt -150.14 71.23 1.06 Allowed 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.536 -171.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.93 158.38 10.58 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.093 178.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.96 -29.25 4.4 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -129.01 152.16 48.92 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.801 177.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.61 153.51 47.97 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.99 -179.09 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.2 -178.75 0.09 OUTLIER 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.513 1.475 . . . . 0.0 112.071 -175.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.76 12.6 10.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -108.44 -5.48 32.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.99 -28.43 14.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.137 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.74 54.46 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.717 -1.23 . . . . 0.0 111.51 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.629 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 47.0 m-85 -53.7 167.17 0.26 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.986 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 3.9 p -163.38 -43.27 0.03 OUTLIER 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.544 177.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -96.56 111.58 23.65 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.706 -2.043 . . . . 0.0 109.119 -179.575 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -150.96 146.9 26.56 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.751 -177.784 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.55 138.2 36.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.222 177.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.491 ' CE1' ' CD1' ' A' ' 38' ' ' ILE . 95.8 m-85 -118.35 134.38 55.1 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.861 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.2 82.38 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.21 158.85 0.43 Allowed Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.825 -176.417 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.3 Cg_endo -74.2 5.16 10.82 Favored 'Cis proline' 0 C--O 1.204 -1.206 0 C-N-CA 124.215 -1.161 . . . . 0.0 111.435 -3.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.664 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -114.36 -162.93 0.84 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 122.195 0.997 . . . . 0.0 111.268 -176.46 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -178.61 144.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.377 -179.538 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.22 111.86 19.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 117.469 -1.692 . . . . 0.0 108.049 170.029 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.629 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -82.87 148.17 27.87 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.211 -170.478 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.74 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.8 OUTLIER -124.06 168.71 12.09 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 178.114 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -77.39 157.6 96.12 Favored 'Cis proline' 0 C--N 1.325 -0.698 0 CA-C-O 122.88 1.117 . . . . 0.0 114.147 4.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.74 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.602 0 CA-C-N 111.981 -2.372 . . . . 0.0 109.711 175.571 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 4' ' ' CYS 0.255 . . -38.14 142.1 0.48 Allowed Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.154 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.86 31.88 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.4 p -85.62 114.56 22.71 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.791 -176.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -77.76 175.41 9.99 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.493 -1.283 . . . . 0.0 110.274 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.7 m -113.24 -177.21 3.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.83 121.47 24.14 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.541 -178.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.93 60.88 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.49 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -123.65 113.6 28.79 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.801 -178.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -74.71 -164.39 0.22 Allowed 'Trans proline' 0 C--O 1.212 -0.795 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 173.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -99.75 2.59 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.31 177.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.594 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.93 161.61 31.73 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.267 -177.232 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -147.42 147.36 18.06 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 174.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 14.9 m-20 -79.62 121.7 25.61 Favored 'General case' 0 C--O 1.17 -3.125 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.008 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.521 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 15.5 tp -92.19 92.79 8.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.842 1.306 . . . . 0.0 112.86 -175.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.538 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 68.6 m95 -74.14 120.12 19.28 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 112.165 -2.289 . . . . 0.0 108.196 174.209 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 mp -84.82 -11.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -171.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 mt -152.41 75.9 1.13 Allowed 'General case' 0 C--N 1.253 -3.59 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.672 -175.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.21 155.53 41.48 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.748 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.4 -26.71 4.16 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.67 151.49 45.97 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.303 175.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -91.36 138.1 25.73 Favored Pre-proline 0 C--N 1.288 -2.082 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.083 -178.781 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.76 152.22 75.68 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 121.035 1.157 . . . . 0.0 111.615 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.66 -16.24 46.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.24 -19.7 59.85 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.617 -1.277 . . . . 0.0 109.93 179.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.88 -60.51 2.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.958 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.75 13.07 0.64 Allowed Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 38.9 m-85 -72.78 170.22 15.07 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.874 1.321 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 p -161.97 -45.75 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 112.066 -2.333 . . . . 0.0 106.065 177.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 123.22 43.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.928 179.786 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -152.12 157.94 42.27 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 117.972 -1.491 . . . . 0.0 114.08 179.143 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.457 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 p -113.97 147.9 37.81 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.253 172.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 40.1 m-85 -116.69 136.83 52.64 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.295 -172.245 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' SG ' ' A' ' 32' ' ' CYS . 4.5 mttt -138.96 70.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.948 178.575 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.4 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -47.83 144.98 4.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.326 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 3.6 Cg_endo -70.57 -7.83 11.64 Favored 'Cis proline' 0 C--O 1.206 -1.105 0 C-N-CA 124.952 -0.853 . . . . 0.0 111.208 -4.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.628 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -93.29 -164.93 1.24 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.297 -177.323 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -179.03 137.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.801 -179.097 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 50.5 m -107.08 105.56 15.63 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.278 174.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -91.27 130.26 37.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.969 -1.469 . . . . 0.0 114.17 -172.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.543 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -97.78 176.27 2.14 Favored Pre-proline 0 N--CA 1.511 2.611 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.095 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 11.7 Cg_exo -58.07 -57.16 0.08 OUTLIER 'Cis proline' 0 N--CA 1.503 2.056 0 N-CA-C 117.339 2.015 . . . . 0.0 117.339 7.172 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.357 0 CA-C-O 116.331 -1.795 . . . . 0.0 109.864 -170.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -72.62 150.78 91.27 Favored Pre-proline 0 N--CA 1.502 2.161 0 C-N-CA 119.743 -0.783 . . . . 0.0 113.001 -176.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.09 31.84 0.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 166.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.67 120.98 19.05 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -175.59 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -174.4 3.53 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.64 -1.624 . . . . 0.0 109.418 -178.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.48 -175.32 4.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.439 178.004 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.58 130.03 38.16 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.271 -176.345 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.24 41.94 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.722 179.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 109.65 21.9 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.819 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.75 150.8 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 N-CA-C 108.959 -1.208 . . . . 0.0 108.959 172.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -89.63 0.47 Allowed Glycine 0 N--CA 1.491 2.304 1 N-CA-C 130.521 6.968 . . . . 0.0 130.521 -177.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.535 ' C ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.08 149.11 17.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.542 -1.263 . . . . 0.0 112.567 179.181 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.78 148.5 20.14 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 175.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.9 m-20 -77.74 121.11 23.59 Favored 'General case' 0 C--O 1.18 -2.605 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.071 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 tp -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.333 -1.747 . . . . 0.0 110.891 179.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -119.75 152.65 36.88 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 111.303 -2.681 . . . . 0.0 106.975 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.561 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.54 -158.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.845 -176.265 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.54 68.84 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 123.128 1.442 . . . . 0.0 108.18 -177.049 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.65 136.73 46.9 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 112.5 -2.136 . . . . 0.0 110.427 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.06 -21.28 78.55 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.17 157.44 35.93 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.708 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.28 157.86 72.54 Favored Pre-proline 0 C--N 1.299 -1.6 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.219 177.894 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.59 -172.76 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 121.268 1.312 . . . . 0.0 111.794 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.69 10.98 10.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.23 -2.11 54.26 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.467 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -102.97 -52.45 3.05 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.16 30.65 2.05 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.598 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 79.0 m-85 -79.55 172.36 13.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.415 1.103 . . . . 0.0 110.999 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.634 ' HG1' ' H ' ' A' ' 30' ' ' SER . 6.1 p -162.41 -45.72 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 112.896 -1.957 . . . . 0.0 106.681 176.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.634 ' H ' ' HG1' ' A' ' 29' ' ' THR . 1.5 p -98.39 97.66 8.98 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 112.861 -1.972 . . . . 0.0 110.36 -178.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.678 HD22 ' H ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -129.64 151.16 50.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.661 -1.215 . . . . 0.0 113.013 -177.804 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 146.07 36.13 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.132 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 8.8 m-85 -120.53 127.99 52.68 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.346 -172.714 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.1 mttt -128.81 73.01 1.48 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.754 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.44 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -35.72 148.45 0.15 Allowed Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.941 179.734 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 4.9 Cg_endo -78.44 36.92 0.57 Allowed 'Cis proline' 0 N--CA 1.487 1.118 0 C-N-CA 125.221 -0.741 . . . . 0.0 111.44 -5.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.1 m-80 -147.48 -162.21 1.5 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.335 -179.403 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.47 140.33 2.1 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.223 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.437 179.652 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 32.0 m -112.83 119.67 38.82 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.171 168.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.0 t -88.86 142.32 27.75 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.848 -171.622 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.496 ' CB ' ' O ' ' A' ' 30' ' ' SER . 1.1 m-85 -122.28 167.76 13.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.444 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -78.82 158.52 91.93 Favored 'Cis proline' 0 C--N 1.32 -0.944 0 CA-C-O 122.914 1.131 . . . . 0.0 114.525 6.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.543 0 CA-C-N 111.975 -2.375 . . . . 0.0 109.245 175.412 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -51.39 141.77 22.13 Favored Pre-proline 0 N--CA 1.505 2.301 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.388 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.41 30.6 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 108.318 -1.455 . . . . 0.0 108.318 166.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -66.52 125.25 25.15 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -174.938 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -78.24 165.33 24.04 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 117.269 -1.772 . . . . 0.0 109.402 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -134.31 176.96 8.13 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.896 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -74.47 139.48 43.92 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.732 -176.552 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.04 -17.81 0.92 Allowed Glycine 0 C--N 1.295 -1.719 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.898 179.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 7' ' ' SER . 7.5 mptt -128.63 107.03 18.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.21 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.41 162.99 27.62 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.908 -1.228 . . . . 0.0 108.908 173.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.85 -90.53 0.52 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.553 178.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.564 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.4 153.33 21.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.808 -176.794 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.72 146.54 18.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 173.287 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 22.0 m-20 -77.59 119.05 20.6 Favored 'General case' 0 C--O 1.173 -2.958 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.2 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -81.22 132.21 35.33 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.008 -1.877 . . . . 0.0 111.711 -178.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.881 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 59.7 m95 -123.34 120.02 31.8 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 111.562 -2.563 . . . . 0.0 105.379 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.454 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -83.84 -16.91 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -168.201 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 mt -151.88 70.9 0.95 Allowed 'General case' 1 C--N 1.239 -4.214 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.087 -171.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -153.73 140.69 19.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 117.064 -1.854 . . . . 0.0 112.928 178.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.49 -25.0 29.31 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 177.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.28 153.68 45.33 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.507 ' N ' ' HH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -90.83 151.53 43.68 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.636 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.31 109.39 0.97 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.922 1.081 . . . . 0.0 111.122 -178.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -21.33 70.44 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.186 -1.483 . . . . 0.0 109.903 178.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.18 -1.88 76.34 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.058 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -92.05 -101.88 0.12 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.18 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.65 -2.48 0.38 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.397 -1.382 . . . . 0.0 111.167 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.881 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 53.0 m-85 -82.77 168.2 17.41 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 122.692 1.234 . . . . 0.0 112.062 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -158.63 -45.55 0.06 Allowed 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 112.153 -2.294 . . . . 0.0 105.78 177.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -98.69 118.15 34.77 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.03 178.751 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.642 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -144.45 149.42 35.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 117.917 -1.513 . . . . 0.0 113.577 179.621 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 148.07 29.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.068 176.282 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.507 ' HH ' ' N ' ' A' ' 22' ' ' CYS . 36.4 m-85 -118.71 137.33 53.41 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.748 -172.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 35' ' ' TRP . 39.7 mmtt -130.21 56.77 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.291 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 34' ' ' LYS . 31.3 t-105 -29.05 139.89 0.11 Allowed Pre-proline 0 N--CA 1.504 2.236 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.596 -177.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -71.89 -7.52 14.41 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.869 -6.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.649 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.58 -158.2 0.44 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.606 -177.003 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER 176.49 139.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.193 -1.916 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.461 -178.55 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 11.5 m -109.37 108.75 19.41 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 117.337 -1.745 . . . . 0.0 107.028 170.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.658 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.4 t -83.78 142.81 30.4 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.627 -171.45 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.6 m-85 -117.7 166.01 14.5 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.273 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -76.31 159.88 96.08 Favored 'Cis proline' 0 CA--C 1.509 -0.735 0 CA-C-O 122.885 1.119 . . . . 0.0 113.651 4.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.564 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.897 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.514 178.282 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.06 0.457 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -79.96 147.77 66.72 Favored Pre-proline 0 N--CA 1.501 2.12 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.269 -177.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -84.24 30.15 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 N-CA-C 108.001 -1.577 . . . . 0.0 108.001 167.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -71.46 119.24 15.33 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -174.728 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.0 160.6 29.01 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.25 -1.78 . . . . 0.0 109.966 -178.331 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.65 179.41 4.35 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.684 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.3 p -80.87 118.98 22.85 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.99 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 -11.16 71.21 Favored Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.203 -179.247 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -127.41 110.95 21.13 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.445 -179.706 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -165.94 0.27 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.062 1.174 . . . . 0.0 109.398 173.466 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.14 -96.78 2.25 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 118.961 -1.59 . . . . 0.0 111.105 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.579 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.88 160.32 30.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.963 -178.591 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -144.54 140.42 9.26 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 172.732 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -76.02 129.18 36.47 Favored 'General case' 0 C--O 1.173 -2.953 0 C-N-CA 118.628 -1.229 . . . . 0.0 108.136 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -83.45 125.65 31.94 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.58 -1.648 . . . . 0.0 111.455 -178.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.732 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 54.3 m95 -122.03 161.39 23.08 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.023 -178.554 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -83.79 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.736 -176.998 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -68.45 68.94 0.14 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.224 1.487 . . . . 0.0 107.807 -177.824 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' ILE . 16.5 mtp85 -101.77 113.34 26.42 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.593 -2.094 . . . . 0.0 110.845 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.32 -35.94 36.25 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.33 -1.414 . . . . 0.0 109.685 179.088 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.22 156.72 45.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.99 178.712 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.12 147.07 49.84 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.768 178.656 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.04 -175.83 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.093 1.195 . . . . 0.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.25 -41.22 1.41 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.64 12.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.488 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 28' ' ' TYR . 7.0 m-85 -81.79 15.48 2.19 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.335 -179.69 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.51 11.49 0.29 Allowed Glycine 0 N--CA 1.487 2.046 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.78 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.732 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 35.7 m-85 -63.93 167.57 6.06 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 117.84 -1.544 . . . . 0.0 111.189 179.455 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -162.59 -43.83 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.372 -2.195 . . . . 0.0 106.616 177.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.62 125.77 42.55 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.929 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.73 HD21 ' H ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -160.52 162.98 33.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.923 -1.511 . . . . 0.0 112.841 -179.718 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.8 p -116.79 137.25 52.33 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.826 176.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.514 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 60.3 m-85 -112.52 120.43 41.58 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.468 -174.42 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -139.69 73.64 1.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.548 179.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.455 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.64 157.83 0.43 Allowed Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.727 -176.793 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' O ' ' CA ' ' A' ' 18' ' ' LEU . 14.0 Cg_endo -80.99 26.48 4.98 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.442 0.4 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.2 m-80 -144.74 178.3 8.09 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.463 175.636 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.514 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -148.07 148.58 16.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.951 -179.534 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 31.6 m -114.14 151.32 32.83 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 166.342 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.2 t -123.05 137.36 54.96 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.839 -1.144 . . . . 0.0 114.012 -169.354 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.553 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.7 m-85 -104.48 176.14 1.89 Allowed Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.631 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.9 Cg_exo -52.74 -62.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.928 0 N-CA-C 117.328 2.011 . . . . 0.0 117.328 4.388 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.579 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 116.265 -1.826 . . . . 0.0 109.6 -170.167 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -70.71 134.41 86.16 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -177.011 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.23 40.79 0.7 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 165.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' H ' ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -82.24 122.61 28.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -175.796 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.05 177.9 8.45 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.871 -1.532 . . . . 0.0 109.526 179.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.63 175.16 9.24 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.642 177.072 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.53 129.27 36.23 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.816 -177.693 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.91 -22.27 6.0 Favored Glycine 0 C--N 1.296 -1.662 0 C-N-CA 119.064 -1.541 . . . . 0.0 110.165 -178.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -110.4 115.41 54.23 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.838 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -76.33 -163.59 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 173.433 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.69 -106.04 2.05 Favored Glycine 0 C--N 1.287 -2.189 0 C-N-CA 118.832 -1.651 . . . . 0.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.548 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 8.2 ptm180 -159.25 177.42 11.05 Favored 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 118.176 -1.41 . . . . 0.0 114.224 -176.325 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -156.61 144.23 10.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 173.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 32.5 m-20 -76.25 124.57 27.69 Favored 'General case' 0 C--O 1.177 -2.719 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.199 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tt -86.09 111.37 20.27 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.019 -1.872 . . . . 0.0 112.296 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' ILE . 46.1 m95 -92.65 -178.13 4.78 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 112.25 -2.25 . . . . 0.0 108.864 176.045 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -102.03 -162.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.691 -176.288 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.72 66.81 0.13 Allowed 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 122.964 1.364 . . . . 0.0 107.726 -177.672 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 17' ' ' ILE . 1.1 mtt85 -111.54 113.26 25.55 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 112.573 -2.103 . . . . 0.0 110.665 -179.398 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.08 -34.52 16.78 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.42 157.4 45.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.305 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -86.03 152.33 55.9 Favored Pre-proline 0 C--N 1.298 -1.633 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.173 179.277 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.98 115.5 2.47 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 120.698 0.932 . . . . 0.0 110.181 174.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.58 -4.87 47.97 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.375 -1.393 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 -0.56 55.87 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.179 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.23 -16.08 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.396 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.75 -3.36 23.02 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.761 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 43.1 m-85 -77.3 169.76 17.75 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.834 1.302 . . . . 0.0 112.471 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -162.97 -45.37 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 112.055 -2.339 . . . . 0.0 106.345 176.056 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 41' ' ' TYR . 80.2 p -99.38 115.29 28.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.066 -179.37 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -143.54 148.8 36.5 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.935 -179.932 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.5 144.47 33.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.788 176.105 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.451 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 26.8 m-85 -117.98 133.21 56.14 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.894 -173.005 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -138.72 75.59 1.53 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.957 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.448 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.9 155.73 0.39 Allowed Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.46 -177.994 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 7.3 Cg_endo -78.08 32.92 0.9 Allowed 'Cis proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.5 -1.042 . . . . 0.0 111.571 -4.51 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.546 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -145.07 -160.7 1.17 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.811 177.754 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.28 147.76 4.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.918 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 39.1 m -116.88 119.05 34.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.015 168.216 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.3 t -90.57 139.15 30.98 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.968 -171.501 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.6 m-85 -112.12 178.41 0.98 Allowed Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 15.7 Cg_exo -59.49 -56.64 0.12 OUTLIER 'Cis proline' 0 N--CA 1.502 2.02 0 N-CA-C 116.695 1.767 . . . . 0.0 116.695 4.818 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.567 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.7 0 CA-C-O 116.439 -1.743 . . . . 0.0 109.325 -171.043 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -39.5 137.86 1.01 Allowed Pre-proline 0 N--CA 1.503 2.187 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.103 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.23 33.7 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 164.249 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.552 ' H ' ' C ' ' A' ' 2' ' ' ALA . 12.7 p -84.98 115.37 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.455 -176.25 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.46 172.7 13.26 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.989 -178.508 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.89 -173.62 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.727 178.877 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -75.41 118.59 18.45 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.631 -175.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.38 44.87 Favored Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.844 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -113.51 109.43 51.01 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.319 -179.503 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.87 -172.6 1.0 Allowed 'Trans proline' 0 C--N 1.32 -0.927 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 173.222 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.3 -110.57 3.58 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.58 -1.772 . . . . 0.0 110.807 179.079 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.577 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -160.35 168.71 24.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.125 -177.967 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.577 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -147.9 157.38 27.32 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 174.268 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.577 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 1.2 m-20 -78.48 130.0 35.53 Favored 'General case' 0 C--O 1.172 -3.005 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.628 178.511 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 13.7 tp -96.08 97.33 9.49 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.923 1.344 . . . . 0.0 111.784 -177.294 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.454 ' O ' ' N ' ' A' ' 38' ' ' ILE . 78.5 m95 -83.08 115.52 21.92 Favored 'General case' 0 C--N 1.263 -3.157 0 CA-C-N 112.063 -2.335 . . . . 0.0 107.494 175.56 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 mt -88.31 -8.85 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 mt -154.83 71.58 0.81 Allowed 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.674 -173.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.591 ' NH2' ' N ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -153.25 162.36 41.39 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 117.592 -1.643 . . . . 0.0 111.95 177.129 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -109.06 -32.48 3.03 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.454 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -136.21 153.94 51.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.412 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.74 149.08 39.84 Favored Pre-proline 0 C--N 1.293 -1.855 0 C-N-CA 118.779 -1.168 . . . . 0.0 110.068 -179.195 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.591 ' N ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 Cg_endo -66.83 146.47 78.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.878 1.052 . . . . 0.0 111.665 -178.69 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.68 -16.48 54.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 177.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.39 -9.13 87.25 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.05 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.73 -30.23 18.18 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.623 178.908 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.66 -9.48 12.82 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.227 177.576 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 45.4 m-85 -63.25 167.17 5.4 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.145 -178.821 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -162.23 -43.43 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 112.224 -2.262 . . . . 0.0 106.107 177.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.469 ' H ' ' HG ' ' A' ' 30' ' ' SER . 2.8 p -97.38 119.01 35.13 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.4 179.627 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.541 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -156.45 155.19 31.63 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.404 -1.718 . . . . 0.0 113.599 179.91 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 150.27 38.58 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.331 176.474 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.497 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 36.4 m-85 -118.23 140.83 49.22 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.693 -171.212 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' ASN . 19.3 mttt -134.9 70.75 1.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.835 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -40.68 140.21 1.06 Allowed Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.222 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.89 2.47 14.57 Favored 'Cis proline' 0 N--CA 1.498 1.793 0 C-N-CA 125.319 -0.7 . . . . 0.0 110.425 -6.428 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -93.41 -163.24 1.02 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.898 0.856 . . . . 0.0 112.301 -175.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 177.5 139.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.081 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.328 178.728 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 36.4 m -110.52 115.42 29.59 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.698 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -97.49 136.57 37.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.842 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.5 m-85 -107.03 179.49 0.88 Allowed Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.254 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 4.1 Cg_exo -65.45 -52.37 0.15 OUTLIER 'Cis proline' 0 N--CA 1.508 2.347 0 N-CA-C 116.632 1.743 . . . . 0.0 116.632 7.856 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.97 0 CA-C-O 116.411 -1.757 . . . . 0.0 109.588 -170.155 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.495 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . -39.86 145.48 0.45 Allowed Pre-proline 0 N--CA 1.506 2.365 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -176.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.72 30.44 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 107.941 -1.6 . . . . 0.0 107.941 164.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.86 123.93 30.43 Favored 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.553 -174.464 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.0 m-85 -84.52 158.69 20.89 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.378 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -124.83 178.89 5.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.573 178.645 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 127.34 32.38 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.355 -175.431 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.28 54.46 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.887 178.747 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 113.25 18.97 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.637 -179.107 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -70.19 -158.73 0.05 OUTLIER 'Trans proline' 0 C--O 1.217 -0.54 0 C-N-CA 121.204 1.269 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 70.43 -108.68 2.56 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.849 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 1.7 ptp180 -160.09 -176.22 5.53 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.059 177.188 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -139.39 160.36 25.94 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 3.4 m-20 -78.95 128.85 33.82 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 118.145 -1.422 . . . . 0.0 108.048 177.695 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.495 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 22.8 tp -92.77 103.55 15.9 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.951 1.358 . . . . 0.0 112.503 -175.409 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.443 ' O ' ' N ' ' A' ' 38' ' ' ILE . 73.9 m95 -93.05 110.05 21.52 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.701 175.17 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.1 mt -81.38 -10.53 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -170.261 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mt -154.32 78.42 1.09 Allowed 'General case' 0 C--N 1.255 -3.519 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.274 -173.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 148.1 11.19 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.454 -1.699 . . . . 0.0 112.219 178.494 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.19 -17.86 28.3 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 177.225 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.75 161.61 39.52 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.608 178.596 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -105.42 150.94 39.55 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.87 179.403 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.22 165.43 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.837 1.024 . . . . 0.0 110.736 175.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.69 -22.13 8.69 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.137 179.62 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.76 83.15 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.193 179.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.5 -13.4 59.13 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.963 179.764 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.47 55.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.091 177.006 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.634 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.9 m-85 -75.75 168.0 20.84 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.241 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -162.85 -45.08 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 111.966 -2.379 . . . . 0.0 105.654 175.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 14.9 p -98.97 113.51 25.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.893 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -138.0 150.7 47.21 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.522 -1.271 . . . . 0.0 113.215 179.318 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -106.01 151.24 24.88 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.065 176.358 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 34.1 m-85 -129.03 145.31 51.29 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.207 -172.701 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 78.02 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.224 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.423 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.76 152.95 0.42 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.426 -175.284 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -73.58 -1.81 14.14 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.444 -1.065 . . . . 0.0 110.64 -5.516 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.644 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -94.16 -166.14 1.44 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.654 1.216 . . . . 0.0 111.524 -178.132 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -172.4 139.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.36 178.772 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 57.7 m -109.7 102.89 11.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 171.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.634 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.9 t -79.01 142.97 36.13 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.558 -171.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -116.86 165.45 15.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.553 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -77.31 160.08 94.4 Favored 'Cis proline' 0 C--O 1.214 -0.691 0 CA-C-O 122.771 1.071 . . . . 0.0 114.27 4.249 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.432 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.34 177.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.584 ' HB2' ' H ' ' A' ' 4' ' ' CYS . . . -62.88 147.77 93.24 Favored Pre-proline 0 N--CA 1.515 2.806 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 -174.621 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.96 20.67 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 107.924 -1.606 . . . . 0.0 107.924 163.604 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' H ' ' HB2' ' A' ' 2' ' ' ALA . 1.9 p -79.95 116.76 20.27 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.917 -178.551 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -80.89 -167.65 1.49 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.766 -173.383 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -175.98 3.7 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.78 176.674 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m -80.74 115.73 20.39 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.205 -178.626 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.7 -13.74 64.91 Favored Glycine 0 C--N 1.296 -1.668 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.237 -179.415 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -111.72 108.62 55.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -73.14 156.89 51.23 Favored 'Trans proline' 0 CA--C 1.507 -0.866 0 C-N-CA 120.999 1.132 . . . . 0.0 109.372 176.371 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.91 -90.56 0.57 Allowed Glycine 0 N--CA 1.484 1.862 1 N-CA-C 130.544 6.977 . . . . 0.0 130.544 -178.517 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' C ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.44 156.59 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.597 178.485 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -149.74 167.98 29.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 175.647 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -82.54 129.42 34.92 Favored 'General case' 0 C--O 1.178 -2.684 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.809 178.695 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.532 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 16.6 tp -96.62 106.6 18.89 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.909 1.338 . . . . 0.0 111.575 -178.535 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.455 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 69.4 m95 -93.47 108.95 20.55 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-N 111.79 -2.459 . . . . 0.0 107.021 176.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.2 mt -83.15 -4.81 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.52 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 mt -151.67 80.24 1.28 Allowed 'General case' 0 C--N 1.253 -3.612 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.604 -174.598 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.19 159.37 4.81 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.659 177.678 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.67 -26.06 3.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 175.224 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 p -128.99 149.09 50.97 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.191 176.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 153.26 39.65 Favored Pre-proline 0 C--N 1.287 -2.112 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.298 -179.346 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.9 Cg_exo -55.3 99.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.857 1.038 . . . . 0.0 111.099 -178.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.06 6.23 4.13 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.291 -1.433 . . . . 0.0 109.756 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -100.24 -17.06 25.77 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.42 -86.27 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.976 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.57 -16.51 0.02 OUTLIER Glycine 0 C--N 1.287 -2.153 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.894 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.647 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 36.7 m-85 -56.18 167.16 0.68 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.702 -178.693 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 p -162.89 -43.93 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 112.337 -2.211 . . . . 0.0 106.094 177.453 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 78.0 p -96.85 116.99 30.12 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.236 -179.952 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.59 155.28 40.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 117.953 -1.499 . . . . 0.0 113.917 -177.835 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -99.4 158.52 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.851 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.468 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 44.0 m-85 -138.58 133.64 32.77 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.909 -176.493 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.79 84.3 0.68 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.766 178.413 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.455 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -49.05 157.34 0.81 Allowed Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.656 -177.469 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.1 Cg_endo -71.16 0.99 7.29 Favored 'Cis proline' 0 C--O 1.206 -1.076 0 C-N-CA 124.277 -1.134 . . . . 0.0 111.042 -3.912 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.66 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -105.74 -165.6 1.12 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.691 1.234 . . . . 0.0 111.774 -177.042 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -172.25 143.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.131 -1.85 . . . . 0.0 107.314 178.735 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.2 m -113.61 109.58 18.84 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.208 174.228 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.647 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -89.62 140.81 29.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.963 -171.997 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.754 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -116.45 169.94 6.51 Favored Pre-proline 0 N--CA 1.503 2.214 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.196 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -81.24 156.49 82.89 Favored 'Cis proline' 0 CA--C 1.507 -0.864 0 CA-C-O 123.03 1.179 . . . . 0.0 114.384 3.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.754 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.979 0 CA-C-N 111.599 -2.546 . . . . 0.0 109.607 174.779 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -66.46 142.9 97.96 Favored Pre-proline 0 N--CA 1.499 2.021 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.394 -177.807 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -84.28 40.51 0.88 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 107.806 -1.652 . . . . 0.0 107.806 166.126 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.93 125.39 29.31 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.847 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.97 168.6 19.64 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.413 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.485 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -127.95 -175.24 3.42 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.951 -179.19 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -74.91 125.52 29.02 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.34 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.53 -2.06 24.69 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.615 -1.278 . . . . 0.0 111.043 178.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -126.4 115.24 23.29 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.94 -179.58 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.4 -175.98 3.01 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 108.16 -1.515 . . . . 0.0 108.16 171.05 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.96 -109.08 3.74 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.735 179.171 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.652 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 4.0 ptm180 -159.51 157.29 29.71 Favored 'General case' 0 C--O 1.207 -1.177 0 C-N-CA 118.58 -1.248 . . . . 0.0 112.791 -178.682 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.36 143.12 13.14 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.348 176.309 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.503 ' OD1' ' NH2' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -77.6 127.87 33.19 Favored 'General case' 0 C--O 1.172 -3.011 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.593 179.69 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.2 tp -86.1 129.5 34.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.825 -1.55 . . . . 0.0 111.186 -179.505 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.59 159.38 30.82 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.102 -178.136 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -84.03 -163.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.452 -177.44 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 70.59 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.131 1.443 . . . . 0.0 108.605 -176.459 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.8 mtp180 -102.12 133.7 46.54 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.474 178.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -60.23 -53.0 49.25 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.73 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.95 158.74 39.43 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.607 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.2 147.94 73.69 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.636 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.35 130.46 39.96 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.775 0.983 . . . . 0.0 111.391 -177.122 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.93 -17.86 58.89 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 178.566 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.98 -14.74 68.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -86.68 -70.54 0.6 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.347 179.632 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.95 -14.12 0.07 OUTLIER Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.128 -1.511 . . . . 0.0 111.751 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 51.4 m-85 -56.25 169.33 0.43 Allowed 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 122.656 1.217 . . . . 0.0 111.778 -179.385 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.602 ' HG1' ' H ' ' A' ' 30' ' ' SER . 7.3 p -162.57 -45.43 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 112.298 -2.228 . . . . 0.0 106.604 177.131 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.602 ' H ' ' HG1' ' A' ' 29' ' ' THR . 82.9 p -98.37 112.13 24.24 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 112.89 -1.959 . . . . 0.0 110.082 -178.693 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.734 HD21 ' H ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.16 156.28 42.41 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.584 -1.246 . . . . 0.0 112.712 -179.092 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 145.76 40.39 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.575 177.771 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.483 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 20.6 m-85 -118.82 126.55 52.08 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.874 -172.525 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 16.7 mttt -122.77 67.19 0.96 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.301 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.449 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 33.3 t-105 -34.8 142.69 0.23 Allowed Pre-proline 0 N--CA 1.496 1.85 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.405 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.3 Cg_endo -79.42 44.33 0.32 Allowed 'Cis proline' 0 N--CA 1.494 1.537 0 C-N-CA 125.62 -0.575 . . . . 0.0 111.487 -5.564 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.47 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -150.79 -157.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.329 178.15 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.483 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -173.95 138.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.99 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.681 -179.892 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 49.1 m -110.76 123.86 50.87 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 117.463 -1.695 . . . . 0.0 106.518 168.535 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.9 t -94.03 141.62 28.33 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.711 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -114.23 179.71 0.74 Allowed Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 176.722 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.535 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.0 Cg_exo -57.34 -56.15 0.09 OUTLIER 'Cis proline' 0 N--CA 1.503 2.054 0 CA-C-N 122.434 1.905 . . . . 0.0 116.95 6.065 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.652 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.475 0 CA-C-O 116.282 -1.818 . . . . 0.0 109.182 -170.669 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . -43.49 146.5 0.92 Allowed Pre-proline 0 N--CA 1.514 2.764 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -175.155 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -84.17 21.87 1.01 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 N-CA-C 107.793 -1.657 . . . . 0.0 107.793 164.245 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.7 p -83.51 118.33 23.71 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.083 -176.788 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -175.42 4.69 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.213 -176.043 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -123.38 -174.44 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 177.308 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.89 110.52 15.33 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.609 -178.313 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.68 73.14 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.517 179.715 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.2 112.79 34.36 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.435 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -71.75 -159.26 0.07 OUTLIER 'Trans proline' 0 C--O 1.213 -0.77 0 N-CA-C 109.144 -1.137 . . . . 0.0 109.144 173.376 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.0 -106.21 2.43 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.901 177.966 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.691 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.54 177.23 9.64 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.096 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.691 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -154.07 175.83 32.17 Favored Glycine 0 N--CA 1.504 3.17 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.469 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.5 m-20 -91.12 126.13 36.12 Favored 'General case' 0 C--O 1.182 -2.465 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.817 177.683 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 13.7 tp -97.12 102.61 14.42 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.038 1.399 . . . . 0.0 111.958 -177.398 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 38' ' ' ILE . 79.3 m95 -88.98 123.97 33.82 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-N 111.758 -2.473 . . . . 0.0 107.112 175.854 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 17' ' ' ILE . 51.3 mt -90.4 -7.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.247 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -168.888 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -150.36 74.83 1.2 Allowed 'General case' 0 C--N 1.254 -3.558 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.264 -173.354 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.63 151.21 1.85 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.559 178.366 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.57 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -101.98 -24.41 8.58 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 173.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 157.13 38.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.565 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -82.28 172.55 9.31 Favored Pre-proline 0 CA--C 1.58 2.109 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.065 -178.38 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.8 Cg_exo -52.22 -139.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.085 2.524 . . . . 0.0 114.557 -170.692 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.87 114.23 2.57 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 176.189 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.94 80.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.25 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.34 -51.53 3.62 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 122.15 0.976 . . . . 0.0 111.606 -175.892 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.96 -19.23 3.11 Favored Glycine 0 C--N 1.281 -2.515 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -174.126 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.583 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 33.8 m-85 -72.74 173.95 8.34 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 122.558 1.171 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p -162.05 -42.66 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.133 177.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.4 p -96.69 126.28 41.75 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.031 178.178 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.416 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -154.74 153.2 30.87 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 117.644 -1.622 . . . . 0.0 113.832 -179.422 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.4 p -114.24 153.87 28.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.781 174.961 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 14.7 m-85 -130.95 130.86 43.97 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.955 -175.701 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -134.67 74.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.577 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.57 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -46.1 153.49 0.68 Allowed Pre-proline 0 C--N 1.298 -1.671 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.48 -174.419 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.5 -0.18 12.67 Favored 'Cis proline' 0 C--O 1.204 -1.223 0 C-N-CA 124.11 -1.204 . . . . 0.0 110.842 -4.195 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.654 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -96.43 -168.12 1.68 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.952 0.882 . . . . 0.0 110.758 -179.008 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.442 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -169.38 141.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 114.372 -1.285 . . . . 0.0 108.679 -179.882 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 56.5 m -110.05 97.21 6.76 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.209 -1.396 . . . . 0.0 107.553 172.958 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.583 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -81.36 127.95 33.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.587 -173.348 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -100.04 171.62 5.39 Favored Pre-proline 0 N--CA 1.514 2.757 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.222 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -84.36 158.1 68.52 Favored 'Cis proline' 0 CA--C 1.507 -0.83 0 CA-C-O 123.246 1.269 . . . . 0.0 114.643 1.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.914 0 CA-C-N 111.271 -2.695 . . . . 0.0 109.744 174.435 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' HB1' ' H ' ' A' ' 15' ' ' LEU . . . -70.19 155.12 93.97 Favored Pre-proline 0 N--CA 1.511 2.603 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.049 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -90.43 31.32 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 109.039 -1.177 . . . . 0.0 109.039 166.763 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.34 130.57 36.33 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -175.218 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.52 165.48 23.68 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.313 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -110.93 180.0 3.89 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.326 177.275 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.1 103.14 13.84 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.118 -178.659 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.04 18.16 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -178.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.06 117.42 9.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.958 -179.05 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -78.11 170.24 19.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 N-CA-C 108.534 -1.372 . . . . 0.0 108.534 172.09 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.57 -96.35 1.06 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.795 178.803 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.78 152.25 19.34 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.556 -1.657 . . . . 0.0 114.455 -178.143 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.28 155.31 23.37 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 174.312 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -79.52 119.13 22.07 Favored 'General case' 0 C--O 1.169 -3.161 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.365 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 17.0 tp -85.77 93.3 8.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.889 -177.654 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ILE . 72.6 m95 -74.24 126.33 30.38 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 112.706 -2.043 . . . . 0.0 107.106 172.211 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 11.6 mt -94.41 -8.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -169.723 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -152.71 55.64 0.79 Allowed 'General case' 0 C--N 1.261 -3.25 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 -173.602 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.96 157.08 46.96 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.563 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.55 -32.32 2.15 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 174.262 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.27 150.43 52.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.58 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -85.92 145.18 40.51 Favored Pre-proline 0 C--N 1.284 -2.264 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.737 -178.861 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.96 -174.76 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 120.865 1.043 . . . . 0.0 111.323 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.06 13.3 9.09 Favored Glycine 0 N--CA 1.484 1.889 1 N-CA-C 128.912 6.325 . . . . 0.0 128.912 177.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.35 -14.73 27.33 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -79.42 -21.17 45.93 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.126 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.46 61.23 Favored Glycine 0 C--N 1.292 -1.862 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.086 179.326 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 43.5 m-85 -56.43 164.34 1.42 Allowed 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 117.967 -1.493 . . . . 0.0 110.934 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -163.16 -45.06 0.03 OUTLIER 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.41 -2.177 . . . . 0.0 106.112 177.61 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.7 p -99.73 110.7 23.08 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.651 -2.068 . . . . 0.0 109.385 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.741 HD21 ' H ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -142.84 147.15 34.93 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.338 -1.345 . . . . 0.0 113.349 -179.007 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 14.5 p -99.57 143.7 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.2 175.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.478 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 61.8 m-85 -119.58 139.12 52.66 Favored 'General case' 0 C--N 1.275 -2.64 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.86 -173.273 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.6 mttt -137.07 60.91 1.64 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.145 176.742 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' LYS . 1.2 t90 -35.06 143.67 0.23 Allowed Pre-proline 0 N--CA 1.497 1.886 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.079 -177.901 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.17 -1.3 10.47 Favored 'Cis proline' 0 N--CA 1.486 1.07 0 C-N-CA 125.106 -0.789 . . . . 0.0 111.469 -4.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.766 HD21 ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -95.55 -162.44 0.95 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.546 0.689 . . . . 0.0 110.881 -178.416 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 175.66 137.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.852 -179.414 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 20.6 m -107.65 121.6 45.01 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 117.718 -1.593 . . . . 0.0 106.976 170.174 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -100.27 139.17 36.32 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -169.305 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -115.31 166.01 12.96 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.268 177.756 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.69 160.32 87.65 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 CA-C-O 122.842 1.101 . . . . 0.0 113.918 5.327 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.577 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.573 0 CA-C-N 112.155 -2.293 . . . . 0.0 109.679 176.124 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.86 156.23 7.04 Favored Pre-proline 0 N--CA 1.503 2.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.019 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -91.15 27.84 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.3 1.333 . . . . 0.0 108.825 167.443 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.596 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -70.39 126.21 28.99 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.802 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -77.47 166.95 22.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 117.712 -1.595 . . . . 0.0 110.653 -177.188 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.52 -179.39 4.75 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.639 0.733 . . . . 0.0 110.203 179.12 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 9' ' ' LYS . 86.2 p -72.1 142.48 49.19 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.427 -179.081 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.86 -10.76 1.07 Allowed Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.634 178.642 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 7' ' ' SER . 4.5 mttt -136.48 113.26 10.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.484 -179.409 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -77.1 -165.72 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 172.795 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -88.1 1.55 Allowed Glycine 0 C--N 1.289 -2.078 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.05 176.447 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.532 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -160.65 154.64 22.81 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 117.827 -1.549 . . . . 0.0 114.069 -175.476 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.1 149.98 21.88 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 172.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 125.64 29.61 Favored 'General case' 0 C--O 1.17 -3.121 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.85 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.63 110.83 20.68 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 116.925 -1.91 . . . . 0.0 112.274 -177.983 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.711 ' HE1' ' HH ' ' A' ' 28' ' ' TYR . 58.0 m95 -96.23 175.51 6.42 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 112.471 -2.15 . . . . 0.0 109.201 176.64 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -102.38 -158.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.769 -176.854 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.69 73.49 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.741 1.734 . . . . 0.0 108.201 -176.374 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.2 mtt-85 -133.82 97.01 3.79 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.845 178.994 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.45 -5.05 0.68 Allowed Glycine 0 N--CA 1.486 1.984 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.608 -179.646 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 19' ' ' ARG . 1.6 p -137.53 151.9 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.221 179.823 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -103.8 142.86 25.46 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.3 179.108 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' CG ' ' CH2' ' A' ' 16' ' ' TRP . 5.8 Cg_exo -55.88 144.64 76.87 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.004 1.136 . . . . 0.0 111.305 179.595 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.79 -2.75 78.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.706 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.49 -19.76 70.6 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.587 -179.757 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -87.09 -12.04 48.38 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.027 -179.168 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.89 76.66 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.612 176.639 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.711 ' HH ' ' HE1' ' A' ' 16' ' ' TRP . 46.9 m-85 -56.48 174.14 0.15 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.213 179.36 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.494 ' HG1' ' H ' ' A' ' 30' ' ' SER . 1.1 p -161.61 -43.67 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.666 -2.061 . . . . 0.0 106.335 175.783 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.3 p -97.21 133.9 41.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.558 179.335 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.632 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -160.04 157.28 28.39 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.849 178.78 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.7 p -113.34 142.74 45.5 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.995 176.139 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 11.9 m-85 -120.44 125.31 47.61 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.272 -174.023 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -146.12 81.67 1.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.707 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.419 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -40.06 157.78 0.15 Allowed Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.461 179.672 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.4 Cg_endo -78.34 28.68 1.78 Allowed 'Cis proline' 0 C--O 1.21 -0.903 0 C-N-CA 124.227 -1.156 . . . . 0.0 110.751 -5.209 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.453 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 4.0 m-80 -145.01 -170.26 3.38 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -154.41 150.12 12.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.773 178.822 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -116.66 158.66 23.42 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 166.282 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -130.52 147.18 52.18 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.518 -1.273 . . . . 0.0 114.103 -170.189 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -118.53 166.91 12.68 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.404 179.734 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.44 158.53 97.26 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 CA-C-O 122.679 1.033 . . . . 0.0 113.94 4.599 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.503 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.502 0 CA-C-N 112.359 -2.201 . . . . 0.0 110.121 177.898 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -52.41 143.33 27.34 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.312 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -81.61 35.27 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 166.179 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.39 123.23 25.65 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.779 -1.168 . . . . 0.0 108.357 -175.25 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.08 179.62 7.24 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.151 -1.42 . . . . 0.0 108.778 179.424 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -179.29 6.11 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.794 -1.162 . . . . 0.0 111.021 178.561 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 9' ' ' LYS . 22.9 p -74.07 128.27 35.08 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.293 -176.146 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -8.48 3.99 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.005 178.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -119.51 107.08 41.4 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.18 -179.803 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -72.07 -173.51 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.078 1.185 . . . . 0.0 109.854 174.717 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.69 -112.36 3.84 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.288 178.291 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.58 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 4.3 ptm180 -152.56 166.25 32.61 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.503 -177.18 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.68 146.78 18.11 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 174.356 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -77.12 117.82 19.06 Favored 'General case' 0 C--O 1.179 -2.615 0 C-N-CA 118.989 -1.085 . . . . 0.0 108.272 178.896 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.21 112.59 19.99 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 116.387 -2.125 . . . . 0.0 112.441 -178.684 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' ILE . 57.2 m95 -94.71 174.26 7.19 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 112.144 -2.298 . . . . 0.0 106.659 173.15 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -96.56 -158.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 C-N-CA 118.651 -1.219 . . . . 0.0 113.02 -174.376 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.94 72.91 0.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 123.619 1.676 . . . . 0.0 108.221 -177.063 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ILE . 5.2 mtp85 -131.84 97.53 4.21 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 111.637 -2.529 . . . . 0.0 109.729 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.53 -22.98 1.18 Allowed Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.019 -179.516 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.427 ' N ' ' C ' ' A' ' 19' ' ' ARG . 1.1 p -130.4 152.31 49.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.983 179.524 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 173.07 8.09 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.35 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 14.9 Cg_endo -67.0 98.9 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.576 1.517 . . . . 0.0 113.364 -174.614 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' PRO . . . -30.85 101.11 0.01 OUTLIER Glycine 0 N--CA 1.512 3.758 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.573 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.78 68.58 0.66 Allowed Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.703 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -117.52 -172.56 2.25 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.189 0.519 . . . . 0.0 110.683 -177.471 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.86 -18.3 54.64 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 172.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 23.1 m-85 -69.94 177.72 3.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.956 1.36 . . . . 0.0 112.476 178.766 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -161.55 -44.36 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.759 -2.473 . . . . 0.0 105.475 176.4 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.21 114.69 27.02 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.751 178.517 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' ND2' ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -136.52 151.85 49.87 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 118.55 -1.26 . . . . 0.0 112.819 178.558 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.35 146.18 43.56 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.766 176.721 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' OH ' ' ND2' ' A' ' 31' ' ' ASN . 7.2 m-85 -126.27 136.21 52.5 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.222 -174.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -147.12 79.79 1.51 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.588 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.404 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -42.75 159.05 0.21 Allowed Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.135 -178.154 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 10.1 Cg_endo -81.15 32.29 2.28 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.542 -1.024 . . . . 0.0 111.635 -3.725 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.0 m-80 -148.98 171.17 16.79 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.411 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -131.62 152.31 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.832 178.35 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 28.9 m -123.46 110.23 14.84 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.014 -1.475 . . . . 0.0 107.523 167.58 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -83.79 133.41 34.77 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.02 -174.31 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -102.89 -173.85 0.31 Allowed Pre-proline 0 N--CA 1.517 2.919 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.647 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.8 Cg_exo -62.56 -48.58 0.18 OUTLIER 'Cis proline' 0 N--CA 1.508 2.348 0 CA-C-N 122.653 1.983 . . . . 0.0 116.497 3.958 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.608 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.987 0 CA-C-O 116.481 -1.724 . . . . 0.0 109.244 -171.382 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -49.8 146.8 7.13 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -176.517 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -81.22 27.77 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 N-CA-C 108.022 -1.569 . . . . 0.0 108.022 164.001 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.3 p -87.95 120.3 29.15 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.097 -177.608 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -82.52 -175.13 5.58 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.111 -173.379 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.44 -176.39 5.57 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.703 176.073 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.7 t -78.92 113.34 16.94 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.584 -177.728 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.23 67.58 Favored Glycine 0 C--N 1.296 -1.65 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -112.25 136.01 21.37 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.802 -178.904 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 9' ' ' LYS . 2.9 Cg_exo -48.74 -166.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.602 2.201 . . . . 0.0 114.244 -173.063 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.94 24.73 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.062 -174.543 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.456 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 8.2 ptm180 -161.36 146.91 13.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 116.695 -2.002 . . . . 0.0 114.612 176.862 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -160.65 173.59 37.2 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 176.088 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 40' ' ' CYS . 2.7 m-20 -84.31 135.0 34.49 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.974 179.89 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.5 ' N ' ' HB1' ' A' ' 2' ' ' ALA . 36.3 tp -96.59 133.62 40.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.358 1.075 . . . . 0.0 110.114 -179.62 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.422 ' N ' ' O ' ' A' ' 38' ' ' ILE . 64.9 m95 -135.08 151.37 50.69 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 112.899 -1.955 . . . . 0.0 108.047 -177.483 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.621 ' H ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -78.56 -157.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.835 -175.562 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.74 67.44 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.017 1.389 . . . . 0.0 108.235 -176.8 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -103.82 112.16 25.0 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.102 -178.972 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -23.52 57.18 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.382 -1.39 . . . . 0.0 109.789 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.85 156.47 40.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.982 178.631 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -91.65 149.82 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.918 179.263 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.91 128.52 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.972 1.115 . . . . 0.0 111.452 -177.614 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.36 6.95 55.87 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.01 179.489 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.51 -7.23 16.44 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.386 -179.975 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.55 -35.77 39.37 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.798 179.604 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.93 -13.07 6.44 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.642 178.367 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 42.9 m-85 -60.7 170.55 1.42 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.744 -179.136 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 p -161.46 -44.96 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 112.319 -2.219 . . . . 0.0 106.038 178.438 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.4 129.8 44.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.714 179.379 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.82 157.3 28.99 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.922 -1.511 . . . . 0.0 112.438 178.266 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 142.19 47.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.141 177.173 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.46 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 21.3 m-85 -117.77 124.62 48.89 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.813 -172.735 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.9 81.06 1.67 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.195 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.422 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.98 159.62 0.13 Allowed Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.883 -178.775 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -77.76 23.06 3.76 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.127 -1.197 . . . . 0.0 110.721 -5.208 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.434 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.8 m-80 -140.76 175.76 9.35 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.968 179.663 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.46 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -136.2 145.83 30.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.523 177.355 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.9 m -115.07 115.69 27.21 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 117.688 -1.605 . . . . 0.0 107.087 169.844 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -87.91 160.37 17.97 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.598 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 30' ' ' SER . 5.7 m-85 -132.62 161.9 60.56 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.139 179.185 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -85.95 160.32 58.35 Favored 'Cis proline' 0 C--N 1.325 -0.708 0 N-CA-C 115.209 1.196 . . . . 0.0 115.209 5.412 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.038 0 CA-C-N 112.02 -2.354 . . . . 0.0 109.588 175.57 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -42.06 140.04 1.61 Allowed Pre-proline 0 N--CA 1.503 2.222 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.187 -178.658 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.88 51.9 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 170.962 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -69.26 141.36 54.41 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -174.396 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -78.38 173.29 12.49 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 117.984 -1.486 . . . . 0.0 108.909 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.33 -168.18 1.28 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.191 -178.656 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 9' ' ' LYS . 4.5 m -65.35 113.63 4.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.107 -177.991 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.8 -3.12 0.73 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.807 179.131 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 7' ' ' SER . 22.3 mttt -93.81 120.95 65.46 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 118.296 -1.362 . . . . 0.0 111.156 -178.99 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -71.11 155.93 60.51 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 N-CA-C 109.386 -1.044 . . . . 0.0 109.386 174.321 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -116.54 3.55 Favored Glycine 0 N--CA 1.482 1.724 1 N-CA-C 129.591 6.596 . . . . 0.0 129.591 -178.008 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.583 ' C ' ' HE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.9 149.33 16.21 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.627 -1.229 . . . . 0.0 112.343 178.683 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . -135.3 158.26 23.55 Favored Glycine 0 C--O 1.195 -2.297 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 172.909 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -77.61 113.63 15.64 Favored 'General case' 0 C--O 1.176 -2.776 0 C-N-CA 118.364 -1.334 . . . . 0.0 108.245 178.871 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.35 85.74 7.18 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 116.715 -1.994 . . . . 0.0 112.826 -176.461 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' ILE . 68.6 m95 -59.43 131.06 49.82 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.199 171.861 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.37 -5.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.017 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -171.021 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 mt -148.92 57.24 1.03 Allowed 'General case' 1 C--N 1.241 -4.115 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.335 -173.399 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -159.95 164.16 33.61 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.406 -1.718 . . . . 0.0 112.315 179.798 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.02 -16.24 5.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 176.144 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 155.5 40.54 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.668 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -103.13 144.44 28.64 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.062 178.518 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.94 130.68 41.13 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.777 0.984 . . . . 0.0 111.516 -178.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.2 -18.5 78.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 177.941 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -13.43 83.64 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.54 -62.04 1.81 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.053 179.933 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.77 -15.19 0.81 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 118.892 -1.623 . . . . 0.0 111.994 178.316 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.626 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.8 m-85 -61.44 170.52 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.708 1.242 . . . . 0.0 112.423 -178.704 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -160.89 -44.87 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 112.123 -2.308 . . . . 0.0 105.917 177.612 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 41' ' ' TYR . 67.9 p -96.04 113.0 24.57 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.859 179.222 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.27 151.24 33.88 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.217 -1.393 . . . . 0.0 113.582 -177.422 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -101.16 140.88 34.84 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.3 175.025 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.47 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 72.9 m-85 -120.76 134.8 55.27 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.405 -174.125 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -149.43 66.89 1.01 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.938 178.779 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.455 ' CD1' ' C ' ' A' ' 35' ' ' TRP . 12.1 t-105 -30.55 147.22 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.01 178.564 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.6 Cg_endo -71.37 2.74 6.77 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 C-N-CA 125.368 -0.68 . . . . 0.0 112.31 -5.321 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -110.19 -165.37 1.0 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.945 0.879 . . . . 0.0 111.693 -176.941 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.47 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -178.26 130.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.349 179.541 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -108.42 109.44 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.526 -1.67 . . . . 0.0 107.349 174.202 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.8 t -87.93 134.72 33.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.484 -2.143 . . . . 0.0 114.214 -168.602 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.54 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.7 m-85 -106.56 -178.53 0.6 Allowed Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 178.086 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.3 Cg_exo -55.85 -59.26 0.03 OUTLIER 'Cis proline' 0 N--CA 1.506 2.255 0 N-CA-C 117.618 2.122 . . . . 0.0 117.618 5.981 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.499 0 CA-C-O 116.337 -1.792 . . . . 0.0 108.924 -169.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.95 39.01 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 109.08 -1.161 . . . . 0.0 109.08 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.41 121.23 22.75 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.838 -175.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 8.4 m-85 -78.23 163.5 25.72 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 117.956 -1.498 . . . . 0.0 109.776 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.93 175.27 8.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.092 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -81.81 116.51 21.53 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.859 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -15.18 63.89 Favored Glycine 0 C--N 1.296 -1.643 0 C-N-CA 119.452 -1.356 . . . . 0.0 109.934 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -130.1 111.67 17.0 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.208 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -74.46 -175.31 2.18 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 N-CA-C 109.079 -1.162 . . . . 0.0 109.079 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.19 -104.67 3.21 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 6.2 ptm180 -160.21 165.4 31.59 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.173 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.13 149.94 20.72 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 173.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -77.22 124.51 27.94 Favored 'General case' 0 C--O 1.166 -3.314 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.29 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 tp -84.69 111.07 19.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.037 -1.865 . . . . 0.0 112.543 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.691 ' CB ' HG23 ' A' ' 38' ' ' ILE . 65.6 m95 -100.64 171.72 7.53 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.675 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.32 -161.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.722 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.99 70.89 0.15 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.298 1.523 . . . . 0.0 108.087 -177.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.565 ' C ' ' H ' ' A' ' 21' ' ' THR . 47.7 mtp180 -115.96 -13.02 11.29 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 112.11 -2.314 . . . . 0.0 110.9 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 48.3 4.67 0.02 OUTLIER Glycine 0 C--N 1.263 -3.511 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.38 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -151.92 154.88 36.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.17 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -116.13 151.19 46.37 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.028 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.69 106.12 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 120.721 0.947 . . . . 0.0 110.908 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.31 89.96 1.01 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.42 -11.06 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.212 -1.47 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.61 -18.76 40.08 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.25 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.59 -16.88 2.24 Favored Glycine 0 N--CA 1.482 1.736 0 C-N-CA 119.51 -1.328 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 29.2 m-85 -77.3 167.73 21.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.992 1.377 . . . . 0.0 112.624 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.3 p -162.59 -46.05 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.749 -2.478 . . . . 0.0 105.65 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' TYR . 70.0 p -98.73 124.41 43.57 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.548 -2.114 . . . . 0.0 110.19 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -148.41 156.09 42.05 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.337 178.222 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.39 147.22 39.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.88 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.829 ' CE2' HD12 ' A' ' 38' ' ' ILE . 7.3 m-85 -127.92 131.26 49.38 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.485 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 77.66 1.62 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.49 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.81 158.94 0.27 Allowed Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.151 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.1 Cg_endo -78.89 35.25 0.8 Allowed 'Cis proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.351 -1.104 . . . . 0.0 112.54 -5.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.49 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 4.0 m-80 -147.73 -166.47 2.53 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.228 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.829 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -156.63 147.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.511 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.8 m -117.35 136.31 53.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 166.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -107.09 140.04 40.55 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -170.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.3 m-85 -107.83 176.71 1.51 Allowed Pre-proline 0 N--CA 1.509 2.507 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 7.8 Cg_exo -58.99 -53.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.164 0 N-CA-C 117.196 1.96 . . . . 0.0 117.196 5.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.622 0 CA-C-O 116.468 -1.729 . . . . 0.0 109.179 -170.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -77.96 35.28 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.6 124.0 29.15 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -176.344 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 164.57 25.15 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.724 -1.591 . . . . 0.0 110.276 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.2 m -109.17 -178.7 3.64 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.306 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.14 111.45 17.59 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.991 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.18 -12.31 48.47 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.471 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.51 115.1 14.68 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.127 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -161.58 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.89 -93.52 1.6 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.154 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.585 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.98 160.06 30.24 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.744 -178.108 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -145.63 141.96 10.24 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 42.3 m-20 -75.33 125.5 29.1 Favored 'General case' 0 C--O 1.175 -2.846 0 C-N-CA 118.217 -1.393 . . . . 0.0 108.135 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -84.15 132.79 34.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 116.931 -1.908 . . . . 0.0 111.448 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.659 ' CB ' HG23 ' A' ' 38' ' ' ILE . 55.7 m95 -124.88 175.65 7.15 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.481 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.672 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -99.33 -162.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.441 -176.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.22 67.36 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.343 1.544 . . . . 0.0 108.343 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.8 mtp85 -103.81 128.88 51.22 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.1 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.3 -49.44 60.09 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.204 -1.474 . . . . 0.0 109.468 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.33 161.37 38.06 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.954 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.36 150.33 76.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.217 179.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.95 129.18 31.99 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 120.937 1.091 . . . . 0.0 110.667 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 26' ' ' TYR . . . -74.18 -48.16 15.87 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.833 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.32 -9.03 0.57 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.397 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.5 m-85 -79.52 -75.97 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.197 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.2 -13.24 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.002 -1.571 . . . . 0.0 112.08 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.632 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 53.4 m-85 -66.25 172.31 4.01 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 122.618 1.199 . . . . 0.0 112.688 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -161.93 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.312 -2.222 . . . . 0.0 106.354 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -97.56 118.87 35.02 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.429 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.472 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.94 158.47 44.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.044 -1.463 . . . . 0.0 112.884 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.416 ' O ' HG13 ' A' ' 38' ' ' ILE . 26.2 p -113.06 147.64 36.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.49 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.606 ' CE2' HD12 ' A' ' 38' ' ' ILE . 40.4 m-85 -122.19 117.51 26.38 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.5 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 31.8 mttp -130.87 75.24 1.64 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.877 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.468 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -41.45 156.02 0.22 Allowed Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.437 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.6 Cg_endo -78.56 28.71 1.88 Allowed 'Cis proline' 0 C--O 1.206 -1.117 0 C-N-CA 124.167 -1.18 . . . . 0.0 112.123 -3.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.468 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.8 m120 -144.98 -160.15 1.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.232 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.672 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -160.93 154.32 3.9 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.046 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.843 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.522 ' N ' HG13 ' A' ' 38' ' ' ILE . 80.4 m -124.56 116.61 22.73 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 117.903 -1.519 . . . . 0.0 107.104 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.632 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.15 148.64 25.59 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.531 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -120.19 167.81 11.8 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.175 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -73.95 159.26 97.87 Favored 'Cis proline' 0 C--O 1.214 -0.71 0 CA-C-O 122.788 1.078 . . . . 0.0 113.838 3.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.191 -2.277 . . . . 0.0 109.928 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -91.22 40.63 0.35 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 109.929 -0.835 . . . . 0.0 109.929 168.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -77.09 126.97 31.84 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.128 -176.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.37 167.2 21.7 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.832 -179.002 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -175.68 2.78 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.9 177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.0 123.22 26.02 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.236 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.0 -11.69 47.03 Favored Glycine 0 C--N 1.299 -1.476 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.735 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -116.47 109.5 43.85 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.433 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.41 -167.7 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 107.684 -1.698 . . . . 0.0 107.684 172.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.71 -111.67 3.75 Favored Glycine 0 C--N 1.283 -2.381 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.378 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -156.11 154.98 31.77 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 118.245 -1.382 . . . . 0.0 114.189 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.07 153.64 23.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -78.97 125.74 29.78 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.971 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 22.7 tp -85.98 108.15 18.08 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.966 -1.494 . . . . 0.0 111.893 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.698 ' CB ' HG23 ' A' ' 38' ' ' ILE . 60.3 m95 -95.16 176.79 6.09 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.616 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -100.14 -162.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.221 -176.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.575 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.87 70.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.288 1.518 . . . . 0.0 108.27 -176.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' ILE . 40.6 mtp180 -112.47 115.64 29.0 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.05 -23.87 18.21 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 110.795 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.73 158.07 42.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.384 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' N ' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -86.34 151.41 53.64 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.837 178.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.6 Cg_exo -50.11 120.94 6.77 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.174 1.249 . . . . 0.0 111.428 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.04 -4.74 4.83 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.512 -1.327 . . . . 0.0 110.29 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -119.72 1.05 13.77 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 130.684 7.034 . . . . 0.0 130.684 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -79.54 -36.43 38.38 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.274 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.84 -17.15 2.19 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.353 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.1 m-85 -60.78 168.95 2.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.303 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.3 p -162.02 -43.0 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 112.283 -2.235 . . . . 0.0 106.418 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.4 p -97.31 121.56 39.34 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.357 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.83 154.8 34.62 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.81 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -110.17 137.84 47.36 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.643 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.665 ' CE2' HD12 ' A' ' 38' ' ' ILE . 38.9 m-85 -113.71 129.93 56.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.553 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -147.77 81.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.149 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.444 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.47 159.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.349 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 4.6 Cg_endo -78.51 28.23 2.01 Favored 'Cis proline' 0 C--O 1.21 -0.879 0 C-N-CA 124.273 -1.136 . . . . 0.0 111.813 -5.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.444 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.8 m120 -147.06 -172.35 3.98 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.709 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.698 HG23 ' CB ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -154.98 147.92 12.93 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.833 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -116.64 142.53 46.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.714 165.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.5 t -112.63 148.53 34.41 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.499 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -119.86 170.44 6.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.15 158.08 83.44 Favored 'Cis proline' 0 CA--C 1.503 -1.039 0 CA-C-O 122.857 1.107 . . . . 0.0 113.661 4.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.966 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.468 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -74.75 57.76 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.06 -1.939 . . . . 0.0 107.06 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.59 138.97 45.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.46 -179.13 6.17 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.869 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -162.66 1.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.111 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 9' ' ' LYS . 8.7 m -59.9 110.94 1.29 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.473 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.8 3.67 0.12 Allowed Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.224 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 7' ' ' SER . 61.5 mttt -94.14 116.81 66.88 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.474 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 9.8 Cg_endo -73.69 -166.19 0.3 Allowed 'Trans proline' 0 C--O 1.206 -1.093 0 N-CA-C 109.264 -1.091 . . . . 0.0 109.264 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 -120.33 5.29 Favored Glycine 0 C--N 1.29 -2.001 0 C-N-CA 118.674 -1.726 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.638 HH22 ' CG ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -161.1 162.19 31.47 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 118.185 -1.406 . . . . 0.0 113.42 -178.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.13 148.31 19.93 Favored Glycine 0 C--O 1.199 -2.092 0 N-CA-C 106.917 -2.473 . . . . 0.0 106.917 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.638 ' CG ' HH22 ' A' ' 12' ' ' ARG . 10.1 m-20 -76.62 128.41 34.65 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.632 -1.227 . . . . 0.0 109.142 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 1.1 tt -88.57 98.43 11.65 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 116.962 -1.895 . . . . 0.0 112.087 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.711 ' HB2' HG23 ' A' ' 38' ' ' ILE . 62.0 m95 -77.34 163.86 26.05 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 111.779 -2.464 . . . . 0.0 109.442 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.697 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -85.55 -158.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 118.846 -1.141 . . . . 0.0 111.268 -177.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.67 72.54 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.916 1.341 . . . . 0.0 109.053 -175.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' ILE . 4.1 mtp180 -121.55 110.17 15.69 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.086 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.88 -20.31 40.36 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.657 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.14 153.64 50.44 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.838 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.82 151.26 43.4 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.046 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -47.81 112.6 0.59 Allowed 'Trans proline' 0 C--O 1.214 -0.724 0 C-N-CA 120.971 1.114 . . . . 0.0 111.444 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.46 -25.93 55.89 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -22.42 71.91 Favored Glycine 0 N--CA 1.485 1.951 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.456 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.51 175.74 10.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.141 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.27 70.68 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 29' ' ' THR . 41.6 m-85 -59.94 167.92 2.04 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.051 -1.459 . . . . 0.0 110.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.0 p -163.13 -43.0 0.03 OUTLIER 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.7 -2.045 . . . . 0.0 106.225 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 8.5 p -97.36 118.46 33.88 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.794 -2.003 . . . . 0.0 109.156 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.556 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.08 152.01 36.63 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.876 -1.53 . . . . 0.0 113.52 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.448 ' O ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -101.66 156.05 17.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.981 174.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.827 ' CE2' HD12 ' A' ' 38' ' ' ILE . 22.4 m-85 -134.98 125.76 27.24 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.545 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 35' ' ' TRP . 6.4 mttt -137.72 71.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.958 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.468 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 17.0 t-105 -38.82 146.19 0.33 Allowed Pre-proline 0 N--CA 1.508 2.46 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.864 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 7.3 Cg_endo -78.06 38.44 0.46 Allowed 'Cis proline' 0 N--CA 1.495 1.603 0 CA-C-N 118.52 0.507 . . . . 0.0 111.69 -5.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.47 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.5 m120 -148.09 -168.03 2.97 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.509 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.827 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.03 144.9 3.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.298 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.65 140.37 50.02 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 117.488 -1.685 . . . . 0.0 107.586 169.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -114.62 135.8 53.75 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -169.251 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -107.96 -179.51 0.71 Allowed Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.555 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 3.0 Cg_exo -64.3 -49.21 0.18 OUTLIER 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 122.036 1.763 . . . . 0.0 116.587 5.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.781 0 CA-C-O 116.28 -1.819 . . . . 0.0 109.565 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.505 2.317 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.26 35.46 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 167.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -75.38 142.87 43.03 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -87.36 166.01 15.17 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 117.79 -1.564 . . . . 0.0 109.335 177.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.469 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -108.84 -173.3 2.24 Favored 'General case' 0 N--CA 1.51 2.538 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.727 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -71.07 117.23 12.31 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.921 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.0 -1.59 3.39 Favored Glycine 0 C--N 1.297 -1.589 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.141 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 7' ' ' SER . 5.6 mttt -108.82 118.05 52.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.367 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -74.87 -168.91 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.14 -113.47 4.13 Favored Glycine 0 C--N 1.291 -1.918 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.178 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.685 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 6.5 ptm180 -157.66 163.09 38.58 Favored 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 118.184 -1.407 . . . . 0.0 114.086 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -148.81 151.21 23.41 Favored Glycine 0 N--CA 1.494 2.503 1 N-CA-C 126.364 5.305 . . . . 0.0 126.364 173.288 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.9 m-20 -77.38 118.57 19.97 Favored 'General case' 0 C--O 1.171 -3.055 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.924 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 48.9 tp -85.7 102.55 13.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.002 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HB2' HG23 ' A' ' 38' ' ' ILE . 58.7 m95 -91.79 165.07 13.46 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 112.3 -2.227 . . . . 0.0 109.968 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -90.61 -159.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.632 -177.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.77 73.87 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.718 1.247 . . . . 0.0 108.793 -174.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -115.26 123.13 48.03 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.317 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.7 -35.27 73.3 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 160.54 42.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.751 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.09 163.54 59.42 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.669 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.51 -164.98 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 121.676 1.584 . . . . 0.0 112.035 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.62 33.56 2.47 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.17 -2.52 1.58 Allowed Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.789 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.45 -70.71 0.62 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.223 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.33 17.19 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.509 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 43.4 m-85 -76.41 171.13 15.09 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.577 1.179 . . . . 0.0 112.068 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.3 p -161.42 -43.95 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.142 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.24 134.2 40.85 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.123 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -160.04 159.61 32.21 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.887 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.0 p -120.9 133.7 55.29 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.567 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.687 ' CE2' HD12 ' A' ' 38' ' ' ILE . 76.1 m-85 -109.1 114.02 27.39 Favored 'General case' 0 C--N 1.259 -3.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.757 -174.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -129.23 71.86 1.45 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.595 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.521 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.46 155.35 0.19 Allowed Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.259 -178.362 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.6 Cg_endo -78.45 33.12 0.97 Allowed 'Cis proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.409 -1.08 . . . . 0.0 111.417 -3.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.521 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 5.3 m120 -147.85 -160.48 1.17 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.805 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -167.87 144.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.383 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 8.1 m -113.57 109.29 18.39 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.577 168.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -80.73 139.85 35.88 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.527 -172.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.9 m-85 -110.97 -177.84 0.49 Allowed Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 19.1 Cg_exo -56.72 -55.43 0.11 OUTLIER 'Cis proline' 0 N--CA 1.505 2.169 0 CA-C-N 122.31 1.861 . . . . 0.0 116.698 5.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.685 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.388 0 CA-C-O 116.379 -1.772 . . . . 0.0 109.228 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.38 57.05 4.67 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 N-CA-C 108.737 -1.293 . . . . 0.0 108.737 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.01 145.95 39.86 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.473 -176.597 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.71 -175.77 5.45 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.135 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.95 179.82 5.85 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.64 0.733 . . . . 0.0 109.685 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.15 114.43 21.77 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.23 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.65 -10.53 72.53 Favored Glycine 0 C--N 1.295 -1.714 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.955 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -117.24 106.85 46.35 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.872 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.8 146.44 66.14 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.676 -1.317 . . . . 0.0 108.676 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.71 -104.58 0.84 Allowed Glycine 0 C--N 1.285 -2.277 1 N-CA-C 129.814 6.686 . . . . 0.0 129.814 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -161.14 151.35 17.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.761 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.14 166.74 25.65 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.7 m-20 -79.68 114.58 18.71 Favored 'General case' 0 C--O 1.172 -2.982 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.158 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 10.3 tp -84.13 96.24 8.87 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.091 -1.843 . . . . 0.0 113.205 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.817 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.5 m95 -69.94 145.81 51.63 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 111.818 -2.446 . . . . 0.0 104.837 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -110.25 -8.41 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -168.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 2.2 mt -153.1 59.63 0.78 Allowed 'General case' 0 C--N 1.248 -3.805 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.872 -173.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -154.89 156.32 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.581 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -109.01 -7.88 28.38 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 174.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 157.0 47.26 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.483 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -107.41 149.4 38.74 Favored Pre-proline 0 N--CA 1.494 1.748 0 C-N-CA 119.62 -0.832 . . . . 0.0 108.867 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -66.35 142.06 64.63 Favored 'Trans proline' 0 C--O 1.217 -0.568 0 C-N-CA 120.6 0.866 . . . . 0.0 111.177 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.62 63.5 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.77 -19.28 27.43 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.684 -1.245 . . . . 0.0 110.458 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.49 -34.59 41.19 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.958 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.95 -3.03 19.41 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.303 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.666 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.5 m-85 -60.5 169.17 1.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.691 1.234 . . . . 0.0 112.561 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.7 p -162.32 -43.76 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.263 -2.244 . . . . 0.0 106.027 176.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.84 114.15 26.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.62 178.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -146.35 154.14 41.32 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.884 -177.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -97.33 149.39 22.14 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.852 175.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.82 ' CD2' HD12 ' A' ' 38' ' ' ILE . 71.1 m-85 -132.01 119.99 21.81 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.009 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -132.41 72.07 1.49 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.441 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -45.57 153.57 0.59 Allowed Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.084 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.52 -5.5 10.08 Favored 'Cis proline' 0 N--CA 1.485 1.012 0 C-N-CA 124.299 -1.125 . . . . 0.0 112.038 -5.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.4 m120 -94.87 178.75 5.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.775 0.797 . . . . 0.0 110.851 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.82 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -158.93 140.43 4.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.034 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -120.19 116.44 25.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.307 172.155 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.666 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -95.42 144.47 25.91 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.866 -1.97 . . . . 0.0 114.955 -167.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -116.85 167.92 9.81 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.63 160.12 88.01 Favored 'Cis proline' 0 C--O 1.217 -0.556 0 CA-C-O 123.262 1.276 . . . . 0.0 114.822 3.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.603 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.251 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.679 ' HB3' ' H ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.38 36.09 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 109.187 -1.12 . . . . 0.0 109.187 166.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -82.07 122.71 28.18 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.388 -176.319 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.48 164.14 24.17 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.833 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.36 -178.39 4.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.072 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t -76.8 127.02 31.96 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.31 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.58 -18.08 31.49 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.562 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.08 105.95 20.04 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.21 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.04 -166.34 0.31 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.26 -98.52 2.38 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.729 -1.7 . . . . 0.0 110.862 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 43' ' ' HIS . 3.1 ptm180 -162.32 160.82 27.14 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.784 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -139.17 150.96 21.56 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 175.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.68 111.59 14.93 Favored 'General case' 0 C--O 1.171 -3.069 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.445 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.679 ' H ' ' HB3' ' A' ' 2' ' ' ALA . 6.3 tt -85.2 93.6 8.7 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.623 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.793 ' HB2' HG23 ' A' ' 38' ' ' ILE . 61.5 m95 -70.13 122.75 20.04 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 112.293 -2.231 . . . . 0.0 107.287 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.26 -8.08 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 C-N-CA 118.983 -1.087 . . . . 0.0 113.499 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 mt -151.89 74.51 1.11 Allowed 'General case' 0 C--N 1.254 -3.553 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.464 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.755 ' CG ' HH11 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -162.95 142.85 9.11 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.222 -1.791 . . . . 0.0 113.085 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.17 -22.04 23.57 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.533 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 1.4 p -143.48 152.32 41.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.514 -0.843 . . . . 0.0 109.24 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -88.53 148.11 41.3 Favored Pre-proline 0 C--N 1.286 -2.178 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.366 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.08 178.44 0.4 Allowed 'Trans proline' 0 C--O 1.219 -0.442 0 C-N-CA 120.379 0.719 . . . . 0.0 111.211 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.15 8.36 25.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.22 -16.36 15.12 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -84.67 -6.89 59.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.04 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.73 11.49 85.18 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.758 -1.21 . . . . 0.0 112.326 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 40.5 m-85 -67.19 170.57 6.86 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.885 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -161.91 -44.07 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 112.763 -2.017 . . . . 0.0 106.691 178.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 41' ' ' TYR . 3.2 p -96.86 125.88 41.62 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -160.07 147.5 16.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 117.19 -1.804 . . . . 0.0 113.132 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 146.42 32.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.002 -1.453 . . . . 0.0 108.049 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.711 ' CE2' HD12 ' A' ' 38' ' ' ILE . 51.0 m-85 -118.01 140.72 49.34 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.688 -170.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 35' ' ' TRP . 7.9 mttt -142.27 59.27 1.46 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.965 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -40.41 147.36 0.38 Allowed Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.31 -176.017 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.79 2.1 6.24 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.635 -4.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.618 ' C ' HG22 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -101.23 -160.59 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.725 0.774 . . . . 0.0 111.359 -177.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.793 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 171.34 141.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.471 -178.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 79.4 m -110.13 110.86 21.89 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 117.741 -1.584 . . . . 0.0 107.176 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.0 t -88.98 151.16 22.46 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.924 -171.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' SER . 3.0 m-85 -125.33 163.14 40.11 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -79.16 162.61 86.47 Favored 'Cis proline' 0 C--N 1.326 -0.64 0 CA-C-O 123.324 1.302 . . . . 0.0 115.374 5.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.393 0 CA-C-N 111.11 -2.768 . . . . 0.0 109.447 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.505 2.295 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -83.34 38.55 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 167.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.87 127.09 33.59 Favored 'General case' 0 N--CA 1.513 2.685 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.082 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.61 159.92 27.83 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 117.924 -1.51 . . . . 0.0 110.299 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.2 m -108.19 -172.89 2.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.38 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -57.68 140.02 52.3 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.327 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 29.01 11.1 0.0 OUTLIER Glycine 0 N--CA 1.481 1.633 1 N-CA-C 125.134 4.814 . . . . 0.0 125.134 -174.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.0 mttt -111.25 102.06 52.01 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 114.385 -0.908 . . . . 0.0 110.041 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.04 -164.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 120.946 1.097 . . . . 0.0 109.303 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.89 -103.17 1.97 Allowed Glycine 0 C--N 1.29 -1.994 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.543 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -161.19 166.12 28.32 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 118.063 -1.455 . . . . 0.0 114.054 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.01 154.21 25.24 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.52 126.62 31.11 Favored 'General case' 0 C--O 1.178 -2.665 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.243 178.287 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 28.0 tp -87.89 108.41 19.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.334 -1.346 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.674 ' CB ' HG23 ' A' ' 38' ' ' ILE . 70.1 m95 -99.65 161.74 13.43 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.313 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.766 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -87.35 -158.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.136 -175.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.96 66.02 0.1 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.464 1.602 . . . . 0.0 107.793 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.32 105.81 15.94 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 112.272 -2.24 . . . . 0.0 110.631 -179.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -44.58 -35.17 3.98 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.03 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -141.42 163.2 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.153 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 157.34 56.21 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.937 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.8 119.42 5.62 Favored 'Trans proline' 0 C--O 1.208 -0.991 0 C-N-CA 120.812 1.008 . . . . 0.0 110.541 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.17 176.83 25.82 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.094 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.76 8.1 38.9 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.97 -168.54 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.18 0.04 74.75 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.428 -1.368 . . . . 0.0 111.443 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 26.1 m-85 -76.55 170.35 16.57 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.371 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -162.11 -44.74 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 112.338 -2.21 . . . . 0.0 106.376 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.6 p -99.0 128.09 45.06 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.867 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.5 142.73 25.09 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 117.939 -1.504 . . . . 0.0 112.385 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 22.2 p -99.62 137.12 38.55 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.778 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CE2' HD12 ' A' ' 38' ' ' ILE . 51.1 m-85 -114.93 121.08 42.08 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.2 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -140.41 77.23 1.59 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.711 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.4 158.58 0.12 Allowed Pre-proline 0 C--N 1.307 -1.27 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.515 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.6 Cg_endo -78.58 30.07 1.53 Allowed 'Cis proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.402 -1.083 . . . . 0.0 111.501 -6.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 8.1 m120 -145.89 -171.28 3.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -153.23 141.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 17.4 m -112.68 117.27 31.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.492 -1.683 . . . . 0.0 106.997 168.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.11 149.19 25.31 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.465 -172.099 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -122.15 174.52 3.21 Favored Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.9 Cg_endo -86.15 155.31 53.52 Favored 'Cis proline' 0 CA--C 1.505 -0.959 0 CA-C-O 122.854 1.106 . . . . 0.0 113.362 -1.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.266 -3.035 0 CA-C-N 111.876 -2.42 . . . . 0.0 109.795 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.504 2.245 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.25 37.93 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 108.564 -1.36 . . . . 0.0 108.564 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.56 124.86 28.6 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -174.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.61 163.18 26.47 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.806 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -100.82 -179.54 4.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.73 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' LYS . 88.7 p -70.96 122.02 19.21 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.47 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.93 -15.59 1.24 Allowed Glycine 0 C--N 1.296 -1.659 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.585 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' SER . 47.6 mttt -106.8 117.01 57.81 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.758 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -77.13 -161.75 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.929 1.086 . . . . 0.0 109.287 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.91 -111.16 3.77 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.232 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.632 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -157.98 157.46 33.07 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.434 -1.306 . . . . 0.0 112.523 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.75 147.5 18.96 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.37 128.24 33.36 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.527 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 40.7 tp -87.51 109.49 19.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.021 -1.472 . . . . 0.0 111.984 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.68 ' HB2' HG23 ' A' ' 38' ' ' ILE . 65.4 m95 -98.16 179.2 4.83 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.844 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.734 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -103.59 -160.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.162 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.389 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.485 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.86 71.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.337 1.541 . . . . 0.0 108.329 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ILE . 12.1 mtp85 -114.12 131.75 56.3 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.197 -2.274 . . . . 0.0 111.236 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.22 86.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.302 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 163.25 37.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.966 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.29 160.26 73.43 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.1 Cg_exo -51.57 92.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 120.792 0.995 . . . . 0.0 111.008 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' CYS . . . -7.91 -32.07 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 1 N-CA-C 132.796 7.878 . . . . 0.0 132.796 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -134.9 43.09 1.28 Allowed Glycine 0 N--CA 1.499 2.843 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.311 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.85 -164.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.417 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.05 -1.61 56.64 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.654 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 m-85 -86.1 169.25 13.31 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 123.129 1.442 . . . . 0.0 113.338 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -160.79 -43.66 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.732 175.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 41' ' ' TYR . 5.1 p -97.94 138.08 35.81 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.594 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.23 151.02 20.6 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.918 176.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.2 p -113.09 142.38 45.81 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.834 176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.768 ' CE2' HD12 ' A' ' 38' ' ' ILE . 18.5 m-85 -114.28 128.96 56.61 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.869 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.539 ' NZ ' ' SG ' ' A' ' 4' ' ' CYS . 12.9 mttt -126.09 67.68 1.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.241 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.448 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 40.2 t-105 -36.55 144.87 0.26 Allowed Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.328 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 2.2 Cg_endo -77.6 35.48 0.59 Allowed 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 125.801 -0.5 . . . . 0.0 112.399 -5.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.8 m120 -145.73 -160.13 1.1 Allowed 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.339 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.768 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -166.37 144.94 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.037 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.416 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.5 m -112.8 147.03 37.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 3.0 t -115.15 143.88 44.54 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.613 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -113.73 -177.22 0.42 Allowed Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.541 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 5.5 Cg_exo -62.84 -51.0 0.16 OUTLIER 'Cis proline' 0 N--CA 1.506 2.22 0 CA-C-N 121.866 1.702 . . . . 0.0 115.907 6.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.632 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.754 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.358 -171.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.504 2.262 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -87.67 38.62 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 N-CA-C 109.321 -1.069 . . . . 0.0 109.321 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.66 124.14 27.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.669 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.78 -176.48 4.96 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.109 -1.436 . . . . 0.0 110.132 -176.068 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.17 -173.91 4.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.037 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -68.85 118.18 11.47 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.616 -176.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.47 -12.62 1.84 Allowed Glycine 0 C--N 1.297 -1.599 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.532 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.9 mttm -96.4 135.47 22.45 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.159 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 9' ' ' LYS . 11.3 Cg_exo -47.14 -169.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.212 1.941 . . . . 0.0 113.875 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.09 32.36 0.25 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 114.297 -1.32 . . . . 0.0 113.959 -174.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.84 137.87 7.83 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 116.294 -2.162 . . . . 0.0 115.352 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -151.08 160.92 28.88 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.75 122.07 26.13 Favored 'General case' 0 C--O 1.18 -2.587 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.186 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 4.0 tt -89.18 118.3 28.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 117.624 -1.631 . . . . 0.0 111.711 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.658 ' CB ' HG23 ' A' ' 38' ' ' ILE . 57.0 m95 -103.41 170.99 7.62 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.351 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.817 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -96.16 -157.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.744 -175.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.805 ' H ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.94 67.57 0.15 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.363 1.554 . . . . 0.0 108.4 -177.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.7 mtt-85 -116.07 100.3 7.85 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.151 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -41.68 -26.48 0.26 Allowed Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.701 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -147.21 160.47 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.147 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -87.13 150.17 49.03 Favored Pre-proline 0 C--N 1.292 -1.9 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.086 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.44 163.54 17.55 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 110.888 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.26 -10.75 47.41 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.84 -26.73 67.43 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.726 -1.226 . . . . 0.0 111.155 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -87.35 -32.95 19.35 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.874 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.56 16.32 29.5 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.813 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 58.8 m-85 -53.97 173.47 0.06 Allowed 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.954 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.0 p -161.33 -46.48 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 112.909 -1.95 . . . . 0.0 106.083 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.84 120.06 38.64 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.646 -2.07 . . . . 0.0 109.312 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.36 148.39 30.32 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.023 -1.471 . . . . 0.0 112.618 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 143.94 40.3 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.553 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.796 ' CE2' HD12 ' A' ' 38' ' ' ILE . 24.7 m-85 -113.3 137.23 51.8 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.307 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.598 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 11.0 mmtt -121.46 70.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.424 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -40.03 140.84 0.86 Allowed Pre-proline 0 C--N 1.294 -1.822 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.091 -176.205 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -72.67 -22.77 11.79 Favored 'Cis proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.743 -4.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.453 ' ND2' ' CD1' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -78.63 -161.38 0.28 Allowed 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 -176.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.796 HD12 ' CE2' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -164.7 154.19 2.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.873 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.8 m -124.66 127.15 46.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.539 164.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -96.53 153.9 17.58 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -172.102 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.562 ' O ' ' O ' ' A' ' 30' ' ' SER . 4.6 m-85 -127.66 165.72 28.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.75 159.21 91.74 Favored 'Cis proline' 0 C--N 1.323 -0.805 0 CA-C-O 122.783 1.076 . . . . 0.0 114.47 1.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.596 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.387 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.259 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.509 2.49 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -87.12 34.75 0.44 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.35 -1.442 . . . . 0.0 108.35 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -74.77 116.33 15.36 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.219 -174.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.6 164.12 24.92 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 117.588 -1.645 . . . . 0.0 108.87 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.58 -178.94 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.36 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 99.9 p -76.99 124.12 27.31 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.143 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.25 -13.16 28.38 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.478 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -115.5 108.9 46.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.981 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.32 -154.21 0.04 OUTLIER 'Trans proline' 0 C--O 1.208 -0.976 0 N-CA-C 109.033 -1.179 . . . . 0.0 109.033 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 -108.92 2.63 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 119.254 -1.45 . . . . 0.0 111.507 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.714 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -160.16 168.63 25.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 118.923 -1.111 . . . . 0.0 113.023 -176.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.7 146.49 18.05 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.444 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -79.48 118.07 21.01 Favored 'General case' 0 C--O 1.171 -3.058 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.115 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 18.1 tp -85.76 92.6 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.526 -1.67 . . . . 0.0 113.723 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.81 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.3 m95 -75.53 126.27 30.67 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.801 -1.999 . . . . 0.0 107.744 172.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -94.88 -7.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.135 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -170.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mt -153.13 73.39 0.99 Allowed 'General case' 0 C--N 1.253 -3.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.469 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -166.16 148.59 7.06 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 116.637 -2.025 . . . . 0.0 113.204 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.08 -13.22 27.62 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -142.87 153.96 43.66 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.235 -0.982 . . . . 0.0 109.22 177.276 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -95.51 152.52 39.29 Favored Pre-proline 0 C--N 1.288 -2.085 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.832 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.83 -170.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.221 1.281 . . . . 0.0 111.651 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.77 -19.27 3.4 Favored Glycine 0 N--CA 1.489 2.212 1 N-CA-C 129.221 6.448 . . . . 0.0 129.221 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.75 4.57 68.91 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -79.35 -56.61 4.21 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.467 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.8 7.05 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.82 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' O ' HG23 ' A' ' 29' ' ' THR . 34.1 m-85 -76.54 165.77 24.32 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 123.016 1.388 . . . . 0.0 112.769 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.6 p -163.32 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 111.757 -2.474 . . . . 0.0 106.005 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' TYR . 13.9 p -98.7 124.26 43.42 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.378 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -153.63 157.1 39.13 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.816 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 147.81 39.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.62 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CE2' HD12 ' A' ' 38' ' ' ILE . 13.1 m-85 -124.31 139.3 54.04 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.539 -172.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 73.72 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.404 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.93 155.42 0.33 Allowed Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.175 -174.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 9.5 Cg_endo -74.87 10.25 8.54 Favored 'Cis proline' 0 N--CA 1.485 1.016 0 C-N-CA 124.293 -1.128 . . . . 0.0 111.142 -2.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.2 m-20 -111.49 -162.07 0.78 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.871 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.813 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -177.33 138.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.536 -178.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 29.0 m -108.21 113.35 26.4 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 117.698 -1.601 . . . . 0.0 106.939 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -93.22 130.72 38.82 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.921 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' CE2' ' O ' ' A' ' 12' ' ' ARG . 24.1 m-85 -106.89 -174.55 0.32 Allowed Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 35.9 Cg_exo -54.81 -49.01 0.14 OUTLIER 'Cis proline' 0 N--CA 1.501 1.913 0 CA-C-N 122.745 2.016 . . . . 0.0 116.727 5.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.714 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.742 0 CA-C-O 116.349 -1.786 . . . . 0.0 109.1 -172.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.508 2.471 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -84.33 20.36 1.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 N-CA-C 107.993 -1.579 . . . . 0.0 107.993 164.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.589 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -81.12 115.41 20.54 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.4 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.85 178.22 8.11 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.43 -174.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -176.91 3.24 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.839 0.828 . . . . 0.0 110.152 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 p -77.66 128.02 33.42 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.34 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.67 -9.19 11.35 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -119.81 108.62 38.76 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -73.95 -163.44 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 -110.45 3.74 Favored Glycine 0 C--N 1.282 -2.472 0 C-N-CA 118.535 -1.793 . . . . 0.0 110.65 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -163.11 164.7 25.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 117.812 -1.555 . . . . 0.0 114.012 -177.355 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.74 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -146.26 -170.3 14.76 Favored Glycine 0 N--CA 1.502 3.053 1 N-CA-C 127.074 5.59 . . . . 0.0 127.074 173.01 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -99.32 127.22 45.31 Favored 'General case' 0 C--O 1.182 -2.463 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.99 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 4.2 tp -102.0 97.1 7.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.922 1.344 . . . . 0.0 110.256 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.74 ' HB2' HG23 ' A' ' 38' ' ' ILE . 80.0 m95 -89.02 151.99 21.95 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.963 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.886 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.38 -157.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.653 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.4 -178.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -70.07 76.82 0.5 Allowed 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 123.627 1.68 . . . . 0.0 109.236 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 21' ' ' THR . 9.9 mtt180 -126.45 75.93 1.58 Allowed 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 110.987 -2.824 . . . . 0.0 110.715 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -17.54 -32.02 0.0 OUTLIER Glycine 0 N--CA 1.499 2.858 1 N-CA-C 126.665 5.426 . . . . 0.0 126.665 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -140.41 154.14 46.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.297 176.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -86.12 153.73 57.13 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.14 -178.505 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.81 172.22 4.99 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.157 1.238 . . . . 0.0 110.81 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.42 18.17 35.92 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.79 -13.63 25.19 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.662 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -90.28 1.93 56.0 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.824 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 -0.14 39.22 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.732 -1.223 . . . . 0.0 111.367 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.678 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.9 m-85 -54.83 169.97 0.19 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.787 1.279 . . . . 0.0 111.736 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.5 p -160.18 -44.82 0.05 OUTLIER 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 112.174 -2.285 . . . . 0.0 105.175 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 12.4 p -98.25 137.39 37.06 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 112.968 -1.924 . . . . 0.0 108.621 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.474 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.0 OUTLIER -155.16 148.98 25.51 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 117.707 -1.597 . . . . 0.0 113.116 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.425 ' O ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -93.43 158.34 15.77 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.852 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.5 m-85 -136.95 131.47 33.06 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.793 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 2.1 mttt -136.56 77.96 1.68 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.43 150.98 1.48 Allowed Pre-proline 0 C--N 1.293 -1.886 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.111 -177.112 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' LEU . 1.9 Cg_endo -69.17 -19.18 10.62 Favored 'Cis proline' 0 C--O 1.198 -1.499 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.285 -3.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.9 -169.44 2.64 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.852 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -149.22 144.74 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.652 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.3 m -117.21 116.52 27.44 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.731 -1.187 . . . . 0.0 107.902 171.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.678 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -97.46 155.0 17.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -131.35 173.13 6.23 Favored Pre-proline 0 N--CA 1.503 2.18 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.9 Cg_endo -88.65 156.05 37.77 Favored 'Cis proline' 0 C--O 1.214 -0.685 0 N-CA-C 115.764 1.409 . . . . 0.0 115.764 0.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 110.985 -2.825 . . . . 0.0 110.109 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 110.827 -0.064 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -76.6 52.67 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 N-CA-C 106.075 -2.317 . . . . 0.0 106.075 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -68.1 131.18 44.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.13 175.02 11.02 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.167 -1.413 . . . . 0.0 110.769 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -158.22 177.43 11.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.779 174.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.7 m -86.77 106.35 17.62 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.894 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.68 -17.78 8.21 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.5 mptt -134.42 136.83 26.52 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.126 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 9' ' ' LYS . 6.0 Cg_exo -50.52 -156.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.378 2.052 . . . . 0.0 114.033 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 31.8 0.1 OUTLIER Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HG2' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -161.34 137.26 8.01 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 115.775 -2.37 . . . . 0.0 116.071 175.28 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.63 -166.82 10.83 Favored Glycine 0 N--CA 1.509 3.546 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.733 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.8 m-20 -108.18 127.31 53.71 Favored 'General case' 0 C--O 1.181 -2.52 0 CA-C-O 118.27 -0.872 . . . . 0.0 109.203 176.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 2.6 tp -91.04 135.61 33.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.964 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.706 ' CB ' HG23 ' A' ' 38' ' ' ILE . 59.7 m95 -127.73 -176.17 3.69 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 111.434 -2.621 . . . . 0.0 108.949 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 18' ' ' LEU . 1.8 mt -105.02 -167.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -173.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.803 ' H ' HG22 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -68.03 68.98 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.978 1.371 . . . . 0.0 107.606 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.1 mtt-85 -116.75 125.45 51.67 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 112.223 -2.262 . . . . 0.0 110.4 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.27 69.61 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -142.98 160.72 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.768 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 158.01 42.77 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.268 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.07 125.56 15.49 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.3 1.333 . . . . 0.0 110.899 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 3.86 69.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.593 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.94 -12.73 58.73 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.56 -46.5 15.64 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.459 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.43 -7.89 5.31 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 29' ' ' THR . 42.9 m-85 -50.22 171.27 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.66 1.219 . . . . 0.0 111.187 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 28' ' ' TYR . 10.6 p -161.87 -45.6 0.04 OUTLIER 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 112.34 -2.209 . . . . 0.0 105.874 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.95 130.19 44.82 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.729 -2.032 . . . . 0.0 110.298 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -157.51 157.29 33.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 117.861 -1.536 . . . . 0.0 112.148 177.036 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 140.02 53.18 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.592 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.747 ' CE2' HD12 ' A' ' 38' ' ' ILE . 22.4 m-85 -112.88 136.47 52.49 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.731 -173.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -142.76 75.5 1.49 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.257 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.523 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -45.51 156.79 0.4 Allowed Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.106 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.7 Cg_endo -78.91 30.72 1.47 Allowed 'Cis proline' 0 C--O 1.194 -1.68 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.196 -1.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.3 m120 -146.62 -168.68 3.09 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.173 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.747 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -152.62 149.03 13.85 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.024 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.115 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -119.84 120.06 35.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.555 167.42 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -91.11 157.57 17.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.254 -171.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' O ' ' O ' ' A' ' 30' ' ' SER . 15.4 m-85 -133.24 167.62 22.04 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.71 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.46 160.93 95.49 Favored 'Cis proline' 0 C--O 1.213 -0.736 0 CA-C-O 122.591 0.996 . . . . 0.0 113.585 0.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.48 ' CE1' ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.579 -2.101 . . . . 0.0 109.859 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -85.76 28.46 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 N-CA-C 106.996 -1.963 . . . . 0.0 106.996 164.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.8 p -88.51 116.58 26.85 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.407 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -177.1 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.803 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -119.79 -176.46 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.567 178.239 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.56 116.86 20.01 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.425 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.7 79.32 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.435 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mppp? -119.74 117.96 32.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.503 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.44 178.58 7.24 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 121.236 1.291 . . . . 0.0 109.821 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.52 -100.19 2.12 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.409 -1.377 . . . . 0.0 111.294 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.1 ptm180 -162.03 178.23 9.02 Favored 'General case' 0 C--O 1.209 -1.078 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.364 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -162.57 165.34 36.15 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 175.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -87.19 132.25 33.93 Favored 'General case' 0 C--O 1.18 -2.553 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.34 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 10.7 tp -97.18 100.07 11.54 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.647 1.213 . . . . 0.0 111.802 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.665 ' HB2' HG23 ' A' ' 38' ' ' ILE . 67.0 m95 -93.01 160.88 14.67 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 112.515 -2.13 . . . . 0.0 110.831 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -84.45 -163.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.919 -176.155 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -68.39 71.77 0.19 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.74 1.257 . . . . 0.0 107.984 -176.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' THR . 38.8 mtt180 -122.08 86.8 2.64 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.765 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -22.23 -28.02 0.0 OUTLIER Glycine 0 N--CA 1.495 2.593 1 N-CA-C 125.837 5.095 . . . . 0.0 125.837 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' ARG . 1.4 p -150.01 151.35 33.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.04 -1.08 . . . . 0.0 109.866 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -85.72 151.57 55.58 Favored Pre-proline 0 C--N 1.289 -2.053 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.385 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.23 146.88 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.073 1.182 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.54 3.44 17.49 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.066 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.68 9.25 5.81 Favored Glycine 0 N--CA 1.491 2.32 1 N-CA-C 130.575 6.99 . . . . 0.0 130.575 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.67 14.94 8.96 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.45 79.82 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.382 -1.389 . . . . 0.0 111.619 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.623 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.7 m-85 -69.91 168.6 14.93 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.188 1.47 . . . . 0.0 113.492 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.6 p -161.57 -46.69 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 111.549 -2.569 . . . . 0.0 105.911 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 119.7 38.28 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.808 -1.996 . . . . 0.0 110.319 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -144.03 152.98 41.73 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.526 178.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -108.76 149.18 29.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.429 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.78 ' CE2' HD12 ' A' ' 38' ' ' ILE . 18.5 m-85 -125.98 134.35 51.52 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.962 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -151.53 76.57 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.603 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.479 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.65 156.65 0.19 Allowed Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.593 -178.109 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 5.8 Cg_endo -79.09 35.05 0.87 Allowed 'Cis proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.768 -0.93 . . . . 0.0 111.464 -5.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.3 m120 -149.03 -171.43 3.87 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.489 -1.284 . . . . 0.0 110.318 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.78 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -154.75 144.91 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.534 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -113.65 107.73 16.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.148 171.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.623 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -83.75 130.92 34.95 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.876 -173.245 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.608 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -103.97 -177.73 0.56 Allowed Pre-proline 0 N--CA 1.505 2.312 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 13.6 Cg_exo -63.11 -50.18 0.16 OUTLIER 'Cis proline' 0 N--CA 1.505 2.196 0 N-CA-C 117.449 2.057 . . . . 0.0 117.449 5.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.792 0 CA-C-O 116.239 -1.838 . . . . 0.0 109.167 -169.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.513 ' O ' ' NH2' ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -82.73 40.47 0.97 Allowed 'Trans proline' 0 CA--C 1.551 1.325 0 N-CA-C 108.634 -1.333 . . . . 0.0 108.634 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.612 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.79 128.99 34.1 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.17 169.51 18.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.422 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.68 178.3 7.33 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.504 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.31 128.02 33.08 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.277 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.71 -16.85 33.86 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.336 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 110.93 23.37 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.386 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -75.49 -179.73 5.38 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 N-CA-C 108.6 -1.346 . . . . 0.0 108.6 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.24 -99.38 2.5 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.814 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 2' ' ' ALA . 2.6 ptm180 -156.12 159.11 38.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.051 -175.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.26 148.42 20.04 Favored Glycine 0 N--CA 1.499 2.837 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.229 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 15.6 m-20 -78.57 124.07 27.76 Favored 'General case' 0 C--O 1.181 -2.552 0 C-N-CA 119.304 -0.959 . . . . 0.0 109.751 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 67.5 tp -83.8 132.74 34.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 117.683 -1.607 . . . . 0.0 110.355 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.68 ' HB2' HG23 ' A' ' 38' ' ' ILE . 53.5 m95 -124.94 167.55 14.53 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.493 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.653 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -90.92 -161.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 C-N-CA 118.109 -1.436 . . . . 0.0 112.639 -175.309 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.526 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.15 69.98 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.532 -176.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 6.0 mtp180 -110.4 119.83 40.48 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 112.109 -2.314 . . . . 0.0 111.803 -177.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.27 -46.93 51.39 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.305 -1.426 . . . . 0.0 109.595 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.93 156.93 48.02 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.212 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.16 160.94 67.11 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -51.09 110.9 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 120.971 1.114 . . . . 0.0 111.662 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -15.73 -113.18 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 1 N-CA-C 130.349 6.899 . . . . 0.0 130.349 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.41 46.62 3.52 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.384 -1.389 . . . . 0.0 109.787 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -83.67 -60.73 2.03 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.32 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -160.38 -27.24 0.02 OUTLIER Glycine 0 C--N 1.288 -2.099 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 48.5 m-85 -84.22 173.04 11.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 122.897 1.332 . . . . 0.0 112.666 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.47 -48.9 0.05 Allowed 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.014 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -100.23 111.3 23.57 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 113.138 -1.846 . . . . 0.0 109.607 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -137.83 143.67 41.1 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.471 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 140.58 38.33 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.802 ' CE2' HD12 ' A' ' 38' ' ' ILE . 28.6 m-85 -115.94 149.27 39.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.203 -173.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.03 81.99 0.71 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.68 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.461 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.51 158.56 0.27 Allowed Pre-proline 0 C--N 1.307 -1.26 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.37 -177.314 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.2 Cg_endo -79.52 33.58 1.24 Allowed 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.44 -1.067 . . . . 0.0 111.456 -5.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.461 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 8.7 m120 -147.92 -160.2 1.13 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.916 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -164.5 137.62 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.113 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.496 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.7 m -108.87 115.47 30.14 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 116.763 -1.975 . . . . 0.0 107.029 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -86.59 148.29 25.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 113.564 -1.653 . . . . 0.0 113.28 -171.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -125.79 168.41 14.0 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -84.32 156.87 68.17 Favored 'Cis proline' 0 N--CA 1.454 -0.849 0 CA-C-O 122.939 1.141 . . . . 0.0 114.062 4.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.625 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.428 175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -92.43 51.49 0.55 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 O-C-N 122.621 0.8 . . . . 0.0 110.664 167.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -88.97 136.25 33.11 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.775 -1.57 . . . . 0.0 107.731 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.4 174.2 11.81 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.837 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -126.4 179.8 5.12 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.708 0.766 . . . . 0.0 109.845 177.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 m -76.86 128.41 34.52 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.455 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.39 27.34 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.846 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -125.28 99.3 34.03 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.51 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.98 155.91 47.83 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 N-CA-C 108.586 -1.351 . . . . 0.0 108.586 173.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.93 -97.62 0.51 Allowed Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.171 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.33 157.46 28.0 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 118.186 -1.405 . . . . 0.0 113.294 -178.62 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -150.82 162.28 29.32 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 77.6 m-20 -78.03 125.2 29.0 Favored 'General case' 0 C--O 1.184 -2.364 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.6 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 8.4 tt -91.06 109.89 21.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.557 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.709 ' CB ' HG23 ' A' ' 38' ' ' ILE . 63.2 m95 -91.56 161.69 14.84 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.931 -2.395 . . . . 0.0 109.052 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.763 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -81.15 -157.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 119.416 -0.913 . . . . 0.0 112.022 -176.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.07 67.01 0.11 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.359 1.552 . . . . 0.0 107.244 -178.498 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -113.86 111.44 21.73 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 112.065 -2.334 . . . . 0.0 110.284 -178.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.12 -20.83 65.34 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.341 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.42 152.58 44.4 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.195 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -94.7 155.08 39.78 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.599 179.144 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -66.91 143.06 64.92 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.037 1.158 . . . . 0.0 110.985 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.22 2.83 87.35 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.81 -22.13 53.94 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.34 -16.98 55.44 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.675 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.39 0.4 73.34 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.093 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.651 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 49.0 m-85 -54.34 161.74 1.28 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.29 -1.364 . . . . 0.0 111.542 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.5 p -146.2 -48.44 0.21 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 112.076 -2.329 . . . . 0.0 105.891 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -100.06 116.43 32.07 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.254 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -139.14 149.18 44.19 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.787 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.6 p -106.05 141.53 37.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CD2' HD12 ' A' ' 38' ' ' ILE . 17.7 m-85 -119.97 138.95 53.17 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.147 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 80.5 0.95 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -44.39 158.4 0.27 Allowed Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.731 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 2.8 Cg_endo -78.04 28.75 1.61 Allowed 'Cis proline' 0 C--O 1.211 -0.857 0 C-N-CA 124.492 -1.045 . . . . 0.0 111.945 -5.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.9 m120 -144.44 179.44 7.26 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.232 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.813 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -145.96 148.44 17.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -122.22 123.37 41.32 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 117.343 -1.743 . . . . 0.0 107.856 167.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.651 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.74 147.09 23.15 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.839 -171.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -121.85 169.32 9.55 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.84 157.62 80.48 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 CA-C-O 123.133 1.222 . . . . 0.0 114.553 3.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.72 0 CA-C-N 111.455 -2.612 . . . . 0.0 110.161 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.03 58.75 5.64 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 N-CA-C 107.234 -1.872 . . . . 0.0 107.234 168.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.33 136.92 39.56 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.3 m-85 -77.96 163.04 26.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.221 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.507 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -104.65 -173.87 2.41 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.659 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.55 122.86 21.24 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.166 -177.39 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.82 -3.34 0.99 Allowed Glycine 0 N--CA 1.48 1.595 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.819 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 7' ' ' SER . 11.2 mttm -107.69 108.59 61.72 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.474 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.22 -173.81 1.21 Allowed 'Trans proline' 0 C--N 1.324 -0.716 0 C-N-CA 120.807 1.004 . . . . 0.0 109.615 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 93.81 -115.26 4.93 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.418 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.41 160.93 32.83 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.216 -1.393 . . . . 0.0 113.471 -178.305 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.82 148.57 20.28 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 9.6 m-20 -76.53 126.7 31.44 Favored 'General case' 0 C--O 1.171 -3.068 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.599 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 10.7 tp -83.11 104.8 13.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.282 -1.767 . . . . 0.0 111.703 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.689 ' HB2' HG23 ' A' ' 38' ' ' ILE . 62.6 m95 -87.56 167.14 14.2 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.466 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -88.58 -161.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.026 -177.184 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.46 73.57 0.15 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.1 1.428 . . . . 0.0 108.599 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 17' ' ' ILE . 23.8 mtp85 -112.83 143.76 43.54 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 112.235 -2.257 . . . . 0.0 111.203 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 21' ' ' THR . . . -80.16 -20.64 66.86 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -156.47 157.19 35.05 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.857 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.87 148.12 71.72 Favored Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.44 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 22' ' ' CYS . 5.8 Cg_exo -53.67 -173.94 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 120.685 0.923 . . . . 0.0 111.054 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.52 -11.39 6.65 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 129.314 6.486 . . . . 0.0 129.314 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.89 19.32 55.23 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.61 -73.76 0.61 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.264 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.73 3.43 0.16 Allowed Glycine 0 N--CA 1.488 2.167 0 C-N-CA 118.974 -1.584 . . . . 0.0 112.418 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.3 m-85 -63.93 171.58 2.76 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.808 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -161.99 -44.86 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 112.592 -2.095 . . . . 0.0 106.433 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 41' ' ' TYR . 4.0 p -99.06 121.66 41.28 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.961 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -146.66 150.81 36.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.109 -1.436 . . . . 0.0 113.197 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.36 147.18 31.91 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.523 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.771 ' CE2' HD12 ' A' ' 38' ' ' ILE . 13.1 m-85 -121.32 136.01 55.02 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.654 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 4.6 mttp -138.35 63.64 1.52 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.572 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.483 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 27.5 t-105 -32.76 145.77 0.1 Allowed Pre-proline 0 N--CA 1.507 2.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.211 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.3 Cg_endo -78.62 40.41 0.4 Allowed 'Cis proline' 0 N--CA 1.499 1.81 0 C-N-CA 125.768 -0.513 . . . . 0.0 111.269 -5.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.483 ' H ' ' CA ' ' A' ' 35' ' ' TRP . 1.6 m120 -148.91 -163.53 1.81 Allowed 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.974 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -166.25 147.2 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.801 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -121.21 131.69 54.38 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 118.076 -1.45 . . . . 0.0 107.888 167.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -101.64 146.94 27.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.527 -1.215 . . . . 0.0 114.27 -168.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -116.51 -179.17 0.59 Allowed Pre-proline 0 N--CA 1.513 2.711 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.0 Cg_exo -63.8 -50.96 0.16 OUTLIER 'Cis proline' 0 N--CA 1.503 2.031 0 CA-C-N 122.117 1.792 . . . . 0.0 116.7 6.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.956 0 CA-C-O 116.356 -1.783 . . . . 0.0 109.24 -171.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.513 2.697 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.43 32.55 0.27 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 N-CA-C 108.804 -1.268 . . . . 0.0 108.804 165.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.78 141.86 33.13 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.227 -174.132 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -89.98 171.32 9.65 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.6 -179.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -115.45 -175.66 2.76 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.11 178.182 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.13 115.09 17.6 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.811 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.47 64.3 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.625 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.92 114.27 46.59 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.067 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -77.03 166.65 26.38 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 N-CA-C 108.277 -1.47 . . . . 0.0 108.277 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.41 -106.18 2.4 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.233 -1.46 . . . . 0.0 111.069 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.66 165.04 31.27 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.105 -1.438 . . . . 0.0 113.903 -177.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.5 -174.7 15.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -104.51 111.86 24.7 Favored 'General case' 0 C--O 1.173 -2.952 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.448 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 23.2 tp -82.9 94.22 7.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 116.89 -1.924 . . . . 0.0 112.954 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 38' ' ' ILE . 73.0 m95 -70.19 111.9 6.15 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 112.458 -2.156 . . . . 0.0 105.859 169.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.31 -10.0 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.979 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -169.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mt -151.05 78.39 1.29 Allowed 'General case' 0 C--N 1.249 -3.796 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.786 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -175.99 166.61 3.0 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 117.641 -1.624 . . . . 0.0 112.209 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.87 -24.26 4.34 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -130.24 152.23 49.89 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.0 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.609 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -88.19 147.91 41.53 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.682 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -59.45 103.57 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.57 0.846 . . . . 0.0 110.597 -176.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 7.79 -93.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.931 1 N-CA-C 130.684 7.033 . . . . 0.0 130.684 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.32 46.04 1.71 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.299 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -79.31 0.66 27.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.577 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.0 27.94 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.1 m-85 -76.41 164.08 26.34 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 122.909 1.338 . . . . 0.0 112.588 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -162.72 -42.84 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.643 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.28 115.03 26.89 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.374 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.33 151.68 37.91 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.309 -1.357 . . . . 0.0 112.994 -177.288 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.91 144.91 32.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.821 ' CE2' HD12 ' A' ' 38' ' ' ILE . 15.9 m-85 -120.03 129.2 54.13 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.683 -173.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -135.93 73.17 1.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.413 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -48.41 154.7 1.07 Allowed Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.28 -175.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -70.96 7.7 3.85 Favored 'Cis proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.105 -1.206 . . . . 0.0 110.901 -5.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' C ' HG22 ' A' ' 38' ' ' ILE . 4.6 m-80 -104.37 -164.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.948 0.88 . . . . 0.0 111.357 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.821 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -177.34 135.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 7.5 m -105.69 113.26 26.72 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 117.807 -1.557 . . . . 0.0 107.625 171.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -91.52 133.25 35.67 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.001 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -110.51 168.38 7.7 Favored Pre-proline 0 N--CA 1.512 2.671 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.324 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 10.8 Cg_endo -83.81 158.79 71.53 Favored 'Cis proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.05 1.187 . . . . 0.0 114.678 2.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.449 0 CA-C-N 111.741 -2.481 . . . . 0.0 109.763 175.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -82.27 36.35 0.62 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 107.701 -1.692 . . . . 0.0 107.701 165.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.24 125.38 29.05 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.385 -174.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -81.6 -175.86 5.75 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 117.896 -1.522 . . . . 0.0 109.388 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -172.14 3.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.669 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -69.82 134.05 48.09 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.507 -176.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.94 -1.76 0.2 Allowed Glycine 0 N--CA 1.482 1.7 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.779 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 7' ' ' SER . 19.0 mttm -121.8 102.54 41.31 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.313 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -170.99 0.59 Allowed 'Trans proline' 0 C--O 1.21 -0.885 0 C-N-CA 121.263 1.309 . . . . 0.0 109.252 175.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 -106.13 3.27 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.726 -1.702 . . . . 0.0 111.323 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 1.2 ptm180 -161.55 165.93 27.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.881 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -146.4 146.13 15.82 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -78.19 118.49 20.47 Favored 'General case' 0 C--O 1.173 -2.933 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.178 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 50.4 tp -81.3 129.5 34.64 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 116.938 -1.905 . . . . 0.0 110.683 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.82 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.9 m95 -117.96 122.01 42.15 Favored 'General case' 0 C--N 1.263 -3.172 0 CA-C-N 111.902 -2.408 . . . . 0.0 105.444 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.651 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -84.64 -12.68 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 mt -152.36 66.86 0.83 Allowed 'General case' 0 C--N 1.246 -3.901 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.226 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.439 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -143.32 123.26 13.52 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.215 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.04 -36.41 31.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.86 155.4 49.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.75 153.38 67.51 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.579 -177.191 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -67.53 -164.73 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.481 1.454 . . . . 0.0 111.684 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -132.98 -18.17 1.1 Allowed Glycine 0 N--CA 1.489 2.206 1 N-CA-C 130.631 7.012 . . . . 0.0 130.631 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.85 47.0 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.326 -1.416 . . . . 0.0 109.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -83.2 -91.06 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.45 25.03 0.02 OUTLIER Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.275 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.4 m-85 -69.27 171.86 7.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.598 1.189 . . . . 0.0 111.099 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 28' ' ' TYR . 4.6 p -162.65 -45.83 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.373 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 125.76 44.72 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.302 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -156.47 149.88 24.48 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 117.534 -1.666 . . . . 0.0 113.369 177.565 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.54 143.96 40.12 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.529 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.782 ' CE2' HD12 ' A' ' 38' ' ' ILE . 57.7 m-85 -111.36 138.01 48.4 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.235 -0.986 . . . . 0.0 113.026 -172.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 35' ' ' TRP . 11.5 mmtm -135.02 60.21 1.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.406 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -41.63 148.58 0.44 Allowed Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.619 -175.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -71.75 -3.81 11.35 Favored 'Cis proline' 0 C--O 1.211 -0.863 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.032 -1.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' HG23 ' A' ' 17' ' ' ILE . 1.6 m120 -99.22 -160.32 0.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.803 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.82 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 178.56 136.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.19 -2.07 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.177 -178.186 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 33.9 m -105.3 117.36 33.81 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.231 -1.787 . . . . 0.0 107.021 171.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -98.48 126.32 43.98 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.535 -170.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 15.7 m-85 -98.5 -172.66 0.28 Allowed Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 16.1 Cg_exo -56.31 -52.11 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 123.206 2.181 . . . . 0.0 115.948 5.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.612 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 116.332 -1.794 . . . . 0.0 109.221 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -85.71 33.74 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 108.516 -1.378 . . . . 0.0 108.516 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.8 136.18 36.66 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -176.256 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.1 -175.83 4.79 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.125 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -128.62 -171.89 2.58 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.291 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -70.71 114.29 8.65 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.78 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.44 1.12 4.11 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.092 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.2 mptm? -103.55 151.15 38.66 Favored Pre-proline 0 N--CA 1.498 1.934 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.192 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 9' ' ' LYS . 17.1 Cg_exo -38.88 177.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.779 2.986 . . . . 0.0 115.051 -173.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.06 31.37 0.65 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.909 -1.496 . . . . 0.0 114.911 -172.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -161.21 142.78 11.77 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 115.884 -2.327 . . . . 0.0 114.754 175.191 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -161.88 152.41 22.82 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.947 174.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 118.37 19.27 Favored 'General case' 0 C--O 1.174 -2.91 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.572 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.616 ' H ' ' HB3' ' A' ' 2' ' ' ALA . 7.2 tt -87.63 94.98 9.89 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.141 -1.824 . . . . 0.0 112.341 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.809 ' HB2' HG23 ' A' ' 38' ' ' ILE . 66.5 m95 -70.56 127.65 33.41 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.307 -2.224 . . . . 0.0 107.464 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.575 HG23 ' ND2' ' A' ' 37' ' ' ASN . 1.2 mp -93.81 -10.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -169.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -153.74 76.43 1.07 Allowed 'General case' 0 C--N 1.247 -3.872 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.477 -174.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -161.69 129.32 4.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 117.239 -1.784 . . . . 0.0 112.737 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.49 -18.74 65.62 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 175.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -142.61 154.66 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.582 -0.809 . . . . 0.0 109.242 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 156.66 39.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.628 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -61.94 -172.99 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 121.163 1.242 . . . . 0.0 111.509 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.91 -5.24 4.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.28 -18.16 47.21 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.438 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.74 -31.21 41.04 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.48 7.01 30.67 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.556 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.9 m-85 -66.03 167.86 9.19 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.591 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 28' ' ' TYR . 8.6 p -161.12 -44.14 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.386 -2.188 . . . . 0.0 105.953 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.22 124.86 41.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.819 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -157.09 158.6 36.7 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.112 -1.435 . . . . 0.0 112.699 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.1 p -115.82 140.64 49.02 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.29 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.692 ' CE2' HD12 ' A' ' 38' ' ' ILE . 35.9 m-85 -108.77 131.76 54.64 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.643 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 30.4 mmtm -131.57 67.65 1.51 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.415 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -45.09 149.24 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.573 -175.065 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.5 Cg_endo -71.68 -5.12 12.16 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.017 -5.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.575 ' ND2' HG23 ' A' ' 17' ' ' ILE . 1.6 m120 -92.68 -161.91 0.88 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.867 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.809 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 176.21 143.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.46 -177.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 71.2 m -112.38 125.41 54.17 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.016 169.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -105.02 138.08 41.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.525 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' CE2' ' ND1' ' A' ' 43' ' ' HIS . 2.2 m-85 -108.16 -178.96 0.62 Allowed Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.6 Cg_exo -58.37 -55.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.507 2.322 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 5.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.672 0 CA-C-O 116.377 -1.773 . . . . 0.0 109.133 -171.012 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.581 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.501 2.121 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -84.93 34.31 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.644 0.896 . . . . 0.0 109.94 168.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.18 123.31 26.75 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.392 -176.044 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -79.31 164.68 23.9 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.551 -1.26 . . . . 0.0 110.083 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 179.22 6.5 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.107 0.956 . . . . 0.0 111.281 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.25 133.23 38.9 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.522 -177.449 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.86 -17.03 28.79 Favored Glycine 0 C--N 1.296 -1.644 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.711 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.94 114.27 10.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -73.72 -160.89 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 N-CA-C 108.627 -1.336 . . . . 0.0 108.627 172.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 79.52 -106.87 2.47 Favored Glycine 0 C--N 1.288 -2.12 0 C-N-CA 118.809 -1.662 . . . . 0.0 111.229 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.642 HH21 ' HB2' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -157.14 158.85 37.08 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.273 -176.686 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.22 161.75 24.97 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 174.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -79.25 128.67 33.6 Favored 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.35 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 16.6 tp -92.4 108.0 19.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.691 1.234 . . . . 0.0 111.958 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.642 ' CB ' HG23 ' A' ' 38' ' ' ILE . 64.8 m95 -99.82 150.38 22.41 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 112.546 -2.115 . . . . 0.0 109.709 177.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -81.22 -155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.341 -177.581 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.75 72.94 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.212 1.482 . . . . 0.0 108.272 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 17' ' ' ILE . 10.5 mtp85 -114.53 103.94 11.52 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.449 179.238 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.99 -27.77 14.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.219 -1.467 . . . . 0.0 109.884 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 157.39 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.75 159.89 70.49 Favored Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.647 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -50.46 168.87 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.071 1.181 . . . . 0.0 110.948 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.02 140.62 15.13 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.845 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.36 85.8 Favored Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.513 -1.327 . . . . 0.0 111.074 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -171.58 2.8 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.696 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.46 6.67 71.38 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.055 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.3 m-85 -86.96 168.02 13.74 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 118.373 -1.331 . . . . 0.0 112.334 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -160.81 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 111.961 -2.382 . . . . 0.0 105.697 177.492 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.33 117.02 32.85 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.534 179.338 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -143.07 153.3 42.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.742 -179.864 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 140.77 47.66 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.222 177.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' CE2' HD12 ' A' ' 38' ' ' ILE . 34.8 m-85 -117.38 142.64 46.86 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.371 -172.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.22 81.25 0.69 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.662 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.532 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -51.06 158.79 1.13 Allowed Pre-proline 0 C--N 1.308 -1.208 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.727 -176.895 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.0 Cg_endo -79.83 33.18 1.43 Allowed 'Cis proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.12 -1.2 . . . . 0.0 111.826 -2.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.532 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 4.3 m120 -145.29 -166.12 2.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.403 176.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -165.98 144.92 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.14 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 3.4 m -115.55 122.16 44.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.048 -1.861 . . . . 0.0 107.289 167.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.49 135.81 33.74 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.865 -172.525 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -105.92 167.19 10.02 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.444 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' A' ' 41' ' ' TYR . 14.3 Cg_endo -86.98 158.66 50.13 Favored 'Cis proline' 0 C--O 1.214 -0.696 0 N-CA-C 115.068 1.142 . . . . 0.0 115.068 2.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.642 ' HB2' HH21 ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 111.926 -2.397 . . . . 0.0 109.508 174.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.02 35.55 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 167.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.06 122.38 20.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -175.081 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.43 178.71 6.97 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 117.558 -1.657 . . . . 0.0 108.863 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.491 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -130.96 -177.48 4.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.381 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -77.73 113.67 15.82 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.961 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.03 64.16 Favored Glycine 0 C--N 1.297 -1.612 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.379 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -119.51 107.07 41.42 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.696 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -72.42 174.15 12.04 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.161 1.24 . . . . 0.0 109.55 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.47 -99.72 1.97 Allowed Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.635 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.599 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -159.38 159.9 34.31 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.666 -176.268 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.44 143.86 12.93 Favored Glycine 0 C--N 1.288 -2.105 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 171.439 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -76.17 127.72 33.5 Favored 'General case' 0 C--O 1.17 -3.079 0 C-N-CA 118.994 -1.082 . . . . 0.0 108.359 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 117.49 23.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 117.542 -1.663 . . . . 0.0 112.139 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.641 ' CB ' HG23 ' A' ' 38' ' ' ILE . 62.8 m95 -111.1 159.69 17.58 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 112.225 -2.261 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -81.93 -163.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.701 -176.443 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.477 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.34 70.78 0.17 Allowed 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 123.181 1.467 . . . . 0.0 108.579 -175.748 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.9 mtp180 -105.74 141.54 37.0 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.997 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.85 -34.31 53.36 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.9 157.72 44.31 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.86 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.0 149.97 64.12 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.035 -179.629 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 144.47 97.47 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 121.006 1.137 . . . . 0.0 111.163 176.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.26 -15.34 72.05 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.089 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.77 -29.76 74.95 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -81.81 4.62 21.5 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.08 16.22 68.39 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.491 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 39.4 m-85 -66.07 169.56 6.75 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.126 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 p -162.15 -46.98 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.474 -2.148 . . . . 0.0 106.117 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 41' ' ' TYR . 33.3 p -98.02 118.21 34.12 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.219 -2.264 . . . . 0.0 110.378 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.408 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -153.77 158.4 40.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.931 -1.508 . . . . 0.0 112.998 179.04 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.43 148.43 45.12 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.312 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.699 ' CE2' HD12 ' A' ' 38' ' ' ILE . 12.2 m-85 -114.93 137.8 51.56 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.511 -171.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 mttp -138.49 73.69 1.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.145 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.491 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 6.9 t-105 -37.78 147.99 0.23 Allowed Pre-proline 0 N--CA 1.504 2.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.445 ' N ' ' CD1' ' A' ' 35' ' ' TRP . 2.4 Cg_endo -78.13 37.68 0.5 Allowed 'Cis proline' 0 N--CA 1.495 1.572 0 C-N-CA 124.976 -0.843 . . . . 0.0 110.87 -6.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.468 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 2.1 m120 -146.29 -155.91 0.66 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.259 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.699 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -170.86 141.72 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.299 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.179 179.185 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.2 m -110.63 144.74 39.07 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 167.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.9 t -117.74 135.42 54.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.545 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.6 m-85 -102.61 174.11 3.07 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 176.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.5 Cg_exo -55.19 -61.5 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.917 0 N-CA-C 117.209 1.965 . . . . 0.0 117.209 5.525 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.599 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.123 0 CA-C-O 116.438 -1.744 . . . . 0.0 109.879 -170.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.457 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.6 Cg_endo -86.1 23.97 0.79 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 N-CA-C 107.089 -1.927 . . . . 0.0 107.089 164.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.7 p -75.07 116.62 16.01 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-N 113.447 -1.706 . . . . 0.0 108.939 -177.081 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.13 179.44 6.85 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.92 -175.359 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -113.09 -173.71 2.31 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.345 177.63 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -75.14 120.37 20.55 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.041 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -8.52 51.1 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.763 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -115.82 100.99 54.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.701 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.56 152.22 37.96 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.188 1.259 . . . . 0.0 109.804 174.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.85 -93.33 0.3 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.929 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -162.05 159.21 25.99 Favored 'General case' 0 C--O 1.199 -1.588 0 C-N-CA 118.624 -1.231 . . . . 0.0 112.217 -178.532 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -153.51 151.18 22.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 174.083 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -78.42 128.08 33.1 Favored 'General case' 0 C--O 1.182 -2.46 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.166 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 12.6 tp -94.08 101.92 13.96 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.865 1.317 . . . . 0.0 111.717 -177.109 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.815 ' HB2' HG23 ' A' ' 38' ' ' ILE . 78.4 m95 -88.87 123.4 33.21 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 111.889 -2.414 . . . . 0.0 107.402 176.041 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.77 -16.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -170.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.8 mt -151.73 71.57 0.99 Allowed 'General case' 0 C--N 1.247 -3.86 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.907 -171.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -156.29 141.19 17.17 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 117.841 -1.544 . . . . 0.0 112.297 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.592 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -91.28 -19.48 41.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.16 43.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.718 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.18 162.07 63.01 Favored Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.948 -179.111 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 5.6 Cg_exo -52.29 114.51 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 121.489 1.459 . . . . 0.0 112.33 -171.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -0.94 65.6 0.0 OUTLIER Glycine 0 N--CA 1.488 2.123 1 N-CA-C 131.162 7.225 . . . . 0.0 131.162 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.11 48.8 71.53 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.033 -1.556 . . . . 0.0 110.365 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.61 -77.78 0.17 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.042 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.11 -23.19 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.504 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.0 m-85 -77.66 170.48 16.5 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.568 1.175 . . . . 0.0 112.337 -179.113 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.6 p -160.88 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 112.353 -2.203 . . . . 0.0 105.957 176.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -96.36 118.06 32.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.333 -179.909 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.56 149.62 29.4 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.031 -1.468 . . . . 0.0 113.185 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.6 p -103.4 142.74 33.72 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.017 175.459 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 38' ' ' ILE . 29.4 m-85 -117.12 134.79 54.34 Favored 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 119.267 -0.973 . . . . 0.0 112.479 -173.072 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -147.56 80.0 1.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.592 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -53.36 152.99 7.67 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.343 -175.437 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 5.2 Cg_endo -72.66 -6.9 15.96 Favored 'Cis proline' 0 C--O 1.208 -0.996 0 C-N-CA 124.197 -1.168 . . . . 0.0 110.451 -5.298 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.494 ' C ' HG22 ' A' ' 38' ' ' ILE . 1.6 m-80 -91.61 -165.15 1.29 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.284 1.04 . . . . 0.0 111.873 -178.021 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.815 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 179.42 142.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.005 -178.116 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 18.4 m -113.56 103.87 11.69 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.421 -1.312 . . . . 0.0 107.795 172.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -82.27 138.05 34.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.32 -1.309 . . . . 0.0 113.342 -172.673 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.567 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -109.73 -178.8 0.58 Allowed Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.781 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.1 Cg_exo -63.81 -50.48 0.17 OUTLIER 'Cis proline' 0 N--CA 1.507 2.287 0 N-CA-C 116.813 1.813 . . . . 0.0 116.813 5.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.589 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.752 0 CA-C-O 116.382 -1.771 . . . . 0.0 110.074 -171.236 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -84.26 29.64 0.54 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 106.586 -2.121 . . . . 0.0 106.586 165.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.598 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.2 p -92.0 117.3 29.69 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.237 -174.082 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 2.2 m-85 -78.06 172.46 13.49 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.398 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -108.78 -171.89 1.94 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.589 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -74.86 114.95 13.9 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.304 -1.358 . . . . 0.0 111.009 -177.693 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.88 3.52 60.0 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.414 178.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -113.05 113.64 49.24 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.093 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.28 -163.22 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.573 1.516 . . . . 0.0 111.664 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 69.22 -118.25 8.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.582 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.9 ptp180 -152.46 -171.52 3.96 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 118.398 -1.321 . . . . 0.0 112.133 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.73 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -152.02 155.95 26.42 Favored Glycine 0 C--N 1.273 -2.925 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 173.374 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -76.28 131.93 39.54 Favored 'General case' 0 C--O 1.176 -2.78 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.936 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 14.5 tp -92.3 110.16 21.55 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.908 1.337 . . . . 0.0 110.774 -177.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.703 ' HB2' HG23 ' A' ' 38' ' ' ILE . 66.0 m95 -106.84 160.0 15.83 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 112.068 -2.333 . . . . 0.0 109.875 -177.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -86.15 -161.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.788 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -67.96 72.95 0.18 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.413 1.577 . . . . 0.0 108.728 -175.706 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.8 mtp85 -110.86 125.75 53.95 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 111.952 -2.385 . . . . 0.0 109.877 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.25 -26.2 70.34 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 p -149.38 153.43 37.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.789 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -81.31 152.37 70.54 Favored Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.164 179.37 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 25' ' ' GLY . 2.7 Cg_exo -51.25 124.53 14.28 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 C-N-CA 121.015 1.143 . . . . 0.0 111.641 -178.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.74 25.23 2.54 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -133.7 -4.27 3.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.572 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -56.36 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.996 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.24 0.72 1.0 Allowed Glycine 0 C--N 1.288 -2.128 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.824 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.597 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 47.7 m-85 -68.62 170.68 8.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 122.569 1.176 . . . . 0.0 111.896 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -161.03 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.544 -2.117 . . . . 0.0 106.055 177.27 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -97.66 123.54 41.62 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.79 178.785 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.2 149.49 26.01 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.882 -1.527 . . . . 0.0 112.485 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 7.8 p -108.81 146.08 34.2 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.441 177.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.727 ' CE2' HD12 ' A' ' 38' ' ' ILE . 46.8 m-85 -123.01 133.89 54.34 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.22 -175.636 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.45 83.17 1.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.278 -0.873 . . . . 0.0 108.754 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.474 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.78 160.19 0.2 Allowed Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.949 -176.221 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 18' ' ' LEU . 8.2 Cg_endo -80.12 34.06 1.36 Allowed 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.21 -1.162 . . . . 0.0 110.435 -5.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.474 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 7.0 m-80 -147.15 -163.32 1.73 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.871 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.727 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -162.22 146.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.031 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.9 m -117.76 105.32 11.86 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.695 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -81.73 141.71 33.32 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.194 -172.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.3 m-85 -110.04 175.8 1.78 Allowed Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.4 Cg_exo -57.49 -58.45 0.04 OUTLIER 'Cis proline' 0 N--CA 1.506 2.215 0 N-CA-C 117.773 2.182 . . . . 0.0 117.773 6.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.179 0 CA-C-O 116.273 -1.823 . . . . 0.0 109.594 -169.728 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.506 2.328 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.55 37.03 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 N-CA-C 108.308 -1.458 . . . . 0.0 108.308 165.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.76 122.14 21.92 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.585 -174.5 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.44 174.03 12.01 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.241 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.41 179.99 6.47 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.012 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -71.75 134.55 46.28 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.534 -174.845 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.68 -12.23 0.53 Allowed Glycine 0 N--CA 1.478 1.464 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.767 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 mttt -113.05 105.86 55.36 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.102 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -72.09 154.58 57.4 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 173.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -105.06 1.25 Allowed Glycine 0 C--N 1.287 -2.152 1 N-CA-C 129.604 6.602 . . . . 0.0 129.604 -176.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.734 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 5.5 ptm180 -162.65 152.84 16.4 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.815 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.69 152.12 23.62 Favored Glycine 0 N--CA 1.493 2.472 1 N-CA-C 125.716 5.046 . . . . 0.0 125.716 171.961 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 4.8 m-20 -77.11 122.34 24.84 Favored 'General case' 0 C--O 1.171 -3.037 0 C-N-CA 118.015 -1.474 . . . . 0.0 109.709 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 20.3 tp -86.56 100.24 12.27 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.335 -178.518 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.674 ' CB ' HG23 ' A' ' 38' ' ' ILE . 61.5 m95 -87.59 165.11 15.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.406 177.627 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.635 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -90.86 -159.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.939 -176.824 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.05 70.27 0.15 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.202 1.477 . . . . 0.0 108.411 -176.073 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' ILE . 3.6 mtp180 -113.62 120.87 42.38 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 112.202 -2.272 . . . . 0.0 110.49 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -23.38 64.94 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.157 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 154.07 38.33 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.934 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.97 149.96 54.42 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.975 179.2 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.83 143.69 95.15 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.83 1.02 . . . . 0.0 110.815 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.23 -1.22 75.82 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.239 -1.457 . . . . 0.0 110.095 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.58 -14.68 70.1 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.15 -91.78 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.036 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.68 24.61 0.03 OUTLIER Glycine 0 C--N 1.29 -2.0 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.54 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.631 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.2 m-85 -86.37 170.11 12.31 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.921 1.343 . . . . 0.0 112.347 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.4 p -162.55 -44.44 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 112.041 -2.345 . . . . 0.0 105.849 176.49 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' TYR . 29.8 p -96.98 114.24 25.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.513 -2.131 . . . . 0.0 109.806 -179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.561 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.55 151.36 37.2 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.956 177.984 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.09 145.65 35.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.752 177.427 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.707 ' CE2' HD12 ' A' ' 38' ' ' ILE . 15.9 m-85 -118.23 125.91 51.1 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.86 -171.572 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 35' ' ' TRP . 25.8 mttt -127.04 70.55 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.612 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.43 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 31.7 t-105 -39.22 144.09 0.47 Allowed Pre-proline 0 C--N 1.296 -1.738 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.483 178.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 9.5 Cg_endo -79.39 39.35 0.57 Allowed 'Cis proline' 0 N--CA 1.494 1.514 0 C-N-CA 125.66 -0.558 . . . . 0.0 111.372 -5.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.457 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 2.3 m120 -149.31 -159.73 1.08 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.474 -1.291 . . . . 0.0 110.935 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.707 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -170.94 142.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.991 179.582 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 16.0 m -111.18 133.15 53.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.348 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -105.82 130.84 53.72 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -170.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -103.83 179.19 1.0 Allowed Pre-proline 0 N--CA 1.513 2.698 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 177.057 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.574 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.0 Cg_exo -59.11 -54.91 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.177 0 N-CA-C 117.217 1.968 . . . . 0.0 117.217 6.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.734 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.659 0 CA-C-O 116.373 -1.775 . . . . 0.0 109.247 -171.389 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 119.502 -0.285 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -80.32 59.49 7.46 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -74.8 142.42 44.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.569 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -78.44 169.14 18.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.369 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -114.0 -166.22 1.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 9' ' ' LYS . 3.0 t -62.27 110.39 1.62 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.671 -177.74 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.91 1.12 0.79 Allowed Glycine 0 N--CA 1.479 1.528 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.208 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 7' ' ' SER . 30.3 mttt -99.33 116.44 65.04 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.573 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 1.2 Cg_endo -70.76 -167.89 0.29 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 173.333 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.97 -119.53 5.46 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.615 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -162.0 159.56 26.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.585 -179.771 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.84 149.77 20.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 172.299 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 12.8 m-20 -77.03 125.84 29.98 Favored 'General case' 0 C--O 1.175 -2.854 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.186 -179.373 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 5.0 tp -83.23 106.42 15.0 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 117.056 -1.858 . . . . 0.0 111.793 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.718 ' HB2' HG23 ' A' ' 38' ' ' ILE . 53.4 m95 -90.48 171.53 9.36 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 111.723 -2.489 . . . . 0.0 110.374 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -88.94 -163.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.079 -178.867 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -68.06 72.31 0.18 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.945 1.355 . . . . 0.0 108.454 -176.197 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.8 mtp85 -113.1 111.1 21.54 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.356 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.49 -24.95 40.46 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.204 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 p -141.77 151.54 42.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.39 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.62 147.26 55.2 Favored Pre-proline 0 C--N 1.289 -2.051 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.387 -179.68 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.55 148.21 54.6 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 121.004 1.136 . . . . 0.0 111.737 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLY . . . -84.48 -33.05 20.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.997 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.97 -28.25 16.53 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.13 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.28 -25.93 42.39 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.733 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . 87.68 12.61 66.42 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.674 -1.25 . . . . 0.0 111.566 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 45.6 m-85 -57.9 172.56 0.39 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.636 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 28' ' ' TYR . 17.1 p -162.36 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.804 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.904 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.67 110.21 22.82 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.318 -177.592 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.08 156.11 40.38 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.339 -1.344 . . . . 0.0 112.778 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 p -112.17 146.81 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.738 176.514 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.802 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.1 m-85 -117.07 133.24 56.24 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.3 -0.96 . . . . 0.0 112.38 -174.044 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -134.82 70.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.588 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 11.8 t-105 -37.92 148.39 0.22 Allowed Pre-proline 0 N--CA 1.506 2.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.725 178.81 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.444 ' N ' ' CD1' ' A' ' 35' ' ' TRP . 6.2 Cg_endo -77.64 33.79 0.73 Allowed 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 125.613 -0.578 . . . . 0.0 111.095 -6.611 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.469 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.2 m120 -147.15 -167.16 2.7 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.22 178.932 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.01 153.32 4.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.904 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -125.2 130.8 52.84 Favored 'General case' 0 C--O 1.216 -0.707 0 C-N-CA 117.948 -1.501 . . . . 0.0 107.586 168.189 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -167.71 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -111.42 -178.07 0.51 Allowed Pre-proline 0 N--CA 1.51 2.566 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.175 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.539 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.9 Cg_exo -57.79 -54.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.506 2.258 0 CA-C-N 122.485 1.923 . . . . 0.0 117.027 4.302 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.483 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.71 -171.132 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.505 2.287 0 CA-C-O 119.774 -0.155 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -81.55 49.73 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 168.128 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.31 138.33 45.37 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.039 -1.064 . . . . 0.0 108.16 -172.762 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.499 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -78.65 175.66 10.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.07 -1.452 . . . . 0.0 109.831 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -111.78 -169.02 1.39 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.813 179.232 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.21 108.52 10.37 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.062 -178.342 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.97 89.14 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.683 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -115.52 113.41 42.92 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.054 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.58 -161.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.793 0 C-N-CA 120.904 1.069 . . . . 0.0 109.335 174.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.47 -109.11 2.77 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.911 178.176 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.627 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.14 177.01 10.07 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.658 -1.217 . . . . 0.0 113.423 -177.353 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.627 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -157.46 158.37 28.91 Favored Glycine 0 N--CA 1.503 3.151 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.3 m-20 -78.06 122.97 26.28 Favored 'General case' 0 C--O 1.177 -2.731 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.287 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 4.5 tt -91.53 99.64 12.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 117.397 -1.721 . . . . 0.0 113.14 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.792 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.3 m95 -75.72 122.68 24.37 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.0 174.339 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 17' ' ' ILE . 44.1 mt -89.96 -10.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.854 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.2 mt -150.14 71.23 1.06 Allowed 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.536 -171.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.93 158.38 10.58 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.093 178.422 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.96 -29.25 4.4 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -129.01 152.16 48.92 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.801 177.826 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.61 153.51 47.97 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.99 -179.09 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.2 -178.75 0.09 OUTLIER 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.513 1.475 . . . . 0.0 112.071 -175.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.76 12.6 10.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.191 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -108.44 -5.48 32.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.99 -28.43 14.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.137 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.74 54.46 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.717 -1.23 . . . . 0.0 111.51 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.629 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 47.0 m-85 -53.7 167.17 0.26 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.986 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.9 p -163.38 -43.27 0.03 OUTLIER 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.544 177.579 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -96.56 111.58 23.65 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.706 -2.043 . . . . 0.0 109.119 -179.575 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -150.96 146.9 26.56 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.751 -177.784 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.55 138.2 36.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.222 177.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.856 ' CD1' HD12 ' A' ' 38' ' ' ILE . 95.8 m-85 -118.35 134.38 55.1 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.861 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.2 82.38 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.506 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.47 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.21 158.85 0.43 Allowed Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.825 -176.417 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.3 Cg_endo -74.2 5.16 10.82 Favored 'Cis proline' 0 C--O 1.204 -1.206 0 C-N-CA 124.215 -1.161 . . . . 0.0 111.435 -3.526 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.2 m-20 -114.36 -162.93 0.84 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 122.195 0.997 . . . . 0.0 111.268 -176.46 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.856 HD12 ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -178.61 144.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.377 -179.538 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.22 111.86 19.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 117.469 -1.692 . . . . 0.0 108.049 170.029 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.629 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -82.87 148.17 27.87 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.211 -170.478 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.516 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER -124.06 168.71 12.09 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 178.114 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -77.39 157.6 96.12 Favored 'Cis proline' 0 C--N 1.325 -0.698 0 CA-C-O 122.88 1.117 . . . . 0.0 114.147 4.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.602 0 CA-C-N 111.981 -2.372 . . . . 0.0 109.711 175.571 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 15' ' ' LEU 0.255 . . . . . . . 0 N--CA 1.506 2.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.86 31.88 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.4 p -85.62 114.56 22.71 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.791 -176.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -77.76 175.41 9.99 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.493 -1.283 . . . . 0.0 110.274 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.7 m -113.24 -177.21 3.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.603 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.83 121.47 24.14 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.541 -178.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.93 60.88 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.49 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -123.65 113.6 28.79 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.801 -178.418 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -74.71 -164.39 0.22 Allowed 'Trans proline' 0 C--O 1.212 -0.795 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 173.087 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -99.75 2.59 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.31 177.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.622 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.93 161.61 31.73 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.267 -177.232 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -147.42 147.36 18.06 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 174.783 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 14.9 m-20 -79.62 121.7 25.61 Favored 'General case' 0 C--O 1.17 -3.125 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.008 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.658 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 15.5 tp -92.19 92.79 8.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.842 1.306 . . . . 0.0 112.86 -175.634 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 38' ' ' ILE . 68.6 m95 -74.14 120.12 19.28 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 112.165 -2.289 . . . . 0.0 108.196 174.209 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.506 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.3 mp -84.82 -11.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -171.504 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 mt -152.41 75.9 1.13 Allowed 'General case' 0 C--N 1.253 -3.59 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.672 -175.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -148.21 155.53 41.48 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.748 178.734 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.4 -26.71 4.16 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.67 151.49 45.97 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.303 175.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -91.36 138.1 25.73 Favored Pre-proline 0 C--N 1.288 -2.082 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.083 -178.781 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.76 152.22 75.68 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 121.035 1.157 . . . . 0.0 111.615 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.66 -16.24 46.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.24 -19.7 59.85 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.617 -1.277 . . . . 0.0 109.93 179.173 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.88 -60.51 2.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.958 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.75 13.07 0.64 Allowed Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 38.9 m-85 -72.78 170.22 15.07 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.874 1.321 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.1 p -161.97 -45.75 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 112.066 -2.333 . . . . 0.0 106.065 177.213 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 123.22 43.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.928 179.786 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -152.12 157.94 42.27 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 117.972 -1.491 . . . . 0.0 114.08 179.143 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.457 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 p -113.97 147.9 37.81 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.253 172.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.735 ' CE2' HD12 ' A' ' 38' ' ' ILE . 40.1 m-85 -116.69 136.83 52.64 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.295 -172.245 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' SG ' ' A' ' 32' ' ' CYS . 4.5 mttt -138.96 70.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.948 178.575 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.422 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -47.83 144.98 4.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.326 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 3.6 Cg_endo -70.57 -7.83 11.64 Favored 'Cis proline' 0 C--O 1.206 -1.105 0 C-N-CA 124.952 -0.853 . . . . 0.0 111.208 -4.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.513 ' C ' HG22 ' A' ' 38' ' ' ILE . 2.1 m120 -93.29 -164.93 1.24 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.297 -177.323 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -179.03 137.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.801 -179.097 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 50.5 m -107.08 105.56 15.63 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.278 174.827 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -91.27 130.26 37.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.969 -1.469 . . . . 0.0 114.17 -172.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.543 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -97.78 176.27 2.14 Favored Pre-proline 0 N--CA 1.511 2.611 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.095 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 11.7 Cg_exo -58.07 -57.16 0.08 OUTLIER 'Cis proline' 0 N--CA 1.503 2.056 0 N-CA-C 117.339 2.015 . . . . 0.0 117.339 7.172 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.622 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.357 0 CA-C-O 116.331 -1.795 . . . . 0.0 109.864 -170.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.09 31.84 0.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 166.136 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.67 120.98 19.05 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -175.59 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -174.4 3.53 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.64 -1.624 . . . . 0.0 109.418 -178.859 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.48 -175.32 4.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.439 178.004 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.58 130.03 38.16 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.271 -176.345 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.24 41.94 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.722 179.238 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 109.65 21.9 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.819 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.75 150.8 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 N-CA-C 108.959 -1.208 . . . . 0.0 108.959 172.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -89.63 0.47 Allowed Glycine 0 N--CA 1.491 2.304 1 N-CA-C 130.521 6.968 . . . . 0.0 130.521 -177.814 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.634 HH22 ' CG ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -160.08 149.11 17.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.542 -1.263 . . . . 0.0 112.567 179.181 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.78 148.5 20.14 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 175.895 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.634 ' CG ' HH22 ' A' ' 12' ' ' ARG . 2.9 m-20 -77.74 121.11 23.59 Favored 'General case' 0 C--O 1.18 -2.605 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.071 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 20.9 tp -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.333 -1.747 . . . . 0.0 110.891 179.383 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.675 ' CB ' HG23 ' A' ' 38' ' ' ILE . 65.6 m95 -119.75 152.65 36.88 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 111.303 -2.681 . . . . 0.0 106.975 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.757 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.54 -158.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.845 -176.265 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.54 68.84 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 123.128 1.442 . . . . 0.0 108.18 -177.049 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.65 136.73 46.9 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 112.5 -2.136 . . . . 0.0 110.427 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.06 -21.28 78.55 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.17 157.44 35.93 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.708 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.28 157.86 72.54 Favored Pre-proline 0 C--N 1.299 -1.6 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.219 177.894 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.59 -172.76 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 121.268 1.312 . . . . 0.0 111.794 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.69 10.98 10.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.23 -2.11 54.26 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.467 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -102.97 -52.45 3.05 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.16 30.65 2.05 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.598 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 79.0 m-85 -79.55 172.36 13.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.415 1.103 . . . . 0.0 110.999 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.1 p -162.41 -45.72 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 112.896 -1.957 . . . . 0.0 106.681 176.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.5 p -98.39 97.66 8.98 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 112.861 -1.972 . . . . 0.0 110.36 -178.28 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -129.64 151.16 50.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.661 -1.215 . . . . 0.0 113.013 -177.804 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 146.07 36.13 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.132 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.717 ' CE2' HD12 ' A' ' 38' ' ' ILE . 8.8 m-85 -120.53 127.99 52.68 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.346 -172.714 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.1 mttt -128.81 73.01 1.48 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.754 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -35.72 148.45 0.15 Allowed Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.941 179.734 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 4.9 Cg_endo -78.44 36.92 0.57 Allowed 'Cis proline' 0 N--CA 1.487 1.118 0 C-N-CA 125.221 -0.741 . . . . 0.0 111.44 -5.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.439 ' H ' ' CA ' ' A' ' 35' ' ' TRP . 6.2 m120 -147.48 -162.21 1.5 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.335 -179.403 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.717 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.47 140.33 2.1 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.223 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.437 179.652 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 32.0 m -112.83 119.67 38.82 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.171 168.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.0 t -88.86 142.32 27.75 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.848 -171.622 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.496 ' CB ' ' O ' ' A' ' 30' ' ' SER . 1.1 m-85 -122.28 167.76 13.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.444 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -78.82 158.52 91.93 Favored 'Cis proline' 0 C--N 1.32 -0.944 0 CA-C-O 122.914 1.131 . . . . 0.0 114.525 6.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.543 0 CA-C-N 111.975 -2.375 . . . . 0.0 109.245 175.412 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.505 2.301 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.41 30.6 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 108.318 -1.455 . . . . 0.0 108.318 166.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -66.52 125.25 25.15 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -174.938 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -78.24 165.33 24.04 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 117.269 -1.772 . . . . 0.0 109.402 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -134.31 176.96 8.13 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.896 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -74.47 139.48 43.92 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.732 -176.552 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.04 -17.81 0.92 Allowed Glycine 0 C--N 1.295 -1.719 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.898 179.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 7' ' ' SER . 7.5 mptt -128.63 107.03 18.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.21 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.41 162.99 27.62 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.908 -1.228 . . . . 0.0 108.908 173.092 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.85 -90.53 0.52 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.553 178.51 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.593 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.4 153.33 21.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.808 -176.794 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.72 146.54 18.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 173.287 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 22.0 m-20 -77.59 119.05 20.6 Favored 'General case' 0 C--O 1.173 -2.958 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.2 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 16' ' ' TRP . 55.4 tp -81.22 132.21 35.33 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.008 -1.877 . . . . 0.0 111.711 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.76 ' HB2' HG23 ' A' ' 38' ' ' ILE . 59.7 m95 -123.34 120.02 31.8 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 111.562 -2.563 . . . . 0.0 105.379 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.771 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -83.84 -16.91 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -168.201 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 mt -151.88 70.9 0.95 Allowed 'General case' 1 C--N 1.239 -4.214 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.087 -171.48 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -153.73 140.69 19.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 117.064 -1.854 . . . . 0.0 112.928 178.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.49 -25.0 29.31 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 177.195 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.28 153.68 45.33 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 151.53 43.68 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.636 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.31 109.39 0.97 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.922 1.081 . . . . 0.0 111.122 -178.595 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -21.33 70.44 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.186 -1.483 . . . . 0.0 109.903 178.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.18 -1.88 76.34 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.058 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -92.05 -101.88 0.12 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.18 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.65 -2.48 0.38 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.397 -1.382 . . . . 0.0 111.167 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.658 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 53.0 m-85 -82.77 168.2 17.41 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 122.692 1.234 . . . . 0.0 112.062 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -158.63 -45.55 0.06 Allowed 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 112.153 -2.294 . . . . 0.0 105.78 177.652 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -98.69 118.15 34.77 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.03 178.751 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -144.45 149.42 35.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 117.917 -1.513 . . . . 0.0 113.577 179.621 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 148.07 29.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.068 176.282 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.624 ' CE2' HD12 ' A' ' 38' ' ' ILE . 36.4 m-85 -118.71 137.33 53.41 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.748 -172.642 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 35' ' ' TRP . 39.7 mmtt -130.21 56.77 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.291 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 34' ' ' LYS . 31.3 t-105 -29.05 139.89 0.11 Allowed Pre-proline 0 N--CA 1.504 2.236 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.596 -177.199 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -71.89 -7.52 14.41 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.869 -6.105 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.551 ' C ' HG22 ' A' ' 38' ' ' ILE . 1.3 m120 -87.58 -158.2 0.44 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.606 -177.003 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.76 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER 176.49 139.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.193 -1.916 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.461 -178.55 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 11.5 m -109.37 108.75 19.41 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 117.337 -1.745 . . . . 0.0 107.028 170.581 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.658 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.4 t -83.78 142.81 30.4 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.627 -171.45 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.6 m-85 -117.7 166.01 14.5 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.273 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -76.31 159.88 96.08 Favored 'Cis proline' 0 CA--C 1.509 -0.735 0 CA-C-O 122.885 1.119 . . . . 0.0 113.651 4.041 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.897 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.514 178.282 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -84.24 30.15 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 N-CA-C 108.001 -1.577 . . . . 0.0 108.001 167.931 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -71.46 119.24 15.33 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -174.728 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.0 160.6 29.01 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.25 -1.78 . . . . 0.0 109.966 -178.331 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.65 179.41 4.35 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.684 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.3 p -80.87 118.98 22.85 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.99 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 -11.16 71.21 Favored Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.203 -179.247 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -127.41 110.95 21.13 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.445 -179.706 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -165.94 0.27 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.062 1.174 . . . . 0.0 109.398 173.466 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.14 -96.78 2.25 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 118.961 -1.59 . . . . 0.0 111.105 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.603 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.88 160.32 30.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.963 -178.591 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -144.54 140.42 9.26 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 172.732 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -76.02 129.18 36.47 Favored 'General case' 0 C--O 1.173 -2.953 0 C-N-CA 118.628 -1.229 . . . . 0.0 108.136 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -83.45 125.65 31.94 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.58 -1.648 . . . . 0.0 111.455 -178.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.645 ' CB ' HG23 ' A' ' 38' ' ' ILE . 54.3 m95 -122.03 161.39 23.08 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.023 -178.554 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.749 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.79 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.736 -176.998 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -68.45 68.94 0.14 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.224 1.487 . . . . 0.0 107.807 -177.824 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' ILE . 16.5 mtp85 -101.77 113.34 26.42 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.593 -2.094 . . . . 0.0 110.845 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.32 -35.94 36.25 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.33 -1.414 . . . . 0.0 109.685 179.088 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.22 156.72 45.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.99 178.712 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.12 147.07 49.84 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.768 178.656 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.04 -175.83 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.093 1.195 . . . . 0.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.25 -41.22 1.41 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.64 12.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.488 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 28' ' ' TYR . 7.0 m-85 -81.79 15.48 2.19 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.335 -179.69 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.51 11.49 0.29 Allowed Glycine 0 N--CA 1.487 2.046 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.78 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 35.7 m-85 -63.93 167.57 6.06 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 117.84 -1.544 . . . . 0.0 111.189 179.455 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.59 -43.83 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.372 -2.195 . . . . 0.0 106.616 177.882 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.62 125.77 42.55 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.929 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -160.52 162.98 33.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.923 -1.511 . . . . 0.0 112.841 -179.718 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.8 p -116.79 137.25 52.33 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.826 176.081 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.682 ' CE2' HD12 ' A' ' 38' ' ' ILE . 60.3 m-85 -112.52 120.43 41.58 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.468 -174.42 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -139.69 73.64 1.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.548 179.61 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.493 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.64 157.83 0.43 Allowed Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.727 -176.793 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 14.0 Cg_endo -80.99 26.48 4.98 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.442 0.4 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.493 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 4.0 m120 -144.74 178.3 8.09 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.463 175.636 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -148.07 148.58 16.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.951 -179.534 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 31.6 m -114.14 151.32 32.83 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 166.342 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.2 t -123.05 137.36 54.96 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.839 -1.144 . . . . 0.0 114.012 -169.354 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.553 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.7 m-85 -104.48 176.14 1.89 Allowed Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.631 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.9 Cg_exo -52.74 -62.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.928 0 N-CA-C 117.328 2.011 . . . . 0.0 117.328 4.388 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.603 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 116.265 -1.826 . . . . 0.0 109.6 -170.167 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.23 40.79 0.7 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 165.902 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -82.24 122.61 28.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -175.796 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.05 177.9 8.45 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.871 -1.532 . . . . 0.0 109.526 179.734 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.63 175.16 9.24 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.642 177.072 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.53 129.27 36.23 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.816 -177.693 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.91 -22.27 6.0 Favored Glycine 0 C--N 1.296 -1.662 0 C-N-CA 119.064 -1.541 . . . . 0.0 110.165 -178.806 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -110.4 115.41 54.23 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.838 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -76.33 -163.59 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 173.433 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.69 -106.04 2.05 Favored Glycine 0 C--N 1.287 -2.189 0 C-N-CA 118.832 -1.651 . . . . 0.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.622 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 8.2 ptm180 -159.25 177.42 11.05 Favored 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 118.176 -1.41 . . . . 0.0 114.224 -176.325 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -156.61 144.23 10.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 173.723 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 32.5 m-20 -76.25 124.57 27.69 Favored 'General case' 0 C--O 1.177 -2.719 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.199 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD12 ' SG ' ' A' ' 39' ' ' CYS . 3.2 tt -86.09 111.37 20.27 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.019 -1.872 . . . . 0.0 112.296 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.707 ' HB2' HG23 ' A' ' 38' ' ' ILE . 46.1 m95 -92.65 -178.13 4.78 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 112.25 -2.25 . . . . 0.0 108.864 176.045 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -102.03 -162.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.691 -176.288 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -68.72 66.81 0.13 Allowed 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 122.964 1.364 . . . . 0.0 107.726 -177.672 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 1.1 mtt85 -111.54 113.26 25.55 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 112.573 -2.103 . . . . 0.0 110.665 -179.398 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.08 -34.52 16.78 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.42 157.4 45.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.305 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -86.03 152.33 55.9 Favored Pre-proline 0 C--N 1.298 -1.633 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.173 179.277 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.98 115.5 2.47 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 120.698 0.932 . . . . 0.0 110.181 174.686 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.58 -4.87 47.97 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.375 -1.393 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 -0.56 55.87 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.179 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.23 -16.08 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.396 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.75 -3.36 23.02 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.761 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 43.1 m-85 -77.3 169.76 17.75 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.834 1.302 . . . . 0.0 112.471 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.97 -45.37 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 112.055 -2.339 . . . . 0.0 106.345 176.056 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 41' ' ' TYR . 80.2 p -99.38 115.29 28.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.066 -179.37 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -143.54 148.8 36.5 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.935 -179.932 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.5 144.47 33.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.788 176.105 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.8 m-85 -117.98 133.21 56.14 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.894 -173.005 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -138.72 75.59 1.53 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.957 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.502 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.9 155.73 0.39 Allowed Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.46 -177.994 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.459 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 7.3 Cg_endo -78.08 32.92 0.9 Allowed 'Cis proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.5 -1.042 . . . . 0.0 111.571 -4.51 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.502 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.4 m120 -145.07 -160.7 1.17 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.811 177.754 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.28 147.76 4.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.918 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 39.1 m -116.88 119.05 34.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.015 168.216 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.3 t -90.57 139.15 30.98 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.968 -171.501 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.6 m-85 -112.12 178.41 0.98 Allowed Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.953 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 15.7 Cg_exo -59.49 -56.64 0.12 OUTLIER 'Cis proline' 0 N--CA 1.502 2.02 0 N-CA-C 116.695 1.767 . . . . 0.0 116.695 4.818 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.622 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.7 0 CA-C-O 116.439 -1.743 . . . . 0.0 109.325 -171.043 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.23 33.7 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 164.249 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 12.7 p -84.98 115.37 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.455 -176.25 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.46 172.7 13.26 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.989 -178.508 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.89 -173.62 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.727 178.877 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -75.41 118.59 18.45 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.631 -175.872 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.38 44.87 Favored Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.844 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 28.1 mttt -113.51 109.43 51.01 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.319 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.87 -172.6 1.0 Allowed 'Trans proline' 0 C--N 1.32 -0.927 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 173.222 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.3 -110.57 3.58 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.58 -1.772 . . . . 0.0 110.807 179.079 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.751 HH11 ' HB2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.35 168.71 24.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.125 -177.967 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -147.9 157.38 27.32 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 174.268 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.563 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 1.2 m-20 -78.48 130.0 35.53 Favored 'General case' 0 C--O 1.172 -3.005 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.628 178.511 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 13.7 tp -96.08 97.33 9.49 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.923 1.344 . . . . 0.0 111.784 -177.294 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.836 ' HB2' HG23 ' A' ' 38' ' ' ILE . 78.5 m95 -83.08 115.52 21.92 Favored 'General case' 0 C--N 1.263 -3.157 0 CA-C-N 112.063 -2.335 . . . . 0.0 107.494 175.56 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.43 ' O ' HG22 ' A' ' 17' ' ' ILE . 8.2 mt -88.31 -8.85 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.974 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 10.9 mt -154.83 71.58 0.81 Allowed 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.674 -173.871 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.591 ' NH2' ' N ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -153.25 162.36 41.39 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 117.592 -1.643 . . . . 0.0 111.95 177.129 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -109.06 -32.48 3.03 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.454 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -136.21 153.94 51.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.412 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.74 149.08 39.84 Favored Pre-proline 0 C--N 1.293 -1.855 0 C-N-CA 118.779 -1.168 . . . . 0.0 110.068 -179.195 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.591 ' N ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 Cg_endo -66.83 146.47 78.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.878 1.052 . . . . 0.0 111.665 -178.69 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.68 -16.48 54.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 177.917 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.39 -9.13 87.25 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.05 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.73 -30.23 18.18 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.623 178.908 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.66 -9.48 12.82 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.227 177.576 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 45.4 m-85 -63.25 167.17 5.4 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.145 -178.821 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.23 -43.43 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 112.224 -2.262 . . . . 0.0 106.107 177.181 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.8 p -97.38 119.01 35.13 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.4 179.627 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -156.45 155.19 31.63 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.404 -1.718 . . . . 0.0 113.599 179.91 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 150.27 38.58 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.331 176.474 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 38' ' ' ILE . 36.4 m-85 -118.23 140.83 49.22 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.693 -171.212 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' ASN . 19.3 mttt -134.9 70.75 1.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.835 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -40.68 140.21 1.06 Allowed Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.222 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.89 2.47 14.57 Favored 'Cis proline' 0 N--CA 1.498 1.793 0 C-N-CA 125.319 -0.7 . . . . 0.0 110.425 -6.428 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' C ' HG22 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -93.41 -163.24 1.02 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.898 0.856 . . . . 0.0 112.301 -175.941 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.836 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 177.5 139.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.081 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.328 178.728 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 36.4 m -110.52 115.42 29.59 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.698 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -97.49 136.57 37.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.842 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.5 m-85 -107.03 179.49 0.88 Allowed Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.254 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 4.1 Cg_exo -65.45 -52.37 0.15 OUTLIER 'Cis proline' 0 N--CA 1.508 2.347 0 N-CA-C 116.632 1.743 . . . . 0.0 116.632 7.856 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.751 ' HB2' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.97 0 CA-C-O 116.411 -1.757 . . . . 0.0 109.588 -170.155 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.506 2.365 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.72 30.44 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 107.941 -1.6 . . . . 0.0 107.941 164.515 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.86 123.93 30.43 Favored 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.553 -174.464 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.0 m-85 -84.52 158.69 20.89 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.378 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -124.83 178.89 5.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.573 178.645 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 127.34 32.38 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.355 -175.431 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.28 54.46 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.887 178.747 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 113.25 18.97 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.637 -179.107 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -70.19 -158.73 0.05 OUTLIER 'Trans proline' 0 C--O 1.217 -0.54 0 C-N-CA 121.204 1.269 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 70.43 -108.68 2.56 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.849 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 1.7 ptp180 -160.09 -176.22 5.53 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.059 177.188 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.684 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -139.39 160.36 25.94 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 3.4 m-20 -78.95 128.85 33.82 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 118.145 -1.422 . . . . 0.0 108.048 177.695 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.646 ' CB ' ' HB2' ' A' ' 2' ' ' ALA . 22.8 tp -92.77 103.55 15.9 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.951 1.358 . . . . 0.0 112.503 -175.409 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.751 ' HB2' HG23 ' A' ' 38' ' ' ILE . 73.9 m95 -93.05 110.05 21.52 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.701 175.17 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 17' ' ' ILE . 87.1 mt -81.38 -10.53 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -170.261 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 5.4 mt -154.32 78.42 1.09 Allowed 'General case' 0 C--N 1.255 -3.519 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.274 -173.734 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 148.1 11.19 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.454 -1.699 . . . . 0.0 112.219 178.494 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.19 -17.86 28.3 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 177.225 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.75 161.61 39.52 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.608 178.596 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -105.42 150.94 39.55 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.87 179.403 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.22 165.43 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.837 1.024 . . . . 0.0 110.736 175.767 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.69 -22.13 8.69 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.137 179.62 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.76 83.15 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.193 179.867 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.5 -13.4 59.13 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.963 179.764 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.47 55.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.091 177.006 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.634 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.9 m-85 -75.75 168.0 20.84 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.241 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.0 p -162.85 -45.08 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 111.966 -2.379 . . . . 0.0 105.654 175.893 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 14.9 p -98.97 113.51 25.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.893 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -138.0 150.7 47.21 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.522 -1.271 . . . . 0.0 113.215 179.318 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -106.01 151.24 24.88 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.065 176.358 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 38' ' ' ILE . 34.1 m-85 -129.03 145.31 51.29 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.207 -172.701 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 78.02 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.224 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.447 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.76 152.95 0.42 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.426 -175.284 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -73.58 -1.81 14.14 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.444 -1.065 . . . . 0.0 110.64 -5.516 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m120 -94.16 -166.14 1.44 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.654 1.216 . . . . 0.0 111.524 -178.132 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -172.4 139.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.36 178.772 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 57.7 m -109.7 102.89 11.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 171.948 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.634 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.9 t -79.01 142.97 36.13 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.558 -171.796 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -116.86 165.45 15.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.553 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -77.31 160.08 94.4 Favored 'Cis proline' 0 C--O 1.214 -0.691 0 CA-C-O 122.771 1.071 . . . . 0.0 114.27 4.249 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.432 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.34 177.856 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.515 2.806 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.96 20.67 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 107.924 -1.606 . . . . 0.0 107.924 163.604 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.9 p -79.95 116.76 20.27 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.917 -178.551 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -80.89 -167.65 1.49 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.766 -173.383 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -175.98 3.7 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.78 176.674 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m -80.74 115.73 20.39 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.205 -178.626 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.7 -13.74 64.91 Favored Glycine 0 C--N 1.296 -1.668 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.237 -179.415 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -111.72 108.62 55.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -73.14 156.89 51.23 Favored 'Trans proline' 0 CA--C 1.507 -0.866 0 C-N-CA 120.999 1.132 . . . . 0.0 109.372 176.371 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.91 -90.56 0.57 Allowed Glycine 0 N--CA 1.484 1.862 1 N-CA-C 130.544 6.977 . . . . 0.0 130.544 -178.517 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.44 156.59 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.597 178.485 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.761 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -149.74 167.98 29.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 175.647 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -82.54 129.42 34.92 Favored 'General case' 0 C--O 1.178 -2.684 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.809 178.695 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 16.6 tp -96.62 106.6 18.89 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.909 1.338 . . . . 0.0 111.575 -178.535 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.628 ' HB2' HG23 ' A' ' 38' ' ' ILE . 69.4 m95 -93.47 108.95 20.55 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-N 111.79 -2.459 . . . . 0.0 107.021 176.349 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 17' ' ' ILE . 78.2 mt -83.15 -4.81 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.52 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 mt -151.67 80.24 1.28 Allowed 'General case' 0 C--N 1.253 -3.612 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.604 -174.598 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -172.19 159.37 4.81 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.659 177.678 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.67 -26.06 3.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 175.224 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 p -128.99 149.09 50.97 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.191 176.203 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 153.26 39.65 Favored Pre-proline 0 C--N 1.287 -2.112 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.298 -179.346 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.9 Cg_exo -55.3 99.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.857 1.038 . . . . 0.0 111.099 -178.726 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.06 6.23 4.13 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.291 -1.433 . . . . 0.0 109.756 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -100.24 -17.06 25.77 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.42 -86.27 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.976 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.57 -16.51 0.02 OUTLIER Glycine 0 C--N 1.287 -2.153 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.894 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.647 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 36.7 m-85 -56.18 167.16 0.68 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.702 -178.693 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 28' ' ' TYR . 4.8 p -162.89 -43.93 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 112.337 -2.211 . . . . 0.0 106.094 177.453 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 78.0 p -96.85 116.99 30.12 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.236 -179.952 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.59 155.28 40.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 117.953 -1.499 . . . . 0.0 113.917 -177.835 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -99.4 158.52 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.851 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.773 ' CE2' HD12 ' A' ' 38' ' ' ILE . 44.0 m-85 -138.58 133.64 32.77 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.909 -176.493 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.79 84.3 0.68 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.766 178.413 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.485 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -49.05 157.34 0.81 Allowed Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.656 -177.469 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.1 Cg_endo -71.16 0.99 7.29 Favored 'Cis proline' 0 C--O 1.206 -1.076 0 C-N-CA 124.277 -1.134 . . . . 0.0 111.042 -3.912 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -105.74 -165.6 1.12 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.691 1.234 . . . . 0.0 111.774 -177.042 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.773 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -172.25 143.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.131 -1.85 . . . . 0.0 107.314 178.735 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.2 m -113.61 109.58 18.84 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.208 174.228 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.647 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -89.62 140.81 29.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.963 -171.997 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -116.45 169.94 6.51 Favored Pre-proline 0 N--CA 1.503 2.214 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.196 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -81.24 156.49 82.89 Favored 'Cis proline' 0 CA--C 1.507 -0.864 0 CA-C-O 123.03 1.179 . . . . 0.0 114.384 3.565 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.979 0 CA-C-N 111.599 -2.546 . . . . 0.0 109.607 174.779 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -84.28 40.51 0.88 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 107.806 -1.652 . . . . 0.0 107.806 166.126 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.93 125.39 29.31 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.847 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.97 168.6 19.64 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.413 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.485 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -127.95 -175.24 3.42 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.951 -179.19 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -74.91 125.52 29.02 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.34 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.53 -2.06 24.69 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.615 -1.278 . . . . 0.0 111.043 178.973 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -126.4 115.24 23.29 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.94 -179.58 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.4 -175.98 3.01 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 108.16 -1.515 . . . . 0.0 108.16 171.05 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.96 -109.08 3.74 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.735 179.171 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.709 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 4.0 ptm180 -159.51 157.29 29.71 Favored 'General case' 0 C--O 1.207 -1.177 0 C-N-CA 118.58 -1.248 . . . . 0.0 112.791 -178.682 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.36 143.12 13.14 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.348 176.309 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -77.6 127.87 33.19 Favored 'General case' 0 C--O 1.172 -3.011 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.593 179.69 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.427 HD12 ' H ' ' A' ' 16' ' ' TRP . 51.2 tp -86.1 129.5 34.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.825 -1.55 . . . . 0.0 111.186 -179.505 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CB ' HG23 ' A' ' 38' ' ' ILE . 55.8 m95 -124.59 159.38 30.82 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.102 -178.136 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -84.03 -163.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.452 -177.44 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 70.59 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.131 1.443 . . . . 0.0 108.605 -176.459 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.8 mtp180 -102.12 133.7 46.54 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.474 178.943 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -60.23 -53.0 49.25 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.73 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.95 158.74 39.43 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.607 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.2 147.94 73.69 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.636 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.35 130.46 39.96 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.775 0.983 . . . . 0.0 111.391 -177.122 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.93 -17.86 58.89 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 178.566 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.98 -14.74 68.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -86.68 -70.54 0.6 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.347 179.632 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.95 -14.12 0.07 OUTLIER Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.128 -1.511 . . . . 0.0 111.751 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 51.4 m-85 -56.25 169.33 0.43 Allowed 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 122.656 1.217 . . . . 0.0 111.778 -179.385 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 28' ' ' TYR . 7.3 p -162.57 -45.43 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 112.298 -2.228 . . . . 0.0 106.604 177.131 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 41' ' ' TYR . 82.9 p -98.37 112.13 24.24 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 112.89 -1.959 . . . . 0.0 110.082 -178.693 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -148.16 156.28 42.41 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.584 -1.246 . . . . 0.0 112.712 -179.092 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 145.76 40.39 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.575 177.771 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.662 ' CE2' HD12 ' A' ' 38' ' ' ILE . 20.6 m-85 -118.82 126.55 52.08 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.874 -172.525 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 16.7 mttt -122.77 67.19 0.96 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.301 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.458 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 33.3 t-105 -34.8 142.69 0.23 Allowed Pre-proline 0 N--CA 1.496 1.85 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.405 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.42 44.33 0.32 Allowed 'Cis proline' 0 N--CA 1.494 1.537 0 C-N-CA 125.62 -0.575 . . . . 0.0 111.487 -5.564 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.469 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.6 m120 -150.79 -157.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.329 178.15 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.662 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -173.95 138.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.99 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.681 -179.892 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 49.1 m -110.76 123.86 50.87 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 117.463 -1.695 . . . . 0.0 106.518 168.535 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.9 t -94.03 141.62 28.33 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.711 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -114.23 179.71 0.74 Allowed Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 176.722 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.535 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.0 Cg_exo -57.34 -56.15 0.09 OUTLIER 'Cis proline' 0 N--CA 1.503 2.054 0 CA-C-N 122.434 1.905 . . . . 0.0 116.95 6.065 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.709 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.475 0 CA-C-O 116.282 -1.818 . . . . 0.0 109.182 -170.669 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.514 2.764 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -84.17 21.87 1.01 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 N-CA-C 107.793 -1.657 . . . . 0.0 107.793 164.245 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 1.7 p -83.51 118.33 23.71 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.083 -176.788 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -175.42 4.69 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.213 -176.043 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -123.38 -174.44 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 177.308 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.89 110.52 15.33 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.609 -178.313 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.68 73.14 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.517 179.715 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.2 112.79 34.36 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.435 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -71.75 -159.26 0.07 OUTLIER 'Trans proline' 0 C--O 1.213 -0.77 0 N-CA-C 109.144 -1.137 . . . . 0.0 109.144 173.376 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.0 -106.21 2.43 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.901 177.966 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.726 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.54 177.23 9.64 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.096 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.726 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -154.07 175.83 32.17 Favored Glycine 0 N--CA 1.504 3.17 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.469 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.5 m-20 -91.12 126.13 36.12 Favored 'General case' 0 C--O 1.182 -2.465 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.817 177.683 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 13.7 tp -97.12 102.61 14.42 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.038 1.399 . . . . 0.0 111.958 -177.398 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.841 ' HB2' HG23 ' A' ' 38' ' ' ILE . 79.3 m95 -88.98 123.97 33.82 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-N 111.758 -2.473 . . . . 0.0 107.112 175.854 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 17' ' ' ILE . 51.3 mt -90.4 -7.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.247 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -168.888 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -150.36 74.83 1.2 Allowed 'General case' 0 C--N 1.254 -3.558 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.264 -173.354 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.63 151.21 1.85 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.559 178.366 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.597 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -101.98 -24.41 8.58 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 173.819 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 157.13 38.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.565 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -82.28 172.55 9.31 Favored Pre-proline 0 CA--C 1.58 2.109 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.065 -178.38 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.8 Cg_exo -52.22 -139.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.085 2.524 . . . . 0.0 114.557 -170.692 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.87 114.23 2.57 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 176.189 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.94 80.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.25 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.405 ' HD1' ' H ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -100.34 -51.53 3.62 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 122.15 0.976 . . . . 0.0 111.606 -175.892 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' H ' ' HD1' ' A' ' 26' ' ' TYR . . . 138.96 -19.23 3.11 Favored Glycine 0 C--N 1.281 -2.515 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -174.126 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.587 ' O ' HG23 ' A' ' 29' ' ' THR . 33.8 m-85 -72.74 173.95 8.34 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 122.558 1.171 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.0 p -162.05 -42.66 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.133 177.172 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.4 p -96.69 126.28 41.75 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.031 178.178 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.439 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -154.74 153.2 30.87 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 117.644 -1.622 . . . . 0.0 113.832 -179.422 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.4 p -114.24 153.87 28.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.781 174.961 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.833 ' CD2' HD12 ' A' ' 38' ' ' ILE . 14.7 m-85 -130.95 130.86 43.97 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.955 -175.701 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -134.67 74.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.577 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -46.1 153.49 0.68 Allowed Pre-proline 0 C--N 1.298 -1.671 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.48 -174.419 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.5 -0.18 12.67 Favored 'Cis proline' 0 C--O 1.204 -1.223 0 C-N-CA 124.11 -1.204 . . . . 0.0 110.842 -4.195 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -96.43 -168.12 1.68 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.952 0.882 . . . . 0.0 110.758 -179.008 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -169.38 141.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 114.372 -1.285 . . . . 0.0 108.679 -179.882 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 56.5 m -110.05 97.21 6.76 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.209 -1.396 . . . . 0.0 107.553 172.958 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.583 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -81.36 127.95 33.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.587 -173.348 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -100.04 171.62 5.39 Favored Pre-proline 0 N--CA 1.514 2.757 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.222 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.1 Cg_endo -84.36 158.1 68.52 Favored 'Cis proline' 0 CA--C 1.507 -0.83 0 CA-C-O 123.246 1.269 . . . . 0.0 114.643 1.938 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.914 0 CA-C-N 111.271 -2.695 . . . . 0.0 109.744 174.435 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.511 2.603 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -90.43 31.32 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 109.039 -1.177 . . . . 0.0 109.039 166.763 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.34 130.57 36.33 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -175.218 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.52 165.48 23.68 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.313 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -110.93 180.0 3.89 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.326 177.275 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.1 103.14 13.84 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.118 -178.659 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.04 18.16 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -178.929 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.06 117.42 9.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.958 -179.05 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -78.11 170.24 19.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 N-CA-C 108.534 -1.372 . . . . 0.0 108.534 172.09 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.57 -96.35 1.06 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.795 178.803 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.78 152.25 19.34 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.556 -1.657 . . . . 0.0 114.455 -178.143 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.28 155.31 23.37 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 174.312 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.651 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -79.52 119.13 22.07 Favored 'General case' 0 C--O 1.169 -3.161 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.365 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 17.0 tp -85.77 93.3 8.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.889 -177.654 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.811 ' HB2' HG23 ' A' ' 38' ' ' ILE . 72.6 m95 -74.24 126.33 30.38 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 112.706 -2.043 . . . . 0.0 107.106 172.211 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 17' ' ' ILE . 11.6 mt -94.41 -8.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -169.723 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -152.71 55.64 0.79 Allowed 'General case' 0 C--N 1.261 -3.25 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 -173.602 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.53 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -133.96 157.08 46.96 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.563 -179.327 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.55 -32.32 2.15 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 174.262 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.27 150.43 52.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.58 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -85.92 145.18 40.51 Favored Pre-proline 0 C--N 1.284 -2.264 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.737 -178.861 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.96 -174.76 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 120.865 1.043 . . . . 0.0 111.323 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.06 13.3 9.09 Favored Glycine 0 N--CA 1.484 1.889 1 N-CA-C 128.912 6.325 . . . . 0.0 128.912 177.957 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.35 -14.73 27.33 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.531 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -79.42 -21.17 45.93 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.126 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.46 61.23 Favored Glycine 0 C--N 1.292 -1.862 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.086 179.326 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 43.5 m-85 -56.43 164.34 1.42 Allowed 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 117.967 -1.493 . . . . 0.0 110.934 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -163.16 -45.06 0.03 OUTLIER 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.41 -2.177 . . . . 0.0 106.112 177.61 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.7 p -99.73 110.7 23.08 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.651 -2.068 . . . . 0.0 109.385 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -142.84 147.15 34.93 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.338 -1.345 . . . . 0.0 113.349 -179.007 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 14.5 p -99.57 143.7 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.2 175.616 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.849 ' CE2' HD12 ' A' ' 38' ' ' ILE . 61.8 m-85 -119.58 139.12 52.66 Favored 'General case' 0 C--N 1.275 -2.64 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.86 -173.273 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.6 mttt -137.07 60.91 1.64 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.145 176.742 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' LYS . 1.2 t90 -35.06 143.67 0.23 Allowed Pre-proline 0 N--CA 1.497 1.886 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.079 -177.901 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.17 -1.3 10.47 Favored 'Cis proline' 0 N--CA 1.486 1.07 0 C-N-CA 125.106 -0.789 . . . . 0.0 111.469 -4.661 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.55 ' C ' HG22 ' A' ' 38' ' ' ILE . 1.7 m120 -95.55 -162.44 0.95 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.546 0.689 . . . . 0.0 110.881 -178.416 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.849 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 175.66 137.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.852 -179.414 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 20.6 m -107.65 121.6 45.01 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 117.718 -1.593 . . . . 0.0 106.976 170.174 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -100.27 139.17 36.32 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -169.305 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.577 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -115.31 166.01 12.96 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.268 177.756 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.69 160.32 87.65 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 CA-C-O 122.842 1.101 . . . . 0.0 113.918 5.327 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.577 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.573 0 CA-C-N 112.155 -2.293 . . . . 0.0 109.679 176.124 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -91.15 27.84 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.3 1.333 . . . . 0.0 108.825 167.443 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.596 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -70.39 126.21 28.99 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.802 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -77.47 166.95 22.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 117.712 -1.595 . . . . 0.0 110.653 -177.188 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.52 -179.39 4.75 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.639 0.733 . . . . 0.0 110.203 179.12 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 9' ' ' LYS . 86.2 p -72.1 142.48 49.19 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.427 -179.081 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.86 -10.76 1.07 Allowed Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.634 178.642 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 7' ' ' SER . 4.5 mttt -136.48 113.26 10.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.484 -179.409 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -77.1 -165.72 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 172.795 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -88.1 1.55 Allowed Glycine 0 C--N 1.289 -2.078 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.05 176.447 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.532 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -160.65 154.64 22.81 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 117.827 -1.549 . . . . 0.0 114.069 -175.476 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.1 149.98 21.88 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 172.99 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 125.64 29.61 Favored 'General case' 0 C--O 1.17 -3.121 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.85 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.63 110.83 20.68 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 116.925 -1.91 . . . . 0.0 112.274 -177.983 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.67 ' CB ' HG23 ' A' ' 38' ' ' ILE . 58.0 m95 -96.23 175.51 6.42 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 112.471 -2.15 . . . . 0.0 109.201 176.64 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -102.38 -158.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.769 -176.854 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -66.69 73.49 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.741 1.734 . . . . 0.0 108.201 -176.374 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.2 mtt-85 -133.82 97.01 3.79 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.845 178.994 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.45 -5.05 0.68 Allowed Glycine 0 N--CA 1.486 1.984 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.608 -179.646 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 19' ' ' ARG . 1.6 p -137.53 151.9 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.221 179.823 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -103.8 142.86 25.46 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.3 179.108 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.408 ' CG ' ' CH2' ' A' ' 16' ' ' TRP . 5.8 Cg_exo -55.88 144.64 76.87 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.004 1.136 . . . . 0.0 111.305 179.595 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.79 -2.75 78.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.706 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.49 -19.76 70.6 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.587 -179.757 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -87.09 -12.04 48.38 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.027 -179.168 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.89 76.66 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.612 176.639 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.628 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.9 m-85 -56.48 174.14 0.15 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.213 179.36 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -161.61 -43.67 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.666 -2.061 . . . . 0.0 106.335 175.783 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.3 p -97.21 133.9 41.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.558 179.335 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -160.04 157.28 28.39 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.849 178.78 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.41 ' O ' HG13 ' A' ' 38' ' ' ILE . 19.7 p -113.34 142.74 45.5 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.995 176.139 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.797 ' CD2' HD12 ' A' ' 38' ' ' ILE . 11.9 m-85 -120.44 125.31 47.61 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.272 -174.023 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -146.12 81.67 1.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.707 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.452 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.06 157.78 0.15 Allowed Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.461 179.672 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.4 Cg_endo -78.34 28.68 1.78 Allowed 'Cis proline' 0 C--O 1.21 -0.903 0 C-N-CA 124.227 -1.156 . . . . 0.0 110.751 -5.209 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.456 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 5.7 m120 -145.01 -170.26 3.38 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.797 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -154.41 150.12 12.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.773 178.822 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -116.66 158.66 23.42 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 166.282 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -130.52 147.18 52.18 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.518 -1.273 . . . . 0.0 114.103 -170.189 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -118.53 166.91 12.68 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.404 179.734 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.44 158.53 97.26 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 CA-C-O 122.679 1.033 . . . . 0.0 113.94 4.599 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.503 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.502 0 CA-C-N 112.359 -2.201 . . . . 0.0 110.121 177.898 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -81.61 35.27 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 166.179 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.39 123.23 25.65 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.779 -1.168 . . . . 0.0 108.357 -175.25 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.08 179.62 7.24 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.151 -1.42 . . . . 0.0 108.778 179.424 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -179.29 6.11 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.794 -1.162 . . . . 0.0 111.021 178.561 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 p -74.07 128.27 35.08 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.293 -176.146 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -8.48 3.99 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.005 178.778 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.51 107.08 41.4 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.18 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -72.07 -173.51 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.078 1.185 . . . . 0.0 109.854 174.717 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.69 -112.36 3.84 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.288 178.291 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.58 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 4.3 ptm180 -152.56 166.25 32.61 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.503 -177.18 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.68 146.78 18.11 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 174.356 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -77.12 117.82 19.06 Favored 'General case' 0 C--O 1.179 -2.615 0 C-N-CA 118.989 -1.085 . . . . 0.0 108.272 178.896 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.21 112.59 19.99 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 116.387 -2.125 . . . . 0.0 112.441 -178.684 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.702 ' CB ' HG23 ' A' ' 38' ' ' ILE . 57.2 m95 -94.71 174.26 7.19 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 112.144 -2.298 . . . . 0.0 106.659 173.15 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.691 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -96.56 -158.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 C-N-CA 118.651 -1.219 . . . . 0.0 113.02 -174.376 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.94 72.91 0.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 123.619 1.676 . . . . 0.0 108.221 -177.063 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ILE . 5.2 mtp85 -131.84 97.53 4.21 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 111.637 -2.529 . . . . 0.0 109.729 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.53 -22.98 1.18 Allowed Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.019 -179.516 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.427 ' N ' ' C ' ' A' ' 19' ' ' ARG . 1.1 p -130.4 152.31 49.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.983 179.524 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 173.07 8.09 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.35 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 14.9 Cg_endo -67.0 98.9 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.576 1.517 . . . . 0.0 113.364 -174.614 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' PRO . . . -30.85 101.11 0.01 OUTLIER Glycine 0 N--CA 1.512 3.758 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.573 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.78 68.58 0.66 Allowed Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.703 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -117.52 -172.56 2.25 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.189 0.519 . . . . 0.0 110.683 -177.471 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.86 -18.3 54.64 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 172.784 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 23.1 m-85 -69.94 177.72 3.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.956 1.36 . . . . 0.0 112.476 178.766 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.7 p -161.55 -44.36 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.759 -2.473 . . . . 0.0 105.475 176.4 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.21 114.69 27.02 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.751 178.517 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.541 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -136.52 151.85 49.87 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 118.55 -1.26 . . . . 0.0 112.819 178.558 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.35 146.18 43.56 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.766 176.721 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.882 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.2 m-85 -126.27 136.21 52.5 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.222 -174.841 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -147.12 79.79 1.51 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.588 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.445 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.75 159.05 0.21 Allowed Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.135 -178.154 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.1 Cg_endo -81.15 32.29 2.28 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.542 -1.024 . . . . 0.0 111.635 -3.725 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.445 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.8 m120 -148.98 171.17 16.79 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.411 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.882 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -131.62 152.31 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.832 178.35 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 28.9 m -123.46 110.23 14.84 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.014 -1.475 . . . . 0.0 107.523 167.58 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -83.79 133.41 34.77 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.02 -174.31 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -102.89 -173.85 0.31 Allowed Pre-proline 0 N--CA 1.517 2.919 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.647 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.8 Cg_exo -62.56 -48.58 0.18 OUTLIER 'Cis proline' 0 N--CA 1.508 2.348 0 CA-C-N 122.653 1.983 . . . . 0.0 116.497 3.958 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.608 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.987 0 CA-C-O 116.481 -1.724 . . . . 0.0 109.244 -171.382 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.501 2.1 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -81.22 27.77 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 N-CA-C 108.022 -1.569 . . . . 0.0 108.022 164.001 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.3 p -87.95 120.3 29.15 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.097 -177.608 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.658 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -82.52 -175.13 5.58 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.111 -173.379 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.44 -176.39 5.57 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.703 176.073 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.7 t -78.92 113.34 16.94 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.584 -177.728 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.23 67.58 Favored Glycine 0 C--N 1.296 -1.65 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -112.25 136.01 21.37 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.802 -178.904 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 9' ' ' LYS . 2.9 Cg_exo -48.74 -166.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.602 2.201 . . . . 0.0 114.244 -173.063 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.94 24.73 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.062 -174.543 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 10' ' ' PRO . 8.2 ptm180 -161.36 146.91 13.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 116.695 -2.002 . . . . 0.0 114.612 176.862 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -160.65 173.59 37.2 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 176.088 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -84.31 135.0 34.49 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.974 179.89 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.63 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 36.3 tp -96.59 133.62 40.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.358 1.075 . . . . 0.0 110.114 -179.62 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.622 ' CB ' HG23 ' A' ' 38' ' ' ILE . 64.9 m95 -135.08 151.37 50.69 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 112.899 -1.955 . . . . 0.0 108.047 -177.483 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.891 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -78.56 -157.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.835 -175.562 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.74 67.44 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.017 1.389 . . . . 0.0 108.235 -176.8 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -103.82 112.16 25.0 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.102 -178.972 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -23.52 57.18 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.382 -1.39 . . . . 0.0 109.789 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.85 156.47 40.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.982 178.631 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -91.65 149.82 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.918 179.263 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.91 128.52 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.972 1.115 . . . . 0.0 111.452 -177.614 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.36 6.95 55.87 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.01 179.489 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.51 -7.23 16.44 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.386 -179.975 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.55 -35.77 39.37 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.798 179.604 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.93 -13.07 6.44 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.642 178.367 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 42.9 m-85 -60.7 170.55 1.42 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.744 -179.136 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 28' ' ' TYR . 10.3 p -161.46 -44.96 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 112.319 -2.219 . . . . 0.0 106.038 178.438 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.4 129.8 44.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.714 179.379 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.82 157.3 28.99 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.922 -1.511 . . . . 0.0 112.438 178.266 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 142.19 47.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.141 177.173 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.695 ' CE2' HD12 ' A' ' 38' ' ' ILE . 21.3 m-85 -117.77 124.62 48.89 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.813 -172.735 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.9 81.06 1.67 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.195 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.449 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.98 159.62 0.13 Allowed Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.883 -178.775 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -77.76 23.06 3.76 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.127 -1.197 . . . . 0.0 110.721 -5.208 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.44 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.9 m120 -140.76 175.76 9.35 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.968 179.663 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -136.2 145.83 30.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.523 177.355 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.9 m -115.07 115.69 27.21 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 117.688 -1.605 . . . . 0.0 107.087 169.844 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -87.91 160.37 17.97 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.598 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 30' ' ' SER . 5.7 m-85 -132.62 161.9 60.56 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.139 179.185 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -85.95 160.32 58.35 Favored 'Cis proline' 0 C--N 1.325 -0.708 0 N-CA-C 115.209 1.196 . . . . 0.0 115.209 5.412 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.038 0 CA-C-N 112.02 -2.354 . . . . 0.0 109.588 175.57 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.88 51.9 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 170.962 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -69.26 141.36 54.41 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -174.396 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -78.38 173.29 12.49 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 117.984 -1.486 . . . . 0.0 108.909 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.33 -168.18 1.28 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.191 -178.656 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 9' ' ' LYS . 4.5 m -65.35 113.63 4.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.107 -177.991 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.8 -3.12 0.73 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.807 179.131 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 7' ' ' SER . 22.3 mttt -93.81 120.95 65.46 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 118.296 -1.362 . . . . 0.0 111.156 -178.99 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -71.11 155.93 60.51 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 N-CA-C 109.386 -1.044 . . . . 0.0 109.386 174.321 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -116.54 3.55 Favored Glycine 0 N--CA 1.482 1.724 1 N-CA-C 129.591 6.596 . . . . 0.0 129.591 -178.008 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.62 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.9 149.33 16.21 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.627 -1.229 . . . . 0.0 112.343 178.683 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . -135.3 158.26 23.55 Favored Glycine 0 C--O 1.195 -2.297 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 172.909 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -77.61 113.63 15.64 Favored 'General case' 0 C--O 1.176 -2.776 0 C-N-CA 118.364 -1.334 . . . . 0.0 108.245 178.871 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 5.4 tt -83.35 85.74 7.18 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 116.715 -1.994 . . . . 0.0 112.826 -176.461 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.846 ' HB2' HG23 ' A' ' 38' ' ' ILE . 68.6 m95 -59.43 131.06 49.82 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.199 171.861 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.509 HG23 HD21 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -102.37 -5.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.017 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -171.021 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 mt -148.92 57.24 1.03 Allowed 'General case' 1 C--N 1.241 -4.115 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.335 -173.399 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -159.95 164.16 33.61 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.406 -1.718 . . . . 0.0 112.315 179.798 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.02 -16.24 5.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 176.144 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 155.5 40.54 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.668 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -103.13 144.44 28.64 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.062 178.518 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.94 130.68 41.13 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.777 0.984 . . . . 0.0 111.516 -178.207 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.2 -18.5 78.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 177.941 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -13.43 83.64 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.54 -62.04 1.81 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.053 179.933 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.77 -15.19 0.81 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 118.892 -1.623 . . . . 0.0 111.994 178.316 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.626 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.8 m-85 -61.44 170.52 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.708 1.242 . . . . 0.0 112.423 -178.704 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -160.89 -44.87 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 112.123 -2.308 . . . . 0.0 105.917 177.612 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 41' ' ' TYR . 67.9 p -96.04 113.0 24.57 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.859 179.222 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.27 151.24 33.88 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.217 -1.393 . . . . 0.0 113.582 -177.422 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -101.16 140.88 34.84 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.3 175.025 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.843 ' CD2' HD12 ' A' ' 38' ' ' ILE . 72.9 m-85 -120.76 134.8 55.27 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.405 -174.125 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -149.43 66.89 1.01 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.938 178.779 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.455 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 12.1 t-105 -30.55 147.22 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.01 178.564 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.6 Cg_endo -71.37 2.74 6.77 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 C-N-CA 125.368 -0.68 . . . . 0.0 112.31 -5.321 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.509 HD21 HG23 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -110.19 -165.37 1.0 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.945 0.879 . . . . 0.0 111.693 -176.941 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.846 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -178.26 130.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.349 179.541 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -108.42 109.44 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.526 -1.67 . . . . 0.0 107.349 174.202 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.8 t -87.93 134.72 33.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.484 -2.143 . . . . 0.0 114.214 -168.602 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.54 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.7 m-85 -106.56 -178.53 0.6 Allowed Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 178.086 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.3 Cg_exo -55.85 -59.26 0.03 OUTLIER 'Cis proline' 0 N--CA 1.506 2.255 0 N-CA-C 117.618 2.122 . . . . 0.0 117.618 5.981 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.499 0 CA-C-O 116.337 -1.792 . . . . 0.0 108.924 -169.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -44.95 139.15 3.96 Favored Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.95 39.01 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 109.08 -1.161 . . . . 0.0 109.08 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.41 121.23 22.75 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.838 -175.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 8.4 m-85 -78.23 163.5 25.72 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 117.956 -1.498 . . . . 0.0 109.776 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.93 175.27 8.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.092 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -81.81 116.51 21.53 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.859 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -15.18 63.89 Favored Glycine 0 C--N 1.296 -1.643 0 C-N-CA 119.452 -1.356 . . . . 0.0 109.934 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -130.1 111.67 17.0 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.208 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -74.46 -175.31 2.18 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 N-CA-C 109.079 -1.162 . . . . 0.0 109.079 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.19 -104.67 3.21 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 6.2 ptm180 -160.21 165.4 31.59 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.173 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.13 149.94 20.72 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 173.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -77.22 124.51 27.94 Favored 'General case' 0 C--O 1.166 -3.314 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.29 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 tp -84.69 111.07 19.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.037 -1.865 . . . . 0.0 112.543 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.691 ' CB ' HG23 ' A' ' 38' ' ' ILE . 65.6 m95 -100.64 171.72 7.53 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.675 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.32 -161.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.722 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.99 70.89 0.15 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.298 1.523 . . . . 0.0 108.087 -177.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.565 ' C ' ' H ' ' A' ' 21' ' ' THR . 47.7 mtp180 -115.96 -13.02 11.29 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 112.11 -2.314 . . . . 0.0 110.9 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 48.3 4.67 0.02 OUTLIER Glycine 0 C--N 1.263 -3.511 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.38 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -151.92 154.88 36.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.17 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -116.13 151.19 46.37 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.028 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.69 106.12 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 120.721 0.947 . . . . 0.0 110.908 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.31 89.96 1.01 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.42 -11.06 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.212 -1.47 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.61 -18.76 40.08 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.25 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.59 -16.88 2.24 Favored Glycine 0 N--CA 1.482 1.736 0 C-N-CA 119.51 -1.328 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 29.2 m-85 -77.3 167.73 21.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.992 1.377 . . . . 0.0 112.624 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.3 p -162.59 -46.05 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.749 -2.478 . . . . 0.0 105.65 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' TYR . 70.0 p -98.73 124.41 43.57 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.548 -2.114 . . . . 0.0 110.19 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -148.41 156.09 42.05 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.337 178.222 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.39 147.22 39.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.88 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.829 ' CE2' HD12 ' A' ' 38' ' ' ILE . 7.3 m-85 -127.92 131.26 49.38 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.485 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 77.66 1.62 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.49 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.81 158.94 0.27 Allowed Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.151 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.1 Cg_endo -78.89 35.25 0.8 Allowed 'Cis proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.351 -1.104 . . . . 0.0 112.54 -5.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 4.0 m-80 -147.73 -166.47 2.53 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.228 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.829 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -156.63 147.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.511 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.8 m -117.35 136.31 53.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 166.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -107.09 140.04 40.55 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -170.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.3 m-85 -107.83 176.71 1.51 Allowed Pre-proline 0 N--CA 1.509 2.507 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 7.8 Cg_exo -58.99 -53.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.164 0 N-CA-C 117.196 1.96 . . . . 0.0 117.196 5.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.622 0 CA-C-O 116.468 -1.729 . . . . 0.0 109.179 -170.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -57.9 138.09 83.25 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -77.96 35.28 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.6 124.0 29.15 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -176.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 164.57 25.15 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.724 -1.591 . . . . 0.0 110.276 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.2 m -109.17 -178.7 3.64 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.306 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.14 111.45 17.59 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.991 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.18 -12.31 48.47 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.471 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.51 115.1 14.68 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.127 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -161.58 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.89 -93.52 1.6 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.154 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.585 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.98 160.06 30.24 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.744 -178.108 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -145.63 141.96 10.24 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 42.3 m-20 -75.33 125.5 29.1 Favored 'General case' 0 C--O 1.175 -2.846 0 C-N-CA 118.217 -1.393 . . . . 0.0 108.135 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -84.15 132.79 34.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 116.931 -1.908 . . . . 0.0 111.448 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.659 ' CB ' HG23 ' A' ' 38' ' ' ILE . 55.7 m95 -124.88 175.65 7.15 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.481 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.672 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -99.33 -162.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.441 -176.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.22 67.36 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.343 1.544 . . . . 0.0 108.343 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.8 mtp85 -103.81 128.88 51.22 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.1 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.3 -49.44 60.09 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.204 -1.474 . . . . 0.0 109.468 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.33 161.37 38.06 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.954 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.36 150.33 76.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.217 179.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.95 129.18 31.99 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 120.937 1.091 . . . . 0.0 110.667 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 26' ' ' TYR . . . -74.18 -48.16 15.87 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.833 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.32 -9.03 0.57 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.397 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.5 m-85 -79.52 -75.97 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.197 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.2 -13.24 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.002 -1.571 . . . . 0.0 112.08 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.632 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 53.4 m-85 -66.25 172.31 4.01 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 122.618 1.199 . . . . 0.0 112.688 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -161.93 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.312 -2.222 . . . . 0.0 106.354 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -97.56 118.87 35.02 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.429 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.472 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.94 158.47 44.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.044 -1.463 . . . . 0.0 112.884 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.416 ' O ' HG13 ' A' ' 38' ' ' ILE . 26.2 p -113.06 147.64 36.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.49 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.606 ' CE2' HD12 ' A' ' 38' ' ' ILE . 40.4 m-85 -122.19 117.51 26.38 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.5 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 31.8 mttp -130.87 75.24 1.64 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.877 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.468 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -41.45 156.02 0.22 Allowed Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.437 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.6 Cg_endo -78.56 28.71 1.88 Allowed 'Cis proline' 0 C--O 1.206 -1.117 0 C-N-CA 124.167 -1.18 . . . . 0.0 112.123 -3.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.8 m120 -144.98 -160.15 1.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.232 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.672 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -160.93 154.32 3.9 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.046 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.843 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.522 ' N ' HG13 ' A' ' 38' ' ' ILE . 80.4 m -124.56 116.61 22.73 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 117.903 -1.519 . . . . 0.0 107.104 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.632 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.15 148.64 25.59 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.531 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -120.19 167.81 11.8 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.175 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -73.95 159.26 97.87 Favored 'Cis proline' 0 C--O 1.214 -0.71 0 CA-C-O 122.788 1.078 . . . . 0.0 113.838 3.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.191 -2.277 . . . . 0.0 109.928 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -60.74 154.81 55.49 Favored Pre-proline 0 N--CA 1.498 1.939 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.085 -178.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -91.22 40.63 0.35 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 109.929 -0.835 . . . . 0.0 109.929 168.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -77.09 126.97 31.84 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.128 -176.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.37 167.2 21.7 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.832 -179.002 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -175.68 2.78 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.9 177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.0 123.22 26.02 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.236 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.0 -11.69 47.03 Favored Glycine 0 C--N 1.299 -1.476 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.735 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -116.47 109.5 43.85 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.433 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.41 -167.7 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 107.684 -1.698 . . . . 0.0 107.684 172.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.71 -111.67 3.75 Favored Glycine 0 C--N 1.283 -2.381 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.378 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -156.11 154.98 31.77 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 118.245 -1.382 . . . . 0.0 114.189 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.07 153.64 23.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -78.97 125.74 29.78 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.971 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 22.7 tp -85.98 108.15 18.08 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.966 -1.494 . . . . 0.0 111.893 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.698 ' CB ' HG23 ' A' ' 38' ' ' ILE . 60.3 m95 -95.16 176.79 6.09 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.616 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -100.14 -162.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.221 -176.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.575 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.87 70.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.288 1.518 . . . . 0.0 108.27 -176.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' ILE . 40.6 mtp180 -112.47 115.64 29.0 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.05 -23.87 18.21 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 110.795 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.73 158.07 42.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.384 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' N ' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -86.34 151.41 53.64 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.837 178.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.6 Cg_exo -50.11 120.94 6.77 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.174 1.249 . . . . 0.0 111.428 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.04 -4.74 4.83 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.512 -1.327 . . . . 0.0 110.29 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -119.72 1.05 13.77 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 130.684 7.034 . . . . 0.0 130.684 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -79.54 -36.43 38.38 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.274 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.84 -17.15 2.19 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.353 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.1 m-85 -60.78 168.95 2.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.303 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.3 p -162.02 -43.0 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 112.283 -2.235 . . . . 0.0 106.418 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.4 p -97.31 121.56 39.34 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.357 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.83 154.8 34.62 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.81 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -110.17 137.84 47.36 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.643 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.665 ' CE2' HD12 ' A' ' 38' ' ' ILE . 38.9 m-85 -113.71 129.93 56.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.553 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -147.77 81.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.149 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.444 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.47 159.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.349 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 4.6 Cg_endo -78.51 28.23 2.01 Favored 'Cis proline' 0 C--O 1.21 -0.879 0 C-N-CA 124.273 -1.136 . . . . 0.0 111.813 -5.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.444 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.8 m120 -147.06 -172.35 3.98 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.709 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.698 HG23 ' CB ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -154.98 147.92 12.93 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.833 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -116.64 142.53 46.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.714 165.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.5 t -112.63 148.53 34.41 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.499 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -119.86 170.44 6.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.15 158.08 83.44 Favored 'Cis proline' 0 CA--C 1.503 -1.039 0 CA-C-O 122.857 1.107 . . . . 0.0 113.661 4.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.966 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.468 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.639 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -40.79 138.72 1.26 Allowed Pre-proline 0 N--CA 1.503 2.181 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.509 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -74.75 57.76 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.06 -1.939 . . . . 0.0 107.06 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.59 138.97 45.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.46 -179.13 6.17 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.869 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -162.66 1.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.111 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 9' ' ' LYS . 8.7 m -59.9 110.94 1.29 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.473 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.8 3.67 0.12 Allowed Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.224 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 7' ' ' SER . 61.5 mttt -94.14 116.81 66.88 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.474 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 9.8 Cg_endo -73.69 -166.19 0.3 Allowed 'Trans proline' 0 C--O 1.206 -1.093 0 N-CA-C 109.264 -1.091 . . . . 0.0 109.264 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 -120.33 5.29 Favored Glycine 0 C--N 1.29 -2.001 0 C-N-CA 118.674 -1.726 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.638 HH22 ' CG ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -161.1 162.19 31.47 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 118.185 -1.406 . . . . 0.0 113.42 -178.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.13 148.31 19.93 Favored Glycine 0 C--O 1.199 -2.092 0 N-CA-C 106.917 -2.473 . . . . 0.0 106.917 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.638 ' CG ' HH22 ' A' ' 12' ' ' ARG . 10.1 m-20 -76.62 128.41 34.65 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.632 -1.227 . . . . 0.0 109.142 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 1.1 tt -88.57 98.43 11.65 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 116.962 -1.895 . . . . 0.0 112.087 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.711 ' HB2' HG23 ' A' ' 38' ' ' ILE . 62.0 m95 -77.34 163.86 26.05 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 111.779 -2.464 . . . . 0.0 109.442 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.697 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -85.55 -158.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 118.846 -1.141 . . . . 0.0 111.268 -177.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.67 72.54 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.916 1.341 . . . . 0.0 109.053 -175.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' ILE . 4.1 mtp180 -121.55 110.17 15.69 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.086 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.88 -20.31 40.36 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.657 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.14 153.64 50.44 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.838 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.82 151.26 43.4 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.046 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -47.81 112.6 0.59 Allowed 'Trans proline' 0 C--O 1.214 -0.724 0 C-N-CA 120.971 1.114 . . . . 0.0 111.444 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.46 -25.93 55.89 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -22.42 71.91 Favored Glycine 0 N--CA 1.485 1.951 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.456 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.51 175.74 10.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.141 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.27 70.68 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 29' ' ' THR . 41.6 m-85 -59.94 167.92 2.04 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.051 -1.459 . . . . 0.0 110.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.0 p -163.13 -43.0 0.03 OUTLIER 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.7 -2.045 . . . . 0.0 106.225 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 8.5 p -97.36 118.46 33.88 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.794 -2.003 . . . . 0.0 109.156 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.556 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.08 152.01 36.63 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.876 -1.53 . . . . 0.0 113.52 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.448 ' O ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -101.66 156.05 17.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.981 174.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.827 ' CE2' HD12 ' A' ' 38' ' ' ILE . 22.4 m-85 -134.98 125.76 27.24 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.545 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 35' ' ' TRP . 6.4 mttt -137.72 71.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.958 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.468 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 17.0 t-105 -38.82 146.19 0.33 Allowed Pre-proline 0 N--CA 1.508 2.46 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.864 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 7.3 Cg_endo -78.06 38.44 0.46 Allowed 'Cis proline' 0 N--CA 1.495 1.603 0 CA-C-N 118.52 0.507 . . . . 0.0 111.69 -5.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.47 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.5 m120 -148.09 -168.03 2.97 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.509 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.827 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.03 144.9 3.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.298 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.65 140.37 50.02 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 117.488 -1.685 . . . . 0.0 107.586 169.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -114.62 135.8 53.75 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -169.251 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -107.96 -179.51 0.71 Allowed Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.555 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 3.0 Cg_exo -64.3 -49.21 0.18 OUTLIER 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 122.036 1.763 . . . . 0.0 116.587 5.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.781 0 CA-C-O 116.28 -1.819 . . . . 0.0 109.565 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -48.86 144.59 7.12 Favored Pre-proline 0 N--CA 1.505 2.317 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.735 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.26 35.46 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 167.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -75.38 142.87 43.03 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -87.36 166.01 15.17 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 117.79 -1.564 . . . . 0.0 109.335 177.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.469 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -108.84 -173.3 2.24 Favored 'General case' 0 N--CA 1.51 2.538 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.727 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -71.07 117.23 12.31 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.921 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.0 -1.59 3.39 Favored Glycine 0 C--N 1.297 -1.589 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.141 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 7' ' ' SER . 5.6 mttt -108.82 118.05 52.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.367 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -74.87 -168.91 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.14 -113.47 4.13 Favored Glycine 0 C--N 1.291 -1.918 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.178 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.685 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 6.5 ptm180 -157.66 163.09 38.58 Favored 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 118.184 -1.407 . . . . 0.0 114.086 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -148.81 151.21 23.41 Favored Glycine 0 N--CA 1.494 2.503 1 N-CA-C 126.364 5.305 . . . . 0.0 126.364 173.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.9 m-20 -77.38 118.57 19.97 Favored 'General case' 0 C--O 1.171 -3.055 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.924 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 48.9 tp -85.7 102.55 13.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.002 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HB2' HG23 ' A' ' 38' ' ' ILE . 58.7 m95 -91.79 165.07 13.46 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 112.3 -2.227 . . . . 0.0 109.968 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -90.61 -159.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.632 -177.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.77 73.87 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.718 1.247 . . . . 0.0 108.793 -174.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -115.26 123.13 48.03 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.317 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.7 -35.27 73.3 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 160.54 42.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.751 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.09 163.54 59.42 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.669 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.51 -164.98 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 121.676 1.584 . . . . 0.0 112.035 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.62 33.56 2.47 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.17 -2.52 1.58 Allowed Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.789 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.45 -70.71 0.62 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.223 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.33 17.19 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.509 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 43.4 m-85 -76.41 171.13 15.09 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.577 1.179 . . . . 0.0 112.068 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.3 p -161.42 -43.95 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.142 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.24 134.2 40.85 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.123 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -160.04 159.61 32.21 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.887 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.0 p -120.9 133.7 55.29 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.567 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.687 ' CE2' HD12 ' A' ' 38' ' ' ILE . 76.1 m-85 -109.1 114.02 27.39 Favored 'General case' 0 C--N 1.259 -3.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.757 -174.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -129.23 71.86 1.45 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.595 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.521 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.46 155.35 0.19 Allowed Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.259 -178.362 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.6 Cg_endo -78.45 33.12 0.97 Allowed 'Cis proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.409 -1.08 . . . . 0.0 111.417 -3.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.521 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 5.3 m120 -147.85 -160.48 1.17 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.805 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -167.87 144.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.383 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 8.1 m -113.57 109.29 18.39 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.577 168.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -80.73 139.85 35.88 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.527 -172.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.9 m-85 -110.97 -177.84 0.49 Allowed Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 19.1 Cg_exo -56.72 -55.43 0.11 OUTLIER 'Cis proline' 0 N--CA 1.505 2.169 0 CA-C-N 122.31 1.861 . . . . 0.0 116.698 5.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.685 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.388 0 CA-C-O 116.379 -1.772 . . . . 0.0 109.228 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.562 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -41.94 143.74 0.94 Allowed Pre-proline 0 N--CA 1.503 2.184 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.96 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.38 57.05 4.67 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 N-CA-C 108.737 -1.293 . . . . 0.0 108.737 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.01 145.95 39.86 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.473 -176.597 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.71 -175.77 5.45 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.135 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.95 179.82 5.85 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.64 0.733 . . . . 0.0 109.685 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.15 114.43 21.77 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.23 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.65 -10.53 72.53 Favored Glycine 0 C--N 1.295 -1.714 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.955 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -117.24 106.85 46.35 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.872 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.8 146.44 66.14 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.676 -1.317 . . . . 0.0 108.676 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.71 -104.58 0.84 Allowed Glycine 0 C--N 1.285 -2.277 1 N-CA-C 129.814 6.686 . . . . 0.0 129.814 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -161.14 151.35 17.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.761 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.14 166.74 25.65 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.7 m-20 -79.68 114.58 18.71 Favored 'General case' 0 C--O 1.172 -2.982 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.158 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.562 ' N ' ' HB1' ' A' ' 1' ' ' ALA . 10.3 tp -84.13 96.24 8.87 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.091 -1.843 . . . . 0.0 113.205 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.817 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.5 m95 -69.94 145.81 51.63 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 111.818 -2.446 . . . . 0.0 104.837 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -110.25 -8.41 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -168.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 2.2 mt -153.1 59.63 0.78 Allowed 'General case' 0 C--N 1.248 -3.805 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.872 -173.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -154.89 156.32 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.581 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -109.01 -7.88 28.38 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 174.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 157.0 47.26 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.483 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -107.41 149.4 38.74 Favored Pre-proline 0 N--CA 1.494 1.748 0 C-N-CA 119.62 -0.832 . . . . 0.0 108.867 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -66.35 142.06 64.63 Favored 'Trans proline' 0 C--O 1.217 -0.568 0 C-N-CA 120.6 0.866 . . . . 0.0 111.177 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.62 63.5 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.77 -19.28 27.43 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.684 -1.245 . . . . 0.0 110.458 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.49 -34.59 41.19 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.958 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.95 -3.03 19.41 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.303 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.666 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.5 m-85 -60.5 169.17 1.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.691 1.234 . . . . 0.0 112.561 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.7 p -162.32 -43.76 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.263 -2.244 . . . . 0.0 106.027 176.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.84 114.15 26.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.62 178.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -146.35 154.14 41.32 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.884 -177.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -97.33 149.39 22.14 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.852 175.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.82 ' CD2' HD12 ' A' ' 38' ' ' ILE . 71.1 m-85 -132.01 119.99 21.81 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.009 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -132.41 72.07 1.49 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.441 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -45.57 153.57 0.59 Allowed Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.084 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.52 -5.5 10.08 Favored 'Cis proline' 0 N--CA 1.485 1.012 0 C-N-CA 124.299 -1.125 . . . . 0.0 112.038 -5.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.4 m120 -94.87 178.75 5.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.775 0.797 . . . . 0.0 110.851 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.82 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -158.93 140.43 4.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.034 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -120.19 116.44 25.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.307 172.155 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.666 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -95.42 144.47 25.91 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.866 -1.97 . . . . 0.0 114.955 -167.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -116.85 167.92 9.81 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.63 160.12 88.01 Favored 'Cis proline' 0 C--O 1.217 -0.556 0 CA-C-O 123.262 1.276 . . . . 0.0 114.822 3.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.603 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.251 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.679 ' HB3' ' H ' ' A' ' 15' ' ' LEU . . . -39.12 137.79 0.91 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.38 36.09 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 109.187 -1.12 . . . . 0.0 109.187 166.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -82.07 122.71 28.18 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.388 -176.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.48 164.14 24.17 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.833 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.36 -178.39 4.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.072 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t -76.8 127.02 31.96 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.31 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.58 -18.08 31.49 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.562 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.08 105.95 20.04 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.21 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.04 -166.34 0.31 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.26 -98.52 2.38 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.729 -1.7 . . . . 0.0 110.862 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 43' ' ' HIS . 3.1 ptm180 -162.32 160.82 27.14 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.784 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -139.17 150.96 21.56 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 175.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.68 111.59 14.93 Favored 'General case' 0 C--O 1.171 -3.069 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.445 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.679 ' H ' ' HB3' ' A' ' 2' ' ' ALA . 6.3 tt -85.2 93.6 8.7 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.623 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.793 ' HB2' HG23 ' A' ' 38' ' ' ILE . 61.5 m95 -70.13 122.75 20.04 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 112.293 -2.231 . . . . 0.0 107.287 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.26 -8.08 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 C-N-CA 118.983 -1.087 . . . . 0.0 113.499 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 mt -151.89 74.51 1.11 Allowed 'General case' 0 C--N 1.254 -3.553 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.464 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.755 ' CG ' HH11 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -162.95 142.85 9.11 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.222 -1.791 . . . . 0.0 113.085 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.17 -22.04 23.57 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.533 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 1.4 p -143.48 152.32 41.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.514 -0.843 . . . . 0.0 109.24 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -88.53 148.11 41.3 Favored Pre-proline 0 C--N 1.286 -2.178 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.366 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.08 178.44 0.4 Allowed 'Trans proline' 0 C--O 1.219 -0.442 0 C-N-CA 120.379 0.719 . . . . 0.0 111.211 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.15 8.36 25.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.22 -16.36 15.12 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -84.67 -6.89 59.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.04 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.73 11.49 85.18 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.758 -1.21 . . . . 0.0 112.326 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 40.5 m-85 -67.19 170.57 6.86 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.885 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -161.91 -44.07 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 112.763 -2.017 . . . . 0.0 106.691 178.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 41' ' ' TYR . 3.2 p -96.86 125.88 41.62 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -160.07 147.5 16.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 117.19 -1.804 . . . . 0.0 113.132 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 146.42 32.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.002 -1.453 . . . . 0.0 108.049 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.711 ' CE2' HD12 ' A' ' 38' ' ' ILE . 51.0 m-85 -118.01 140.72 49.34 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.688 -170.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 35' ' ' TRP . 7.9 mttt -142.27 59.27 1.46 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.965 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -40.41 147.36 0.38 Allowed Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.31 -176.017 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.79 2.1 6.24 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.635 -4.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' C ' HG22 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -101.23 -160.59 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.725 0.774 . . . . 0.0 111.359 -177.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.793 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 171.34 141.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.471 -178.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 79.4 m -110.13 110.86 21.89 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 117.741 -1.584 . . . . 0.0 107.176 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.0 t -88.98 151.16 22.46 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.924 -171.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' SER . 3.0 m-85 -125.33 163.14 40.11 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -79.16 162.61 86.47 Favored 'Cis proline' 0 C--N 1.326 -0.64 0 CA-C-O 123.324 1.302 . . . . 0.0 115.374 5.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.393 0 CA-C-N 111.11 -2.768 . . . . 0.0 109.447 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -42.63 143.75 1.1 Allowed Pre-proline 0 N--CA 1.505 2.295 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -83.34 38.55 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 167.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.87 127.09 33.59 Favored 'General case' 0 N--CA 1.513 2.685 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.082 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.61 159.92 27.83 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 117.924 -1.51 . . . . 0.0 110.299 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.2 m -108.19 -172.89 2.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.38 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -57.68 140.02 52.3 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.327 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 29.01 11.1 0.0 OUTLIER Glycine 0 N--CA 1.481 1.633 1 N-CA-C 125.134 4.814 . . . . 0.0 125.134 -174.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.0 mttt -111.25 102.06 52.01 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 114.385 -0.908 . . . . 0.0 110.041 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.04 -164.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 120.946 1.097 . . . . 0.0 109.303 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.89 -103.17 1.97 Allowed Glycine 0 C--N 1.29 -1.994 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.543 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -161.19 166.12 28.32 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 118.063 -1.455 . . . . 0.0 114.054 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.01 154.21 25.24 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.52 126.62 31.11 Favored 'General case' 0 C--O 1.178 -2.665 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.243 178.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 28.0 tp -87.89 108.41 19.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.334 -1.346 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.674 ' CB ' HG23 ' A' ' 38' ' ' ILE . 70.1 m95 -99.65 161.74 13.43 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.313 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.766 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -87.35 -158.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.136 -175.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.96 66.02 0.1 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.464 1.602 . . . . 0.0 107.793 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.32 105.81 15.94 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 112.272 -2.24 . . . . 0.0 110.631 -179.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -44.58 -35.17 3.98 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.03 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -141.42 163.2 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.153 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 157.34 56.21 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.937 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.8 119.42 5.62 Favored 'Trans proline' 0 C--O 1.208 -0.991 0 C-N-CA 120.812 1.008 . . . . 0.0 110.541 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.17 176.83 25.82 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.094 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.76 8.1 38.9 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.97 -168.54 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.18 0.04 74.75 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.428 -1.368 . . . . 0.0 111.443 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 26.1 m-85 -76.55 170.35 16.57 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.371 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -162.11 -44.74 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 112.338 -2.21 . . . . 0.0 106.376 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.6 p -99.0 128.09 45.06 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.867 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.5 142.73 25.09 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 117.939 -1.504 . . . . 0.0 112.385 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 22.2 p -99.62 137.12 38.55 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.778 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CE2' HD12 ' A' ' 38' ' ' ILE . 51.1 m-85 -114.93 121.08 42.08 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.2 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -140.41 77.23 1.59 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.711 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.4 158.58 0.12 Allowed Pre-proline 0 C--N 1.307 -1.27 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.515 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.6 Cg_endo -78.58 30.07 1.53 Allowed 'Cis proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.402 -1.083 . . . . 0.0 111.501 -6.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 8.1 m120 -145.89 -171.28 3.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -153.23 141.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 17.4 m -112.68 117.27 31.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.492 -1.683 . . . . 0.0 106.997 168.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.11 149.19 25.31 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.465 -172.099 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -122.15 174.52 3.21 Favored Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.9 Cg_endo -86.15 155.31 53.52 Favored 'Cis proline' 0 CA--C 1.505 -0.959 0 CA-C-O 122.854 1.106 . . . . 0.0 113.362 -1.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.266 -3.035 0 CA-C-N 111.876 -2.42 . . . . 0.0 109.795 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.564 ' HB3' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -47.96 146.01 4.44 Favored Pre-proline 0 N--CA 1.504 2.245 0 C-N-CA 119.784 -0.767 . . . . 0.0 112.11 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.25 37.93 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 108.564 -1.36 . . . . 0.0 108.564 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.56 124.86 28.6 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -174.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.61 163.18 26.47 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.806 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -100.82 -179.54 4.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.73 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' LYS . 88.7 p -70.96 122.02 19.21 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.47 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.93 -15.59 1.24 Allowed Glycine 0 C--N 1.296 -1.659 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.585 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' SER . 47.6 mttt -106.8 117.01 57.81 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.758 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -77.13 -161.75 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.929 1.086 . . . . 0.0 109.287 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.91 -111.16 3.77 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.232 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.632 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -157.98 157.46 33.07 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.434 -1.306 . . . . 0.0 112.523 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.75 147.5 18.96 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.37 128.24 33.36 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.527 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 40.7 tp -87.51 109.49 19.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.021 -1.472 . . . . 0.0 111.984 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.68 ' HB2' HG23 ' A' ' 38' ' ' ILE . 65.4 m95 -98.16 179.2 4.83 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.844 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.734 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -103.59 -160.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.162 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.389 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.485 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.86 71.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.337 1.541 . . . . 0.0 108.329 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ILE . 12.1 mtp85 -114.12 131.75 56.3 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.197 -2.274 . . . . 0.0 111.236 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.22 86.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.302 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 163.25 37.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.966 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.29 160.26 73.43 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.1 Cg_exo -51.57 92.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 120.792 0.995 . . . . 0.0 111.008 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' CYS . . . -7.91 -32.07 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 1 N-CA-C 132.796 7.878 . . . . 0.0 132.796 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -134.9 43.09 1.28 Allowed Glycine 0 N--CA 1.499 2.843 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.311 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.85 -164.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.417 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.05 -1.61 56.64 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.654 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 m-85 -86.1 169.25 13.31 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 123.129 1.442 . . . . 0.0 113.338 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -160.79 -43.66 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.732 175.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 41' ' ' TYR . 5.1 p -97.94 138.08 35.81 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.594 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.23 151.02 20.6 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.918 176.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.2 p -113.09 142.38 45.81 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.834 176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.768 ' CE2' HD12 ' A' ' 38' ' ' ILE . 18.5 m-85 -114.28 128.96 56.61 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.869 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.539 ' NZ ' ' SG ' ' A' ' 4' ' ' CYS . 12.9 mttt -126.09 67.68 1.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.241 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.448 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 40.2 t-105 -36.55 144.87 0.26 Allowed Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.328 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 2.2 Cg_endo -77.6 35.48 0.59 Allowed 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 125.801 -0.5 . . . . 0.0 112.399 -5.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.8 m120 -145.73 -160.13 1.1 Allowed 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.339 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.768 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -166.37 144.94 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.037 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.416 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.5 m -112.8 147.03 37.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 3.0 t -115.15 143.88 44.54 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.613 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -113.73 -177.22 0.42 Allowed Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.541 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 5.5 Cg_exo -62.84 -51.0 0.16 OUTLIER 'Cis proline' 0 N--CA 1.506 2.22 0 CA-C-N 121.866 1.702 . . . . 0.0 115.907 6.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.632 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.754 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.358 -171.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -40.69 149.22 0.33 Allowed Pre-proline 0 N--CA 1.504 2.262 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -87.67 38.62 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 N-CA-C 109.321 -1.069 . . . . 0.0 109.321 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.66 124.14 27.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.669 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.78 -176.48 4.96 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.109 -1.436 . . . . 0.0 110.132 -176.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.17 -173.91 4.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.037 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -68.85 118.18 11.47 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.616 -176.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.47 -12.62 1.84 Allowed Glycine 0 C--N 1.297 -1.599 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.532 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.9 mttm -96.4 135.47 22.45 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.159 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 9' ' ' LYS . 11.3 Cg_exo -47.14 -169.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.212 1.941 . . . . 0.0 113.875 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.09 32.36 0.25 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 114.297 -1.32 . . . . 0.0 113.959 -174.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.84 137.87 7.83 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 116.294 -2.162 . . . . 0.0 115.352 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -151.08 160.92 28.88 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.75 122.07 26.13 Favored 'General case' 0 C--O 1.18 -2.587 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.186 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 4.0 tt -89.18 118.3 28.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 117.624 -1.631 . . . . 0.0 111.711 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.658 ' CB ' HG23 ' A' ' 38' ' ' ILE . 57.0 m95 -103.41 170.99 7.62 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.351 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.817 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -96.16 -157.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.744 -175.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.805 ' H ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.94 67.57 0.15 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.363 1.554 . . . . 0.0 108.4 -177.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.7 mtt-85 -116.07 100.3 7.85 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.151 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -41.68 -26.48 0.26 Allowed Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.701 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -147.21 160.47 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.147 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -87.13 150.17 49.03 Favored Pre-proline 0 C--N 1.292 -1.9 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.086 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.44 163.54 17.55 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 110.888 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.26 -10.75 47.41 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.84 -26.73 67.43 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.726 -1.226 . . . . 0.0 111.155 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -87.35 -32.95 19.35 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.874 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.56 16.32 29.5 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.813 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 58.8 m-85 -53.97 173.47 0.06 Allowed 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.954 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.0 p -161.33 -46.48 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 112.909 -1.95 . . . . 0.0 106.083 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.84 120.06 38.64 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.646 -2.07 . . . . 0.0 109.312 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.36 148.39 30.32 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.023 -1.471 . . . . 0.0 112.618 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 143.94 40.3 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.553 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.796 ' CE2' HD12 ' A' ' 38' ' ' ILE . 24.7 m-85 -113.3 137.23 51.8 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.307 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.598 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 11.0 mmtt -121.46 70.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.424 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -40.03 140.84 0.86 Allowed Pre-proline 0 C--N 1.294 -1.822 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.091 -176.205 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -72.67 -22.77 11.79 Favored 'Cis proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.743 -4.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.453 ' ND2' ' CD1' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -78.63 -161.38 0.28 Allowed 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 -176.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.796 HD12 ' CE2' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -164.7 154.19 2.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.873 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.8 m -124.66 127.15 46.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.539 164.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -96.53 153.9 17.58 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -172.102 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.562 ' O ' ' O ' ' A' ' 30' ' ' SER . 4.6 m-85 -127.66 165.72 28.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.75 159.21 91.74 Favored 'Cis proline' 0 C--N 1.323 -0.805 0 CA-C-O 122.783 1.076 . . . . 0.0 114.47 1.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.596 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.387 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.259 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -49.82 147.36 6.57 Favored Pre-proline 0 N--CA 1.509 2.49 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -87.12 34.75 0.44 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.35 -1.442 . . . . 0.0 108.35 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -74.77 116.33 15.36 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.219 -174.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.6 164.12 24.92 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 117.588 -1.645 . . . . 0.0 108.87 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.58 -178.94 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.36 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 99.9 p -76.99 124.12 27.31 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.143 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.25 -13.16 28.38 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.478 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -115.5 108.9 46.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.981 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.32 -154.21 0.04 OUTLIER 'Trans proline' 0 C--O 1.208 -0.976 0 N-CA-C 109.033 -1.179 . . . . 0.0 109.033 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 -108.92 2.63 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 119.254 -1.45 . . . . 0.0 111.507 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.714 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -160.16 168.63 25.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 118.923 -1.111 . . . . 0.0 113.023 -176.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.7 146.49 18.05 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.444 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -79.48 118.07 21.01 Favored 'General case' 0 C--O 1.171 -3.058 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.115 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 18.1 tp -85.76 92.6 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.526 -1.67 . . . . 0.0 113.723 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.81 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.3 m95 -75.53 126.27 30.67 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.801 -1.999 . . . . 0.0 107.744 172.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -94.88 -7.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.135 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -170.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mt -153.13 73.39 0.99 Allowed 'General case' 0 C--N 1.253 -3.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.469 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -166.16 148.59 7.06 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 116.637 -2.025 . . . . 0.0 113.204 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.08 -13.22 27.62 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -142.87 153.96 43.66 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.235 -0.982 . . . . 0.0 109.22 177.276 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -95.51 152.52 39.29 Favored Pre-proline 0 C--N 1.288 -2.085 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.832 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.83 -170.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.221 1.281 . . . . 0.0 111.651 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.77 -19.27 3.4 Favored Glycine 0 N--CA 1.489 2.212 1 N-CA-C 129.221 6.448 . . . . 0.0 129.221 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.75 4.57 68.91 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -79.35 -56.61 4.21 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.467 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.8 7.05 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.82 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' O ' HG23 ' A' ' 29' ' ' THR . 34.1 m-85 -76.54 165.77 24.32 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 123.016 1.388 . . . . 0.0 112.769 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.6 p -163.32 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 111.757 -2.474 . . . . 0.0 106.005 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' TYR . 13.9 p -98.7 124.26 43.42 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.378 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -153.63 157.1 39.13 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.816 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 147.81 39.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.62 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CE2' HD12 ' A' ' 38' ' ' ILE . 13.1 m-85 -124.31 139.3 54.04 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.539 -172.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 73.72 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.404 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.93 155.42 0.33 Allowed Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.175 -174.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 9.5 Cg_endo -74.87 10.25 8.54 Favored 'Cis proline' 0 N--CA 1.485 1.016 0 C-N-CA 124.293 -1.128 . . . . 0.0 111.142 -2.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.2 m-20 -111.49 -162.07 0.78 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.871 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.813 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -177.33 138.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.536 -178.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 29.0 m -108.21 113.35 26.4 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 117.698 -1.601 . . . . 0.0 106.939 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -93.22 130.72 38.82 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.921 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' CE2' ' O ' ' A' ' 12' ' ' ARG . 24.1 m-85 -106.89 -174.55 0.32 Allowed Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 35.9 Cg_exo -54.81 -49.01 0.14 OUTLIER 'Cis proline' 0 N--CA 1.501 1.913 0 CA-C-N 122.745 2.016 . . . . 0.0 116.727 5.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.714 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.742 0 CA-C-O 116.349 -1.786 . . . . 0.0 109.1 -172.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.742 ' H2 ' HH12 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -39.13 146.41 0.34 Allowed Pre-proline 0 N--CA 1.508 2.471 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -84.33 20.36 1.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 N-CA-C 107.993 -1.579 . . . . 0.0 107.993 164.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.589 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -81.12 115.41 20.54 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.4 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.85 178.22 8.11 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.43 -174.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -176.91 3.24 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.839 0.828 . . . . 0.0 110.152 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 p -77.66 128.02 33.42 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.34 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.67 -9.19 11.35 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -119.81 108.62 38.76 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -73.95 -163.44 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 -110.45 3.74 Favored Glycine 0 C--N 1.282 -2.472 0 C-N-CA 118.535 -1.793 . . . . 0.0 110.65 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.742 HH12 ' H2 ' ' A' ' 1' ' ' ALA . 0.3 OUTLIER -163.11 164.7 25.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 117.812 -1.555 . . . . 0.0 114.012 -177.355 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.74 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -146.26 -170.3 14.76 Favored Glycine 0 N--CA 1.502 3.053 1 N-CA-C 127.074 5.59 . . . . 0.0 127.074 173.01 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -99.32 127.22 45.31 Favored 'General case' 0 C--O 1.182 -2.463 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.99 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 4.2 tp -102.0 97.1 7.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.922 1.344 . . . . 0.0 110.256 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.74 ' HB2' HG23 ' A' ' 38' ' ' ILE . 80.0 m95 -89.02 151.99 21.95 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.963 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.886 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.38 -157.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.653 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.4 -178.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -70.07 76.82 0.5 Allowed 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 123.627 1.68 . . . . 0.0 109.236 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 21' ' ' THR . 9.9 mtt180 -126.45 75.93 1.58 Allowed 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 110.987 -2.824 . . . . 0.0 110.715 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -17.54 -32.02 0.0 OUTLIER Glycine 0 N--CA 1.499 2.858 1 N-CA-C 126.665 5.426 . . . . 0.0 126.665 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -140.41 154.14 46.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.297 176.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -86.12 153.73 57.13 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.14 -178.505 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.81 172.22 4.99 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.157 1.238 . . . . 0.0 110.81 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.42 18.17 35.92 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.79 -13.63 25.19 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.662 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -90.28 1.93 56.0 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.824 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 -0.14 39.22 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.732 -1.223 . . . . 0.0 111.367 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.678 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.9 m-85 -54.83 169.97 0.19 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.787 1.279 . . . . 0.0 111.736 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.5 p -160.18 -44.82 0.05 OUTLIER 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 112.174 -2.285 . . . . 0.0 105.175 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 12.4 p -98.25 137.39 37.06 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 112.968 -1.924 . . . . 0.0 108.621 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.474 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.0 OUTLIER -155.16 148.98 25.51 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 117.707 -1.597 . . . . 0.0 113.116 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.425 ' O ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -93.43 158.34 15.77 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.852 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.5 m-85 -136.95 131.47 33.06 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.793 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 2.1 mttt -136.56 77.96 1.68 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.43 150.98 1.48 Allowed Pre-proline 0 C--N 1.293 -1.886 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.111 -177.112 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' LEU . 1.9 Cg_endo -69.17 -19.18 10.62 Favored 'Cis proline' 0 C--O 1.198 -1.499 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.285 -3.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.9 -169.44 2.64 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.852 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -149.22 144.74 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.652 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.3 m -117.21 116.52 27.44 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.731 -1.187 . . . . 0.0 107.902 171.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.678 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -97.46 155.0 17.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -131.35 173.13 6.23 Favored Pre-proline 0 N--CA 1.503 2.18 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.9 Cg_endo -88.65 156.05 37.77 Favored 'Cis proline' 0 C--O 1.214 -0.685 0 N-CA-C 115.764 1.409 . . . . 0.0 115.764 0.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 110.985 -2.825 . . . . 0.0 110.109 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 14' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -41.86 146.88 0.56 Allowed Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.827 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -76.6 52.67 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 N-CA-C 106.075 -2.317 . . . . 0.0 106.075 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -68.1 131.18 44.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.13 175.02 11.02 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.167 -1.413 . . . . 0.0 110.769 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -158.22 177.43 11.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.779 174.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.7 m -86.77 106.35 17.62 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.894 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.68 -17.78 8.21 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.5 mptt -134.42 136.83 26.52 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.126 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 9' ' ' LYS . 6.0 Cg_exo -50.52 -156.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.378 2.052 . . . . 0.0 114.033 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 31.8 0.1 OUTLIER Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HG2' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -161.34 137.26 8.01 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 115.775 -2.37 . . . . 0.0 116.071 175.28 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.63 -166.82 10.83 Favored Glycine 0 N--CA 1.509 3.546 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.733 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.8 m-20 -108.18 127.31 53.71 Favored 'General case' 0 C--O 1.181 -2.52 0 CA-C-O 118.27 -0.872 . . . . 0.0 109.203 176.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 2.6 tp -91.04 135.61 33.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.964 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.706 ' CB ' HG23 ' A' ' 38' ' ' ILE . 59.7 m95 -127.73 -176.17 3.69 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 111.434 -2.621 . . . . 0.0 108.949 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 18' ' ' LEU . 1.8 mt -105.02 -167.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -173.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.803 ' H ' HG22 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -68.03 68.98 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.978 1.371 . . . . 0.0 107.606 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.1 mtt-85 -116.75 125.45 51.67 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 112.223 -2.262 . . . . 0.0 110.4 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.27 69.61 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -142.98 160.72 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.768 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 158.01 42.77 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.268 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.07 125.56 15.49 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.3 1.333 . . . . 0.0 110.899 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 3.86 69.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.593 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.94 -12.73 58.73 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.56 -46.5 15.64 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.459 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.43 -7.89 5.31 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 29' ' ' THR . 42.9 m-85 -50.22 171.27 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.66 1.219 . . . . 0.0 111.187 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 28' ' ' TYR . 10.6 p -161.87 -45.6 0.04 OUTLIER 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 112.34 -2.209 . . . . 0.0 105.874 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.95 130.19 44.82 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.729 -2.032 . . . . 0.0 110.298 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -157.51 157.29 33.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 117.861 -1.536 . . . . 0.0 112.148 177.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 140.02 53.18 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.592 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.747 ' CE2' HD12 ' A' ' 38' ' ' ILE . 22.4 m-85 -112.88 136.47 52.49 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.731 -173.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -142.76 75.5 1.49 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.257 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.523 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -45.51 156.79 0.4 Allowed Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.106 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.7 Cg_endo -78.91 30.72 1.47 Allowed 'Cis proline' 0 C--O 1.194 -1.68 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.196 -1.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.3 m120 -146.62 -168.68 3.09 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.173 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.747 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -152.62 149.03 13.85 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.024 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.115 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -119.84 120.06 35.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.555 167.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -91.11 157.57 17.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.254 -171.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' O ' ' O ' ' A' ' 30' ' ' SER . 15.4 m-85 -133.24 167.62 22.04 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.71 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.46 160.93 95.49 Favored 'Cis proline' 0 C--O 1.213 -0.736 0 CA-C-O 122.591 0.996 . . . . 0.0 113.585 0.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.48 ' CE1' ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.579 -2.101 . . . . 0.0 109.859 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -41.9 147.52 0.53 Allowed Pre-proline 0 N--CA 1.502 2.138 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -85.76 28.46 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 N-CA-C 106.996 -1.963 . . . . 0.0 106.996 164.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.8 p -88.51 116.58 26.85 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.407 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -177.1 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.803 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -119.79 -176.46 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.567 178.239 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.56 116.86 20.01 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.425 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.7 79.32 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.435 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mppp? -119.74 117.96 32.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.503 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.44 178.58 7.24 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 121.236 1.291 . . . . 0.0 109.821 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.52 -100.19 2.12 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.409 -1.377 . . . . 0.0 111.294 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.1 ptm180 -162.03 178.23 9.02 Favored 'General case' 0 C--O 1.209 -1.078 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.364 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -162.57 165.34 36.15 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 175.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -87.19 132.25 33.93 Favored 'General case' 0 C--O 1.18 -2.553 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.34 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 10.7 tp -97.18 100.07 11.54 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.647 1.213 . . . . 0.0 111.802 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.665 ' HB2' HG23 ' A' ' 38' ' ' ILE . 67.0 m95 -93.01 160.88 14.67 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 112.515 -2.13 . . . . 0.0 110.831 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -84.45 -163.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.919 -176.155 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -68.39 71.77 0.19 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.74 1.257 . . . . 0.0 107.984 -176.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' THR . 38.8 mtt180 -122.08 86.8 2.64 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.765 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -22.23 -28.02 0.0 OUTLIER Glycine 0 N--CA 1.495 2.593 1 N-CA-C 125.837 5.095 . . . . 0.0 125.837 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' ARG . 1.4 p -150.01 151.35 33.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.04 -1.08 . . . . 0.0 109.866 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -85.72 151.57 55.58 Favored Pre-proline 0 C--N 1.289 -2.053 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.385 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.23 146.88 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.073 1.182 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.54 3.44 17.49 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.066 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.68 9.25 5.81 Favored Glycine 0 N--CA 1.491 2.32 1 N-CA-C 130.575 6.99 . . . . 0.0 130.575 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.67 14.94 8.96 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.45 79.82 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.382 -1.389 . . . . 0.0 111.619 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.623 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.7 m-85 -69.91 168.6 14.93 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.188 1.47 . . . . 0.0 113.492 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.6 p -161.57 -46.69 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 111.549 -2.569 . . . . 0.0 105.911 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 119.7 38.28 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.808 -1.996 . . . . 0.0 110.319 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -144.03 152.98 41.73 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.526 178.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -108.76 149.18 29.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.429 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.78 ' CE2' HD12 ' A' ' 38' ' ' ILE . 18.5 m-85 -125.98 134.35 51.52 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.962 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -151.53 76.57 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.603 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.479 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.65 156.65 0.19 Allowed Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.593 -178.109 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 5.8 Cg_endo -79.09 35.05 0.87 Allowed 'Cis proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.768 -0.93 . . . . 0.0 111.464 -5.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.3 m120 -149.03 -171.43 3.87 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.489 -1.284 . . . . 0.0 110.318 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.78 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -154.75 144.91 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.534 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -113.65 107.73 16.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.148 171.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.623 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -83.75 130.92 34.95 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.876 -173.245 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.608 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -103.97 -177.73 0.56 Allowed Pre-proline 0 N--CA 1.505 2.312 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 13.6 Cg_exo -63.11 -50.18 0.16 OUTLIER 'Cis proline' 0 N--CA 1.505 2.196 0 N-CA-C 117.449 2.057 . . . . 0.0 117.449 5.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.792 0 CA-C-O 116.239 -1.838 . . . . 0.0 109.167 -169.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' O ' ' NH2' ' A' ' 12' ' ' ARG . . . -62.76 142.98 97.05 Favored Pre-proline 0 N--CA 1.502 2.171 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -82.73 40.47 0.97 Allowed 'Trans proline' 0 CA--C 1.551 1.325 0 N-CA-C 108.634 -1.333 . . . . 0.0 108.634 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.612 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.79 128.99 34.1 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.17 169.51 18.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.422 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.68 178.3 7.33 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.504 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.31 128.02 33.08 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.277 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.71 -16.85 33.86 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.336 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 110.93 23.37 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.386 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -75.49 -179.73 5.38 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 N-CA-C 108.6 -1.346 . . . . 0.0 108.6 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.24 -99.38 2.5 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.814 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 2' ' ' ALA . 2.6 ptm180 -156.12 159.11 38.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.051 -175.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.26 148.42 20.04 Favored Glycine 0 N--CA 1.499 2.837 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.229 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 15.6 m-20 -78.57 124.07 27.76 Favored 'General case' 0 C--O 1.181 -2.552 0 C-N-CA 119.304 -0.959 . . . . 0.0 109.751 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 67.5 tp -83.8 132.74 34.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 117.683 -1.607 . . . . 0.0 110.355 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.68 ' HB2' HG23 ' A' ' 38' ' ' ILE . 53.5 m95 -124.94 167.55 14.53 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.493 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.653 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -90.92 -161.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 C-N-CA 118.109 -1.436 . . . . 0.0 112.639 -175.309 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.526 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.15 69.98 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.532 -176.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 6.0 mtp180 -110.4 119.83 40.48 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 112.109 -2.314 . . . . 0.0 111.803 -177.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.27 -46.93 51.39 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.305 -1.426 . . . . 0.0 109.595 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.93 156.93 48.02 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.212 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.16 160.94 67.11 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -51.09 110.9 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 120.971 1.114 . . . . 0.0 111.662 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -15.73 -113.18 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 1 N-CA-C 130.349 6.899 . . . . 0.0 130.349 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.41 46.62 3.52 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.384 -1.389 . . . . 0.0 109.787 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -83.67 -60.73 2.03 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.32 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -160.38 -27.24 0.02 OUTLIER Glycine 0 C--N 1.288 -2.099 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 48.5 m-85 -84.22 173.04 11.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 122.897 1.332 . . . . 0.0 112.666 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.47 -48.9 0.05 Allowed 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.014 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -100.23 111.3 23.57 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 113.138 -1.846 . . . . 0.0 109.607 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -137.83 143.67 41.1 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.471 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 140.58 38.33 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.802 ' CE2' HD12 ' A' ' 38' ' ' ILE . 28.6 m-85 -115.94 149.27 39.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.203 -173.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.03 81.99 0.71 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.68 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.461 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.51 158.56 0.27 Allowed Pre-proline 0 C--N 1.307 -1.26 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.37 -177.314 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.2 Cg_endo -79.52 33.58 1.24 Allowed 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.44 -1.067 . . . . 0.0 111.456 -5.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.461 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 8.7 m120 -147.92 -160.2 1.13 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.916 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -164.5 137.62 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.113 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.496 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.7 m -108.87 115.47 30.14 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 116.763 -1.975 . . . . 0.0 107.029 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -86.59 148.29 25.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 113.564 -1.653 . . . . 0.0 113.28 -171.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -125.79 168.41 14.0 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -84.32 156.87 68.17 Favored 'Cis proline' 0 N--CA 1.454 -0.849 0 CA-C-O 122.939 1.141 . . . . 0.0 114.062 4.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.625 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.428 175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -39.86 155.45 0.17 Allowed Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -92.43 51.49 0.55 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 O-C-N 122.621 0.8 . . . . 0.0 110.664 167.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -88.97 136.25 33.11 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.775 -1.57 . . . . 0.0 107.731 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.4 174.2 11.81 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.837 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -126.4 179.8 5.12 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.708 0.766 . . . . 0.0 109.845 177.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 m -76.86 128.41 34.52 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.455 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.39 27.34 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.846 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -125.28 99.3 34.03 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.51 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.98 155.91 47.83 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 N-CA-C 108.586 -1.351 . . . . 0.0 108.586 173.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.93 -97.62 0.51 Allowed Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.171 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.33 157.46 28.0 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 118.186 -1.405 . . . . 0.0 113.294 -178.62 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -150.82 162.28 29.32 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 77.6 m-20 -78.03 125.2 29.0 Favored 'General case' 0 C--O 1.184 -2.364 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.6 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 8.4 tt -91.06 109.89 21.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.557 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.709 ' CB ' HG23 ' A' ' 38' ' ' ILE . 63.2 m95 -91.56 161.69 14.84 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.931 -2.395 . . . . 0.0 109.052 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.763 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -81.15 -157.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 119.416 -0.913 . . . . 0.0 112.022 -176.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.07 67.01 0.11 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.359 1.552 . . . . 0.0 107.244 -178.498 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -113.86 111.44 21.73 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 112.065 -2.334 . . . . 0.0 110.284 -178.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.12 -20.83 65.34 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.341 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.42 152.58 44.4 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.195 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -94.7 155.08 39.78 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.599 179.144 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -66.91 143.06 64.92 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.037 1.158 . . . . 0.0 110.985 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.22 2.83 87.35 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.81 -22.13 53.94 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.34 -16.98 55.44 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.675 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.39 0.4 73.34 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.093 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.651 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 49.0 m-85 -54.34 161.74 1.28 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.29 -1.364 . . . . 0.0 111.542 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.5 p -146.2 -48.44 0.21 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 112.076 -2.329 . . . . 0.0 105.891 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -100.06 116.43 32.07 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.254 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -139.14 149.18 44.19 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.787 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.6 p -106.05 141.53 37.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CD2' HD12 ' A' ' 38' ' ' ILE . 17.7 m-85 -119.97 138.95 53.17 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.147 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 80.5 0.95 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -44.39 158.4 0.27 Allowed Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.731 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 2.8 Cg_endo -78.04 28.75 1.61 Allowed 'Cis proline' 0 C--O 1.211 -0.857 0 C-N-CA 124.492 -1.045 . . . . 0.0 111.945 -5.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.9 m120 -144.44 179.44 7.26 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.232 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.813 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -145.96 148.44 17.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -122.22 123.37 41.32 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 117.343 -1.743 . . . . 0.0 107.856 167.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.651 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.74 147.09 23.15 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.839 -171.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -121.85 169.32 9.55 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.84 157.62 80.48 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 CA-C-O 123.133 1.222 . . . . 0.0 114.553 3.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.72 0 CA-C-N 111.455 -2.612 . . . . 0.0 110.161 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.625 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -46.53 140.0 5.9 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.417 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.03 58.75 5.64 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 N-CA-C 107.234 -1.872 . . . . 0.0 107.234 168.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.33 136.92 39.56 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.3 m-85 -77.96 163.04 26.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.221 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.507 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -104.65 -173.87 2.41 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.659 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.55 122.86 21.24 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.166 -177.39 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.82 -3.34 0.99 Allowed Glycine 0 N--CA 1.48 1.595 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.819 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 7' ' ' SER . 11.2 mttm -107.69 108.59 61.72 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.474 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.22 -173.81 1.21 Allowed 'Trans proline' 0 C--N 1.324 -0.716 0 C-N-CA 120.807 1.004 . . . . 0.0 109.615 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 93.81 -115.26 4.93 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.418 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.41 160.93 32.83 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.216 -1.393 . . . . 0.0 113.471 -178.305 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.82 148.57 20.28 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 9.6 m-20 -76.53 126.7 31.44 Favored 'General case' 0 C--O 1.171 -3.068 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.599 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 10.7 tp -83.11 104.8 13.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.282 -1.767 . . . . 0.0 111.703 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.689 ' HB2' HG23 ' A' ' 38' ' ' ILE . 62.6 m95 -87.56 167.14 14.2 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.466 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -88.58 -161.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.026 -177.184 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.46 73.57 0.15 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.1 1.428 . . . . 0.0 108.599 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 17' ' ' ILE . 23.8 mtp85 -112.83 143.76 43.54 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 112.235 -2.257 . . . . 0.0 111.203 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 21' ' ' THR . . . -80.16 -20.64 66.86 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -156.47 157.19 35.05 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.857 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.87 148.12 71.72 Favored Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.44 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 22' ' ' CYS . 5.8 Cg_exo -53.67 -173.94 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 120.685 0.923 . . . . 0.0 111.054 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.52 -11.39 6.65 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 129.314 6.486 . . . . 0.0 129.314 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.89 19.32 55.23 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.61 -73.76 0.61 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.264 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.73 3.43 0.16 Allowed Glycine 0 N--CA 1.488 2.167 0 C-N-CA 118.974 -1.584 . . . . 0.0 112.418 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.3 m-85 -63.93 171.58 2.76 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.808 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -161.99 -44.86 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 112.592 -2.095 . . . . 0.0 106.433 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 41' ' ' TYR . 4.0 p -99.06 121.66 41.28 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.961 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -146.66 150.81 36.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.109 -1.436 . . . . 0.0 113.197 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.36 147.18 31.91 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.523 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.771 ' CE2' HD12 ' A' ' 38' ' ' ILE . 13.1 m-85 -121.32 136.01 55.02 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.654 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 4.6 mttp -138.35 63.64 1.52 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.572 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.483 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 27.5 t-105 -32.76 145.77 0.1 Allowed Pre-proline 0 N--CA 1.507 2.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.211 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.3 Cg_endo -78.62 40.41 0.4 Allowed 'Cis proline' 0 N--CA 1.499 1.81 0 C-N-CA 125.768 -0.513 . . . . 0.0 111.269 -5.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.483 ' H ' ' CA ' ' A' ' 35' ' ' TRP . 1.6 m120 -148.91 -163.53 1.81 Allowed 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.974 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -166.25 147.2 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.801 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -121.21 131.69 54.38 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 118.076 -1.45 . . . . 0.0 107.888 167.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -101.64 146.94 27.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.527 -1.215 . . . . 0.0 114.27 -168.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -116.51 -179.17 0.59 Allowed Pre-proline 0 N--CA 1.513 2.711 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.0 Cg_exo -63.8 -50.96 0.16 OUTLIER 'Cis proline' 0 N--CA 1.503 2.031 0 CA-C-N 122.117 1.792 . . . . 0.0 116.7 6.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.956 0 CA-C-O 116.356 -1.783 . . . . 0.0 109.24 -171.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -82.28 160.98 61.27 Favored Pre-proline 0 N--CA 1.513 2.697 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.43 32.55 0.27 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 N-CA-C 108.804 -1.268 . . . . 0.0 108.804 165.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.78 141.86 33.13 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.227 -174.132 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -89.98 171.32 9.65 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.6 -179.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -115.45 -175.66 2.76 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.11 178.182 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.13 115.09 17.6 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.811 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.47 64.3 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.625 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.92 114.27 46.59 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.067 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -77.03 166.65 26.38 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 N-CA-C 108.277 -1.47 . . . . 0.0 108.277 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.41 -106.18 2.4 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.233 -1.46 . . . . 0.0 111.069 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.66 165.04 31.27 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.105 -1.438 . . . . 0.0 113.903 -177.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.5 -174.7 15.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -104.51 111.86 24.7 Favored 'General case' 0 C--O 1.173 -2.952 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.448 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 23.2 tp -82.9 94.22 7.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 116.89 -1.924 . . . . 0.0 112.954 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 38' ' ' ILE . 73.0 m95 -70.19 111.9 6.15 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 112.458 -2.156 . . . . 0.0 105.859 169.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.31 -10.0 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.979 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -169.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mt -151.05 78.39 1.29 Allowed 'General case' 0 C--N 1.249 -3.796 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.786 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -175.99 166.61 3.0 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 117.641 -1.624 . . . . 0.0 112.209 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.87 -24.26 4.34 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -130.24 152.23 49.89 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.0 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.609 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -88.19 147.91 41.53 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.682 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -59.45 103.57 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.57 0.846 . . . . 0.0 110.597 -176.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 7.79 -93.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.931 1 N-CA-C 130.684 7.033 . . . . 0.0 130.684 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.32 46.04 1.71 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.299 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -79.31 0.66 27.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.577 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.0 27.94 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.1 m-85 -76.41 164.08 26.34 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 122.909 1.338 . . . . 0.0 112.588 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -162.72 -42.84 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.643 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.28 115.03 26.89 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.374 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.33 151.68 37.91 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.309 -1.357 . . . . 0.0 112.994 -177.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.91 144.91 32.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.821 ' CE2' HD12 ' A' ' 38' ' ' ILE . 15.9 m-85 -120.03 129.2 54.13 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.683 -173.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -135.93 73.17 1.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.413 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -48.41 154.7 1.07 Allowed Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.28 -175.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -70.96 7.7 3.85 Favored 'Cis proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.105 -1.206 . . . . 0.0 110.901 -5.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' C ' HG22 ' A' ' 38' ' ' ILE . 4.6 m-80 -104.37 -164.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.948 0.88 . . . . 0.0 111.357 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.821 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -177.34 135.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 7.5 m -105.69 113.26 26.72 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 117.807 -1.557 . . . . 0.0 107.625 171.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -91.52 133.25 35.67 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.001 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -110.51 168.38 7.7 Favored Pre-proline 0 N--CA 1.512 2.671 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.324 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 10.8 Cg_endo -83.81 158.79 71.53 Favored 'Cis proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.05 1.187 . . . . 0.0 114.678 2.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.449 0 CA-C-N 111.741 -2.481 . . . . 0.0 109.763 175.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -67.67 142.49 96.02 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 119.543 -0.863 . . . . 0.0 113.053 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -82.27 36.35 0.62 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 107.701 -1.692 . . . . 0.0 107.701 165.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.24 125.38 29.05 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.385 -174.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -81.6 -175.86 5.75 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 117.896 -1.522 . . . . 0.0 109.388 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -172.14 3.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.669 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -69.82 134.05 48.09 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.507 -176.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.94 -1.76 0.2 Allowed Glycine 0 N--CA 1.482 1.7 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.779 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 7' ' ' SER . 19.0 mttm -121.8 102.54 41.31 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.313 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -170.99 0.59 Allowed 'Trans proline' 0 C--O 1.21 -0.885 0 C-N-CA 121.263 1.309 . . . . 0.0 109.252 175.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 -106.13 3.27 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.726 -1.702 . . . . 0.0 111.323 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 1.2 ptm180 -161.55 165.93 27.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.881 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -146.4 146.13 15.82 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -78.19 118.49 20.47 Favored 'General case' 0 C--O 1.173 -2.933 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.178 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.424 ' H ' ' H ' ' A' ' 2' ' ' ALA . 50.4 tp -81.3 129.5 34.64 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 116.938 -1.905 . . . . 0.0 110.683 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.82 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.9 m95 -117.96 122.01 42.15 Favored 'General case' 0 C--N 1.263 -3.172 0 CA-C-N 111.902 -2.408 . . . . 0.0 105.444 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.651 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -84.64 -12.68 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 mt -152.36 66.86 0.83 Allowed 'General case' 0 C--N 1.246 -3.901 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.226 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.439 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -143.32 123.26 13.52 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.215 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.04 -36.41 31.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.86 155.4 49.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.75 153.38 67.51 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.579 -177.191 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -67.53 -164.73 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.481 1.454 . . . . 0.0 111.684 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -132.98 -18.17 1.1 Allowed Glycine 0 N--CA 1.489 2.206 1 N-CA-C 130.631 7.012 . . . . 0.0 130.631 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.85 47.0 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.326 -1.416 . . . . 0.0 109.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -83.2 -91.06 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.45 25.03 0.02 OUTLIER Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.275 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.4 m-85 -69.27 171.86 7.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.598 1.189 . . . . 0.0 111.099 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 28' ' ' TYR . 4.6 p -162.65 -45.83 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.373 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 125.76 44.72 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.302 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -156.47 149.88 24.48 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 117.534 -1.666 . . . . 0.0 113.369 177.565 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.54 143.96 40.12 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.529 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.782 ' CE2' HD12 ' A' ' 38' ' ' ILE . 57.7 m-85 -111.36 138.01 48.4 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.235 -0.986 . . . . 0.0 113.026 -172.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 35' ' ' TRP . 11.5 mmtm -135.02 60.21 1.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.406 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -41.63 148.58 0.44 Allowed Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.619 -175.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -71.75 -3.81 11.35 Favored 'Cis proline' 0 C--O 1.211 -0.863 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.032 -1.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' HG23 ' A' ' 17' ' ' ILE . 1.6 m120 -99.22 -160.32 0.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.803 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.82 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 178.56 136.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.19 -2.07 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.177 -178.186 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 33.9 m -105.3 117.36 33.81 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.231 -1.787 . . . . 0.0 107.021 171.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -98.48 126.32 43.98 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.535 -170.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 15.7 m-85 -98.5 -172.66 0.28 Allowed Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 16.1 Cg_exo -56.31 -52.11 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 123.206 2.181 . . . . 0.0 115.948 5.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.612 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 116.332 -1.794 . . . . 0.0 109.221 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 15' ' ' LEU . . . -71.38 145.64 90.82 Favored Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -85.71 33.74 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 108.516 -1.378 . . . . 0.0 108.516 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.8 136.18 36.66 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -176.256 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.1 -175.83 4.79 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.125 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -128.62 -171.89 2.58 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.291 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -70.71 114.29 8.65 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.78 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.44 1.12 4.11 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.092 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.2 mptm? -103.55 151.15 38.66 Favored Pre-proline 0 N--CA 1.498 1.934 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.192 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 9' ' ' LYS . 17.1 Cg_exo -38.88 177.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.779 2.986 . . . . 0.0 115.051 -173.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.06 31.37 0.65 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.909 -1.496 . . . . 0.0 114.911 -172.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -161.21 142.78 11.77 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 115.884 -2.327 . . . . 0.0 114.754 175.191 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -161.88 152.41 22.82 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.947 174.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 118.37 19.27 Favored 'General case' 0 C--O 1.174 -2.91 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.572 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.616 ' H ' ' HB3' ' A' ' 2' ' ' ALA . 7.2 tt -87.63 94.98 9.89 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.141 -1.824 . . . . 0.0 112.341 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.809 ' HB2' HG23 ' A' ' 38' ' ' ILE . 66.5 m95 -70.56 127.65 33.41 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.307 -2.224 . . . . 0.0 107.464 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.575 HG23 ' ND2' ' A' ' 37' ' ' ASN . 1.2 mp -93.81 -10.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -169.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -153.74 76.43 1.07 Allowed 'General case' 0 C--N 1.247 -3.872 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.477 -174.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -161.69 129.32 4.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 117.239 -1.784 . . . . 0.0 112.737 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.49 -18.74 65.62 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 175.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -142.61 154.66 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.582 -0.809 . . . . 0.0 109.242 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 156.66 39.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.628 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -61.94 -172.99 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 121.163 1.242 . . . . 0.0 111.509 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.91 -5.24 4.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.28 -18.16 47.21 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.438 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.74 -31.21 41.04 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.48 7.01 30.67 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.556 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.9 m-85 -66.03 167.86 9.19 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.591 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 28' ' ' TYR . 8.6 p -161.12 -44.14 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.386 -2.188 . . . . 0.0 105.953 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.22 124.86 41.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.819 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -157.09 158.6 36.7 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.112 -1.435 . . . . 0.0 112.699 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.1 p -115.82 140.64 49.02 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.29 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.692 ' CE2' HD12 ' A' ' 38' ' ' ILE . 35.9 m-85 -108.77 131.76 54.64 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.643 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 30.4 mmtm -131.57 67.65 1.51 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.415 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -45.09 149.24 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.573 -175.065 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.5 Cg_endo -71.68 -5.12 12.16 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.017 -5.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.575 ' ND2' HG23 ' A' ' 17' ' ' ILE . 1.6 m120 -92.68 -161.91 0.88 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.867 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.809 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 176.21 143.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.46 -177.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 71.2 m -112.38 125.41 54.17 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.016 169.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -105.02 138.08 41.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.525 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' CE2' ' ND1' ' A' ' 43' ' ' HIS . 2.2 m-85 -108.16 -178.96 0.62 Allowed Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.6 Cg_exo -58.37 -55.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.507 2.322 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 5.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.672 0 CA-C-O 116.377 -1.773 . . . . 0.0 109.133 -171.012 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.581 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -52.0 148.53 10.69 Favored Pre-proline 0 N--CA 1.501 2.121 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.996 -177.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -84.93 34.31 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.644 0.896 . . . . 0.0 109.94 168.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.18 123.31 26.75 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.392 -176.044 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -79.31 164.68 23.9 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.551 -1.26 . . . . 0.0 110.083 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 179.22 6.5 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.107 0.956 . . . . 0.0 111.281 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.25 133.23 38.9 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.522 -177.449 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.86 -17.03 28.79 Favored Glycine 0 C--N 1.296 -1.644 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.711 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.94 114.27 10.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -73.72 -160.89 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 N-CA-C 108.627 -1.336 . . . . 0.0 108.627 172.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 79.52 -106.87 2.47 Favored Glycine 0 C--N 1.288 -2.12 0 C-N-CA 118.809 -1.662 . . . . 0.0 111.229 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.642 HH21 ' HB2' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -157.14 158.85 37.08 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.273 -176.686 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.22 161.75 24.97 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 174.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -79.25 128.67 33.6 Favored 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.35 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 16.6 tp -92.4 108.0 19.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.691 1.234 . . . . 0.0 111.958 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.642 ' CB ' HG23 ' A' ' 38' ' ' ILE . 64.8 m95 -99.82 150.38 22.41 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 112.546 -2.115 . . . . 0.0 109.709 177.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -81.22 -155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.341 -177.581 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.75 72.94 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.212 1.482 . . . . 0.0 108.272 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 17' ' ' ILE . 10.5 mtp85 -114.53 103.94 11.52 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.449 179.238 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.99 -27.77 14.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.219 -1.467 . . . . 0.0 109.884 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 157.39 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.75 159.89 70.49 Favored Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.647 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -50.46 168.87 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.071 1.181 . . . . 0.0 110.948 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.02 140.62 15.13 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.845 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.36 85.8 Favored Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.513 -1.327 . . . . 0.0 111.074 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -171.58 2.8 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.696 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.46 6.67 71.38 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.055 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.3 m-85 -86.96 168.02 13.74 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 118.373 -1.331 . . . . 0.0 112.334 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -160.81 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 111.961 -2.382 . . . . 0.0 105.697 177.492 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.33 117.02 32.85 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.534 179.338 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -143.07 153.3 42.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.742 -179.864 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 140.77 47.66 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.222 177.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' CE2' HD12 ' A' ' 38' ' ' ILE . 34.8 m-85 -117.38 142.64 46.86 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.371 -172.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.22 81.25 0.69 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.662 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.532 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -51.06 158.79 1.13 Allowed Pre-proline 0 C--N 1.308 -1.208 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.727 -176.895 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.0 Cg_endo -79.83 33.18 1.43 Allowed 'Cis proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.12 -1.2 . . . . 0.0 111.826 -2.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.532 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 4.3 m120 -145.29 -166.12 2.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.403 176.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -165.98 144.92 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.14 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 3.4 m -115.55 122.16 44.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.048 -1.861 . . . . 0.0 107.289 167.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.49 135.81 33.74 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.865 -172.525 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -105.92 167.19 10.02 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.444 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' A' ' 41' ' ' TYR . 14.3 Cg_endo -86.98 158.66 50.13 Favored 'Cis proline' 0 C--O 1.214 -0.696 0 N-CA-C 115.068 1.142 . . . . 0.0 115.068 2.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.642 ' HB2' HH21 ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 111.926 -2.397 . . . . 0.0 109.508 174.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -46.8 135.94 7.95 Favored Pre-proline 0 N--CA 1.495 1.812 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.61 -177.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.02 35.55 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 167.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.06 122.38 20.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -175.081 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.43 178.71 6.97 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 117.558 -1.657 . . . . 0.0 108.863 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.491 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -130.96 -177.48 4.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.381 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -77.73 113.67 15.82 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.961 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.03 64.16 Favored Glycine 0 C--N 1.297 -1.612 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.379 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -119.51 107.07 41.42 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.696 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -72.42 174.15 12.04 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.161 1.24 . . . . 0.0 109.55 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.47 -99.72 1.97 Allowed Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.635 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.599 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -159.38 159.9 34.31 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.666 -176.268 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.44 143.86 12.93 Favored Glycine 0 C--N 1.288 -2.105 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 171.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -76.17 127.72 33.5 Favored 'General case' 0 C--O 1.17 -3.079 0 C-N-CA 118.994 -1.082 . . . . 0.0 108.359 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 117.49 23.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 117.542 -1.663 . . . . 0.0 112.139 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.641 ' CB ' HG23 ' A' ' 38' ' ' ILE . 62.8 m95 -111.1 159.69 17.58 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 112.225 -2.261 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -81.93 -163.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.701 -176.443 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.477 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.34 70.78 0.17 Allowed 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 123.181 1.467 . . . . 0.0 108.579 -175.748 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.9 mtp180 -105.74 141.54 37.0 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.997 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.85 -34.31 53.36 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.9 157.72 44.31 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.86 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.0 149.97 64.12 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.035 -179.629 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 144.47 97.47 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 121.006 1.137 . . . . 0.0 111.163 176.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.26 -15.34 72.05 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.089 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.77 -29.76 74.95 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -81.81 4.62 21.5 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.08 16.22 68.39 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.491 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 39.4 m-85 -66.07 169.56 6.75 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.126 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 p -162.15 -46.98 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.474 -2.148 . . . . 0.0 106.117 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 41' ' ' TYR . 33.3 p -98.02 118.21 34.12 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.219 -2.264 . . . . 0.0 110.378 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.408 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -153.77 158.4 40.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.931 -1.508 . . . . 0.0 112.998 179.04 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.43 148.43 45.12 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.312 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.699 ' CE2' HD12 ' A' ' 38' ' ' ILE . 12.2 m-85 -114.93 137.8 51.56 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.511 -171.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 mttp -138.49 73.69 1.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.145 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.491 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 6.9 t-105 -37.78 147.99 0.23 Allowed Pre-proline 0 N--CA 1.504 2.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.445 ' N ' ' CD1' ' A' ' 35' ' ' TRP . 2.4 Cg_endo -78.13 37.68 0.5 Allowed 'Cis proline' 0 N--CA 1.495 1.572 0 C-N-CA 124.976 -0.843 . . . . 0.0 110.87 -6.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 2.1 m120 -146.29 -155.91 0.66 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.259 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.699 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -170.86 141.72 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.299 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.179 179.185 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.2 m -110.63 144.74 39.07 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 167.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.9 t -117.74 135.42 54.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.6 m-85 -102.61 174.11 3.07 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 176.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.5 Cg_exo -55.19 -61.5 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.917 0 N-CA-C 117.209 1.965 . . . . 0.0 117.209 5.525 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.599 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.123 0 CA-C-O 116.438 -1.744 . . . . 0.0 109.879 -170.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -48.79 144.99 6.59 Favored Pre-proline 0 N--CA 1.504 2.259 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.6 Cg_endo -86.1 23.97 0.79 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 N-CA-C 107.089 -1.927 . . . . 0.0 107.089 164.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.7 p -75.07 116.62 16.01 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-N 113.447 -1.706 . . . . 0.0 108.939 -177.081 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.13 179.44 6.85 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.92 -175.359 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -113.09 -173.71 2.31 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.345 177.63 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -75.14 120.37 20.55 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.041 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -8.52 51.1 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.763 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -115.82 100.99 54.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.701 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.56 152.22 37.96 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.188 1.259 . . . . 0.0 109.804 174.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.85 -93.33 0.3 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.929 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -162.05 159.21 25.99 Favored 'General case' 0 C--O 1.199 -1.588 0 C-N-CA 118.624 -1.231 . . . . 0.0 112.217 -178.532 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -153.51 151.18 22.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 174.083 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -78.42 128.08 33.1 Favored 'General case' 0 C--O 1.182 -2.46 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.166 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 12.6 tp -94.08 101.92 13.96 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.865 1.317 . . . . 0.0 111.717 -177.109 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.815 ' HB2' HG23 ' A' ' 38' ' ' ILE . 78.4 m95 -88.87 123.4 33.21 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 111.889 -2.414 . . . . 0.0 107.402 176.041 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.77 -16.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -170.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.8 mt -151.73 71.57 0.99 Allowed 'General case' 0 C--N 1.247 -3.86 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.907 -171.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -156.29 141.19 17.17 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 117.841 -1.544 . . . . 0.0 112.297 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.592 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -91.28 -19.48 41.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.16 43.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.18 162.07 63.01 Favored Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.948 -179.111 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 5.6 Cg_exo -52.29 114.51 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 121.489 1.459 . . . . 0.0 112.33 -171.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -0.94 65.6 0.0 OUTLIER Glycine 0 N--CA 1.488 2.123 1 N-CA-C 131.162 7.225 . . . . 0.0 131.162 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.11 48.8 71.53 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.033 -1.556 . . . . 0.0 110.365 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.61 -77.78 0.17 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.042 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.11 -23.19 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.504 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.0 m-85 -77.66 170.48 16.5 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.568 1.175 . . . . 0.0 112.337 -179.113 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.6 p -160.88 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 112.353 -2.203 . . . . 0.0 105.957 176.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -96.36 118.06 32.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.333 -179.909 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.56 149.62 29.4 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.031 -1.468 . . . . 0.0 113.185 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.6 p -103.4 142.74 33.72 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.017 175.459 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 38' ' ' ILE . 29.4 m-85 -117.12 134.79 54.34 Favored 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 119.267 -0.973 . . . . 0.0 112.479 -173.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -147.56 80.0 1.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.592 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -53.36 152.99 7.67 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.343 -175.437 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 5.2 Cg_endo -72.66 -6.9 15.96 Favored 'Cis proline' 0 C--O 1.208 -0.996 0 C-N-CA 124.197 -1.168 . . . . 0.0 110.451 -5.298 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.494 ' C ' HG22 ' A' ' 38' ' ' ILE . 1.6 m-80 -91.61 -165.15 1.29 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.284 1.04 . . . . 0.0 111.873 -178.021 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.815 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 179.42 142.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.005 -178.116 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 18.4 m -113.56 103.87 11.69 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.421 -1.312 . . . . 0.0 107.795 172.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -82.27 138.05 34.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.32 -1.309 . . . . 0.0 113.342 -172.673 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.567 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -109.73 -178.8 0.58 Allowed Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.781 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.1 Cg_exo -63.81 -50.48 0.17 OUTLIER 'Cis proline' 0 N--CA 1.507 2.287 0 N-CA-C 116.813 1.813 . . . . 0.0 116.813 5.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.589 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.752 0 CA-C-O 116.382 -1.771 . . . . 0.0 110.074 -171.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -39.21 145.17 0.41 Allowed Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -177.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -84.26 29.64 0.54 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 106.586 -2.121 . . . . 0.0 106.586 165.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.598 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.2 p -92.0 117.3 29.69 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.237 -174.082 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 2.2 m-85 -78.06 172.46 13.49 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.398 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -108.78 -171.89 1.94 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.589 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -74.86 114.95 13.9 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.304 -1.358 . . . . 0.0 111.009 -177.693 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.88 3.52 60.0 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.414 178.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -113.05 113.64 49.24 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.093 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.28 -163.22 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.573 1.516 . . . . 0.0 111.664 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 69.22 -118.25 8.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.582 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.9 ptp180 -152.46 -171.52 3.96 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 118.398 -1.321 . . . . 0.0 112.133 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.73 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -152.02 155.95 26.42 Favored Glycine 0 C--N 1.273 -2.925 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 173.374 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -76.28 131.93 39.54 Favored 'General case' 0 C--O 1.176 -2.78 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.936 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 14.5 tp -92.3 110.16 21.55 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.908 1.337 . . . . 0.0 110.774 -177.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.703 ' HB2' HG23 ' A' ' 38' ' ' ILE . 66.0 m95 -106.84 160.0 15.83 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 112.068 -2.333 . . . . 0.0 109.875 -177.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -86.15 -161.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.788 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -67.96 72.95 0.18 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.413 1.577 . . . . 0.0 108.728 -175.706 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.8 mtp85 -110.86 125.75 53.95 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 111.952 -2.385 . . . . 0.0 109.877 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.25 -26.2 70.34 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 p -149.38 153.43 37.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.789 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -81.31 152.37 70.54 Favored Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.164 179.37 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 25' ' ' GLY . 2.7 Cg_exo -51.25 124.53 14.28 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 C-N-CA 121.015 1.143 . . . . 0.0 111.641 -178.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.74 25.23 2.54 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -133.7 -4.27 3.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.572 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -56.36 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.996 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.24 0.72 1.0 Allowed Glycine 0 C--N 1.288 -2.128 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.824 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.597 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 47.7 m-85 -68.62 170.68 8.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 122.569 1.176 . . . . 0.0 111.896 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -161.03 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.544 -2.117 . . . . 0.0 106.055 177.27 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -97.66 123.54 41.62 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.79 178.785 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.2 149.49 26.01 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.882 -1.527 . . . . 0.0 112.485 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 7.8 p -108.81 146.08 34.2 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.441 177.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.727 ' CE2' HD12 ' A' ' 38' ' ' ILE . 46.8 m-85 -123.01 133.89 54.34 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.22 -175.636 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.45 83.17 1.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.278 -0.873 . . . . 0.0 108.754 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.474 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.78 160.19 0.2 Allowed Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.949 -176.221 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 18' ' ' LEU . 8.2 Cg_endo -80.12 34.06 1.36 Allowed 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.21 -1.162 . . . . 0.0 110.435 -5.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.474 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 7.0 m-80 -147.15 -163.32 1.73 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.871 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.727 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -162.22 146.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.031 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.9 m -117.76 105.32 11.86 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.695 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -81.73 141.71 33.32 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.194 -172.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.3 m-85 -110.04 175.8 1.78 Allowed Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.4 Cg_exo -57.49 -58.45 0.04 OUTLIER 'Cis proline' 0 N--CA 1.506 2.215 0 N-CA-C 117.773 2.182 . . . . 0.0 117.773 6.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.179 0 CA-C-O 116.273 -1.823 . . . . 0.0 109.594 -169.728 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -50.28 144.74 11.1 Favored Pre-proline 0 N--CA 1.506 2.328 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.313 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.55 37.03 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 N-CA-C 108.308 -1.458 . . . . 0.0 108.308 165.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.76 122.14 21.92 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.585 -174.5 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.44 174.03 12.01 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.241 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.41 179.99 6.47 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.012 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -71.75 134.55 46.28 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.534 -174.845 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.68 -12.23 0.53 Allowed Glycine 0 N--CA 1.478 1.464 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.767 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 mttt -113.05 105.86 55.36 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.102 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -72.09 154.58 57.4 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 173.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -105.06 1.25 Allowed Glycine 0 C--N 1.287 -2.152 1 N-CA-C 129.604 6.602 . . . . 0.0 129.604 -176.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.734 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 5.5 ptm180 -162.65 152.84 16.4 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.815 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.69 152.12 23.62 Favored Glycine 0 N--CA 1.493 2.472 1 N-CA-C 125.716 5.046 . . . . 0.0 125.716 171.961 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 4.8 m-20 -77.11 122.34 24.84 Favored 'General case' 0 C--O 1.171 -3.037 0 C-N-CA 118.015 -1.474 . . . . 0.0 109.709 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 20.3 tp -86.56 100.24 12.27 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.335 -178.518 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.674 ' CB ' HG23 ' A' ' 38' ' ' ILE . 61.5 m95 -87.59 165.11 15.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.406 177.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.635 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -90.86 -159.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.939 -176.824 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.05 70.27 0.15 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.202 1.477 . . . . 0.0 108.411 -176.073 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' ILE . 3.6 mtp180 -113.62 120.87 42.38 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 112.202 -2.272 . . . . 0.0 110.49 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -23.38 64.94 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.157 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 154.07 38.33 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.934 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.97 149.96 54.42 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.975 179.2 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.83 143.69 95.15 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.83 1.02 . . . . 0.0 110.815 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.23 -1.22 75.82 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.239 -1.457 . . . . 0.0 110.095 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.58 -14.68 70.1 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.15 -91.78 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.036 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.68 24.61 0.03 OUTLIER Glycine 0 C--N 1.29 -2.0 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.54 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.631 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.2 m-85 -86.37 170.11 12.31 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.921 1.343 . . . . 0.0 112.347 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.4 p -162.55 -44.44 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 112.041 -2.345 . . . . 0.0 105.849 176.49 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' TYR . 29.8 p -96.98 114.24 25.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.513 -2.131 . . . . 0.0 109.806 -179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.561 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.55 151.36 37.2 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.956 177.984 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.09 145.65 35.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.752 177.427 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.707 ' CE2' HD12 ' A' ' 38' ' ' ILE . 15.9 m-85 -118.23 125.91 51.1 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.86 -171.572 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 35' ' ' TRP . 25.8 mttt -127.04 70.55 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.612 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.43 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 31.7 t-105 -39.22 144.09 0.47 Allowed Pre-proline 0 C--N 1.296 -1.738 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.483 178.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 9.5 Cg_endo -79.39 39.35 0.57 Allowed 'Cis proline' 0 N--CA 1.494 1.514 0 C-N-CA 125.66 -0.558 . . . . 0.0 111.372 -5.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.457 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 2.3 m120 -149.31 -159.73 1.08 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.474 -1.291 . . . . 0.0 110.935 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.707 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -170.94 142.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.991 179.582 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 16.0 m -111.18 133.15 53.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -105.82 130.84 53.72 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -170.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -103.83 179.19 1.0 Allowed Pre-proline 0 N--CA 1.513 2.698 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 177.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.574 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.0 Cg_exo -59.11 -54.91 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.177 0 N-CA-C 117.217 1.968 . . . . 0.0 117.217 6.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.734 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.659 0 CA-C-O 116.373 -1.775 . . . . 0.0 109.247 -171.389 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.696 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -39.66 146.84 0.35 Allowed Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.956 179.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -80.32 59.49 7.46 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -74.8 142.42 44.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.569 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -78.44 169.14 18.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.369 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -114.0 -166.22 1.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 9' ' ' LYS . 3.0 t -62.27 110.39 1.62 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.671 -177.74 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.91 1.12 0.79 Allowed Glycine 0 N--CA 1.479 1.528 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.208 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 7' ' ' SER . 30.3 mttt -99.33 116.44 65.04 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.573 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 1.2 Cg_endo -70.76 -167.89 0.29 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 173.333 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.97 -119.53 5.46 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.615 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -162.0 159.56 26.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.585 -179.771 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.84 149.77 20.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 172.299 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 12.8 m-20 -77.03 125.84 29.98 Favored 'General case' 0 C--O 1.175 -2.854 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.186 -179.373 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.696 ' N ' ' HB1' ' A' ' 1' ' ' ALA . 5.0 tp -83.23 106.42 15.0 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 117.056 -1.858 . . . . 0.0 111.793 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.718 ' HB2' HG23 ' A' ' 38' ' ' ILE . 53.4 m95 -90.48 171.53 9.36 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 111.723 -2.489 . . . . 0.0 110.374 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -88.94 -163.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.079 -178.867 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -68.06 72.31 0.18 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.945 1.355 . . . . 0.0 108.454 -176.197 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.8 mtp85 -113.1 111.1 21.54 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.356 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.49 -24.95 40.46 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.204 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 p -141.77 151.54 42.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.39 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.62 147.26 55.2 Favored Pre-proline 0 C--N 1.289 -2.051 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.387 -179.68 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.55 148.21 54.6 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 121.004 1.136 . . . . 0.0 111.737 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLY . . . -84.48 -33.05 20.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.997 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.97 -28.25 16.53 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.13 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.28 -25.93 42.39 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.733 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . 87.68 12.61 66.42 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.674 -1.25 . . . . 0.0 111.566 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 45.6 m-85 -57.9 172.56 0.39 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.636 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 28' ' ' TYR . 17.1 p -162.36 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.804 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.904 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.67 110.21 22.82 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.318 -177.592 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.08 156.11 40.38 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.339 -1.344 . . . . 0.0 112.778 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 p -112.17 146.81 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.738 176.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.802 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.1 m-85 -117.07 133.24 56.24 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.3 -0.96 . . . . 0.0 112.38 -174.044 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -134.82 70.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.588 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 11.8 t-105 -37.92 148.39 0.22 Allowed Pre-proline 0 N--CA 1.506 2.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.725 178.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' N ' ' CD1' ' A' ' 35' ' ' TRP . 6.2 Cg_endo -77.64 33.79 0.73 Allowed 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 125.613 -0.578 . . . . 0.0 111.095 -6.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.469 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.2 m120 -147.15 -167.16 2.7 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.22 178.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.01 153.32 4.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.904 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -125.2 130.8 52.84 Favored 'General case' 0 C--O 1.216 -0.707 0 C-N-CA 117.948 -1.501 . . . . 0.0 107.586 168.189 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -167.71 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -111.42 -178.07 0.51 Allowed Pre-proline 0 N--CA 1.51 2.566 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.175 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.9 Cg_exo -57.79 -54.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.506 2.258 0 CA-C-N 122.485 1.923 . . . . 0.0 117.027 4.302 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.483 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.71 -171.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.756 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -39.52 151.57 0.22 Allowed Pre-proline 0 N--CA 1.505 2.287 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.916 -179.275 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -81.55 49.73 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 168.128 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.31 138.33 45.37 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.039 -1.064 . . . . 0.0 108.16 -172.762 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.499 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -78.65 175.66 10.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.07 -1.452 . . . . 0.0 109.831 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -111.78 -169.02 1.39 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.813 179.232 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.21 108.52 10.37 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.062 -178.342 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.97 89.14 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.683 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -115.52 113.41 42.92 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.054 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.58 -161.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.793 0 C-N-CA 120.904 1.069 . . . . 0.0 109.335 174.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.47 -109.11 2.77 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.911 178.176 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.627 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.14 177.01 10.07 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.658 -1.217 . . . . 0.0 113.423 -177.353 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.627 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -157.46 158.37 28.91 Favored Glycine 0 N--CA 1.503 3.151 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.3 m-20 -78.06 122.97 26.28 Favored 'General case' 0 C--O 1.177 -2.731 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.287 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.756 ' N ' ' HB1' ' A' ' 1' ' ' ALA . 4.5 tt -91.53 99.64 12.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 117.397 -1.721 . . . . 0.0 113.14 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.792 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.3 m95 -75.72 122.68 24.37 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.0 174.339 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 17' ' ' ILE . 44.1 mt -89.96 -10.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.854 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.2 mt -150.14 71.23 1.06 Allowed 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.536 -171.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.93 158.38 10.58 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.093 178.422 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.96 -29.25 4.4 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -129.01 152.16 48.92 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.801 177.826 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.61 153.51 47.97 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.99 -179.09 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.2 -178.75 0.09 OUTLIER 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.513 1.475 . . . . 0.0 112.071 -175.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.76 12.6 10.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -108.44 -5.48 32.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.99 -28.43 14.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.137 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.74 54.46 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.717 -1.23 . . . . 0.0 111.51 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.629 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 47.0 m-85 -53.7 167.17 0.26 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.986 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.9 p -163.38 -43.27 0.03 OUTLIER 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.544 177.579 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -96.56 111.58 23.65 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.706 -2.043 . . . . 0.0 109.119 -179.575 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -150.96 146.9 26.56 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.751 -177.784 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.55 138.2 36.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.222 177.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.856 ' CD1' HD12 ' A' ' 38' ' ' ILE . 95.8 m-85 -118.35 134.38 55.1 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.861 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.2 82.38 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.506 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.47 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.21 158.85 0.43 Allowed Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.825 -176.417 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.3 Cg_endo -74.2 5.16 10.82 Favored 'Cis proline' 0 C--O 1.204 -1.206 0 C-N-CA 124.215 -1.161 . . . . 0.0 111.435 -3.526 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.2 m-20 -114.36 -162.93 0.84 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 122.195 0.997 . . . . 0.0 111.268 -176.46 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.856 HD12 ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -178.61 144.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.377 -179.538 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.22 111.86 19.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 117.469 -1.692 . . . . 0.0 108.049 170.029 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.629 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -82.87 148.17 27.87 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.211 -170.478 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.516 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER -124.06 168.71 12.09 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 178.114 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -77.39 157.6 96.12 Favored 'Cis proline' 0 C--N 1.325 -0.698 0 CA-C-O 122.88 1.117 . . . . 0.0 114.147 4.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.602 0 CA-C-N 111.981 -2.372 . . . . 0.0 109.711 175.571 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 15' ' ' LEU 0.255 . . -38.14 142.1 0.48 Allowed Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.154 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.86 31.88 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.4 p -85.62 114.56 22.71 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.791 -176.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -77.76 175.41 9.99 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.493 -1.283 . . . . 0.0 110.274 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.7 m -113.24 -177.21 3.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.603 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.83 121.47 24.14 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.541 -178.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.93 60.88 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.49 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -123.65 113.6 28.79 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.801 -178.418 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -74.71 -164.39 0.22 Allowed 'Trans proline' 0 C--O 1.212 -0.795 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 173.087 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -99.75 2.59 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.31 177.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.622 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.93 161.61 31.73 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.267 -177.232 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -147.42 147.36 18.06 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 174.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 14.9 m-20 -79.62 121.7 25.61 Favored 'General case' 0 C--O 1.17 -3.125 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.008 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.658 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 15.5 tp -92.19 92.79 8.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.842 1.306 . . . . 0.0 112.86 -175.634 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 38' ' ' ILE . 68.6 m95 -74.14 120.12 19.28 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 112.165 -2.289 . . . . 0.0 108.196 174.209 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.506 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.3 mp -84.82 -11.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -171.504 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 mt -152.41 75.9 1.13 Allowed 'General case' 0 C--N 1.253 -3.59 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.672 -175.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -148.21 155.53 41.48 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.748 178.734 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.4 -26.71 4.16 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.67 151.49 45.97 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.303 175.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -91.36 138.1 25.73 Favored Pre-proline 0 C--N 1.288 -2.082 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.083 -178.781 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.76 152.22 75.68 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 121.035 1.157 . . . . 0.0 111.615 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.66 -16.24 46.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.24 -19.7 59.85 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.617 -1.277 . . . . 0.0 109.93 179.173 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.88 -60.51 2.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.958 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.75 13.07 0.64 Allowed Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 38.9 m-85 -72.78 170.22 15.07 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.874 1.321 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.1 p -161.97 -45.75 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 112.066 -2.333 . . . . 0.0 106.065 177.213 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 123.22 43.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.928 179.786 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -152.12 157.94 42.27 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 117.972 -1.491 . . . . 0.0 114.08 179.143 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.457 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 p -113.97 147.9 37.81 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.253 172.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.735 ' CE2' HD12 ' A' ' 38' ' ' ILE . 40.1 m-85 -116.69 136.83 52.64 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.295 -172.245 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' SG ' ' A' ' 32' ' ' CYS . 4.5 mttt -138.96 70.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.948 178.575 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.422 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -47.83 144.98 4.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.326 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 3.6 Cg_endo -70.57 -7.83 11.64 Favored 'Cis proline' 0 C--O 1.206 -1.105 0 C-N-CA 124.952 -0.853 . . . . 0.0 111.208 -4.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.513 ' C ' HG22 ' A' ' 38' ' ' ILE . 2.1 m120 -93.29 -164.93 1.24 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.297 -177.323 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -179.03 137.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.801 -179.097 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 50.5 m -107.08 105.56 15.63 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.278 174.827 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -91.27 130.26 37.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.969 -1.469 . . . . 0.0 114.17 -172.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.543 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -97.78 176.27 2.14 Favored Pre-proline 0 N--CA 1.511 2.611 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.095 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 11.7 Cg_exo -58.07 -57.16 0.08 OUTLIER 'Cis proline' 0 N--CA 1.503 2.056 0 N-CA-C 117.339 2.015 . . . . 0.0 117.339 7.172 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.622 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.357 0 CA-C-O 116.331 -1.795 . . . . 0.0 109.864 -170.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -72.62 150.78 91.27 Favored Pre-proline 0 N--CA 1.502 2.161 0 C-N-CA 119.743 -0.783 . . . . 0.0 113.001 -176.9 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.09 31.84 0.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 166.136 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.67 120.98 19.05 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -175.59 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -174.4 3.53 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.64 -1.624 . . . . 0.0 109.418 -178.859 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.48 -175.32 4.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.439 178.004 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.58 130.03 38.16 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.271 -176.345 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.24 41.94 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.722 179.238 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 109.65 21.9 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.819 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.75 150.8 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 N-CA-C 108.959 -1.208 . . . . 0.0 108.959 172.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -89.63 0.47 Allowed Glycine 0 N--CA 1.491 2.304 1 N-CA-C 130.521 6.968 . . . . 0.0 130.521 -177.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.634 HH22 ' CG ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -160.08 149.11 17.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.542 -1.263 . . . . 0.0 112.567 179.181 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.78 148.5 20.14 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 175.895 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.634 ' CG ' HH22 ' A' ' 12' ' ' ARG . 2.9 m-20 -77.74 121.11 23.59 Favored 'General case' 0 C--O 1.18 -2.605 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.071 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.444 ' H ' ' H ' ' A' ' 2' ' ' ALA . 20.9 tp -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.333 -1.747 . . . . 0.0 110.891 179.383 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.675 ' CB ' HG23 ' A' ' 38' ' ' ILE . 65.6 m95 -119.75 152.65 36.88 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 111.303 -2.681 . . . . 0.0 106.975 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.757 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.54 -158.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.845 -176.265 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.54 68.84 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 123.128 1.442 . . . . 0.0 108.18 -177.049 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.65 136.73 46.9 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 112.5 -2.136 . . . . 0.0 110.427 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.06 -21.28 78.55 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.17 157.44 35.93 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.708 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.28 157.86 72.54 Favored Pre-proline 0 C--N 1.299 -1.6 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.219 177.894 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.59 -172.76 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 121.268 1.312 . . . . 0.0 111.794 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.69 10.98 10.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.23 -2.11 54.26 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.467 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -102.97 -52.45 3.05 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.16 30.65 2.05 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.598 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 79.0 m-85 -79.55 172.36 13.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.415 1.103 . . . . 0.0 110.999 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.1 p -162.41 -45.72 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 112.896 -1.957 . . . . 0.0 106.681 176.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.5 p -98.39 97.66 8.98 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 112.861 -1.972 . . . . 0.0 110.36 -178.28 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -129.64 151.16 50.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.661 -1.215 . . . . 0.0 113.013 -177.804 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 146.07 36.13 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.132 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.717 ' CE2' HD12 ' A' ' 38' ' ' ILE . 8.8 m-85 -120.53 127.99 52.68 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.346 -172.714 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.1 mttt -128.81 73.01 1.48 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.754 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -35.72 148.45 0.15 Allowed Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.941 179.734 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 4.9 Cg_endo -78.44 36.92 0.57 Allowed 'Cis proline' 0 N--CA 1.487 1.118 0 C-N-CA 125.221 -0.741 . . . . 0.0 111.44 -5.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.439 ' H ' ' CA ' ' A' ' 35' ' ' TRP . 6.2 m120 -147.48 -162.21 1.5 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.335 -179.403 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.717 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.47 140.33 2.1 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.223 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.437 179.652 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 32.0 m -112.83 119.67 38.82 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.171 168.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.0 t -88.86 142.32 27.75 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.848 -171.622 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.496 ' CB ' ' O ' ' A' ' 30' ' ' SER . 1.1 m-85 -122.28 167.76 13.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.444 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -78.82 158.52 91.93 Favored 'Cis proline' 0 C--N 1.32 -0.944 0 CA-C-O 122.914 1.131 . . . . 0.0 114.525 6.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.543 0 CA-C-N 111.975 -2.375 . . . . 0.0 109.245 175.412 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -51.39 141.77 22.13 Favored Pre-proline 0 N--CA 1.505 2.301 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.388 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.41 30.6 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 108.318 -1.455 . . . . 0.0 108.318 166.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -66.52 125.25 25.15 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -174.938 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -78.24 165.33 24.04 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 117.269 -1.772 . . . . 0.0 109.402 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -134.31 176.96 8.13 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.896 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -74.47 139.48 43.92 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.732 -176.552 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.04 -17.81 0.92 Allowed Glycine 0 C--N 1.295 -1.719 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.898 179.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 7' ' ' SER . 7.5 mptt -128.63 107.03 18.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.21 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.41 162.99 27.62 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.908 -1.228 . . . . 0.0 108.908 173.092 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.85 -90.53 0.52 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.553 178.51 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.593 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.4 153.33 21.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.808 -176.794 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.72 146.54 18.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 173.287 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 22.0 m-20 -77.59 119.05 20.6 Favored 'General case' 0 C--O 1.173 -2.958 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.2 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 16' ' ' TRP . 55.4 tp -81.22 132.21 35.33 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.008 -1.877 . . . . 0.0 111.711 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.76 ' HB2' HG23 ' A' ' 38' ' ' ILE . 59.7 m95 -123.34 120.02 31.8 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 111.562 -2.563 . . . . 0.0 105.379 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.771 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -83.84 -16.91 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -168.201 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 mt -151.88 70.9 0.95 Allowed 'General case' 1 C--N 1.239 -4.214 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.087 -171.48 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -153.73 140.69 19.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 117.064 -1.854 . . . . 0.0 112.928 178.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.49 -25.0 29.31 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 177.195 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.28 153.68 45.33 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 151.53 43.68 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.636 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.31 109.39 0.97 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.922 1.081 . . . . 0.0 111.122 -178.595 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -21.33 70.44 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.186 -1.483 . . . . 0.0 109.903 178.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.18 -1.88 76.34 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.058 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -92.05 -101.88 0.12 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.18 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.65 -2.48 0.38 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.397 -1.382 . . . . 0.0 111.167 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.658 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 53.0 m-85 -82.77 168.2 17.41 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 122.692 1.234 . . . . 0.0 112.062 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -158.63 -45.55 0.06 Allowed 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 112.153 -2.294 . . . . 0.0 105.78 177.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -98.69 118.15 34.77 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.03 178.751 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -144.45 149.42 35.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 117.917 -1.513 . . . . 0.0 113.577 179.621 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 148.07 29.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.068 176.282 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.624 ' CE2' HD12 ' A' ' 38' ' ' ILE . 36.4 m-85 -118.71 137.33 53.41 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.748 -172.642 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 35' ' ' TRP . 39.7 mmtt -130.21 56.77 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.291 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 34' ' ' LYS . 31.3 t-105 -29.05 139.89 0.11 Allowed Pre-proline 0 N--CA 1.504 2.236 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.596 -177.199 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -71.89 -7.52 14.41 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.869 -6.105 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.551 ' C ' HG22 ' A' ' 38' ' ' ILE . 1.3 m120 -87.58 -158.2 0.44 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.606 -177.003 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.76 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER 176.49 139.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.193 -1.916 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.461 -178.55 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 11.5 m -109.37 108.75 19.41 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 117.337 -1.745 . . . . 0.0 107.028 170.581 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.658 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.4 t -83.78 142.81 30.4 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.627 -171.45 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.6 m-85 -117.7 166.01 14.5 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.273 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -76.31 159.88 96.08 Favored 'Cis proline' 0 CA--C 1.509 -0.735 0 CA-C-O 122.885 1.119 . . . . 0.0 113.651 4.041 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.897 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.514 178.282 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.06 0.457 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -79.96 147.77 66.72 Favored Pre-proline 0 N--CA 1.501 2.12 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.269 -177.942 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -84.24 30.15 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 N-CA-C 108.001 -1.577 . . . . 0.0 108.001 167.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -71.46 119.24 15.33 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -174.728 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.0 160.6 29.01 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.25 -1.78 . . . . 0.0 109.966 -178.331 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.65 179.41 4.35 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.684 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.3 p -80.87 118.98 22.85 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.99 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 -11.16 71.21 Favored Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.203 -179.247 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -127.41 110.95 21.13 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.445 -179.706 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -165.94 0.27 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.062 1.174 . . . . 0.0 109.398 173.466 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.14 -96.78 2.25 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 118.961 -1.59 . . . . 0.0 111.105 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.603 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.88 160.32 30.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.963 -178.591 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -144.54 140.42 9.26 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 172.732 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -76.02 129.18 36.47 Favored 'General case' 0 C--O 1.173 -2.953 0 C-N-CA 118.628 -1.229 . . . . 0.0 108.136 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -83.45 125.65 31.94 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.58 -1.648 . . . . 0.0 111.455 -178.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.645 ' CB ' HG23 ' A' ' 38' ' ' ILE . 54.3 m95 -122.03 161.39 23.08 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.023 -178.554 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.749 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.79 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.736 -176.998 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -68.45 68.94 0.14 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.224 1.487 . . . . 0.0 107.807 -177.824 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' ILE . 16.5 mtp85 -101.77 113.34 26.42 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.593 -2.094 . . . . 0.0 110.845 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.32 -35.94 36.25 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.33 -1.414 . . . . 0.0 109.685 179.088 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.22 156.72 45.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.99 178.712 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.12 147.07 49.84 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.768 178.656 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.04 -175.83 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.093 1.195 . . . . 0.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.25 -41.22 1.41 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.64 12.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.488 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 28' ' ' TYR . 7.0 m-85 -81.79 15.48 2.19 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.335 -179.69 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.51 11.49 0.29 Allowed Glycine 0 N--CA 1.487 2.046 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.78 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 35.7 m-85 -63.93 167.57 6.06 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 117.84 -1.544 . . . . 0.0 111.189 179.455 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.59 -43.83 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.372 -2.195 . . . . 0.0 106.616 177.882 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.62 125.77 42.55 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.929 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -160.52 162.98 33.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.923 -1.511 . . . . 0.0 112.841 -179.718 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.8 p -116.79 137.25 52.33 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.826 176.081 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.682 ' CE2' HD12 ' A' ' 38' ' ' ILE . 60.3 m-85 -112.52 120.43 41.58 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.468 -174.42 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -139.69 73.64 1.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.548 179.61 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.493 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.64 157.83 0.43 Allowed Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.727 -176.793 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 14.0 Cg_endo -80.99 26.48 4.98 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.442 0.4 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.493 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 4.0 m120 -144.74 178.3 8.09 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.463 175.636 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -148.07 148.58 16.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.951 -179.534 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 31.6 m -114.14 151.32 32.83 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 166.342 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.2 t -123.05 137.36 54.96 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.839 -1.144 . . . . 0.0 114.012 -169.354 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.553 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.7 m-85 -104.48 176.14 1.89 Allowed Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.631 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.9 Cg_exo -52.74 -62.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.928 0 N-CA-C 117.328 2.011 . . . . 0.0 117.328 4.388 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.603 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 116.265 -1.826 . . . . 0.0 109.6 -170.167 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -70.71 134.41 86.16 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -177.011 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.23 40.79 0.7 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 165.902 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -82.24 122.61 28.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -175.796 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.05 177.9 8.45 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.871 -1.532 . . . . 0.0 109.526 179.734 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.63 175.16 9.24 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.642 177.072 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.53 129.27 36.23 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.816 -177.693 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.91 -22.27 6.0 Favored Glycine 0 C--N 1.296 -1.662 0 C-N-CA 119.064 -1.541 . . . . 0.0 110.165 -178.806 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -110.4 115.41 54.23 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.838 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -76.33 -163.59 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 173.433 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.69 -106.04 2.05 Favored Glycine 0 C--N 1.287 -2.189 0 C-N-CA 118.832 -1.651 . . . . 0.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.622 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 8.2 ptm180 -159.25 177.42 11.05 Favored 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 118.176 -1.41 . . . . 0.0 114.224 -176.325 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -156.61 144.23 10.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 173.723 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 32.5 m-20 -76.25 124.57 27.69 Favored 'General case' 0 C--O 1.177 -2.719 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.199 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD12 ' SG ' ' A' ' 39' ' ' CYS . 3.2 tt -86.09 111.37 20.27 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.019 -1.872 . . . . 0.0 112.296 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.707 ' HB2' HG23 ' A' ' 38' ' ' ILE . 46.1 m95 -92.65 -178.13 4.78 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 112.25 -2.25 . . . . 0.0 108.864 176.045 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -102.03 -162.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.691 -176.288 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -68.72 66.81 0.13 Allowed 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 122.964 1.364 . . . . 0.0 107.726 -177.672 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 1.1 mtt85 -111.54 113.26 25.55 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 112.573 -2.103 . . . . 0.0 110.665 -179.398 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.08 -34.52 16.78 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.42 157.4 45.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.305 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -86.03 152.33 55.9 Favored Pre-proline 0 C--N 1.298 -1.633 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.173 179.277 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.98 115.5 2.47 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 120.698 0.932 . . . . 0.0 110.181 174.686 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.58 -4.87 47.97 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.375 -1.393 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 -0.56 55.87 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.179 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.23 -16.08 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.396 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.75 -3.36 23.02 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.761 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 43.1 m-85 -77.3 169.76 17.75 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.834 1.302 . . . . 0.0 112.471 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.97 -45.37 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 112.055 -2.339 . . . . 0.0 106.345 176.056 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 41' ' ' TYR . 80.2 p -99.38 115.29 28.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.066 -179.37 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -143.54 148.8 36.5 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.935 -179.932 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.5 144.47 33.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.788 176.105 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.8 m-85 -117.98 133.21 56.14 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.894 -173.005 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -138.72 75.59 1.53 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.957 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.502 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.9 155.73 0.39 Allowed Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.46 -177.994 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.459 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 7.3 Cg_endo -78.08 32.92 0.9 Allowed 'Cis proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.5 -1.042 . . . . 0.0 111.571 -4.51 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.502 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.4 m120 -145.07 -160.7 1.17 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.811 177.754 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.28 147.76 4.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.918 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 39.1 m -116.88 119.05 34.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.015 168.216 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.3 t -90.57 139.15 30.98 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.968 -171.501 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.6 m-85 -112.12 178.41 0.98 Allowed Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.953 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 15.7 Cg_exo -59.49 -56.64 0.12 OUTLIER 'Cis proline' 0 N--CA 1.502 2.02 0 N-CA-C 116.695 1.767 . . . . 0.0 116.695 4.818 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.622 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.7 0 CA-C-O 116.439 -1.743 . . . . 0.0 109.325 -171.043 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.567 ' HB3' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -39.5 137.86 1.01 Allowed Pre-proline 0 N--CA 1.503 2.187 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.103 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.23 33.7 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 164.249 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 12.7 p -84.98 115.37 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.455 -176.25 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.46 172.7 13.26 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.989 -178.508 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.89 -173.62 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.727 178.877 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -75.41 118.59 18.45 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.631 -175.872 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.38 44.87 Favored Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.844 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 28.1 mttt -113.51 109.43 51.01 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.319 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.87 -172.6 1.0 Allowed 'Trans proline' 0 C--N 1.32 -0.927 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 173.222 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.3 -110.57 3.58 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.58 -1.772 . . . . 0.0 110.807 179.079 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.751 HH11 ' HB2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.35 168.71 24.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.125 -177.967 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -147.9 157.38 27.32 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 174.268 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.563 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 1.2 m-20 -78.48 130.0 35.53 Favored 'General case' 0 C--O 1.172 -3.005 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.628 178.511 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 13.7 tp -96.08 97.33 9.49 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.923 1.344 . . . . 0.0 111.784 -177.294 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.836 ' HB2' HG23 ' A' ' 38' ' ' ILE . 78.5 m95 -83.08 115.52 21.92 Favored 'General case' 0 C--N 1.263 -3.157 0 CA-C-N 112.063 -2.335 . . . . 0.0 107.494 175.56 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.43 ' O ' HG22 ' A' ' 17' ' ' ILE . 8.2 mt -88.31 -8.85 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.974 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 10.9 mt -154.83 71.58 0.81 Allowed 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.674 -173.871 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.591 ' NH2' ' N ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -153.25 162.36 41.39 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 117.592 -1.643 . . . . 0.0 111.95 177.129 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -109.06 -32.48 3.03 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.454 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -136.21 153.94 51.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.412 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.74 149.08 39.84 Favored Pre-proline 0 C--N 1.293 -1.855 0 C-N-CA 118.779 -1.168 . . . . 0.0 110.068 -179.195 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.591 ' N ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 Cg_endo -66.83 146.47 78.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.878 1.052 . . . . 0.0 111.665 -178.69 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.68 -16.48 54.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 177.917 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.39 -9.13 87.25 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.05 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.73 -30.23 18.18 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.623 178.908 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.66 -9.48 12.82 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.227 177.576 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 45.4 m-85 -63.25 167.17 5.4 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.145 -178.821 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.23 -43.43 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 112.224 -2.262 . . . . 0.0 106.107 177.181 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.8 p -97.38 119.01 35.13 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.4 179.627 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -156.45 155.19 31.63 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.404 -1.718 . . . . 0.0 113.599 179.91 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 150.27 38.58 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.331 176.474 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 38' ' ' ILE . 36.4 m-85 -118.23 140.83 49.22 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.693 -171.212 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' ASN . 19.3 mttt -134.9 70.75 1.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.835 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -40.68 140.21 1.06 Allowed Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.222 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.89 2.47 14.57 Favored 'Cis proline' 0 N--CA 1.498 1.793 0 C-N-CA 125.319 -0.7 . . . . 0.0 110.425 -6.428 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' C ' HG22 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -93.41 -163.24 1.02 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.898 0.856 . . . . 0.0 112.301 -175.941 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.836 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 177.5 139.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.081 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.328 178.728 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 36.4 m -110.52 115.42 29.59 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.698 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -97.49 136.57 37.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.842 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.5 m-85 -107.03 179.49 0.88 Allowed Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.254 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 4.1 Cg_exo -65.45 -52.37 0.15 OUTLIER 'Cis proline' 0 N--CA 1.508 2.347 0 N-CA-C 116.632 1.743 . . . . 0.0 116.632 7.856 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.751 ' HB2' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.97 0 CA-C-O 116.411 -1.757 . . . . 0.0 109.588 -170.155 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -39.86 145.48 0.45 Allowed Pre-proline 0 N--CA 1.506 2.365 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -176.374 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.72 30.44 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 107.941 -1.6 . . . . 0.0 107.941 164.515 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.86 123.93 30.43 Favored 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.553 -174.464 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.0 m-85 -84.52 158.69 20.89 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.378 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -124.83 178.89 5.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.573 178.645 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 127.34 32.38 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.355 -175.431 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.28 54.46 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.887 178.747 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 113.25 18.97 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.637 -179.107 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -70.19 -158.73 0.05 OUTLIER 'Trans proline' 0 C--O 1.217 -0.54 0 C-N-CA 121.204 1.269 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 70.43 -108.68 2.56 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.849 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 1.7 ptp180 -160.09 -176.22 5.53 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.059 177.188 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.684 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -139.39 160.36 25.94 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 3.4 m-20 -78.95 128.85 33.82 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 118.145 -1.422 . . . . 0.0 108.048 177.695 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.646 ' CB ' ' HB2' ' A' ' 2' ' ' ALA . 22.8 tp -92.77 103.55 15.9 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.951 1.358 . . . . 0.0 112.503 -175.409 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.751 ' HB2' HG23 ' A' ' 38' ' ' ILE . 73.9 m95 -93.05 110.05 21.52 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.701 175.17 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 17' ' ' ILE . 87.1 mt -81.38 -10.53 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -170.261 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 5.4 mt -154.32 78.42 1.09 Allowed 'General case' 0 C--N 1.255 -3.519 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.274 -173.734 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 148.1 11.19 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.454 -1.699 . . . . 0.0 112.219 178.494 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.19 -17.86 28.3 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 177.225 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.75 161.61 39.52 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.608 178.596 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -105.42 150.94 39.55 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.87 179.403 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.22 165.43 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.837 1.024 . . . . 0.0 110.736 175.767 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.69 -22.13 8.69 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.137 179.62 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.76 83.15 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.193 179.867 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.5 -13.4 59.13 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.963 179.764 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.47 55.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.091 177.006 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.634 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.9 m-85 -75.75 168.0 20.84 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.241 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.0 p -162.85 -45.08 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 111.966 -2.379 . . . . 0.0 105.654 175.893 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 14.9 p -98.97 113.51 25.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.893 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -138.0 150.7 47.21 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.522 -1.271 . . . . 0.0 113.215 179.318 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -106.01 151.24 24.88 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.065 176.358 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 38' ' ' ILE . 34.1 m-85 -129.03 145.31 51.29 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.207 -172.701 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 78.02 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.224 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.447 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.76 152.95 0.42 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.426 -175.284 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -73.58 -1.81 14.14 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.444 -1.065 . . . . 0.0 110.64 -5.516 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m120 -94.16 -166.14 1.44 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.654 1.216 . . . . 0.0 111.524 -178.132 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -172.4 139.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.36 178.772 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 57.7 m -109.7 102.89 11.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 171.948 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.634 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.9 t -79.01 142.97 36.13 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.558 -171.796 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -116.86 165.45 15.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.553 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -77.31 160.08 94.4 Favored 'Cis proline' 0 C--O 1.214 -0.691 0 CA-C-O 122.771 1.071 . . . . 0.0 114.27 4.249 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.432 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.34 177.856 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -62.88 147.77 93.24 Favored Pre-proline 0 N--CA 1.515 2.806 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 -174.621 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.96 20.67 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 107.924 -1.606 . . . . 0.0 107.924 163.604 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.9 p -79.95 116.76 20.27 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.917 -178.551 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -80.89 -167.65 1.49 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.766 -173.383 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -175.98 3.7 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.78 176.674 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m -80.74 115.73 20.39 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.205 -178.626 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.7 -13.74 64.91 Favored Glycine 0 C--N 1.296 -1.668 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.237 -179.415 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -111.72 108.62 55.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -73.14 156.89 51.23 Favored 'Trans proline' 0 CA--C 1.507 -0.866 0 C-N-CA 120.999 1.132 . . . . 0.0 109.372 176.371 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.91 -90.56 0.57 Allowed Glycine 0 N--CA 1.484 1.862 1 N-CA-C 130.544 6.977 . . . . 0.0 130.544 -178.517 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.44 156.59 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.597 178.485 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.761 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -149.74 167.98 29.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 175.647 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -82.54 129.42 34.92 Favored 'General case' 0 C--O 1.178 -2.684 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.809 178.695 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 16.6 tp -96.62 106.6 18.89 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.909 1.338 . . . . 0.0 111.575 -178.535 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.628 ' HB2' HG23 ' A' ' 38' ' ' ILE . 69.4 m95 -93.47 108.95 20.55 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-N 111.79 -2.459 . . . . 0.0 107.021 176.349 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 17' ' ' ILE . 78.2 mt -83.15 -4.81 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.52 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 mt -151.67 80.24 1.28 Allowed 'General case' 0 C--N 1.253 -3.612 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.604 -174.598 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -172.19 159.37 4.81 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.659 177.678 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.67 -26.06 3.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 175.224 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 p -128.99 149.09 50.97 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.191 176.203 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 153.26 39.65 Favored Pre-proline 0 C--N 1.287 -2.112 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.298 -179.346 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.9 Cg_exo -55.3 99.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.857 1.038 . . . . 0.0 111.099 -178.726 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.06 6.23 4.13 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.291 -1.433 . . . . 0.0 109.756 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -100.24 -17.06 25.77 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.42 -86.27 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.976 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.57 -16.51 0.02 OUTLIER Glycine 0 C--N 1.287 -2.153 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.894 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.647 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 36.7 m-85 -56.18 167.16 0.68 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.702 -178.693 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 28' ' ' TYR . 4.8 p -162.89 -43.93 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 112.337 -2.211 . . . . 0.0 106.094 177.453 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 78.0 p -96.85 116.99 30.12 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.236 -179.952 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.59 155.28 40.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 117.953 -1.499 . . . . 0.0 113.917 -177.835 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -99.4 158.52 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.851 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.773 ' CE2' HD12 ' A' ' 38' ' ' ILE . 44.0 m-85 -138.58 133.64 32.77 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.909 -176.493 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.79 84.3 0.68 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.766 178.413 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.485 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -49.05 157.34 0.81 Allowed Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.656 -177.469 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.1 Cg_endo -71.16 0.99 7.29 Favored 'Cis proline' 0 C--O 1.206 -1.076 0 C-N-CA 124.277 -1.134 . . . . 0.0 111.042 -3.912 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -105.74 -165.6 1.12 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.691 1.234 . . . . 0.0 111.774 -177.042 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.773 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -172.25 143.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.131 -1.85 . . . . 0.0 107.314 178.735 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.2 m -113.61 109.58 18.84 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.208 174.228 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.647 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -89.62 140.81 29.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.963 -171.997 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -116.45 169.94 6.51 Favored Pre-proline 0 N--CA 1.503 2.214 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.196 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -81.24 156.49 82.89 Favored 'Cis proline' 0 CA--C 1.507 -0.864 0 CA-C-O 123.03 1.179 . . . . 0.0 114.384 3.565 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.979 0 CA-C-N 111.599 -2.546 . . . . 0.0 109.607 174.779 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' HB3' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -66.46 142.9 97.96 Favored Pre-proline 0 N--CA 1.499 2.021 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.394 -177.807 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -84.28 40.51 0.88 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 107.806 -1.652 . . . . 0.0 107.806 166.126 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.93 125.39 29.31 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.847 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.97 168.6 19.64 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.413 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.485 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -127.95 -175.24 3.42 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.951 -179.19 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -74.91 125.52 29.02 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.34 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.53 -2.06 24.69 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.615 -1.278 . . . . 0.0 111.043 178.973 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -126.4 115.24 23.29 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.94 -179.58 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.4 -175.98 3.01 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 108.16 -1.515 . . . . 0.0 108.16 171.05 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.96 -109.08 3.74 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.735 179.171 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.709 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 4.0 ptm180 -159.51 157.29 29.71 Favored 'General case' 0 C--O 1.207 -1.177 0 C-N-CA 118.58 -1.248 . . . . 0.0 112.791 -178.682 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.36 143.12 13.14 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.348 176.309 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -77.6 127.87 33.19 Favored 'General case' 0 C--O 1.172 -3.011 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.593 179.69 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.427 HD12 ' H ' ' A' ' 16' ' ' TRP . 51.2 tp -86.1 129.5 34.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.825 -1.55 . . . . 0.0 111.186 -179.505 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CB ' HG23 ' A' ' 38' ' ' ILE . 55.8 m95 -124.59 159.38 30.82 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.102 -178.136 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -84.03 -163.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.452 -177.44 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 70.59 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.131 1.443 . . . . 0.0 108.605 -176.459 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.8 mtp180 -102.12 133.7 46.54 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.474 178.943 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -60.23 -53.0 49.25 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.73 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.95 158.74 39.43 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.607 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.2 147.94 73.69 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.636 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.35 130.46 39.96 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.775 0.983 . . . . 0.0 111.391 -177.122 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.93 -17.86 58.89 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 178.566 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.98 -14.74 68.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -86.68 -70.54 0.6 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.347 179.632 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.95 -14.12 0.07 OUTLIER Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.128 -1.511 . . . . 0.0 111.751 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 51.4 m-85 -56.25 169.33 0.43 Allowed 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 122.656 1.217 . . . . 0.0 111.778 -179.385 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 28' ' ' TYR . 7.3 p -162.57 -45.43 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 112.298 -2.228 . . . . 0.0 106.604 177.131 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 41' ' ' TYR . 82.9 p -98.37 112.13 24.24 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 112.89 -1.959 . . . . 0.0 110.082 -178.693 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -148.16 156.28 42.41 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.584 -1.246 . . . . 0.0 112.712 -179.092 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 145.76 40.39 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.575 177.771 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.662 ' CE2' HD12 ' A' ' 38' ' ' ILE . 20.6 m-85 -118.82 126.55 52.08 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.874 -172.525 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 16.7 mttt -122.77 67.19 0.96 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.301 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.458 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 33.3 t-105 -34.8 142.69 0.23 Allowed Pre-proline 0 N--CA 1.496 1.85 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.405 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.42 44.33 0.32 Allowed 'Cis proline' 0 N--CA 1.494 1.537 0 C-N-CA 125.62 -0.575 . . . . 0.0 111.487 -5.564 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.469 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 1.6 m120 -150.79 -157.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.329 178.15 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.662 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -173.95 138.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.99 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.681 -179.892 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 49.1 m -110.76 123.86 50.87 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 117.463 -1.695 . . . . 0.0 106.518 168.535 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.9 t -94.03 141.62 28.33 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.711 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -114.23 179.71 0.74 Allowed Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 176.722 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.535 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.0 Cg_exo -57.34 -56.15 0.09 OUTLIER 'Cis proline' 0 N--CA 1.503 2.054 0 CA-C-N 122.434 1.905 . . . . 0.0 116.95 6.065 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.709 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.475 0 CA-C-O 116.282 -1.818 . . . . 0.0 109.182 -170.669 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.655 ' HB3' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -43.49 146.5 0.92 Allowed Pre-proline 0 N--CA 1.514 2.764 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -175.155 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -84.17 21.87 1.01 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 N-CA-C 107.793 -1.657 . . . . 0.0 107.793 164.245 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 1.7 p -83.51 118.33 23.71 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.083 -176.788 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -175.42 4.69 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.213 -176.043 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -123.38 -174.44 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 177.308 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.89 110.52 15.33 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.609 -178.313 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.68 73.14 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.517 179.715 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.2 112.79 34.36 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.435 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -71.75 -159.26 0.07 OUTLIER 'Trans proline' 0 C--O 1.213 -0.77 0 N-CA-C 109.144 -1.137 . . . . 0.0 109.144 173.376 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.0 -106.21 2.43 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.901 177.966 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.726 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.54 177.23 9.64 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.096 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.726 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -154.07 175.83 32.17 Favored Glycine 0 N--CA 1.504 3.17 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.469 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.5 m-20 -91.12 126.13 36.12 Favored 'General case' 0 C--O 1.182 -2.465 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.817 177.683 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 13.7 tp -97.12 102.61 14.42 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.038 1.399 . . . . 0.0 111.958 -177.398 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.841 ' HB2' HG23 ' A' ' 38' ' ' ILE . 79.3 m95 -88.98 123.97 33.82 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-N 111.758 -2.473 . . . . 0.0 107.112 175.854 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 17' ' ' ILE . 51.3 mt -90.4 -7.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.247 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -168.888 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -150.36 74.83 1.2 Allowed 'General case' 0 C--N 1.254 -3.558 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.264 -173.354 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.63 151.21 1.85 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.559 178.366 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.597 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -101.98 -24.41 8.58 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 173.819 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 157.13 38.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.565 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -82.28 172.55 9.31 Favored Pre-proline 0 CA--C 1.58 2.109 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.065 -178.38 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.8 Cg_exo -52.22 -139.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.085 2.524 . . . . 0.0 114.557 -170.692 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.87 114.23 2.57 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 176.189 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.94 80.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.25 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' HD1' ' H ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -100.34 -51.53 3.62 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 122.15 0.976 . . . . 0.0 111.606 -175.892 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' H ' ' HD1' ' A' ' 26' ' ' TYR . . . 138.96 -19.23 3.11 Favored Glycine 0 C--N 1.281 -2.515 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -174.126 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.587 ' O ' HG23 ' A' ' 29' ' ' THR . 33.8 m-85 -72.74 173.95 8.34 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 122.558 1.171 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.0 p -162.05 -42.66 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.133 177.172 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.4 p -96.69 126.28 41.75 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.031 178.178 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -154.74 153.2 30.87 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 117.644 -1.622 . . . . 0.0 113.832 -179.422 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.4 p -114.24 153.87 28.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.781 174.961 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.833 ' CD2' HD12 ' A' ' 38' ' ' ILE . 14.7 m-85 -130.95 130.86 43.97 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.955 -175.701 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -134.67 74.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.577 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -46.1 153.49 0.68 Allowed Pre-proline 0 C--N 1.298 -1.671 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.48 -174.419 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.5 -0.18 12.67 Favored 'Cis proline' 0 C--O 1.204 -1.223 0 C-N-CA 124.11 -1.204 . . . . 0.0 110.842 -4.195 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -96.43 -168.12 1.68 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.952 0.882 . . . . 0.0 110.758 -179.008 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -169.38 141.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 114.372 -1.285 . . . . 0.0 108.679 -179.882 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 56.5 m -110.05 97.21 6.76 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.209 -1.396 . . . . 0.0 107.553 172.958 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.583 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -81.36 127.95 33.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.587 -173.348 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -100.04 171.62 5.39 Favored Pre-proline 0 N--CA 1.514 2.757 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.222 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.1 Cg_endo -84.36 158.1 68.52 Favored 'Cis proline' 0 CA--C 1.507 -0.83 0 CA-C-O 123.246 1.269 . . . . 0.0 114.643 1.938 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.914 0 CA-C-N 111.271 -2.695 . . . . 0.0 109.744 174.435 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -70.19 155.12 93.97 Favored Pre-proline 0 N--CA 1.511 2.603 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.049 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -90.43 31.32 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 109.039 -1.177 . . . . 0.0 109.039 166.763 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.34 130.57 36.33 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -175.218 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.52 165.48 23.68 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.313 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -110.93 180.0 3.89 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.326 177.275 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.1 103.14 13.84 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.118 -178.659 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.04 18.16 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -178.929 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.06 117.42 9.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.958 -179.05 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -78.11 170.24 19.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 N-CA-C 108.534 -1.372 . . . . 0.0 108.534 172.09 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.57 -96.35 1.06 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.795 178.803 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.78 152.25 19.34 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.556 -1.657 . . . . 0.0 114.455 -178.143 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.28 155.31 23.37 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 174.312 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.651 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -79.52 119.13 22.07 Favored 'General case' 0 C--O 1.169 -3.161 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.365 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 17.0 tp -85.77 93.3 8.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.889 -177.654 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.811 ' HB2' HG23 ' A' ' 38' ' ' ILE . 72.6 m95 -74.24 126.33 30.38 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 112.706 -2.043 . . . . 0.0 107.106 172.211 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 17' ' ' ILE . 11.6 mt -94.41 -8.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -169.723 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -152.71 55.64 0.79 Allowed 'General case' 0 C--N 1.261 -3.25 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 -173.602 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.53 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -133.96 157.08 46.96 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.563 -179.327 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.55 -32.32 2.15 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 174.262 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.27 150.43 52.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.58 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -85.92 145.18 40.51 Favored Pre-proline 0 C--N 1.284 -2.264 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.737 -178.861 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.96 -174.76 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 120.865 1.043 . . . . 0.0 111.323 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.06 13.3 9.09 Favored Glycine 0 N--CA 1.484 1.889 1 N-CA-C 128.912 6.325 . . . . 0.0 128.912 177.957 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.35 -14.73 27.33 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.531 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -79.42 -21.17 45.93 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.126 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.46 61.23 Favored Glycine 0 C--N 1.292 -1.862 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.086 179.326 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 43.5 m-85 -56.43 164.34 1.42 Allowed 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 117.967 -1.493 . . . . 0.0 110.934 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -163.16 -45.06 0.03 OUTLIER 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.41 -2.177 . . . . 0.0 106.112 177.61 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.7 p -99.73 110.7 23.08 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.651 -2.068 . . . . 0.0 109.385 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -142.84 147.15 34.93 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.338 -1.345 . . . . 0.0 113.349 -179.007 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 14.5 p -99.57 143.7 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.2 175.616 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.849 ' CE2' HD12 ' A' ' 38' ' ' ILE . 61.8 m-85 -119.58 139.12 52.66 Favored 'General case' 0 C--N 1.275 -2.64 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.86 -173.273 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.6 mttt -137.07 60.91 1.64 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.145 176.742 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' LYS . 1.2 t90 -35.06 143.67 0.23 Allowed Pre-proline 0 N--CA 1.497 1.886 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.079 -177.901 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.17 -1.3 10.47 Favored 'Cis proline' 0 N--CA 1.486 1.07 0 C-N-CA 125.106 -0.789 . . . . 0.0 111.469 -4.661 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.55 ' C ' HG22 ' A' ' 38' ' ' ILE . 1.7 m120 -95.55 -162.44 0.95 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.546 0.689 . . . . 0.0 110.881 -178.416 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.849 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 175.66 137.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.852 -179.414 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 20.6 m -107.65 121.6 45.01 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 117.718 -1.593 . . . . 0.0 106.976 170.174 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -100.27 139.17 36.32 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -169.305 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.577 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -115.31 166.01 12.96 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.268 177.756 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.69 160.32 87.65 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 CA-C-O 122.842 1.101 . . . . 0.0 113.918 5.327 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.577 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.573 0 CA-C-N 112.155 -2.293 . . . . 0.0 109.679 176.124 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.86 156.23 7.04 Favored Pre-proline 0 N--CA 1.503 2.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.019 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -91.15 27.84 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.3 1.333 . . . . 0.0 108.825 167.443 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.596 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -70.39 126.21 28.99 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.802 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -77.47 166.95 22.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 117.712 -1.595 . . . . 0.0 110.653 -177.188 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.52 -179.39 4.75 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.639 0.733 . . . . 0.0 110.203 179.12 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 9' ' ' LYS . 86.2 p -72.1 142.48 49.19 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.427 -179.081 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.86 -10.76 1.07 Allowed Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.634 178.642 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 7' ' ' SER . 4.5 mttt -136.48 113.26 10.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.484 -179.409 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -77.1 -165.72 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 172.795 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -88.1 1.55 Allowed Glycine 0 C--N 1.289 -2.078 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.05 176.447 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.532 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -160.65 154.64 22.81 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 117.827 -1.549 . . . . 0.0 114.069 -175.476 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.1 149.98 21.88 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 172.99 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 125.64 29.61 Favored 'General case' 0 C--O 1.17 -3.121 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.85 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.63 110.83 20.68 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 116.925 -1.91 . . . . 0.0 112.274 -177.983 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.67 ' CB ' HG23 ' A' ' 38' ' ' ILE . 58.0 m95 -96.23 175.51 6.42 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 112.471 -2.15 . . . . 0.0 109.201 176.64 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -102.38 -158.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.769 -176.854 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -66.69 73.49 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.741 1.734 . . . . 0.0 108.201 -176.374 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.2 mtt-85 -133.82 97.01 3.79 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.845 178.994 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.45 -5.05 0.68 Allowed Glycine 0 N--CA 1.486 1.984 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.608 -179.646 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 19' ' ' ARG . 1.6 p -137.53 151.9 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.221 179.823 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -103.8 142.86 25.46 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.3 179.108 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' CG ' ' CH2' ' A' ' 16' ' ' TRP . 5.8 Cg_exo -55.88 144.64 76.87 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.004 1.136 . . . . 0.0 111.305 179.595 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.79 -2.75 78.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.706 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.49 -19.76 70.6 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.587 -179.757 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -87.09 -12.04 48.38 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.027 -179.168 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.89 76.66 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.612 176.639 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.628 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.9 m-85 -56.48 174.14 0.15 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.213 179.36 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -161.61 -43.67 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.666 -2.061 . . . . 0.0 106.335 175.783 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.3 p -97.21 133.9 41.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.558 179.335 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -160.04 157.28 28.39 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.849 178.78 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.41 ' O ' HG13 ' A' ' 38' ' ' ILE . 19.7 p -113.34 142.74 45.5 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.995 176.139 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.797 ' CD2' HD12 ' A' ' 38' ' ' ILE . 11.9 m-85 -120.44 125.31 47.61 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.272 -174.023 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -146.12 81.67 1.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.707 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.452 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.06 157.78 0.15 Allowed Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.461 179.672 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.4 Cg_endo -78.34 28.68 1.78 Allowed 'Cis proline' 0 C--O 1.21 -0.903 0 C-N-CA 124.227 -1.156 . . . . 0.0 110.751 -5.209 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.456 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 5.7 m120 -145.01 -170.26 3.38 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.797 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -154.41 150.12 12.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.773 178.822 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -116.66 158.66 23.42 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 166.282 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -130.52 147.18 52.18 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.518 -1.273 . . . . 0.0 114.103 -170.189 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -118.53 166.91 12.68 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.404 179.734 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.44 158.53 97.26 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 CA-C-O 122.679 1.033 . . . . 0.0 113.94 4.599 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.503 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.502 0 CA-C-N 112.359 -2.201 . . . . 0.0 110.121 177.898 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -52.41 143.33 27.34 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.312 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -81.61 35.27 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 166.179 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.39 123.23 25.65 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.779 -1.168 . . . . 0.0 108.357 -175.25 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.08 179.62 7.24 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.151 -1.42 . . . . 0.0 108.778 179.424 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -179.29 6.11 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.794 -1.162 . . . . 0.0 111.021 178.561 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 p -74.07 128.27 35.08 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.293 -176.146 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -8.48 3.99 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.005 178.778 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.51 107.08 41.4 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.18 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -72.07 -173.51 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.078 1.185 . . . . 0.0 109.854 174.717 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.69 -112.36 3.84 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.288 178.291 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.58 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 4.3 ptm180 -152.56 166.25 32.61 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.503 -177.18 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.68 146.78 18.11 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 174.356 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -77.12 117.82 19.06 Favored 'General case' 0 C--O 1.179 -2.615 0 C-N-CA 118.989 -1.085 . . . . 0.0 108.272 178.896 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.21 112.59 19.99 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 116.387 -2.125 . . . . 0.0 112.441 -178.684 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.702 ' CB ' HG23 ' A' ' 38' ' ' ILE . 57.2 m95 -94.71 174.26 7.19 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 112.144 -2.298 . . . . 0.0 106.659 173.15 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.691 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -96.56 -158.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 C-N-CA 118.651 -1.219 . . . . 0.0 113.02 -174.376 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.94 72.91 0.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 123.619 1.676 . . . . 0.0 108.221 -177.063 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ILE . 5.2 mtp85 -131.84 97.53 4.21 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 111.637 -2.529 . . . . 0.0 109.729 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.53 -22.98 1.18 Allowed Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.019 -179.516 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.427 ' N ' ' C ' ' A' ' 19' ' ' ARG . 1.1 p -130.4 152.31 49.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.983 179.524 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 173.07 8.09 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.35 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 14.9 Cg_endo -67.0 98.9 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.576 1.517 . . . . 0.0 113.364 -174.614 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' PRO . . . -30.85 101.11 0.01 OUTLIER Glycine 0 N--CA 1.512 3.758 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.573 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.78 68.58 0.66 Allowed Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.703 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -117.52 -172.56 2.25 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.189 0.519 . . . . 0.0 110.683 -177.471 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.86 -18.3 54.64 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 172.784 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 23.1 m-85 -69.94 177.72 3.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.956 1.36 . . . . 0.0 112.476 178.766 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.7 p -161.55 -44.36 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.759 -2.473 . . . . 0.0 105.475 176.4 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.21 114.69 27.02 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.751 178.517 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.541 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -136.52 151.85 49.87 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 118.55 -1.26 . . . . 0.0 112.819 178.558 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.35 146.18 43.56 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.766 176.721 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.882 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.2 m-85 -126.27 136.21 52.5 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.222 -174.841 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -147.12 79.79 1.51 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.588 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.445 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.75 159.05 0.21 Allowed Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.135 -178.154 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.1 Cg_endo -81.15 32.29 2.28 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.542 -1.024 . . . . 0.0 111.635 -3.725 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.445 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.8 m120 -148.98 171.17 16.79 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.411 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.882 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -131.62 152.31 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.832 178.35 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 28.9 m -123.46 110.23 14.84 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.014 -1.475 . . . . 0.0 107.523 167.58 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -83.79 133.41 34.77 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.02 -174.31 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -102.89 -173.85 0.31 Allowed Pre-proline 0 N--CA 1.517 2.919 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.647 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.8 Cg_exo -62.56 -48.58 0.18 OUTLIER 'Cis proline' 0 N--CA 1.508 2.348 0 CA-C-N 122.653 1.983 . . . . 0.0 116.497 3.958 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.608 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.987 0 CA-C-O 116.481 -1.724 . . . . 0.0 109.244 -171.382 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -49.8 146.8 7.13 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -176.517 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -81.22 27.77 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 N-CA-C 108.022 -1.569 . . . . 0.0 108.022 164.001 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.3 p -87.95 120.3 29.15 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.097 -177.608 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.658 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -82.52 -175.13 5.58 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.111 -173.379 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.44 -176.39 5.57 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.703 176.073 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.7 t -78.92 113.34 16.94 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.584 -177.728 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.23 67.58 Favored Glycine 0 C--N 1.296 -1.65 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -112.25 136.01 21.37 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.802 -178.904 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 9' ' ' LYS . 2.9 Cg_exo -48.74 -166.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.602 2.201 . . . . 0.0 114.244 -173.063 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.94 24.73 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.062 -174.543 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 10' ' ' PRO . 8.2 ptm180 -161.36 146.91 13.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 116.695 -2.002 . . . . 0.0 114.612 176.862 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -160.65 173.59 37.2 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 176.088 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -84.31 135.0 34.49 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.974 179.89 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.63 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 36.3 tp -96.59 133.62 40.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.358 1.075 . . . . 0.0 110.114 -179.62 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.622 ' CB ' HG23 ' A' ' 38' ' ' ILE . 64.9 m95 -135.08 151.37 50.69 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 112.899 -1.955 . . . . 0.0 108.047 -177.483 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.891 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -78.56 -157.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.835 -175.562 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.74 67.44 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.017 1.389 . . . . 0.0 108.235 -176.8 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -103.82 112.16 25.0 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.102 -178.972 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -23.52 57.18 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.382 -1.39 . . . . 0.0 109.789 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.85 156.47 40.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.982 178.631 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -91.65 149.82 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.918 179.263 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.91 128.52 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.972 1.115 . . . . 0.0 111.452 -177.614 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.36 6.95 55.87 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.01 179.489 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.51 -7.23 16.44 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.386 -179.975 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.55 -35.77 39.37 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.798 179.604 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.93 -13.07 6.44 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.642 178.367 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 42.9 m-85 -60.7 170.55 1.42 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.744 -179.136 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 28' ' ' TYR . 10.3 p -161.46 -44.96 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 112.319 -2.219 . . . . 0.0 106.038 178.438 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.4 129.8 44.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.714 179.379 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.82 157.3 28.99 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.922 -1.511 . . . . 0.0 112.438 178.266 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 142.19 47.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.141 177.173 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.695 ' CE2' HD12 ' A' ' 38' ' ' ILE . 21.3 m-85 -117.77 124.62 48.89 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.813 -172.735 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.9 81.06 1.67 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.195 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.449 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.98 159.62 0.13 Allowed Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.883 -178.775 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -77.76 23.06 3.76 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.127 -1.197 . . . . 0.0 110.721 -5.208 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.44 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 6.9 m120 -140.76 175.76 9.35 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.968 179.663 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -136.2 145.83 30.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.523 177.355 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.9 m -115.07 115.69 27.21 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 117.688 -1.605 . . . . 0.0 107.087 169.844 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -87.91 160.37 17.97 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.598 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 30' ' ' SER . 5.7 m-85 -132.62 161.9 60.56 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.139 179.185 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -85.95 160.32 58.35 Favored 'Cis proline' 0 C--N 1.325 -0.708 0 N-CA-C 115.209 1.196 . . . . 0.0 115.209 5.412 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.038 0 CA-C-N 112.02 -2.354 . . . . 0.0 109.588 175.57 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.551 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -42.06 140.04 1.61 Allowed Pre-proline 0 N--CA 1.503 2.222 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.187 -178.658 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.88 51.9 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 170.962 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -69.26 141.36 54.41 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -174.396 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -78.38 173.29 12.49 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 117.984 -1.486 . . . . 0.0 108.909 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.33 -168.18 1.28 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.191 -178.656 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 9' ' ' LYS . 4.5 m -65.35 113.63 4.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.107 -177.991 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.8 -3.12 0.73 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.807 179.131 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 7' ' ' SER . 22.3 mttt -93.81 120.95 65.46 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 118.296 -1.362 . . . . 0.0 111.156 -178.99 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -71.11 155.93 60.51 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 N-CA-C 109.386 -1.044 . . . . 0.0 109.386 174.321 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -116.54 3.55 Favored Glycine 0 N--CA 1.482 1.724 1 N-CA-C 129.591 6.596 . . . . 0.0 129.591 -178.008 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.62 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.9 149.33 16.21 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.627 -1.229 . . . . 0.0 112.343 178.683 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . -135.3 158.26 23.55 Favored Glycine 0 C--O 1.195 -2.297 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 172.909 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -77.61 113.63 15.64 Favored 'General case' 0 C--O 1.176 -2.776 0 C-N-CA 118.364 -1.334 . . . . 0.0 108.245 178.871 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 5.4 tt -83.35 85.74 7.18 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 116.715 -1.994 . . . . 0.0 112.826 -176.461 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.846 ' HB2' HG23 ' A' ' 38' ' ' ILE . 68.6 m95 -59.43 131.06 49.82 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.199 171.861 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.509 HG23 HD21 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -102.37 -5.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.017 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -171.021 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 mt -148.92 57.24 1.03 Allowed 'General case' 1 C--N 1.241 -4.115 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.335 -173.399 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -159.95 164.16 33.61 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.406 -1.718 . . . . 0.0 112.315 179.798 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.02 -16.24 5.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 176.144 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 155.5 40.54 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.668 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -103.13 144.44 28.64 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.062 178.518 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.94 130.68 41.13 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.777 0.984 . . . . 0.0 111.516 -178.207 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.2 -18.5 78.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 177.941 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -13.43 83.64 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.54 -62.04 1.81 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.053 179.933 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.77 -15.19 0.81 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 118.892 -1.623 . . . . 0.0 111.994 178.316 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.626 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.8 m-85 -61.44 170.52 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.708 1.242 . . . . 0.0 112.423 -178.704 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -160.89 -44.87 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 112.123 -2.308 . . . . 0.0 105.917 177.612 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 41' ' ' TYR . 67.9 p -96.04 113.0 24.57 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.859 179.222 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.27 151.24 33.88 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.217 -1.393 . . . . 0.0 113.582 -177.422 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -101.16 140.88 34.84 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.3 175.025 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.843 ' CD2' HD12 ' A' ' 38' ' ' ILE . 72.9 m-85 -120.76 134.8 55.27 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.405 -174.125 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -149.43 66.89 1.01 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.938 178.779 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.455 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 12.1 t-105 -30.55 147.22 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.01 178.564 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.6 Cg_endo -71.37 2.74 6.77 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 C-N-CA 125.368 -0.68 . . . . 0.0 112.31 -5.321 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.509 HD21 HG23 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -110.19 -165.37 1.0 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.945 0.879 . . . . 0.0 111.693 -176.941 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.846 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -178.26 130.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.349 179.541 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -108.42 109.44 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.526 -1.67 . . . . 0.0 107.349 174.202 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.8 t -87.93 134.72 33.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.484 -2.143 . . . . 0.0 114.214 -168.602 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.54 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.7 m-85 -106.56 -178.53 0.6 Allowed Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 178.086 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.3 Cg_exo -55.85 -59.26 0.03 OUTLIER 'Cis proline' 0 N--CA 1.506 2.255 0 N-CA-C 117.618 2.122 . . . . 0.0 117.618 5.981 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.499 0 CA-C-O 116.337 -1.792 . . . . 0.0 108.924 -169.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.95 39.01 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 109.08 -1.161 . . . . 0.0 109.08 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.41 121.23 22.75 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.838 -175.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 8.4 m-85 -78.23 163.5 25.72 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 117.956 -1.498 . . . . 0.0 109.776 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.93 175.27 8.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.092 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -81.81 116.51 21.53 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.859 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -15.18 63.89 Favored Glycine 0 C--N 1.296 -1.643 0 C-N-CA 119.452 -1.356 . . . . 0.0 109.934 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -130.1 111.67 17.0 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.208 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -74.46 -175.31 2.18 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 N-CA-C 109.079 -1.162 . . . . 0.0 109.079 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.19 -104.67 3.21 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 6.2 ptm180 -160.21 165.4 31.59 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.173 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.13 149.94 20.72 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 173.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -77.22 124.51 27.94 Favored 'General case' 0 C--O 1.166 -3.314 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.29 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 tp -84.69 111.07 19.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.037 -1.865 . . . . 0.0 112.543 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.691 ' CB ' HG23 ' A' ' 38' ' ' ILE . 65.6 m95 -100.64 171.72 7.53 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.675 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.32 -161.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.722 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.99 70.89 0.15 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.298 1.523 . . . . 0.0 108.087 -177.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.565 ' C ' ' H ' ' A' ' 21' ' ' THR . 47.7 mtp180 -115.96 -13.02 11.29 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 112.11 -2.314 . . . . 0.0 110.9 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 48.3 4.67 0.02 OUTLIER Glycine 0 C--N 1.263 -3.511 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.38 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -151.92 154.88 36.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.17 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -116.13 151.19 46.37 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.028 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.69 106.12 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 120.721 0.947 . . . . 0.0 110.908 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.31 89.96 1.01 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.42 -11.06 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.212 -1.47 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.61 -18.76 40.08 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.25 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.59 -16.88 2.24 Favored Glycine 0 N--CA 1.482 1.736 0 C-N-CA 119.51 -1.328 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 29.2 m-85 -77.3 167.73 21.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.992 1.377 . . . . 0.0 112.624 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.3 p -162.59 -46.05 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.749 -2.478 . . . . 0.0 105.65 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' TYR . 70.0 p -98.73 124.41 43.57 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.548 -2.114 . . . . 0.0 110.19 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -148.41 156.09 42.05 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.337 178.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.39 147.22 39.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.88 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.829 ' CE2' HD12 ' A' ' 38' ' ' ILE . 7.3 m-85 -127.92 131.26 49.38 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.485 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 77.66 1.62 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.49 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.81 158.94 0.27 Allowed Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.151 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.1 Cg_endo -78.89 35.25 0.8 Allowed 'Cis proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.351 -1.104 . . . . 0.0 112.54 -5.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.49 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 4.0 m-80 -147.73 -166.47 2.53 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.228 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.829 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -156.63 147.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.511 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.8 m -117.35 136.31 53.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 166.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -107.09 140.04 40.55 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -170.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.3 m-85 -107.83 176.71 1.51 Allowed Pre-proline 0 N--CA 1.509 2.507 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 7.8 Cg_exo -58.99 -53.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.164 0 N-CA-C 117.196 1.96 . . . . 0.0 117.196 5.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.622 0 CA-C-O 116.468 -1.729 . . . . 0.0 109.179 -170.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -77.96 35.28 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.6 124.0 29.15 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -176.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 164.57 25.15 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.724 -1.591 . . . . 0.0 110.276 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.2 m -109.17 -178.7 3.64 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.306 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.14 111.45 17.59 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.991 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.18 -12.31 48.47 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.471 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.51 115.1 14.68 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.127 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -161.58 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.89 -93.52 1.6 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.154 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.585 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.98 160.06 30.24 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.744 -178.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -145.63 141.96 10.24 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 42.3 m-20 -75.33 125.5 29.1 Favored 'General case' 0 C--O 1.175 -2.846 0 C-N-CA 118.217 -1.393 . . . . 0.0 108.135 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -84.15 132.79 34.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 116.931 -1.908 . . . . 0.0 111.448 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.659 ' CB ' HG23 ' A' ' 38' ' ' ILE . 55.7 m95 -124.88 175.65 7.15 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.481 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.672 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -99.33 -162.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.441 -176.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.22 67.36 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.343 1.544 . . . . 0.0 108.343 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.8 mtp85 -103.81 128.88 51.22 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.1 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.3 -49.44 60.09 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.204 -1.474 . . . . 0.0 109.468 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.33 161.37 38.06 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.954 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.36 150.33 76.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.217 179.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.95 129.18 31.99 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 120.937 1.091 . . . . 0.0 110.667 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 26' ' ' TYR . . . -74.18 -48.16 15.87 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.833 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.32 -9.03 0.57 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.397 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.5 m-85 -79.52 -75.97 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.197 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.2 -13.24 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.002 -1.571 . . . . 0.0 112.08 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.632 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 53.4 m-85 -66.25 172.31 4.01 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 122.618 1.199 . . . . 0.0 112.688 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -161.93 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.312 -2.222 . . . . 0.0 106.354 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -97.56 118.87 35.02 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.429 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.472 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.94 158.47 44.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.044 -1.463 . . . . 0.0 112.884 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.416 ' O ' HG13 ' A' ' 38' ' ' ILE . 26.2 p -113.06 147.64 36.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.49 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.606 ' CE2' HD12 ' A' ' 38' ' ' ILE . 40.4 m-85 -122.19 117.51 26.38 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.5 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 31.8 mttp -130.87 75.24 1.64 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.877 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.468 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -41.45 156.02 0.22 Allowed Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.437 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.6 Cg_endo -78.56 28.71 1.88 Allowed 'Cis proline' 0 C--O 1.206 -1.117 0 C-N-CA 124.167 -1.18 . . . . 0.0 112.123 -3.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.468 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.2 m-80 -144.98 -160.15 1.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.232 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.672 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -160.93 154.32 3.9 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.046 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.843 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.522 ' N ' HG13 ' A' ' 38' ' ' ILE . 80.4 m -124.56 116.61 22.73 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 117.903 -1.519 . . . . 0.0 107.104 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.632 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.15 148.64 25.59 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.531 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -120.19 167.81 11.8 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -73.95 159.26 97.87 Favored 'Cis proline' 0 C--O 1.214 -0.71 0 CA-C-O 122.788 1.078 . . . . 0.0 113.838 3.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.191 -2.277 . . . . 0.0 109.928 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -91.22 40.63 0.35 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 109.929 -0.835 . . . . 0.0 109.929 168.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -77.09 126.97 31.84 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.128 -176.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.37 167.2 21.7 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.832 -179.002 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -175.68 2.78 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.9 177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.0 123.22 26.02 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.236 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.0 -11.69 47.03 Favored Glycine 0 C--N 1.299 -1.476 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.735 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -116.47 109.5 43.85 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.433 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.41 -167.7 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 107.684 -1.698 . . . . 0.0 107.684 172.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.71 -111.67 3.75 Favored Glycine 0 C--N 1.283 -2.381 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.378 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -156.11 154.98 31.77 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 118.245 -1.382 . . . . 0.0 114.189 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.07 153.64 23.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -78.97 125.74 29.78 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.971 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 22.7 tp -85.98 108.15 18.08 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.966 -1.494 . . . . 0.0 111.893 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.698 ' CB ' HG23 ' A' ' 38' ' ' ILE . 60.3 m95 -95.16 176.79 6.09 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.616 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -100.14 -162.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.221 -176.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.575 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.87 70.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.288 1.518 . . . . 0.0 108.27 -176.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' ILE . 40.6 mtp180 -112.47 115.64 29.0 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.05 -23.87 18.21 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 110.795 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.73 158.07 42.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.384 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' N ' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -86.34 151.41 53.64 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.837 178.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.6 Cg_exo -50.11 120.94 6.77 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.174 1.249 . . . . 0.0 111.428 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.04 -4.74 4.83 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.512 -1.327 . . . . 0.0 110.29 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -119.72 1.05 13.77 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 130.684 7.034 . . . . 0.0 130.684 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -79.54 -36.43 38.38 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.274 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.84 -17.15 2.19 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.353 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.1 m-85 -60.78 168.95 2.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.303 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.3 p -162.02 -43.0 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 112.283 -2.235 . . . . 0.0 106.418 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.4 p -97.31 121.56 39.34 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.357 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.83 154.8 34.62 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.81 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -110.17 137.84 47.36 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.643 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.665 ' CE2' HD12 ' A' ' 38' ' ' ILE . 38.9 m-85 -113.71 129.93 56.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.553 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -147.77 81.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.149 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.444 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.47 159.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.349 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 4.6 Cg_endo -78.51 28.23 2.01 Favored 'Cis proline' 0 C--O 1.21 -0.879 0 C-N-CA 124.273 -1.136 . . . . 0.0 111.813 -5.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.2 m-80 -147.06 -172.35 3.98 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.709 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.698 HG23 ' CB ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -154.98 147.92 12.93 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.833 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -116.64 142.53 46.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.714 165.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.5 t -112.63 148.53 34.41 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.499 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -119.86 170.44 6.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.15 158.08 83.44 Favored 'Cis proline' 0 CA--C 1.503 -1.039 0 CA-C-O 122.857 1.107 . . . . 0.0 113.661 4.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.966 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.468 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -74.75 57.76 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.06 -1.939 . . . . 0.0 107.06 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.59 138.97 45.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.46 -179.13 6.17 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.869 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -162.66 1.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.111 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 9' ' ' LYS . 8.7 m -59.9 110.94 1.29 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.473 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.8 3.67 0.12 Allowed Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.224 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 7' ' ' SER . 61.5 mttt -94.14 116.81 66.88 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.474 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 9.8 Cg_endo -73.69 -166.19 0.3 Allowed 'Trans proline' 0 C--O 1.206 -1.093 0 N-CA-C 109.264 -1.091 . . . . 0.0 109.264 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 -120.33 5.29 Favored Glycine 0 C--N 1.29 -2.001 0 C-N-CA 118.674 -1.726 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.638 HH22 ' CG ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -161.1 162.19 31.47 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 118.185 -1.406 . . . . 0.0 113.42 -178.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.13 148.31 19.93 Favored Glycine 0 C--O 1.199 -2.092 0 N-CA-C 106.917 -2.473 . . . . 0.0 106.917 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.638 ' CG ' HH22 ' A' ' 12' ' ' ARG . 10.1 m-20 -76.62 128.41 34.65 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.632 -1.227 . . . . 0.0 109.142 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 1.1 tt -88.57 98.43 11.65 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 116.962 -1.895 . . . . 0.0 112.087 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.711 ' HB2' HG23 ' A' ' 38' ' ' ILE . 62.0 m95 -77.34 163.86 26.05 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 111.779 -2.464 . . . . 0.0 109.442 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.697 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -85.55 -158.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 118.846 -1.141 . . . . 0.0 111.268 -177.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.67 72.54 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.916 1.341 . . . . 0.0 109.053 -175.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' ILE . 4.1 mtp180 -121.55 110.17 15.69 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.086 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.88 -20.31 40.36 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.657 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.14 153.64 50.44 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.838 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.82 151.26 43.4 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -47.81 112.6 0.59 Allowed 'Trans proline' 0 C--O 1.214 -0.724 0 C-N-CA 120.971 1.114 . . . . 0.0 111.444 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.46 -25.93 55.89 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -22.42 71.91 Favored Glycine 0 N--CA 1.485 1.951 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.456 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.51 175.74 10.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.141 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.27 70.68 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 29' ' ' THR . 41.6 m-85 -59.94 167.92 2.04 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.051 -1.459 . . . . 0.0 110.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.0 p -163.13 -43.0 0.03 OUTLIER 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.7 -2.045 . . . . 0.0 106.225 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 8.5 p -97.36 118.46 33.88 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.794 -2.003 . . . . 0.0 109.156 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.556 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.08 152.01 36.63 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.876 -1.53 . . . . 0.0 113.52 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.448 ' O ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -101.66 156.05 17.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.981 174.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.827 ' CE2' HD12 ' A' ' 38' ' ' ILE . 22.4 m-85 -134.98 125.76 27.24 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.545 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 35' ' ' TRP . 6.4 mttt -137.72 71.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.958 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.468 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 17.0 t-105 -38.82 146.19 0.33 Allowed Pre-proline 0 N--CA 1.508 2.46 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.864 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.488 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 7.3 Cg_endo -78.06 38.44 0.46 Allowed 'Cis proline' 0 N--CA 1.495 1.603 0 CA-C-N 118.52 0.507 . . . . 0.0 111.69 -5.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.532 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -148.09 -168.03 2.97 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.509 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.827 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.03 144.9 3.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.298 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.65 140.37 50.02 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 117.488 -1.685 . . . . 0.0 107.586 169.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -114.62 135.8 53.75 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -169.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -107.96 -179.51 0.71 Allowed Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.555 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 3.0 Cg_exo -64.3 -49.21 0.18 OUTLIER 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 122.036 1.763 . . . . 0.0 116.587 5.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.781 0 CA-C-O 116.28 -1.819 . . . . 0.0 109.565 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.505 2.317 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.26 35.46 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 167.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -75.38 142.87 43.03 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -87.36 166.01 15.17 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 117.79 -1.564 . . . . 0.0 109.335 177.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.469 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -108.84 -173.3 2.24 Favored 'General case' 0 N--CA 1.51 2.538 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.727 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -71.07 117.23 12.31 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.921 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.0 -1.59 3.39 Favored Glycine 0 C--N 1.297 -1.589 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.141 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 7' ' ' SER . 5.6 mttt -108.82 118.05 52.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.367 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -74.87 -168.91 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.14 -113.47 4.13 Favored Glycine 0 C--N 1.291 -1.918 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.178 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.685 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 6.5 ptm180 -157.66 163.09 38.58 Favored 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 118.184 -1.407 . . . . 0.0 114.086 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -148.81 151.21 23.41 Favored Glycine 0 N--CA 1.494 2.503 1 N-CA-C 126.364 5.305 . . . . 0.0 126.364 173.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.9 m-20 -77.38 118.57 19.97 Favored 'General case' 0 C--O 1.171 -3.055 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.924 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 48.9 tp -85.7 102.55 13.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.002 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HB2' HG23 ' A' ' 38' ' ' ILE . 58.7 m95 -91.79 165.07 13.46 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 112.3 -2.227 . . . . 0.0 109.968 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -90.61 -159.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.632 -177.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.77 73.87 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.718 1.247 . . . . 0.0 108.793 -174.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -115.26 123.13 48.03 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.317 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.7 -35.27 73.3 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 160.54 42.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.751 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.09 163.54 59.42 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.669 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.51 -164.98 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 121.676 1.584 . . . . 0.0 112.035 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.62 33.56 2.47 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.17 -2.52 1.58 Allowed Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.789 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.45 -70.71 0.62 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.223 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.33 17.19 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.509 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 43.4 m-85 -76.41 171.13 15.09 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.577 1.179 . . . . 0.0 112.068 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.3 p -161.42 -43.95 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.142 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.24 134.2 40.85 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.123 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -160.04 159.61 32.21 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.887 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.0 p -120.9 133.7 55.29 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.567 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.687 ' CE2' HD12 ' A' ' 38' ' ' ILE . 76.1 m-85 -109.1 114.02 27.39 Favored 'General case' 0 C--N 1.259 -3.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.757 -174.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -129.23 71.86 1.45 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.595 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.521 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.46 155.35 0.19 Allowed Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.259 -178.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.6 Cg_endo -78.45 33.12 0.97 Allowed 'Cis proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.409 -1.08 . . . . 0.0 111.417 -3.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.521 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 3.5 m-80 -147.85 -160.48 1.17 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.805 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -167.87 144.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.383 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 8.1 m -113.57 109.29 18.39 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.577 168.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -80.73 139.85 35.88 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.527 -172.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.9 m-85 -110.97 -177.84 0.49 Allowed Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 19.1 Cg_exo -56.72 -55.43 0.11 OUTLIER 'Cis proline' 0 N--CA 1.505 2.169 0 CA-C-N 122.31 1.861 . . . . 0.0 116.698 5.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.685 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.388 0 CA-C-O 116.379 -1.772 . . . . 0.0 109.228 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.38 57.05 4.67 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 N-CA-C 108.737 -1.293 . . . . 0.0 108.737 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.01 145.95 39.86 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.473 -176.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.71 -175.77 5.45 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.135 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.95 179.82 5.85 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.64 0.733 . . . . 0.0 109.685 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.15 114.43 21.77 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.23 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.65 -10.53 72.53 Favored Glycine 0 C--N 1.295 -1.714 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.955 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -117.24 106.85 46.35 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.872 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.8 146.44 66.14 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.676 -1.317 . . . . 0.0 108.676 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.71 -104.58 0.84 Allowed Glycine 0 C--N 1.285 -2.277 1 N-CA-C 129.814 6.686 . . . . 0.0 129.814 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -161.14 151.35 17.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.761 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.14 166.74 25.65 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.7 m-20 -79.68 114.58 18.71 Favored 'General case' 0 C--O 1.172 -2.982 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.158 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 10.3 tp -84.13 96.24 8.87 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.091 -1.843 . . . . 0.0 113.205 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.817 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.5 m95 -69.94 145.81 51.63 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 111.818 -2.446 . . . . 0.0 104.837 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -110.25 -8.41 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -168.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 2.2 mt -153.1 59.63 0.78 Allowed 'General case' 0 C--N 1.248 -3.805 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.872 -173.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -154.89 156.32 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.581 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -109.01 -7.88 28.38 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 174.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 157.0 47.26 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.483 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -107.41 149.4 38.74 Favored Pre-proline 0 N--CA 1.494 1.748 0 C-N-CA 119.62 -0.832 . . . . 0.0 108.867 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -66.35 142.06 64.63 Favored 'Trans proline' 0 C--O 1.217 -0.568 0 C-N-CA 120.6 0.866 . . . . 0.0 111.177 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.62 63.5 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.77 -19.28 27.43 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.684 -1.245 . . . . 0.0 110.458 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.49 -34.59 41.19 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.958 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.95 -3.03 19.41 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.303 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.666 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.5 m-85 -60.5 169.17 1.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.691 1.234 . . . . 0.0 112.561 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.7 p -162.32 -43.76 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.263 -2.244 . . . . 0.0 106.027 176.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.84 114.15 26.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.62 178.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.631 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -146.35 154.14 41.32 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.884 -177.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -97.33 149.39 22.14 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.852 175.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.82 ' CD2' HD12 ' A' ' 38' ' ' ILE . 71.1 m-85 -132.01 119.99 21.81 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.009 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -132.41 72.07 1.49 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.441 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -45.57 153.57 0.59 Allowed Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.084 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.52 -5.5 10.08 Favored 'Cis proline' 0 N--CA 1.485 1.012 0 C-N-CA 124.299 -1.125 . . . . 0.0 112.038 -5.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.806 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -94.87 178.75 5.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.775 0.797 . . . . 0.0 110.851 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.82 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -158.93 140.43 4.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.034 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -120.19 116.44 25.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.307 172.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.666 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -95.42 144.47 25.91 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.866 -1.97 . . . . 0.0 114.955 -167.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -116.85 167.92 9.81 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.63 160.12 88.01 Favored 'Cis proline' 0 C--O 1.217 -0.556 0 CA-C-O 123.262 1.276 . . . . 0.0 114.822 3.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.603 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.251 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.679 ' HB3' ' H ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.38 36.09 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 109.187 -1.12 . . . . 0.0 109.187 166.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -82.07 122.71 28.18 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.388 -176.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.48 164.14 24.17 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.833 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.36 -178.39 4.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.072 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t -76.8 127.02 31.96 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.31 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.58 -18.08 31.49 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.562 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.08 105.95 20.04 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.21 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.04 -166.34 0.31 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.26 -98.52 2.38 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.729 -1.7 . . . . 0.0 110.862 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 43' ' ' HIS . 3.1 ptm180 -162.32 160.82 27.14 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.784 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -139.17 150.96 21.56 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 175.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.68 111.59 14.93 Favored 'General case' 0 C--O 1.171 -3.069 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.445 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.679 ' H ' ' HB3' ' A' ' 2' ' ' ALA . 6.3 tt -85.2 93.6 8.7 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.623 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.793 ' HB2' HG23 ' A' ' 38' ' ' ILE . 61.5 m95 -70.13 122.75 20.04 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 112.293 -2.231 . . . . 0.0 107.287 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.26 -8.08 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 C-N-CA 118.983 -1.087 . . . . 0.0 113.499 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 mt -151.89 74.51 1.11 Allowed 'General case' 0 C--N 1.254 -3.553 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.464 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.755 ' CG ' HH11 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -162.95 142.85 9.11 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.222 -1.791 . . . . 0.0 113.085 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.17 -22.04 23.57 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.533 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 1.4 p -143.48 152.32 41.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.514 -0.843 . . . . 0.0 109.24 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -88.53 148.11 41.3 Favored Pre-proline 0 C--N 1.286 -2.178 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.366 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.08 178.44 0.4 Allowed 'Trans proline' 0 C--O 1.219 -0.442 0 C-N-CA 120.379 0.719 . . . . 0.0 111.211 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.15 8.36 25.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.22 -16.36 15.12 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -84.67 -6.89 59.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.04 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.73 11.49 85.18 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.758 -1.21 . . . . 0.0 112.326 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 40.5 m-85 -67.19 170.57 6.86 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.885 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -161.91 -44.07 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 112.763 -2.017 . . . . 0.0 106.691 178.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 41' ' ' TYR . 3.2 p -96.86 125.88 41.62 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -160.07 147.5 16.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 117.19 -1.804 . . . . 0.0 113.132 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 146.42 32.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.002 -1.453 . . . . 0.0 108.049 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.711 ' CE2' HD12 ' A' ' 38' ' ' ILE . 51.0 m-85 -118.01 140.72 49.34 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.688 -170.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 35' ' ' TRP . 7.9 mttt -142.27 59.27 1.46 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.965 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -40.41 147.36 0.38 Allowed Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.31 -176.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.79 2.1 6.24 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.635 -4.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.618 ' C ' HG22 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -101.23 -160.59 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.725 0.774 . . . . 0.0 111.359 -177.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.793 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 171.34 141.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.471 -178.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 79.4 m -110.13 110.86 21.89 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 117.741 -1.584 . . . . 0.0 107.176 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.0 t -88.98 151.16 22.46 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.924 -171.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' SER . 3.0 m-85 -125.33 163.14 40.11 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -79.16 162.61 86.47 Favored 'Cis proline' 0 C--N 1.326 -0.64 0 CA-C-O 123.324 1.302 . . . . 0.0 115.374 5.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.393 0 CA-C-N 111.11 -2.768 . . . . 0.0 109.447 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.505 2.295 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -83.34 38.55 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 167.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.87 127.09 33.59 Favored 'General case' 0 N--CA 1.513 2.685 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.082 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.61 159.92 27.83 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 117.924 -1.51 . . . . 0.0 110.299 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.2 m -108.19 -172.89 2.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.38 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -57.68 140.02 52.3 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.327 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 29.01 11.1 0.0 OUTLIER Glycine 0 N--CA 1.481 1.633 1 N-CA-C 125.134 4.814 . . . . 0.0 125.134 -174.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.0 mttt -111.25 102.06 52.01 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 114.385 -0.908 . . . . 0.0 110.041 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.04 -164.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 120.946 1.097 . . . . 0.0 109.303 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.89 -103.17 1.97 Allowed Glycine 0 C--N 1.29 -1.994 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.543 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -161.19 166.12 28.32 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 118.063 -1.455 . . . . 0.0 114.054 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.01 154.21 25.24 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.52 126.62 31.11 Favored 'General case' 0 C--O 1.178 -2.665 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.243 178.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 28.0 tp -87.89 108.41 19.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.334 -1.346 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.674 ' CB ' HG23 ' A' ' 38' ' ' ILE . 70.1 m95 -99.65 161.74 13.43 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.313 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.766 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -87.35 -158.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.136 -175.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.96 66.02 0.1 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.464 1.602 . . . . 0.0 107.793 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.32 105.81 15.94 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 112.272 -2.24 . . . . 0.0 110.631 -179.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -44.58 -35.17 3.98 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.03 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -141.42 163.2 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.153 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 157.34 56.21 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.937 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.8 119.42 5.62 Favored 'Trans proline' 0 C--O 1.208 -0.991 0 C-N-CA 120.812 1.008 . . . . 0.0 110.541 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.17 176.83 25.82 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.094 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.76 8.1 38.9 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.97 -168.54 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.18 0.04 74.75 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.428 -1.368 . . . . 0.0 111.443 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 26.1 m-85 -76.55 170.35 16.57 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.371 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -162.11 -44.74 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 112.338 -2.21 . . . . 0.0 106.376 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.6 p -99.0 128.09 45.06 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.867 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.5 142.73 25.09 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 117.939 -1.504 . . . . 0.0 112.385 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 22.2 p -99.62 137.12 38.55 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.778 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CE2' HD12 ' A' ' 38' ' ' ILE . 51.1 m-85 -114.93 121.08 42.08 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.2 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -140.41 77.23 1.59 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.711 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.4 158.58 0.12 Allowed Pre-proline 0 C--N 1.307 -1.27 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.515 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 1.6 Cg_endo -78.58 30.07 1.53 Allowed 'Cis proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.402 -1.083 . . . . 0.0 111.501 -6.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 3.1 m-80 -145.89 -171.28 3.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -153.23 141.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 17.4 m -112.68 117.27 31.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.492 -1.683 . . . . 0.0 106.997 168.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.11 149.19 25.31 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.465 -172.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -122.15 174.52 3.21 Favored Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.9 Cg_endo -86.15 155.31 53.52 Favored 'Cis proline' 0 CA--C 1.505 -0.959 0 CA-C-O 122.854 1.106 . . . . 0.0 113.362 -1.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.266 -3.035 0 CA-C-N 111.876 -2.42 . . . . 0.0 109.795 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.504 2.245 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.25 37.93 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 108.564 -1.36 . . . . 0.0 108.564 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.56 124.86 28.6 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -174.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.61 163.18 26.47 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.806 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -100.82 -179.54 4.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.73 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' LYS . 88.7 p -70.96 122.02 19.21 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.47 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.93 -15.59 1.24 Allowed Glycine 0 C--N 1.296 -1.659 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.585 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' SER . 47.6 mttt -106.8 117.01 57.81 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.758 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -77.13 -161.75 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.929 1.086 . . . . 0.0 109.287 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.91 -111.16 3.77 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.232 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.632 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -157.98 157.46 33.07 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.434 -1.306 . . . . 0.0 112.523 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.75 147.5 18.96 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.37 128.24 33.36 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.527 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 40.7 tp -87.51 109.49 19.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.021 -1.472 . . . . 0.0 111.984 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.68 ' HB2' HG23 ' A' ' 38' ' ' ILE . 65.4 m95 -98.16 179.2 4.83 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.844 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.734 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -103.59 -160.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.162 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.389 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.485 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.86 71.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.337 1.541 . . . . 0.0 108.329 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ILE . 12.1 mtp85 -114.12 131.75 56.3 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.197 -2.274 . . . . 0.0 111.236 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.22 86.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.302 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 163.25 37.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.966 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.29 160.26 73.43 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.1 Cg_exo -51.57 92.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 120.792 0.995 . . . . 0.0 111.008 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' CYS . . . -7.91 -32.07 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 1 N-CA-C 132.796 7.878 . . . . 0.0 132.796 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -134.9 43.09 1.28 Allowed Glycine 0 N--CA 1.499 2.843 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.311 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.85 -164.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.417 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.05 -1.61 56.64 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.654 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 m-85 -86.1 169.25 13.31 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 123.129 1.442 . . . . 0.0 113.338 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -160.79 -43.66 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.732 175.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 41' ' ' TYR . 5.1 p -97.94 138.08 35.81 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.594 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.23 151.02 20.6 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.918 176.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.2 p -113.09 142.38 45.81 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.834 176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.768 ' CE2' HD12 ' A' ' 38' ' ' ILE . 18.5 m-85 -114.28 128.96 56.61 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.869 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.539 ' NZ ' ' SG ' ' A' ' 4' ' ' CYS . 12.9 mttt -126.09 67.68 1.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.241 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.448 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 40.2 t-105 -36.55 144.87 0.26 Allowed Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.328 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 2.2 Cg_endo -77.6 35.48 0.59 Allowed 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 125.801 -0.5 . . . . 0.0 112.399 -5.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.541 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -145.73 -160.13 1.1 Allowed 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.339 178.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.768 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -166.37 144.94 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.037 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.416 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.5 m -112.8 147.03 37.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 3.0 t -115.15 143.88 44.54 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.613 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -113.73 -177.22 0.42 Allowed Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.541 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 5.5 Cg_exo -62.84 -51.0 0.16 OUTLIER 'Cis proline' 0 N--CA 1.506 2.22 0 CA-C-N 121.866 1.702 . . . . 0.0 115.907 6.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.632 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.754 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.358 -171.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.504 2.262 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -87.67 38.62 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 N-CA-C 109.321 -1.069 . . . . 0.0 109.321 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.66 124.14 27.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.669 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.78 -176.48 4.96 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.109 -1.436 . . . . 0.0 110.132 -176.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.17 -173.91 4.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.037 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -68.85 118.18 11.47 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.616 -176.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.47 -12.62 1.84 Allowed Glycine 0 C--N 1.297 -1.599 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.532 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.9 mttm -96.4 135.47 22.45 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.159 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 9' ' ' LYS . 11.3 Cg_exo -47.14 -169.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.212 1.941 . . . . 0.0 113.875 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.09 32.36 0.25 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 114.297 -1.32 . . . . 0.0 113.959 -174.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.84 137.87 7.83 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 116.294 -2.162 . . . . 0.0 115.352 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -151.08 160.92 28.88 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.75 122.07 26.13 Favored 'General case' 0 C--O 1.18 -2.587 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.186 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 4.0 tt -89.18 118.3 28.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 117.624 -1.631 . . . . 0.0 111.711 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.658 ' CB ' HG23 ' A' ' 38' ' ' ILE . 57.0 m95 -103.41 170.99 7.62 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.351 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.817 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -96.16 -157.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.744 -175.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.805 ' H ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.94 67.57 0.15 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.363 1.554 . . . . 0.0 108.4 -177.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.7 mtt-85 -116.07 100.3 7.85 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.151 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -41.68 -26.48 0.26 Allowed Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.701 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -147.21 160.47 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.147 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -87.13 150.17 49.03 Favored Pre-proline 0 C--N 1.292 -1.9 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.086 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.44 163.54 17.55 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 110.888 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.26 -10.75 47.41 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.84 -26.73 67.43 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.726 -1.226 . . . . 0.0 111.155 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -87.35 -32.95 19.35 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.874 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.56 16.32 29.5 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.813 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 58.8 m-85 -53.97 173.47 0.06 Allowed 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.954 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.0 p -161.33 -46.48 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 112.909 -1.95 . . . . 0.0 106.083 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.84 120.06 38.64 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.646 -2.07 . . . . 0.0 109.312 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.36 148.39 30.32 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.023 -1.471 . . . . 0.0 112.618 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 143.94 40.3 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.553 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.796 ' CE2' HD12 ' A' ' 38' ' ' ILE . 24.7 m-85 -113.3 137.23 51.8 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.307 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.598 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 11.0 mmtt -121.46 70.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.424 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -40.03 140.84 0.86 Allowed Pre-proline 0 C--N 1.294 -1.822 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.091 -176.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -72.67 -22.77 11.79 Favored 'Cis proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.743 -4.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.73 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -78.63 -161.38 0.28 Allowed 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 -176.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.796 HD12 ' CE2' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -164.7 154.19 2.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.873 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.8 m -124.66 127.15 46.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.539 164.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -96.53 153.9 17.58 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -172.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.562 ' O ' ' O ' ' A' ' 30' ' ' SER . 4.6 m-85 -127.66 165.72 28.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.75 159.21 91.74 Favored 'Cis proline' 0 C--N 1.323 -0.805 0 CA-C-O 122.783 1.076 . . . . 0.0 114.47 1.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.596 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.387 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.259 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.509 2.49 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -87.12 34.75 0.44 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.35 -1.442 . . . . 0.0 108.35 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -74.77 116.33 15.36 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.219 -174.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.6 164.12 24.92 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 117.588 -1.645 . . . . 0.0 108.87 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.58 -178.94 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.36 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 99.9 p -76.99 124.12 27.31 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.143 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.25 -13.16 28.38 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.478 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -115.5 108.9 46.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.981 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.32 -154.21 0.04 OUTLIER 'Trans proline' 0 C--O 1.208 -0.976 0 N-CA-C 109.033 -1.179 . . . . 0.0 109.033 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 -108.92 2.63 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 119.254 -1.45 . . . . 0.0 111.507 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.714 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -160.16 168.63 25.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 118.923 -1.111 . . . . 0.0 113.023 -176.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.7 146.49 18.05 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.444 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -79.48 118.07 21.01 Favored 'General case' 0 C--O 1.171 -3.058 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.115 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 18.1 tp -85.76 92.6 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.526 -1.67 . . . . 0.0 113.723 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.81 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.3 m95 -75.53 126.27 30.67 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.801 -1.999 . . . . 0.0 107.744 172.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -94.88 -7.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.135 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -170.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mt -153.13 73.39 0.99 Allowed 'General case' 0 C--N 1.253 -3.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.469 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -166.16 148.59 7.06 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 116.637 -2.025 . . . . 0.0 113.204 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.08 -13.22 27.62 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -142.87 153.96 43.66 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.235 -0.982 . . . . 0.0 109.22 177.276 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -95.51 152.52 39.29 Favored Pre-proline 0 C--N 1.288 -2.085 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.832 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.83 -170.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.221 1.281 . . . . 0.0 111.651 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.77 -19.27 3.4 Favored Glycine 0 N--CA 1.489 2.212 1 N-CA-C 129.221 6.448 . . . . 0.0 129.221 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.75 4.57 68.91 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -79.35 -56.61 4.21 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.467 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.8 7.05 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.82 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' O ' HG23 ' A' ' 29' ' ' THR . 34.1 m-85 -76.54 165.77 24.32 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 123.016 1.388 . . . . 0.0 112.769 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.6 p -163.32 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 111.757 -2.474 . . . . 0.0 106.005 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' TYR . 13.9 p -98.7 124.26 43.42 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.378 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.662 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -153.63 157.1 39.13 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.816 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 147.81 39.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.62 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CE2' HD12 ' A' ' 38' ' ' ILE . 13.1 m-85 -124.31 139.3 54.04 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.539 -172.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 73.72 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.404 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.93 155.42 0.33 Allowed Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.175 -174.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.772 ' C ' HD22 ' A' ' 37' ' ' ASN . 9.5 Cg_endo -74.87 10.25 8.54 Favored 'Cis proline' 0 N--CA 1.485 1.016 0 C-N-CA 124.293 -1.128 . . . . 0.0 111.142 -2.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.909 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.3 OUTLIER -111.49 -162.07 0.78 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.871 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.813 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -177.33 138.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.536 -178.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 29.0 m -108.21 113.35 26.4 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 117.698 -1.601 . . . . 0.0 106.939 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -93.22 130.72 38.82 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.921 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' CE2' ' O ' ' A' ' 12' ' ' ARG . 24.1 m-85 -106.89 -174.55 0.32 Allowed Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 35.9 Cg_exo -54.81 -49.01 0.14 OUTLIER 'Cis proline' 0 N--CA 1.501 1.913 0 CA-C-N 122.745 2.016 . . . . 0.0 116.727 5.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.714 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.742 0 CA-C-O 116.349 -1.786 . . . . 0.0 109.1 -172.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.508 2.471 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -84.33 20.36 1.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 N-CA-C 107.993 -1.579 . . . . 0.0 107.993 164.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.589 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -81.12 115.41 20.54 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.4 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.85 178.22 8.11 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.43 -174.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -176.91 3.24 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.839 0.828 . . . . 0.0 110.152 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 p -77.66 128.02 33.42 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.34 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.67 -9.19 11.35 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -119.81 108.62 38.76 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -73.95 -163.44 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 -110.45 3.74 Favored Glycine 0 C--N 1.282 -2.472 0 C-N-CA 118.535 -1.793 . . . . 0.0 110.65 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -163.11 164.7 25.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 117.812 -1.555 . . . . 0.0 114.012 -177.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.74 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -146.26 -170.3 14.76 Favored Glycine 0 N--CA 1.502 3.053 1 N-CA-C 127.074 5.59 . . . . 0.0 127.074 173.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -99.32 127.22 45.31 Favored 'General case' 0 C--O 1.182 -2.463 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.99 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 4.2 tp -102.0 97.1 7.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.922 1.344 . . . . 0.0 110.256 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.74 ' HB2' HG23 ' A' ' 38' ' ' ILE . 80.0 m95 -89.02 151.99 21.95 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.963 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.886 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.38 -157.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.653 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.4 -178.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -70.07 76.82 0.5 Allowed 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 123.627 1.68 . . . . 0.0 109.236 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 21' ' ' THR . 9.9 mtt180 -126.45 75.93 1.58 Allowed 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 110.987 -2.824 . . . . 0.0 110.715 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -17.54 -32.02 0.0 OUTLIER Glycine 0 N--CA 1.499 2.858 1 N-CA-C 126.665 5.426 . . . . 0.0 126.665 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -140.41 154.14 46.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.297 176.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -86.12 153.73 57.13 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.14 -178.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.81 172.22 4.99 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.157 1.238 . . . . 0.0 110.81 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.42 18.17 35.92 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.79 -13.63 25.19 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.662 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -90.28 1.93 56.0 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.824 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 -0.14 39.22 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.732 -1.223 . . . . 0.0 111.367 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.678 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.9 m-85 -54.83 169.97 0.19 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.787 1.279 . . . . 0.0 111.736 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.5 p -160.18 -44.82 0.05 OUTLIER 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 112.174 -2.285 . . . . 0.0 105.175 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 12.4 p -98.25 137.39 37.06 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 112.968 -1.924 . . . . 0.0 108.621 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -155.16 148.98 25.51 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 117.707 -1.597 . . . . 0.0 113.116 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.425 ' O ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -93.43 158.34 15.77 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.852 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.5 m-85 -136.95 131.47 33.06 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.793 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 2.1 mttt -136.56 77.96 1.68 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.43 150.98 1.48 Allowed Pre-proline 0 C--N 1.293 -1.886 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.111 -177.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' LEU . 1.9 Cg_endo -69.17 -19.18 10.62 Favored 'Cis proline' 0 C--O 1.198 -1.499 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.285 -3.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.716 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -85.9 -169.44 2.64 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -177.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.852 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -149.22 144.74 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.652 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.3 m -117.21 116.52 27.44 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.731 -1.187 . . . . 0.0 107.902 171.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.678 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -97.46 155.0 17.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -131.35 173.13 6.23 Favored Pre-proline 0 N--CA 1.503 2.18 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.9 Cg_endo -88.65 156.05 37.77 Favored 'Cis proline' 0 C--O 1.214 -0.685 0 N-CA-C 115.764 1.409 . . . . 0.0 115.764 0.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 110.985 -2.825 . . . . 0.0 110.109 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 110.827 -0.064 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -76.6 52.67 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 N-CA-C 106.075 -2.317 . . . . 0.0 106.075 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -68.1 131.18 44.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.13 175.02 11.02 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.167 -1.413 . . . . 0.0 110.769 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -158.22 177.43 11.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.779 174.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.7 m -86.77 106.35 17.62 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.894 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.68 -17.78 8.21 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.5 mptt -134.42 136.83 26.52 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.126 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 9' ' ' LYS . 6.0 Cg_exo -50.52 -156.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.378 2.052 . . . . 0.0 114.033 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 31.8 0.1 OUTLIER Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -161.34 137.26 8.01 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 115.775 -2.37 . . . . 0.0 116.071 175.28 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.63 -166.82 10.83 Favored Glycine 0 N--CA 1.509 3.546 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.733 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.8 m-20 -108.18 127.31 53.71 Favored 'General case' 0 C--O 1.181 -2.52 0 CA-C-O 118.27 -0.872 . . . . 0.0 109.203 176.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 2.6 tp -91.04 135.61 33.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.964 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.706 ' CB ' HG23 ' A' ' 38' ' ' ILE . 59.7 m95 -127.73 -176.17 3.69 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 111.434 -2.621 . . . . 0.0 108.949 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 18' ' ' LEU . 1.8 mt -105.02 -167.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -173.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.803 ' H ' HG22 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -68.03 68.98 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.978 1.371 . . . . 0.0 107.606 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.1 mtt-85 -116.75 125.45 51.67 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 112.223 -2.262 . . . . 0.0 110.4 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.27 69.61 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -142.98 160.72 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.768 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 158.01 42.77 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.268 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.07 125.56 15.49 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.3 1.333 . . . . 0.0 110.899 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 3.86 69.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.593 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.94 -12.73 58.73 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.56 -46.5 15.64 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.459 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.43 -7.89 5.31 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 29' ' ' THR . 42.9 m-85 -50.22 171.27 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.66 1.219 . . . . 0.0 111.187 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 28' ' ' TYR . 10.6 p -161.87 -45.6 0.04 OUTLIER 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 112.34 -2.209 . . . . 0.0 105.874 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.95 130.19 44.82 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.729 -2.032 . . . . 0.0 110.298 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -157.51 157.29 33.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 117.861 -1.536 . . . . 0.0 112.148 177.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 140.02 53.18 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.592 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.747 ' CE2' HD12 ' A' ' 38' ' ' ILE . 22.4 m-85 -112.88 136.47 52.49 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.731 -173.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -142.76 75.5 1.49 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.257 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.523 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -45.51 156.79 0.4 Allowed Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.106 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.473 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 8.7 Cg_endo -78.91 30.72 1.47 Allowed 'Cis proline' 0 C--O 1.194 -1.68 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.196 -1.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 m-80 -146.62 -168.68 3.09 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.173 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.747 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -152.62 149.03 13.85 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.024 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.115 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -119.84 120.06 35.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.555 167.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -91.11 157.57 17.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.254 -171.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' O ' ' O ' ' A' ' 30' ' ' SER . 15.4 m-85 -133.24 167.62 22.04 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.71 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.46 160.93 95.49 Favored 'Cis proline' 0 C--O 1.213 -0.736 0 CA-C-O 122.591 0.996 . . . . 0.0 113.585 0.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.579 -2.101 . . . . 0.0 109.859 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -85.76 28.46 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 N-CA-C 106.996 -1.963 . . . . 0.0 106.996 164.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.8 p -88.51 116.58 26.85 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.407 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -177.1 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.803 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -119.79 -176.46 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.567 178.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.56 116.86 20.01 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.425 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.7 79.32 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.435 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mppp? -119.74 117.96 32.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.503 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.44 178.58 7.24 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 121.236 1.291 . . . . 0.0 109.821 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.52 -100.19 2.12 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.409 -1.377 . . . . 0.0 111.294 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.1 ptm180 -162.03 178.23 9.02 Favored 'General case' 0 C--O 1.209 -1.078 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.364 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -162.57 165.34 36.15 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 175.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -87.19 132.25 33.93 Favored 'General case' 0 C--O 1.18 -2.553 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.34 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 10.7 tp -97.18 100.07 11.54 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.647 1.213 . . . . 0.0 111.802 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.665 ' HB2' HG23 ' A' ' 38' ' ' ILE . 67.0 m95 -93.01 160.88 14.67 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 112.515 -2.13 . . . . 0.0 110.831 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -84.45 -163.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.919 -176.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -68.39 71.77 0.19 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.74 1.257 . . . . 0.0 107.984 -176.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' THR . 38.8 mtt180 -122.08 86.8 2.64 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.765 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -22.23 -28.02 0.0 OUTLIER Glycine 0 N--CA 1.495 2.593 1 N-CA-C 125.837 5.095 . . . . 0.0 125.837 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' ARG . 1.4 p -150.01 151.35 33.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.04 -1.08 . . . . 0.0 109.866 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -85.72 151.57 55.58 Favored Pre-proline 0 C--N 1.289 -2.053 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.385 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.23 146.88 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.073 1.182 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.54 3.44 17.49 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.066 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.68 9.25 5.81 Favored Glycine 0 N--CA 1.491 2.32 1 N-CA-C 130.575 6.99 . . . . 0.0 130.575 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.67 14.94 8.96 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.45 79.82 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.382 -1.389 . . . . 0.0 111.619 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.623 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.7 m-85 -69.91 168.6 14.93 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.188 1.47 . . . . 0.0 113.492 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.6 p -161.57 -46.69 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 111.549 -2.569 . . . . 0.0 105.911 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 119.7 38.28 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.808 -1.996 . . . . 0.0 110.319 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -144.03 152.98 41.73 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.526 178.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -108.76 149.18 29.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.429 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.78 ' CE2' HD12 ' A' ' 38' ' ' ILE . 18.5 m-85 -125.98 134.35 51.52 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.962 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -151.53 76.57 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.603 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.479 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.65 156.65 0.19 Allowed Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.593 -178.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.487 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.8 Cg_endo -79.09 35.05 0.87 Allowed 'Cis proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.768 -0.93 . . . . 0.0 111.464 -5.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.2 m-80 -149.03 -171.43 3.87 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.489 -1.284 . . . . 0.0 110.318 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.78 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -154.75 144.91 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.534 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -113.65 107.73 16.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.148 171.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.623 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -83.75 130.92 34.95 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.876 -173.245 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.608 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -103.97 -177.73 0.56 Allowed Pre-proline 0 N--CA 1.505 2.312 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 13.6 Cg_exo -63.11 -50.18 0.16 OUTLIER 'Cis proline' 0 N--CA 1.505 2.196 0 N-CA-C 117.449 2.057 . . . . 0.0 117.449 5.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.792 0 CA-C-O 116.239 -1.838 . . . . 0.0 109.167 -169.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.513 ' O ' ' NH2' ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -82.73 40.47 0.97 Allowed 'Trans proline' 0 CA--C 1.551 1.325 0 N-CA-C 108.634 -1.333 . . . . 0.0 108.634 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.612 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.79 128.99 34.1 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.17 169.51 18.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.422 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.68 178.3 7.33 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.504 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.31 128.02 33.08 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.277 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.71 -16.85 33.86 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.336 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 110.93 23.37 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.386 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -75.49 -179.73 5.38 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 N-CA-C 108.6 -1.346 . . . . 0.0 108.6 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.24 -99.38 2.5 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.814 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 2' ' ' ALA . 2.6 ptm180 -156.12 159.11 38.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.051 -175.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.26 148.42 20.04 Favored Glycine 0 N--CA 1.499 2.837 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.229 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 15.6 m-20 -78.57 124.07 27.76 Favored 'General case' 0 C--O 1.181 -2.552 0 C-N-CA 119.304 -0.959 . . . . 0.0 109.751 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 67.5 tp -83.8 132.74 34.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 117.683 -1.607 . . . . 0.0 110.355 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.68 ' HB2' HG23 ' A' ' 38' ' ' ILE . 53.5 m95 -124.94 167.55 14.53 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.493 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.653 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -90.92 -161.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 C-N-CA 118.109 -1.436 . . . . 0.0 112.639 -175.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.526 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.15 69.98 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.532 -176.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 6.0 mtp180 -110.4 119.83 40.48 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 112.109 -2.314 . . . . 0.0 111.803 -177.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.27 -46.93 51.39 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.305 -1.426 . . . . 0.0 109.595 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.93 156.93 48.02 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.212 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.16 160.94 67.11 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -51.09 110.9 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 120.971 1.114 . . . . 0.0 111.662 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -15.73 -113.18 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 1 N-CA-C 130.349 6.899 . . . . 0.0 130.349 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.41 46.62 3.52 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.384 -1.389 . . . . 0.0 109.787 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -83.67 -60.73 2.03 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.32 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -160.38 -27.24 0.02 OUTLIER Glycine 0 C--N 1.288 -2.099 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 48.5 m-85 -84.22 173.04 11.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 122.897 1.332 . . . . 0.0 112.666 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.47 -48.9 0.05 Allowed 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.014 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -100.23 111.3 23.57 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 113.138 -1.846 . . . . 0.0 109.607 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.0 OUTLIER -137.83 143.67 41.1 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.471 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 140.58 38.33 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.802 ' CE2' HD12 ' A' ' 38' ' ' ILE . 28.6 m-85 -115.94 149.27 39.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.203 -173.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.03 81.99 0.71 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.68 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.461 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.51 158.56 0.27 Allowed Pre-proline 0 C--N 1.307 -1.26 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.37 -177.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.2 Cg_endo -79.52 33.58 1.24 Allowed 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.44 -1.067 . . . . 0.0 111.456 -5.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.461 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 7.5 m-80 -147.92 -160.2 1.13 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.916 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -164.5 137.62 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.113 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.496 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.7 m -108.87 115.47 30.14 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 116.763 -1.975 . . . . 0.0 107.029 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -86.59 148.29 25.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 113.564 -1.653 . . . . 0.0 113.28 -171.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -125.79 168.41 14.0 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -84.32 156.87 68.17 Favored 'Cis proline' 0 N--CA 1.454 -0.849 0 CA-C-O 122.939 1.141 . . . . 0.0 114.062 4.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.625 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.428 175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -92.43 51.49 0.55 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 O-C-N 122.621 0.8 . . . . 0.0 110.664 167.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -88.97 136.25 33.11 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.775 -1.57 . . . . 0.0 107.731 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.4 174.2 11.81 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.837 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -126.4 179.8 5.12 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.708 0.766 . . . . 0.0 109.845 177.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 m -76.86 128.41 34.52 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.455 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.39 27.34 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.846 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -125.28 99.3 34.03 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.51 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.98 155.91 47.83 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 N-CA-C 108.586 -1.351 . . . . 0.0 108.586 173.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.93 -97.62 0.51 Allowed Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.171 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.33 157.46 28.0 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 118.186 -1.405 . . . . 0.0 113.294 -178.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -150.82 162.28 29.32 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 77.6 m-20 -78.03 125.2 29.0 Favored 'General case' 0 C--O 1.184 -2.364 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.6 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 8.4 tt -91.06 109.89 21.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.557 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.709 ' CB ' HG23 ' A' ' 38' ' ' ILE . 63.2 m95 -91.56 161.69 14.84 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.931 -2.395 . . . . 0.0 109.052 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.763 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -81.15 -157.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 119.416 -0.913 . . . . 0.0 112.022 -176.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.07 67.01 0.11 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.359 1.552 . . . . 0.0 107.244 -178.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -113.86 111.44 21.73 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 112.065 -2.334 . . . . 0.0 110.284 -178.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.12 -20.83 65.34 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.341 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.42 152.58 44.4 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.195 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -94.7 155.08 39.78 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.599 179.144 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -66.91 143.06 64.92 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.037 1.158 . . . . 0.0 110.985 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.22 2.83 87.35 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.81 -22.13 53.94 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.34 -16.98 55.44 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.675 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.39 0.4 73.34 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.093 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.651 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 49.0 m-85 -54.34 161.74 1.28 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.29 -1.364 . . . . 0.0 111.542 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.5 p -146.2 -48.44 0.21 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 112.076 -2.329 . . . . 0.0 105.891 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -100.06 116.43 32.07 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.254 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -139.14 149.18 44.19 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.787 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.6 p -106.05 141.53 37.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CD2' HD12 ' A' ' 38' ' ' ILE . 17.7 m-85 -119.97 138.95 53.17 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.147 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 80.5 0.95 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -44.39 158.4 0.27 Allowed Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.731 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 2.8 Cg_endo -78.04 28.75 1.61 Allowed 'Cis proline' 0 C--O 1.211 -0.857 0 C-N-CA 124.492 -1.045 . . . . 0.0 111.945 -5.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.46 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -144.44 179.44 7.26 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.232 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.813 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -145.96 148.44 17.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -122.22 123.37 41.32 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 117.343 -1.743 . . . . 0.0 107.856 167.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.651 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.74 147.09 23.15 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.839 -171.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -121.85 169.32 9.55 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.84 157.62 80.48 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 CA-C-O 123.133 1.222 . . . . 0.0 114.553 3.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.72 0 CA-C-N 111.455 -2.612 . . . . 0.0 110.161 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.03 58.75 5.64 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 N-CA-C 107.234 -1.872 . . . . 0.0 107.234 168.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.33 136.92 39.56 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.3 m-85 -77.96 163.04 26.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.221 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.507 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -104.65 -173.87 2.41 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.659 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.55 122.86 21.24 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.166 -177.39 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.82 -3.34 0.99 Allowed Glycine 0 N--CA 1.48 1.595 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.819 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 7' ' ' SER . 11.2 mttm -107.69 108.59 61.72 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.474 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.22 -173.81 1.21 Allowed 'Trans proline' 0 C--N 1.324 -0.716 0 C-N-CA 120.807 1.004 . . . . 0.0 109.615 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 93.81 -115.26 4.93 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.418 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.41 160.93 32.83 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.216 -1.393 . . . . 0.0 113.471 -178.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.82 148.57 20.28 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 9.6 m-20 -76.53 126.7 31.44 Favored 'General case' 0 C--O 1.171 -3.068 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.599 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 10.7 tp -83.11 104.8 13.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.282 -1.767 . . . . 0.0 111.703 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.689 ' HB2' HG23 ' A' ' 38' ' ' ILE . 62.6 m95 -87.56 167.14 14.2 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.466 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -88.58 -161.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.026 -177.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.46 73.57 0.15 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.1 1.428 . . . . 0.0 108.599 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 17' ' ' ILE . 23.8 mtp85 -112.83 143.76 43.54 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 112.235 -2.257 . . . . 0.0 111.203 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 21' ' ' THR . . . -80.16 -20.64 66.86 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -156.47 157.19 35.05 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.857 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.87 148.12 71.72 Favored Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.44 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 22' ' ' CYS . 5.8 Cg_exo -53.67 -173.94 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 120.685 0.923 . . . . 0.0 111.054 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.52 -11.39 6.65 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 129.314 6.486 . . . . 0.0 129.314 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.89 19.32 55.23 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.61 -73.76 0.61 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.264 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.73 3.43 0.16 Allowed Glycine 0 N--CA 1.488 2.167 0 C-N-CA 118.974 -1.584 . . . . 0.0 112.418 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.3 m-85 -63.93 171.58 2.76 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.808 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -161.99 -44.86 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 112.592 -2.095 . . . . 0.0 106.433 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 41' ' ' TYR . 4.0 p -99.06 121.66 41.28 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.961 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.632 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.66 150.81 36.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.109 -1.436 . . . . 0.0 113.197 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.36 147.18 31.91 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.523 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.771 ' CE2' HD12 ' A' ' 38' ' ' ILE . 13.1 m-85 -121.32 136.01 55.02 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.654 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 4.6 mttp -138.35 63.64 1.52 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.572 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.483 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 27.5 t-105 -32.76 145.77 0.1 Allowed Pre-proline 0 N--CA 1.507 2.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.211 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.3 Cg_endo -78.62 40.41 0.4 Allowed 'Cis proline' 0 N--CA 1.499 1.81 0 C-N-CA 125.768 -0.513 . . . . 0.0 111.269 -5.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.483 ' H ' ' CA ' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -148.91 -163.53 1.81 Allowed 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.974 177.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -166.25 147.2 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.801 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -121.21 131.69 54.38 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 118.076 -1.45 . . . . 0.0 107.888 167.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -101.64 146.94 27.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.527 -1.215 . . . . 0.0 114.27 -168.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -116.51 -179.17 0.59 Allowed Pre-proline 0 N--CA 1.513 2.711 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.0 Cg_exo -63.8 -50.96 0.16 OUTLIER 'Cis proline' 0 N--CA 1.503 2.031 0 CA-C-N 122.117 1.792 . . . . 0.0 116.7 6.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.956 0 CA-C-O 116.356 -1.783 . . . . 0.0 109.24 -171.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.513 2.697 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.43 32.55 0.27 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 N-CA-C 108.804 -1.268 . . . . 0.0 108.804 165.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.78 141.86 33.13 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.227 -174.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -89.98 171.32 9.65 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.6 -179.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -115.45 -175.66 2.76 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.11 178.182 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.13 115.09 17.6 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.811 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.47 64.3 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.625 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.92 114.27 46.59 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.067 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -77.03 166.65 26.38 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 N-CA-C 108.277 -1.47 . . . . 0.0 108.277 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.41 -106.18 2.4 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.233 -1.46 . . . . 0.0 111.069 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.66 165.04 31.27 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.105 -1.438 . . . . 0.0 113.903 -177.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.5 -174.7 15.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -104.51 111.86 24.7 Favored 'General case' 0 C--O 1.173 -2.952 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.448 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 23.2 tp -82.9 94.22 7.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 116.89 -1.924 . . . . 0.0 112.954 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 38' ' ' ILE . 73.0 m95 -70.19 111.9 6.15 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 112.458 -2.156 . . . . 0.0 105.859 169.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.31 -10.0 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.979 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -169.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mt -151.05 78.39 1.29 Allowed 'General case' 0 C--N 1.249 -3.796 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.786 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -175.99 166.61 3.0 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 117.641 -1.624 . . . . 0.0 112.209 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.87 -24.26 4.34 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -130.24 152.23 49.89 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.0 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.609 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -88.19 147.91 41.53 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.682 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -59.45 103.57 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.57 0.846 . . . . 0.0 110.597 -176.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 7.79 -93.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.931 1 N-CA-C 130.684 7.033 . . . . 0.0 130.684 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.32 46.04 1.71 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.299 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -79.31 0.66 27.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.577 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.0 27.94 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.1 m-85 -76.41 164.08 26.34 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 122.909 1.338 . . . . 0.0 112.588 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -162.72 -42.84 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.643 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.28 115.03 26.89 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.374 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.33 151.68 37.91 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.309 -1.357 . . . . 0.0 112.994 -177.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.91 144.91 32.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.821 ' CE2' HD12 ' A' ' 38' ' ' ILE . 15.9 m-85 -120.03 129.2 54.13 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.683 -173.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -135.93 73.17 1.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.413 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -48.41 154.7 1.07 Allowed Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.28 -175.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -70.96 7.7 3.85 Favored 'Cis proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.105 -1.206 . . . . 0.0 110.901 -5.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' C ' HG22 ' A' ' 38' ' ' ILE . 4.6 m-80 -104.37 -164.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.948 0.88 . . . . 0.0 111.357 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.821 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -177.34 135.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 7.5 m -105.69 113.26 26.72 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 117.807 -1.557 . . . . 0.0 107.625 171.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -91.52 133.25 35.67 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.001 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -110.51 168.38 7.7 Favored Pre-proline 0 N--CA 1.512 2.671 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.324 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 10.8 Cg_endo -83.81 158.79 71.53 Favored 'Cis proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.05 1.187 . . . . 0.0 114.678 2.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.449 0 CA-C-N 111.741 -2.481 . . . . 0.0 109.763 175.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -82.27 36.35 0.62 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 107.701 -1.692 . . . . 0.0 107.701 165.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.24 125.38 29.05 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.385 -174.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -81.6 -175.86 5.75 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 117.896 -1.522 . . . . 0.0 109.388 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -172.14 3.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.669 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -69.82 134.05 48.09 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.507 -176.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.94 -1.76 0.2 Allowed Glycine 0 N--CA 1.482 1.7 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.779 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 7' ' ' SER . 19.0 mttm -121.8 102.54 41.31 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.313 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -170.99 0.59 Allowed 'Trans proline' 0 C--O 1.21 -0.885 0 C-N-CA 121.263 1.309 . . . . 0.0 109.252 175.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 -106.13 3.27 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.726 -1.702 . . . . 0.0 111.323 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 1.2 ptm180 -161.55 165.93 27.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.881 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -146.4 146.13 15.82 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -78.19 118.49 20.47 Favored 'General case' 0 C--O 1.173 -2.933 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.178 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 50.4 tp -81.3 129.5 34.64 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 116.938 -1.905 . . . . 0.0 110.683 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.82 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.9 m95 -117.96 122.01 42.15 Favored 'General case' 0 C--N 1.263 -3.172 0 CA-C-N 111.902 -2.408 . . . . 0.0 105.444 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.651 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -84.64 -12.68 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 mt -152.36 66.86 0.83 Allowed 'General case' 0 C--N 1.246 -3.901 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.226 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.439 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -143.32 123.26 13.52 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.215 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.04 -36.41 31.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.86 155.4 49.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.75 153.38 67.51 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.579 -177.191 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -67.53 -164.73 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.481 1.454 . . . . 0.0 111.684 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -132.98 -18.17 1.1 Allowed Glycine 0 N--CA 1.489 2.206 1 N-CA-C 130.631 7.012 . . . . 0.0 130.631 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.85 47.0 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.326 -1.416 . . . . 0.0 109.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -83.2 -91.06 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.45 25.03 0.02 OUTLIER Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.275 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.4 m-85 -69.27 171.86 7.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.598 1.189 . . . . 0.0 111.099 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 28' ' ' TYR . 4.6 p -162.65 -45.83 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.373 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 125.76 44.72 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.302 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.635 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -156.47 149.88 24.48 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 117.534 -1.666 . . . . 0.0 113.369 177.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.54 143.96 40.12 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.529 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.782 ' CE2' HD12 ' A' ' 38' ' ' ILE . 57.7 m-85 -111.36 138.01 48.4 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.235 -0.986 . . . . 0.0 113.026 -172.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 35' ' ' TRP . 11.5 mmtm -135.02 60.21 1.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.406 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -41.63 148.58 0.44 Allowed Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.619 -175.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -71.75 -3.81 11.35 Favored 'Cis proline' 0 C--O 1.211 -0.863 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.032 -1.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.73 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -99.22 -160.32 0.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.803 -178.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.82 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 178.56 136.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.19 -2.07 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.177 -178.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 33.9 m -105.3 117.36 33.81 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.231 -1.787 . . . . 0.0 107.021 171.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -98.48 126.32 43.98 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.535 -170.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 15.7 m-85 -98.5 -172.66 0.28 Allowed Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 16.1 Cg_exo -56.31 -52.11 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 123.206 2.181 . . . . 0.0 115.948 5.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.612 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 116.332 -1.794 . . . . 0.0 109.221 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -85.71 33.74 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 108.516 -1.378 . . . . 0.0 108.516 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.8 136.18 36.66 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -176.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.1 -175.83 4.79 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.125 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -128.62 -171.89 2.58 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.291 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -70.71 114.29 8.65 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.78 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.44 1.12 4.11 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.092 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.2 mptm? -103.55 151.15 38.66 Favored Pre-proline 0 N--CA 1.498 1.934 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.192 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 9' ' ' LYS . 17.1 Cg_exo -38.88 177.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.779 2.986 . . . . 0.0 115.051 -173.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.06 31.37 0.65 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.909 -1.496 . . . . 0.0 114.911 -172.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -161.21 142.78 11.77 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 115.884 -2.327 . . . . 0.0 114.754 175.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -161.88 152.41 22.82 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.947 174.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 118.37 19.27 Favored 'General case' 0 C--O 1.174 -2.91 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.572 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.616 ' H ' ' HB3' ' A' ' 2' ' ' ALA . 7.2 tt -87.63 94.98 9.89 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.141 -1.824 . . . . 0.0 112.341 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.809 ' HB2' HG23 ' A' ' 38' ' ' ILE . 66.5 m95 -70.56 127.65 33.41 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.307 -2.224 . . . . 0.0 107.464 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.2 mp -93.81 -10.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -169.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -153.74 76.43 1.07 Allowed 'General case' 0 C--N 1.247 -3.872 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.477 -174.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -161.69 129.32 4.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 117.239 -1.784 . . . . 0.0 112.737 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.49 -18.74 65.62 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 175.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -142.61 154.66 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.582 -0.809 . . . . 0.0 109.242 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 156.66 39.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.628 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -61.94 -172.99 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 121.163 1.242 . . . . 0.0 111.509 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.91 -5.24 4.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.28 -18.16 47.21 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.438 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.74 -31.21 41.04 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.48 7.01 30.67 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.556 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.9 m-85 -66.03 167.86 9.19 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.591 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 28' ' ' TYR . 8.6 p -161.12 -44.14 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.386 -2.188 . . . . 0.0 105.953 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.22 124.86 41.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.819 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -157.09 158.6 36.7 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.112 -1.435 . . . . 0.0 112.699 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.1 p -115.82 140.64 49.02 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.29 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.692 ' CE2' HD12 ' A' ' 38' ' ' ILE . 35.9 m-85 -108.77 131.76 54.64 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.643 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 30.4 mmtm -131.57 67.65 1.51 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.415 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -45.09 149.24 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.573 -175.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.5 Cg_endo -71.68 -5.12 12.16 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.017 -5.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.838 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -92.68 -161.91 0.88 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.867 -177.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.809 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 176.21 143.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.46 -177.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 71.2 m -112.38 125.41 54.17 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.016 169.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -105.02 138.08 41.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' CE2' ' ND1' ' A' ' 43' ' ' HIS . 2.2 m-85 -108.16 -178.96 0.62 Allowed Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.6 Cg_exo -58.37 -55.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.507 2.322 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 5.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.672 0 CA-C-O 116.377 -1.773 . . . . 0.0 109.133 -171.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.581 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.501 2.121 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -84.93 34.31 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.644 0.896 . . . . 0.0 109.94 168.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.18 123.31 26.75 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.392 -176.044 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -79.31 164.68 23.9 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.551 -1.26 . . . . 0.0 110.083 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 179.22 6.5 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.107 0.956 . . . . 0.0 111.281 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.25 133.23 38.9 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.522 -177.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.86 -17.03 28.79 Favored Glycine 0 C--N 1.296 -1.644 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.711 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.94 114.27 10.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -73.72 -160.89 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 N-CA-C 108.627 -1.336 . . . . 0.0 108.627 172.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 79.52 -106.87 2.47 Favored Glycine 0 C--N 1.288 -2.12 0 C-N-CA 118.809 -1.662 . . . . 0.0 111.229 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.642 HH21 ' HB2' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -157.14 158.85 37.08 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.273 -176.686 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.22 161.75 24.97 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 174.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -79.25 128.67 33.6 Favored 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.35 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 16.6 tp -92.4 108.0 19.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.691 1.234 . . . . 0.0 111.958 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.642 ' CB ' HG23 ' A' ' 38' ' ' ILE . 64.8 m95 -99.82 150.38 22.41 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 112.546 -2.115 . . . . 0.0 109.709 177.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -81.22 -155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.341 -177.581 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.75 72.94 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.212 1.482 . . . . 0.0 108.272 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 17' ' ' ILE . 10.5 mtp85 -114.53 103.94 11.52 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.449 179.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.99 -27.77 14.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.219 -1.467 . . . . 0.0 109.884 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 157.39 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.75 159.89 70.49 Favored Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.647 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -50.46 168.87 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.071 1.181 . . . . 0.0 110.948 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.02 140.62 15.13 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.845 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.36 85.8 Favored Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.513 -1.327 . . . . 0.0 111.074 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -171.58 2.8 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.696 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.46 6.67 71.38 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.055 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.3 m-85 -86.96 168.02 13.74 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 118.373 -1.331 . . . . 0.0 112.334 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -160.81 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 111.961 -2.382 . . . . 0.0 105.697 177.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.33 117.02 32.85 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.534 179.338 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -143.07 153.3 42.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.742 -179.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 140.77 47.66 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.222 177.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' CE2' HD12 ' A' ' 38' ' ' ILE . 34.8 m-85 -117.38 142.64 46.86 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.371 -172.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.22 81.25 0.69 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.662 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.532 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -51.06 158.79 1.13 Allowed Pre-proline 0 C--N 1.308 -1.208 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.727 -176.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.0 Cg_endo -79.83 33.18 1.43 Allowed 'Cis proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.12 -1.2 . . . . 0.0 111.826 -2.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.532 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 m-80 -145.29 -166.12 2.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.403 176.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -165.98 144.92 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.14 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 3.4 m -115.55 122.16 44.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.048 -1.861 . . . . 0.0 107.289 167.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.49 135.81 33.74 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.865 -172.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -105.92 167.19 10.02 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.444 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' A' ' 41' ' ' TYR . 14.3 Cg_endo -86.98 158.66 50.13 Favored 'Cis proline' 0 C--O 1.214 -0.696 0 N-CA-C 115.068 1.142 . . . . 0.0 115.068 2.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.642 ' HB2' HH21 ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 111.926 -2.397 . . . . 0.0 109.508 174.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.02 35.55 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 167.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.06 122.38 20.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -175.081 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.43 178.71 6.97 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 117.558 -1.657 . . . . 0.0 108.863 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.491 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -130.96 -177.48 4.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.381 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -77.73 113.67 15.82 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.961 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.03 64.16 Favored Glycine 0 C--N 1.297 -1.612 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.379 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -119.51 107.07 41.42 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.696 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -72.42 174.15 12.04 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.161 1.24 . . . . 0.0 109.55 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.47 -99.72 1.97 Allowed Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.635 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.599 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -159.38 159.9 34.31 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.666 -176.268 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.44 143.86 12.93 Favored Glycine 0 C--N 1.288 -2.105 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 171.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -76.17 127.72 33.5 Favored 'General case' 0 C--O 1.17 -3.079 0 C-N-CA 118.994 -1.082 . . . . 0.0 108.359 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 117.49 23.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 117.542 -1.663 . . . . 0.0 112.139 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.641 ' CB ' HG23 ' A' ' 38' ' ' ILE . 62.8 m95 -111.1 159.69 17.58 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 112.225 -2.261 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -81.93 -163.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.701 -176.443 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.477 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.34 70.78 0.17 Allowed 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 123.181 1.467 . . . . 0.0 108.579 -175.748 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.9 mtp180 -105.74 141.54 37.0 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.997 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.85 -34.31 53.36 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.9 157.72 44.31 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.86 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.0 149.97 64.12 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.035 -179.629 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 144.47 97.47 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 121.006 1.137 . . . . 0.0 111.163 176.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.26 -15.34 72.05 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.089 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.77 -29.76 74.95 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -81.81 4.62 21.5 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.08 16.22 68.39 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.491 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 39.4 m-85 -66.07 169.56 6.75 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.126 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 p -162.15 -46.98 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.474 -2.148 . . . . 0.0 106.117 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 41' ' ' TYR . 33.3 p -98.02 118.21 34.12 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.219 -2.264 . . . . 0.0 110.378 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.606 HD22 ' HE1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -153.77 158.4 40.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.931 -1.508 . . . . 0.0 112.998 179.04 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.43 148.43 45.12 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.312 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.699 ' CE2' HD12 ' A' ' 38' ' ' ILE . 12.2 m-85 -114.93 137.8 51.56 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.511 -171.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 mttp -138.49 73.69 1.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.145 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.491 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 6.9 t-105 -37.78 147.99 0.23 Allowed Pre-proline 0 N--CA 1.504 2.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 2.4 Cg_endo -78.13 37.68 0.5 Allowed 'Cis proline' 0 N--CA 1.495 1.572 0 C-N-CA 124.976 -0.843 . . . . 0.0 110.87 -6.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -146.29 -155.91 0.66 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.259 -179.101 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.699 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -170.86 141.72 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.299 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.179 179.185 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.2 m -110.63 144.74 39.07 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 167.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.9 t -117.74 135.42 54.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.6 m-85 -102.61 174.11 3.07 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 176.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.5 Cg_exo -55.19 -61.5 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.917 0 N-CA-C 117.209 1.965 . . . . 0.0 117.209 5.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.599 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.123 0 CA-C-O 116.438 -1.744 . . . . 0.0 109.879 -170.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.457 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.6 Cg_endo -86.1 23.97 0.79 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 N-CA-C 107.089 -1.927 . . . . 0.0 107.089 164.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.7 p -75.07 116.62 16.01 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-N 113.447 -1.706 . . . . 0.0 108.939 -177.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.13 179.44 6.85 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.92 -175.359 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -113.09 -173.71 2.31 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.345 177.63 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -75.14 120.37 20.55 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.041 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -8.52 51.1 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.763 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -115.82 100.99 54.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.701 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.56 152.22 37.96 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.188 1.259 . . . . 0.0 109.804 174.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.85 -93.33 0.3 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.929 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -162.05 159.21 25.99 Favored 'General case' 0 C--O 1.199 -1.588 0 C-N-CA 118.624 -1.231 . . . . 0.0 112.217 -178.532 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -153.51 151.18 22.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 174.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -78.42 128.08 33.1 Favored 'General case' 0 C--O 1.182 -2.46 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.166 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 12.6 tp -94.08 101.92 13.96 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.865 1.317 . . . . 0.0 111.717 -177.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.815 ' HB2' HG23 ' A' ' 38' ' ' ILE . 78.4 m95 -88.87 123.4 33.21 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 111.889 -2.414 . . . . 0.0 107.402 176.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.77 -16.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -170.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.8 mt -151.73 71.57 0.99 Allowed 'General case' 0 C--N 1.247 -3.86 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.907 -171.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -156.29 141.19 17.17 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 117.841 -1.544 . . . . 0.0 112.297 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.592 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -91.28 -19.48 41.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.16 43.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.18 162.07 63.01 Favored Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.948 -179.111 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 5.6 Cg_exo -52.29 114.51 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 121.489 1.459 . . . . 0.0 112.33 -171.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -0.94 65.6 0.0 OUTLIER Glycine 0 N--CA 1.488 2.123 1 N-CA-C 131.162 7.225 . . . . 0.0 131.162 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.11 48.8 71.53 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.033 -1.556 . . . . 0.0 110.365 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.61 -77.78 0.17 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.042 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.11 -23.19 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.504 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.0 m-85 -77.66 170.48 16.5 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.568 1.175 . . . . 0.0 112.337 -179.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.6 p -160.88 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 112.353 -2.203 . . . . 0.0 105.957 176.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -96.36 118.06 32.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.333 -179.909 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.56 149.62 29.4 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.031 -1.468 . . . . 0.0 113.185 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.6 p -103.4 142.74 33.72 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.017 175.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 38' ' ' ILE . 29.4 m-85 -117.12 134.79 54.34 Favored 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 119.267 -0.973 . . . . 0.0 112.479 -173.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -147.56 80.0 1.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.592 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -53.36 152.99 7.67 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.343 -175.437 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 5.2 Cg_endo -72.66 -6.9 15.96 Favored 'Cis proline' 0 C--O 1.208 -0.996 0 C-N-CA 124.197 -1.168 . . . . 0.0 110.451 -5.298 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.494 ' C ' HG22 ' A' ' 38' ' ' ILE . 1.6 m-80 -91.61 -165.15 1.29 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.284 1.04 . . . . 0.0 111.873 -178.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.815 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 179.42 142.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.005 -178.116 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 18.4 m -113.56 103.87 11.69 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.421 -1.312 . . . . 0.0 107.795 172.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -82.27 138.05 34.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.32 -1.309 . . . . 0.0 113.342 -172.673 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.567 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -109.73 -178.8 0.58 Allowed Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.1 Cg_exo -63.81 -50.48 0.17 OUTLIER 'Cis proline' 0 N--CA 1.507 2.287 0 N-CA-C 116.813 1.813 . . . . 0.0 116.813 5.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.589 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.752 0 CA-C-O 116.382 -1.771 . . . . 0.0 110.074 -171.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -84.26 29.64 0.54 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 106.586 -2.121 . . . . 0.0 106.586 165.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.598 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.2 p -92.0 117.3 29.69 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.237 -174.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 2.2 m-85 -78.06 172.46 13.49 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.398 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -108.78 -171.89 1.94 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.589 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -74.86 114.95 13.9 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.304 -1.358 . . . . 0.0 111.009 -177.693 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.88 3.52 60.0 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.414 178.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -113.05 113.64 49.24 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.093 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.28 -163.22 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.573 1.516 . . . . 0.0 111.664 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 69.22 -118.25 8.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.582 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.9 ptp180 -152.46 -171.52 3.96 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 118.398 -1.321 . . . . 0.0 112.133 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.73 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -152.02 155.95 26.42 Favored Glycine 0 C--N 1.273 -2.925 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 173.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -76.28 131.93 39.54 Favored 'General case' 0 C--O 1.176 -2.78 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.936 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 14.5 tp -92.3 110.16 21.55 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.908 1.337 . . . . 0.0 110.774 -177.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.703 ' HB2' HG23 ' A' ' 38' ' ' ILE . 66.0 m95 -106.84 160.0 15.83 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 112.068 -2.333 . . . . 0.0 109.875 -177.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -86.15 -161.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.788 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -67.96 72.95 0.18 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.413 1.577 . . . . 0.0 108.728 -175.706 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.8 mtp85 -110.86 125.75 53.95 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 111.952 -2.385 . . . . 0.0 109.877 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.25 -26.2 70.34 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 p -149.38 153.43 37.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.789 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -81.31 152.37 70.54 Favored Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.164 179.37 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 25' ' ' GLY . 2.7 Cg_exo -51.25 124.53 14.28 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 C-N-CA 121.015 1.143 . . . . 0.0 111.641 -178.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.74 25.23 2.54 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -133.7 -4.27 3.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.572 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -56.36 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.996 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.24 0.72 1.0 Allowed Glycine 0 C--N 1.288 -2.128 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.824 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.597 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 47.7 m-85 -68.62 170.68 8.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 122.569 1.176 . . . . 0.0 111.896 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -161.03 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.544 -2.117 . . . . 0.0 106.055 177.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -97.66 123.54 41.62 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.79 178.785 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.578 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -155.2 149.49 26.01 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.882 -1.527 . . . . 0.0 112.485 178.911 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 7.8 p -108.81 146.08 34.2 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.441 177.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.727 ' CE2' HD12 ' A' ' 38' ' ' ILE . 46.8 m-85 -123.01 133.89 54.34 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.22 -175.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.45 83.17 1.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.278 -0.873 . . . . 0.0 108.754 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.474 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.78 160.19 0.2 Allowed Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.949 -176.221 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 18' ' ' LEU . 8.2 Cg_endo -80.12 34.06 1.36 Allowed 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.21 -1.162 . . . . 0.0 110.435 -5.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.474 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 7.0 m-80 -147.15 -163.32 1.73 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.871 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.727 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -162.22 146.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.031 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.9 m -117.76 105.32 11.86 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.695 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -81.73 141.71 33.32 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.194 -172.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.3 m-85 -110.04 175.8 1.78 Allowed Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.4 Cg_exo -57.49 -58.45 0.04 OUTLIER 'Cis proline' 0 N--CA 1.506 2.215 0 N-CA-C 117.773 2.182 . . . . 0.0 117.773 6.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.179 0 CA-C-O 116.273 -1.823 . . . . 0.0 109.594 -169.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.506 2.328 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.55 37.03 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 N-CA-C 108.308 -1.458 . . . . 0.0 108.308 165.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.76 122.14 21.92 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.585 -174.5 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.44 174.03 12.01 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.241 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.41 179.99 6.47 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.012 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -71.75 134.55 46.28 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.534 -174.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.68 -12.23 0.53 Allowed Glycine 0 N--CA 1.478 1.464 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.767 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 mttt -113.05 105.86 55.36 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.102 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -72.09 154.58 57.4 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 173.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -105.06 1.25 Allowed Glycine 0 C--N 1.287 -2.152 1 N-CA-C 129.604 6.602 . . . . 0.0 129.604 -176.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.734 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 5.5 ptm180 -162.65 152.84 16.4 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.815 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.69 152.12 23.62 Favored Glycine 0 N--CA 1.493 2.472 1 N-CA-C 125.716 5.046 . . . . 0.0 125.716 171.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 4.8 m-20 -77.11 122.34 24.84 Favored 'General case' 0 C--O 1.171 -3.037 0 C-N-CA 118.015 -1.474 . . . . 0.0 109.709 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 20.3 tp -86.56 100.24 12.27 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.335 -178.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.674 ' CB ' HG23 ' A' ' 38' ' ' ILE . 61.5 m95 -87.59 165.11 15.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.406 177.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.635 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -90.86 -159.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.939 -176.824 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.05 70.27 0.15 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.202 1.477 . . . . 0.0 108.411 -176.073 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' ILE . 3.6 mtp180 -113.62 120.87 42.38 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 112.202 -2.272 . . . . 0.0 110.49 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -23.38 64.94 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.157 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 154.07 38.33 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.934 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.97 149.96 54.42 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.975 179.2 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.83 143.69 95.15 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.83 1.02 . . . . 0.0 110.815 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.23 -1.22 75.82 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.239 -1.457 . . . . 0.0 110.095 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.58 -14.68 70.1 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.15 -91.78 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.036 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.68 24.61 0.03 OUTLIER Glycine 0 C--N 1.29 -2.0 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.54 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.631 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.2 m-85 -86.37 170.11 12.31 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.921 1.343 . . . . 0.0 112.347 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.4 p -162.55 -44.44 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 112.041 -2.345 . . . . 0.0 105.849 176.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' TYR . 29.8 p -96.98 114.24 25.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.513 -2.131 . . . . 0.0 109.806 -179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.561 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.55 151.36 37.2 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.956 177.984 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.09 145.65 35.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.752 177.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.707 ' CE2' HD12 ' A' ' 38' ' ' ILE . 15.9 m-85 -118.23 125.91 51.1 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.86 -171.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 35' ' ' TRP . 25.8 mttt -127.04 70.55 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.612 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.43 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 31.7 t-105 -39.22 144.09 0.47 Allowed Pre-proline 0 C--N 1.296 -1.738 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.483 178.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 9.5 Cg_endo -79.39 39.35 0.57 Allowed 'Cis proline' 0 N--CA 1.494 1.514 0 C-N-CA 125.66 -0.558 . . . . 0.0 111.372 -5.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.457 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -149.31 -159.73 1.08 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.474 -1.291 . . . . 0.0 110.935 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.707 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -170.94 142.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.991 179.582 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 16.0 m -111.18 133.15 53.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -105.82 130.84 53.72 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -170.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -103.83 179.19 1.0 Allowed Pre-proline 0 N--CA 1.513 2.698 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 177.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.574 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.0 Cg_exo -59.11 -54.91 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.177 0 N-CA-C 117.217 1.968 . . . . 0.0 117.217 6.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.734 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.659 0 CA-C-O 116.373 -1.775 . . . . 0.0 109.247 -171.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 119.502 -0.285 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -80.32 59.49 7.46 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -74.8 142.42 44.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.569 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -78.44 169.14 18.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.369 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -114.0 -166.22 1.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 9' ' ' LYS . 3.0 t -62.27 110.39 1.62 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.671 -177.74 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.91 1.12 0.79 Allowed Glycine 0 N--CA 1.479 1.528 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.208 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 7' ' ' SER . 30.3 mttt -99.33 116.44 65.04 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.573 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 1.2 Cg_endo -70.76 -167.89 0.29 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 173.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.97 -119.53 5.46 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.615 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -162.0 159.56 26.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.585 -179.771 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.84 149.77 20.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 172.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 12.8 m-20 -77.03 125.84 29.98 Favored 'General case' 0 C--O 1.175 -2.854 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.186 -179.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 5.0 tp -83.23 106.42 15.0 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 117.056 -1.858 . . . . 0.0 111.793 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.718 ' HB2' HG23 ' A' ' 38' ' ' ILE . 53.4 m95 -90.48 171.53 9.36 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 111.723 -2.489 . . . . 0.0 110.374 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -88.94 -163.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.079 -178.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -68.06 72.31 0.18 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.945 1.355 . . . . 0.0 108.454 -176.197 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.8 mtp85 -113.1 111.1 21.54 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.356 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.49 -24.95 40.46 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.204 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 p -141.77 151.54 42.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.39 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.62 147.26 55.2 Favored Pre-proline 0 C--N 1.289 -2.051 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.387 -179.68 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.55 148.21 54.6 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 121.004 1.136 . . . . 0.0 111.737 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLY . . . -84.48 -33.05 20.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.997 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.97 -28.25 16.53 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.13 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.28 -25.93 42.39 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.733 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . 87.68 12.61 66.42 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.674 -1.25 . . . . 0.0 111.566 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 45.6 m-85 -57.9 172.56 0.39 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.636 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 28' ' ' TYR . 17.1 p -162.36 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.804 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.904 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.67 110.21 22.82 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.318 -177.592 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.08 156.11 40.38 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.339 -1.344 . . . . 0.0 112.778 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 p -112.17 146.81 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.738 176.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.802 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.1 m-85 -117.07 133.24 56.24 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.3 -0.96 . . . . 0.0 112.38 -174.044 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -134.82 70.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.588 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 11.8 t-105 -37.92 148.39 0.22 Allowed Pre-proline 0 N--CA 1.506 2.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.725 178.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 6.2 Cg_endo -77.64 33.79 0.73 Allowed 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 125.613 -0.578 . . . . 0.0 111.095 -6.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.558 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -147.15 -167.16 2.7 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.22 178.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.01 153.32 4.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.904 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -125.2 130.8 52.84 Favored 'General case' 0 C--O 1.216 -0.707 0 C-N-CA 117.948 -1.501 . . . . 0.0 107.586 168.189 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -167.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -111.42 -178.07 0.51 Allowed Pre-proline 0 N--CA 1.51 2.566 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.175 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.539 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.9 Cg_exo -57.79 -54.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.506 2.258 0 CA-C-N 122.485 1.923 . . . . 0.0 117.027 4.302 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.483 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.71 -171.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.505 2.287 0 CA-C-O 119.774 -0.155 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -81.55 49.73 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 168.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.31 138.33 45.37 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.039 -1.064 . . . . 0.0 108.16 -172.762 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.499 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -78.65 175.66 10.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.07 -1.452 . . . . 0.0 109.831 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -111.78 -169.02 1.39 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.813 179.232 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.21 108.52 10.37 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.062 -178.342 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.97 89.14 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.683 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -115.52 113.41 42.92 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.054 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.58 -161.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.793 0 C-N-CA 120.904 1.069 . . . . 0.0 109.335 174.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.47 -109.11 2.77 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.911 178.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.627 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.14 177.01 10.07 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.658 -1.217 . . . . 0.0 113.423 -177.353 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.627 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -157.46 158.37 28.91 Favored Glycine 0 N--CA 1.503 3.151 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.3 m-20 -78.06 122.97 26.28 Favored 'General case' 0 C--O 1.177 -2.731 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.287 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 4.5 tt -91.53 99.64 12.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 117.397 -1.721 . . . . 0.0 113.14 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.792 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.3 m95 -75.72 122.68 24.37 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.0 174.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 17' ' ' ILE . 44.1 mt -89.96 -10.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.2 mt -150.14 71.23 1.06 Allowed 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.536 -171.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.93 158.38 10.58 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.093 178.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.96 -29.25 4.4 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -129.01 152.16 48.92 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.801 177.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.61 153.51 47.97 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.99 -179.09 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.2 -178.75 0.09 OUTLIER 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.513 1.475 . . . . 0.0 112.071 -175.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.76 12.6 10.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -108.44 -5.48 32.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.99 -28.43 14.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.137 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.74 54.46 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.717 -1.23 . . . . 0.0 111.51 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.629 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 47.0 m-85 -53.7 167.17 0.26 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.986 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.9 p -163.38 -43.27 0.03 OUTLIER 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.544 177.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -96.56 111.58 23.65 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.706 -2.043 . . . . 0.0 109.119 -179.575 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -150.96 146.9 26.56 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.751 -177.784 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.55 138.2 36.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.222 177.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.856 ' CD1' HD12 ' A' ' 38' ' ' ILE . 95.8 m-85 -118.35 134.38 55.1 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.861 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.2 82.38 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.47 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.21 158.85 0.43 Allowed Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.825 -176.417 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.829 ' C ' HD22 ' A' ' 37' ' ' ASN . 6.3 Cg_endo -74.2 5.16 10.82 Favored 'Cis proline' 0 C--O 1.204 -1.206 0 C-N-CA 124.215 -1.161 . . . . 0.0 111.435 -3.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.944 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.3 OUTLIER -114.36 -162.93 0.84 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 122.195 0.997 . . . . 0.0 111.268 -176.46 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.856 HD12 ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -178.61 144.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.377 -179.538 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.22 111.86 19.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 117.469 -1.692 . . . . 0.0 108.049 170.029 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.629 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -82.87 148.17 27.87 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.211 -170.478 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.516 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER -124.06 168.71 12.09 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 178.114 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -77.39 157.6 96.12 Favored 'Cis proline' 0 C--N 1.325 -0.698 0 CA-C-O 122.88 1.117 . . . . 0.0 114.147 4.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.602 0 CA-C-N 111.981 -2.372 . . . . 0.0 109.711 175.571 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 15' ' ' LEU 0.255 . . . . . . . 0 N--CA 1.506 2.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.86 31.88 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.4 p -85.62 114.56 22.71 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.791 -176.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -77.76 175.41 9.99 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.493 -1.283 . . . . 0.0 110.274 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.7 m -113.24 -177.21 3.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.83 121.47 24.14 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.541 -178.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.93 60.88 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.49 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -123.65 113.6 28.79 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.801 -178.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -74.71 -164.39 0.22 Allowed 'Trans proline' 0 C--O 1.212 -0.795 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 173.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -99.75 2.59 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.31 177.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.622 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.93 161.61 31.73 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.267 -177.232 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -147.42 147.36 18.06 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 174.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 14.9 m-20 -79.62 121.7 25.61 Favored 'General case' 0 C--O 1.17 -3.125 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.008 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.658 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 15.5 tp -92.19 92.79 8.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.842 1.306 . . . . 0.0 112.86 -175.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 38' ' ' ILE . 68.6 m95 -74.14 120.12 19.28 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 112.165 -2.289 . . . . 0.0 108.196 174.209 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.506 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.3 mp -84.82 -11.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -171.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 mt -152.41 75.9 1.13 Allowed 'General case' 0 C--N 1.253 -3.59 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.672 -175.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -148.21 155.53 41.48 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.748 178.734 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.4 -26.71 4.16 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.67 151.49 45.97 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.303 175.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -91.36 138.1 25.73 Favored Pre-proline 0 C--N 1.288 -2.082 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.083 -178.781 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.76 152.22 75.68 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 121.035 1.157 . . . . 0.0 111.615 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.66 -16.24 46.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.24 -19.7 59.85 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.617 -1.277 . . . . 0.0 109.93 179.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.88 -60.51 2.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.958 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.75 13.07 0.64 Allowed Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 38.9 m-85 -72.78 170.22 15.07 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.874 1.321 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.1 p -161.97 -45.75 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 112.066 -2.333 . . . . 0.0 106.065 177.213 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 123.22 43.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.928 179.786 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -152.12 157.94 42.27 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 117.972 -1.491 . . . . 0.0 114.08 179.143 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.457 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 p -113.97 147.9 37.81 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.253 172.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.735 ' CE2' HD12 ' A' ' 38' ' ' ILE . 40.1 m-85 -116.69 136.83 52.64 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.295 -172.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' SG ' ' A' ' 32' ' ' CYS . 4.5 mttt -138.96 70.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.948 178.575 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.422 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -47.83 144.98 4.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.326 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 3.6 Cg_endo -70.57 -7.83 11.64 Favored 'Cis proline' 0 C--O 1.206 -1.105 0 C-N-CA 124.952 -0.853 . . . . 0.0 111.208 -4.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.804 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -93.29 -164.93 1.24 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.297 -177.323 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -179.03 137.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.801 -179.097 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 50.5 m -107.08 105.56 15.63 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.278 174.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -91.27 130.26 37.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.969 -1.469 . . . . 0.0 114.17 -172.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.543 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -97.78 176.27 2.14 Favored Pre-proline 0 N--CA 1.511 2.611 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.095 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 11.7 Cg_exo -58.07 -57.16 0.08 OUTLIER 'Cis proline' 0 N--CA 1.503 2.056 0 N-CA-C 117.339 2.015 . . . . 0.0 117.339 7.172 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.622 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.357 0 CA-C-O 116.331 -1.795 . . . . 0.0 109.864 -170.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.09 31.84 0.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 166.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.67 120.98 19.05 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -175.59 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -174.4 3.53 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.64 -1.624 . . . . 0.0 109.418 -178.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.48 -175.32 4.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.439 178.004 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.58 130.03 38.16 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.271 -176.345 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.24 41.94 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.722 179.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 109.65 21.9 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.819 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.75 150.8 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 N-CA-C 108.959 -1.208 . . . . 0.0 108.959 172.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -89.63 0.47 Allowed Glycine 0 N--CA 1.491 2.304 1 N-CA-C 130.521 6.968 . . . . 0.0 130.521 -177.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.634 HH22 ' CG ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -160.08 149.11 17.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.542 -1.263 . . . . 0.0 112.567 179.181 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.78 148.5 20.14 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 175.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.634 ' CG ' HH22 ' A' ' 12' ' ' ARG . 2.9 m-20 -77.74 121.11 23.59 Favored 'General case' 0 C--O 1.18 -2.605 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.071 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 20.9 tp -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.333 -1.747 . . . . 0.0 110.891 179.383 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.675 ' CB ' HG23 ' A' ' 38' ' ' ILE . 65.6 m95 -119.75 152.65 36.88 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 111.303 -2.681 . . . . 0.0 106.975 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.757 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.54 -158.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.845 -176.265 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.54 68.84 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 123.128 1.442 . . . . 0.0 108.18 -177.049 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.65 136.73 46.9 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 112.5 -2.136 . . . . 0.0 110.427 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.06 -21.28 78.55 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.17 157.44 35.93 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.708 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.28 157.86 72.54 Favored Pre-proline 0 C--N 1.299 -1.6 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.219 177.894 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.59 -172.76 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 121.268 1.312 . . . . 0.0 111.794 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.69 10.98 10.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.23 -2.11 54.26 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.467 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -102.97 -52.45 3.05 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.16 30.65 2.05 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.598 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 79.0 m-85 -79.55 172.36 13.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.415 1.103 . . . . 0.0 110.999 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.1 p -162.41 -45.72 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 112.896 -1.957 . . . . 0.0 106.681 176.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.5 p -98.39 97.66 8.98 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 112.861 -1.972 . . . . 0.0 110.36 -178.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.689 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -129.64 151.16 50.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.661 -1.215 . . . . 0.0 113.013 -177.804 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 146.07 36.13 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.132 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.717 ' CE2' HD12 ' A' ' 38' ' ' ILE . 8.8 m-85 -120.53 127.99 52.68 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.346 -172.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.1 mttt -128.81 73.01 1.48 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.754 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -35.72 148.45 0.15 Allowed Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.941 179.734 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 4.9 Cg_endo -78.44 36.92 0.57 Allowed 'Cis proline' 0 N--CA 1.487 1.118 0 C-N-CA 125.221 -0.741 . . . . 0.0 111.44 -5.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.1 m-80 -147.48 -162.21 1.5 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.335 -179.403 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.717 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.47 140.33 2.1 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.223 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.437 179.652 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 32.0 m -112.83 119.67 38.82 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.171 168.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.0 t -88.86 142.32 27.75 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.848 -171.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.496 ' CB ' ' O ' ' A' ' 30' ' ' SER . 1.1 m-85 -122.28 167.76 13.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -78.82 158.52 91.93 Favored 'Cis proline' 0 C--N 1.32 -0.944 0 CA-C-O 122.914 1.131 . . . . 0.0 114.525 6.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.543 0 CA-C-N 111.975 -2.375 . . . . 0.0 109.245 175.412 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.505 2.301 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.41 30.6 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 108.318 -1.455 . . . . 0.0 108.318 166.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -66.52 125.25 25.15 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -174.938 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -78.24 165.33 24.04 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 117.269 -1.772 . . . . 0.0 109.402 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -134.31 176.96 8.13 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.896 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -74.47 139.48 43.92 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.732 -176.552 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.04 -17.81 0.92 Allowed Glycine 0 C--N 1.295 -1.719 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.898 179.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 7' ' ' SER . 7.5 mptt -128.63 107.03 18.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.21 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.41 162.99 27.62 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.908 -1.228 . . . . 0.0 108.908 173.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.85 -90.53 0.52 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.553 178.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.593 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.4 153.33 21.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.808 -176.794 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.72 146.54 18.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 173.287 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 22.0 m-20 -77.59 119.05 20.6 Favored 'General case' 0 C--O 1.173 -2.958 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.2 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 16' ' ' TRP . 55.4 tp -81.22 132.21 35.33 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.008 -1.877 . . . . 0.0 111.711 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.76 ' HB2' HG23 ' A' ' 38' ' ' ILE . 59.7 m95 -123.34 120.02 31.8 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 111.562 -2.563 . . . . 0.0 105.379 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.771 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -83.84 -16.91 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -168.201 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 mt -151.88 70.9 0.95 Allowed 'General case' 1 C--N 1.239 -4.214 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.087 -171.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -153.73 140.69 19.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 117.064 -1.854 . . . . 0.0 112.928 178.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.49 -25.0 29.31 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 177.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.28 153.68 45.33 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 151.53 43.68 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.636 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.31 109.39 0.97 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.922 1.081 . . . . 0.0 111.122 -178.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -21.33 70.44 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.186 -1.483 . . . . 0.0 109.903 178.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.18 -1.88 76.34 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.058 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -92.05 -101.88 0.12 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.18 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.65 -2.48 0.38 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.397 -1.382 . . . . 0.0 111.167 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.658 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 53.0 m-85 -82.77 168.2 17.41 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 122.692 1.234 . . . . 0.0 112.062 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -158.63 -45.55 0.06 Allowed 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 112.153 -2.294 . . . . 0.0 105.78 177.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -98.69 118.15 34.77 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.03 178.751 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.642 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -144.45 149.42 35.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 117.917 -1.513 . . . . 0.0 113.577 179.621 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 148.07 29.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.068 176.282 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.624 ' CE2' HD12 ' A' ' 38' ' ' ILE . 36.4 m-85 -118.71 137.33 53.41 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.748 -172.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 35' ' ' TRP . 39.7 mmtt -130.21 56.77 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.291 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 34' ' ' LYS . 31.3 t-105 -29.05 139.89 0.11 Allowed Pre-proline 0 N--CA 1.504 2.236 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.596 -177.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -71.89 -7.52 14.41 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.869 -6.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.861 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.58 -158.2 0.44 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.606 -177.003 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.76 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER 176.49 139.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.193 -1.916 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.461 -178.55 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 11.5 m -109.37 108.75 19.41 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 117.337 -1.745 . . . . 0.0 107.028 170.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.658 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.4 t -83.78 142.81 30.4 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.627 -171.45 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.6 m-85 -117.7 166.01 14.5 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.273 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -76.31 159.88 96.08 Favored 'Cis proline' 0 CA--C 1.509 -0.735 0 CA-C-O 122.885 1.119 . . . . 0.0 113.651 4.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.897 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.514 178.282 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -84.24 30.15 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 N-CA-C 108.001 -1.577 . . . . 0.0 108.001 167.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -71.46 119.24 15.33 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -174.728 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.0 160.6 29.01 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.25 -1.78 . . . . 0.0 109.966 -178.331 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.65 179.41 4.35 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.684 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.3 p -80.87 118.98 22.85 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.99 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 -11.16 71.21 Favored Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.203 -179.247 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -127.41 110.95 21.13 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.445 -179.706 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -165.94 0.27 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.062 1.174 . . . . 0.0 109.398 173.466 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.14 -96.78 2.25 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 118.961 -1.59 . . . . 0.0 111.105 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.603 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.88 160.32 30.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.963 -178.591 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -144.54 140.42 9.26 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 172.732 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -76.02 129.18 36.47 Favored 'General case' 0 C--O 1.173 -2.953 0 C-N-CA 118.628 -1.229 . . . . 0.0 108.136 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -83.45 125.65 31.94 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.58 -1.648 . . . . 0.0 111.455 -178.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.645 ' CB ' HG23 ' A' ' 38' ' ' ILE . 54.3 m95 -122.03 161.39 23.08 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.023 -178.554 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.749 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.79 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.736 -176.998 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -68.45 68.94 0.14 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.224 1.487 . . . . 0.0 107.807 -177.824 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' ILE . 16.5 mtp85 -101.77 113.34 26.42 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.593 -2.094 . . . . 0.0 110.845 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.32 -35.94 36.25 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.33 -1.414 . . . . 0.0 109.685 179.088 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.22 156.72 45.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.99 178.712 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.12 147.07 49.84 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.768 178.656 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.04 -175.83 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.093 1.195 . . . . 0.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.25 -41.22 1.41 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.64 12.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.488 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 28' ' ' TYR . 7.0 m-85 -81.79 15.48 2.19 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.335 -179.69 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.51 11.49 0.29 Allowed Glycine 0 N--CA 1.487 2.046 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.78 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 35.7 m-85 -63.93 167.57 6.06 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 117.84 -1.544 . . . . 0.0 111.189 179.455 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.59 -43.83 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.372 -2.195 . . . . 0.0 106.616 177.882 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.62 125.77 42.55 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.929 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.676 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -160.52 162.98 33.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.923 -1.511 . . . . 0.0 112.841 -179.718 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.8 p -116.79 137.25 52.33 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.826 176.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.682 ' CE2' HD12 ' A' ' 38' ' ' ILE . 60.3 m-85 -112.52 120.43 41.58 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.468 -174.42 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -139.69 73.64 1.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.548 179.61 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.493 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.64 157.83 0.43 Allowed Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.727 -176.793 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 14.0 Cg_endo -80.99 26.48 4.98 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.442 0.4 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.493 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.2 m-80 -144.74 178.3 8.09 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.463 175.636 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -148.07 148.58 16.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.951 -179.534 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 31.6 m -114.14 151.32 32.83 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 166.342 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.2 t -123.05 137.36 54.96 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.839 -1.144 . . . . 0.0 114.012 -169.354 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.553 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.7 m-85 -104.48 176.14 1.89 Allowed Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.631 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.9 Cg_exo -52.74 -62.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.928 0 N-CA-C 117.328 2.011 . . . . 0.0 117.328 4.388 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.603 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 116.265 -1.826 . . . . 0.0 109.6 -170.167 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.23 40.79 0.7 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 165.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -82.24 122.61 28.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -175.796 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.05 177.9 8.45 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.871 -1.532 . . . . 0.0 109.526 179.734 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.63 175.16 9.24 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.642 177.072 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.53 129.27 36.23 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.816 -177.693 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.91 -22.27 6.0 Favored Glycine 0 C--N 1.296 -1.662 0 C-N-CA 119.064 -1.541 . . . . 0.0 110.165 -178.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -110.4 115.41 54.23 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.838 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -76.33 -163.59 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 173.433 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.69 -106.04 2.05 Favored Glycine 0 C--N 1.287 -2.189 0 C-N-CA 118.832 -1.651 . . . . 0.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.622 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 8.2 ptm180 -159.25 177.42 11.05 Favored 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 118.176 -1.41 . . . . 0.0 114.224 -176.325 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -156.61 144.23 10.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 173.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 32.5 m-20 -76.25 124.57 27.69 Favored 'General case' 0 C--O 1.177 -2.719 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.199 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD12 ' SG ' ' A' ' 39' ' ' CYS . 3.2 tt -86.09 111.37 20.27 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.019 -1.872 . . . . 0.0 112.296 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.707 ' HB2' HG23 ' A' ' 38' ' ' ILE . 46.1 m95 -92.65 -178.13 4.78 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 112.25 -2.25 . . . . 0.0 108.864 176.045 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -102.03 -162.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.691 -176.288 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -68.72 66.81 0.13 Allowed 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 122.964 1.364 . . . . 0.0 107.726 -177.672 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 1.1 mtt85 -111.54 113.26 25.55 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 112.573 -2.103 . . . . 0.0 110.665 -179.398 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.08 -34.52 16.78 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.42 157.4 45.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.305 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -86.03 152.33 55.9 Favored Pre-proline 0 C--N 1.298 -1.633 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.173 179.277 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.98 115.5 2.47 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 120.698 0.932 . . . . 0.0 110.181 174.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.58 -4.87 47.97 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.375 -1.393 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 -0.56 55.87 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.179 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.23 -16.08 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.396 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.75 -3.36 23.02 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.761 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 43.1 m-85 -77.3 169.76 17.75 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.834 1.302 . . . . 0.0 112.471 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.97 -45.37 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 112.055 -2.339 . . . . 0.0 106.345 176.056 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 41' ' ' TYR . 80.2 p -99.38 115.29 28.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.066 -179.37 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -143.54 148.8 36.5 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.935 -179.932 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.5 144.47 33.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.788 176.105 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.8 m-85 -117.98 133.21 56.14 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.894 -173.005 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -138.72 75.59 1.53 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.957 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.502 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.9 155.73 0.39 Allowed Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.46 -177.994 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.459 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 7.3 Cg_endo -78.08 32.92 0.9 Allowed 'Cis proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.5 -1.042 . . . . 0.0 111.571 -4.51 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.502 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -145.07 -160.7 1.17 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.811 177.754 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.28 147.76 4.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.918 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 39.1 m -116.88 119.05 34.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.015 168.216 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.3 t -90.57 139.15 30.98 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.968 -171.501 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.6 m-85 -112.12 178.41 0.98 Allowed Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 15.7 Cg_exo -59.49 -56.64 0.12 OUTLIER 'Cis proline' 0 N--CA 1.502 2.02 0 N-CA-C 116.695 1.767 . . . . 0.0 116.695 4.818 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.622 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.7 0 CA-C-O 116.439 -1.743 . . . . 0.0 109.325 -171.043 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.23 33.7 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 164.249 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 12.7 p -84.98 115.37 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.455 -176.25 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.46 172.7 13.26 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.989 -178.508 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.89 -173.62 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.727 178.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -75.41 118.59 18.45 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.631 -175.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.38 44.87 Favored Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.844 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 28.1 mttt -113.51 109.43 51.01 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.319 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.87 -172.6 1.0 Allowed 'Trans proline' 0 C--N 1.32 -0.927 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 173.222 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.3 -110.57 3.58 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.58 -1.772 . . . . 0.0 110.807 179.079 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.751 HH11 ' HB2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.35 168.71 24.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.125 -177.967 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -147.9 157.38 27.32 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 174.268 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.563 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 1.2 m-20 -78.48 130.0 35.53 Favored 'General case' 0 C--O 1.172 -3.005 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.628 178.511 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 13.7 tp -96.08 97.33 9.49 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.923 1.344 . . . . 0.0 111.784 -177.294 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.836 ' HB2' HG23 ' A' ' 38' ' ' ILE . 78.5 m95 -83.08 115.52 21.92 Favored 'General case' 0 C--N 1.263 -3.157 0 CA-C-N 112.063 -2.335 . . . . 0.0 107.494 175.56 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.43 ' O ' HG22 ' A' ' 17' ' ' ILE . 8.2 mt -88.31 -8.85 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 10.9 mt -154.83 71.58 0.81 Allowed 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.674 -173.871 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.591 ' NH2' ' N ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -153.25 162.36 41.39 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 117.592 -1.643 . . . . 0.0 111.95 177.129 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -109.06 -32.48 3.03 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.454 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -136.21 153.94 51.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.412 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.74 149.08 39.84 Favored Pre-proline 0 C--N 1.293 -1.855 0 C-N-CA 118.779 -1.168 . . . . 0.0 110.068 -179.195 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.591 ' N ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 Cg_endo -66.83 146.47 78.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.878 1.052 . . . . 0.0 111.665 -178.69 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.68 -16.48 54.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 177.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.39 -9.13 87.25 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.05 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.73 -30.23 18.18 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.623 178.908 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.66 -9.48 12.82 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.227 177.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 45.4 m-85 -63.25 167.17 5.4 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.145 -178.821 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.23 -43.43 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 112.224 -2.262 . . . . 0.0 106.107 177.181 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.8 p -97.38 119.01 35.13 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.4 179.627 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.541 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -156.45 155.19 31.63 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.404 -1.718 . . . . 0.0 113.599 179.91 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 150.27 38.58 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.331 176.474 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 38' ' ' ILE . 36.4 m-85 -118.23 140.83 49.22 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.693 -171.212 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' ASN . 19.3 mttt -134.9 70.75 1.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.835 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -40.68 140.21 1.06 Allowed Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.222 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.89 2.47 14.57 Favored 'Cis proline' 0 N--CA 1.498 1.793 0 C-N-CA 125.319 -0.7 . . . . 0.0 110.425 -6.428 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' C ' HG22 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -93.41 -163.24 1.02 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.898 0.856 . . . . 0.0 112.301 -175.941 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.836 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 177.5 139.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.081 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.328 178.728 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 36.4 m -110.52 115.42 29.59 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.698 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -97.49 136.57 37.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.842 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.5 m-85 -107.03 179.49 0.88 Allowed Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.254 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 4.1 Cg_exo -65.45 -52.37 0.15 OUTLIER 'Cis proline' 0 N--CA 1.508 2.347 0 N-CA-C 116.632 1.743 . . . . 0.0 116.632 7.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.751 ' HB2' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.97 0 CA-C-O 116.411 -1.757 . . . . 0.0 109.588 -170.155 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.506 2.365 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.72 30.44 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 107.941 -1.6 . . . . 0.0 107.941 164.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.86 123.93 30.43 Favored 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.553 -174.464 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.0 m-85 -84.52 158.69 20.89 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.378 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -124.83 178.89 5.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.573 178.645 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 127.34 32.38 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.355 -175.431 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.28 54.46 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.887 178.747 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 113.25 18.97 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.637 -179.107 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -70.19 -158.73 0.05 OUTLIER 'Trans proline' 0 C--O 1.217 -0.54 0 C-N-CA 121.204 1.269 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 70.43 -108.68 2.56 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.849 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 1.7 ptp180 -160.09 -176.22 5.53 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.059 177.188 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.684 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -139.39 160.36 25.94 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 3.4 m-20 -78.95 128.85 33.82 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 118.145 -1.422 . . . . 0.0 108.048 177.695 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.646 ' CB ' ' HB2' ' A' ' 2' ' ' ALA . 22.8 tp -92.77 103.55 15.9 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.951 1.358 . . . . 0.0 112.503 -175.409 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.751 ' HB2' HG23 ' A' ' 38' ' ' ILE . 73.9 m95 -93.05 110.05 21.52 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.701 175.17 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 17' ' ' ILE . 87.1 mt -81.38 -10.53 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -170.261 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 5.4 mt -154.32 78.42 1.09 Allowed 'General case' 0 C--N 1.255 -3.519 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.274 -173.734 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 148.1 11.19 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.454 -1.699 . . . . 0.0 112.219 178.494 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.19 -17.86 28.3 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 177.225 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.75 161.61 39.52 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.608 178.596 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -105.42 150.94 39.55 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.87 179.403 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.22 165.43 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.837 1.024 . . . . 0.0 110.736 175.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.69 -22.13 8.69 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.137 179.62 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.76 83.15 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.193 179.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.5 -13.4 59.13 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.963 179.764 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.47 55.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.091 177.006 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.634 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.9 m-85 -75.75 168.0 20.84 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.241 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.0 p -162.85 -45.08 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 111.966 -2.379 . . . . 0.0 105.654 175.893 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 14.9 p -98.97 113.51 25.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.893 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -138.0 150.7 47.21 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.522 -1.271 . . . . 0.0 113.215 179.318 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -106.01 151.24 24.88 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.065 176.358 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 38' ' ' ILE . 34.1 m-85 -129.03 145.31 51.29 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.207 -172.701 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 78.02 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.224 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.447 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.76 152.95 0.42 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.426 -175.284 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -73.58 -1.81 14.14 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.444 -1.065 . . . . 0.0 110.64 -5.516 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.888 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.3 OUTLIER -94.16 -166.14 1.44 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.654 1.216 . . . . 0.0 111.524 -178.132 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -172.4 139.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.36 178.772 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 57.7 m -109.7 102.89 11.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 171.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.634 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.9 t -79.01 142.97 36.13 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.558 -171.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -116.86 165.45 15.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.553 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -77.31 160.08 94.4 Favored 'Cis proline' 0 C--O 1.214 -0.691 0 CA-C-O 122.771 1.071 . . . . 0.0 114.27 4.249 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.432 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.34 177.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.515 2.806 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.96 20.67 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 107.924 -1.606 . . . . 0.0 107.924 163.604 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.9 p -79.95 116.76 20.27 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.917 -178.551 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -80.89 -167.65 1.49 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.766 -173.383 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -175.98 3.7 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.78 176.674 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m -80.74 115.73 20.39 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.205 -178.626 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.7 -13.74 64.91 Favored Glycine 0 C--N 1.296 -1.668 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.237 -179.415 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -111.72 108.62 55.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -73.14 156.89 51.23 Favored 'Trans proline' 0 CA--C 1.507 -0.866 0 C-N-CA 120.999 1.132 . . . . 0.0 109.372 176.371 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.91 -90.56 0.57 Allowed Glycine 0 N--CA 1.484 1.862 1 N-CA-C 130.544 6.977 . . . . 0.0 130.544 -178.517 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.44 156.59 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.597 178.485 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.761 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -149.74 167.98 29.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 175.647 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -82.54 129.42 34.92 Favored 'General case' 0 C--O 1.178 -2.684 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.809 178.695 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 16.6 tp -96.62 106.6 18.89 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.909 1.338 . . . . 0.0 111.575 -178.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.628 ' HB2' HG23 ' A' ' 38' ' ' ILE . 69.4 m95 -93.47 108.95 20.55 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-N 111.79 -2.459 . . . . 0.0 107.021 176.349 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 17' ' ' ILE . 78.2 mt -83.15 -4.81 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.52 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 mt -151.67 80.24 1.28 Allowed 'General case' 0 C--N 1.253 -3.612 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.604 -174.598 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -172.19 159.37 4.81 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.659 177.678 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.67 -26.06 3.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 175.224 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 p -128.99 149.09 50.97 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.191 176.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 153.26 39.65 Favored Pre-proline 0 C--N 1.287 -2.112 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.298 -179.346 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.9 Cg_exo -55.3 99.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.857 1.038 . . . . 0.0 111.099 -178.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.06 6.23 4.13 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.291 -1.433 . . . . 0.0 109.756 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -100.24 -17.06 25.77 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.42 -86.27 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.976 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.57 -16.51 0.02 OUTLIER Glycine 0 C--N 1.287 -2.153 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.894 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.647 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 36.7 m-85 -56.18 167.16 0.68 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.702 -178.693 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 28' ' ' TYR . 4.8 p -162.89 -43.93 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 112.337 -2.211 . . . . 0.0 106.094 177.453 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 78.0 p -96.85 116.99 30.12 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.236 -179.952 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.59 155.28 40.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 117.953 -1.499 . . . . 0.0 113.917 -177.835 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -99.4 158.52 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.851 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.773 ' CE2' HD12 ' A' ' 38' ' ' ILE . 44.0 m-85 -138.58 133.64 32.77 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.909 -176.493 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.79 84.3 0.68 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.766 178.413 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.485 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -49.05 157.34 0.81 Allowed Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.656 -177.469 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.528 ' C ' HD22 ' A' ' 37' ' ' ASN . 1.1 Cg_endo -71.16 0.99 7.29 Favored 'Cis proline' 0 C--O 1.206 -1.076 0 C-N-CA 124.277 -1.134 . . . . 0.0 111.042 -3.912 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.944 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.2 OUTLIER -105.74 -165.6 1.12 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.691 1.234 . . . . 0.0 111.774 -177.042 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.773 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -172.25 143.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.131 -1.85 . . . . 0.0 107.314 178.735 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.2 m -113.61 109.58 18.84 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.208 174.228 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.647 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -89.62 140.81 29.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.963 -171.997 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -116.45 169.94 6.51 Favored Pre-proline 0 N--CA 1.503 2.214 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.196 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -81.24 156.49 82.89 Favored 'Cis proline' 0 CA--C 1.507 -0.864 0 CA-C-O 123.03 1.179 . . . . 0.0 114.384 3.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.979 0 CA-C-N 111.599 -2.546 . . . . 0.0 109.607 174.779 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -84.28 40.51 0.88 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 107.806 -1.652 . . . . 0.0 107.806 166.126 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.93 125.39 29.31 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.847 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.97 168.6 19.64 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.413 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.485 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -127.95 -175.24 3.42 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.951 -179.19 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -74.91 125.52 29.02 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.34 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.53 -2.06 24.69 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.615 -1.278 . . . . 0.0 111.043 178.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -126.4 115.24 23.29 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.94 -179.58 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.4 -175.98 3.01 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 108.16 -1.515 . . . . 0.0 108.16 171.05 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.96 -109.08 3.74 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.735 179.171 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.709 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 4.0 ptm180 -159.51 157.29 29.71 Favored 'General case' 0 C--O 1.207 -1.177 0 C-N-CA 118.58 -1.248 . . . . 0.0 112.791 -178.682 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.36 143.12 13.14 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.348 176.309 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -77.6 127.87 33.19 Favored 'General case' 0 C--O 1.172 -3.011 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.593 179.69 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.427 HD12 ' H ' ' A' ' 16' ' ' TRP . 51.2 tp -86.1 129.5 34.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.825 -1.55 . . . . 0.0 111.186 -179.505 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CB ' HG23 ' A' ' 38' ' ' ILE . 55.8 m95 -124.59 159.38 30.82 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.102 -178.136 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -84.03 -163.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.452 -177.44 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 70.59 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.131 1.443 . . . . 0.0 108.605 -176.459 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.8 mtp180 -102.12 133.7 46.54 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.474 178.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -60.23 -53.0 49.25 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.73 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.95 158.74 39.43 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.607 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.2 147.94 73.69 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.636 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.35 130.46 39.96 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.775 0.983 . . . . 0.0 111.391 -177.122 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.93 -17.86 58.89 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 178.566 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.98 -14.74 68.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -86.68 -70.54 0.6 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.347 179.632 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.95 -14.12 0.07 OUTLIER Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.128 -1.511 . . . . 0.0 111.751 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 51.4 m-85 -56.25 169.33 0.43 Allowed 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 122.656 1.217 . . . . 0.0 111.778 -179.385 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 28' ' ' TYR . 7.3 p -162.57 -45.43 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 112.298 -2.228 . . . . 0.0 106.604 177.131 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 41' ' ' TYR . 82.9 p -98.37 112.13 24.24 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 112.89 -1.959 . . . . 0.0 110.082 -178.693 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.631 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.16 156.28 42.41 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.584 -1.246 . . . . 0.0 112.712 -179.092 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 145.76 40.39 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.575 177.771 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.662 ' CE2' HD12 ' A' ' 38' ' ' ILE . 20.6 m-85 -118.82 126.55 52.08 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.874 -172.525 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 16.7 mttt -122.77 67.19 0.96 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.301 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.458 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 33.3 t-105 -34.8 142.69 0.23 Allowed Pre-proline 0 N--CA 1.496 1.85 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.405 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.42 44.33 0.32 Allowed 'Cis proline' 0 N--CA 1.494 1.537 0 C-N-CA 125.62 -0.575 . . . . 0.0 111.487 -5.564 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.469 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -150.79 -157.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.329 178.15 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.662 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -173.95 138.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.99 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.681 -179.892 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 49.1 m -110.76 123.86 50.87 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 117.463 -1.695 . . . . 0.0 106.518 168.535 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.9 t -94.03 141.62 28.33 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.711 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -114.23 179.71 0.74 Allowed Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 176.722 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.535 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.0 Cg_exo -57.34 -56.15 0.09 OUTLIER 'Cis proline' 0 N--CA 1.503 2.054 0 CA-C-N 122.434 1.905 . . . . 0.0 116.95 6.065 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.709 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.475 0 CA-C-O 116.282 -1.818 . . . . 0.0 109.182 -170.669 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.514 2.764 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -84.17 21.87 1.01 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 N-CA-C 107.793 -1.657 . . . . 0.0 107.793 164.245 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 1.7 p -83.51 118.33 23.71 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.083 -176.788 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -175.42 4.69 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.213 -176.043 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -123.38 -174.44 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 177.308 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.89 110.52 15.33 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.609 -178.313 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.68 73.14 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.517 179.715 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.2 112.79 34.36 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.435 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -71.75 -159.26 0.07 OUTLIER 'Trans proline' 0 C--O 1.213 -0.77 0 N-CA-C 109.144 -1.137 . . . . 0.0 109.144 173.376 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.0 -106.21 2.43 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.901 177.966 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.726 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.54 177.23 9.64 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.096 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.726 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -154.07 175.83 32.17 Favored Glycine 0 N--CA 1.504 3.17 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.469 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.5 m-20 -91.12 126.13 36.12 Favored 'General case' 0 C--O 1.182 -2.465 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.817 177.683 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 13.7 tp -97.12 102.61 14.42 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.038 1.399 . . . . 0.0 111.958 -177.398 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.841 ' HB2' HG23 ' A' ' 38' ' ' ILE . 79.3 m95 -88.98 123.97 33.82 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-N 111.758 -2.473 . . . . 0.0 107.112 175.854 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 17' ' ' ILE . 51.3 mt -90.4 -7.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.247 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -168.888 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -150.36 74.83 1.2 Allowed 'General case' 0 C--N 1.254 -3.558 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.264 -173.354 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.63 151.21 1.85 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.559 178.366 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.597 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -101.98 -24.41 8.58 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 173.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 157.13 38.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.565 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -82.28 172.55 9.31 Favored Pre-proline 0 CA--C 1.58 2.109 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.065 -178.38 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.8 Cg_exo -52.22 -139.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.085 2.524 . . . . 0.0 114.557 -170.692 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.87 114.23 2.57 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 176.189 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.94 80.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.25 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.405 ' HD1' ' H ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -100.34 -51.53 3.62 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 122.15 0.976 . . . . 0.0 111.606 -175.892 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' H ' ' HD1' ' A' ' 26' ' ' TYR . . . 138.96 -19.23 3.11 Favored Glycine 0 C--N 1.281 -2.515 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -174.126 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.587 ' O ' HG23 ' A' ' 29' ' ' THR . 33.8 m-85 -72.74 173.95 8.34 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 122.558 1.171 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.0 p -162.05 -42.66 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.133 177.172 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.4 p -96.69 126.28 41.75 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.031 178.178 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.439 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -154.74 153.2 30.87 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 117.644 -1.622 . . . . 0.0 113.832 -179.422 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.4 p -114.24 153.87 28.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.781 174.961 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.833 ' CD2' HD12 ' A' ' 38' ' ' ILE . 14.7 m-85 -130.95 130.86 43.97 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.955 -175.701 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -134.67 74.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.577 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -46.1 153.49 0.68 Allowed Pre-proline 0 C--N 1.298 -1.671 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.48 -174.419 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.5 -0.18 12.67 Favored 'Cis proline' 0 C--O 1.204 -1.223 0 C-N-CA 124.11 -1.204 . . . . 0.0 110.842 -4.195 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.91 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.3 OUTLIER -96.43 -168.12 1.68 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.952 0.882 . . . . 0.0 110.758 -179.008 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -169.38 141.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 114.372 -1.285 . . . . 0.0 108.679 -179.882 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 56.5 m -110.05 97.21 6.76 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.209 -1.396 . . . . 0.0 107.553 172.958 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.583 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -81.36 127.95 33.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.587 -173.348 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -100.04 171.62 5.39 Favored Pre-proline 0 N--CA 1.514 2.757 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.222 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.1 Cg_endo -84.36 158.1 68.52 Favored 'Cis proline' 0 CA--C 1.507 -0.83 0 CA-C-O 123.246 1.269 . . . . 0.0 114.643 1.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.914 0 CA-C-N 111.271 -2.695 . . . . 0.0 109.744 174.435 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.511 2.603 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -90.43 31.32 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 109.039 -1.177 . . . . 0.0 109.039 166.763 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.34 130.57 36.33 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -175.218 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.52 165.48 23.68 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.313 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -110.93 180.0 3.89 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.326 177.275 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.1 103.14 13.84 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.118 -178.659 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.04 18.16 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -178.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.06 117.42 9.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.958 -179.05 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -78.11 170.24 19.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 N-CA-C 108.534 -1.372 . . . . 0.0 108.534 172.09 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.57 -96.35 1.06 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.795 178.803 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.78 152.25 19.34 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.556 -1.657 . . . . 0.0 114.455 -178.143 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.28 155.31 23.37 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 174.312 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.651 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -79.52 119.13 22.07 Favored 'General case' 0 C--O 1.169 -3.161 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.365 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 17.0 tp -85.77 93.3 8.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.889 -177.654 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.811 ' HB2' HG23 ' A' ' 38' ' ' ILE . 72.6 m95 -74.24 126.33 30.38 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 112.706 -2.043 . . . . 0.0 107.106 172.211 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 17' ' ' ILE . 11.6 mt -94.41 -8.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -169.723 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -152.71 55.64 0.79 Allowed 'General case' 0 C--N 1.261 -3.25 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 -173.602 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.53 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -133.96 157.08 46.96 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.563 -179.327 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.55 -32.32 2.15 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 174.262 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.27 150.43 52.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.58 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -85.92 145.18 40.51 Favored Pre-proline 0 C--N 1.284 -2.264 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.737 -178.861 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.96 -174.76 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 120.865 1.043 . . . . 0.0 111.323 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.06 13.3 9.09 Favored Glycine 0 N--CA 1.484 1.889 1 N-CA-C 128.912 6.325 . . . . 0.0 128.912 177.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.35 -14.73 27.33 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -79.42 -21.17 45.93 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.126 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.46 61.23 Favored Glycine 0 C--N 1.292 -1.862 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.086 179.326 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 43.5 m-85 -56.43 164.34 1.42 Allowed 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 117.967 -1.493 . . . . 0.0 110.934 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -163.16 -45.06 0.03 OUTLIER 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.41 -2.177 . . . . 0.0 106.112 177.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.7 p -99.73 110.7 23.08 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.651 -2.068 . . . . 0.0 109.385 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.678 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -142.84 147.15 34.93 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.338 -1.345 . . . . 0.0 113.349 -179.007 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 14.5 p -99.57 143.7 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.2 175.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.849 ' CE2' HD12 ' A' ' 38' ' ' ILE . 61.8 m-85 -119.58 139.12 52.66 Favored 'General case' 0 C--N 1.275 -2.64 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.86 -173.273 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.6 mttt -137.07 60.91 1.64 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.145 176.742 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' LYS . 1.2 t90 -35.06 143.67 0.23 Allowed Pre-proline 0 N--CA 1.497 1.886 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.079 -177.901 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.17 -1.3 10.47 Favored 'Cis proline' 0 N--CA 1.486 1.07 0 C-N-CA 125.106 -0.789 . . . . 0.0 111.469 -4.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.69 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -95.55 -162.44 0.95 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.546 0.689 . . . . 0.0 110.881 -178.416 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.849 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 175.66 137.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.852 -179.414 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 20.6 m -107.65 121.6 45.01 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 117.718 -1.593 . . . . 0.0 106.976 170.174 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -100.27 139.17 36.32 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -169.305 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.577 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -115.31 166.01 12.96 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.268 177.756 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.69 160.32 87.65 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 CA-C-O 122.842 1.101 . . . . 0.0 113.918 5.327 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.577 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.573 0 CA-C-N 112.155 -2.293 . . . . 0.0 109.679 176.124 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -91.15 27.84 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.3 1.333 . . . . 0.0 108.825 167.443 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.596 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -70.39 126.21 28.99 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.802 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -77.47 166.95 22.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 117.712 -1.595 . . . . 0.0 110.653 -177.188 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.52 -179.39 4.75 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.639 0.733 . . . . 0.0 110.203 179.12 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 9' ' ' LYS . 86.2 p -72.1 142.48 49.19 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.427 -179.081 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.86 -10.76 1.07 Allowed Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.634 178.642 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 7' ' ' SER . 4.5 mttt -136.48 113.26 10.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.484 -179.409 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -77.1 -165.72 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 172.795 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -88.1 1.55 Allowed Glycine 0 C--N 1.289 -2.078 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.05 176.447 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.532 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -160.65 154.64 22.81 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 117.827 -1.549 . . . . 0.0 114.069 -175.476 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.1 149.98 21.88 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 172.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 125.64 29.61 Favored 'General case' 0 C--O 1.17 -3.121 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.85 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.63 110.83 20.68 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 116.925 -1.91 . . . . 0.0 112.274 -177.983 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.67 ' CB ' HG23 ' A' ' 38' ' ' ILE . 58.0 m95 -96.23 175.51 6.42 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 112.471 -2.15 . . . . 0.0 109.201 176.64 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -102.38 -158.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.769 -176.854 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -66.69 73.49 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.741 1.734 . . . . 0.0 108.201 -176.374 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.2 mtt-85 -133.82 97.01 3.79 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.845 178.994 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.45 -5.05 0.68 Allowed Glycine 0 N--CA 1.486 1.984 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.608 -179.646 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 19' ' ' ARG . 1.6 p -137.53 151.9 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.221 179.823 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -103.8 142.86 25.46 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.3 179.108 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.408 ' CG ' ' CH2' ' A' ' 16' ' ' TRP . 5.8 Cg_exo -55.88 144.64 76.87 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.004 1.136 . . . . 0.0 111.305 179.595 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.79 -2.75 78.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.706 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.49 -19.76 70.6 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.587 -179.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -87.09 -12.04 48.38 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.027 -179.168 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.89 76.66 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.612 176.639 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.628 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.9 m-85 -56.48 174.14 0.15 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.213 179.36 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -161.61 -43.67 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.666 -2.061 . . . . 0.0 106.335 175.783 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.3 p -97.21 133.9 41.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.558 179.335 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.632 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -160.04 157.28 28.39 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.849 178.78 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.41 ' O ' HG13 ' A' ' 38' ' ' ILE . 19.7 p -113.34 142.74 45.5 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.995 176.139 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.797 ' CD2' HD12 ' A' ' 38' ' ' ILE . 11.9 m-85 -120.44 125.31 47.61 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.272 -174.023 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -146.12 81.67 1.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.707 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.452 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.06 157.78 0.15 Allowed Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.461 179.672 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.4 Cg_endo -78.34 28.68 1.78 Allowed 'Cis proline' 0 C--O 1.21 -0.903 0 C-N-CA 124.227 -1.156 . . . . 0.0 110.751 -5.209 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.456 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 4.0 m-80 -145.01 -170.26 3.38 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.797 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -154.41 150.12 12.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.773 178.822 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -116.66 158.66 23.42 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 166.282 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -130.52 147.18 52.18 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.518 -1.273 . . . . 0.0 114.103 -170.189 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -118.53 166.91 12.68 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.404 179.734 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.44 158.53 97.26 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 CA-C-O 122.679 1.033 . . . . 0.0 113.94 4.599 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.503 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.502 0 CA-C-N 112.359 -2.201 . . . . 0.0 110.121 177.898 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -81.61 35.27 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 166.179 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.39 123.23 25.65 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.779 -1.168 . . . . 0.0 108.357 -175.25 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.08 179.62 7.24 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.151 -1.42 . . . . 0.0 108.778 179.424 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -179.29 6.11 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.794 -1.162 . . . . 0.0 111.021 178.561 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 p -74.07 128.27 35.08 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.293 -176.146 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -8.48 3.99 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.005 178.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.51 107.08 41.4 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.18 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -72.07 -173.51 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.078 1.185 . . . . 0.0 109.854 174.717 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.69 -112.36 3.84 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.288 178.291 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.58 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 4.3 ptm180 -152.56 166.25 32.61 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.503 -177.18 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.68 146.78 18.11 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 174.356 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -77.12 117.82 19.06 Favored 'General case' 0 C--O 1.179 -2.615 0 C-N-CA 118.989 -1.085 . . . . 0.0 108.272 178.896 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.21 112.59 19.99 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 116.387 -2.125 . . . . 0.0 112.441 -178.684 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.702 ' CB ' HG23 ' A' ' 38' ' ' ILE . 57.2 m95 -94.71 174.26 7.19 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 112.144 -2.298 . . . . 0.0 106.659 173.15 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.691 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -96.56 -158.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 C-N-CA 118.651 -1.219 . . . . 0.0 113.02 -174.376 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.94 72.91 0.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 123.619 1.676 . . . . 0.0 108.221 -177.063 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ILE . 5.2 mtp85 -131.84 97.53 4.21 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 111.637 -2.529 . . . . 0.0 109.729 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.53 -22.98 1.18 Allowed Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.019 -179.516 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.427 ' N ' ' C ' ' A' ' 19' ' ' ARG . 1.1 p -130.4 152.31 49.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.983 179.524 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 173.07 8.09 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.35 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 14.9 Cg_endo -67.0 98.9 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.576 1.517 . . . . 0.0 113.364 -174.614 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' PRO . . . -30.85 101.11 0.01 OUTLIER Glycine 0 N--CA 1.512 3.758 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.573 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.78 68.58 0.66 Allowed Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.703 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -117.52 -172.56 2.25 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.189 0.519 . . . . 0.0 110.683 -177.471 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.86 -18.3 54.64 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 172.784 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 23.1 m-85 -69.94 177.72 3.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.956 1.36 . . . . 0.0 112.476 178.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.7 p -161.55 -44.36 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.759 -2.473 . . . . 0.0 105.475 176.4 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.21 114.69 27.02 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.751 178.517 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.541 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.52 151.85 49.87 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 118.55 -1.26 . . . . 0.0 112.819 178.558 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.35 146.18 43.56 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.766 176.721 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.882 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.2 m-85 -126.27 136.21 52.5 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.222 -174.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -147.12 79.79 1.51 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.588 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.445 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.75 159.05 0.21 Allowed Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.135 -178.154 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.498 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 10.1 Cg_endo -81.15 32.29 2.28 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.542 -1.024 . . . . 0.0 111.635 -3.725 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.0 m-80 -148.98 171.17 16.79 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.411 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.882 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -131.62 152.31 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.832 178.35 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 28.9 m -123.46 110.23 14.84 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.014 -1.475 . . . . 0.0 107.523 167.58 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -83.79 133.41 34.77 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.02 -174.31 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -102.89 -173.85 0.31 Allowed Pre-proline 0 N--CA 1.517 2.919 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.647 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.8 Cg_exo -62.56 -48.58 0.18 OUTLIER 'Cis proline' 0 N--CA 1.508 2.348 0 CA-C-N 122.653 1.983 . . . . 0.0 116.497 3.958 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.608 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.987 0 CA-C-O 116.481 -1.724 . . . . 0.0 109.244 -171.382 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.501 2.1 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -81.22 27.77 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 N-CA-C 108.022 -1.569 . . . . 0.0 108.022 164.001 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.3 p -87.95 120.3 29.15 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.097 -177.608 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.658 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -82.52 -175.13 5.58 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.111 -173.379 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.44 -176.39 5.57 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.703 176.073 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.7 t -78.92 113.34 16.94 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.584 -177.728 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.23 67.58 Favored Glycine 0 C--N 1.296 -1.65 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -112.25 136.01 21.37 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.802 -178.904 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 9' ' ' LYS . 2.9 Cg_exo -48.74 -166.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.602 2.201 . . . . 0.0 114.244 -173.063 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.94 24.73 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.062 -174.543 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 10' ' ' PRO . 8.2 ptm180 -161.36 146.91 13.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 116.695 -2.002 . . . . 0.0 114.612 176.862 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -160.65 173.59 37.2 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 176.088 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -84.31 135.0 34.49 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.974 179.89 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.63 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 36.3 tp -96.59 133.62 40.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.358 1.075 . . . . 0.0 110.114 -179.62 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.622 ' CB ' HG23 ' A' ' 38' ' ' ILE . 64.9 m95 -135.08 151.37 50.69 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 112.899 -1.955 . . . . 0.0 108.047 -177.483 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.891 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -78.56 -157.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.835 -175.562 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.74 67.44 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.017 1.389 . . . . 0.0 108.235 -176.8 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -103.82 112.16 25.0 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.102 -178.972 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -23.52 57.18 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.382 -1.39 . . . . 0.0 109.789 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.85 156.47 40.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.982 178.631 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -91.65 149.82 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.918 179.263 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.91 128.52 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.972 1.115 . . . . 0.0 111.452 -177.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.36 6.95 55.87 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.01 179.489 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.51 -7.23 16.44 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.386 -179.975 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.55 -35.77 39.37 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.798 179.604 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.93 -13.07 6.44 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.642 178.367 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 42.9 m-85 -60.7 170.55 1.42 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.744 -179.136 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 28' ' ' TYR . 10.3 p -161.46 -44.96 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 112.319 -2.219 . . . . 0.0 106.038 178.438 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.4 129.8 44.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.714 179.379 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.82 157.3 28.99 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.922 -1.511 . . . . 0.0 112.438 178.266 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 142.19 47.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.141 177.173 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.695 ' CE2' HD12 ' A' ' 38' ' ' ILE . 21.3 m-85 -117.77 124.62 48.89 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.813 -172.735 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.9 81.06 1.67 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.195 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.449 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.98 159.62 0.13 Allowed Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.883 -178.775 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -77.76 23.06 3.76 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.127 -1.197 . . . . 0.0 110.721 -5.208 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.44 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.8 m-80 -140.76 175.76 9.35 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.968 179.663 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -136.2 145.83 30.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.523 177.355 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.9 m -115.07 115.69 27.21 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 117.688 -1.605 . . . . 0.0 107.087 169.844 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -87.91 160.37 17.97 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.598 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 30' ' ' SER . 5.7 m-85 -132.62 161.9 60.56 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.139 179.185 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -85.95 160.32 58.35 Favored 'Cis proline' 0 C--N 1.325 -0.708 0 N-CA-C 115.209 1.196 . . . . 0.0 115.209 5.412 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.038 0 CA-C-N 112.02 -2.354 . . . . 0.0 109.588 175.57 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.88 51.9 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 170.962 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -69.26 141.36 54.41 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -174.396 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -78.38 173.29 12.49 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 117.984 -1.486 . . . . 0.0 108.909 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.33 -168.18 1.28 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.191 -178.656 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 9' ' ' LYS . 4.5 m -65.35 113.63 4.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.107 -177.991 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.8 -3.12 0.73 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.807 179.131 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 7' ' ' SER . 22.3 mttt -93.81 120.95 65.46 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 118.296 -1.362 . . . . 0.0 111.156 -178.99 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -71.11 155.93 60.51 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 N-CA-C 109.386 -1.044 . . . . 0.0 109.386 174.321 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -116.54 3.55 Favored Glycine 0 N--CA 1.482 1.724 1 N-CA-C 129.591 6.596 . . . . 0.0 129.591 -178.008 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.62 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.9 149.33 16.21 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.627 -1.229 . . . . 0.0 112.343 178.683 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . -135.3 158.26 23.55 Favored Glycine 0 C--O 1.195 -2.297 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 172.909 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -77.61 113.63 15.64 Favored 'General case' 0 C--O 1.176 -2.776 0 C-N-CA 118.364 -1.334 . . . . 0.0 108.245 178.871 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 5.4 tt -83.35 85.74 7.18 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 116.715 -1.994 . . . . 0.0 112.826 -176.461 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.846 ' HB2' HG23 ' A' ' 38' ' ' ILE . 68.6 m95 -59.43 131.06 49.82 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.199 171.861 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.37 -5.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.017 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -171.021 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 mt -148.92 57.24 1.03 Allowed 'General case' 1 C--N 1.241 -4.115 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.335 -173.399 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -159.95 164.16 33.61 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.406 -1.718 . . . . 0.0 112.315 179.798 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.02 -16.24 5.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 176.144 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 155.5 40.54 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.668 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -103.13 144.44 28.64 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.062 178.518 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.94 130.68 41.13 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.777 0.984 . . . . 0.0 111.516 -178.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.2 -18.5 78.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 177.941 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -13.43 83.64 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.54 -62.04 1.81 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.053 179.933 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.77 -15.19 0.81 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 118.892 -1.623 . . . . 0.0 111.994 178.316 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.626 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.8 m-85 -61.44 170.52 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.708 1.242 . . . . 0.0 112.423 -178.704 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -160.89 -44.87 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 112.123 -2.308 . . . . 0.0 105.917 177.612 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 41' ' ' TYR . 67.9 p -96.04 113.0 24.57 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.859 179.222 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.27 151.24 33.88 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.217 -1.393 . . . . 0.0 113.582 -177.422 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -101.16 140.88 34.84 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.3 175.025 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.843 ' CD2' HD12 ' A' ' 38' ' ' ILE . 72.9 m-85 -120.76 134.8 55.27 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.405 -174.125 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -149.43 66.89 1.01 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.938 178.779 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.455 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 12.1 t-105 -30.55 147.22 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.01 178.564 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.6 Cg_endo -71.37 2.74 6.77 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 C-N-CA 125.368 -0.68 . . . . 0.0 112.31 -5.321 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.561 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -110.19 -165.37 1.0 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.945 0.879 . . . . 0.0 111.693 -176.941 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.846 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -178.26 130.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.349 179.541 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -108.42 109.44 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.526 -1.67 . . . . 0.0 107.349 174.202 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.8 t -87.93 134.72 33.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.484 -2.143 . . . . 0.0 114.214 -168.602 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.54 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.7 m-85 -106.56 -178.53 0.6 Allowed Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 178.086 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.3 Cg_exo -55.85 -59.26 0.03 OUTLIER 'Cis proline' 0 N--CA 1.506 2.255 0 N-CA-C 117.618 2.122 . . . . 0.0 117.618 5.981 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.499 0 CA-C-O 116.337 -1.792 . . . . 0.0 108.924 -169.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -44.95 139.15 3.96 Favored Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.95 39.01 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 109.08 -1.161 . . . . 0.0 109.08 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.41 121.23 22.75 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.838 -175.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 8.4 m-85 -78.23 163.5 25.72 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 117.956 -1.498 . . . . 0.0 109.776 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.93 175.27 8.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.092 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -81.81 116.51 21.53 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.859 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -15.18 63.89 Favored Glycine 0 C--N 1.296 -1.643 0 C-N-CA 119.452 -1.356 . . . . 0.0 109.934 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -130.1 111.67 17.0 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.208 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -74.46 -175.31 2.18 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 N-CA-C 109.079 -1.162 . . . . 0.0 109.079 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.19 -104.67 3.21 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 6.2 ptm180 -160.21 165.4 31.59 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.173 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.13 149.94 20.72 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 173.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -77.22 124.51 27.94 Favored 'General case' 0 C--O 1.166 -3.314 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.29 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 tp -84.69 111.07 19.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.037 -1.865 . . . . 0.0 112.543 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.691 ' CB ' HG23 ' A' ' 38' ' ' ILE . 65.6 m95 -100.64 171.72 7.53 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.675 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.548 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.32 -161.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.722 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.99 70.89 0.15 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.298 1.523 . . . . 0.0 108.087 -177.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.565 ' C ' ' H ' ' A' ' 21' ' ' THR . 47.7 mtp180 -115.96 -13.02 11.29 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 112.11 -2.314 . . . . 0.0 110.9 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 48.3 4.67 0.02 OUTLIER Glycine 0 C--N 1.263 -3.511 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.38 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -151.92 154.88 36.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.17 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -116.13 151.19 46.37 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.028 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.69 106.12 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 120.721 0.947 . . . . 0.0 110.908 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.31 89.96 1.01 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.42 -11.06 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.212 -1.47 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.61 -18.76 40.08 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.25 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.59 -16.88 2.24 Favored Glycine 0 N--CA 1.482 1.736 0 C-N-CA 119.51 -1.328 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 29.2 m-85 -77.3 167.73 21.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.992 1.377 . . . . 0.0 112.624 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.3 p -162.59 -46.05 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.749 -2.478 . . . . 0.0 105.65 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' TYR . 70.0 p -98.73 124.41 43.57 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.548 -2.114 . . . . 0.0 110.19 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -148.41 156.09 42.05 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.337 178.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.39 147.22 39.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.88 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.829 ' CE2' HD12 ' A' ' 38' ' ' ILE . 7.3 m-85 -127.92 131.26 49.38 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.485 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 77.66 1.62 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.49 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.81 158.94 0.27 Allowed Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.151 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.1 Cg_endo -78.89 35.25 0.8 Allowed 'Cis proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.351 -1.104 . . . . 0.0 112.54 -5.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 4.0 m-80 -147.73 -166.47 2.53 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.228 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.829 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -156.63 147.84 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.511 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.8 m -117.35 136.31 53.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 166.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -107.09 140.04 40.55 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -170.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.3 m-85 -107.83 176.71 1.51 Allowed Pre-proline 0 N--CA 1.509 2.507 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 7.8 Cg_exo -58.99 -53.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.164 0 N-CA-C 117.196 1.96 . . . . 0.0 117.196 5.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.622 0 CA-C-O 116.468 -1.729 . . . . 0.0 109.179 -170.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -57.9 138.09 83.25 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -77.96 35.28 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.6 124.0 29.15 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -176.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 164.57 25.15 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.724 -1.591 . . . . 0.0 110.276 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.2 m -109.17 -178.7 3.64 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.306 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.14 111.45 17.59 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.991 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.18 -12.31 48.47 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.471 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.51 115.1 14.68 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.127 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -161.58 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.89 -93.52 1.6 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.154 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.585 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.98 160.06 30.24 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.256 -1.378 . . . . 0.0 112.744 -178.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -145.63 141.96 10.24 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 42.3 m-20 -75.33 125.5 29.1 Favored 'General case' 0 C--O 1.175 -2.846 0 C-N-CA 118.217 -1.393 . . . . 0.0 108.135 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -84.15 132.79 34.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 116.931 -1.908 . . . . 0.0 111.448 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.659 ' CB ' HG23 ' A' ' 38' ' ' ILE . 55.7 m95 -124.88 175.65 7.15 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.481 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.672 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -99.33 -162.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.136 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.441 -176.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.22 67.36 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.343 1.544 . . . . 0.0 108.343 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.8 mtp85 -103.81 128.88 51.22 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.1 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.3 -49.44 60.09 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.204 -1.474 . . . . 0.0 109.468 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.33 161.37 38.06 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.954 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.36 150.33 76.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.217 179.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.95 129.18 31.99 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 120.937 1.091 . . . . 0.0 110.667 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 26' ' ' TYR . . . -74.18 -48.16 15.87 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.833 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.32 -9.03 0.57 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.397 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.5 m-85 -79.52 -75.97 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.197 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.2 -13.24 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.002 -1.571 . . . . 0.0 112.08 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.632 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 53.4 m-85 -66.25 172.31 4.01 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 122.618 1.199 . . . . 0.0 112.688 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -161.93 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.312 -2.222 . . . . 0.0 106.354 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -97.56 118.87 35.02 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.429 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.472 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.94 158.47 44.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.044 -1.463 . . . . 0.0 112.884 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.416 ' O ' HG13 ' A' ' 38' ' ' ILE . 26.2 p -113.06 147.64 36.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.49 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.606 ' CE2' HD12 ' A' ' 38' ' ' ILE . 40.4 m-85 -122.19 117.51 26.38 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.5 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 31.8 mttp -130.87 75.24 1.64 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.877 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.468 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -41.45 156.02 0.22 Allowed Pre-proline 0 C--N 1.3 -1.581 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.437 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.6 Cg_endo -78.56 28.71 1.88 Allowed 'Cis proline' 0 C--O 1.206 -1.117 0 C-N-CA 124.167 -1.18 . . . . 0.0 112.123 -3.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.2 m-80 -144.98 -160.15 1.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.232 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.672 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -160.93 154.32 3.9 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.046 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.843 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.522 ' N ' HG13 ' A' ' 38' ' ' ILE . 80.4 m -124.56 116.61 22.73 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 117.903 -1.519 . . . . 0.0 107.104 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.632 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.15 148.64 25.59 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.531 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -120.19 167.81 11.8 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -73.95 159.26 97.87 Favored 'Cis proline' 0 C--O 1.214 -0.71 0 CA-C-O 122.788 1.078 . . . . 0.0 113.838 3.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.191 -2.277 . . . . 0.0 109.928 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -60.74 154.81 55.49 Favored Pre-proline 0 N--CA 1.498 1.939 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.085 -178.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -91.22 40.63 0.35 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 109.929 -0.835 . . . . 0.0 109.929 168.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -77.09 126.97 31.84 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.128 -176.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.37 167.2 21.7 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.832 -179.002 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -175.68 2.78 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.9 177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.0 123.22 26.02 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.236 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.0 -11.69 47.03 Favored Glycine 0 C--N 1.299 -1.476 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.735 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -116.47 109.5 43.85 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.433 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.41 -167.7 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 107.684 -1.698 . . . . 0.0 107.684 172.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.71 -111.67 3.75 Favored Glycine 0 C--N 1.283 -2.381 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.378 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -156.11 154.98 31.77 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 118.245 -1.382 . . . . 0.0 114.189 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.07 153.64 23.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -78.97 125.74 29.78 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.971 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 22.7 tp -85.98 108.15 18.08 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.966 -1.494 . . . . 0.0 111.893 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.698 ' CB ' HG23 ' A' ' 38' ' ' ILE . 60.3 m95 -95.16 176.79 6.09 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.616 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -100.14 -162.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.221 -176.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.575 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.87 70.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.288 1.518 . . . . 0.0 108.27 -176.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' ILE . 40.6 mtp180 -112.47 115.64 29.0 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.05 -23.87 18.21 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.736 -1.221 . . . . 0.0 110.795 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.73 158.07 42.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.384 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' N ' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -86.34 151.41 53.64 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.837 178.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.6 Cg_exo -50.11 120.94 6.77 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.174 1.249 . . . . 0.0 111.428 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.04 -4.74 4.83 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.512 -1.327 . . . . 0.0 110.29 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -119.72 1.05 13.77 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 130.684 7.034 . . . . 0.0 130.684 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -79.54 -36.43 38.38 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.274 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.84 -17.15 2.19 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.353 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.1 m-85 -60.78 168.95 2.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.303 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.3 p -162.02 -43.0 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 112.283 -2.235 . . . . 0.0 106.418 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.4 p -97.31 121.56 39.34 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.357 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.83 154.8 34.62 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.81 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -110.17 137.84 47.36 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.643 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.665 ' CE2' HD12 ' A' ' 38' ' ' ILE . 38.9 m-85 -113.71 129.93 56.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.553 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -147.77 81.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.149 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.444 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.47 159.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.349 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 4.6 Cg_endo -78.51 28.23 2.01 Favored 'Cis proline' 0 C--O 1.21 -0.879 0 C-N-CA 124.273 -1.136 . . . . 0.0 111.813 -5.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.2 m-80 -147.06 -172.35 3.98 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.709 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.698 HG23 ' CB ' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -154.98 147.92 12.93 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.833 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -116.64 142.53 46.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.714 165.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.5 t -112.63 148.53 34.41 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.499 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -119.86 170.44 6.89 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.15 158.08 83.44 Favored 'Cis proline' 0 CA--C 1.503 -1.039 0 CA-C-O 122.857 1.107 . . . . 0.0 113.661 4.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.966 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.468 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.639 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -40.79 138.72 1.26 Allowed Pre-proline 0 N--CA 1.503 2.181 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.509 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -74.75 57.76 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 107.06 -1.939 . . . . 0.0 107.06 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.59 138.97 45.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.46 -179.13 6.17 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.869 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -162.66 1.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.111 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 9' ' ' LYS . 8.7 m -59.9 110.94 1.29 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.473 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.8 3.67 0.12 Allowed Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.224 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 7' ' ' SER . 61.5 mttt -94.14 116.81 66.88 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.474 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 9.8 Cg_endo -73.69 -166.19 0.3 Allowed 'Trans proline' 0 C--O 1.206 -1.093 0 N-CA-C 109.264 -1.091 . . . . 0.0 109.264 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 -120.33 5.29 Favored Glycine 0 C--N 1.29 -2.001 0 C-N-CA 118.674 -1.726 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.638 HH22 ' CG ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -161.1 162.19 31.47 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 118.185 -1.406 . . . . 0.0 113.42 -178.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.13 148.31 19.93 Favored Glycine 0 C--O 1.199 -2.092 0 N-CA-C 106.917 -2.473 . . . . 0.0 106.917 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.638 ' CG ' HH22 ' A' ' 12' ' ' ARG . 10.1 m-20 -76.62 128.41 34.65 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.632 -1.227 . . . . 0.0 109.142 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 1.1 tt -88.57 98.43 11.65 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 116.962 -1.895 . . . . 0.0 112.087 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.711 ' HB2' HG23 ' A' ' 38' ' ' ILE . 62.0 m95 -77.34 163.86 26.05 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 111.779 -2.464 . . . . 0.0 109.442 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.697 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -85.55 -158.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 118.846 -1.141 . . . . 0.0 111.268 -177.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.67 72.54 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.916 1.341 . . . . 0.0 109.053 -175.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' ILE . 4.1 mtp180 -121.55 110.17 15.69 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.086 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.88 -20.31 40.36 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.657 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.14 153.64 50.44 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.838 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.82 151.26 43.4 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -47.81 112.6 0.59 Allowed 'Trans proline' 0 C--O 1.214 -0.724 0 C-N-CA 120.971 1.114 . . . . 0.0 111.444 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.46 -25.93 55.89 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -22.42 71.91 Favored Glycine 0 N--CA 1.485 1.951 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.456 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.51 175.74 10.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.141 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.27 70.68 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 29' ' ' THR . 41.6 m-85 -59.94 167.92 2.04 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 118.051 -1.459 . . . . 0.0 110.874 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.0 p -163.13 -43.0 0.03 OUTLIER 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.7 -2.045 . . . . 0.0 106.225 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 8.5 p -97.36 118.46 33.88 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.794 -2.003 . . . . 0.0 109.156 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.556 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.08 152.01 36.63 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.876 -1.53 . . . . 0.0 113.52 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.448 ' O ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -101.66 156.05 17.73 Favored 'General case' 0 C--O 1.191 -2.025 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.981 174.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.827 ' CE2' HD12 ' A' ' 38' ' ' ILE . 22.4 m-85 -134.98 125.76 27.24 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.545 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 35' ' ' TRP . 6.4 mttt -137.72 71.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.958 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.468 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 17.0 t-105 -38.82 146.19 0.33 Allowed Pre-proline 0 N--CA 1.508 2.46 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.864 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.488 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 7.3 Cg_endo -78.06 38.44 0.46 Allowed 'Cis proline' 0 N--CA 1.495 1.603 0 CA-C-N 118.52 0.507 . . . . 0.0 111.69 -5.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.532 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -148.09 -168.03 2.97 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.509 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.827 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.03 144.9 3.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.298 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.65 140.37 50.02 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 117.488 -1.685 . . . . 0.0 107.586 169.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -114.62 135.8 53.75 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -169.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -107.96 -179.51 0.71 Allowed Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.555 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 3.0 Cg_exo -64.3 -49.21 0.18 OUTLIER 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 122.036 1.763 . . . . 0.0 116.587 5.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.781 0 CA-C-O 116.28 -1.819 . . . . 0.0 109.565 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -48.86 144.59 7.12 Favored Pre-proline 0 N--CA 1.505 2.317 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.735 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.26 35.46 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 167.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -75.38 142.87 43.03 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -87.36 166.01 15.17 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 117.79 -1.564 . . . . 0.0 109.335 177.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.469 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -108.84 -173.3 2.24 Favored 'General case' 0 N--CA 1.51 2.538 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.727 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -71.07 117.23 12.31 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.921 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.0 -1.59 3.39 Favored Glycine 0 C--N 1.297 -1.589 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.141 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 7' ' ' SER . 5.6 mttt -108.82 118.05 52.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.367 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -74.87 -168.91 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.14 -113.47 4.13 Favored Glycine 0 C--N 1.291 -1.918 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.178 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.685 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 6.5 ptm180 -157.66 163.09 38.58 Favored 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 118.184 -1.407 . . . . 0.0 114.086 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -148.81 151.21 23.41 Favored Glycine 0 N--CA 1.494 2.503 1 N-CA-C 126.364 5.305 . . . . 0.0 126.364 173.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.9 m-20 -77.38 118.57 19.97 Favored 'General case' 0 C--O 1.171 -3.055 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.924 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 48.9 tp -85.7 102.55 13.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.002 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HB2' HG23 ' A' ' 38' ' ' ILE . 58.7 m95 -91.79 165.07 13.46 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 112.3 -2.227 . . . . 0.0 109.968 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -90.61 -159.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.632 -177.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.77 73.87 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.718 1.247 . . . . 0.0 108.793 -174.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -115.26 123.13 48.03 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.317 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.7 -35.27 73.3 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 160.54 42.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.751 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.09 163.54 59.42 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.669 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.51 -164.98 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 121.676 1.584 . . . . 0.0 112.035 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.62 33.56 2.47 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.17 -2.52 1.58 Allowed Glycine 0 N--CA 1.496 2.665 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.789 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.45 -70.71 0.62 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.223 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.33 17.19 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.509 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 43.4 m-85 -76.41 171.13 15.09 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.577 1.179 . . . . 0.0 112.068 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.3 p -161.42 -43.95 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.142 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.24 134.2 40.85 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.123 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -160.04 159.61 32.21 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.887 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.0 p -120.9 133.7 55.29 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.567 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.687 ' CE2' HD12 ' A' ' 38' ' ' ILE . 76.1 m-85 -109.1 114.02 27.39 Favored 'General case' 0 C--N 1.259 -3.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.757 -174.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -129.23 71.86 1.45 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.595 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.521 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.46 155.35 0.19 Allowed Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.259 -178.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.6 Cg_endo -78.45 33.12 0.97 Allowed 'Cis proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.409 -1.08 . . . . 0.0 111.417 -3.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.521 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 3.5 m-80 -147.85 -160.48 1.17 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.805 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -167.87 144.52 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.383 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 8.1 m -113.57 109.29 18.39 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.577 168.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -80.73 139.85 35.88 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.527 -172.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.564 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.9 m-85 -110.97 -177.84 0.49 Allowed Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 19.1 Cg_exo -56.72 -55.43 0.11 OUTLIER 'Cis proline' 0 N--CA 1.505 2.169 0 CA-C-N 122.31 1.861 . . . . 0.0 116.698 5.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.685 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.388 0 CA-C-O 116.379 -1.772 . . . . 0.0 109.228 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.562 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -41.94 143.74 0.94 Allowed Pre-proline 0 N--CA 1.503 2.184 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.96 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.38 57.05 4.67 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 N-CA-C 108.737 -1.293 . . . . 0.0 108.737 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.01 145.95 39.86 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.473 -176.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.71 -175.77 5.45 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.135 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.95 179.82 5.85 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.64 0.733 . . . . 0.0 109.685 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.15 114.43 21.77 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.23 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.65 -10.53 72.53 Favored Glycine 0 C--N 1.295 -1.714 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.955 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -117.24 106.85 46.35 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.872 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.8 146.44 66.14 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.676 -1.317 . . . . 0.0 108.676 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.71 -104.58 0.84 Allowed Glycine 0 C--N 1.285 -2.277 1 N-CA-C 129.814 6.686 . . . . 0.0 129.814 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -161.14 151.35 17.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.761 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.14 166.74 25.65 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.7 m-20 -79.68 114.58 18.71 Favored 'General case' 0 C--O 1.172 -2.982 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.158 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.562 ' N ' ' HB1' ' A' ' 1' ' ' ALA . 10.3 tp -84.13 96.24 8.87 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.091 -1.843 . . . . 0.0 113.205 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.817 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.5 m95 -69.94 145.81 51.63 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 111.818 -2.446 . . . . 0.0 104.837 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -110.25 -8.41 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -168.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 2.2 mt -153.1 59.63 0.78 Allowed 'General case' 0 C--N 1.248 -3.805 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.872 -173.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -154.89 156.32 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.581 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -109.01 -7.88 28.38 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 174.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 157.0 47.26 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.483 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -107.41 149.4 38.74 Favored Pre-proline 0 N--CA 1.494 1.748 0 C-N-CA 119.62 -0.832 . . . . 0.0 108.867 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -66.35 142.06 64.63 Favored 'Trans proline' 0 C--O 1.217 -0.568 0 C-N-CA 120.6 0.866 . . . . 0.0 111.177 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.62 63.5 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.77 -19.28 27.43 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.684 -1.245 . . . . 0.0 110.458 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -79.49 -34.59 41.19 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.958 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.95 -3.03 19.41 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.303 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.666 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.5 m-85 -60.5 169.17 1.83 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.691 1.234 . . . . 0.0 112.561 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.7 p -162.32 -43.76 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.263 -2.244 . . . . 0.0 106.027 176.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.84 114.15 26.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.62 178.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.631 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -146.35 154.14 41.32 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.884 -177.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -97.33 149.39 22.14 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.852 175.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.82 ' CD2' HD12 ' A' ' 38' ' ' ILE . 71.1 m-85 -132.01 119.99 21.81 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.009 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -132.41 72.07 1.49 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.441 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -45.57 153.57 0.59 Allowed Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.084 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.52 -5.5 10.08 Favored 'Cis proline' 0 N--CA 1.485 1.012 0 C-N-CA 124.299 -1.125 . . . . 0.0 112.038 -5.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.806 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -94.87 178.75 5.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.775 0.797 . . . . 0.0 110.851 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.82 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -158.93 140.43 4.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.034 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -120.19 116.44 25.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.307 172.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.666 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -95.42 144.47 25.91 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.866 -1.97 . . . . 0.0 114.955 -167.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -116.85 167.92 9.81 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -79.63 160.12 88.01 Favored 'Cis proline' 0 C--O 1.217 -0.556 0 CA-C-O 123.262 1.276 . . . . 0.0 114.822 3.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.603 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.251 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.679 ' HB3' ' H ' ' A' ' 15' ' ' LEU . . . -39.12 137.79 0.91 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.38 36.09 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 109.187 -1.12 . . . . 0.0 109.187 166.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -82.07 122.71 28.18 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.388 -176.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.48 164.14 24.17 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.833 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.36 -178.39 4.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.072 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t -76.8 127.02 31.96 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.31 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.58 -18.08 31.49 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.562 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.08 105.95 20.04 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.21 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.04 -166.34 0.31 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.26 -98.52 2.38 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.729 -1.7 . . . . 0.0 110.862 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 43' ' ' HIS . 3.1 ptm180 -162.32 160.82 27.14 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.784 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -139.17 150.96 21.56 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 175.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.68 111.59 14.93 Favored 'General case' 0 C--O 1.171 -3.069 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.445 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.679 ' H ' ' HB3' ' A' ' 2' ' ' ALA . 6.3 tt -85.2 93.6 8.7 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.623 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.793 ' HB2' HG23 ' A' ' 38' ' ' ILE . 61.5 m95 -70.13 122.75 20.04 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 112.293 -2.231 . . . . 0.0 107.287 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.26 -8.08 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 C-N-CA 118.983 -1.087 . . . . 0.0 113.499 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 mt -151.89 74.51 1.11 Allowed 'General case' 0 C--N 1.254 -3.553 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.464 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.755 ' CG ' HH11 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -162.95 142.85 9.11 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.222 -1.791 . . . . 0.0 113.085 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.17 -22.04 23.57 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.533 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 1.4 p -143.48 152.32 41.36 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.514 -0.843 . . . . 0.0 109.24 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -88.53 148.11 41.3 Favored Pre-proline 0 C--N 1.286 -2.178 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.366 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.08 178.44 0.4 Allowed 'Trans proline' 0 C--O 1.219 -0.442 0 C-N-CA 120.379 0.719 . . . . 0.0 111.211 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.15 8.36 25.02 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.22 -16.36 15.12 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -84.67 -6.89 59.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.04 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.73 11.49 85.18 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.758 -1.21 . . . . 0.0 112.326 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 40.5 m-85 -67.19 170.57 6.86 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.885 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -161.91 -44.07 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 112.763 -2.017 . . . . 0.0 106.691 178.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 41' ' ' TYR . 3.2 p -96.86 125.88 41.62 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -160.07 147.5 16.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 117.19 -1.804 . . . . 0.0 113.132 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 146.42 32.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.002 -1.453 . . . . 0.0 108.049 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.711 ' CE2' HD12 ' A' ' 38' ' ' ILE . 51.0 m-85 -118.01 140.72 49.34 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.968 -1.093 . . . . 0.0 113.688 -170.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 35' ' ' TRP . 7.9 mttt -142.27 59.27 1.46 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.965 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -40.41 147.36 0.38 Allowed Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.31 -176.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.2 Cg_endo -70.79 2.1 6.24 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.934 -0.861 . . . . 0.0 111.635 -4.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' C ' HG22 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -101.23 -160.59 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.725 0.774 . . . . 0.0 111.359 -177.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.793 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 171.34 141.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.471 -178.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 79.4 m -110.13 110.86 21.89 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 117.741 -1.584 . . . . 0.0 107.176 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.0 t -88.98 151.16 22.46 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.924 -171.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' SER . 3.0 m-85 -125.33 163.14 40.11 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -79.16 162.61 86.47 Favored 'Cis proline' 0 C--N 1.326 -0.64 0 CA-C-O 123.324 1.302 . . . . 0.0 115.374 5.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.393 0 CA-C-N 111.11 -2.768 . . . . 0.0 109.447 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -42.63 143.75 1.1 Allowed Pre-proline 0 N--CA 1.505 2.295 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -83.34 38.55 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 N-CA-C 109.086 -1.159 . . . . 0.0 109.086 167.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.87 127.09 33.59 Favored 'General case' 0 N--CA 1.513 2.685 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.082 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.61 159.92 27.83 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 117.924 -1.51 . . . . 0.0 110.299 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.2 m -108.19 -172.89 2.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.38 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -57.68 140.02 52.3 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.327 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 29.01 11.1 0.0 OUTLIER Glycine 0 N--CA 1.481 1.633 1 N-CA-C 125.134 4.814 . . . . 0.0 125.134 -174.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.0 mttt -111.25 102.06 52.01 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 114.385 -0.908 . . . . 0.0 110.041 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.04 -164.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 120.946 1.097 . . . . 0.0 109.303 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.89 -103.17 1.97 Allowed Glycine 0 C--N 1.29 -1.994 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.543 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -161.19 166.12 28.32 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 118.063 -1.455 . . . . 0.0 114.054 -178.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.01 154.21 25.24 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.52 126.62 31.11 Favored 'General case' 0 C--O 1.178 -2.665 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.243 178.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 28.0 tp -87.89 108.41 19.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.334 -1.346 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.674 ' CB ' HG23 ' A' ' 38' ' ' ILE . 70.1 m95 -99.65 161.74 13.43 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.313 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.766 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -87.35 -158.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.136 -175.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.96 66.02 0.1 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.464 1.602 . . . . 0.0 107.793 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.32 105.81 15.94 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 112.272 -2.24 . . . . 0.0 110.631 -179.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -44.58 -35.17 3.98 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.03 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -141.42 163.2 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.153 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 157.34 56.21 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.937 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.8 119.42 5.62 Favored 'Trans proline' 0 C--O 1.208 -0.991 0 C-N-CA 120.812 1.008 . . . . 0.0 110.541 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.17 176.83 25.82 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.094 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.76 8.1 38.9 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.97 -168.54 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.18 0.04 74.75 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.428 -1.368 . . . . 0.0 111.443 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 26.1 m-85 -76.55 170.35 16.57 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.371 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -162.11 -44.74 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 112.338 -2.21 . . . . 0.0 106.376 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.6 p -99.0 128.09 45.06 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.867 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.5 142.73 25.09 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 117.939 -1.504 . . . . 0.0 112.385 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 22.2 p -99.62 137.12 38.55 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.778 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CE2' HD12 ' A' ' 38' ' ' ILE . 51.1 m-85 -114.93 121.08 42.08 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.2 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -140.41 77.23 1.59 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.711 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.4 158.58 0.12 Allowed Pre-proline 0 C--N 1.307 -1.27 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.515 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 1.6 Cg_endo -78.58 30.07 1.53 Allowed 'Cis proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.402 -1.083 . . . . 0.0 111.501 -6.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 3.1 m-80 -145.89 -171.28 3.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -153.23 141.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 17.4 m -112.68 117.27 31.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.492 -1.683 . . . . 0.0 106.997 168.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -86.11 149.19 25.31 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.465 -172.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -122.15 174.52 3.21 Favored Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.9 Cg_endo -86.15 155.31 53.52 Favored 'Cis proline' 0 CA--C 1.505 -0.959 0 CA-C-O 122.854 1.106 . . . . 0.0 113.362 -1.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.266 -3.035 0 CA-C-N 111.876 -2.42 . . . . 0.0 109.795 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.564 ' HB3' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -47.96 146.01 4.44 Favored Pre-proline 0 N--CA 1.504 2.245 0 C-N-CA 119.784 -0.767 . . . . 0.0 112.11 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.25 37.93 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 108.564 -1.36 . . . . 0.0 108.564 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.56 124.86 28.6 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -174.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.61 163.18 26.47 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.806 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -100.82 -179.54 4.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.73 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' LYS . 88.7 p -70.96 122.02 19.21 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.47 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.93 -15.59 1.24 Allowed Glycine 0 C--N 1.296 -1.659 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.585 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' SER . 47.6 mttt -106.8 117.01 57.81 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.758 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -77.13 -161.75 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.929 1.086 . . . . 0.0 109.287 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.91 -111.16 3.77 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.232 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.632 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -157.98 157.46 33.07 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.434 -1.306 . . . . 0.0 112.523 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.75 147.5 18.96 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.37 128.24 33.36 Favored 'General case' 0 C--O 1.173 -2.966 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.527 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 40.7 tp -87.51 109.49 19.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.021 -1.472 . . . . 0.0 111.984 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.68 ' HB2' HG23 ' A' ' 38' ' ' ILE . 65.4 m95 -98.16 179.2 4.83 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.844 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.734 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -103.59 -160.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.162 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.389 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.485 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.86 71.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.337 1.541 . . . . 0.0 108.329 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ILE . 12.1 mtp85 -114.12 131.75 56.3 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.197 -2.274 . . . . 0.0 111.236 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.22 86.67 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.302 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 163.25 37.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.966 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -78.29 160.26 73.43 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.1 Cg_exo -51.57 92.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 120.792 0.995 . . . . 0.0 111.008 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' CYS . . . -7.91 -32.07 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 1 N-CA-C 132.796 7.878 . . . . 0.0 132.796 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -134.9 43.09 1.28 Allowed Glycine 0 N--CA 1.499 2.843 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.311 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.85 -164.74 1.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.417 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.05 -1.61 56.64 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.654 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 m-85 -86.1 169.25 13.31 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 123.129 1.442 . . . . 0.0 113.338 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -160.79 -43.66 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.732 175.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 41' ' ' TYR . 5.1 p -97.94 138.08 35.81 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.118 -1.856 . . . . 0.0 110.594 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.23 151.02 20.6 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.918 176.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.2 p -113.09 142.38 45.81 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.834 176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.768 ' CE2' HD12 ' A' ' 38' ' ' ILE . 18.5 m-85 -114.28 128.96 56.61 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.869 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.539 ' NZ ' ' SG ' ' A' ' 4' ' ' CYS . 12.9 mttt -126.09 67.68 1.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.241 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.448 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 40.2 t-105 -36.55 144.87 0.26 Allowed Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.328 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 2.2 Cg_endo -77.6 35.48 0.59 Allowed 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 125.801 -0.5 . . . . 0.0 112.399 -5.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.541 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -145.73 -160.13 1.1 Allowed 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.339 178.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.768 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -166.37 144.94 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.19 -2.037 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.416 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.5 m -112.8 147.03 37.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 3.0 t -115.15 143.88 44.54 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.613 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -113.73 -177.22 0.42 Allowed Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.541 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 5.5 Cg_exo -62.84 -51.0 0.16 OUTLIER 'Cis proline' 0 N--CA 1.506 2.22 0 CA-C-N 121.866 1.702 . . . . 0.0 115.907 6.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.632 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.754 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.358 -171.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -40.69 149.22 0.33 Allowed Pre-proline 0 N--CA 1.504 2.262 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -87.67 38.62 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 N-CA-C 109.321 -1.069 . . . . 0.0 109.321 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.66 124.14 27.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.669 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.78 -176.48 4.96 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.109 -1.436 . . . . 0.0 110.132 -176.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.17 -173.91 4.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.037 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -68.85 118.18 11.47 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.616 -176.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.47 -12.62 1.84 Allowed Glycine 0 C--N 1.297 -1.599 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.532 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.9 mttm -96.4 135.47 22.45 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.159 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 9' ' ' LYS . 11.3 Cg_exo -47.14 -169.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.212 1.941 . . . . 0.0 113.875 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.09 32.36 0.25 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 114.297 -1.32 . . . . 0.0 113.959 -174.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.84 137.87 7.83 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 116.294 -2.162 . . . . 0.0 115.352 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -151.08 160.92 28.88 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -79.75 122.07 26.13 Favored 'General case' 0 C--O 1.18 -2.587 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.186 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 4.0 tt -89.18 118.3 28.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 117.624 -1.631 . . . . 0.0 111.711 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.658 ' CB ' HG23 ' A' ' 38' ' ' ILE . 57.0 m95 -103.41 170.99 7.62 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.351 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.817 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -96.16 -157.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 C-N-CA 119.076 -1.05 . . . . 0.0 112.744 -175.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.805 ' H ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.94 67.57 0.15 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 123.363 1.554 . . . . 0.0 108.4 -177.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.7 mtt-85 -116.07 100.3 7.85 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 112.003 -2.362 . . . . 0.0 110.151 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -41.68 -26.48 0.26 Allowed Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.701 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -147.21 160.47 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.147 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -87.13 150.17 49.03 Favored Pre-proline 0 C--N 1.292 -1.9 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.086 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.44 163.54 17.55 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 110.888 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.26 -10.75 47.41 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.84 -26.73 67.43 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.726 -1.226 . . . . 0.0 111.155 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -87.35 -32.95 19.35 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.874 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.56 16.32 29.5 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.813 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 58.8 m-85 -53.97 173.47 0.06 Allowed 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.954 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.0 p -161.33 -46.48 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 112.909 -1.95 . . . . 0.0 106.083 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.84 120.06 38.64 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.646 -2.07 . . . . 0.0 109.312 179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.36 148.39 30.32 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.023 -1.471 . . . . 0.0 112.618 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 143.94 40.3 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.553 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.796 ' CE2' HD12 ' A' ' 38' ' ' ILE . 24.7 m-85 -113.3 137.23 51.8 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.307 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.598 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 11.0 mmtt -121.46 70.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.424 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -40.03 140.84 0.86 Allowed Pre-proline 0 C--N 1.294 -1.822 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.091 -176.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -72.67 -22.77 11.79 Favored 'Cis proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.585 -1.006 . . . . 0.0 111.743 -4.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.73 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -78.63 -161.38 0.28 Allowed 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 -176.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.796 HD12 ' CE2' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -164.7 154.19 2.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.873 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.8 m -124.66 127.15 46.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.539 164.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -96.53 153.9 17.58 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -172.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.562 ' O ' ' O ' ' A' ' 30' ' ' SER . 4.6 m-85 -127.66 165.72 28.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.75 159.21 91.74 Favored 'Cis proline' 0 C--N 1.323 -0.805 0 CA-C-O 122.783 1.076 . . . . 0.0 114.47 1.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.596 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.281 -2.387 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.259 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -49.82 147.36 6.57 Favored Pre-proline 0 N--CA 1.509 2.49 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -87.12 34.75 0.44 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.35 -1.442 . . . . 0.0 108.35 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -74.77 116.33 15.36 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.219 -174.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.6 164.12 24.92 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 117.588 -1.645 . . . . 0.0 108.87 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.58 -178.94 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.36 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 99.9 p -76.99 124.12 27.31 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.143 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.25 -13.16 28.38 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.478 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -115.5 108.9 46.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.981 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.32 -154.21 0.04 OUTLIER 'Trans proline' 0 C--O 1.208 -0.976 0 N-CA-C 109.033 -1.179 . . . . 0.0 109.033 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 -108.92 2.63 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 119.254 -1.45 . . . . 0.0 111.507 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.714 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -160.16 168.63 25.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 118.923 -1.111 . . . . 0.0 113.023 -176.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.7 146.49 18.05 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.444 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -79.48 118.07 21.01 Favored 'General case' 0 C--O 1.171 -3.058 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.115 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 18.1 tp -85.76 92.6 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.526 -1.67 . . . . 0.0 113.723 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.81 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.3 m95 -75.53 126.27 30.67 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.801 -1.999 . . . . 0.0 107.744 172.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 mp -94.88 -7.3 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.135 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -170.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mt -153.13 73.39 0.99 Allowed 'General case' 0 C--N 1.253 -3.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.469 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -166.16 148.59 7.06 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 116.637 -2.025 . . . . 0.0 113.204 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.08 -13.22 27.62 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -142.87 153.96 43.66 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.235 -0.982 . . . . 0.0 109.22 177.276 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -95.51 152.52 39.29 Favored Pre-proline 0 C--N 1.288 -2.085 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.832 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.83 -170.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.221 1.281 . . . . 0.0 111.651 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.77 -19.27 3.4 Favored Glycine 0 N--CA 1.489 2.212 1 N-CA-C 129.221 6.448 . . . . 0.0 129.221 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.75 4.57 68.91 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -79.35 -56.61 4.21 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.467 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.8 7.05 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.82 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' O ' HG23 ' A' ' 29' ' ' THR . 34.1 m-85 -76.54 165.77 24.32 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 123.016 1.388 . . . . 0.0 112.769 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.6 p -163.32 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 111.757 -2.474 . . . . 0.0 106.005 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' TYR . 13.9 p -98.7 124.26 43.42 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.378 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.662 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -153.63 157.1 39.13 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.816 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 147.81 39.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.62 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CE2' HD12 ' A' ' 38' ' ' ILE . 13.1 m-85 -124.31 139.3 54.04 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.539 -172.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 73.72 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.404 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.93 155.42 0.33 Allowed Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.175 -174.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.772 ' C ' HD22 ' A' ' 37' ' ' ASN . 9.5 Cg_endo -74.87 10.25 8.54 Favored 'Cis proline' 0 N--CA 1.485 1.016 0 C-N-CA 124.293 -1.128 . . . . 0.0 111.142 -2.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.909 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.3 OUTLIER -111.49 -162.07 0.78 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.871 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.813 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -177.33 138.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.536 -178.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 29.0 m -108.21 113.35 26.4 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 117.698 -1.601 . . . . 0.0 106.939 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -93.22 130.72 38.82 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.921 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' CE2' ' O ' ' A' ' 12' ' ' ARG . 24.1 m-85 -106.89 -174.55 0.32 Allowed Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 35.9 Cg_exo -54.81 -49.01 0.14 OUTLIER 'Cis proline' 0 N--CA 1.501 1.913 0 CA-C-N 122.745 2.016 . . . . 0.0 116.727 5.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.714 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.742 0 CA-C-O 116.349 -1.786 . . . . 0.0 109.1 -172.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.742 ' H2 ' HH12 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -39.13 146.41 0.34 Allowed Pre-proline 0 N--CA 1.508 2.471 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -84.33 20.36 1.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 N-CA-C 107.993 -1.579 . . . . 0.0 107.993 164.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.589 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -81.12 115.41 20.54 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.4 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.85 178.22 8.11 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.43 -174.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -176.91 3.24 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.839 0.828 . . . . 0.0 110.152 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 p -77.66 128.02 33.42 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.34 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.67 -9.19 11.35 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -119.81 108.62 38.76 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -73.95 -163.44 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 -110.45 3.74 Favored Glycine 0 C--N 1.282 -2.472 0 C-N-CA 118.535 -1.793 . . . . 0.0 110.65 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.742 HH12 ' H2 ' ' A' ' 1' ' ' ALA . 0.3 OUTLIER -163.11 164.7 25.26 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 117.812 -1.555 . . . . 0.0 114.012 -177.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.74 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -146.26 -170.3 14.76 Favored Glycine 0 N--CA 1.502 3.053 1 N-CA-C 127.074 5.59 . . . . 0.0 127.074 173.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -99.32 127.22 45.31 Favored 'General case' 0 C--O 1.182 -2.463 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.99 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 4.2 tp -102.0 97.1 7.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.922 1.344 . . . . 0.0 110.256 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.74 ' HB2' HG23 ' A' ' 38' ' ' ILE . 80.0 m95 -89.02 151.99 21.95 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.963 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.886 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.38 -157.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.653 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.4 -178.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -70.07 76.82 0.5 Allowed 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 123.627 1.68 . . . . 0.0 109.236 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 21' ' ' THR . 9.9 mtt180 -126.45 75.93 1.58 Allowed 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 110.987 -2.824 . . . . 0.0 110.715 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -17.54 -32.02 0.0 OUTLIER Glycine 0 N--CA 1.499 2.858 1 N-CA-C 126.665 5.426 . . . . 0.0 126.665 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -140.41 154.14 46.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.297 176.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -86.12 153.73 57.13 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.14 -178.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.81 172.22 4.99 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.157 1.238 . . . . 0.0 110.81 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.42 18.17 35.92 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.79 -13.63 25.19 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.662 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -90.28 1.93 56.0 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.824 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 -0.14 39.22 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.732 -1.223 . . . . 0.0 111.367 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.678 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.9 m-85 -54.83 169.97 0.19 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.787 1.279 . . . . 0.0 111.736 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.5 p -160.18 -44.82 0.05 OUTLIER 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 112.174 -2.285 . . . . 0.0 105.175 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 12.4 p -98.25 137.39 37.06 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 112.968 -1.924 . . . . 0.0 108.621 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -155.16 148.98 25.51 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 117.707 -1.597 . . . . 0.0 113.116 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.425 ' O ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -93.43 158.34 15.77 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.852 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.5 m-85 -136.95 131.47 33.06 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.793 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 2.1 mttt -136.56 77.96 1.68 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.43 150.98 1.48 Allowed Pre-proline 0 C--N 1.293 -1.886 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.111 -177.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' LEU . 1.9 Cg_endo -69.17 -19.18 10.62 Favored 'Cis proline' 0 C--O 1.198 -1.499 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.285 -3.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.716 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -85.9 -169.44 2.64 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -177.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.852 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -149.22 144.74 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.652 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 1.3 m -117.21 116.52 27.44 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.731 -1.187 . . . . 0.0 107.902 171.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.678 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -97.46 155.0 17.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -172.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -131.35 173.13 6.23 Favored Pre-proline 0 N--CA 1.503 2.18 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.9 Cg_endo -88.65 156.05 37.77 Favored 'Cis proline' 0 C--O 1.214 -0.685 0 N-CA-C 115.764 1.409 . . . . 0.0 115.764 0.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 110.985 -2.825 . . . . 0.0 110.109 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 14' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -41.86 146.88 0.56 Allowed Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.827 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -76.6 52.67 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 N-CA-C 106.075 -2.317 . . . . 0.0 106.075 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -68.1 131.18 44.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.13 175.02 11.02 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.167 -1.413 . . . . 0.0 110.769 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -158.22 177.43 11.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.779 174.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.7 m -86.77 106.35 17.62 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.894 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.68 -17.78 8.21 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.5 mptt -134.42 136.83 26.52 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.126 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 9' ' ' LYS . 6.0 Cg_exo -50.52 -156.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.378 2.052 . . . . 0.0 114.033 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 31.8 0.1 OUTLIER Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -161.34 137.26 8.01 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 115.775 -2.37 . . . . 0.0 116.071 175.28 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.63 -166.82 10.83 Favored Glycine 0 N--CA 1.509 3.546 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.733 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.8 m-20 -108.18 127.31 53.71 Favored 'General case' 0 C--O 1.181 -2.52 0 CA-C-O 118.27 -0.872 . . . . 0.0 109.203 176.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 2.6 tp -91.04 135.61 33.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.964 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.706 ' CB ' HG23 ' A' ' 38' ' ' ILE . 59.7 m95 -127.73 -176.17 3.69 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 111.434 -2.621 . . . . 0.0 108.949 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 18' ' ' LEU . 1.8 mt -105.02 -167.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -173.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.803 ' H ' HG22 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -68.03 68.98 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.978 1.371 . . . . 0.0 107.606 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.1 mtt-85 -116.75 125.45 51.67 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 112.223 -2.262 . . . . 0.0 110.4 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.27 69.61 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -142.98 160.72 39.81 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.768 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 158.01 42.77 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.268 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.07 125.56 15.49 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.3 1.333 . . . . 0.0 110.899 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 3.86 69.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.593 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.94 -12.73 58.73 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.589 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.56 -46.5 15.64 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.459 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.43 -7.89 5.31 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 29' ' ' THR . 42.9 m-85 -50.22 171.27 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.66 1.219 . . . . 0.0 111.187 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 28' ' ' TYR . 10.6 p -161.87 -45.6 0.04 OUTLIER 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 112.34 -2.209 . . . . 0.0 105.874 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.95 130.19 44.82 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.729 -2.032 . . . . 0.0 110.298 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -157.51 157.29 33.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 117.861 -1.536 . . . . 0.0 112.148 177.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 140.02 53.18 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.592 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.747 ' CE2' HD12 ' A' ' 38' ' ' ILE . 22.4 m-85 -112.88 136.47 52.49 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.731 -173.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -142.76 75.5 1.49 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.257 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.523 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -45.51 156.79 0.4 Allowed Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.106 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.473 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 8.7 Cg_endo -78.91 30.72 1.47 Allowed 'Cis proline' 0 C--O 1.194 -1.68 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.196 -1.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 m-80 -146.62 -168.68 3.09 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.173 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.747 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -152.62 149.03 13.85 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.024 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.115 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -119.84 120.06 35.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.555 167.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -91.11 157.57 17.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.356 -1.293 . . . . 0.0 114.254 -171.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' O ' ' O ' ' A' ' 30' ' ' SER . 15.4 m-85 -133.24 167.62 22.04 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.71 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.46 160.93 95.49 Favored 'Cis proline' 0 C--O 1.213 -0.736 0 CA-C-O 122.591 0.996 . . . . 0.0 113.585 0.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.629 0 CA-C-N 112.579 -2.101 . . . . 0.0 109.859 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -41.9 147.52 0.53 Allowed Pre-proline 0 N--CA 1.502 2.138 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -85.76 28.46 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 N-CA-C 106.996 -1.963 . . . . 0.0 106.996 164.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.8 p -88.51 116.58 26.85 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.407 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -177.1 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.803 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -119.79 -176.46 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.567 178.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.56 116.86 20.01 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.425 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.7 79.32 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.435 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mppp? -119.74 117.96 32.25 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.503 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.44 178.58 7.24 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 121.236 1.291 . . . . 0.0 109.821 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.52 -100.19 2.12 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.409 -1.377 . . . . 0.0 111.294 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.1 ptm180 -162.03 178.23 9.02 Favored 'General case' 0 C--O 1.209 -1.078 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.364 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -162.57 165.34 36.15 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 175.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -87.19 132.25 33.93 Favored 'General case' 0 C--O 1.18 -2.553 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.34 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 10.7 tp -97.18 100.07 11.54 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.647 1.213 . . . . 0.0 111.802 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.665 ' HB2' HG23 ' A' ' 38' ' ' ILE . 67.0 m95 -93.01 160.88 14.67 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 112.515 -2.13 . . . . 0.0 110.831 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -84.45 -163.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.919 -176.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -68.39 71.77 0.19 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.74 1.257 . . . . 0.0 107.984 -176.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' THR . 38.8 mtt180 -122.08 86.8 2.64 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 112.565 -2.107 . . . . 0.0 112.765 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -22.23 -28.02 0.0 OUTLIER Glycine 0 N--CA 1.495 2.593 1 N-CA-C 125.837 5.095 . . . . 0.0 125.837 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' ARG . 1.4 p -150.01 151.35 33.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.04 -1.08 . . . . 0.0 109.866 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -85.72 151.57 55.58 Favored Pre-proline 0 C--N 1.289 -2.053 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.385 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.23 146.88 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.073 1.182 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.54 3.44 17.49 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.066 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.68 9.25 5.81 Favored Glycine 0 N--CA 1.491 2.32 1 N-CA-C 130.575 6.99 . . . . 0.0 130.575 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.67 14.94 8.96 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.45 79.82 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.382 -1.389 . . . . 0.0 111.619 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.623 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 27.7 m-85 -69.91 168.6 14.93 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.188 1.47 . . . . 0.0 113.492 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.6 p -161.57 -46.69 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 111.549 -2.569 . . . . 0.0 105.911 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 119.7 38.28 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.808 -1.996 . . . . 0.0 110.319 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -144.03 152.98 41.73 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.526 178.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -108.76 149.18 29.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.429 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.78 ' CE2' HD12 ' A' ' 38' ' ' ILE . 18.5 m-85 -125.98 134.35 51.52 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.962 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -151.53 76.57 1.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.603 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.479 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.65 156.65 0.19 Allowed Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.593 -178.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.487 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 5.8 Cg_endo -79.09 35.05 0.87 Allowed 'Cis proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.768 -0.93 . . . . 0.0 111.464 -5.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.2 m-80 -149.03 -171.43 3.87 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.489 -1.284 . . . . 0.0 110.318 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.78 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -154.75 144.91 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.534 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -113.65 107.73 16.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.091 -1.444 . . . . 0.0 108.148 171.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.623 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -83.75 130.92 34.95 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.876 -173.245 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.608 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -103.97 -177.73 0.56 Allowed Pre-proline 0 N--CA 1.505 2.312 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 13.6 Cg_exo -63.11 -50.18 0.16 OUTLIER 'Cis proline' 0 N--CA 1.505 2.196 0 N-CA-C 117.449 2.057 . . . . 0.0 117.449 5.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.792 0 CA-C-O 116.239 -1.838 . . . . 0.0 109.167 -169.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' O ' ' NH2' ' A' ' 12' ' ' ARG . . . -62.76 142.98 97.05 Favored Pre-proline 0 N--CA 1.502 2.171 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -82.73 40.47 0.97 Allowed 'Trans proline' 0 CA--C 1.551 1.325 0 N-CA-C 108.634 -1.333 . . . . 0.0 108.634 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.612 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.79 128.99 34.1 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -78.17 169.51 18.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.968 -1.493 . . . . 0.0 110.422 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.68 178.3 7.33 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.504 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.31 128.02 33.08 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.277 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.71 -16.85 33.86 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.336 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 110.93 23.37 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.386 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -75.49 -179.73 5.38 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 N-CA-C 108.6 -1.346 . . . . 0.0 108.6 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.24 -99.38 2.5 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.814 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 2' ' ' ALA . 2.6 ptm180 -156.12 159.11 38.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.051 -175.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.26 148.42 20.04 Favored Glycine 0 N--CA 1.499 2.837 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.229 176.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 15.6 m-20 -78.57 124.07 27.76 Favored 'General case' 0 C--O 1.181 -2.552 0 C-N-CA 119.304 -0.959 . . . . 0.0 109.751 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 67.5 tp -83.8 132.74 34.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 117.683 -1.607 . . . . 0.0 110.355 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.68 ' HB2' HG23 ' A' ' 38' ' ' ILE . 53.5 m95 -124.94 167.55 14.53 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.493 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.653 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -90.92 -161.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 C-N-CA 118.109 -1.436 . . . . 0.0 112.639 -175.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.526 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.15 69.98 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.532 -176.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 6.0 mtp180 -110.4 119.83 40.48 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 112.109 -2.314 . . . . 0.0 111.803 -177.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.27 -46.93 51.39 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.305 -1.426 . . . . 0.0 109.595 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.93 156.93 48.02 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.212 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.16 160.94 67.11 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -51.09 110.9 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 120.971 1.114 . . . . 0.0 111.662 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -15.73 -113.18 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 1 N-CA-C 130.349 6.899 . . . . 0.0 130.349 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.41 46.62 3.52 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.384 -1.389 . . . . 0.0 109.787 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -83.67 -60.73 2.03 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.32 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -160.38 -27.24 0.02 OUTLIER Glycine 0 C--N 1.288 -2.099 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.654 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 48.5 m-85 -84.22 173.04 11.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 122.897 1.332 . . . . 0.0 112.666 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.47 -48.9 0.05 Allowed 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.014 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -100.23 111.3 23.57 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 113.138 -1.846 . . . . 0.0 109.607 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 0.0 OUTLIER -137.83 143.67 41.1 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.471 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 140.58 38.33 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.455 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.802 ' CE2' HD12 ' A' ' 38' ' ' ILE . 28.6 m-85 -115.94 149.27 39.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.203 -173.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.03 81.99 0.71 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.68 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.461 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.51 158.56 0.27 Allowed Pre-proline 0 C--N 1.307 -1.26 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.37 -177.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.2 Cg_endo -79.52 33.58 1.24 Allowed 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.44 -1.067 . . . . 0.0 111.456 -5.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.461 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 7.5 m-80 -147.92 -160.2 1.13 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.916 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -164.5 137.62 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.113 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.496 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.7 m -108.87 115.47 30.14 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 116.763 -1.975 . . . . 0.0 107.029 169.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.654 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -86.59 148.29 25.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 113.564 -1.653 . . . . 0.0 113.28 -171.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -125.79 168.41 14.0 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -84.32 156.87 68.17 Favored 'Cis proline' 0 N--CA 1.454 -0.849 0 CA-C-O 122.939 1.141 . . . . 0.0 114.062 4.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.625 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.428 175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -39.86 155.45 0.17 Allowed Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -92.43 51.49 0.55 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 O-C-N 122.621 0.8 . . . . 0.0 110.664 167.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -88.97 136.25 33.11 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.775 -1.57 . . . . 0.0 107.731 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.4 174.2 11.81 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.837 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -126.4 179.8 5.12 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.708 0.766 . . . . 0.0 109.845 177.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 m -76.86 128.41 34.52 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.455 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.39 27.34 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.846 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -125.28 99.3 34.03 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.51 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.98 155.91 47.83 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 N-CA-C 108.586 -1.351 . . . . 0.0 108.586 173.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.93 -97.62 0.51 Allowed Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.171 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.33 157.46 28.0 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 118.186 -1.405 . . . . 0.0 113.294 -178.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -150.82 162.28 29.32 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 77.6 m-20 -78.03 125.2 29.0 Favored 'General case' 0 C--O 1.184 -2.364 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.6 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 8.4 tt -91.06 109.89 21.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.557 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.709 ' CB ' HG23 ' A' ' 38' ' ' ILE . 63.2 m95 -91.56 161.69 14.84 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.931 -2.395 . . . . 0.0 109.052 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.763 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -81.15 -157.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 119.416 -0.913 . . . . 0.0 112.022 -176.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.07 67.01 0.11 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.359 1.552 . . . . 0.0 107.244 -178.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -113.86 111.44 21.73 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 112.065 -2.334 . . . . 0.0 110.284 -178.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.12 -20.83 65.34 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.341 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.42 152.58 44.4 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.195 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.562 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -94.7 155.08 39.78 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.599 179.144 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -66.91 143.06 64.92 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.037 1.158 . . . . 0.0 110.985 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.22 2.83 87.35 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.81 -22.13 53.94 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.34 -16.98 55.44 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.675 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.39 0.4 73.34 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.093 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.651 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 49.0 m-85 -54.34 161.74 1.28 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.29 -1.364 . . . . 0.0 111.542 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.5 p -146.2 -48.44 0.21 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 112.076 -2.329 . . . . 0.0 105.891 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -100.06 116.43 32.07 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.254 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -139.14 149.18 44.19 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.787 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.6 p -106.05 141.53 37.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CD2' HD12 ' A' ' 38' ' ' ILE . 17.7 m-85 -119.97 138.95 53.17 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.147 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 80.5 0.95 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -44.39 158.4 0.27 Allowed Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.731 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 2.8 Cg_endo -78.04 28.75 1.61 Allowed 'Cis proline' 0 C--O 1.211 -0.857 0 C-N-CA 124.492 -1.045 . . . . 0.0 111.945 -5.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.46 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -144.44 179.44 7.26 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.232 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.813 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -145.96 148.44 17.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -122.22 123.37 41.32 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 117.343 -1.743 . . . . 0.0 107.856 167.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.651 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.74 147.09 23.15 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.944 -1.48 . . . . 0.0 113.839 -171.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -121.85 169.32 9.55 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.84 157.62 80.48 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 CA-C-O 123.133 1.222 . . . . 0.0 114.553 3.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.72 0 CA-C-N 111.455 -2.612 . . . . 0.0 110.161 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.625 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -46.53 140.0 5.9 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.417 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.03 58.75 5.64 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 N-CA-C 107.234 -1.872 . . . . 0.0 107.234 168.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.33 136.92 39.56 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.3 m-85 -77.96 163.04 26.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.221 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.507 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -104.65 -173.87 2.41 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.659 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.55 122.86 21.24 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.166 -177.39 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.82 -3.34 0.99 Allowed Glycine 0 N--CA 1.48 1.595 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.819 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 7' ' ' SER . 11.2 mttm -107.69 108.59 61.72 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.474 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.22 -173.81 1.21 Allowed 'Trans proline' 0 C--N 1.324 -0.716 0 C-N-CA 120.807 1.004 . . . . 0.0 109.615 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 93.81 -115.26 4.93 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.418 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.41 160.93 32.83 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.216 -1.393 . . . . 0.0 113.471 -178.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.82 148.57 20.28 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 9.6 m-20 -76.53 126.7 31.44 Favored 'General case' 0 C--O 1.171 -3.068 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.599 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 10.7 tp -83.11 104.8 13.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.282 -1.767 . . . . 0.0 111.703 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.689 ' HB2' HG23 ' A' ' 38' ' ' ILE . 62.6 m95 -87.56 167.14 14.2 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.466 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -88.58 -161.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.026 -177.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.46 73.57 0.15 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.1 1.428 . . . . 0.0 108.599 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 17' ' ' ILE . 23.8 mtp85 -112.83 143.76 43.54 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 112.235 -2.257 . . . . 0.0 111.203 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 21' ' ' THR . . . -80.16 -20.64 66.86 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -156.47 157.19 35.05 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.857 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.87 148.12 71.72 Favored Pre-proline 0 C--N 1.292 -1.927 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.44 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 22' ' ' CYS . 5.8 Cg_exo -53.67 -173.94 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 120.685 0.923 . . . . 0.0 111.054 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.52 -11.39 6.65 Favored Glycine 0 N--CA 1.489 2.222 1 N-CA-C 129.314 6.486 . . . . 0.0 129.314 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.89 19.32 55.23 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.61 -73.76 0.61 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.264 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.73 3.43 0.16 Allowed Glycine 0 N--CA 1.488 2.167 0 C-N-CA 118.974 -1.584 . . . . 0.0 112.418 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.3 m-85 -63.93 171.58 2.76 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.808 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -161.99 -44.86 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 112.592 -2.095 . . . . 0.0 106.433 176.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 41' ' ' TYR . 4.0 p -99.06 121.66 41.28 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.961 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.632 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.66 150.81 36.15 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.109 -1.436 . . . . 0.0 113.197 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.36 147.18 31.91 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.523 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.771 ' CE2' HD12 ' A' ' 38' ' ' ILE . 13.1 m-85 -121.32 136.01 55.02 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.654 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 4.6 mttp -138.35 63.64 1.52 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.572 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.483 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 27.5 t-105 -32.76 145.77 0.1 Allowed Pre-proline 0 N--CA 1.507 2.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.211 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.3 Cg_endo -78.62 40.41 0.4 Allowed 'Cis proline' 0 N--CA 1.499 1.81 0 C-N-CA 125.768 -0.513 . . . . 0.0 111.269 -5.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.483 ' H ' ' CA ' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -148.91 -163.53 1.81 Allowed 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.974 177.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -166.25 147.2 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.801 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -121.21 131.69 54.38 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 118.076 -1.45 . . . . 0.0 107.888 167.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -101.64 146.94 27.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.527 -1.215 . . . . 0.0 114.27 -168.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -116.51 -179.17 0.59 Allowed Pre-proline 0 N--CA 1.513 2.711 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.0 Cg_exo -63.8 -50.96 0.16 OUTLIER 'Cis proline' 0 N--CA 1.503 2.031 0 CA-C-N 122.117 1.792 . . . . 0.0 116.7 6.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.956 0 CA-C-O 116.356 -1.783 . . . . 0.0 109.24 -171.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -82.28 160.98 61.27 Favored Pre-proline 0 N--CA 1.513 2.697 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.43 32.55 0.27 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 N-CA-C 108.804 -1.268 . . . . 0.0 108.804 165.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -81.78 141.86 33.13 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.227 -174.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -89.98 171.32 9.65 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.6 -179.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -115.45 -175.66 2.76 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.11 178.182 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.13 115.09 17.6 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.811 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.47 64.3 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.625 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.92 114.27 46.59 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.067 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -77.03 166.65 26.38 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 N-CA-C 108.277 -1.47 . . . . 0.0 108.277 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.41 -106.18 2.4 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.233 -1.46 . . . . 0.0 111.069 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.66 165.04 31.27 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.105 -1.438 . . . . 0.0 113.903 -177.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.5 -174.7 15.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -104.51 111.86 24.7 Favored 'General case' 0 C--O 1.173 -2.952 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.448 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 23.2 tp -82.9 94.22 7.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 116.89 -1.924 . . . . 0.0 112.954 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 38' ' ' ILE . 73.0 m95 -70.19 111.9 6.15 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 112.458 -2.156 . . . . 0.0 105.859 169.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.31 -10.0 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.979 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -169.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mt -151.05 78.39 1.29 Allowed 'General case' 0 C--N 1.249 -3.796 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.786 -172.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -175.99 166.61 3.0 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 117.641 -1.624 . . . . 0.0 112.209 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.87 -24.26 4.34 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 p -130.24 152.23 49.89 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.0 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.609 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -88.19 147.91 41.53 Favored Pre-proline 0 C--N 1.292 -1.93 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.682 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -59.45 103.57 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.57 0.846 . . . . 0.0 110.597 -176.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 7.79 -93.35 0.01 OUTLIER Glycine 0 N--CA 1.485 1.931 1 N-CA-C 130.684 7.033 . . . . 0.0 130.684 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.32 46.04 1.71 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.299 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -79.31 0.66 27.99 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.577 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.0 27.94 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.1 m-85 -76.41 164.08 26.34 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 122.909 1.338 . . . . 0.0 112.588 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -162.72 -42.84 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 111.948 -2.387 . . . . 0.0 105.643 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.28 115.03 26.89 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.374 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -146.33 151.68 37.91 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.309 -1.357 . . . . 0.0 112.994 -177.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.91 144.91 32.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.821 ' CE2' HD12 ' A' ' 38' ' ' ILE . 15.9 m-85 -120.03 129.2 54.13 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.683 -173.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -135.93 73.17 1.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.413 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -48.41 154.7 1.07 Allowed Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.28 -175.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -70.96 7.7 3.85 Favored 'Cis proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.105 -1.206 . . . . 0.0 110.901 -5.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' C ' HG22 ' A' ' 38' ' ' ILE . 4.6 m-80 -104.37 -164.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.948 0.88 . . . . 0.0 111.357 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.821 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -177.34 135.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 7.5 m -105.69 113.26 26.72 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 117.807 -1.557 . . . . 0.0 107.625 171.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.611 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.8 t -91.52 133.25 35.67 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.001 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -110.51 168.38 7.7 Favored Pre-proline 0 N--CA 1.512 2.671 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.324 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 10.8 Cg_endo -83.81 158.79 71.53 Favored 'Cis proline' 0 C--O 1.214 -0.714 0 CA-C-O 123.05 1.187 . . . . 0.0 114.678 2.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.449 0 CA-C-N 111.741 -2.481 . . . . 0.0 109.763 175.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -67.67 142.49 96.02 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 119.543 -0.863 . . . . 0.0 113.053 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -82.27 36.35 0.62 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 107.701 -1.692 . . . . 0.0 107.701 165.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.24 125.38 29.05 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.385 -174.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -81.6 -175.86 5.75 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 117.896 -1.522 . . . . 0.0 109.388 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -172.14 3.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.669 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -69.82 134.05 48.09 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.507 -176.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.94 -1.76 0.2 Allowed Glycine 0 N--CA 1.482 1.7 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.779 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 7' ' ' SER . 19.0 mttm -121.8 102.54 41.31 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.313 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -170.99 0.59 Allowed 'Trans proline' 0 C--O 1.21 -0.885 0 C-N-CA 121.263 1.309 . . . . 0.0 109.252 175.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 -106.13 3.27 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.726 -1.702 . . . . 0.0 111.323 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 1.2 ptm180 -161.55 165.93 27.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.881 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -146.4 146.13 15.82 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -78.19 118.49 20.47 Favored 'General case' 0 C--O 1.173 -2.933 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.178 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.424 ' H ' ' H ' ' A' ' 2' ' ' ALA . 50.4 tp -81.3 129.5 34.64 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 116.938 -1.905 . . . . 0.0 110.683 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.82 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.9 m95 -117.96 122.01 42.15 Favored 'General case' 0 C--N 1.263 -3.172 0 CA-C-N 111.902 -2.408 . . . . 0.0 105.444 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.651 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -84.64 -12.68 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 mt -152.36 66.86 0.83 Allowed 'General case' 0 C--N 1.246 -3.901 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.226 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.439 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -143.32 123.26 13.52 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 117.624 -1.63 . . . . 0.0 113.215 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.04 -36.41 31.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.86 155.4 49.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.75 153.38 67.51 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.579 -177.191 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -67.53 -164.73 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.481 1.454 . . . . 0.0 111.684 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -132.98 -18.17 1.1 Allowed Glycine 0 N--CA 1.489 2.206 1 N-CA-C 130.631 7.012 . . . . 0.0 130.631 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.85 47.0 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.326 -1.416 . . . . 0.0 109.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -83.2 -91.06 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.45 25.03 0.02 OUTLIER Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.275 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 28.4 m-85 -69.27 171.86 7.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.598 1.189 . . . . 0.0 111.099 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 28' ' ' TYR . 4.6 p -162.65 -45.83 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.373 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 125.76 44.72 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.302 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.635 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -156.47 149.88 24.48 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 117.534 -1.666 . . . . 0.0 113.369 177.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.54 143.96 40.12 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.529 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.782 ' CE2' HD12 ' A' ' 38' ' ' ILE . 57.7 m-85 -111.36 138.01 48.4 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.235 -0.986 . . . . 0.0 113.026 -172.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 35' ' ' TRP . 11.5 mmtm -135.02 60.21 1.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.406 ' C ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -41.63 148.58 0.44 Allowed Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.619 -175.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -71.75 -3.81 11.35 Favored 'Cis proline' 0 C--O 1.211 -0.863 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.032 -1.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.73 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -99.22 -160.32 0.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.803 -178.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.82 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 178.56 136.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.19 -2.07 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.177 -178.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 33.9 m -105.3 117.36 33.81 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.231 -1.787 . . . . 0.0 107.021 171.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -98.48 126.32 43.98 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.535 -170.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 15.7 m-85 -98.5 -172.66 0.28 Allowed Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 16.1 Cg_exo -56.31 -52.11 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 123.206 2.181 . . . . 0.0 115.948 5.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.612 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 116.332 -1.794 . . . . 0.0 109.221 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 15' ' ' LEU . . . -71.38 145.64 90.82 Favored Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -85.71 33.74 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 108.516 -1.378 . . . . 0.0 108.516 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.8 136.18 36.66 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -176.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.1 -175.83 4.79 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.125 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -128.62 -171.89 2.58 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.291 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -70.71 114.29 8.65 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.78 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.44 1.12 4.11 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.092 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 10' ' ' PRO . 2.2 mptm? -103.55 151.15 38.66 Favored Pre-proline 0 N--CA 1.498 1.934 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.192 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 9' ' ' LYS . 17.1 Cg_exo -38.88 177.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.779 2.986 . . . . 0.0 115.051 -173.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.06 31.37 0.65 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.909 -1.496 . . . . 0.0 114.911 -172.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -161.21 142.78 11.77 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 115.884 -2.327 . . . . 0.0 114.754 175.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -161.88 152.41 22.82 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.947 174.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 118.37 19.27 Favored 'General case' 0 C--O 1.174 -2.91 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.572 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.616 ' H ' ' HB3' ' A' ' 2' ' ' ALA . 7.2 tt -87.63 94.98 9.89 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 117.141 -1.824 . . . . 0.0 112.341 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.809 ' HB2' HG23 ' A' ' 38' ' ' ILE . 66.5 m95 -70.56 127.65 33.41 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.307 -2.224 . . . . 0.0 107.464 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.2 mp -93.81 -10.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -169.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -153.74 76.43 1.07 Allowed 'General case' 0 C--N 1.247 -3.872 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.477 -174.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -161.69 129.32 4.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 117.239 -1.784 . . . . 0.0 112.737 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.49 -18.74 65.62 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 175.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -142.61 154.66 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.582 -0.809 . . . . 0.0 109.242 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 156.66 39.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.628 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -61.94 -172.99 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 121.163 1.242 . . . . 0.0 111.509 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.91 -5.24 4.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.28 -18.16 47.21 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.438 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.74 -31.21 41.04 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.48 7.01 30.67 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.556 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.9 m-85 -66.03 167.86 9.19 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.591 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 28' ' ' TYR . 8.6 p -161.12 -44.14 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.386 -2.188 . . . . 0.0 105.953 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.22 124.86 41.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.819 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -157.09 158.6 36.7 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.112 -1.435 . . . . 0.0 112.699 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.1 p -115.82 140.64 49.02 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.29 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.692 ' CE2' HD12 ' A' ' 38' ' ' ILE . 35.9 m-85 -108.77 131.76 54.64 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.643 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' A' ' 38' ' ' ILE . 30.4 mmtm -131.57 67.65 1.51 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.415 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -45.09 149.24 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.573 -175.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.5 Cg_endo -71.68 -5.12 12.16 Favored 'Cis proline' 0 N--CA 1.487 1.096 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.017 -5.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.838 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -92.68 -161.91 0.88 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.867 -177.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.809 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER 176.21 143.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.46 -177.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 71.2 m -112.38 125.41 54.17 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.016 169.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -105.02 138.08 41.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' CE2' ' ND1' ' A' ' 43' ' ' HIS . 2.2 m-85 -108.16 -178.96 0.62 Allowed Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.6 Cg_exo -58.37 -55.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.507 2.322 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 5.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.672 0 CA-C-O 116.377 -1.773 . . . . 0.0 109.133 -171.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.581 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -52.0 148.53 10.69 Favored Pre-proline 0 N--CA 1.501 2.121 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.996 -177.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -84.93 34.31 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.644 0.896 . . . . 0.0 109.94 168.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.18 123.31 26.75 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.392 -176.044 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -79.31 164.68 23.9 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.551 -1.26 . . . . 0.0 110.083 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 179.22 6.5 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.107 0.956 . . . . 0.0 111.281 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.25 133.23 38.9 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.522 -177.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.86 -17.03 28.79 Favored Glycine 0 C--N 1.296 -1.644 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.711 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.94 114.27 10.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -73.72 -160.89 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 N-CA-C 108.627 -1.336 . . . . 0.0 108.627 172.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 79.52 -106.87 2.47 Favored Glycine 0 C--N 1.288 -2.12 0 C-N-CA 118.809 -1.662 . . . . 0.0 111.229 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.642 HH21 ' HB2' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -157.14 158.85 37.08 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.273 -176.686 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.22 161.75 24.97 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 174.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.5 m-20 -79.25 128.67 33.6 Favored 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.35 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 16.6 tp -92.4 108.0 19.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.691 1.234 . . . . 0.0 111.958 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.642 ' CB ' HG23 ' A' ' 38' ' ' ILE . 64.8 m95 -99.82 150.38 22.41 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 112.546 -2.115 . . . . 0.0 109.709 177.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -81.22 -155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.341 -177.581 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.75 72.94 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.212 1.482 . . . . 0.0 108.272 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 17' ' ' ILE . 10.5 mtp85 -114.53 103.94 11.52 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.449 179.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.99 -27.77 14.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.219 -1.467 . . . . 0.0 109.884 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 157.39 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -79.75 159.89 70.49 Favored Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.647 -179.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -50.46 168.87 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.071 1.181 . . . . 0.0 110.948 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.02 140.62 15.13 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.845 -178.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.36 85.8 Favored Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.513 -1.327 . . . . 0.0 111.074 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.34 -171.58 2.8 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.696 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.46 6.67 71.38 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.055 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 31.3 m-85 -86.96 168.02 13.74 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 118.373 -1.331 . . . . 0.0 112.334 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -160.81 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 111.961 -2.382 . . . . 0.0 105.697 177.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.33 117.02 32.85 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.534 179.338 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -143.07 153.3 42.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.742 -179.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 140.77 47.66 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.222 177.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' CE2' HD12 ' A' ' 38' ' ' ILE . 34.8 m-85 -117.38 142.64 46.86 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.371 -172.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.22 81.25 0.69 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.662 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.532 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -51.06 158.79 1.13 Allowed Pre-proline 0 C--N 1.308 -1.208 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.727 -176.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.0 Cg_endo -79.83 33.18 1.43 Allowed 'Cis proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.12 -1.2 . . . . 0.0 111.826 -2.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.532 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 m-80 -145.29 -166.12 2.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.403 176.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -165.98 144.92 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.14 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 3.4 m -115.55 122.16 44.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 117.048 -1.861 . . . . 0.0 107.289 167.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -92.49 135.81 33.74 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.865 -172.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -105.92 167.19 10.02 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.444 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' A' ' 41' ' ' TYR . 14.3 Cg_endo -86.98 158.66 50.13 Favored 'Cis proline' 0 C--O 1.214 -0.696 0 N-CA-C 115.068 1.142 . . . . 0.0 115.068 2.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.642 ' HB2' HH21 ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 111.926 -2.397 . . . . 0.0 109.508 174.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -46.8 135.94 7.95 Favored Pre-proline 0 N--CA 1.495 1.812 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.61 -177.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.02 35.55 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 167.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.06 122.38 20.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -175.081 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.43 178.71 6.97 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 117.558 -1.657 . . . . 0.0 108.863 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.491 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -130.96 -177.48 4.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.381 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m -77.73 113.67 15.82 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.961 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.03 64.16 Favored Glycine 0 C--N 1.297 -1.612 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.379 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -119.51 107.07 41.42 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.696 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -72.42 174.15 12.04 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.161 1.24 . . . . 0.0 109.55 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.47 -99.72 1.97 Allowed Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.635 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.599 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -159.38 159.9 34.31 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.666 -176.268 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.44 143.86 12.93 Favored Glycine 0 C--N 1.288 -2.105 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 171.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -76.17 127.72 33.5 Favored 'General case' 0 C--O 1.17 -3.079 0 C-N-CA 118.994 -1.082 . . . . 0.0 108.359 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.2 117.49 23.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 117.542 -1.663 . . . . 0.0 112.139 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.641 ' CB ' HG23 ' A' ' 38' ' ' ILE . 62.8 m95 -111.1 159.69 17.58 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 112.225 -2.261 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -81.93 -163.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.701 -176.443 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.477 ' CD1' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.34 70.78 0.17 Allowed 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 123.181 1.467 . . . . 0.0 108.579 -175.748 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 17' ' ' ILE . 11.9 mtp180 -105.74 141.54 37.0 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.997 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.85 -34.31 53.36 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.9 157.72 44.31 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.86 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.0 149.97 64.12 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.035 -179.629 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 144.47 97.47 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 121.006 1.137 . . . . 0.0 111.163 176.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.26 -15.34 72.05 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.089 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.77 -29.76 74.95 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -81.81 4.62 21.5 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.08 16.22 68.39 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.491 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.62 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 39.4 m-85 -66.07 169.56 6.75 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.126 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 p -162.15 -46.98 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.474 -2.148 . . . . 0.0 106.117 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 41' ' ' TYR . 33.3 p -98.02 118.21 34.12 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.219 -2.264 . . . . 0.0 110.378 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.606 HD22 ' HE1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -153.77 158.4 40.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.931 -1.508 . . . . 0.0 112.998 179.04 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.43 148.43 45.12 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.312 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.699 ' CE2' HD12 ' A' ' 38' ' ' ILE . 12.2 m-85 -114.93 137.8 51.56 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.511 -171.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 mttp -138.49 73.69 1.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.145 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.491 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 6.9 t-105 -37.78 147.99 0.23 Allowed Pre-proline 0 N--CA 1.504 2.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 2.4 Cg_endo -78.13 37.68 0.5 Allowed 'Cis proline' 0 N--CA 1.495 1.572 0 C-N-CA 124.976 -0.843 . . . . 0.0 110.87 -6.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -146.29 -155.91 0.66 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.259 -179.101 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.699 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -170.86 141.72 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.299 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.179 179.185 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.2 m -110.63 144.74 39.07 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 167.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.62 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.9 t -117.74 135.42 54.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.6 m-85 -102.61 174.11 3.07 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 176.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.5 Cg_exo -55.19 -61.5 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.917 0 N-CA-C 117.209 1.965 . . . . 0.0 117.209 5.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.599 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.123 0 CA-C-O 116.438 -1.744 . . . . 0.0 109.879 -170.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -48.79 144.99 6.59 Favored Pre-proline 0 N--CA 1.504 2.259 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.6 Cg_endo -86.1 23.97 0.79 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 N-CA-C 107.089 -1.927 . . . . 0.0 107.089 164.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.7 p -75.07 116.62 16.01 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-N 113.447 -1.706 . . . . 0.0 108.939 -177.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -78.13 179.44 6.85 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.92 -175.359 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -113.09 -173.71 2.31 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.345 177.63 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -75.14 120.37 20.55 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.041 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -8.52 51.1 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.763 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -115.82 100.99 54.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.701 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.56 152.22 37.96 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.188 1.259 . . . . 0.0 109.804 174.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.85 -93.33 0.3 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.929 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.589 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -162.05 159.21 25.99 Favored 'General case' 0 C--O 1.199 -1.588 0 C-N-CA 118.624 -1.231 . . . . 0.0 112.217 -178.532 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -153.51 151.18 22.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 174.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.4 m-20 -78.42 128.08 33.1 Favored 'General case' 0 C--O 1.182 -2.46 0 C-N-CA 118.912 -1.115 . . . . 0.0 109.166 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 12.6 tp -94.08 101.92 13.96 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.865 1.317 . . . . 0.0 111.717 -177.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.815 ' HB2' HG23 ' A' ' 38' ' ' ILE . 78.4 m95 -88.87 123.4 33.21 Favored 'General case' 0 C--N 1.26 -3.324 0 CA-C-N 111.889 -2.414 . . . . 0.0 107.402 176.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.77 -16.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -170.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.8 mt -151.73 71.57 0.99 Allowed 'General case' 0 C--N 1.247 -3.86 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.907 -171.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -156.29 141.19 17.17 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 117.841 -1.544 . . . . 0.0 112.297 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.592 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -91.28 -19.48 41.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.16 43.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.18 162.07 63.01 Favored Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.948 -179.111 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 5.6 Cg_exo -52.29 114.51 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 121.489 1.459 . . . . 0.0 112.33 -171.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -0.94 65.6 0.0 OUTLIER Glycine 0 N--CA 1.488 2.123 1 N-CA-C 131.162 7.225 . . . . 0.0 131.162 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.11 48.8 71.53 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.033 -1.556 . . . . 0.0 110.365 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.61 -77.78 0.17 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.042 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.11 -23.19 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.504 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 42.0 m-85 -77.66 170.48 16.5 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 122.568 1.175 . . . . 0.0 112.337 -179.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.6 p -160.88 -44.41 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 112.353 -2.203 . . . . 0.0 105.957 176.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -96.36 118.06 32.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.333 -179.909 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.56 149.62 29.4 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.031 -1.468 . . . . 0.0 113.185 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.6 p -103.4 142.74 33.72 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.017 175.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 38' ' ' ILE . 29.4 m-85 -117.12 134.79 54.34 Favored 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 119.267 -0.973 . . . . 0.0 112.479 -173.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -147.56 80.0 1.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.592 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -53.36 152.99 7.67 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.343 -175.437 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 5.2 Cg_endo -72.66 -6.9 15.96 Favored 'Cis proline' 0 C--O 1.208 -0.996 0 C-N-CA 124.197 -1.168 . . . . 0.0 110.451 -5.298 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.494 ' C ' HG22 ' A' ' 38' ' ' ILE . 1.6 m-80 -91.61 -165.15 1.29 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.284 1.04 . . . . 0.0 111.873 -178.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.815 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 179.42 142.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.005 -178.116 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 18.4 m -113.56 103.87 11.69 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.421 -1.312 . . . . 0.0 107.795 172.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -82.27 138.05 34.7 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.32 -1.309 . . . . 0.0 113.342 -172.673 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.567 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -109.73 -178.8 0.58 Allowed Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.1 Cg_exo -63.81 -50.48 0.17 OUTLIER 'Cis proline' 0 N--CA 1.507 2.287 0 N-CA-C 116.813 1.813 . . . . 0.0 116.813 5.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.589 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.273 -2.752 0 CA-C-O 116.382 -1.771 . . . . 0.0 110.074 -171.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -39.21 145.17 0.41 Allowed Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -177.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -84.26 29.64 0.54 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 106.586 -2.121 . . . . 0.0 106.586 165.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.598 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.2 p -92.0 117.3 29.69 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.237 -174.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 2.2 m-85 -78.06 172.46 13.49 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.398 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -108.78 -171.89 1.94 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.589 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -74.86 114.95 13.9 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.304 -1.358 . . . . 0.0 111.009 -177.693 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.88 3.52 60.0 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.414 178.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -113.05 113.64 49.24 Favored Pre-proline 0 N--CA 1.496 1.839 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.093 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.28 -163.22 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.573 1.516 . . . . 0.0 111.664 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 69.22 -118.25 8.51 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.582 ' O ' ' CE1' ' A' ' 41' ' ' TYR . 4.9 ptp180 -152.46 -171.52 3.96 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 118.398 -1.321 . . . . 0.0 112.133 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.73 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -152.02 155.95 26.42 Favored Glycine 0 C--N 1.273 -2.925 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 173.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -76.28 131.93 39.54 Favored 'General case' 0 C--O 1.176 -2.78 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.936 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 14.5 tp -92.3 110.16 21.55 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 122.908 1.337 . . . . 0.0 110.774 -177.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.703 ' HB2' HG23 ' A' ' 38' ' ' ILE . 66.0 m95 -106.84 160.0 15.83 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 112.068 -2.333 . . . . 0.0 109.875 -177.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -86.15 -161.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.788 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -67.96 72.95 0.18 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.413 1.577 . . . . 0.0 108.728 -175.706 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.8 mtp85 -110.86 125.75 53.95 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 111.952 -2.385 . . . . 0.0 109.877 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.25 -26.2 70.34 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.233 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 p -149.38 153.43 37.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.789 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -81.31 152.37 70.54 Favored Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.164 179.37 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 25' ' ' GLY . 2.7 Cg_exo -51.25 124.53 14.28 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 C-N-CA 121.015 1.143 . . . . 0.0 111.641 -178.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.74 25.23 2.54 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -133.7 -4.27 3.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.572 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -56.36 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.996 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.24 0.72 1.0 Allowed Glycine 0 C--N 1.288 -2.128 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.824 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.597 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 47.7 m-85 -68.62 170.68 8.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 122.569 1.176 . . . . 0.0 111.896 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -161.03 -44.22 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.544 -2.117 . . . . 0.0 106.055 177.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -97.66 123.54 41.62 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.79 178.785 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.578 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -155.2 149.49 26.01 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.882 -1.527 . . . . 0.0 112.485 178.911 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 7.8 p -108.81 146.08 34.2 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.441 177.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.727 ' CE2' HD12 ' A' ' 38' ' ' ILE . 46.8 m-85 -123.01 133.89 54.34 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.22 -175.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.45 83.17 1.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.278 -0.873 . . . . 0.0 108.754 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.474 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.78 160.19 0.2 Allowed Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.949 -176.221 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 18' ' ' LEU . 8.2 Cg_endo -80.12 34.06 1.36 Allowed 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.21 -1.162 . . . . 0.0 110.435 -5.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.474 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 7.0 m-80 -147.15 -163.32 1.73 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.871 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.727 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -162.22 146.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.031 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 19.9 m -117.76 105.32 11.86 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.695 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.6 t -81.73 141.71 33.32 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.194 -172.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.3 m-85 -110.04 175.8 1.78 Allowed Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.4 Cg_exo -57.49 -58.45 0.04 OUTLIER 'Cis proline' 0 N--CA 1.506 2.215 0 N-CA-C 117.773 2.182 . . . . 0.0 117.773 6.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' ND1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.179 0 CA-C-O 116.273 -1.823 . . . . 0.0 109.594 -169.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -50.28 144.74 11.1 Favored Pre-proline 0 N--CA 1.506 2.328 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.313 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.55 37.03 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 N-CA-C 108.308 -1.458 . . . . 0.0 108.308 165.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.76 122.14 21.92 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.585 -174.5 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.44 174.03 12.01 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.241 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.41 179.99 6.47 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.012 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -71.75 134.55 46.28 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.534 -174.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.68 -12.23 0.53 Allowed Glycine 0 N--CA 1.478 1.464 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.767 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 mttt -113.05 105.86 55.36 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.102 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -72.09 154.58 57.4 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 173.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -105.06 1.25 Allowed Glycine 0 C--N 1.287 -2.152 1 N-CA-C 129.604 6.602 . . . . 0.0 129.604 -176.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.734 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 5.5 ptm180 -162.65 152.84 16.4 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.815 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -142.69 152.12 23.62 Favored Glycine 0 N--CA 1.493 2.472 1 N-CA-C 125.716 5.046 . . . . 0.0 125.716 171.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 4.8 m-20 -77.11 122.34 24.84 Favored 'General case' 0 C--O 1.171 -3.037 0 C-N-CA 118.015 -1.474 . . . . 0.0 109.709 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 20.3 tp -86.56 100.24 12.27 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.335 -178.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.674 ' CB ' HG23 ' A' ' 38' ' ' ILE . 61.5 m95 -87.59 165.11 15.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.406 177.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.635 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -90.86 -159.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.939 -176.824 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.05 70.27 0.15 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.202 1.477 . . . . 0.0 108.411 -176.073 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' ILE . 3.6 mtp180 -113.62 120.87 42.38 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 112.202 -2.272 . . . . 0.0 110.49 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -23.38 64.94 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.157 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 154.07 38.33 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.934 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.97 149.96 54.42 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.975 179.2 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.83 143.69 95.15 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.83 1.02 . . . . 0.0 110.815 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.23 -1.22 75.82 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.239 -1.457 . . . . 0.0 110.095 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.58 -14.68 70.1 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.15 -91.78 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.036 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.68 24.61 0.03 OUTLIER Glycine 0 C--N 1.29 -2.0 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.54 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.631 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 44.2 m-85 -86.37 170.11 12.31 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.921 1.343 . . . . 0.0 112.347 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.4 p -162.55 -44.44 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 112.041 -2.345 . . . . 0.0 105.849 176.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' TYR . 29.8 p -96.98 114.24 25.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.513 -2.131 . . . . 0.0 109.806 -179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.561 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.55 151.36 37.2 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.956 177.984 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.09 145.65 35.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.752 177.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.707 ' CE2' HD12 ' A' ' 38' ' ' ILE . 15.9 m-85 -118.23 125.91 51.1 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.86 -171.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 35' ' ' TRP . 25.8 mttt -127.04 70.55 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.612 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.43 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 31.7 t-105 -39.22 144.09 0.47 Allowed Pre-proline 0 C--N 1.296 -1.738 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.483 178.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 9.5 Cg_endo -79.39 39.35 0.57 Allowed 'Cis proline' 0 N--CA 1.494 1.514 0 C-N-CA 125.66 -0.558 . . . . 0.0 111.372 -5.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.457 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -149.31 -159.73 1.08 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.474 -1.291 . . . . 0.0 110.935 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.707 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -170.94 142.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.991 179.582 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 16.0 m -111.18 133.15 53.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 168.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -105.82 130.84 53.72 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -170.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -103.83 179.19 1.0 Allowed Pre-proline 0 N--CA 1.513 2.698 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 177.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.574 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.0 Cg_exo -59.11 -54.91 0.14 OUTLIER 'Cis proline' 0 N--CA 1.505 2.177 0 N-CA-C 117.217 1.968 . . . . 0.0 117.217 6.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.734 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.659 0 CA-C-O 116.373 -1.775 . . . . 0.0 109.247 -171.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.696 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -39.66 146.84 0.35 Allowed Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.956 179.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -80.32 59.49 7.46 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 N-CA-C 107.178 -1.893 . . . . 0.0 107.178 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -74.8 142.42 44.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.569 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -78.44 169.14 18.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.369 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -114.0 -166.22 1.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 9' ' ' LYS . 3.0 t -62.27 110.39 1.62 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.671 -177.74 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.91 1.12 0.79 Allowed Glycine 0 N--CA 1.479 1.528 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.208 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 7' ' ' SER . 30.3 mttt -99.33 116.44 65.04 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.573 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' O ' ' OH ' ' A' ' 41' ' ' TYR . 1.2 Cg_endo -70.76 -167.89 0.29 Allowed 'Trans proline' 0 C--O 1.213 -0.76 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 173.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.97 -119.53 5.46 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.615 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -162.0 159.56 26.58 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.585 -179.771 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -136.84 149.77 20.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 172.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 12.8 m-20 -77.03 125.84 29.98 Favored 'General case' 0 C--O 1.175 -2.854 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.186 -179.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.696 ' N ' ' HB1' ' A' ' 1' ' ' ALA . 5.0 tp -83.23 106.42 15.0 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 117.056 -1.858 . . . . 0.0 111.793 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.718 ' HB2' HG23 ' A' ' 38' ' ' ILE . 53.4 m95 -90.48 171.53 9.36 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 111.723 -2.489 . . . . 0.0 110.374 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -88.94 -163.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.079 -178.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -68.06 72.31 0.18 Allowed 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 122.945 1.355 . . . . 0.0 108.454 -176.197 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.8 mtp85 -113.1 111.1 21.54 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.356 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.49 -24.95 40.46 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.204 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 p -141.77 151.54 42.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.39 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -82.62 147.26 55.2 Favored Pre-proline 0 C--N 1.289 -2.051 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.387 -179.68 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.55 148.21 54.6 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 121.004 1.136 . . . . 0.0 111.737 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLY . . . -84.48 -33.05 20.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.997 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.97 -28.25 16.53 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.13 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.28 -25.93 42.39 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.733 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . 87.68 12.61 66.42 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.674 -1.25 . . . . 0.0 111.566 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 45.6 m-85 -57.9 172.56 0.39 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.636 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 28' ' ' TYR . 17.1 p -162.36 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.804 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.904 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -97.67 110.21 22.82 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.318 -177.592 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.08 156.11 40.38 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.339 -1.344 . . . . 0.0 112.778 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 p -112.17 146.81 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.738 176.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.802 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.1 m-85 -117.07 133.24 56.24 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 119.3 -0.96 . . . . 0.0 112.38 -174.044 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -134.82 70.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.588 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 11.8 t-105 -37.92 148.39 0.22 Allowed Pre-proline 0 N--CA 1.506 2.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.725 178.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 6.2 Cg_endo -77.64 33.79 0.73 Allowed 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 125.613 -0.578 . . . . 0.0 111.095 -6.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.558 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -147.15 -167.16 2.7 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.22 178.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.01 153.32 4.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.904 -179.424 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -125.2 130.8 52.84 Favored 'General case' 0 C--O 1.216 -0.707 0 C-N-CA 117.948 -1.501 . . . . 0.0 107.586 168.189 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.608 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -167.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -111.42 -178.07 0.51 Allowed Pre-proline 0 N--CA 1.51 2.566 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.175 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.9 Cg_exo -57.79 -54.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.506 2.258 0 CA-C-N 122.485 1.923 . . . . 0.0 117.027 4.302 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.483 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.71 -171.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.756 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -39.52 151.57 0.22 Allowed Pre-proline 0 N--CA 1.505 2.287 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.916 -179.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -81.55 49.73 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 168.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -73.31 138.33 45.37 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.039 -1.064 . . . . 0.0 108.16 -172.762 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.499 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -78.65 175.66 10.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.07 -1.452 . . . . 0.0 109.831 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -111.78 -169.02 1.39 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.813 179.232 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.21 108.52 10.37 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.062 -178.342 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.92 -0.97 89.14 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.683 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -115.52 113.41 42.92 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.054 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.58 -161.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.793 0 C-N-CA 120.904 1.069 . . . . 0.0 109.335 174.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.47 -109.11 2.77 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.911 178.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.627 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.14 177.01 10.07 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.658 -1.217 . . . . 0.0 113.423 -177.353 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.627 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -157.46 158.37 28.91 Favored Glycine 0 N--CA 1.503 3.151 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 10.3 m-20 -78.06 122.97 26.28 Favored 'General case' 0 C--O 1.177 -2.731 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.287 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.756 ' N ' ' HB1' ' A' ' 1' ' ' ALA . 4.5 tt -91.53 99.64 12.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 117.397 -1.721 . . . . 0.0 113.14 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.792 ' HB2' HG23 ' A' ' 38' ' ' ILE . 70.3 m95 -75.72 122.68 24.37 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.0 174.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 17' ' ' ILE . 44.1 mt -89.96 -10.35 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.2 mt -150.14 71.23 1.06 Allowed 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.536 -171.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.93 158.38 10.58 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.093 178.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.96 -29.25 4.4 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -129.01 152.16 48.92 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.801 177.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.61 153.51 47.97 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.99 -179.09 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.2 -178.75 0.09 OUTLIER 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.513 1.475 . . . . 0.0 112.071 -175.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.76 12.6 10.03 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -108.44 -5.48 32.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.99 -28.43 14.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.137 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.74 54.46 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.717 -1.23 . . . . 0.0 111.51 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.629 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 47.0 m-85 -53.7 167.17 0.26 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.986 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.9 p -163.38 -43.27 0.03 OUTLIER 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.544 177.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -96.56 111.58 23.65 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.706 -2.043 . . . . 0.0 109.119 -179.575 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -150.96 146.9 26.56 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.751 -177.784 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.55 138.2 36.09 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.222 177.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.856 ' CD1' HD12 ' A' ' 38' ' ' ILE . 95.8 m-85 -118.35 134.38 55.1 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.861 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.2 82.38 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.47 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -47.21 158.85 0.43 Allowed Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.825 -176.417 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.829 ' C ' HD22 ' A' ' 37' ' ' ASN . 6.3 Cg_endo -74.2 5.16 10.82 Favored 'Cis proline' 0 C--O 1.204 -1.206 0 C-N-CA 124.215 -1.161 . . . . 0.0 111.435 -3.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.944 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.3 OUTLIER -114.36 -162.93 0.84 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 122.195 0.997 . . . . 0.0 111.268 -176.46 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.856 HD12 ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -178.61 144.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.377 -179.538 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -118.22 111.86 19.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 117.469 -1.692 . . . . 0.0 108.049 170.029 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.629 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -82.87 148.17 27.87 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.211 -170.478 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.516 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER -124.06 168.71 12.09 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 178.114 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -77.39 157.6 96.12 Favored 'Cis proline' 0 C--N 1.325 -0.698 0 CA-C-O 122.88 1.117 . . . . 0.0 114.147 4.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.591 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.602 0 CA-C-N 111.981 -2.372 . . . . 0.0 109.711 175.571 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 15' ' ' LEU 0.255 . . -38.14 142.1 0.48 Allowed Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.154 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.86 31.88 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.4 p -85.62 114.56 22.71 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.791 -176.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -77.76 175.41 9.99 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.493 -1.283 . . . . 0.0 110.274 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 1.7 m -113.24 -177.21 3.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.83 121.47 24.14 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.541 -178.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.93 60.88 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.49 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -123.65 113.6 28.79 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.801 -178.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -74.71 -164.39 0.22 Allowed 'Trans proline' 0 C--O 1.212 -0.795 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 173.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -99.75 2.59 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.31 177.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.622 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -160.93 161.61 31.73 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.267 -177.232 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -147.42 147.36 18.06 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 174.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 14.9 m-20 -79.62 121.7 25.61 Favored 'General case' 0 C--O 1.17 -3.125 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.008 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.658 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 15.5 tp -92.19 92.79 8.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.842 1.306 . . . . 0.0 112.86 -175.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 38' ' ' ILE . 68.6 m95 -74.14 120.12 19.28 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 112.165 -2.289 . . . . 0.0 108.196 174.209 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.506 ' H ' HD12 ' A' ' 17' ' ' ILE . 1.3 mp -84.82 -11.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -171.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 mt -152.41 75.9 1.13 Allowed 'General case' 0 C--N 1.253 -3.59 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.672 -175.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -148.21 155.53 41.48 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.748 178.734 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.4 -26.71 4.16 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.67 151.49 45.97 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.303 175.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -91.36 138.1 25.73 Favored Pre-proline 0 C--N 1.288 -2.082 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.083 -178.781 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.76 152.22 75.68 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 121.035 1.157 . . . . 0.0 111.615 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.66 -16.24 46.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.24 -19.7 59.85 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.617 -1.277 . . . . 0.0 109.93 179.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.88 -60.51 2.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.958 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.75 13.07 0.64 Allowed Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 38.9 m-85 -72.78 170.22 15.07 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.874 1.321 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.1 p -161.97 -45.75 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 112.066 -2.333 . . . . 0.0 106.065 177.213 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -99.12 123.22 43.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.928 179.786 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -152.12 157.94 42.27 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 117.972 -1.491 . . . . 0.0 114.08 179.143 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.457 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 p -113.97 147.9 37.81 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.253 172.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.735 ' CE2' HD12 ' A' ' 38' ' ' ILE . 40.1 m-85 -116.69 136.83 52.64 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.295 -172.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' NZ ' ' SG ' ' A' ' 32' ' ' CYS . 4.5 mttt -138.96 70.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.948 178.575 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.422 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -47.83 144.98 4.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.326 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 3.6 Cg_endo -70.57 -7.83 11.64 Favored 'Cis proline' 0 C--O 1.206 -1.105 0 C-N-CA 124.952 -0.853 . . . . 0.0 111.208 -4.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.804 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -93.29 -164.93 1.24 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.297 -177.323 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -179.03 137.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.801 -179.097 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 50.5 m -107.08 105.56 15.63 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.278 174.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.7 t -91.27 130.26 37.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.969 -1.469 . . . . 0.0 114.17 -172.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.543 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -97.78 176.27 2.14 Favored Pre-proline 0 N--CA 1.511 2.611 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.095 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 11.7 Cg_exo -58.07 -57.16 0.08 OUTLIER 'Cis proline' 0 N--CA 1.503 2.056 0 N-CA-C 117.339 2.015 . . . . 0.0 117.339 7.172 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.622 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.357 0 CA-C-O 116.331 -1.795 . . . . 0.0 109.864 -170.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -72.62 150.78 91.27 Favored Pre-proline 0 N--CA 1.502 2.161 0 C-N-CA 119.743 -0.783 . . . . 0.0 113.001 -176.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.09 31.84 0.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 166.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -72.67 120.98 19.05 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -175.59 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -174.4 3.53 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.64 -1.624 . . . . 0.0 109.418 -178.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.48 -175.32 4.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.439 178.004 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.58 130.03 38.16 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.271 -176.345 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.24 41.94 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.722 179.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 109.65 21.9 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.819 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.75 150.8 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 N-CA-C 108.959 -1.208 . . . . 0.0 108.959 172.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -89.63 0.47 Allowed Glycine 0 N--CA 1.491 2.304 1 N-CA-C 130.521 6.968 . . . . 0.0 130.521 -177.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.634 HH22 ' CG ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -160.08 149.11 17.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.542 -1.263 . . . . 0.0 112.567 179.181 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.78 148.5 20.14 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 175.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.634 ' CG ' HH22 ' A' ' 12' ' ' ARG . 2.9 m-20 -77.74 121.11 23.59 Favored 'General case' 0 C--O 1.18 -2.605 0 C-N-CA 118.829 -1.149 . . . . 0.0 109.071 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.444 ' H ' ' H ' ' A' ' 2' ' ' ALA . 20.9 tp -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.333 -1.747 . . . . 0.0 110.891 179.383 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.675 ' CB ' HG23 ' A' ' 38' ' ' ILE . 65.6 m95 -119.75 152.65 36.88 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 111.303 -2.681 . . . . 0.0 106.975 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.757 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -80.54 -158.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.845 -176.265 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.54 68.84 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 123.128 1.442 . . . . 0.0 108.18 -177.049 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -107.65 136.73 46.9 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 112.5 -2.136 . . . . 0.0 110.427 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.06 -21.28 78.55 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.319 -1.42 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.17 157.44 35.93 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.708 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -80.28 157.86 72.54 Favored Pre-proline 0 C--N 1.299 -1.6 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.219 177.894 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.59 -172.76 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 121.268 1.312 . . . . 0.0 111.794 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.69 10.98 10.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.23 -2.11 54.26 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.467 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -102.97 -52.45 3.05 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.16 30.65 2.05 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.598 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 79.0 m-85 -79.55 172.36 13.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.415 1.103 . . . . 0.0 110.999 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 28' ' ' TYR . 6.1 p -162.41 -45.72 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 112.896 -1.957 . . . . 0.0 106.681 176.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.5 p -98.39 97.66 8.98 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 112.861 -1.972 . . . . 0.0 110.36 -178.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.689 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -129.64 151.16 50.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.661 -1.215 . . . . 0.0 113.013 -177.804 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 146.07 36.13 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.132 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.717 ' CE2' HD12 ' A' ' 38' ' ' ILE . 8.8 m-85 -120.53 127.99 52.68 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.346 -172.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.1 mttt -128.81 73.01 1.48 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.754 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -35.72 148.45 0.15 Allowed Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.941 179.734 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 4.9 Cg_endo -78.44 36.92 0.57 Allowed 'Cis proline' 0 N--CA 1.487 1.118 0 C-N-CA 125.221 -0.741 . . . . 0.0 111.44 -5.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.1 m-80 -147.48 -162.21 1.5 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.335 -179.403 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.717 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -162.47 140.33 2.1 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.223 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.437 179.652 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 32.0 m -112.83 119.67 38.82 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.171 168.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.0 t -88.86 142.32 27.75 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.848 -171.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.496 ' CB ' ' O ' ' A' ' 30' ' ' SER . 1.1 m-85 -122.28 167.76 13.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -78.82 158.52 91.93 Favored 'Cis proline' 0 C--N 1.32 -0.944 0 CA-C-O 122.914 1.131 . . . . 0.0 114.525 6.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.543 0 CA-C-N 111.975 -2.375 . . . . 0.0 109.245 175.412 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -51.39 141.77 22.13 Favored Pre-proline 0 N--CA 1.505 2.301 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.388 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.41 30.6 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 108.318 -1.455 . . . . 0.0 108.318 166.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.595 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -66.52 125.25 25.15 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -174.938 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -78.24 165.33 24.04 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 117.269 -1.772 . . . . 0.0 109.402 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -134.31 176.96 8.13 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.896 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -74.47 139.48 43.92 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.732 -176.552 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.04 -17.81 0.92 Allowed Glycine 0 C--N 1.295 -1.719 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.898 179.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 7' ' ' SER . 7.5 mptt -128.63 107.03 18.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.21 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.41 162.99 27.62 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.908 -1.228 . . . . 0.0 108.908 173.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.85 -90.53 0.52 Allowed Glycine 0 N--CA 1.498 2.794 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.553 178.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.593 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -160.4 153.33 21.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.808 -176.794 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.72 146.54 18.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 173.287 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 22.0 m-20 -77.59 119.05 20.6 Favored 'General case' 0 C--O 1.173 -2.958 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.2 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 16' ' ' TRP . 55.4 tp -81.22 132.21 35.33 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.008 -1.877 . . . . 0.0 111.711 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.76 ' HB2' HG23 ' A' ' 38' ' ' ILE . 59.7 m95 -123.34 120.02 31.8 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 111.562 -2.563 . . . . 0.0 105.379 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.771 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -83.84 -16.91 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -168.201 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 mt -151.88 70.9 0.95 Allowed 'General case' 1 C--N 1.239 -4.214 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.087 -171.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -153.73 140.69 19.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 117.064 -1.854 . . . . 0.0 112.928 178.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.49 -25.0 29.31 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 177.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.28 153.68 45.33 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 151.53 43.68 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.636 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.31 109.39 0.97 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.922 1.081 . . . . 0.0 111.122 -178.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -21.33 70.44 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.186 -1.483 . . . . 0.0 109.903 178.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.18 -1.88 76.34 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.058 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -92.05 -101.88 0.12 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.18 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.65 -2.48 0.38 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.397 -1.382 . . . . 0.0 111.167 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.658 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 53.0 m-85 -82.77 168.2 17.41 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 122.692 1.234 . . . . 0.0 112.062 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 p -158.63 -45.55 0.06 Allowed 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 112.153 -2.294 . . . . 0.0 105.78 177.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -98.69 118.15 34.77 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.03 178.751 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.642 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -144.45 149.42 35.98 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 117.917 -1.513 . . . . 0.0 113.577 179.621 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 148.07 29.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.068 176.282 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.624 ' CE2' HD12 ' A' ' 38' ' ' ILE . 36.4 m-85 -118.71 137.33 53.41 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.748 -172.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 35' ' ' TRP . 39.7 mmtt -130.21 56.77 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.291 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 34' ' ' LYS . 31.3 t-105 -29.05 139.89 0.11 Allowed Pre-proline 0 N--CA 1.504 2.236 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.596 -177.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -71.89 -7.52 14.41 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.869 -6.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.861 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -87.58 -158.2 0.44 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.606 -177.003 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.76 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER 176.49 139.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.193 -1.916 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.461 -178.55 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 11.5 m -109.37 108.75 19.41 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 117.337 -1.745 . . . . 0.0 107.028 170.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.658 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.4 t -83.78 142.81 30.4 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.627 -171.45 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.6 m-85 -117.7 166.01 14.5 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.273 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -76.31 159.88 96.08 Favored 'Cis proline' 0 CA--C 1.509 -0.735 0 CA-C-O 122.885 1.119 . . . . 0.0 113.651 4.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.897 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.514 178.282 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.06 0.457 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -79.96 147.77 66.72 Favored Pre-proline 0 N--CA 1.501 2.12 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.269 -177.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -84.24 30.15 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 N-CA-C 108.001 -1.577 . . . . 0.0 108.001 167.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -71.46 119.24 15.33 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -174.728 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.0 160.6 29.01 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.25 -1.78 . . . . 0.0 109.966 -178.331 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.65 179.41 4.35 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.684 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.3 p -80.87 118.98 22.85 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.99 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 -11.16 71.21 Favored Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.203 -179.247 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -127.41 110.95 21.13 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.445 -179.706 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -165.94 0.27 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.062 1.174 . . . . 0.0 109.398 173.466 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.14 -96.78 2.25 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 118.961 -1.59 . . . . 0.0 111.105 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.603 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.88 160.32 30.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.963 -178.591 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -144.54 140.42 9.26 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 172.732 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.2 m-20 -76.02 129.18 36.47 Favored 'General case' 0 C--O 1.173 -2.953 0 C-N-CA 118.628 -1.229 . . . . 0.0 108.136 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -83.45 125.65 31.94 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.58 -1.648 . . . . 0.0 111.455 -178.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.645 ' CB ' HG23 ' A' ' 38' ' ' ILE . 54.3 m95 -122.03 161.39 23.08 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.023 -178.554 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.749 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.79 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.736 -176.998 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' CA ' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -68.45 68.94 0.14 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.224 1.487 . . . . 0.0 107.807 -177.824 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' ILE . 16.5 mtp85 -101.77 113.34 26.42 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.593 -2.094 . . . . 0.0 110.845 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.32 -35.94 36.25 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.33 -1.414 . . . . 0.0 109.685 179.088 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.22 156.72 45.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.99 178.712 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -84.12 147.07 49.84 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.768 178.656 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.04 -175.83 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.093 1.195 . . . . 0.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.25 -41.22 1.41 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.64 12.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.488 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 28' ' ' TYR . 7.0 m-85 -81.79 15.48 2.19 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.335 -179.69 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.51 11.49 0.29 Allowed Glycine 0 N--CA 1.487 2.046 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.78 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 35.7 m-85 -63.93 167.57 6.06 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 117.84 -1.544 . . . . 0.0 111.189 179.455 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.59 -43.83 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.372 -2.195 . . . . 0.0 106.616 177.882 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.3 p -97.62 125.77 42.55 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.929 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.676 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -160.52 162.98 33.16 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.923 -1.511 . . . . 0.0 112.841 -179.718 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.8 p -116.79 137.25 52.33 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.826 176.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.682 ' CE2' HD12 ' A' ' 38' ' ' ILE . 60.3 m-85 -112.52 120.43 41.58 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.468 -174.42 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -139.69 73.64 1.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.548 179.61 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.493 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -46.64 157.83 0.43 Allowed Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.727 -176.793 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 14.0 Cg_endo -80.99 26.48 4.98 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.442 0.4 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.493 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.2 m-80 -144.74 178.3 8.09 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.463 175.636 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -148.07 148.58 16.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.951 -179.534 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 31.6 m -114.14 151.32 32.83 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 166.342 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.2 t -123.05 137.36 54.96 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.839 -1.144 . . . . 0.0 114.012 -169.354 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.553 ' CE1' ' O ' ' A' ' 12' ' ' ARG . 2.7 m-85 -104.48 176.14 1.89 Allowed Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.631 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 14.9 Cg_exo -52.74 -62.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.501 1.928 0 N-CA-C 117.328 2.011 . . . . 0.0 117.328 4.388 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.603 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 116.265 -1.826 . . . . 0.0 109.6 -170.167 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 4' ' ' CYS . . . -70.71 134.41 86.16 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -177.011 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.23 40.79 0.7 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 165.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -82.24 122.61 28.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -175.796 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.05 177.9 8.45 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.871 -1.532 . . . . 0.0 109.526 179.734 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.63 175.16 9.24 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.642 177.072 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.53 129.27 36.23 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.816 -177.693 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.91 -22.27 6.0 Favored Glycine 0 C--N 1.296 -1.662 0 C-N-CA 119.064 -1.541 . . . . 0.0 110.165 -178.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -110.4 115.41 54.23 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.838 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -76.33 -163.59 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 173.433 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.69 -106.04 2.05 Favored Glycine 0 C--N 1.287 -2.189 0 C-N-CA 118.832 -1.651 . . . . 0.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.622 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 8.2 ptm180 -159.25 177.42 11.05 Favored 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 118.176 -1.41 . . . . 0.0 114.224 -176.325 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -156.61 144.23 10.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 173.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 32.5 m-20 -76.25 124.57 27.69 Favored 'General case' 0 C--O 1.177 -2.719 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.199 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD12 ' SG ' ' A' ' 39' ' ' CYS . 3.2 tt -86.09 111.37 20.27 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.019 -1.872 . . . . 0.0 112.296 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.707 ' HB2' HG23 ' A' ' 38' ' ' ILE . 46.1 m95 -92.65 -178.13 4.78 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 112.25 -2.25 . . . . 0.0 108.864 176.045 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -102.03 -162.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.691 -176.288 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -68.72 66.81 0.13 Allowed 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 122.964 1.364 . . . . 0.0 107.726 -177.672 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' ILE . 1.1 mtt85 -111.54 113.26 25.55 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 112.573 -2.103 . . . . 0.0 110.665 -179.398 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.08 -34.52 16.78 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.42 157.4 45.22 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.305 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -86.03 152.33 55.9 Favored Pre-proline 0 C--N 1.298 -1.633 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.173 179.277 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.98 115.5 2.47 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 120.698 0.932 . . . . 0.0 110.181 174.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.58 -4.87 47.97 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.375 -1.393 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 -0.56 55.87 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.179 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.23 -16.08 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.396 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.75 -3.36 23.02 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.761 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 43.1 m-85 -77.3 169.76 17.75 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.834 1.302 . . . . 0.0 112.471 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.97 -45.37 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 112.055 -2.339 . . . . 0.0 106.345 176.056 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 41' ' ' TYR . 80.2 p -99.38 115.29 28.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.066 -179.37 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -143.54 148.8 36.5 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.935 -179.932 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.5 144.47 33.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.788 176.105 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD12 ' A' ' 38' ' ' ILE . 26.8 m-85 -117.98 133.21 56.14 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.894 -173.005 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -138.72 75.59 1.53 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.957 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.502 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -44.9 155.73 0.39 Allowed Pre-proline 0 C--N 1.307 -1.267 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.46 -177.994 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.459 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 7.3 Cg_endo -78.08 32.92 0.9 Allowed 'Cis proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.5 -1.042 . . . . 0.0 111.571 -4.51 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.502 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -145.07 -160.7 1.17 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.811 177.754 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -161.28 147.76 4.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.918 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 39.1 m -116.88 119.05 34.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.015 168.216 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.613 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.3 t -90.57 139.15 30.98 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.968 -171.501 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 2.6 m-85 -112.12 178.41 0.98 Allowed Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.552 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 15.7 Cg_exo -59.49 -56.64 0.12 OUTLIER 'Cis proline' 0 N--CA 1.502 2.02 0 N-CA-C 116.695 1.767 . . . . 0.0 116.695 4.818 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.622 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.7 0 CA-C-O 116.439 -1.743 . . . . 0.0 109.325 -171.043 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.567 ' HB3' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -39.5 137.86 1.01 Allowed Pre-proline 0 N--CA 1.503 2.187 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.103 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.23 33.7 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 164.249 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 12.7 p -84.98 115.37 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.455 -176.25 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.46 172.7 13.26 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.989 -178.508 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.89 -173.62 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.727 178.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -75.41 118.59 18.45 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.631 -175.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.38 44.87 Favored Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.844 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 28.1 mttt -113.51 109.43 51.01 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.319 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.87 -172.6 1.0 Allowed 'Trans proline' 0 C--N 1.32 -0.927 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 173.222 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.3 -110.57 3.58 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.58 -1.772 . . . . 0.0 110.807 179.079 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.751 HH11 ' HB2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -160.35 168.71 24.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.125 -177.967 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -147.9 157.38 27.32 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 174.268 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.563 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 1.2 m-20 -78.48 130.0 35.53 Favored 'General case' 0 C--O 1.172 -3.005 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.628 178.511 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 13.7 tp -96.08 97.33 9.49 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.923 1.344 . . . . 0.0 111.784 -177.294 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.836 ' HB2' HG23 ' A' ' 38' ' ' ILE . 78.5 m95 -83.08 115.52 21.92 Favored 'General case' 0 C--N 1.263 -3.157 0 CA-C-N 112.063 -2.335 . . . . 0.0 107.494 175.56 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.43 ' O ' HG22 ' A' ' 17' ' ' ILE . 8.2 mt -88.31 -8.85 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 10.9 mt -154.83 71.58 0.81 Allowed 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.674 -173.871 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.591 ' NH2' ' N ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -153.25 162.36 41.39 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 117.592 -1.643 . . . . 0.0 111.95 177.129 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -109.06 -32.48 3.03 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.454 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -136.21 153.94 51.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.412 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -90.74 149.08 39.84 Favored Pre-proline 0 C--N 1.293 -1.855 0 C-N-CA 118.779 -1.168 . . . . 0.0 110.068 -179.195 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.591 ' N ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 Cg_endo -66.83 146.47 78.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.878 1.052 . . . . 0.0 111.665 -178.69 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.68 -16.48 54.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 177.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.39 -9.13 87.25 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.05 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.73 -30.23 18.18 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.623 178.908 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.66 -9.48 12.82 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.227 177.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 45.4 m-85 -63.25 167.17 5.4 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.145 -178.821 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.4 p -162.23 -43.43 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 112.224 -2.262 . . . . 0.0 106.107 177.181 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.8 p -97.38 119.01 35.13 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.4 179.627 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.541 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -156.45 155.19 31.63 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.404 -1.718 . . . . 0.0 113.599 179.91 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 150.27 38.58 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.331 176.474 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 38' ' ' ILE . 36.4 m-85 -118.23 140.83 49.22 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.693 -171.212 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' ASN . 19.3 mttt -134.9 70.75 1.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.835 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -40.68 140.21 1.06 Allowed Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.222 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.89 2.47 14.57 Favored 'Cis proline' 0 N--CA 1.498 1.793 0 C-N-CA 125.319 -0.7 . . . . 0.0 110.425 -6.428 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' C ' HG22 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -93.41 -163.24 1.02 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.898 0.856 . . . . 0.0 112.301 -175.941 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.836 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER 177.5 139.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.081 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.328 178.728 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 36.4 m -110.52 115.42 29.59 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.698 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.616 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -97.49 136.57 37.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.842 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.5 m-85 -107.03 179.49 0.88 Allowed Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.254 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 4.1 Cg_exo -65.45 -52.37 0.15 OUTLIER 'Cis proline' 0 N--CA 1.508 2.347 0 N-CA-C 116.632 1.743 . . . . 0.0 116.632 7.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.751 ' HB2' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.97 0 CA-C-O 116.411 -1.757 . . . . 0.0 109.588 -170.155 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -39.86 145.48 0.45 Allowed Pre-proline 0 N--CA 1.506 2.365 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -176.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.72 30.44 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 107.941 -1.6 . . . . 0.0 107.941 164.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -83.86 123.93 30.43 Favored 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.553 -174.464 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 11' ' ' GLY . 4.0 m-85 -84.52 158.69 20.89 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.378 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -124.83 178.89 5.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.573 178.645 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 127.34 32.38 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.355 -175.431 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.28 54.46 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.887 178.747 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 113.25 18.97 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.637 -179.107 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -70.19 -158.73 0.05 OUTLIER 'Trans proline' 0 C--O 1.217 -0.54 0 C-N-CA 121.204 1.269 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 5' ' ' PHE . . . 70.43 -108.68 2.56 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.849 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' HIS . 1.7 ptp180 -160.09 -176.22 5.53 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.059 177.188 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.684 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -139.39 160.36 25.94 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 3.4 m-20 -78.95 128.85 33.82 Favored 'General case' 0 C--O 1.173 -2.947 0 C-N-CA 118.145 -1.422 . . . . 0.0 108.048 177.695 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.646 ' CB ' ' HB2' ' A' ' 2' ' ' ALA . 22.8 tp -92.77 103.55 15.9 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.951 1.358 . . . . 0.0 112.503 -175.409 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.751 ' HB2' HG23 ' A' ' 38' ' ' ILE . 73.9 m95 -93.05 110.05 21.52 Favored 'General case' 0 C--N 1.267 -2.982 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.701 175.17 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 17' ' ' ILE . 87.1 mt -81.38 -10.53 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -170.261 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 5.4 mt -154.32 78.42 1.09 Allowed 'General case' 0 C--N 1.255 -3.519 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.274 -173.734 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 148.1 11.19 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.454 -1.699 . . . . 0.0 112.219 178.494 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.19 -17.86 28.3 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 177.225 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.75 161.61 39.52 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.608 178.596 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -105.42 150.94 39.55 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.87 179.403 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.22 165.43 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.837 1.024 . . . . 0.0 110.736 175.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.69 -22.13 8.69 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.137 179.62 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.76 83.15 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.193 179.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.5 -13.4 59.13 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.963 179.764 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.47 55.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.091 177.006 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.634 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.9 m-85 -75.75 168.0 20.84 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.241 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 28' ' ' TYR . 3.0 p -162.85 -45.08 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 111.966 -2.379 . . . . 0.0 105.654 175.893 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 14.9 p -98.97 113.51 25.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.893 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -138.0 150.7 47.21 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.522 -1.271 . . . . 0.0 113.215 179.318 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -106.01 151.24 24.88 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.065 176.358 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.702 ' CE2' HD12 ' A' ' 38' ' ' ILE . 34.1 m-85 -129.03 145.31 51.29 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.207 -172.701 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 78.02 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.224 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.447 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -43.76 152.95 0.42 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.426 -175.284 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -73.58 -1.81 14.14 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.444 -1.065 . . . . 0.0 110.64 -5.516 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.888 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.3 OUTLIER -94.16 -166.14 1.44 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.654 1.216 . . . . 0.0 111.524 -178.132 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -172.4 139.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.36 178.772 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 57.7 m -109.7 102.89 11.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 171.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.634 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 1.9 t -79.01 142.97 36.13 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.558 -171.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -116.86 165.45 15.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.553 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -77.31 160.08 94.4 Favored 'Cis proline' 0 C--O 1.214 -0.691 0 CA-C-O 122.771 1.071 . . . . 0.0 114.27 4.249 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.28 -2.432 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.34 177.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -62.88 147.77 93.24 Favored Pre-proline 0 N--CA 1.515 2.806 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 -174.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.96 20.67 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 107.924 -1.606 . . . . 0.0 107.924 163.604 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.9 p -79.95 116.76 20.27 Favored 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.917 -178.551 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -80.89 -167.65 1.49 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.766 -173.383 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -175.98 3.7 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.78 176.674 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m -80.74 115.73 20.39 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.205 -178.626 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.7 -13.74 64.91 Favored Glycine 0 C--N 1.296 -1.668 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.237 -179.415 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -111.72 108.62 55.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -73.14 156.89 51.23 Favored 'Trans proline' 0 CA--C 1.507 -0.866 0 C-N-CA 120.999 1.132 . . . . 0.0 109.372 176.371 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.91 -90.56 0.57 Allowed Glycine 0 N--CA 1.484 1.862 1 N-CA-C 130.544 6.977 . . . . 0.0 130.544 -178.517 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.44 156.59 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.597 178.485 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.761 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -149.74 167.98 29.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 175.647 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -82.54 129.42 34.92 Favored 'General case' 0 C--O 1.178 -2.684 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.809 178.695 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 16.6 tp -96.62 106.6 18.89 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.909 1.338 . . . . 0.0 111.575 -178.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.628 ' HB2' HG23 ' A' ' 38' ' ' ILE . 69.4 m95 -93.47 108.95 20.55 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-N 111.79 -2.459 . . . . 0.0 107.021 176.349 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 17' ' ' ILE . 78.2 mt -83.15 -4.81 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.52 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 mt -151.67 80.24 1.28 Allowed 'General case' 0 C--N 1.253 -3.612 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.604 -174.598 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -172.19 159.37 4.81 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 117.932 -1.507 . . . . 0.0 111.659 177.678 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.67 -26.06 3.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 175.224 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 p -128.99 149.09 50.97 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.191 176.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 153.26 39.65 Favored Pre-proline 0 C--N 1.287 -2.112 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.298 -179.346 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 25' ' ' GLY . 4.9 Cg_exo -55.3 99.15 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.857 1.038 . . . . 0.0 111.099 -178.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.06 6.23 4.13 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.291 -1.433 . . . . 0.0 109.756 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . -100.24 -17.06 25.77 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.42 -86.27 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.976 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.57 -16.51 0.02 OUTLIER Glycine 0 C--N 1.287 -2.153 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.894 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.647 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 36.7 m-85 -56.18 167.16 0.68 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.702 -178.693 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 28' ' ' TYR . 4.8 p -162.89 -43.93 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 112.337 -2.211 . . . . 0.0 106.094 177.453 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 41' ' ' TYR . 78.0 p -96.85 116.99 30.12 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.236 -179.952 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.59 155.28 40.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 117.953 -1.499 . . . . 0.0 113.917 -177.835 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -99.4 158.52 15.67 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 174.851 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.773 ' CE2' HD12 ' A' ' 38' ' ' ILE . 44.0 m-85 -138.58 133.64 32.77 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.909 -176.493 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.79 84.3 0.68 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.766 178.413 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.485 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -49.05 157.34 0.81 Allowed Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.656 -177.469 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' C ' HD22 ' A' ' 37' ' ' ASN . 1.1 Cg_endo -71.16 0.99 7.29 Favored 'Cis proline' 0 C--O 1.206 -1.076 0 C-N-CA 124.277 -1.134 . . . . 0.0 111.042 -3.912 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.944 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.2 OUTLIER -105.74 -165.6 1.12 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.691 1.234 . . . . 0.0 111.774 -177.042 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.773 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -172.25 143.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.131 -1.85 . . . . 0.0 107.314 178.735 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.2 m -113.61 109.58 18.84 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.208 174.228 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.647 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -89.62 140.81 29.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.963 -171.997 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -116.45 169.94 6.51 Favored Pre-proline 0 N--CA 1.503 2.214 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.196 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -81.24 156.49 82.89 Favored 'Cis proline' 0 CA--C 1.507 -0.864 0 CA-C-O 123.03 1.179 . . . . 0.0 114.384 3.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.578 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.979 0 CA-C-N 111.599 -2.546 . . . . 0.0 109.607 174.779 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' HB3' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -66.46 142.9 97.96 Favored Pre-proline 0 N--CA 1.499 2.021 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.394 -177.807 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -84.28 40.51 0.88 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 107.806 -1.652 . . . . 0.0 107.806 166.126 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.93 125.39 29.31 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.847 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.97 168.6 19.64 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.413 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.485 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -127.95 -175.24 3.42 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.951 -179.19 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -74.91 125.52 29.02 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.34 -176.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.53 -2.06 24.69 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.615 -1.278 . . . . 0.0 111.043 178.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -126.4 115.24 23.29 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.94 -179.58 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -78.4 -175.98 3.01 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 108.16 -1.515 . . . . 0.0 108.16 171.05 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.96 -109.08 3.74 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.735 179.171 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.709 ' H ' ' CE1' ' A' ' 43' ' ' HIS . 4.0 ptm180 -159.51 157.29 29.71 Favored 'General case' 0 C--O 1.207 -1.177 0 C-N-CA 118.58 -1.248 . . . . 0.0 112.791 -178.682 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -140.36 143.12 13.14 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.348 176.309 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -77.6 127.87 33.19 Favored 'General case' 0 C--O 1.172 -3.011 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.593 179.69 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.427 HD12 ' H ' ' A' ' 16' ' ' TRP . 51.2 tp -86.1 129.5 34.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.825 -1.55 . . . . 0.0 111.186 -179.505 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CB ' HG23 ' A' ' 38' ' ' ILE . 55.8 m95 -124.59 159.38 30.82 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.102 -178.136 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -84.03 -163.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.452 -177.44 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 70.59 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.131 1.443 . . . . 0.0 108.605 -176.459 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' ILE . 17.8 mtp180 -102.12 133.7 46.54 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.474 178.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' CE2' ' A' ' 33' ' ' TYR . . . -60.23 -53.0 49.25 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.73 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.95 158.74 39.43 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.607 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -78.2 147.94 73.69 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.636 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.35 130.46 39.96 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.775 0.983 . . . . 0.0 111.391 -177.122 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.93 -17.86 58.89 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 178.566 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.98 -14.74 68.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -86.68 -70.54 0.6 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.347 179.632 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.95 -14.12 0.07 OUTLIER Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.128 -1.511 . . . . 0.0 111.751 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.624 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 51.4 m-85 -56.25 169.33 0.43 Allowed 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 122.656 1.217 . . . . 0.0 111.778 -179.385 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 28' ' ' TYR . 7.3 p -162.57 -45.43 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 112.298 -2.228 . . . . 0.0 106.604 177.131 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 41' ' ' TYR . 82.9 p -98.37 112.13 24.24 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 112.89 -1.959 . . . . 0.0 110.082 -178.693 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.631 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -148.16 156.28 42.41 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.584 -1.246 . . . . 0.0 112.712 -179.092 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 145.76 40.39 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.575 177.771 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.662 ' CE2' HD12 ' A' ' 38' ' ' ILE . 20.6 m-85 -118.82 126.55 52.08 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.874 -172.525 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 16.7 mttt -122.77 67.19 0.96 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.301 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.458 ' CA ' ' H ' ' A' ' 37' ' ' ASN . 33.3 t-105 -34.8 142.69 0.23 Allowed Pre-proline 0 N--CA 1.496 1.85 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.405 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.42 44.33 0.32 Allowed 'Cis proline' 0 N--CA 1.494 1.537 0 C-N-CA 125.62 -0.575 . . . . 0.0 111.487 -5.564 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.469 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -150.79 -157.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.329 178.15 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.662 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -173.95 138.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.99 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.681 -179.892 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 49.1 m -110.76 123.86 50.87 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 117.463 -1.695 . . . . 0.0 106.518 168.535 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.624 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 2.9 t -94.03 141.62 28.33 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.711 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 1.8 m-85 -114.23 179.71 0.74 Allowed Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 176.722 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.535 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 6.0 Cg_exo -57.34 -56.15 0.09 OUTLIER 'Cis proline' 0 N--CA 1.503 2.054 0 CA-C-N 122.434 1.905 . . . . 0.0 116.95 6.065 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.709 ' CE1' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.475 0 CA-C-O 116.282 -1.818 . . . . 0.0 109.182 -170.669 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.655 ' HB3' HH22 ' A' ' 12' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -43.49 146.5 0.92 Allowed Pre-proline 0 N--CA 1.514 2.764 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -175.155 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -84.17 21.87 1.01 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 N-CA-C 107.793 -1.657 . . . . 0.0 107.793 164.245 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 1.7 p -83.51 118.33 23.71 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.083 -176.788 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -175.42 4.69 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.213 -176.043 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -123.38 -174.44 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 177.308 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.89 110.52 15.33 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.609 -178.313 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.68 73.14 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.517 179.715 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.2 112.79 34.36 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.435 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -71.75 -159.26 0.07 OUTLIER 'Trans proline' 0 C--O 1.213 -0.77 0 N-CA-C 109.144 -1.137 . . . . 0.0 109.144 173.376 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.0 -106.21 2.43 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.901 177.966 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.726 ' HE ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -162.54 177.23 9.64 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.096 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.726 ' N ' ' HE ' ' A' ' 12' ' ' ARG . . . -154.07 175.83 32.17 Favored Glycine 0 N--CA 1.504 3.17 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.469 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.5 m-20 -91.12 126.13 36.12 Favored 'General case' 0 C--O 1.182 -2.465 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.817 177.683 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 13.7 tp -97.12 102.61 14.42 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.038 1.399 . . . . 0.0 111.958 -177.398 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.841 ' HB2' HG23 ' A' ' 38' ' ' ILE . 79.3 m95 -88.98 123.97 33.82 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-N 111.758 -2.473 . . . . 0.0 107.112 175.854 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 17' ' ' ILE . 51.3 mt -90.4 -7.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.247 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -168.888 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -150.36 74.83 1.2 Allowed 'General case' 0 C--N 1.254 -3.558 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.264 -173.354 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.63 151.21 1.85 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.559 178.366 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.597 ' CA ' ' HE1' ' A' ' 35' ' ' TRP . . . -101.98 -24.41 8.58 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 173.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 157.13 38.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.565 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -82.28 172.55 9.31 Favored Pre-proline 0 CA--C 1.58 2.109 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.065 -178.38 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 22' ' ' CYS . 2.8 Cg_exo -52.22 -139.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.085 2.524 . . . . 0.0 114.557 -170.692 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.87 114.23 2.57 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 176.189 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.94 80.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.25 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' HD1' ' H ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -100.34 -51.53 3.62 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 122.15 0.976 . . . . 0.0 111.606 -175.892 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' H ' ' HD1' ' A' ' 26' ' ' TYR . . . 138.96 -19.23 3.11 Favored Glycine 0 C--N 1.281 -2.515 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 -174.126 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.587 ' O ' HG23 ' A' ' 29' ' ' THR . 33.8 m-85 -72.74 173.95 8.34 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 122.558 1.171 . . . . 0.0 111.339 177.967 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' TYR . 2.0 p -162.05 -42.66 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 112.615 -2.084 . . . . 0.0 106.133 177.172 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 41' ' ' TYR . 2.4 p -96.69 126.28 41.75 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.031 178.178 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -154.74 153.2 30.87 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 117.644 -1.622 . . . . 0.0 113.832 -179.422 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 1.4 p -114.24 153.87 28.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.781 174.961 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.833 ' CD2' HD12 ' A' ' 38' ' ' ILE . 14.7 m-85 -130.95 130.86 43.97 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.955 -175.701 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -134.67 74.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.577 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HE1' ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -46.1 153.49 0.68 Allowed Pre-proline 0 C--N 1.298 -1.671 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.48 -174.419 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.5 -0.18 12.67 Favored 'Cis proline' 0 C--O 1.204 -1.223 0 C-N-CA 124.11 -1.204 . . . . 0.0 110.842 -4.195 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.91 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.3 OUTLIER -96.43 -168.12 1.68 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.952 0.882 . . . . 0.0 110.758 -179.008 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -169.38 141.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 114.372 -1.285 . . . . 0.0 108.679 -179.882 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 56.5 m -110.05 97.21 6.76 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.209 -1.396 . . . . 0.0 107.553 172.958 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.583 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -81.36 127.95 33.31 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.587 -173.348 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -100.04 171.62 5.39 Favored Pre-proline 0 N--CA 1.514 2.757 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.222 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 41' ' ' TYR . 11.1 Cg_endo -84.36 158.1 68.52 Favored 'Cis proline' 0 CA--C 1.507 -0.83 0 CA-C-O 123.246 1.269 . . . . 0.0 114.643 1.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.584 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.914 0 CA-C-N 111.271 -2.695 . . . . 0.0 109.744 174.435 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -70.19 155.12 93.97 Favored Pre-proline 0 N--CA 1.511 2.603 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.049 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -90.43 31.32 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 109.039 -1.177 . . . . 0.0 109.039 166.763 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.34 130.57 36.33 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -175.218 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.52 165.48 23.68 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.313 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -110.93 180.0 3.89 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.326 177.275 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.1 103.14 13.84 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.118 -178.659 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.01 -10.04 18.16 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -178.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.06 117.42 9.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.958 -179.05 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -78.11 170.24 19.05 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 N-CA-C 108.534 -1.372 . . . . 0.0 108.534 172.09 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.57 -96.35 1.06 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.795 178.803 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.78 152.25 19.34 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.556 -1.657 . . . . 0.0 114.455 -178.143 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -138.28 155.31 23.37 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 174.312 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.651 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -79.52 119.13 22.07 Favored 'General case' 0 C--O 1.169 -3.161 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.365 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 17.0 tp -85.77 93.3 8.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.889 -177.654 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.811 ' HB2' HG23 ' A' ' 38' ' ' ILE . 72.6 m95 -74.24 126.33 30.38 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 112.706 -2.043 . . . . 0.0 107.106 172.211 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 17' ' ' ILE . 11.6 mt -94.41 -8.84 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -169.723 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -152.71 55.64 0.79 Allowed 'General case' 0 C--N 1.261 -3.25 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 -173.602 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.53 ' HB3' HG21 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -133.96 157.08 46.96 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.563 -179.327 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.55 -32.32 2.15 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 174.262 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.27 150.43 52.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.58 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -85.92 145.18 40.51 Favored Pre-proline 0 C--N 1.284 -2.264 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.737 -178.861 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.96 -174.76 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.528 0 C-N-CA 120.865 1.043 . . . . 0.0 111.323 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.06 13.3 9.09 Favored Glycine 0 N--CA 1.484 1.889 1 N-CA-C 128.912 6.325 . . . . 0.0 128.912 177.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.35 -14.73 27.33 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -79.42 -21.17 45.93 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.126 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.46 61.23 Favored Glycine 0 C--N 1.292 -1.862 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.086 179.326 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CG ' ' SG ' ' A' ' 40' ' ' CYS . 43.5 m-85 -56.43 164.34 1.42 Allowed 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 117.967 -1.493 . . . . 0.0 110.934 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -163.16 -45.06 0.03 OUTLIER 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 112.41 -2.177 . . . . 0.0 106.112 177.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.7 p -99.73 110.7 23.08 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 112.651 -2.068 . . . . 0.0 109.385 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.678 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -142.84 147.15 34.93 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.338 -1.345 . . . . 0.0 113.349 -179.007 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 14.5 p -99.57 143.7 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.2 175.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.849 ' CE2' HD12 ' A' ' 38' ' ' ILE . 61.8 m-85 -119.58 139.12 52.66 Favored 'General case' 0 C--N 1.275 -2.64 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.86 -173.273 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 35' ' ' TRP . 20.6 mttt -137.07 60.91 1.64 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.145 176.742 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' LYS . 1.2 t90 -35.06 143.67 0.23 Allowed Pre-proline 0 N--CA 1.497 1.886 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.079 -177.901 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.17 -1.3 10.47 Favored 'Cis proline' 0 N--CA 1.486 1.07 0 C-N-CA 125.106 -0.789 . . . . 0.0 111.469 -4.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.69 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -95.55 -162.44 0.95 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.546 0.689 . . . . 0.0 110.881 -178.416 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.849 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER 175.66 137.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.852 -179.414 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 20.6 m -107.65 121.6 45.01 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 117.718 -1.593 . . . . 0.0 106.976 170.174 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CG ' ' A' ' 28' ' ' TYR . 4.3 t -100.27 139.17 36.32 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -169.305 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.577 ' HH ' ' HD1' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -115.31 166.01 12.96 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.268 177.756 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.69 160.32 87.65 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 CA-C-O 122.842 1.101 . . . . 0.0 113.918 5.327 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.577 ' HD1' ' HH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.277 -2.573 0 CA-C-N 112.155 -2.293 . . . . 0.0 109.679 176.124 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.86 156.23 7.04 Favored Pre-proline 0 N--CA 1.503 2.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.019 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -91.15 27.84 0.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.3 1.333 . . . . 0.0 108.825 167.443 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.596 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -70.39 126.21 28.99 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.802 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -77.47 166.95 22.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 117.712 -1.595 . . . . 0.0 110.653 -177.188 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.52 -179.39 4.75 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.639 0.733 . . . . 0.0 110.203 179.12 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 9' ' ' LYS . 86.2 p -72.1 142.48 49.19 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.427 -179.081 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.86 -10.76 1.07 Allowed Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.634 178.642 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 7' ' ' SER . 4.5 mttt -136.48 113.26 10.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.484 -179.409 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -77.1 -165.72 0.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 N-CA-C 108.364 -1.437 . . . . 0.0 108.364 172.795 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -88.1 1.55 Allowed Glycine 0 C--N 1.289 -2.078 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.05 176.447 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.532 ' O ' ' CZ ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -160.65 154.64 22.81 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 117.827 -1.549 . . . . 0.0 114.069 -175.476 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -143.1 149.98 21.88 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 172.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -76.71 125.64 29.61 Favored 'General case' 0 C--O 1.17 -3.121 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.85 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.63 110.83 20.68 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 116.925 -1.91 . . . . 0.0 112.274 -177.983 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.67 ' CB ' HG23 ' A' ' 38' ' ' ILE . 58.0 m95 -96.23 175.51 6.42 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 112.471 -2.15 . . . . 0.0 109.201 176.64 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -102.38 -158.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.769 -176.854 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -66.69 73.49 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.741 1.734 . . . . 0.0 108.201 -176.374 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 17' ' ' ILE . 46.2 mtt-85 -133.82 97.01 3.79 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.845 178.994 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.45 -5.05 0.68 Allowed Glycine 0 N--CA 1.486 1.984 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.608 -179.646 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 19' ' ' ARG . 1.6 p -137.53 151.9 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.221 179.823 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -103.8 142.86 25.46 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.3 179.108 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' CG ' ' CH2' ' A' ' 16' ' ' TRP . 5.8 Cg_exo -55.88 144.64 76.87 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.004 1.136 . . . . 0.0 111.305 179.595 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.79 -2.75 78.12 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.706 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.49 -19.76 70.6 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.587 -179.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -87.09 -12.04 48.38 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.027 -179.168 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.89 76.66 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.452 -1.356 . . . . 0.0 112.612 176.639 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.628 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 46.9 m-85 -56.48 174.14 0.15 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.213 179.36 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.1 p -161.61 -43.67 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.666 -2.061 . . . . 0.0 106.335 175.783 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 41' ' ' TYR . 1.3 p -97.21 133.9 41.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.558 179.335 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.632 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -160.04 157.28 28.39 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.849 178.78 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.41 ' O ' HG13 ' A' ' 38' ' ' ILE . 19.7 p -113.34 142.74 45.5 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.995 176.139 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.797 ' CD2' HD12 ' A' ' 38' ' ' ILE . 11.9 m-85 -120.44 125.31 47.61 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.272 -174.023 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -146.12 81.67 1.59 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.707 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.452 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -40.06 157.78 0.15 Allowed Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.461 179.672 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 8.4 Cg_endo -78.34 28.68 1.78 Allowed 'Cis proline' 0 C--O 1.21 -0.903 0 C-N-CA 124.227 -1.156 . . . . 0.0 110.751 -5.209 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.456 ' HA ' ' C ' ' A' ' 17' ' ' ILE . 4.0 m-80 -145.01 -170.26 3.38 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.797 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -154.41 150.12 12.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.773 178.822 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 13.2 m -116.66 158.66 23.42 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 166.282 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.7 t -130.52 147.18 52.18 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.518 -1.273 . . . . 0.0 114.103 -170.189 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 1.6 m-85 -118.53 166.91 12.68 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.404 179.734 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.44 158.53 97.26 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 CA-C-O 122.679 1.033 . . . . 0.0 113.94 4.599 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.503 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.502 0 CA-C-N 112.359 -2.201 . . . . 0.0 110.121 177.898 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -52.41 143.33 27.34 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.312 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -81.61 35.27 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 166.179 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -76.39 123.23 25.65 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.779 -1.168 . . . . 0.0 108.357 -175.25 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -79.08 179.62 7.24 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.151 -1.42 . . . . 0.0 108.778 179.424 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.82 -179.29 6.11 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.794 -1.162 . . . . 0.0 111.021 178.561 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 p -74.07 128.27 35.08 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.293 -176.146 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -8.48 3.99 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.005 178.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.51 107.08 41.4 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.18 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -72.07 -173.51 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.078 1.185 . . . . 0.0 109.854 174.717 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.69 -112.36 3.84 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.288 178.291 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.58 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 4.3 ptm180 -152.56 166.25 32.61 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.503 -177.18 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -141.68 146.78 18.11 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 174.356 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -77.12 117.82 19.06 Favored 'General case' 0 C--O 1.179 -2.615 0 C-N-CA 118.989 -1.085 . . . . 0.0 108.272 178.896 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.21 112.59 19.99 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 116.387 -2.125 . . . . 0.0 112.441 -178.684 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.702 ' CB ' HG23 ' A' ' 38' ' ' ILE . 57.2 m95 -94.71 174.26 7.19 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 112.144 -2.298 . . . . 0.0 106.659 173.15 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.691 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -96.56 -158.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 C-N-CA 118.651 -1.219 . . . . 0.0 113.02 -174.376 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.94 72.91 0.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 123.619 1.676 . . . . 0.0 108.221 -177.063 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ILE . 5.2 mtp85 -131.84 97.53 4.21 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 111.637 -2.529 . . . . 0.0 109.729 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.53 -22.98 1.18 Allowed Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.019 -179.516 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.427 ' N ' ' C ' ' A' ' 19' ' ' ARG . 1.1 p -130.4 152.31 49.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.983 179.524 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 173.07 8.09 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.35 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 14.9 Cg_endo -67.0 98.9 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.576 1.517 . . . . 0.0 113.364 -174.614 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' PRO . . . -30.85 101.11 0.01 OUTLIER Glycine 0 N--CA 1.512 3.758 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.573 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.78 68.58 0.66 Allowed Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.703 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -117.52 -172.56 2.25 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.189 0.519 . . . . 0.0 110.683 -177.471 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.86 -18.3 54.64 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 172.784 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 23.1 m-85 -69.94 177.72 3.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.956 1.36 . . . . 0.0 112.476 178.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.7 p -161.55 -44.36 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.759 -2.473 . . . . 0.0 105.475 176.4 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -98.21 114.69 27.02 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.751 178.517 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.541 ' HA ' ' H ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.52 151.85 49.87 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 118.55 -1.26 . . . . 0.0 112.819 178.558 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.35 146.18 43.56 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.766 176.721 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.882 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.2 m-85 -126.27 136.21 52.5 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.222 -174.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -147.12 79.79 1.51 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.588 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.445 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -42.75 159.05 0.21 Allowed Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.135 -178.154 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 10.1 Cg_endo -81.15 32.29 2.28 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.542 -1.024 . . . . 0.0 111.635 -3.725 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' C ' ' A' ' 36' ' ' PRO . 2.0 m-80 -148.98 171.17 16.79 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.411 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.882 HD12 ' CD2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -131.62 152.31 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.832 178.35 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 28.9 m -123.46 110.23 14.84 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.014 -1.475 . . . . 0.0 107.523 167.58 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -83.79 133.41 34.77 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.02 -174.31 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -102.89 -173.85 0.31 Allowed Pre-proline 0 N--CA 1.517 2.919 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.647 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 8.8 Cg_exo -62.56 -48.58 0.18 OUTLIER 'Cis proline' 0 N--CA 1.508 2.348 0 CA-C-N 122.653 1.983 . . . . 0.0 116.497 3.958 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.608 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -2.987 0 CA-C-O 116.481 -1.724 . . . . 0.0 109.244 -171.382 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 15' ' ' LEU . . . -49.8 146.8 7.13 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -176.517 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -81.22 27.77 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 N-CA-C 108.022 -1.569 . . . . 0.0 108.022 164.001 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.3 p -87.95 120.3 29.15 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.097 -177.608 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.658 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -82.52 -175.13 5.58 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.111 -173.379 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.44 -176.39 5.57 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.703 176.073 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.7 t -78.92 113.34 16.94 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.584 -177.728 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.23 67.58 Favored Glycine 0 C--N 1.296 -1.65 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.374 -179.967 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -112.25 136.01 21.37 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.802 -178.904 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 9' ' ' LYS . 2.9 Cg_exo -48.74 -166.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.602 2.201 . . . . 0.0 114.244 -173.063 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.94 24.73 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.062 -174.543 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 10' ' ' PRO . 8.2 ptm180 -161.36 146.91 13.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 116.695 -2.002 . . . . 0.0 114.612 176.862 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 2' ' ' ALA . . . -160.65 173.59 37.2 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 176.088 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 2.7 m-20 -84.31 135.0 34.49 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.974 179.89 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.63 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 36.3 tp -96.59 133.62 40.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.358 1.075 . . . . 0.0 110.114 -179.62 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.622 ' CB ' HG23 ' A' ' 38' ' ' ILE . 64.9 m95 -135.08 151.37 50.69 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 112.899 -1.955 . . . . 0.0 108.047 -177.483 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.891 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -78.56 -157.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.835 -175.562 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -67.74 67.44 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.017 1.389 . . . . 0.0 108.235 -176.8 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -103.82 112.16 25.0 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.102 -178.972 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -23.52 57.18 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.382 -1.39 . . . . 0.0 109.789 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.85 156.47 40.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.982 178.631 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -91.65 149.82 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.918 179.263 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.91 128.52 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.972 1.115 . . . . 0.0 111.452 -177.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.36 6.95 55.87 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.01 179.489 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.51 -7.23 16.44 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.386 -179.975 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -79.55 -35.77 39.37 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.798 179.604 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.93 -13.07 6.44 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.642 178.367 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 42.9 m-85 -60.7 170.55 1.42 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.744 -179.136 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 28' ' ' TYR . 10.3 p -161.46 -44.96 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 112.319 -2.219 . . . . 0.0 106.038 178.438 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -97.4 129.8 44.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.714 179.379 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -159.82 157.3 28.99 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.922 -1.511 . . . . 0.0 112.438 178.266 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 142.19 47.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.141 177.173 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.695 ' CE2' HD12 ' A' ' 38' ' ' ILE . 21.3 m-85 -117.77 124.62 48.89 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.813 -172.735 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.9 81.06 1.67 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.195 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.449 ' CG ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.98 159.62 0.13 Allowed Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.883 -178.775 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 6.1 Cg_endo -77.76 23.06 3.76 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.127 -1.197 . . . . 0.0 110.721 -5.208 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.44 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.8 m-80 -140.76 175.76 9.35 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.968 179.663 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -136.2 145.83 30.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.523 177.355 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 34.9 m -115.07 115.69 27.21 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 117.688 -1.605 . . . . 0.0 107.087 169.844 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.607 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -87.91 160.37 17.97 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.598 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 30' ' ' SER . 5.7 m-85 -132.62 161.9 60.56 Favored Pre-proline 0 N--CA 1.484 1.262 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.139 179.185 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -85.95 160.32 58.35 Favored 'Cis proline' 0 C--N 1.325 -0.708 0 N-CA-C 115.209 1.196 . . . . 0.0 115.209 5.412 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.038 0 CA-C-N 112.02 -2.354 . . . . 0.0 109.588 175.57 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.551 ' HB1' ' N ' ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . . . -42.06 140.04 1.61 Allowed Pre-proline 0 N--CA 1.503 2.222 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.187 -178.658 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.88 51.9 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 170.962 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -69.26 141.36 54.41 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -174.396 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -78.38 173.29 12.49 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 117.984 -1.486 . . . . 0.0 108.909 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.33 -168.18 1.28 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.191 -178.656 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 9' ' ' LYS . 4.5 m -65.35 113.63 4.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.107 -177.991 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.8 -3.12 0.73 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 119.68 -1.247 . . . . 0.0 110.807 179.131 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 7' ' ' SER . 22.3 mttt -93.81 120.95 65.46 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 118.296 -1.362 . . . . 0.0 111.156 -178.99 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -71.11 155.93 60.51 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 N-CA-C 109.386 -1.044 . . . . 0.0 109.386 174.321 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.17 -116.54 3.55 Favored Glycine 0 N--CA 1.482 1.724 1 N-CA-C 129.591 6.596 . . . . 0.0 129.591 -178.008 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.62 ' HE ' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -160.9 149.33 16.21 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.627 -1.229 . . . . 0.0 112.343 178.683 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . -135.3 158.26 23.55 Favored Glycine 0 C--O 1.195 -2.297 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 172.909 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -77.61 113.63 15.64 Favored 'General case' 0 C--O 1.176 -2.776 0 C-N-CA 118.364 -1.334 . . . . 0.0 108.245 178.871 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 5.4 tt -83.35 85.74 7.18 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 116.715 -1.994 . . . . 0.0 112.826 -176.461 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.846 ' HB2' HG23 ' A' ' 38' ' ' ILE . 68.6 m95 -59.43 131.06 49.82 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.199 171.861 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.37 -5.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.017 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -171.021 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 mt -148.92 57.24 1.03 Allowed 'General case' 1 C--N 1.241 -4.115 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.335 -173.399 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -159.95 164.16 33.61 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.406 -1.718 . . . . 0.0 112.315 179.798 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.02 -16.24 5.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 176.144 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 155.5 40.54 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.668 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -103.13 144.44 28.64 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.062 178.518 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.94 130.68 41.13 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.777 0.984 . . . . 0.0 111.516 -178.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.2 -18.5 78.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 177.941 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -13.43 83.64 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -79.54 -62.04 1.81 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.053 179.933 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.77 -15.19 0.81 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 118.892 -1.623 . . . . 0.0 111.994 178.316 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.626 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 37.8 m-85 -61.44 170.52 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.708 1.242 . . . . 0.0 112.423 -178.704 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -160.89 -44.87 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 112.123 -2.308 . . . . 0.0 105.917 177.612 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 41' ' ' TYR . 67.9 p -96.04 113.0 24.57 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.859 179.222 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -149.27 151.24 33.88 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.217 -1.393 . . . . 0.0 113.582 -177.422 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -101.16 140.88 34.84 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.3 175.025 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.843 ' CD2' HD12 ' A' ' 38' ' ' ILE . 72.9 m-85 -120.76 134.8 55.27 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.405 -174.125 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -149.43 66.89 1.01 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.938 178.779 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.455 ' C ' ' CD1' ' A' ' 35' ' ' TRP . 12.1 t-105 -30.55 147.22 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.01 178.564 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 1.6 Cg_endo -71.37 2.74 6.77 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 C-N-CA 125.368 -0.68 . . . . 0.0 112.31 -5.321 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.561 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -110.19 -165.37 1.0 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.945 0.879 . . . . 0.0 111.693 -176.941 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.846 HG23 ' HB2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -178.26 130.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.349 179.541 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -108.42 109.44 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.526 -1.67 . . . . 0.0 107.349 174.202 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 2.8 t -87.93 134.72 33.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.484 -2.143 . . . . 0.0 114.214 -168.602 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.54 ' CZ ' ' ND1' ' A' ' 43' ' ' HIS . 1.7 m-85 -106.56 -178.53 0.6 Allowed Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 178.086 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.536 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 16.3 Cg_exo -55.85 -59.26 0.03 OUTLIER 'Cis proline' 0 N--CA 1.506 2.255 0 N-CA-C 117.618 2.122 . . . . 0.0 117.618 5.981 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.499 0 CA-C-O 116.337 -1.792 . . . . 0.0 108.924 -169.31 . . . . . . . . 2 2 . 1 stop_ save_